data_2kla_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kla _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -131.07 138.09 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 65.25 52.02 1.52 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.442 2.297 . . . . 0.0 113.254 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 ttt -82.87 154.53 24.58 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.245 168.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 15.6 mtpp -147.73 121.8 9.48 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.62 156.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.595 1.089 . . . . 0.0 108.902 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.47 118.1 35.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.543 1.137 . . . . 0.0 108.25 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.37 129.43 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.6 p -79.49 104.79 10.34 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.985 1.314 . . . . 0.0 109.576 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.92 151.74 22.11 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.174 -0.954 . . . . 0.0 111.011 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.36 -85.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.42 -39.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 O-C-N 119.883 -1.76 . . . . 0.0 108.238 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.74 3.35 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 -178.63 5.91 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.584 -1.323 . . . . 0.0 110.371 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.2 mt -53.58 127.52 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.746 1.619 . . . . 0.0 109.807 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.1 p -72.41 161.42 30.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.981 0.912 . . . . 0.0 110.248 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.93 -41.24 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -157.46 161.07 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -58.2 -42.58 86.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.353 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -15.33 57.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.052 1.741 . . . . 0.0 113.179 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.12 10.03 8.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.924 0.89 . . . . 0.0 112.734 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 p -64.9 160.71 19.94 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.652 -1.28 . . . . 0.0 109.616 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -107.55 -29.85 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.227 1.411 . . . . 0.0 107.886 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -153.55 167.0 30.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.755 0.788 . . . . 0.0 109.821 167.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -104.58 126.58 51.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.704 2.002 . . . . 0.0 108.063 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.13 113.89 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 166.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -83.32 105.03 12.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.96 141.91 14.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -117.12 123.45 46.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.046 1.739 . . . . 0.0 106.523 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 mt -124.02 136.4 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -136.03 -6.72 2.1 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.036 -173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.08 67.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.22 5.34 0.11 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.889 2.076 . . . . 0.0 115.201 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -134.2 152.62 51.91 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.366 1.466 . . . . 0.0 109.231 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.16 108.13 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.42 1.888 . . . . 0.0 109.393 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -96.62 -6.11 37.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.665 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 p -170.83 179.55 3.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.299 1.409 . . . . 0.0 111.069 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -147.93 168.48 22.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.402 1.081 . . . . 0.0 111.002 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.68 153.98 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 109.559 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.79 115.91 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.85 109.51 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -59.54 155.9 14.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.718 1.144 . . . . 0.0 109.92 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.07 65.93 0.89 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.222 0.609 . . . . 0.0 112.225 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -136.43 81.53 1.89 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.1 -72.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.403 1.881 . . . . 0.0 113.713 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -56.21 -25.93 49.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.234 1.813 . . . . 0.0 111.063 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -61.57 7.0 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 125.198 1.38 . . . . 0.0 111.813 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -58.0 -36.48 72.72 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.144 0.978 . . . . 0.0 110.87 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -52.3 -47.31 66.0 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 111.006 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.6 m -63.09 -37.93 89.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.252 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.9 mt -52.54 -38.16 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.485 1.114 . . . . 0.0 110.202 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -59.72 -48.94 85.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.54 -0.725 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -82.09 -14.14 56.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.39 1.076 . . . . 0.0 112.442 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 28.5 mm-40 -64.28 -23.14 67.19 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.775 1.17 . . . . 0.0 111.206 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 55.4 54.97 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.437 1.095 . . . . 0.0 109.681 -170.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.66 147.61 8.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.917 0.887 . . . . 0.0 109.286 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -78.53 -48.18 15.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.502 1.921 . . . . 0.0 110.099 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.43 158.48 41.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.199 0.6 . . . . 0.0 112.289 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.1 mt -110.77 147.02 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.98 135.59 60.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.2 p -155.47 161.21 41.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.655 1.182 . . . . 0.0 109.691 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -73.29 -36.42 66.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.241 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.71 165.97 33.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.257 1.39 . . . . 0.0 109.098 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 tt -140.28 153.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 107.845 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.2 p -77.1 150.86 35.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.584 0.353 . . . . 0.0 110.45 163.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -58.55 -45.11 89.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.771 0.828 . . . . 0.0 110.257 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.98 -50.43 72.13 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.924 -0.485 . . . . 0.0 111.171 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.24 -35.99 81.85 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.747 0.419 . . . . 0.0 109.984 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -54.65 -54.69 38.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.396 0.543 . . . . 0.0 110.215 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -58.39 -26.3 63.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 111.659 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -71.46 -62.15 1.51 Allowed 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.014 0.824 . . . . 0.0 110.205 171.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -77.27 -25.96 51.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.779 -164.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -73.53 30.77 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.735 2.014 . . . . 0.0 112.621 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.84 13.7 13.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.449 1.9 . . . . 0.0 111.575 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 mttt 179.11 -11.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.012 2.125 . . . . 0.0 113.172 164.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -116.39 128.98 73.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -77.42 121.84 24.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.537 1.135 . . . . 0.0 108.44 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.5 mt -100.08 127.39 53.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -118.32 154.61 32.05 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.254 1.422 . . . . 0.0 110.252 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.39 135.47 33.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.415 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.36 151.76 46.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 160.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -125.77 24.03 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.778 2.431 . . . . 0.0 109.428 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.09 -169.84 42.29 Favored Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.837 -1.164 . . . . 0.0 112.325 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.97 -21.55 9.45 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.961 2.105 . . . . 0.0 108.335 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.07 104.25 6.51 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.8 -40.64 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.81 -35.83 70.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.986 0.812 . . . . 0.0 110.265 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -61.17 -39.76 91.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.371 -0.831 . . . . 0.0 110.642 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -73.92 -27.28 60.95 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.179 -0.95 . . . . 0.0 111.276 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.65 -52.09 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p -58.64 -44.58 90.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 111.241 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.6 mt -61.92 -37.66 85.48 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.644 -0.66 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -70.1 -39.48 75.51 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.536 -0.728 . . . . 0.0 111.842 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.33 -44.2 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.648 1.179 . . . . 0.0 109.226 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.06 -16.03 45.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 19.92 63.73 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.009 0.822 . . . . 0.0 112.41 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.28 -22.56 60.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 111.916 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.52 137.7 54.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.86 0.754 . . . . 0.0 110.224 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.4 m -69.27 126.36 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.543 1.537 . . . . 0.0 111.809 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -74.7 119.21 18.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.672 1.189 . . . . 0.0 108.632 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.242 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tpt . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.3 mt -132.06 145.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 73.3 11.42 4.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.375 1.47 . . . . 0.0 114.27 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.4 ' HE3' ' CZ ' ' A' ' 93' ' ' PHE . 2.7 tpp -74.51 145.7 43.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.585 1.084 . . . . 0.0 110.146 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -131.91 144.22 50.69 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.827 1.251 . . . . 0.0 107.734 161.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -136.45 143.81 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.593 1.157 . . . . 0.0 108.434 172.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.54 124.37 44.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.935 0.894 . . . . 0.0 109.243 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.5 125.89 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 108.167 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -83.07 96.34 8.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.218 1.009 . . . . 0.0 110.747 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.5 mtp -94.3 164.94 12.82 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.121 1.368 . . . . 0.0 111.174 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.97 -60.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.375 1.47 . . . . 0.0 108.946 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -142.95 -68.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -132.4 9.03 4.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.631 1.205 . . . . 0.0 112.479 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -155.35 173.09 17.14 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.041 2.536 . . . . 0.0 107.954 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.67 147.48 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -81.57 -85.26 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.831 0.852 . . . . 0.0 111.097 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -174.58 -39.09 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.373 1.469 . . . . 0.0 108.714 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -145.66 -171.29 3.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.013 0.37 . . . . 0.0 111.526 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -95.01 -8.09 37.83 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.398 1.879 . . . . 0.0 111.244 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 6.15 10.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 112.095 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -137.47 0.75 2.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.711 1.604 . . . . 0.0 109.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 p -76.46 166.62 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.126 0.97 . . . . 0.0 110.989 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -101.98 -35.77 8.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.418 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -154.31 173.59 15.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.837 0.827 . . . . 0.0 110.518 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -116.9 113.41 22.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 128.047 2.539 . . . . 0.0 106.676 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.38 108.36 13.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.7 94.66 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 145.3 12.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 166.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -134.12 123.49 24.52 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.0 mt -118.0 128.26 75.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -126.88 -19.07 4.53 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -155.76 74.04 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 162.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.43 10.78 1.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.6 2.36 . . . . 0.0 114.146 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -137.69 161.49 36.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.637 2.375 . . . . 0.0 110.085 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.99 115.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -117.28 -17.95 10.04 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.835 -1.166 . . . . 0.0 112.667 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -149.79 162.67 39.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.744 1.156 . . . . 0.0 108.752 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -144.38 160.54 40.87 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.942 1.297 . . . . 0.0 108.357 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.5 155.68 42.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.354 1.861 . . . . 0.0 107.703 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.9 t -111.78 145.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 168.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mt -135.08 109.5 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.24 146.94 14.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.043 0.838 . . . . 0.0 110.55 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.51 82.22 3.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.51 172.39 12.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 129.734 3.214 . . . . 0.0 104.586 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.39 -40.48 95.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.28 -0.887 . . . . 0.0 113.389 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.0 t -67.84 -21.35 65.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -67.78 1.99 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.461 1.13 . . . . 0.0 111.471 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -59.45 -54.66 44.06 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.9 1.227 . . . . 0.0 109.183 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -54.77 -39.69 68.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.379 0.672 . . . . 0.0 111.114 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mt -57.45 -46.71 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.014 0.825 . . . . 0.0 110.749 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -57.2 -39.57 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.571 0.623 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.3 7.86 30.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.198 0.999 . . . . 0.0 112.612 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.54 152.15 21.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.758 1.163 . . . . 0.0 108.915 172.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.73 43.65 0.34 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.783 1.233 . . . . 0.0 110.715 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.85 137.6 24.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 166.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.25 -36.76 14.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.44 159.95 41.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.251 0.62 . . . . 0.0 109.629 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.26 142.66 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.8 mt -107.56 131.29 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 167.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.1 p -150.69 158.04 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 167.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -72.96 -44.17 61.44 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.128 163.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -135.55 155.17 50.92 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 tt -153.21 119.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -59.94 146.79 41.1 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.199 0.6 . . . . 0.0 109.569 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.402 ' HG2' ' HZ3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -52.79 -47.64 67.42 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.395 2.278 . . . . 0.0 111.545 -172.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -25.47 67.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.969 0.508 . . . . 0.0 111.275 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -84.13 -47.46 10.86 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.318 1.047 . . . . 0.0 110.27 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -54.98 -53.27 57.87 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.668 1.122 . . . . 0.0 110.239 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HZ3' ' HG2' ' A' ' 66' ' ' GLU . 34.5 mttp -57.76 -22.63 48.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.406 1.083 . . . . 0.0 112.56 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -79.59 -60.99 2.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.924 0.89 . . . . 0.0 109.096 173.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -65.92 -33.54 76.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.802 -166.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -65.81 -10.14 35.06 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -16.35 32.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.203 1.401 . . . . 0.0 114.385 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -154.55 -45.58 0.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.693 -1.255 . . . . 0.0 109.673 166.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.1 mt -63.46 138.04 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.79 1.236 . . . . 0.0 108.223 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -92.39 126.36 37.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.131 1.372 . . . . 0.0 107.538 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.62 130.02 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.66 148.0 44.51 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.256 1.423 . . . . 0.0 109.392 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -80.86 143.88 32.41 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.353 1.061 . . . . 0.0 108.705 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.86 116.79 23.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.509 0.671 . . . . 0.0 109.324 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.02 79.68 0.66 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.236 1.414 . . . . 0.0 108.243 163.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.01 25.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.137 0.854 . . . . 0.0 114.034 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.7 -14.25 40.35 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.414 1.485 . . . . 0.0 110.4 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -82.02 100.84 9.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.044 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.62 -49.02 6.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 123.941 0.896 . . . . 0.0 109.575 170.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.36 -39.75 77.89 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.882 0.765 . . . . 0.0 110.503 -169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -56.89 -41.75 78.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -75.32 -34.63 61.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.091 0.556 . . . . 0.0 112.244 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mt -61.6 -53.78 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p -62.47 -46.22 89.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.795 0.438 . . . . 0.0 111.282 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.83 -39.98 82.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.909 0.322 . . . . 0.0 110.513 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 6' ' ' VAL . 23.6 t80 -66.46 -50.39 63.5 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.362 0.665 . . . . 0.0 111.747 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.76 -36.72 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.977 0.911 . . . . 0.0 109.759 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.33 -5.41 59.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.068 1.347 . . . . 0.0 113.332 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.48 86.51 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.766 -1.575 . . . . 0.0 113.112 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -29.28 67.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.291 1.437 . . . . 0.0 114.18 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.74 137.82 58.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.478 1.035 . . . . 0.0 110.684 -174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 p -78.74 130.51 35.86 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.941 0.897 . . . . 0.0 109.885 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -71.85 148.7 45.92 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.21 -0.931 . . . . 0.0 109.633 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--O 1.239 0.517 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.508 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 C--O 1.233 0.23 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 mt -138.49 143.68 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.566 1.146 . . . . 0.0 110.134 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.262 58.6 t30 44.62 45.54 7.98 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.966 2.506 . . . . 0.0 112.733 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.2 tpp -72.47 145.69 47.38 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 163.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -136.32 137.97 41.21 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 163.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 93' ' ' PHE . 70.1 t -137.99 140.47 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.6 99.06 8.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.684 1.194 . . . . 0.0 108.72 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.72 114.16 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 p -68.32 128.62 37.24 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.317 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mtp -127.14 162.0 27.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.759 1.223 . . . . 0.0 110.805 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.7 -61.92 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.293 1.437 . . . . 0.0 109.53 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.14 -46.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 O-C-N 120.841 -1.162 . . . . 0.0 109.441 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -140.3 2.69 1.89 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.283 0.633 . . . . 0.0 112.211 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -157.57 175.21 14.24 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.449 1.5 . . . . 0.0 110.537 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.7 141.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.8 p -70.6 159.29 34.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.204 0.525 . . . . 0.0 110.643 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.02 -34.48 78.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.962 1.305 . . . . 0.0 111.266 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 167.12 25.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.506 0.722 . . . . 0.0 111.492 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' C ' ' H ' ' A' ' 21' ' ' ASP . 21.2 t80 -72.85 -53.31 11.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 18.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.211 1.405 . . . . 0.0 111.848 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 19' ' ' PHE . 16.6 t70 -145.18 5.52 1.11 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.563 1.945 . . . . 0.0 110.934 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 p -80.1 172.44 13.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.719 -1.238 . . . . 0.0 110.15 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -111.94 -24.58 9.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.672 1.589 . . . . 0.0 110.589 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -160.12 175.07 13.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.952 0.796 . . . . 0.0 110.071 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.68 126.62 51.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 170.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 111.69 18.97 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -79.83 104.22 7.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.64 150.21 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -124.63 115.89 21.52 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.81 123.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 167.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -126.66 -5.67 6.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.303 1.041 . . . . 0.0 111.536 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -158.51 55.46 0.44 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.93 2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.586 2.355 . . . . 0.0 116.386 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -118.77 154.01 33.5 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 129.712 3.205 . . . . 0.0 108.888 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.57 102.98 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-O 121.91 0.862 . . . . 0.0 108.806 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -71.68 -46.0 60.15 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -158.52 167.5 29.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.663 0.785 . . . . 0.0 110.406 -171.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -138.34 125.81 21.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.086 1.754 . . . . 0.0 108.981 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.84 164.39 14.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 109.604 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.13 134.31 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.3 mt -123.77 104.27 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.875 1.67 . . . . 0.0 106.551 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -58.09 136.53 57.2 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.473 0.579 . . . . 0.0 110.25 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -80.74 70.78 7.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.267 1.027 . . . . 0.0 110.773 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.65 84.74 1.62 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 71.14 -74.07 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.101 2.16 . . . . 0.0 113.375 151.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.7 t -52.34 -33.02 40.95 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.838 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.63 -59.85 9.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -58.58 -39.17 79.56 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.349 -1.089 . . . . 0.0 110.425 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -55.01 -46.36 75.21 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 118.662 0.665 . . . . 0.0 110.373 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.9 m -61.01 -36.32 79.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.631 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.33 -48.38 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.773 1.169 . . . . 0.0 109.452 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.08 -39.84 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.086 0.554 . . . . 0.0 110.396 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -73.17 -17.87 61.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.121 -0.987 . . . . 0.0 112.463 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.91 -174.53 5.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 120.273 1.397 . . . . 0.0 110.529 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -112.98 40.84 2.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.011 1.724 . . . . 0.0 109.235 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.75 141.49 17.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.24 -41.38 12.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.322 1.049 . . . . 0.0 109.943 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.15 151.09 36.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.29 1.036 . . . . 0.0 111.272 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.43 139.54 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 166.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.8 mt -116.51 127.53 74.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.7 p -154.19 176.42 12.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.527 1.531 . . . . 0.0 108.085 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -106.33 -24.77 12.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.607 1.163 . . . . 0.0 111.648 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -152.96 159.31 42.93 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.0 tt -161.02 137.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.552 ' H ' ' ND2' ' A' ' 68' ' ' ASN . 8.9 m -85.23 168.37 14.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.28 -35.42 75.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.286 1.434 . . . . 0.0 111.221 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.87 -47.03 32.37 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.365 1.078 . . . . 0.0 109.726 -170.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -58.48 -46.54 86.43 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.243 1.817 . . . . 0.0 110.057 172.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -54.6 -62.16 1.84 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.693 0.397 . . . . 0.0 111.109 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.98 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 112.553 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -62.81 1.52 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.893 0.877 . . . . 0.0 109.432 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -79.93 -30.49 39.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.971 -164.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -58.27 -12.45 3.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.454 1.102 . . . . 0.0 113.857 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -52.28 -31.57 33.3 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.124 -0.985 . . . . 0.0 111.871 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -151.82 -8.08 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mt -114.78 123.52 70.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.69 160.61 19.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.69 0.757 . . . . 0.0 109.434 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.7 mt -137.69 128.77 38.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.24 160.89 34.83 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.88 1.272 . . . . 0.0 111.534 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -106.71 121.82 45.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.892 1.677 . . . . 0.0 110.169 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.5 125.24 29.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.755 0.422 . . . . 0.0 110.163 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -9.38 29.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.341 1.857 . . . . 0.0 113.065 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.96 174.33 41.51 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -163.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -90.3 -6.3 55.29 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 99.68 5.45 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -173.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.6 t -49.82 -39.17 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 122.874 0.47 . . . . 0.0 110.277 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.19 -42.71 68.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -166.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -62.47 -45.36 93.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.853 -0.529 . . . . 0.0 110.383 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -71.75 -32.57 67.84 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.17 -0.331 . . . . 0.0 111.238 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.94 -50.91 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 p -67.0 -31.5 72.11 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 mt -69.18 -42.56 75.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 109.973 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CE2' HG22 ' A' ' 6' ' ' VAL . 40.5 t80 -59.25 -42.88 92.16 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.181 0.993 . . . . 0.0 113.124 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.3 mt -47.9 -54.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.429 1.492 . . . . 0.0 109.466 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -4.92 49.15 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.505 1.522 . . . . 0.0 113.306 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.09 14.76 80.2 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.079 0.854 . . . . 0.0 112.601 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.86 -19.4 61.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 112.116 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.13 140.48 50.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.07 0.938 . . . . 0.0 110.575 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -68.8 140.05 55.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.839 1.256 . . . . 0.0 108.749 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -72.59 153.82 41.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 165.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.328 -0.349 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 160.894 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 mm -120.63 136.4 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 124.738 1.215 . . . . 0.0 108.309 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 47.78 53.41 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.008 1.723 . . . . 0.0 113.851 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -69.95 156.16 39.52 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 163.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -132.31 159.42 39.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 152.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 28' ' ' VAL . 12.0 p -156.64 163.8 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.7 124.8 47.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 164.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.39 113.58 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.7 p -57.38 128.39 36.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.2 mtp -131.16 157.71 42.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.489 1.04 . . . . 0.0 110.426 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.32 -63.29 1.14 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.555 1.542 . . . . 0.0 108.417 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -142.93 -74.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -119.43 10.88 12.0 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.031 1.332 . . . . 0.0 112.935 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.52 170.17 21.42 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.13 1.372 . . . . 0.0 108.35 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.8 mt -58.11 133.83 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 p -73.63 159.72 32.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.847 2.059 . . . . 0.0 111.311 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -73.55 -25.1 60.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.7 p -149.64 174.01 13.03 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.841 1.2 . . . . 0.0 111.605 169.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -72.56 -13.72 61.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.596 1.958 . . . . 0.0 111.653 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.94 7.99 15.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 111.467 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -133.01 2.9 3.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.073 1.749 . . . . 0.0 110.243 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.98 153.96 42.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.733 -1.23 . . . . 0.0 109.625 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -101.16 -24.67 14.23 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.87 1.268 . . . . 0.0 109.192 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.447 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 40.8 p90 -157.72 173.76 16.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.242 0.928 . . . . 0.0 111.003 171.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -115.83 105.1 12.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.308 2.243 . . . . 0.0 107.924 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.94 107.17 7.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -79.46 133.03 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.809 1.244 . . . . 0.0 109.027 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 6' ' ' VAL . 2.0 t -105.94 105.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttt-85 -98.68 103.99 15.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.56 138.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -125.25 -5.63 7.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.483 0.713 . . . . 0.0 112.689 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.491 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 5.5 p-10 -173.38 48.28 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.83 1.252 . . . . 0.0 108.855 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.36 18.67 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.184 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.74 152.96 47.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.37 90.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 122.549 1.166 . . . . 0.0 107.891 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.491 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 2.8 mmtp -73.02 -35.09 66.72 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 120.735 -1.228 . . . . 0.0 110.185 167.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 t -162.25 131.97 4.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.792 1.178 . . . . 0.0 110.075 167.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 174.71 9.82 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.272 1.029 . . . . 0.0 111.523 165.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.12 168.34 26.82 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 127.168 2.187 . . . . 0.0 110.303 171.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.553 0.9 OUTLIER -135.16 144.22 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 129.924 3.29 . . . . 0.0 117.476 171.104 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.7 mt -134.29 114.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 127.757 2.423 . . . . 0.0 106.655 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -61.44 136.11 57.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.213 0.915 . . . . 0.0 110.733 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -83.13 85.71 7.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.771 1.228 . . . . 0.0 108.545 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.54 -85.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 46' ' ' SER . 10.4 pt-20 -131.83 -64.09 0.8 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.394 -0.816 . . . . 0.0 111.67 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.422 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -57.99 -24.18 57.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.968 174.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.59 -74.08 0.36 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -57.71 -27.27 62.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.731 1.265 . . . . 0.0 111.537 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.32 -51.15 62.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.8 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -60.93 -37.4 82.2 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.669 1.588 . . . . 0.0 110.067 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.3 mt -52.46 -45.33 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.086 1.755 . . . . 0.0 110.93 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.71 -42.71 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 120.876 -1.14 . . . . 0.0 110.14 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.55 -30.63 59.77 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 118.445 0.566 . . . . 0.0 111.651 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -74.08 -19.84 60.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.533 0.606 . . . . 0.0 109.4 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.7 t30 50.89 55.38 9.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.703 2.801 . . . . 0.0 112.305 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.19 144.16 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.123 1.769 . . . . 0.0 111.543 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -39.99 18.53 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.111 1.364 . . . . 0.0 111.155 173.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.25 160.95 40.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 112.989 -166.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.3 mt -132.25 105.25 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 119.909 -1.745 . . . . 0.0 108.966 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.06 128.69 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -151.06 167.98 26.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.592 1.087 . . . . 0.0 111.189 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -82.2 -45.38 15.15 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.224 1.81 . . . . 0.0 109.262 165.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -147.43 164.26 33.89 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.379 0.991 . . . . 0.0 109.927 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.5 tt -154.32 138.1 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 m -73.31 155.99 38.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.327 0.512 . . . . 0.0 110.68 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.431 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 36.8 tt0 -66.67 -31.49 72.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.734 0.414 . . . . 0.0 111.4 -171.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.74 -50.91 31.07 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.087 0.858 . . . . 0.0 110.997 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -56.54 -43.8 80.24 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.734 0.414 . . . . 0.0 110.644 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -54.69 -60.79 2.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.512 1.125 . . . . 0.0 109.363 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HE3' ' HG2' ' A' ' 66' ' ' GLU . 50.5 mttt -64.31 -17.06 63.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.453 0.701 . . . . 0.0 112.61 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.34 -51.91 5.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.112 1.365 . . . . 0.0 110.338 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -76.55 -30.29 57.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.338 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -63.18 -7.77 6.6 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -20.06 39.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.937 -1.102 . . . . 0.0 111.709 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -145.14 2.59 1.01 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.944 1.247 . . . . 0.0 112.158 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.5 129.03 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -171.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.08 107.65 17.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.002 1.721 . . . . 0.0 109.645 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -87.16 131.89 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 120.455 -1.403 . . . . 0.0 108.52 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -118.16 144.22 45.87 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.702 1.601 . . . . 0.0 111.084 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -87.01 132.58 33.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.458 1.503 . . . . 0.0 107.583 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.81 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.241 -0.409 . . . . 0.0 110.541 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -12.53 60.43 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 169.64 34.15 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 126.99 2.234 . . . . 0.0 108.26 -164.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.7 -16.96 63.98 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.551 2.34 . . . . 0.0 111.37 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.64 97.34 3.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -168.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.1 t -50.38 -42.75 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.65 -44.52 81.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.404 0.682 . . . . 0.0 109.252 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -58.06 -42.54 85.69 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.89 0.852 . . . . 0.0 111.31 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -71.96 -27.2 62.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.113 -0.992 . . . . 0.0 111.974 -172.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.23 -53.7 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 p -61.23 -39.08 88.94 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.7 0.8 . . . . 0.0 111.332 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.4 mt -66.3 -44.59 83.04 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.148 0.579 . . . . 0.0 110.881 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.25 -39.06 85.43 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.987 0.812 . . . . 0.0 111.6 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.53 -42.82 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.436 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.35 -12.5 60.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.878 0.763 . . . . 0.0 112.632 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.11 6.94 84.12 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.927 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -34.17 77.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 112.536 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -55.61 140.43 41.1 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -61.56 130.12 44.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 108.947 172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -69.81 131.67 44.87 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.22 -0.925 . . . . 0.0 108.589 165.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.232 0.164 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.722 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -137.34 138.61 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 69.38 17.47 8.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.587 1.955 . . . . 0.0 113.255 168.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.5 tpp -60.33 151.93 26.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.357 -0.839 . . . . 0.0 109.002 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -137.61 129.17 28.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 165.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.9 t -136.68 129.85 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-N 119.979 1.263 . . . . 0.0 108.717 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.05 83.79 2.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.584 1.553 . . . . 0.0 111.243 -169.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mt -83.74 129.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 120.873 -1.142 . . . . 0.0 110.088 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 p -71.07 94.47 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.482 1.113 . . . . 0.0 112.028 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 mtp -100.01 161.1 13.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.552 1.141 . . . . 0.0 111.341 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.5 -63.31 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 109.155 170.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.68 -60.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -130.41 -0.47 4.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.364 1.078 . . . . 0.0 112.528 -162.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -163.25 178.28 8.32 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.346 2.258 . . . . 0.0 108.736 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 99.1 mt -62.12 145.4 13.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -86.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.726 0.774 . . . . 0.0 109.772 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 175.8 -44.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.022 -1.049 . . . . 0.0 108.684 -156.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 p -158.78 169.36 24.55 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.373 0.988 . . . . 0.0 110.08 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -66.27 -34.04 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.131 0.973 . . . . 0.0 110.822 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -92.48 4.05 54.28 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -131.03 17.99 5.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.307 1.051 . . . . 0.0 111.303 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.93 167.6 16.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.294 1.045 . . . . 0.0 110.344 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.13 -31.24 7.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.215 1.406 . . . . 0.0 109.402 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -154.86 161.24 41.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.991 0.901 . . . . 0.0 109.89 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -100.09 111.7 23.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -76.46 108.97 9.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.6 mm -77.36 100.09 2.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.4 133.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.416 ' HE ' ' HB2' ' A' ' 37' ' ' SER . 26.7 mtm180 -115.68 114.45 24.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 mt -107.06 115.47 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.01 -10.98 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.441 1.088 . . . . 0.0 112.098 -162.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.64 57.19 0.62 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 122.352 1.072 . . . . 0.0 108.626 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.62 -9.92 0.08 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 129.137 2.975 . . . . 0.0 116.305 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -107.82 158.99 16.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.426 1.09 . . . . 0.0 110.4 170.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.76 90.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.278 1.431 . . . . 0.0 109.974 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.66 -20.88 30.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.779 1.632 . . . . 0.0 112.487 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.416 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 1.6 m -150.55 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 167.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 p -131.82 158.79 40.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 161.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 157.73 46.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 126.202 1.801 . . . . 0.0 106.723 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.24 140.87 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.1 mt -130.8 100.57 4.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -58.86 137.52 57.74 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -73.92 85.37 1.75 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.358 1.463 . . . . 0.0 108.042 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.5 33.83 2.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.462 1.505 . . . . 0.0 110.174 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 66.33 -69.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.144 1.777 . . . . 0.0 109.839 -172.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.3 t -52.99 -29.33 28.51 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.172 2.189 . . . . 0.0 111.413 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.1 16.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.983 0.81 . . . . 0.0 111.286 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -57.6 -32.2 66.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.086 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -56.5 -40.13 74.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.363 0.983 . . . . 0.0 108.397 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -30.79 66.97 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.136 0.974 . . . . 0.0 110.655 -172.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.85 -42.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.391 1.076 . . . . 0.0 108.308 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.1 -13.2 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.126 -0.984 . . . . 0.0 111.269 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -8.03 16.19 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.622 -1.298 . . . . 0.0 112.277 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -91.48 -15.09 29.33 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.557 1.526 . . . . 0.0 113.791 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 57.87 59.14 3.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.826 1.251 . . . . 0.0 109.946 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -47.8 140.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 161.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -50.96 19.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.62 39.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.898 0.479 . . . . 0.0 110.582 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mt -113.86 150.54 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.94 1.296 . . . . 0.0 107.707 173.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -120.22 121.9 66.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -144.24 168.89 18.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.212 1.005 . . . . 0.0 108.635 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -71.83 -57.3 4.45 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 155.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -140.7 160.72 39.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.401 0.546 . . . . 0.0 110.711 -167.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.2 tt -152.61 126.99 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 126.25 1.82 . . . . 0.0 106.613 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -54.44 143.54 23.61 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.621 1.568 . . . . 0.0 110.221 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -48.45 -49.04 37.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.169 1.787 . . . . 0.0 111.462 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.03 -42.04 99.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 0.0 110.666 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -68.5 -43.56 76.57 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.594 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.4 -57.83 9.25 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.02 -14.04 51.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.676 1.191 . . . . 0.0 113.628 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -90.99 -58.11 2.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.448 1.499 . . . . 0.0 109.793 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.33 -27.44 62.43 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 112.335 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -60.7 -11.85 8.67 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -58.18 -42.81 86.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 0.0 112.271 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 13.56 1.78 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.806 1.185 . . . . 0.0 111.743 -175.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mt -136.41 140.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.77 153.09 19.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.949 0.9 . . . . 0.0 108.779 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.52 113.59 23.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -160.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.86 151.07 37.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.544 1.137 . . . . 0.0 110.898 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -99.12 120.19 39.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.442 1.497 . . . . 0.0 109.95 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 138.94 55.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.414 0.686 . . . . 0.0 111.747 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -102.29 99.08 9.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 127.178 2.191 . . . . 0.0 109.284 172.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.42 -179.11 53.63 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -85.37 -10.84 55.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.703 0.801 . . . . 0.0 110.662 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.35 102.23 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.062 0.945 . . . . 0.0 110.563 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -48.35 -43.86 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 118.79 -0.624 . . . . 0.0 109.609 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.58 -42.84 77.7 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.968 0.804 . . . . 0.0 110.219 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -57.26 -40.02 76.83 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.902 -0.499 . . . . 0.0 110.289 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.51 -32.85 42.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.15 -50.47 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 p -62.4 -46.51 88.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.726 0.811 . . . . 0.0 111.436 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 122.56 0.344 . . . . 0.0 110.161 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -61.74 -52.5 64.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.321 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.3 mt -50.27 -40.93 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.969 1.308 . . . . 0.0 111.005 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.23 -2.84 50.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.941 0.896 . . . . 0.0 113.108 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.02 81.35 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.0 1.286 . . . . 0.0 111.193 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -27.26 61.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.41 1.884 . . . . 0.0 113.029 -174.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.38 139.47 58.56 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.577 0.704 . . . . 0.0 109.582 -174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.8 m -75.93 143.05 41.86 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -76.98 151.52 35.62 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 166.278 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.0 mt -139.54 152.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 47.18 73.02 0.21 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.874 1.67 . . . . 0.0 110.734 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ttt -131.92 152.33 51.14 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.157 -0.964 . . . . 0.0 108.59 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.6 141.52 33.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 165.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -134.05 132.62 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 171.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.99 144.57 25.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.71 119.98 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -75.88 84.16 2.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.147 0.979 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -86.3 155.26 20.73 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.895 2.478 . . . . 0.0 111.7 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -105.27 -55.96 2.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.128 0.966 . . . . 0.0 110.979 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -146.77 -55.02 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.8 -1.79 0.49 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.519 -158.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -157.06 173.17 17.41 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.706 2.002 . . . . 0.0 107.426 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.41 134.15 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -66.84 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.53 -38.66 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.395 1.478 . . . . 0.0 108.95 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 166.21 29.18 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.974 0.416 . . . . 0.0 111.042 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -55.88 -50.19 71.33 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.726 2.01 . . . . 0.0 108.891 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.12 -3.06 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.724 1.609 . . . . 0.0 112.812 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -120.91 -4.66 9.62 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.835 1.254 . . . . 0.0 111.068 -171.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.3 p -80.11 175.24 10.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.802 -1.186 . . . . 0.0 111.957 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -112.08 -34.67 5.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.741 1.616 . . . . 0.0 110.035 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -149.05 164.24 35.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.357 0.98 . . . . 0.0 111.904 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -109.85 103.35 12.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.382 2.673 . . . . 0.0 106.456 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tp -81.15 101.45 9.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.09 96.1 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 127.381 2.273 . . . . 0.0 107.31 168.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.52 139.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 160.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 118.55 18.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.868 0.758 . . . . 0.0 109.093 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.3 mt -119.82 138.28 50.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -164.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.0 -9.12 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -155.86 65.87 0.59 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.09 -8.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.21 3.004 . . . . 0.0 115.91 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.15 157.46 27.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 111.235 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.13 83.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.301 1.841 . . . . 0.0 106.864 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -64.85 -31.75 73.13 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.884 -1.135 . . . . 0.0 109.974 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -150.72 163.38 38.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.96 0.904 . . . . 0.0 109.469 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.67 161.28 36.91 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 108.231 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 137.8 19.11 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.92 0.888 . . . . 0.0 110.041 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.535 1.1 p -99.97 133.21 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 161.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.43 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 11.1 mt -129.74 114.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -63.31 160.42 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.156 1.343 . . . . 0.0 110.409 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -78.54 76.62 5.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.902 1.281 . . . . 0.0 109.777 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -125.74 170.17 11.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.34 1.456 . . . . 0.0 109.502 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -55.38 -40.67 71.65 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.445 -0.784 . . . . 0.0 110.672 164.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 m -76.34 -11.29 59.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.783 1.233 . . . . 0.0 111.693 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.43 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -72.47 -60.3 4.11 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 163.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 mppt? -62.58 -20.25 64.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -63.57 -46.25 86.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.932 1.242 . . . . 0.0 110.512 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 m -71.84 -40.79 68.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.223 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.7 mt -45.46 -51.44 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.929 1.292 . . . . 0.0 111.85 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.68 -34.69 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.87 -0.519 . . . . 0.0 111.468 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.89 -14.24 45.45 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.661 -0.649 . . . . 0.0 111.374 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.17 -16.21 61.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.525 1.53 . . . . 0.0 110.883 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 t30 47.47 65.06 1.36 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.975 2.11 . . . . 0.0 110.28 -167.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -67.45 140.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.94 -42.26 15.14 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.511 1.524 . . . . 0.0 109.979 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.69 160.95 39.82 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.422 1.089 . . . . 0.0 109.414 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -122.76 138.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.85 122.09 50.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.03 157.09 44.55 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.688 0.756 . . . . 0.0 111.255 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -68.99 -53.0 22.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 163.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -139.33 159.39 42.28 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.594 1.543 . . . . 0.0 111.204 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.9 tt -156.83 126.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.141 1.776 . . . . 0.0 110.257 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -61.13 141.89 57.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.222 1.009 . . . . 0.0 110.003 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.75 -37.62 76.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 111.845 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.61 -40.41 94.72 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.499 -0.75 . . . . 0.0 111.503 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -69.16 -47.58 64.59 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.792 0.837 . . . . 0.0 109.805 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -50.51 -58.68 5.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.858 1.263 . . . . 0.0 109.758 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -60.97 -18.12 55.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.436 0.694 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HE3' ' HA ' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -82.38 -47.45 12.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.06 -1.025 . . . . 0.0 111.04 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -84.87 -25.37 28.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.958 0.344 . . . . 0.0 111.027 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -62.12 -7.7 4.43 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.61 1.164 . . . . 0.0 113.231 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -40.42 11.56 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.208 1.403 . . . . 0.0 110.787 173.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -145.16 -30.55 0.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.552 1.141 . . . . 0.0 111.857 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.3 mt -90.04 135.1 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -163.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.56 139.2 33.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.679 . . . . 0.0 107.801 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.8 mt -119.74 114.21 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.24 -0.913 . . . . 0.0 108.671 -172.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 55.8 m-85 -104.63 139.85 38.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.096 1.758 . . . . 0.0 110.835 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.42 127.62 32.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 123.07 19.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -83.3 6.76 18.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.057 1.743 . . . . 0.0 112.389 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.4 -169.81 38.97 Favored Glycine 0 N--CA 1.449 -0.477 0 O-C-N 120.509 -1.369 . . . . 0.0 111.68 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.15 -18.05 15.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.921 1.688 . . . . 0.0 109.894 168.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -66.86 101.7 0.86 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.386 1.474 . . . . 0.0 107.387 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.4 t -57.73 -41.11 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.217 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.51 -36.31 73.69 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.578 0.751 . . . . 0.0 110.359 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -60.77 -42.07 96.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 171.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -71.87 -26.84 62.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.701 -0.625 . . . . 0.0 111.566 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -56.9 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.78 1.632 . . . . 0.0 107.561 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.7 p -65.57 -40.69 93.07 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.36 0.413 . . . . 0.0 110.605 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.12 -42.87 99.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.651 0.78 . . . . 0.0 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 6' ' ' VAL . 68.7 t80 -61.19 -52.59 64.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.528 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.2 mt -58.25 -40.74 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.496 1.119 . . . . 0.0 109.58 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -68.22 -18.71 64.64 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.26 8.24 78.51 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.717 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -69.92 -27.31 64.66 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.084 1.442 . . . . 0.0 112.329 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.31 138.83 55.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.432 1.111 . . . . 0.0 110.272 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.8 m -74.09 138.92 44.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.3 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 31.4 mtmm -78.98 147.75 32.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 162.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.9 mt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 123.7 0.625 . . . . 0.0 110.854 -174.84 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.93 153.05 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.317 1.847 . . . . 0.0 107.86 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 67.01 8.93 6.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.1 1.76 . . . . 0.0 114.473 168.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 tpp -78.1 155.17 30.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.182 1.356 . . . . 0.0 108.938 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.42 143.42 25.71 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.18 141.93 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 108.962 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.72 101.89 13.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 166.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.47 117.91 28.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.5 p -66.38 143.78 56.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.8 mmm -138.66 149.07 44.77 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 119.449 -2.032 . . . . 0.0 109.078 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -89.44 -67.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.507 1.123 . . . . 0.0 109.01 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.9 t -140.53 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.38 -7.42 18.81 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -147.16 177.34 9.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.272 1.429 . . . . 0.0 110.155 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mt -62.77 141.22 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 t -71.02 -86.76 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 t30 174.75 -28.12 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.856 1.663 . . . . 0.0 112.068 -167.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.73 164.68 29.44 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.736 1.153 . . . . 0.0 110.726 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -66.32 -37.59 85.74 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.222 1.009 . . . . 0.0 108.435 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 1.0 56.64 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.416 1.486 . . . . 0.0 113.175 -171.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.54 -7.54 6.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.018 1.327 . . . . 0.0 111.74 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.9 p -65.66 169.37 6.37 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 123.471 1.605 . . . . 0.0 110.277 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -114.9 -19.59 10.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.722 -2.036 . . . . 0.0 111.119 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -161.33 172.16 17.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.67 0.668 . . . . 0.0 111.388 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -117.02 103.61 10.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.369 2.268 . . . . 0.0 106.441 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 tp -76.97 99.04 5.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.41 102.14 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 128.064 2.545 . . . . 0.0 105.923 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 t -95.87 112.2 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.0 140.57 34.04 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.679 1.127 . . . . 0.0 108.495 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -132.68 123.12 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -168.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.19 3.99 1.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -165.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -154.63 60.6 0.68 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 122.491 1.139 . . . . 0.0 109.702 155.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.18 7.32 1.58 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.637 1.575 . . . . 0.0 114.692 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -135.7 155.09 50.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 131.349 3.86 . . . . 0.0 106.807 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.65 124.72 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.616 1.166 . . . . 0.0 109.027 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -111.97 -34.34 6.01 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.641 0.776 . . . . 0.0 112.543 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 131.64 27.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -96.96 154.71 17.14 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 162.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 147.85 33.18 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.938 1.695 . . . . 0.0 107.093 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.453 1.2 p -106.83 134.87 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 125.791 1.636 . . . . 0.0 115.287 155.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.16 122.14 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -65.64 161.08 21.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.594 1.088 . . . . 0.0 111.213 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -81.14 99.83 8.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 167.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -154.47 38.22 0.43 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 108.486 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 60.49 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.103 2.961 . . . . 0.0 112.854 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 t -62.23 -10.78 11.72 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.586 -1.321 . . . . 0.0 111.464 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.7 -60.24 6.6 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 160.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -61.29 -26.88 68.08 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.183 0.993 . . . . 0.0 112.348 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -64.69 -53.0 54.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 120.078 1.308 . . . . 0.0 108.874 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 t -53.55 -45.95 70.03 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 110.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.8 mt -50.36 -43.04 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.882 0.873 . . . . 0.0 110.709 -176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.19 -23.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 O-C-N 121.052 -1.03 . . . . 0.0 111.906 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -98.64 12.42 35.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.078 0.951 . . . . 0.0 111.266 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.53 -6.42 11.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.807 0.843 . . . . 0.0 112.211 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.0 t30 49.89 61.95 2.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.406 1.483 . . . . 0.0 111.694 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.51 142.13 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 166.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -76.13 -52.72 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.27 162.5 39.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.56 141.16 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.88 2.072 . . . . 0.0 110.396 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.9 mt -127.14 125.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.201 1.8 . . . . 0.0 106.792 167.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 38.1 m -149.62 -13.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp 75.78 -34.42 0.24 Allowed 'General case' 0 C--O 1.221 -0.425 1 C-N-CA 132.526 4.331 . . . . 0.0 113.35 -162.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -149.97 168.07 24.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 122.088 2.222 . . . . 0.0 111.748 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -163.53 120.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.645 1.178 . . . . 0.0 108.65 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.35 147.79 43.61 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.18 -47.49 65.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.933 2.093 . . . . 0.0 111.345 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -59.76 -42.25 92.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.753 0.787 . . . . 0.0 111.154 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -72.56 -41.49 65.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.888 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.75 -61.17 2.42 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.201 0.91 . . . . 0.0 109.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -64.89 -24.08 67.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.89 -38.63 61.83 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 120.905 -1.122 . . . . 0.0 111.301 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.49 -30.46 21.97 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.056 -1.027 . . . . 0.0 111.485 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -63.8 -12.73 38.18 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -27.34 5.62 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.328 1.451 . . . . 0.0 113.903 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -155.75 -2.66 0.14 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.026 0.83 . . . . 0.0 113.207 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.29 121.07 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -75.06 117.36 16.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.484 1.513 . . . . 0.0 107.271 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.48 134.92 28.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -120.15 155.38 33.19 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 108.792 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -85.37 141.29 30.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 168.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.52 150.16 23.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.354 0.525 . . . . 0.0 110.486 173.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.77 71.36 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.876 2.47 . . . . 0.0 108.118 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.43 -178.85 17.52 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 124.466 1.031 . . . . 0.0 112.852 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -33.63 75.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.028 153.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.55 100.83 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 124.446 1.091 . . . . 0.0 109.9 -155.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -52.18 -43.85 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -44.22 92.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.575 0.625 . . . . 0.0 109.962 -175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.19 -39.26 78.47 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.69 -0.631 . . . . 0.0 110.982 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -76.87 -27.25 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 112.529 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.09 -50.43 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.6 p -61.87 -46.42 89.49 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.012 0.824 . . . . 0.0 110.898 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.4 mt -63.06 -30.24 71.44 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.084 0.554 . . . . 0.0 110.621 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.62 -48.38 48.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.46 -37.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.261 . . . . 0.0 109.928 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -76.84 -34.35 57.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.898 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.57 15.16 32.78 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.99 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -34.82 74.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.821 2.048 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.31 142.15 52.73 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.605 1.093 . . . . 0.0 109.495 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.4 t -91.55 144.75 25.22 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 123.275 1.512 . . . . 0.0 110.244 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -85.08 130.7 34.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.985 1.714 . . . . 0.0 108.896 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.2 mt . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.694 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.609 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 9.4 tpt . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.485 0.183 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.53 150.86 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 172.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m120 66.23 8.94 5.95 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 171.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.405 ' HE2' ' CE2' ' A' ' 93' ' ' PHE . 3.7 ttp -68.5 155.8 39.21 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.351 1.432 . . . . 0.0 110.202 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -139.12 146.34 40.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.018 1.727 . . . . 0.0 107.517 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.433 HG21 ' CE2' ' A' ' 93' ' ' PHE . 31.3 t -137.75 135.08 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.675 1.19 . . . . 0.0 108.122 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 124.12 33.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 166.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mt -104.03 112.53 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -66.2 91.63 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.784 1.234 . . . . 0.0 110.007 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 91.3 mmm -92.08 159.51 15.66 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.492 1.117 . . . . 0.0 111.183 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.81 -81.4 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.178 2.191 . . . . 0.0 108.372 165.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.4 t -140.41 -59.71 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -121.87 2.69 9.99 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 170.44 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.645 1.178 . . . . 0.0 110.09 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.5 mt -53.96 139.54 12.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.793 1.637 . . . . 0.0 108.087 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -74.25 -179.49 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.707 1.603 . . . . 0.0 110.625 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -86.0 -34.39 20.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.705 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -153.27 168.3 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -67.03 -23.04 65.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.247 2.219 . . . . 0.0 111.406 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.8 19.72 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.052 1.341 . . . . 0.0 110.916 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.14 -7.3 1.58 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.2 p -74.46 154.49 38.7 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.265 1.031 . . . . 0.0 109.889 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.59 -34.25 14.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.365 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -158.54 175.55 13.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.656 0.741 . . . . 0.0 109.533 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -117.05 108.91 16.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.72 104.9 8.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 mm -69.0 99.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.18 147.37 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 161.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.03 140.22 51.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mt -110.55 142.52 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.28 124.55 10.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 175.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 44.46 57.7 4.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.614 1.565 . . . . 0.0 111.51 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.609 ' ND2' ' H ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 49.62 28.49 2.6 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 128.89 2.876 . . . . 0.0 114.138 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -132.07 157.16 44.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.09 1.314 . . . . 0.0 111.139 166.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.52 120.15 17.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -126.15 -7.62 6.52 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t -157.13 170.67 21.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 122.021 2.191 . . . . 0.0 107.813 164.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.24 156.26 45.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.609 1.564 . . . . 0.0 109.535 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 160.55 43.86 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 125.911 1.685 . . . . 0.0 109.142 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.7 OUTLIER -127.1 137.28 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 C-N-CA 130.062 3.345 . . . . 0.0 116.581 167.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.84 116.25 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -64.05 148.92 48.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.57 0.623 . . . . 0.0 110.25 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -69.95 88.73 0.58 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.2 166.23 24.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 128.309 2.644 . . . . 0.0 105.042 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.73 -45.98 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.49 -0.757 . . . . 0.0 109.778 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -26.3 68.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 110.178 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.18 -49.73 38.12 Favored Glycine 0 N--CA 1.444 -0.819 0 O-C-N 121.729 -0.607 . . . . 0.0 111.677 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -67.82 -21.52 65.21 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.067 0.934 . . . . 0.0 111.506 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.03 -58.16 6.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.736 -1.126 . . . . 0.0 110.551 161.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -53.51 -33.88 56.08 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.333 0.97 . . . . 0.0 112.824 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 mt -45.3 -46.64 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.557 1.143 . . . . 0.0 111.513 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.33 -33.37 63.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 123.225 0.61 . . . . 0.0 110.199 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -27.09 29.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.298 0.499 . . . . 0.0 111.223 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.02 -20.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.099 0.863 . . . . 0.0 112.155 -170.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.01 32.87 1.74 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.053 1.341 . . . . 0.0 110.58 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.02 146.1 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.34 -48.83 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.794 1.238 . . . . 0.0 109.669 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.47 163.3 40.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 110.057 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -117.19 150.07 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.7 mt -120.24 132.14 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 t -163.95 161.53 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.715 2.406 . . . . 0.0 108.476 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.3 -39.03 93.43 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.537 169.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.66 167.96 24.95 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.029 1.286 . . . . 0.0 109.34 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.9 tt -162.49 138.02 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.025 1.73 . . . . 0.0 107.751 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -76.29 152.11 36.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.964 -0.46 . . . . 0.0 110.581 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -48.91 -45.64 41.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.507 1.123 . . . . 0.0 111.456 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.493 ' CD ' ' HZ2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.768 0.827 . . . . 0.0 108.824 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -60.12 -41.5 92.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.99 0.916 . . . . 0.0 111.903 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -56.03 -65.01 0.67 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.915 0.78 . . . . 0.0 109.252 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -60.38 -28.1 67.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.634 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.493 ' HZ2' ' CD ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -67.88 -55.4 13.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.721 1.146 . . . . 0.0 110.341 176.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.88 -22.25 37.0 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.531 0.605 . . . . 0.0 112.589 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 t -72.44 69.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.029 1.395 . . . . 0.0 110.618 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 -32.49 0.28 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 129.006 2.922 . . . . 0.0 110.259 175.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.82 -6.32 0.6 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.81 136.67 58.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.62 155.46 19.23 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.977 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.3 mt -128.14 118.19 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.63 1.172 . . . . 0.0 108.658 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 60.1 m-85 -106.06 164.36 12.04 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.161 0.984 . . . . 0.0 110.321 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -98.41 145.97 26.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.885 0.766 . . . . 0.0 110.017 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.91 117.16 29.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.598 1.159 . . . . 0.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.24 -9.8 58.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.89 34.39 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.45 -18.26 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 158.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 98.53 0.91 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.985 2.514 . . . . 0.0 107.276 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -48.13 -41.42 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.02 -43.59 74.46 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.385 -0.822 . . . . 0.0 110.35 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -36.07 82.29 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 122.084 -0.385 . . . . 0.0 110.502 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.51 -38.32 74.28 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.736 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.05 -50.32 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -60.4 -36.45 78.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.623 0.647 . . . . 0.0 111.863 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.8 mt -67.89 -44.97 75.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.023 0.44 . . . . 0.0 110.77 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 6' ' ' VAL . 43.6 t80 -59.36 -37.19 77.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.358 1.063 . . . . 0.0 112.839 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.7 mt -64.34 -48.41 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.445 1.098 . . . . 0.0 109.807 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.72 -24.07 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.982 0.81 . . . . 0.0 110.868 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.16 8.37 58.92 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 123.914 0.769 . . . . 0.0 113.279 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -45.64 73.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.128 2.171 . . . . 0.0 109.901 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.62 137.78 42.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 124.204 1.002 . . . . 0.0 110.847 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 t -84.47 157.81 21.22 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 57.0 mtpt -76.35 145.63 39.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.173 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.566 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.0 tpt . . . . . 0 CA--C 1.515 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mm -134.01 143.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.533 2.333 . . . . 0.0 107.496 -167.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 45.65 58.74 4.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.464 1.506 . . . . 0.0 113.101 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -103.11 155.02 18.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.609 1.163 . . . . 0.0 108.328 166.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 143.12 31.9 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.495 1.918 . . . . 0.0 105.981 164.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 93' ' ' PHE . 95.4 t -132.78 137.17 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.49 74.26 0.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.689 0.796 . . . . 0.0 109.553 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.92 120.56 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.888 1.275 . . . . 0.0 109.103 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -67.96 117.92 10.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.046 0.938 . . . . 0.0 111.124 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.2 mmm -124.89 157.11 36.76 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.707 1.603 . . . . 0.0 110.159 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -106.78 -62.02 1.46 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.024 1.73 . . . . 0.0 110.635 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -142.27 -85.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 170.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.71 -8.45 24.3 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 165.93 19.99 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.799 1.24 . . . . 0.0 110.35 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.48 142.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 125.31 1.631 . . . . 0.0 108.036 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -73.18 -179.34 3.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.136 1.375 . . . . 0.0 112.881 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -88.14 -32.3 18.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.553 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.1 t -152.67 177.88 10.21 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.262 1.825 . . . . 0.0 108.289 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.32 -34.87 78.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 128.218 2.607 . . . . 0.0 110.723 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.8 -1.94 45.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.005 0.82 . . . . 0.0 111.979 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -121.1 52.77 1.18 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 p -133.25 173.04 11.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.184 2.994 . . . . 0.0 108.572 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -118.01 -28.65 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.906 1.682 . . . . 0.0 109.385 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -156.42 176.1 13.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.953 0.797 . . . . 0.0 111.78 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -123.08 115.92 22.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.823 2.849 . . . . 0.0 108.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 tp -89.07 103.35 15.97 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.327 2.251 . . . . 0.0 106.424 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 mm -68.79 76.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 129.732 3.213 . . . . 0.0 111.16 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -69.14 99.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -76.64 136.49 39.17 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 164.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.14 129.77 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 159.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -132.43 2.19 3.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 t0 174.59 72.13 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.253 3.021 . . . . 0.0 103.217 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 64.9 -25.56 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 131.146 3.778 . . . . 0.0 116.608 173.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -107.39 166.12 10.89 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.22 118.97 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.107 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 -5.35 8.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 113.203 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.7 m -170.02 168.14 8.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.7 2.4 . . . . 0.0 107.005 166.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 p -136.23 -46.01 0.63 Allowed 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.41 175.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.253 2.621 . . . . 0.0 117.682 -171.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.7 t -143.25 106.02 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mt -96.49 115.52 36.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 165.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -65.43 162.26 18.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.871 1.669 . . . . 0.0 110.461 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -73.58 80.98 1.49 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 0.0 108.1 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -134.04 168.16 19.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.628 1.171 . . . . 0.0 107.906 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -52.14 -46.46 65.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.199 1.799 . . . . 0.0 109.835 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -70.82 -39.92 72.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.784 1.234 . . . . 0.0 107.933 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -61.31 7.32 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -58.98 -39.54 82.08 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.23 1.012 . . . . 0.0 110.373 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -58.68 -42.44 88.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.137 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -44.42 92.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.578 1.551 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.7 mt -50.75 -43.81 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.15 -32.41 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.976 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -84.31 -25.93 28.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.47 1.032 . . . . 0.0 110.361 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.95 156.62 33.01 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.793 1.237 . . . . 0.0 108.503 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -83.17 28.31 0.53 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.178 1.391 . . . . 0.0 110.916 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.29 134.78 23.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 120.935 1.698 . . . . 0.0 108.559 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -82.26 -44.63 16.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.023 1.729 . . . . 0.0 109.655 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.25 162.2 40.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.121 0.568 . . . . 0.0 110.412 -168.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mt -113.51 141.69 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 171.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.14 122.64 55.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 162.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.04 151.72 38.19 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.914 1.285 . . . . 0.0 110.664 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -65.91 -46.65 77.49 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 163.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -148.21 166.89 26.56 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.83 119.85 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -52.05 138.58 24.88 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.506 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -51.87 -43.1 63.13 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.973 1.709 . . . . 0.0 112.071 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -22.72 66.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 0.0 112.625 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -84.61 -41.5 16.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.571 -0.705 . . . . 0.0 109.891 167.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.94 -59.95 4.29 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.941 1.246 . . . . 0.0 110.721 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -58.35 -22.8 54.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.904 0.482 . . . . 0.0 111.959 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.96 -50.05 8.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.834 1.254 . . . . 0.0 111.098 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -79.59 -24.27 42.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.095 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -60.85 -7.58 2.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.168 0.895 . . . . 0.0 113.302 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -39.33 21.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.332 1.453 . . . . 0.0 113.864 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -165.17 4.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.282 0.947 . . . . 0.0 112.173 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.7 mt -120.95 126.71 75.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.38 136.79 42.45 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.29 132.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.3 151.66 37.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.681 1.192 . . . . 0.0 109.908 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -99.54 134.56 42.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.968 1.707 . . . . 0.0 110.59 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.427 0.632 . . . . 0.0 109.94 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -128.85 26.67 5.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.791 2.436 . . . . 0.0 108.584 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.11 36.78 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.598 -1.314 . . . . 0.0 111.879 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -89.67 -23.93 21.74 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.966 1.306 . . . . 0.0 109.784 165.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.79 104.02 1.0 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.222 1.809 . . . . 0.0 107.705 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.73 -46.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.217 1.007 . . . . 0.0 108.844 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.33 -41.72 93.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.215 0.916 . . . . 0.0 109.609 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -56.54 -44.79 81.2 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.607 -0.683 . . . . 0.0 110.353 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -70.21 -44.93 67.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.096 -0.378 . . . . 0.0 110.894 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -41.52 92.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 97.4 p -68.52 -34.41 75.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.568 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.62 -41.36 84.09 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 120.991 0.424 . . . . 0.0 110.397 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 6' ' ' VAL . 56.0 t80 -61.66 -40.17 93.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.592 0.757 . . . . 0.0 112.051 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.1 mt -51.07 -52.47 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 109.163 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -74.11 -22.52 59.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.048 0.84 . . . . 0.0 112.445 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.65 -3.76 39.51 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.897 -0.946 . . . . 0.0 114.26 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -17.41 62.53 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.677 1.991 . . . . 0.0 113.577 -164.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.67 140.96 49.88 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.8 -1.188 . . . . 0.0 109.149 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -57.35 134.91 56.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -68.77 130.75 43.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 153.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.4 mt . . . . . 0 C--O 1.235 0.329 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 160.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 CA--C 1.515 -0.401 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.1 mt -139.05 143.37 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.48 52.47 14.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.381 1.472 . . . . 0.0 111.433 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttp -113.55 137.77 51.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.871 1.268 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -133.85 153.05 52.01 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 126.098 1.759 . . . . 0.0 106.935 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.4 t -147.04 141.32 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.25 94.09 8.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.55 98.32 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 p -67.95 123.8 21.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.672 1.589 . . . . 0.0 113.032 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.1 mtp -124.46 162.02 24.82 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.453 -1.405 . . . . 0.0 112.403 -171.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.49 -60.76 1.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.681 1.192 . . . . 0.0 109.439 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -146.74 -73.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -122.59 0.46 9.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.944 1.298 . . . . 0.0 111.928 -167.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 178.18 7.34 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.25 -0.907 . . . . 0.0 110.547 165.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.8 mt -52.53 139.98 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.038 1.735 . . . . 0.0 109.156 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -68.39 166.39 16.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.041 1.336 . . . . 0.0 112.964 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.97 -46.29 71.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.39 1.476 . . . . 0.0 112.264 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 t -158.41 168.6 26.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 0.0 109.418 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.95 -33.52 75.53 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.534 1.934 . . . . 0.0 111.112 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.49 24.4 12.66 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.859 1.264 . . . . 0.0 110.198 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -139.99 32.17 1.98 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.829 0.852 . . . . 0.0 109.602 161.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.2 p -108.32 164.42 12.33 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.42 -29.22 9.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.091 0.956 . . . . 0.0 110.004 -171.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 31.8 p90 -159.96 163.53 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.339 0.59 . . . . 0.0 111.909 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' HD12 ' A' ' 51' ' ' ILE . 62.8 m-85 -104.87 107.57 18.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.69 1.996 . . . . 0.0 107.498 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 93.59 2.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -72.98 91.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 121.15 -0.969 . . . . 0.0 108.5 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 1.2 p -64.98 165.96 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.541 1.137 . . . . 0.0 109.939 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 127.52 24.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.973 1.715 . . . . 0.0 110.48 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.34 110.94 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 125.63 1.572 . . . . 0.0 107.233 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -118.04 -13.5 9.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.531 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -157.63 63.77 0.47 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 122.875 1.321 . . . . 0.0 108.615 170.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 53.58 18.59 1.48 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.123 2.169 . . . . 0.0 116.08 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.91 171.42 14.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.92 1.688 . . . . 0.0 108.355 170.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 113.24 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -105.35 -39.45 6.15 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.647 -0.658 . . . . 0.0 109.263 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.56 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.447 1.099 . . . . 0.0 108.078 176.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 28' ' ' VAL . 0.7 OUTLIER -159.98 176.93 11.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.513 1.925 . . . . 0.0 108.642 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.01 164.48 36.72 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 125.982 1.713 . . . . 0.0 110.903 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.477 0.6 OUTLIER -132.57 141.18 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 128.836 2.854 . . . . 0.0 117.076 164.728 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -129.47 117.82 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 129.695 3.198 . . . . 0.0 104.35 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -64.7 158.55 24.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.856 1.207 . . . . 0.0 111.758 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.84 89.37 4.06 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.578 0.751 . . . . 0.0 109.496 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -144.78 29.63 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.985 0.898 . . . . 0.0 112.546 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 75.24 -55.83 0.63 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.357 2.263 . . . . 0.0 111.771 170.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -60.48 -28.63 68.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.346 1.058 . . . . 0.0 109.864 166.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.04 -49.68 41.89 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -56.97 -39.04 73.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.884 0.842 . . . . 0.0 111.169 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -58.9 -47.16 85.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.463 1.029 . . . . 0.0 111.477 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 m -64.07 -33.54 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.051 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.424 HD12 ' CD2' ' A' ' 25' ' ' PHE . 84.2 mt -55.68 -40.35 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.148 0.885 . . . . 0.0 110.216 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -54.94 -47.12 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -81.21 -13.04 58.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -63.97 -19.34 65.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.221 1.373 . . . . 0.0 111.865 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 55.87 56.53 5.95 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.181 1.392 . . . . 0.0 109.068 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.31 146.45 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 171.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.93 -37.48 13.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.228 2.611 . . . . 0.0 110.578 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.6 168.12 24.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.159 0.983 . . . . 0.0 112.627 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -127.21 119.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.2 132.89 37.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 163.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.9 p -147.55 163.54 36.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.266 0.939 . . . . 0.0 108.672 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -75.07 -40.64 60.02 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 121.48 -0.763 . . . . 0.0 108.994 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -157.46 170.01 23.41 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.4 tt -163.49 124.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.64 0.776 . . . . 0.0 111.017 -170.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -51.15 141.31 14.63 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.56 0.744 . . . . 0.0 111.732 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.87 -45.82 60.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.852 1.661 . . . . 0.0 112.176 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -58.98 -52.43 65.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.97 0.804 . . . . 0.0 110.583 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -63.0 -41.41 99.58 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.227 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.15 -61.28 2.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.651 0.78 . . . . 0.0 109.642 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -63.49 -24.23 67.73 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 119.171 -0.442 . . . . 0.0 112.182 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -61.71 1.71 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.977 0.911 . . . . 0.0 109.517 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.69 -21.82 60.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.752 0.821 . . . . 0.0 112.499 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -63.15 -1.81 1.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -70.22 -32.96 71.09 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.999 -1.688 . . . . 0.0 113.492 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -153.86 13.56 0.46 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.301 1.409 . . . . 0.0 112.573 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -135.36 133.95 52.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -87.91 126.22 34.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.769 1.627 . . . . 0.0 108.601 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.2 mt -109.54 121.75 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.69 -1.256 . . . . 0.0 109.139 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 72.3 m-85 -121.18 146.9 46.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.364 2.266 . . . . 0.0 111.518 -166.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -90.1 146.58 24.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.73 0.412 . . . . 0.0 110.387 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 129.69 36.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.66 20.35 6.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.902 0.881 . . . . 0.0 112.135 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.74 -165.21 38.71 Favored Glycine 0 C--N 1.335 0.506 0 O-C-N 120.496 -1.378 . . . . 0.0 111.675 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.12 1.01 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.116 1.366 . . . . 0.0 109.499 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -86.92 104.75 16.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.6 -42.04 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -64.17 -47.48 79.68 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -168.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -61.53 -37.11 82.54 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.997 -1.065 . . . . 0.0 111.862 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.88 -33.8 76.39 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 120.891 -1.13 . . . . 0.0 111.386 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.97 -51.08 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -64.23 -37.68 88.33 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.447 0.567 . . . . 0.0 111.242 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.06 -43.91 94.04 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.065 0.393 . . . . 0.0 110.033 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -59.82 -44.81 93.84 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.72 0.408 . . . . 0.0 111.55 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.0 -48.49 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.228 1.011 . . . . 0.0 109.433 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.69 -36.53 84.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.911 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 9.11 21.34 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.062 -0.854 . . . . 0.0 113.237 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -29.66 59.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.289 1.036 . . . . 0.0 112.063 -167.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.73 138.38 58.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 135.68 42.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.6 mtmm -64.42 132.2 49.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 163.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.1 mt . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.433 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 mt -124.22 151.24 29.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 126.435 1.894 . . . . 0.0 108.789 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.3 t30 61.55 27.81 17.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.321 2.248 . . . . 0.0 113.198 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpp -78.08 149.12 33.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -140.81 140.39 34.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' A' ' 93' ' ' PHE . 54.7 t -140.69 130.86 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.284 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.26 106.89 18.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -92.32 123.75 44.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.453 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 79.3 p -62.43 128.32 35.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.588 1.086 . . . . 0.0 110.613 169.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 mtp -126.66 159.99 32.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.653 1.115 . . . . 0.0 110.689 172.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.22 -65.55 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.152 1.381 . . . . 0.0 107.948 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.54 -73.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 167.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -119.79 9.67 11.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.307 1.051 . . . . 0.0 112.482 -154.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 178.03 8.7 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 128.293 2.637 . . . . 0.0 107.603 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.82 146.03 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 p -83.54 -156.78 0.21 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.715 2.006 . . . . 0.0 111.985 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.55 -21.65 12.62 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' A' ' 63' ' ' ASN . 96.8 p -154.52 -167.89 2.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.892 1.224 . . . . 0.0 110.789 168.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -79.63 -29.01 40.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.84 1.256 . . . . 0.0 110.969 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -89.26 -43.17 11.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.764 0.711 . . . . 0.0 109.83 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.5 62.39 6.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.8 p -121.98 165.41 16.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.319 149.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -110.36 -29.31 8.18 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.702 1.201 . . . . 0.0 108.805 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.47 169.72 20.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 109.678 167.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.3 119.69 39.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.196 2.198 . . . . 0.0 105.662 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -79.98 105.72 11.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 mm -79.76 98.69 3.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 t -66.14 146.94 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 167.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.08 89.92 2.88 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.05 126.86 29.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 166.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -127.3 1.92 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 118.396 -0.812 . . . . 0.0 113.035 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -166.52 45.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.009 0.909 . . . . 0.0 110.488 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.66 8.56 1.79 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.895 -1.128 . . . . 0.0 114.01 -168.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.73 154.27 46.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.693 1.197 . . . . 0.0 109.883 162.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.64 108.12 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 107.757 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -88.95 -30.37 18.86 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.999 -1.063 . . . . 0.0 111.691 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -144.87 164.18 31.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 162.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 p -118.02 144.88 45.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.763 1.625 . . . . 0.0 106.912 165.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.86 155.59 27.65 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.535 1.134 . . . . 0.0 108.161 169.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.5 132.06 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.76 111.35 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -62.35 152.71 33.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.517 1.053 . . . . 0.0 109.768 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -74.73 88.3 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.67 165.28 27.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.174 1.789 . . . . 0.0 106.225 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -61.16 -39.31 89.64 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.523 -0.736 . . . . 0.0 111.737 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 t -63.97 -45.02 90.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.238 1.015 . . . . 0.0 108.481 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.95 -60.78 8.2 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 125.237 1.398 . . . . 0.0 112.062 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -62.75 -36.59 83.54 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 121.834 -0.804 . . . . 0.0 110.11 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -54.02 -44.87 71.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.637 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.1 m -70.69 -23.46 62.48 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.738 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.98 -46.18 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 121.478 1.944 . . . . 0.0 109.687 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -55.47 -18.11 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.64 . . . . 0.0 112.15 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.68 -14.85 14.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.735 -1.126 . . . . 0.0 112.592 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.06 -27.67 69.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.787 1.63 . . . . 0.0 111.026 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 63.42 53.89 2.06 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 125.238 1.415 . . . . 0.0 109.737 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.75 148.76 10.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -38.33 9.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.416 1.886 . . . . 0.0 110.257 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 161.17 43.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.07 0.548 . . . . 0.0 111.132 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -119.87 142.04 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.178 1.791 . . . . 0.0 107.221 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.34 106.35 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.749 1.22 . . . . 0.0 108.282 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 4.1 m -142.99 173.04 11.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' C ' HD21 ' A' ' 63' ' ' ASN . 64.1 mttt -71.86 -70.82 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.413 HD21 ' C ' ' A' ' 62' ' ' LYS . 2.6 m120 -119.58 170.26 9.33 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.532 -1.355 . . . . 0.0 108.021 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.89 137.87 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -68.5 141.32 55.61 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.194 0.997 . . . . 0.0 110.408 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -45.24 -52.35 9.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.355 2.262 . . . . 0.0 111.288 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -39.35 89.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.812 0.445 . . . . 0.0 110.966 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -69.86 -47.5 62.38 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -51.09 -62.97 1.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.38 -36.03 70.73 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.189 0.596 . . . . 0.0 110.993 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -63.95 -59.7 4.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.805 -0.56 . . . . 0.0 110.494 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -75.82 -28.75 58.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.544 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -65.78 -5.68 9.55 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.702 1.201 . . . . 0.0 113.548 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -47.03 -51.49 17.26 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.513 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -140.39 -15.97 0.94 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 87.9 mt -73.03 123.99 29.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.21 147.7 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.25 119.3 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -120.22 154.34 35.0 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.831 1.252 . . . . 0.0 110.555 -170.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -90.13 128.72 36.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 109.662 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.1 123.81 20.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.421 0.688 . . . . 0.0 111.037 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -108.39 100.42 9.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.925 2.09 . . . . 0.0 108.184 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.75 157.77 27.6 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -27.98 62.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.134 2.174 . . . . 0.0 111.823 164.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.8 103.66 6.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.058 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -44.75 -44.48 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 123.719 0.807 . . . . 0.0 109.097 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.17 -34.62 61.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.98 0.355 . . . . 0.0 110.603 -169.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -50.81 -53.16 34.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -67.22 -29.25 68.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.349 -170.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.09 -46.19 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -66.96 -39.3 87.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.887 0.767 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.4 -46.41 90.09 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CE2' HG21 ' A' ' 6' ' ' VAL . 78.5 t80 -62.05 -40.51 96.02 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 mt -55.68 -49.75 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.626 1.171 . . . . 0.0 109.464 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -73.22 -14.95 61.44 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.544 0.738 . . . . 0.0 112.805 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.81 18.53 63.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.077 0.853 . . . . 0.0 112.3 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.14 -27.92 62.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.548 1.539 . . . . 0.0 112.502 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.39 154.53 40.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.015 1.28 . . . . 0.0 109.464 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.35 149.5 35.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.043 0.937 . . . . 0.0 109.42 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -83.14 136.18 34.54 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 122.104 -0.373 . . . . 0.0 111.551 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.579 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.536 HG23 ' H ' ' A' ' 3' ' ' ASN . 2.1 mm -95.17 -161.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.013 2.125 . . . . 0.0 108.164 -178.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.536 ' H ' HG23 ' A' ' 2' ' ' ILE . 17.3 t-20 -53.07 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.195 2.598 . . . . 0.0 110.424 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.462 ' HE2' ' CE2' ' A' ' 93' ' ' PHE . 1.4 ttp -110.17 148.49 31.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -131.22 129.65 41.93 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 125.674 1.589 . . . . 0.0 106.747 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.405 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.5 t -136.35 132.66 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.5 111.37 22.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.4 123.58 44.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -73.46 127.71 33.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 117.821 0.282 . . . . 0.0 110.279 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtp -130.65 156.63 44.57 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.189 1.396 . . . . 0.0 111.053 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -104.06 -69.93 0.79 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 109.675 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.8 t -146.75 -47.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.23 17.59 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.773 0.797 . . . . 0.0 111.14 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -160.79 172.64 16.67 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 120.481 -1.387 . . . . 0.0 109.087 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.6 138.6 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 107.88 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.3 p -73.38 167.99 20.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.739 0.781 . . . . 0.0 111.025 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.29 -46.11 57.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.266 0.3 OUTLIER -137.89 161.68 36.01 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.59 -1.319 . . . . 0.0 108.441 -175.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -68.33 -45.77 72.03 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.979 -1.076 . . . . 0.0 108.299 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.69 -33.32 75.62 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.374 0.67 . . . . 0.0 110.692 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.73 58.02 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.916 1.341 . . . . 0.0 107.807 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 p -121.35 175.91 5.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.481 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -104.69 -35.34 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.584 0.754 . . . . 0.0 109.53 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 29.5 p90 -156.1 170.76 21.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.422 0.629 . . . . 0.0 110.533 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.87 115.99 27.19 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.022 1.729 . . . . 0.0 107.257 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.14 107.28 11.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.01 100.17 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -63.31 137.38 24.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -125.01 118.46 26.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -119.02 139.89 44.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -140.36 7.06 2.15 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.603 0.761 . . . . 0.0 109.517 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -168.44 51.08 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.571 1.548 . . . . 0.0 112.127 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 64.15 -5.3 0.33 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.177 1.791 . . . . 0.0 115.323 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -121.64 154.2 37.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.22 2.208 . . . . 0.0 109.296 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.74 96.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 107.321 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -70.33 -33.31 71.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 171.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 m -161.77 167.09 25.55 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.087 0.858 . . . . 0.0 111.127 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -127.02 118.66 24.9 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.509 1.523 . . . . 0.0 108.77 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 168.53 9.01 Favored 'General case' 0 C--O 1.213 -0.861 0 C-N-CA 125.754 1.622 . . . . 0.0 108.792 171.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.79 1.1 p -155.17 124.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 131.085 3.754 . . . . 0.0 115.947 -175.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.52 109.41 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 129.586 3.155 . . . . 0.0 102.921 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -61.36 156.11 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.122 0.874 . . . . 0.0 109.654 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -72.43 55.85 0.35 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.84 2.056 . . . . 0.0 111.121 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -107.29 168.57 9.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.2 -43.89 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.854 0.862 . . . . 0.0 109.614 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -77.36 -34.19 55.11 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.21 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.76 17.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.107 0.861 . . . . 0.0 111.25 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -61.1 -37.68 83.6 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.078 -1.248 . . . . 0.0 109.622 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -59.39 -34.71 72.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.923 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -65.49 -48.69 71.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 119.36 0.982 . . . . 0.0 110.453 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -55.15 -44.16 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.153 0.888 . . . . 0.0 110.521 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.0 t -55.76 -35.59 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.632 0.773 . . . . 0.0 110.825 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -95.59 -3.09 47.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.915 0.779 . . . . 0.0 112.287 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.91 168.41 18.77 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.757 1.162 . . . . 0.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -95.39 37.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.102 1.761 . . . . 0.0 110.045 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.94 138.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -82.18 -45.62 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.438 1.495 . . . . 0.0 109.968 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.4 158.65 42.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.285 1.034 . . . . 0.0 109.949 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.25 122.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.89 123.02 47.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -148.07 161.15 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.421 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -81.78 -34.21 30.46 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 124.245 1.018 . . . . 0.0 111.335 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -149.85 159.78 44.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.674 1.579 . . . . 0.0 107.533 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.39 136.22 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.946 2.098 . . . . 0.0 108.69 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -77.94 148.88 34.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.22 -38.55 89.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.0 0.52 . . . . 0.0 112.104 -165.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.49 -42.97 99.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.195 0.598 . . . . 0.0 109.4 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -70.35 -31.74 69.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.941 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -58.41 -58.39 8.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.22 1.373 . . . . 0.0 109.655 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -54.95 -43.66 73.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.922 0.489 . . . . 0.0 110.586 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -54.0 -58.58 6.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.006 1.722 . . . . 0.0 111.276 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -78.38 -35.3 47.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.34 -0.838 . . . . 0.0 112.983 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.9 t -50.44 -27.19 6.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.547 1.939 . . . . 0.0 111.546 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -45.05 -46.07 11.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.226 1.01 . . . . 0.0 113.094 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -149.03 14.68 0.91 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.198 -172.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.6 mt -136.44 122.94 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.29 126.88 31.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.767 1.227 . . . . 0.0 108.647 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.87 129.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -116.49 148.79 40.45 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.885 2.074 . . . . 0.0 109.534 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -88.62 142.16 27.92 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.75 48.99 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 161.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -108.1 8.41 28.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.726 1.61 . . . . 0.0 111.107 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.09 -174.96 39.27 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.872 0.76 . . . . 0.0 111.235 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.78 -14.3 15.27 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.759 1.224 . . . . 0.0 110.635 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.1 106.72 5.08 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.419 1.088 . . . . 0.0 108.199 173.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -54.86 -43.71 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.917 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.47 -34.28 70.06 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.877 0.762 . . . . 0.0 109.039 -168.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -59.02 -49.3 78.43 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 120.853 -1.154 . . . . 0.0 109.448 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -74.04 -28.37 61.39 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.403 -0.811 . . . . 0.0 112.515 -170.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mt -66.0 -55.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 31.6 p -61.7 -38.73 88.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.331 0.514 . . . . 0.0 112.132 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.1 mt -61.53 -34.17 75.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.05 0.54 . . . . 0.0 111.434 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.462 ' CE2' ' HE2' ' A' ' 4' ' ' MET . 85.1 t80 -72.79 -41.16 65.29 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.953 -1.092 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 83.7 mt -51.01 -54.57 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.159 1.384 . . . . 0.0 109.698 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.68 -20.84 63.55 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.694 0.798 . . . . 0.0 111.668 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.45 56.59 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -41.78 88.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.925 1.29 . . . . 0.0 110.366 164.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.58 140.71 53.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.418 1.008 . . . . 0.0 111.968 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.9 m -75.61 142.72 42.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.827 1.251 . . . . 0.0 111.104 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -76.37 150.82 36.78 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 160.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.258 -177.858 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.11 148.38 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t30 56.54 36.85 28.22 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.669 1.588 . . . . 0.0 112.948 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.9 tpp -80.76 148.74 29.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 174.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -137.27 141.59 41.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 165.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.77 138.65 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.378 171.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.7 104.35 16.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.31 111.37 24.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.2 p -63.21 151.06 41.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.195 1.816 . . . . 0.0 110.513 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 mtp -138.53 160.61 39.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.471 1.508 . . . . 0.0 109.06 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.57 -68.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.797 1.239 . . . . 0.0 108.417 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -142.89 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 120.369 -1.457 . . . . 0.0 108.295 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -118.14 -31.43 5.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.357 1.063 . . . . 0.0 112.199 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -139.44 179.66 6.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.367 1.067 . . . . 0.0 110.176 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.3 mt -51.47 127.36 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.495 1.918 . . . . 0.0 109.098 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 t -71.32 179.18 3.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.676 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -85.35 -31.09 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -161.44 148.17 14.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.393 1.451 . . . . 0.0 112.032 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.62 -27.08 66.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.496 1.518 . . . . 0.0 111.309 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.54 11.53 28.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.483 1.913 . . . . 0.0 113.001 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -139.89 -6.42 1.28 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.394 1.478 . . . . 0.0 112.734 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 p -74.23 161.55 29.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.151 0.581 . . . . 0.0 111.34 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -99.75 -32.58 10.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.147 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -155.61 171.14 20.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.451 -0.78 . . . . 0.0 111.588 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -115.61 115.27 26.13 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.742 2.017 . . . . 0.0 107.283 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.55 99.47 4.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.34 97.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.59 150.06 7.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.995 1.318 . . . . 0.0 108.398 168.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -127.28 132.18 50.37 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.68 143.9 39.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 170.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -147.96 -6.03 0.45 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -152.1 59.08 0.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 160.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.67 -24.19 0.12 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 128.788 2.835 . . . . 0.0 114.718 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -92.27 155.48 17.93 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.658 1.983 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.76 130.52 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.148 1.379 . . . . 0.0 109.108 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.18 -27.61 6.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 m -163.44 164.7 24.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 108.484 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.1 p -120.5 148.92 43.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 109.488 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 155.59 49.74 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.512 1.125 . . . . 0.0 108.805 172.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.6 OUTLIER -124.08 128.71 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 128.714 2.806 . . . . 0.0 117.538 166.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.56 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.98 134.85 53.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.982 0.81 . . . . 0.0 109.051 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -80.55 97.14 7.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -144.19 -68.95 0.31 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.317 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 46' ' ' SER . 1.6 pt-20 -155.78 -63.33 0.11 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.555 0.742 . . . . 0.0 109.058 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.436 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 39.0 m -53.9 -36.89 63.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.319 170.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.7 -63.07 3.68 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.163 0.887 . . . . 0.0 112.04 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -63.16 -37.13 86.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.856 0.862 . . . . 0.0 112.01 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -56.94 -44.01 82.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.751 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -64.55 -45.85 85.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.685 1.594 . . . . 0.0 111.273 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.8 mt -49.79 -44.45 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 120.156 1.344 . . . . 0.0 110.869 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.39 -31.92 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.245 -0.909 . . . . 0.0 110.964 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 8.64 43.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.867 0.867 . . . . 0.0 110.929 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -168.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -130.31 51.71 2.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.18 147.87 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -98.76 -31.31 11.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.5 1.12 . . . . 0.0 110.534 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.11 161.5 40.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.943 0.497 . . . . 0.0 111.936 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.97 125.37 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.69 114.83 40.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.1 m -141.04 165.5 27.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -69.13 -35.67 76.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.605 1.162 . . . . 0.0 111.207 172.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -155.3 161.8 41.02 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.79 142.65 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.044 1.738 . . . . 0.0 108.123 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -65.94 154.26 39.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.58 -51.74 68.63 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.075 0.55 . . . . 0.0 109.986 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.2 -46.38 88.59 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.08 -35.47 80.59 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.393 0.677 . . . . 0.0 111.791 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -59.92 -60.96 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.736 1.153 . . . . 0.0 109.693 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -65.37 -21.54 66.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 0.0 110.383 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -70.7 -66.91 0.55 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.443 1.497 . . . . 0.0 109.538 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.17 -18.77 60.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.547 -165.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 p -59.45 -9.35 2.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -74.36 104.79 5.24 Favored 'General case' 0 C--O 1.23 0.075 0 O-C-N 120.6 -1.313 . . . . 0.0 109.901 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 67.78 11.47 8.39 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.437 1.895 . . . . 0.0 114.031 174.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.4 142.84 42.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -109.8 144.03 38.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -122.12 117.35 51.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -164.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.4 148.87 42.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.399 1.88 . . . . 0.0 110.522 -167.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -96.12 118.97 33.77 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.573 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.62 124.83 22.9 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.806 0.843 . . . . 0.0 110.849 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.85 105.31 15.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.874 1.67 . . . . 0.0 107.923 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.7 176.93 49.42 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-O 122.623 1.124 . . . . 0.0 110.921 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.48 24.97 10.94 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.266 1.827 . . . . 0.0 107.046 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.55 105.84 15.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -52.42 -42.88 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.73 -47.06 86.98 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -57.14 -41.58 79.4 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.29 0.495 . . . . 0.0 110.898 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.45 -32.28 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.242 -0.911 . . . . 0.0 111.322 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.2 mt -67.95 -50.85 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 p -62.06 -42.96 99.73 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.937 0.789 . . . . 0.0 111.164 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.55 -43.31 99.09 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.956 0.502 . . . . 0.0 109.976 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -65.46 -48.46 72.61 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -52.61 -36.41 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.789 1.235 . . . . 0.0 110.237 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.05 -12.39 58.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.395 1.078 . . . . 0.0 113.538 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.94 4.38 88.62 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.838 1.209 . . . . 0.0 112.719 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -27.09 63.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.271 1.028 . . . . 0.0 112.572 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.56 145.64 55.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.688 0.677 . . . . 0.0 110.497 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -78.98 151.8 31.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.989 0.916 . . . . 0.0 108.615 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -81.0 134.84 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.1 mt . . . . . 0 C--O 1.241 0.616 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.409 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.6 mm -127.63 154.98 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.346 1.458 . . . . 0.0 108.692 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 54.58 21.25 3.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.433 1.893 . . . . 0.0 113.457 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.52 134.18 35.2 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.747 -1.845 . . . . 0.0 108.763 -169.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -138.36 113.48 9.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.511 0.724 . . . . 0.0 109.298 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 t -120.44 144.61 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 102.45 13.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.798 1.239 . . . . 0.0 108.61 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mt -84.85 128.18 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 p -75.49 123.36 25.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 117.984 0.356 . . . . 0.0 111.001 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.7 mtp -123.19 154.71 38.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.254 1.022 . . . . 0.0 111.116 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -107.43 -61.57 1.54 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.716 2.006 . . . . 0.0 109.732 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.4 t -140.11 -76.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.38 14.32 8.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.031 0.933 . . . . 0.0 110.965 -169.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 21.3 ptmt -148.67 169.73 19.74 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.883 1.273 . . . . 0.0 108.649 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.17 131.39 28.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -67.35 159.09 30.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.577 0.751 . . . . 0.0 110.099 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -51.49 -36.02 42.74 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.698 0.799 . . . . 0.0 111.623 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -158.47 178.26 10.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.047 0.385 . . . . 0.0 111.377 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -73.15 -10.11 59.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.757 2.423 . . . . 0.0 111.817 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -107.87 -10.0 15.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.844 -1.16 . . . . 0.0 112.643 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -116.3 10.19 14.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.094 1.357 . . . . 0.0 110.415 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.9 p -70.13 164.47 24.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.716 -1.24 . . . . 0.0 110.038 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -119.95 -21.48 7.11 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.216 1.806 . . . . 0.0 109.898 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -158.88 176.42 12.35 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.956 0.884 . . . . 0.0 110.45 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -124.48 111.07 15.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.924 2.49 . . . . 0.0 106.212 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.9 tp -79.04 110.7 14.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -84.47 93.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.17 148.07 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.31 1.844 . . . . 0.0 107.892 171.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -133.9 86.75 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -80.81 130.6 35.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.15 1.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.01 64.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 159.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.28 10.6 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.133 1.373 . . . . 0.0 114.41 -172.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -138.29 150.37 46.58 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.48 1.912 . . . . 0.0 108.779 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.22 95.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 128.021 2.528 . . . . 0.0 108.374 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -88.77 -27.21 21.29 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.907 -1.121 . . . . 0.0 110.88 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.85 178.87 8.53 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.467 1.031 . . . . 0.0 109.704 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -140.27 178.48 7.26 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.508 1.523 . . . . 0.0 109.542 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.27 162.82 33.73 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.924 2.089 . . . . 0.0 107.036 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.22 142.4 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.2 mt -128.14 109.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 166.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -60.3 142.14 55.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.564 1.074 . . . . 0.0 110.609 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -77.94 65.57 3.39 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.873 1.669 . . . . 0.0 108.949 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.01 95.15 2.52 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 52.71 -69.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.348 3.059 . . . . 0.0 115.465 157.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -44.95 -33.35 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.574 1.95 . . . . 0.0 110.88 157.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.27 -67.22 2.28 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 124.019 0.819 . . . . 0.0 111.371 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.66 -27.12 66.59 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -52.85 -51.46 60.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.686 1.13 . . . . 0.0 110.634 163.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -70.67 -20.93 62.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.986 0.514 . . . . 0.0 112.079 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.18 -11.73 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.592 1.157 . . . . 0.0 111.035 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.77 -23.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 119.906 -1.746 . . . . 0.0 111.16 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -114.7 52.64 0.84 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.537 1.062 . . . . 0.0 110.155 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -168.07 2.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.69 32.76 4.08 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.13 1.772 . . . . 0.0 109.397 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.67 140.92 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.94 -37.39 12.26 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.827 1.251 . . . . 0.0 109.168 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.33 151.45 26.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.229 1.012 . . . . 0.0 111.476 -171.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.5 mt -98.48 151.96 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 165.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.7 mt -124.28 130.05 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 161.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.1 p -146.65 160.82 41.7 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.88 1.272 . . . . 0.0 109.689 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -66.66 -47.72 71.62 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 167.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -154.88 172.87 17.33 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.0 tt -167.26 121.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -169.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -56.49 146.71 23.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -48.98 -43.99 40.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.341 1.456 . . . . 0.0 111.348 -174.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.25 -49.72 66.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.646 -0.658 . . . . 0.0 112.118 177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -58.28 -41.28 84.01 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.704 1.202 . . . . 0.0 109.849 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -59.35 -63.27 1.36 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.408 1.083 . . . . 0.0 109.529 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HG3' ' A' ' 66' ' ' GLU . 36.9 mttt -62.38 -21.89 65.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.711 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -72.76 -60.45 2.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.133 0.973 . . . . 0.0 110.03 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -75.46 -10.46 59.47 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.0 p -63.58 -9.02 11.36 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -77.2 117.93 19.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 120.414 -1.429 . . . . 0.0 108.311 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? 75.4 -31.48 0.21 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.335 3.054 . . . . 0.0 112.47 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mt -103.67 120.13 53.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.4 153.98 31.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.98 116.74 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.316 -1.49 . . . . 0.0 107.111 -166.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 7.1 m-85 -113.17 160.64 18.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.534 1.933 . . . . 0.0 110.703 -168.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -99.46 130.89 45.76 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 0.0 110.617 -173.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 131.04 36.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.019 0.927 . . . . 0.0 109.526 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -110.26 15.64 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.421 1.488 . . . . 0.0 112.271 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.76 172.64 31.14 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.437 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 13.0 m-20 -83.61 -24.13 31.6 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.567 0.747 . . . . 0.0 109.673 151.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.1 106.86 4.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.1 0.56 . . . . 0.0 109.776 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.6 -46.93 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.147 0.979 . . . . 0.0 109.517 168.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.0 -58.3 9.03 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -45.09 -49.55 11.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.974 1.309 . . . . 0.0 110.853 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.69 -41.56 87.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.953 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.58 -48.15 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -15.03 63.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.4 mt -83.71 -38.84 20.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.371 1.442 . . . . 0.0 109.226 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.564 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 54.5 t80 -65.21 -41.42 94.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -169.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.14 -45.93 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.288 2.235 . . . . 0.0 110.728 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.31 -19.52 56.3 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.942 -1.099 . . . . 0.0 111.816 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.0 39.27 63.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -17.88 62.02 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.086 0.943 . . . . 0.0 109.054 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -89.54 124.92 34.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 m -72.67 153.72 41.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.617 169.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 9.3 mtpm? -61.19 144.06 54.4 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 C--O 1.236 0.385 0 C-N-CA 124.516 1.126 . . . . 0.0 108.275 168.156 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.5 142.66 41.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.986 0.914 . . . . 0.0 109.551 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 44.65 66.31 0.9 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.166 2.986 . . . . 0.0 113.267 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.3 ttt -107.15 147.82 29.6 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -133.66 129.22 36.53 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.9 t -132.54 144.84 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 118.314 -0.85 . . . . 0.0 108.707 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.35 77.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.384 1.073 . . . . 0.0 108.785 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.23 141.89 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 0.0 109.68 -165.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 p -74.46 115.73 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.71 0.631 . . . . 0.0 111.491 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.1 mtp -122.21 148.49 44.89 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.27 -0.894 . . . . 0.0 111.102 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.98 -75.34 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 109.54 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 t -144.12 -46.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.598 1.159 . . . . 0.0 107.925 -167.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.53 2.35 1.24 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.56 -179.9 8.51 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 126.858 2.063 . . . . 0.0 108.808 -176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.9 139.29 19.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.3 p -69.71 -84.52 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.704 1.602 . . . . 0.0 110.271 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 t30 177.0 -55.03 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 127.518 2.327 . . . . 0.0 107.304 -167.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.3 t -126.42 -175.15 3.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.931 1.242 . . . . 0.0 110.228 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -85.4 -43.3 13.76 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.3 1.44 . . . . 0.0 108.544 166.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.66 -19.43 60.84 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.028 -0.42 . . . . 0.0 110.414 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -119.96 74.32 1.02 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.0 p -134.27 165.16 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.212 1.805 . . . . 0.0 107.825 151.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -90.45 -37.43 13.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.352 0.661 . . . . 0.0 109.783 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.31 171.09 19.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.673 0.749 . . . . 0.0 110.456 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.04 108.8 16.19 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.091 2.556 . . . . 0.0 106.304 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.72 103.71 8.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.3 mm -79.19 88.36 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.558 0.695 . . . . 0.0 109.192 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -58.24 125.88 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 168.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -103.53 110.09 22.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.26 143.65 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 161.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -136.05 -0.36 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.92 45.52 0.28 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.665 0.745 . . . . 0.0 110.136 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.6 -9.7 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.252 2.221 . . . . 0.0 115.318 -167.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.99 163.46 22.27 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.105 1.32 . . . . 0.0 111.648 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -44.51 128.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 128.375 2.67 . . . . 0.0 111.159 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -91.17 -86.92 0.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.52 -0.66 9.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.316 1.416 . . . . 0.0 113.904 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 p 49.61 -166.4 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.894 -1.129 . . . . 0.0 110.723 -160.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.44 166.35 3.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.488 2.315 . . . . 0.0 107.442 165.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.89 132.3 65.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.9 mt -127.84 119.54 51.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.32 157.96 35.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.533 1.06 . . . . 0.0 110.722 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -84.11 65.21 8.63 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.884 -1.135 . . . . 0.0 108.578 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -130.55 28.42 4.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.236 1.017 . . . . 0.0 113.717 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 70.9 -54.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 128.759 2.824 . . . . 0.0 111.231 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.8 t -53.68 -36.27 61.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.085 1.354 . . . . 0.0 110.583 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.59 8.53 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 125.243 1.402 . . . . 0.0 111.891 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.83 -34.7 69.98 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.97 -0.724 . . . . 0.0 110.959 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -49.74 -44.03 48.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.018 0.927 . . . . 0.0 111.438 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -43.7 85.51 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.345 0.658 . . . . 0.0 111.315 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.6 -37.85 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 110.258 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -54.61 -45.43 71.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.138 0.427 . . . . 0.0 110.626 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -34.84 66.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.12 -14.75 62.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.859 -159.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.96 63.63 1.66 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.556 1.542 . . . . 0.0 109.355 -172.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.21 140.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.223 157.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -73.61 -47.82 37.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.1 40.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.22 108.0 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.23 125.37 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -142.51 177.02 8.57 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.573 1.149 . . . . 0.0 108.925 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -88.2 -38.45 15.29 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.273 -0.892 . . . . 0.0 110.972 166.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.65 162.79 35.04 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.495 1.043 . . . . 0.0 109.189 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 tt -165.56 132.72 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.257 1.423 . . . . 0.0 108.53 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.1 p -65.02 157.91 27.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.157 0.983 . . . . 0.0 112.162 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -50.8 -53.64 30.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.502 1.521 . . . . 0.0 110.635 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -38.5 79.31 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.42 0.628 . . . . 0.0 111.294 -166.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.96 -37.78 72.78 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.967 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -55.69 -57.01 13.78 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 120.045 1.293 . . . . 0.0 111.154 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -57.19 -43.51 82.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.774 0.716 . . . . 0.0 110.533 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -53.43 -69.36 0.12 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.648 1.579 . . . . 0.0 110.129 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -68.37 -36.69 79.57 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.346 0.521 . . . . 0.0 110.854 -169.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.2 t -54.14 -24.37 17.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.516 1.526 . . . . 0.0 112.908 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -65.2 -10.52 32.23 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.697 -1.252 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -156.16 3.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.932 1.696 . . . . 0.0 112.942 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -141.21 125.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.87 133.34 35.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.87 138.03 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 120.644 -1.285 . . . . 0.0 108.845 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -129.81 156.3 44.56 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.537 1.935 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -98.15 137.65 36.61 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.043 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.49 122.92 32.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.274 2.23 . . . . 0.0 112.498 -174.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.09 108.93 20.51 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.716 2.006 . . . . 0.0 109.939 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.48 -176.7 53.6 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -163.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -118.14 -2.21 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.918 0.887 . . . . 0.0 110.211 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.67 103.48 7.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.21 1.004 . . . . 0.0 108.475 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.45 -38.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.144 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.29 -40.97 86.15 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.878 0.763 . . . . 0.0 109.697 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -64.29 -43.04 96.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.875 -0.516 . . . . 0.0 110.727 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.18 -33.23 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.459 -1.401 . . . . 0.0 110.483 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.79 -51.68 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.548 1.539 . . . . 0.0 108.088 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 p -75.01 -18.75 60.31 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.83 -37.74 62.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.515 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 80.2 t80 -67.79 -42.58 81.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.776 -0.577 . . . . 0.0 111.963 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 mt -51.86 -50.99 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.72 1.608 . . . . 0.0 108.377 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.8 -18.39 62.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.529 1.132 . . . . 0.0 113.978 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.65 23.11 54.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 118.85 0.75 . . . . 0.0 111.919 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -28.6 66.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.118 1.459 . . . . 0.0 109.32 -170.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 1.2 mm? -82.11 135.73 35.27 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.78 1.232 . . . . 0.0 108.899 -163.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.5 p -71.06 157.45 38.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.469 1.107 . . . . 0.0 108.842 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -87.87 132.86 34.04 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt . . . . . 0 C--O 1.236 0.36 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.674 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 CA--C 1.511 -0.556 0 CA-C-O 121.352 0.596 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.62 146.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.547 1.539 . . . . 0.0 108.601 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 47.51 32.92 2.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.423 1.889 . . . . 0.0 115.061 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.9 151.06 31.17 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.663 -1.273 . . . . 0.0 107.625 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 155.04 50.29 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 156.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.424 ' CG1' ' HB ' ' A' ' 28' ' ' VAL . 7.3 p -146.68 165.74 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 128.097 2.559 . . . . 0.0 104.903 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.45 133.6 55.63 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 120.178 1.353 . . . . 0.0 111.646 153.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mt -105.43 119.29 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -62.45 114.32 3.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.864 1.211 . . . . 0.0 108.715 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.7 mtp -117.98 156.31 28.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 110.906 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.31 -69.63 0.76 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 127.752 2.421 . . . . 0.0 108.27 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 t -137.71 -67.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 168.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.3 -7.24 11.78 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 171.48 13.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.505 1.522 . . . . 0.0 110.058 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -59.54 139.32 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 p -84.04 166.42 17.74 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.528 0.731 . . . . 0.0 111.076 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -50.47 -43.99 55.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.833 1.653 . . . . 0.0 113.934 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.08 168.36 19.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.409 0.549 . . . . 0.0 110.133 -166.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -67.72 -23.45 65.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.01 1.724 . . . . 0.0 112.499 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.79 -30.19 13.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.791 1.178 . . . . 0.0 111.54 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.74 10.12 8.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.221 1.408 . . . . 0.0 111.809 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.5 p -80.1 167.62 20.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 122.174 0.988 . . . . 0.0 110.631 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -108.12 -28.71 9.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.516 1.526 . . . . 0.0 109.217 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -159.36 178.35 10.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.603 0.638 . . . . 0.0 111.451 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -125.49 105.64 9.2 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 129.24 3.016 . . . . 0.0 106.612 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.83 111.99 11.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -81.24 98.32 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 6' ' ' VAL . 2.9 t -63.96 132.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.08 98.51 6.11 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 163.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.37 152.75 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.41 -20.35 1.06 Allowed 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -161.31 68.59 0.31 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 169.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.6 m120 54.9 10.62 0.4 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.301 2.241 . . . . 0.0 115.269 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -129.23 158.54 38.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.379 1.072 . . . . 0.0 112.503 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.49 96.13 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.709 1.604 . . . . 0.0 107.753 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -100.48 -20.21 15.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.202 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -156.78 148.89 23.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.248 1.385 . . . . 0.0 111.167 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 p -126.18 156.94 39.39 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.534 1.934 . . . . 0.0 109.427 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 162.26 37.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.729 1.211 . . . . 0.0 108.881 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.82 112.11 23.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.26 115.57 34.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 161.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -66.77 158.09 31.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.081 1.31 . . . . 0.0 110.524 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.22 81.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -130.3 -170.97 2.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.685 1.231 . . . . 0.0 108.739 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.51 -49.92 75.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.33 1.852 . . . . 0.0 111.061 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.3 m -65.46 -37.68 87.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.894 0.316 . . . . 0.0 110.776 175.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.48 -62.98 5.73 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 123.552 0.596 . . . . 0.0 112.795 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -59.67 -28.93 67.69 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.589 0.756 . . . . 0.0 111.219 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -71.35 -32.51 68.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.943 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -65.22 -38.22 89.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 119.257 0.935 . . . . 0.0 110.357 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -62.49 -17.31 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 118.753 0.706 . . . . 0.0 111.715 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.7 t -82.2 -30.18 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 119.51 -1.994 . . . . 0.0 112.205 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.83 54.84 1.13 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.544 1.138 . . . . 0.0 109.08 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 -165.14 1.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.854 1.662 . . . . 0.0 111.017 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.46 19.33 7.44 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.199 2.2 . . . . 0.0 108.94 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.4 166.06 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.95 1.25 . . . . 0.0 109.944 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.72 -33.34 6.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 109.522 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.6 163.11 34.91 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -161.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.4 mt -134.14 118.34 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 163.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mt -81.08 133.35 29.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 120.488 1.494 . . . . 0.0 107.171 166.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 p -144.51 168.13 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.86 1.209 . . . . 0.0 112.251 168.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -93.4 -27.2 16.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 117.455 -1.259 . . . . 0.0 112.727 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -161.26 161.37 30.7 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.005 1.722 . . . . 0.0 107.061 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -151.46 127.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 126.403 1.881 . . . . 0.0 108.515 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -54.8 148.35 13.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.125 0.97 . . . . 0.0 110.442 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -61.6 -38.8 88.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.416 1.007 . . . . 0.0 111.524 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.21 -51.65 62.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -57.81 -43.13 85.47 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -56.41 -58.57 7.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.128 0.422 . . . . 0.0 110.145 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.46 -20.67 66.45 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 122.374 -0.204 . . . . 0.0 111.275 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -75.44 -35.74 60.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.18 -0.95 . . . . 0.0 111.941 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.09 -16.67 18.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.698 0.799 . . . . 0.0 111.812 -172.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.82 -17.45 56.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -71.99 106.99 4.48 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 120.566 -1.334 . . . . 0.0 109.611 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 tttm 73.95 21.28 2.66 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.143 1.777 . . . . 0.0 111.954 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.64 144.11 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.597 1.559 . . . . 0.0 107.742 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -102.59 108.8 20.21 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.42 114.83 30.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -105.92 149.15 26.85 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.685 1.194 . . . . 0.0 110.117 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -83.13 147.17 28.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.78 168.05 20.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 109.924 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.6 5.9 14.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.419 2.287 . . . . 0.0 112.366 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.96 -169.37 41.8 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.15 -14.17 34.14 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.539 1.135 . . . . 0.0 110.0 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.66 99.35 2.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.744 1.218 . . . . 0.0 109.659 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -52.97 -42.05 42.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.37 -38.49 71.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.116 0.871 . . . . 0.0 110.305 -171.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -57.14 -50.35 73.09 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.61 -31.74 65.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.1 -54.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.895 1.278 . . . . 0.0 108.053 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 p -66.82 -36.57 82.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.357 0.526 . . . . 0.0 111.184 -172.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.3 mt -63.93 -40.46 96.5 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.243 0.617 . . . . 0.0 111.171 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -63.85 -34.42 77.88 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.478 0.711 . . . . 0.0 112.223 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.4 mt -59.21 -45.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 -18.55 60.7 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.214 1.006 . . . . 0.0 112.135 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.73 14.17 81.4 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.468 -0.77 . . . . 0.0 112.217 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -19.9 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.631 1.973 . . . . 0.0 112.592 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -67.13 140.81 57.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.016 -1.052 . . . . 0.0 109.492 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.0 m -64.6 125.51 24.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.452 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -81.04 126.88 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--O 1.24 0.58 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.8 mt -122.06 148.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.47 23.21 10.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.998 1.719 . . . . 0.0 113.42 171.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpp -68.57 147.06 52.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -134.34 141.09 46.78 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 166.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.24 140.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 110.02 21.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.493 0.717 . . . . 0.0 109.436 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.7 mt -95.07 123.96 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 p -80.91 112.19 18.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtp -108.87 158.12 17.97 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -108.08 -53.13 2.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 127.738 2.415 . . . . 0.0 109.143 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.26 -79.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.41 -3.37 16.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.134 0.974 . . . . 0.0 112.003 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 171.23 16.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.304 1.842 . . . . 0.0 110.955 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.5 mt -64.98 124.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.738 1.615 . . . . 0.0 107.3 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 t -66.55 173.1 3.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.155 0.889 . . . . 0.0 111.229 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.67 -27.75 67.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.53 0.732 . . . . 0.0 111.749 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 p -147.69 177.2 9.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.69 -0.631 . . . . 0.0 110.373 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -69.26 -37.28 77.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.511 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -88.48 -39.24 14.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.481 0.713 . . . . 0.0 109.629 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.27 31.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.648 2.379 . . . . 0.0 111.276 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 p -99.28 172.53 7.29 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 119.968 -1.707 . . . . 0.0 111.096 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -103.59 -30.05 10.73 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.592 1.557 . . . . 0.0 110.065 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -166.82 176.94 6.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 43' ' ' ASN . 41.9 m-85 -123.7 102.55 7.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 126.409 1.884 . . . . 0.0 107.29 -169.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 103.32 11.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.87 95.42 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.349 1.86 . . . . 0.0 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 t -76.2 92.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.83 115.99 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 156.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.59 131.89 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.06 3.03 3.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.55 44.33 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 111.545 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.55 8.16 2.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.007 0.923 . . . . 0.0 112.577 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -134.18 165.41 25.15 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 126.967 2.107 . . . . 0.0 111.212 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -61.82 128.73 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 127.068 2.147 . . . . 0.0 109.614 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.15 -85.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.757 -0.639 . . . . 0.0 109.7 167.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -15.19 14.45 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 44.84 -168.34 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.373 1.069 . . . . 0.0 112.11 -163.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 163.43 8.57 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 125.164 1.385 . . . . 0.0 109.784 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.669 0.7 OUTLIER -118.91 140.16 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 119.456 3.132 . . . . 0.0 119.456 159.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.7 mt -124.56 122.93 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 129.261 3.024 . . . . 0.0 105.175 164.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -68.01 155.57 39.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.365 1.893 . . . . 0.0 111.057 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 45.0 t30 -77.31 61.79 2.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.52 1.528 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -97.38 161.92 13.57 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 165.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -44.04 93.35 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.113 -0.992 . . . . 0.0 108.324 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -70.4 -16.23 62.93 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.962 -1.086 . . . . 0.0 111.293 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -64.03 2.89 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 166.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 43.3 pttt -65.87 -23.37 66.64 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.76 -0.847 . . . . 0.0 111.977 -172.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -38.57 83.92 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 171.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -72.86 -32.08 65.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.925 1.29 . . . . 0.0 110.172 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.407 HD13 ' CD2' ' A' ' 25' ' ' PHE . 58.8 mt -55.07 -42.97 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.78 1.232 . . . . 0.0 109.761 176.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.12 -26.36 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.406 -0.809 . . . . 0.0 111.667 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -97.7 -28.22 14.0 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.865 0.866 . . . . 0.0 110.97 -172.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -25.52 63.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.695 1.198 . . . . 0.0 111.884 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.2 t30 74.2 51.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.406 2.282 . . . . 0.0 109.958 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -50.82 152.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.868 1.667 . . . . 0.0 109.324 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -42.97 10.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.091 1.357 . . . . 0.0 109.175 171.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.24 160.12 42.72 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.3 mt -116.42 144.0 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.685 1.194 . . . . 0.0 107.962 171.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.8 mt -123.04 121.28 62.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.0 p -149.3 170.81 17.64 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.773 1.229 . . . . 0.0 109.345 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -82.66 -40.04 21.25 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.104 167.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -147.64 164.42 33.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.502 1.501 . . . . 0.0 109.61 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.5 tt -144.77 145.38 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.406 1.482 . . . . 0.0 109.095 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -62.49 155.47 25.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.197 0.908 . . . . 0.0 109.562 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.04 -43.37 87.75 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 118.824 0.738 . . . . 0.0 109.04 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.39 -45.24 94.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 110.666 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -61.79 -47.94 82.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.783 1.233 . . . . 0.0 109.263 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.56 -58.94 5.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.724 1.147 . . . . 0.0 110.541 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.51 -22.39 66.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.581 0.628 . . . . 0.0 111.892 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -76.66 -44.04 35.51 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 120.829 -1.169 . . . . 0.0 110.885 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -88.04 -8.28 55.8 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.148 0.979 . . . . 0.0 112.753 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 p -73.26 43.14 0.13 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.835 1.652 . . . . 0.0 112.551 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -139.91 111.84 7.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.412 1.885 . . . . 0.0 106.662 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? 60.81 -1.22 0.25 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 113.948 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.5 mt -131.27 134.25 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -169.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.56 130.49 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.499 1.52 . . . . 0.0 107.034 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.5 mt -104.17 118.5 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -110.29 155.38 22.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.237 1.815 . . . . 0.0 110.821 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -99.06 118.1 35.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.798 1.239 . . . . 0.0 110.348 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.95 135.15 57.7 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 168.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HG3' HD22 ' A' ' 89' ' ' ASN . 0.0 OUTLIER -79.74 -16.24 55.98 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.291 1.036 . . . . 0.0 112.722 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.89 -178.73 46.87 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 126.11 1.814 . . . . 0.0 109.078 -149.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -96.48 -15.35 21.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.097 0.959 . . . . 0.0 110.042 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.41 99.81 2.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.45 1.5 . . . . 0.0 110.014 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.57 -41.79 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.27 -39.28 89.31 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.8 0.727 . . . . 0.0 110.997 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -46.23 90.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.519 0.676 . . . . 0.0 109.517 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.413 HD22 ' HG3' ' A' ' 82' ' ' GLU . 32.6 m-80 -74.17 -26.22 60.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.702 -170.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.0 mt -67.19 -51.26 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.006 0.821 . . . . 0.0 108.797 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.8 p -71.38 -33.05 69.17 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.429 0.558 . . . . 0.0 111.503 -173.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -42.68 95.88 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.69 -0.631 . . . . 0.0 110.268 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -57.89 -47.56 82.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.781 0.433 . . . . 0.0 111.872 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 mt -51.03 -56.49 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.168 1.387 . . . . 0.0 111.119 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -73.43 -1.93 20.32 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.055 1.298 . . . . 0.0 113.573 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.61 86.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.263 0.935 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -27.56 67.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.077 1.751 . . . . 0.0 112.146 -173.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.22 144.42 57.15 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.46 139.39 49.61 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.33 -0.857 . . . . 0.0 110.188 172.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.92 123.0 30.76 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 C--O 1.239 0.536 0 C-N-CA 124.475 1.11 . . . . 0.0 109.752 -175.167 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.2 mt -146.8 46.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.352 0.596 . . . . 0.0 112.097 -173.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 t30 173.54 42.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.846 2.059 . . . . 0.0 107.509 163.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 146.79 32.94 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 120.598 -1.314 . . . . 0.0 108.127 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -145.85 120.41 9.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.892 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.9 152.98 25.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 109.613 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.75 120.62 40.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.653 1.181 . . . . 0.0 108.359 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.15 118.9 54.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -63.2 105.41 0.71 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.757 0.823 . . . . 0.0 109.636 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.15 155.85 22.26 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -93.71 -76.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.603 1.961 . . . . 0.0 107.393 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -139.61 -56.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 1.26 3.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -160.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -156.6 173.79 16.41 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.252 2.221 . . . . 0.0 108.519 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.31 139.31 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.788 0.68 . . . . 0.0 111.147 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 163.48 21.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 111.308 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.83 -16.82 60.02 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -166.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.46 172.63 17.92 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.672 1.989 . . . . 0.0 107.335 170.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.18 -50.54 73.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.34 1.056 . . . . 0.0 108.768 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -74.5 -44.49 51.13 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -165.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.9 4.15 0.91 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 128.55 2.74 . . . . 0.0 113.641 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 p -67.57 165.92 15.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 123.057 1.408 . . . . 0.0 110.742 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -106.58 -30.75 8.84 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.919 1.687 . . . . 0.0 108.688 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 28.2 p90 -155.35 164.94 38.07 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.158 0.98 . . . . 0.0 109.834 172.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.55 112.48 25.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.04 114.01 14.2 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mm -84.04 93.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.08 101.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -91.72 121.6 33.51 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -125.75 115.69 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.63 -0.64 6.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.387 -169.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.09 61.24 0.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.135 0.969 . . . . 0.0 110.433 156.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.63 6.89 0.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.238 1.815 . . . . 0.0 114.679 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.18 163.29 23.48 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.1 2.56 . . . . 0.0 109.378 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.91 74.96 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 122.408 1.099 . . . . 0.0 108.101 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -57.37 -29.58 64.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.909 1.684 . . . . 0.0 112.118 -170.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 m -154.82 115.26 3.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.401 1.0 . . . . 0.0 108.845 164.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -64.02 141.62 58.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 161.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.09 161.2 38.8 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 124.53 1.132 . . . . 0.0 109.274 -178.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.474 0.6 OUTLIER -142.53 132.44 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 178.602 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.423 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 66.0 mt -119.59 113.13 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -65.46 152.07 44.84 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.773 0.715 . . . . 0.0 109.439 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -75.57 87.38 2.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.57 174.99 10.0 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.57 2.748 . . . . 0.0 105.038 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -62.13 -38.64 89.71 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.487 -1.383 . . . . 0.0 111.567 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 t -61.43 -18.56 59.43 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.697 -0.627 . . . . 0.0 111.316 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -75.23 -61.09 3.1 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -66.91 -15.4 63.64 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.368 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -60.98 -64.57 0.91 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.837 1.199 . . . . 0.0 109.639 161.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.3 m -54.13 -37.73 64.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.991 0.916 . . . . 0.0 113.344 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.4 mt -50.74 -40.4 19.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.075 1.35 . . . . 0.0 111.608 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.48 -46.88 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.082 -1.012 . . . . 0.0 109.063 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -73.66 -21.77 60.17 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.833 0.853 . . . . 0.0 112.978 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.81 -26.65 63.41 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.346 -0.847 . . . . 0.0 111.094 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 74.25 38.33 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.849 1.66 . . . . 0.0 112.536 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.44 138.13 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.558 1.143 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -66.48 -56.68 9.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.019 1.728 . . . . 0.0 108.74 168.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.82 29.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -169.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.56 148.44 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.5 mt -119.41 123.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.35 2.26 . . . . 0.0 104.978 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.76 154.33 31.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.803 1.638 . . . . 0.0 111.141 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -71.94 -25.9 62.07 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.34 -0.85 . . . . 0.0 111.124 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -172.23 166.15 5.96 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.84 132.84 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.017 0.436 . . . . 0.0 110.285 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.42 147.25 32.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.528 0.731 . . . . 0.0 109.622 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -48.71 79.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.343 1.057 . . . . 0.0 110.506 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -56.67 -47.97 78.64 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -64.51 -44.94 89.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.724 1.21 . . . . 0.0 110.424 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -54.9 -64.88 0.7 Allowed 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 118.682 0.674 . . . . 0.0 109.552 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -57.02 -33.15 66.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.771 0.828 . . . . 0.0 111.518 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -71.33 -34.34 70.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.56 1.944 . . . . 0.0 113.457 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -99.26 -23.39 15.21 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.706 0.685 . . . . 0.0 112.541 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -68.68 15.24 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -166.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -19.04 13.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.754 1.161 . . . . 0.0 113.151 -174.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -34.78 0.48 Allowed 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.188 -0.945 . . . . 0.0 113.188 175.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.6 mt -89.53 127.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.95 145.44 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.132 0.973 . . . . 0.0 108.66 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -113.67 122.67 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 120.377 -1.452 . . . . 0.0 107.748 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 72.5 m-85 -105.81 156.07 18.68 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.43 1.892 . . . . 0.0 108.257 172.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -68.06 177.19 2.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.283 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.75 149.54 48.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.959 1.303 . . . . 0.0 110.45 165.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.254 19.6 mp0 -106.22 -162.35 0.85 Allowed 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 129.09 2.956 . . . . 0.0 106.097 -165.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.3 166.88 0.04 OUTLIER Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.043 -1.035 . . . . 0.0 114.272 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -23.3 19.53 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.185 1.794 . . . . 0.0 113.555 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -72.13 101.83 2.87 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 125.083 1.489 . . . . 0.0 107.645 -171.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -53.55 -39.89 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -39.7 82.38 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -174.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -59.3 -45.58 90.9 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.24 -0.912 . . . . 0.0 109.339 170.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.93 -38.8 89.6 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.453 1.024 . . . . 0.0 111.046 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.07 -49.45 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 108.522 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 p -65.98 -36.89 84.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.813 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.4 mt -61.67 -44.44 96.96 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.709 0.686 . . . . 0.0 109.22 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -57.78 -57.25 13.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.288 0.635 . . . . 0.0 110.91 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.6 mt -51.82 -34.42 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.496 1.919 . . . . 0.0 111.183 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -84.96 -14.86 46.22 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 24.61 54.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 119.509 1.05 . . . . 0.0 112.395 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -24.54 36.19 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.793 1.237 . . . . 0.0 112.54 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 29.3 mt -73.18 142.92 47.39 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.274 1.035 . . . . 0.0 110.402 -171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 133.27 34.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 110.819 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 9.9 mtpm? -72.07 142.76 49.24 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 C--O 1.239 0.51 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.544 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HB2' ' A' ' 4' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.01 147.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.793 172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.58 56.89 1.93 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.341 2.656 . . . . 0.0 112.162 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.412 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 25.1 tpp -83.78 149.33 26.5 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.907 0.776 . . . . 0.0 109.928 170.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 38.6 mtpt -142.56 132.95 24.93 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.232 0.958 . . . . 0.0 108.491 153.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 28' ' ' VAL . 4.9 p -128.93 166.14 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 128.523 2.729 . . . . 0.0 107.439 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.64 110.47 13.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.37 1.468 . . . . 0.0 109.74 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -94.72 122.65 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.242 0.928 . . . . 0.0 108.932 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 p -72.11 97.45 1.93 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.128 1.371 . . . . 0.0 109.95 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.0 mtp -102.98 154.73 18.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.27 1.028 . . . . 0.0 110.6 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.79 -61.08 1.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.2 t -141.7 -71.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.77 10.72 7.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.8 1.286 . . . . 0.0 112.944 -167.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 175.54 12.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.811 2.444 . . . . 0.0 108.948 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.42 140.72 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.763 1.225 . . . . 0.0 108.456 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 t -73.61 -87.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -178.48 -36.45 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.795 1.638 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.27 154.32 36.56 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.336 0.588 . . . . 0.0 110.332 -177.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.48 -48.32 82.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.766 0.826 . . . . 0.0 110.047 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -78.17 -6.41 54.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.395 0.678 . . . . 0.0 112.804 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.16 -16.71 14.03 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.08 0.854 . . . . 0.0 111.063 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.0 p -72.62 170.65 14.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 122.154 0.978 . . . . 0.0 111.755 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -106.09 -26.32 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.881 1.272 . . . . 0.0 110.331 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -161.22 166.49 27.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.518 0.675 . . . . 0.0 110.364 170.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -105.36 116.41 31.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.423 1.489 . . . . 0.0 108.044 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.61 118.44 20.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 170.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -92.0 95.11 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.394 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 6' ' ' VAL . 1.9 t -78.33 104.09 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.82 140.8 36.69 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 156.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 145.19 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 164.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.19 18.64 0.36 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.98 52.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 128.506 2.722 . . . . 0.0 107.263 169.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.75 2.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 129.288 3.035 . . . . 0.0 113.694 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.16 150.84 40.67 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 128.203 2.601 . . . . 0.0 107.876 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.3 91.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.042 2.137 . . . . 0.0 109.884 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -53.55 -70.16 0.1 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 110.979 174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -151.79 112.71 4.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -69.26 164.17 23.37 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.23 1.412 . . . . 0.0 110.452 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 164.79 30.18 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 125.944 1.698 . . . . 0.0 108.534 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.54 148.23 26.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mt -134.33 105.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 166.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -57.34 145.46 32.26 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.61 97.95 0.34 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.406 1.882 . . . . 0.0 106.096 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -51.26 67.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.068 0.947 . . . . 0.0 109.339 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 t -68.45 -26.54 65.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.968 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -63.58 4.97 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -65.39 -22.61 66.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.461 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -68.96 -47.42 65.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.222 1.374 . . . . 0.0 109.039 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -44.6 73.16 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 110.102 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.1 mt -52.59 -35.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.648 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.21 -40.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 120.586 -1.321 . . . . 0.0 110.649 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.2 -8.75 44.57 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.346 0.658 . . . . 0.0 111.854 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' CD ' ' HZ3' ' A' ' 5' ' ' LYS . 10.5 mm-40 -60.3 -16.37 33.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.538 1.535 . . . . 0.0 111.226 166.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 53.29 36.47 22.83 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.985 1.714 . . . . 0.0 111.031 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.13 134.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -73.05 -39.63 65.75 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.422 1.889 . . . . 0.0 110.519 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.58 165.47 26.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mt -131.45 132.5 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.068 1.347 . . . . 0.0 107.5 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -104.12 130.97 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -146.46 175.83 10.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.649 0.659 . . . . 0.0 111.32 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -96.9 -24.27 15.93 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.099 1.36 . . . . 0.0 111.47 164.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -155.74 161.33 40.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.075 1.75 . . . . 0.0 108.311 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.82 130.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.833 1.653 . . . . 0.0 108.643 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -63.41 147.1 52.14 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.417 1.087 . . . . 0.0 110.489 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -55.29 -45.17 76.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.247 2.219 . . . . 0.0 111.998 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.37 -50.95 63.62 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.721 -0.612 . . . . 0.0 109.743 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -62.51 -39.13 92.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.75 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -51.53 -56.61 12.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.396 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -61.6 -43.26 99.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.198 0.599 . . . . 0.0 110.45 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -59.35 -40.91 87.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.19 1.396 . . . . 0.0 112.783 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -92.39 -34.66 14.07 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.259 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 t -70.56 16.33 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.144 1.778 . . . . 0.0 114.185 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -100.64 -17.26 17.11 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.977 1.711 . . . . 0.0 113.031 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -145.22 -6.57 0.64 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.838 0.855 . . . . 0.0 112.776 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.7 mt -136.19 133.5 50.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -165.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.72 113.34 22.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.586 1.554 . . . . 0.0 108.307 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.05 130.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -126.45 146.62 50.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.759 1.224 . . . . 0.0 109.799 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -95.62 119.53 34.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.539 1.135 . . . . 0.0 109.332 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.43 119.72 10.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.69 -12.6 61.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.66 172.34 44.14 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -166.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.2 -5.14 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.883 0.873 . . . . 0.0 109.812 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.51 102.71 8.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.493 1.917 . . . . 0.0 107.386 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -52.44 -40.31 32.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.23 -45.7 72.55 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 118.36 0.527 . . . . 0.0 110.393 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -57.7 -37.18 73.04 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.943 0.497 . . . . 0.0 110.764 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -77.46 -22.6 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.232 -0.918 . . . . 0.0 112.191 -176.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.2 mt -70.87 -50.78 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 p -61.65 -48.21 81.89 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.685 0.675 . . . . 0.0 111.035 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.2 mt -56.51 -47.02 80.23 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.24 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.1 -44.9 87.89 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.759 0.823 . . . . 0.0 112.426 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.96 -41.09 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.55 -13.22 59.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.055 0.843 . . . . 0.0 112.638 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.51 -1.29 61.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.535 1.064 . . . . 0.0 113.758 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -12.48 61.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.386 2.274 . . . . 0.0 115.461 -171.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.77 143.15 57.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.823 1.647 . . . . 0.0 108.25 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -72.34 142.14 48.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -80.17 150.98 29.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.322 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 mm -116.63 138.52 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 t30 45.42 63.99 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.302 1.041 . . . . 0.0 112.01 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpp -94.47 151.97 18.94 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -141.53 138.55 32.82 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 167.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.1 t -133.47 148.33 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.87 105.1 14.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.662 0.785 . . . . 0.0 108.981 168.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.73 117.73 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.2 p -73.55 111.16 8.42 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mmm -113.86 161.28 17.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 110.094 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.23 -73.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.951 1.3 . . . . 0.0 108.06 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.26 -45.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -135.58 -13.7 1.97 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.2 174.39 12.03 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.31 1.444 . . . . 0.0 107.901 -171.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mt -54.48 139.46 13.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.162 0.982 . . . . 0.0 108.524 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 p -68.33 163.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.485 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -71.58 -31.15 66.65 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.83 -0.544 . . . . 0.0 111.586 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.88 158.67 33.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.383 0.992 . . . . 0.0 109.859 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -66.05 -39.72 90.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HG2' HD21 ' A' ' 68' ' ' ASN . 1.4 mm-40 -78.74 1.27 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 175.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.16 1.17 8.5 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.846 0.859 . . . . 0.0 111.394 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 p -67.79 169.7 9.23 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.928 -1.107 . . . . 0.0 111.201 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -110.75 -25.7 9.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.124 1.37 . . . . 0.0 109.078 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -158.3 170.83 21.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.03 0.919 . . . . 0.0 111.488 174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -114.44 102.42 10.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.073 2.549 . . . . 0.0 106.259 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -77.79 97.65 5.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.4 mm -68.91 124.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.929 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.05 126.96 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 126.395 1.878 . . . . 0.0 105.934 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.68 97.51 6.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 165.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.81 149.55 5.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 163.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.23 133.77 10.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.648 1.179 . . . . 0.0 109.03 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t0 46.44 44.93 13.47 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.892 1.805 . . . . 0.0 110.945 -167.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 70.17 -13.8 0.42 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.686 3.195 . . . . 0.0 114.825 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.94 165.88 11.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.473 1.909 . . . . 0.0 110.091 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.2 129.47 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.786 -1.197 . . . . 0.0 111.616 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -100.02 -44.66 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 t -165.33 166.46 18.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.8 161.96 26.19 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.931 1.693 . . . . 0.0 108.039 -172.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.12 31.66 Favored 'General case' 0 C--O 1.19 -2.033 0 O-C-N 120.139 -1.601 . . . . 0.0 109.65 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.462 1.4 p -107.98 124.95 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 160.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -108.09 112.84 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.635 2.774 . . . . 0.0 103.747 165.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -59.4 154.59 16.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.824 1.193 . . . . 0.0 110.156 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -81.3 85.93 6.33 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -152.81 175.55 12.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.286 1.035 . . . . 0.0 109.129 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -52.61 -52.17 56.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.059 1.344 . . . . 0.0 110.509 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -5.78 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.762 0.425 . . . . 0.0 110.914 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.6 -69.76 1.38 Allowed Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -55.74 -29.05 58.9 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.513 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -34.92 63.85 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 120.16 1.345 . . . . 0.0 111.072 176.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -87.58 -24.16 24.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 116.582 -1.675 . . . . 0.0 113.034 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.583 ' HA ' ' CG ' ' A' ' 54' ' ' GLU . 62.2 mt -63.53 -30.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 121.357 1.89 . . . . 0.0 109.364 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.26 -3.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 119.82 -1.8 . . . . 0.0 111.314 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -110.53 21.99 15.97 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.114 -0.991 . . . . 0.0 109.517 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.583 ' CG ' ' HA ' ' A' ' 51' ' ' ILE . 8.1 pt-20 -138.63 144.67 39.83 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.969 -2.332 . . . . 0.0 111.215 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.85 62.51 7.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 109.409 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.01 134.88 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.63 -48.5 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.02 156.7 43.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.57 136.99 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 166.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.35 124.37 65.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.88 167.62 23.47 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -80.02 -32.51 39.58 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.381 -0.824 . . . . 0.0 112.01 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -155.98 173.76 16.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.458 1.026 . . . . 0.0 109.611 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.3 tt -165.14 154.67 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.802 1.241 . . . . 0.0 108.418 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -81.22 153.12 27.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.871 0.869 . . . . 0.0 112.128 169.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.56 -51.51 65.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.613 1.965 . . . . 0.0 110.929 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.61 -39.89 88.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.44 HD21 ' HG2' ' A' ' 20' ' ' GLU . 1.3 t-20 -66.68 -41.61 87.83 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.739 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -51.76 -63.79 1.02 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.83 -24.43 67.54 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.96 -0.462 . . . . 0.0 111.705 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -76.83 -36.11 57.09 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -98.52 -24.04 15.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.078 1.308 . . . . 0.0 112.062 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -71.86 9.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.622 1.969 . . . . 0.0 113.028 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -80.72 -0.13 37.06 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.965 -1.084 . . . . 0.0 113.517 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -165.63 -64.15 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.779 0.832 . . . . 0.0 109.858 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.91 144.67 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.953 . . . . 0.0 107.82 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -113.17 126.33 55.32 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 125.101 1.361 . . . . 0.0 109.477 -169.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.63 131.48 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 120.105 -1.622 . . . . 0.0 109.483 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 50.6 m-85 -116.04 150.63 36.96 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.76 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -80.14 135.82 36.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.99 128.1 34.35 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -24.82 43.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.725 0.774 . . . . 0.0 112.294 -174.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.52 161.53 28.9 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 127.308 2.385 . . . . 0.0 107.519 -159.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.54 -9.79 59.68 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.621 1.168 . . . . 0.0 110.343 -167.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.56 98.84 2.39 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.211 1.404 . . . . 0.0 108.686 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 t -51.36 -40.83 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 121.759 -0.588 . . . . 0.0 110.356 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -40.35 87.22 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.664 0.385 . . . . 0.0 110.4 -171.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -42.65 95.92 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.343 0.592 . . . . 0.0 110.783 171.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.809 -0.557 . . . . 0.0 110.661 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.22 -50.25 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.302 1.041 . . . . 0.0 108.781 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 p -64.21 -35.27 80.27 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.756 0.707 . . . . 0.0 111.475 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -66.14 -37.34 85.44 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.263 -0.898 . . . . 0.0 111.091 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -67.72 -44.04 78.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.183 0.593 . . . . 0.0 111.865 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.9 -41.26 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.266 1.027 . . . . 0.0 109.862 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -79.67 -30.83 41.31 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.48 4.38 52.79 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.021 -0.877 . . . . 0.0 113.985 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -39.22 81.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.228 1.411 . . . . 0.0 111.513 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.57 131.98 50.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.188 0.595 . . . . 0.0 110.722 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.32 156.97 30.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.57 1.176 . . . . 0.0 110.632 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 61.9 mtpt -82.58 156.32 24.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.651 171.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.595 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 74.8 m80 57.54 176.26 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.56 1.544 . . . . 0.0 114.011 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -160.56 147.43 15.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.688 1.195 . . . . 0.0 107.877 171.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -131.07 138.09 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 65.25 52.02 1.52 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.442 2.297 . . . . 0.0 113.254 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 ttt -82.87 154.53 24.58 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.245 168.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 15.6 mtpp -147.73 121.8 9.48 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.62 156.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.595 1.089 . . . . 0.0 108.902 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.47 118.1 35.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.543 1.137 . . . . 0.0 108.25 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.37 129.43 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.6 p -79.49 104.79 10.34 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.985 1.314 . . . . 0.0 109.576 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.92 151.74 22.11 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.174 -0.954 . . . . 0.0 111.011 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.36 -85.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.42 -39.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 O-C-N 119.883 -1.76 . . . . 0.0 108.238 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.74 3.35 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 -178.63 5.91 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.584 -1.323 . . . . 0.0 110.371 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.2 mt -53.58 127.52 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.746 1.619 . . . . 0.0 109.807 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.1 p -72.41 161.42 30.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.981 0.912 . . . . 0.0 110.248 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.93 -41.24 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -157.46 161.07 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -58.2 -42.58 86.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.353 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -15.33 57.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.052 1.741 . . . . 0.0 113.179 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.12 10.03 8.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.924 0.89 . . . . 0.0 112.734 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 p -64.9 160.71 19.94 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.652 -1.28 . . . . 0.0 109.616 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -107.55 -29.85 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.227 1.411 . . . . 0.0 107.886 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -153.55 167.0 30.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.755 0.788 . . . . 0.0 109.821 167.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -104.58 126.58 51.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.704 2.002 . . . . 0.0 108.063 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.13 113.89 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 166.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -83.32 105.03 12.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.96 141.91 14.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -117.12 123.45 46.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.046 1.739 . . . . 0.0 106.523 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 mt -124.02 136.4 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -136.03 -6.72 2.1 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.036 -173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.08 67.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.22 5.34 0.11 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.889 2.076 . . . . 0.0 115.201 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -134.2 152.62 51.91 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.366 1.466 . . . . 0.0 109.231 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.16 108.13 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.42 1.888 . . . . 0.0 109.393 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -96.62 -6.11 37.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.665 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 p -170.83 179.55 3.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.299 1.409 . . . . 0.0 111.069 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -147.93 168.48 22.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.402 1.081 . . . . 0.0 111.002 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.68 153.98 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 109.559 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.79 115.91 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.85 109.51 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -59.54 155.9 14.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.718 1.144 . . . . 0.0 109.92 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.07 65.93 0.89 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.222 0.609 . . . . 0.0 112.225 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -136.43 81.53 1.89 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.1 -72.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.403 1.881 . . . . 0.0 113.713 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -56.21 -25.93 49.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.234 1.813 . . . . 0.0 111.063 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -61.57 7.0 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 125.198 1.38 . . . . 0.0 111.813 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -58.0 -36.48 72.72 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.144 0.978 . . . . 0.0 110.87 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -52.3 -47.31 66.0 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 111.006 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.6 m -63.09 -37.93 89.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.252 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.9 mt -52.54 -38.16 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.485 1.114 . . . . 0.0 110.202 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -59.72 -48.94 85.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.54 -0.725 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -82.09 -14.14 56.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.39 1.076 . . . . 0.0 112.442 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 28.5 mm-40 -64.28 -23.14 67.19 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.775 1.17 . . . . 0.0 111.206 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 55.4 54.97 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.437 1.095 . . . . 0.0 109.681 -170.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.66 147.61 8.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.917 0.887 . . . . 0.0 109.286 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -78.53 -48.18 15.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.502 1.921 . . . . 0.0 110.099 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.43 158.48 41.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.199 0.6 . . . . 0.0 112.289 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.1 mt -110.77 147.02 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.98 135.59 60.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.2 p -155.47 161.21 41.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.655 1.182 . . . . 0.0 109.691 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -73.29 -36.42 66.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.241 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.71 165.97 33.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.257 1.39 . . . . 0.0 109.098 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 tt -140.28 153.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 107.845 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.2 p -77.1 150.86 35.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.584 0.353 . . . . 0.0 110.45 163.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -58.55 -45.11 89.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.771 0.828 . . . . 0.0 110.257 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.98 -50.43 72.13 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.924 -0.485 . . . . 0.0 111.171 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.24 -35.99 81.85 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.747 0.419 . . . . 0.0 109.984 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -54.65 -54.69 38.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.396 0.543 . . . . 0.0 110.215 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -58.39 -26.3 63.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 111.659 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -71.46 -62.15 1.51 Allowed 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.014 0.824 . . . . 0.0 110.205 171.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -77.27 -25.96 51.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.779 -164.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -73.53 30.77 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.735 2.014 . . . . 0.0 112.621 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.84 13.7 13.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.449 1.9 . . . . 0.0 111.575 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 mttt 179.11 -11.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.012 2.125 . . . . 0.0 113.172 164.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -116.39 128.98 73.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -77.42 121.84 24.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.537 1.135 . . . . 0.0 108.44 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.5 mt -100.08 127.39 53.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -118.32 154.61 32.05 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.254 1.422 . . . . 0.0 110.252 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.39 135.47 33.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.415 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.36 151.76 46.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 160.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -125.77 24.03 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.778 2.431 . . . . 0.0 109.428 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.09 -169.84 42.29 Favored Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.837 -1.164 . . . . 0.0 112.325 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.97 -21.55 9.45 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.961 2.105 . . . . 0.0 108.335 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.07 104.25 6.51 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.8 -40.64 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.81 -35.83 70.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.986 0.812 . . . . 0.0 110.265 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -61.17 -39.76 91.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.371 -0.831 . . . . 0.0 110.642 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -73.92 -27.28 60.95 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.179 -0.95 . . . . 0.0 111.276 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.65 -52.09 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p -58.64 -44.58 90.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 111.241 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.6 mt -61.92 -37.66 85.48 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.644 -0.66 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -70.1 -39.48 75.51 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.536 -0.728 . . . . 0.0 111.842 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.33 -44.2 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.648 1.179 . . . . 0.0 109.226 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.06 -16.03 45.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 19.92 63.73 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.009 0.822 . . . . 0.0 112.41 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.28 -22.56 60.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 111.916 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.52 137.7 54.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.86 0.754 . . . . 0.0 110.224 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.4 m -69.27 126.36 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.543 1.537 . . . . 0.0 111.809 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -74.7 119.21 18.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.672 1.189 . . . . 0.0 108.632 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.61 111.42 5.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -119.0 -0.07 11.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.287 1.035 . . . . 0.0 111.386 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -131.3 67.0 79.94 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 127.319 2.248 . . . . 0.0 109.928 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.316 2.011 . . . . 0.0 109.618 168.888 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.413 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.8 m80 57.24 178.12 0.05 OUTLIER 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.867 2.067 . . . . 0.0 112.231 -167.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tpt -142.31 132.8 25.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.83 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.3 mt -132.06 145.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 73.3 11.42 4.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.375 1.47 . . . . 0.0 114.27 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.4 ' HE3' ' CZ ' ' A' ' 93' ' ' PHE . 2.7 tpp -74.51 145.7 43.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.585 1.084 . . . . 0.0 110.146 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -131.91 144.22 50.69 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.827 1.251 . . . . 0.0 107.734 161.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -136.45 143.81 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.593 1.157 . . . . 0.0 108.434 172.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.54 124.37 44.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.935 0.894 . . . . 0.0 109.243 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.5 125.89 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 108.167 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -83.07 96.34 8.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.218 1.009 . . . . 0.0 110.747 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.5 mtp -94.3 164.94 12.82 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.121 1.368 . . . . 0.0 111.174 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.97 -60.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.375 1.47 . . . . 0.0 108.946 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -142.95 -68.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -132.4 9.03 4.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.631 1.205 . . . . 0.0 112.479 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -155.35 173.09 17.14 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.041 2.536 . . . . 0.0 107.954 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.67 147.48 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -81.57 -85.26 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.831 0.852 . . . . 0.0 111.097 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -174.58 -39.09 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.373 1.469 . . . . 0.0 108.714 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -145.66 -171.29 3.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.013 0.37 . . . . 0.0 111.526 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -95.01 -8.09 37.83 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.398 1.879 . . . . 0.0 111.244 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 6.15 10.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 112.095 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -137.47 0.75 2.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.711 1.604 . . . . 0.0 109.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 p -76.46 166.62 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.126 0.97 . . . . 0.0 110.989 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -101.98 -35.77 8.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.418 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -154.31 173.59 15.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.837 0.827 . . . . 0.0 110.518 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -116.9 113.41 22.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 128.047 2.539 . . . . 0.0 106.676 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.38 108.36 13.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.7 94.66 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 145.3 12.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 166.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -134.12 123.49 24.52 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.0 mt -118.0 128.26 75.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -126.88 -19.07 4.53 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -155.76 74.04 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 162.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.43 10.78 1.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.6 2.36 . . . . 0.0 114.146 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -137.69 161.49 36.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.637 2.375 . . . . 0.0 110.085 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.99 115.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -117.28 -17.95 10.04 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.835 -1.166 . . . . 0.0 112.667 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -149.79 162.67 39.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.744 1.156 . . . . 0.0 108.752 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -144.38 160.54 40.87 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.942 1.297 . . . . 0.0 108.357 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.5 155.68 42.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.354 1.861 . . . . 0.0 107.703 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.9 t -111.78 145.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 168.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mt -135.08 109.5 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.24 146.94 14.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.043 0.838 . . . . 0.0 110.55 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.51 82.22 3.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.51 172.39 12.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 129.734 3.214 . . . . 0.0 104.586 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.39 -40.48 95.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.28 -0.887 . . . . 0.0 113.389 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.0 t -67.84 -21.35 65.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -67.78 1.99 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.461 1.13 . . . . 0.0 111.471 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -59.45 -54.66 44.06 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.9 1.227 . . . . 0.0 109.183 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -54.77 -39.69 68.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.379 0.672 . . . . 0.0 111.114 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mt -57.45 -46.71 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.014 0.825 . . . . 0.0 110.749 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -57.2 -39.57 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.571 0.623 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.3 7.86 30.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.198 0.999 . . . . 0.0 112.612 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.54 152.15 21.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.758 1.163 . . . . 0.0 108.915 172.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.73 43.65 0.34 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.783 1.233 . . . . 0.0 110.715 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.85 137.6 24.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 166.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.25 -36.76 14.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.44 159.95 41.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.251 0.62 . . . . 0.0 109.629 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.26 142.66 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.8 mt -107.56 131.29 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 167.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.1 p -150.69 158.04 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 167.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -72.96 -44.17 61.44 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.128 163.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -135.55 155.17 50.92 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 tt -153.21 119.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -59.94 146.79 41.1 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.199 0.6 . . . . 0.0 109.569 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.402 ' HG2' ' HZ3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -52.79 -47.64 67.42 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.395 2.278 . . . . 0.0 111.545 -172.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -25.47 67.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.969 0.508 . . . . 0.0 111.275 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -84.13 -47.46 10.86 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.318 1.047 . . . . 0.0 110.27 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -54.98 -53.27 57.87 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.668 1.122 . . . . 0.0 110.239 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HZ3' ' HG2' ' A' ' 66' ' ' GLU . 34.5 mttp -57.76 -22.63 48.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.406 1.083 . . . . 0.0 112.56 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -79.59 -60.99 2.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.924 0.89 . . . . 0.0 109.096 173.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -65.92 -33.54 76.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.802 -166.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -65.81 -10.14 35.06 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -16.35 32.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.203 1.401 . . . . 0.0 114.385 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -154.55 -45.58 0.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.693 -1.255 . . . . 0.0 109.673 166.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.1 mt -63.46 138.04 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.79 1.236 . . . . 0.0 108.223 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -92.39 126.36 37.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.131 1.372 . . . . 0.0 107.538 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.62 130.02 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.66 148.0 44.51 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.256 1.423 . . . . 0.0 109.392 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -80.86 143.88 32.41 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.353 1.061 . . . . 0.0 108.705 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.86 116.79 23.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.509 0.671 . . . . 0.0 109.324 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.02 79.68 0.66 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.236 1.414 . . . . 0.0 108.243 163.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.01 25.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.137 0.854 . . . . 0.0 114.034 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.7 -14.25 40.35 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.414 1.485 . . . . 0.0 110.4 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -82.02 100.84 9.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.044 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.62 -49.02 6.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 123.941 0.896 . . . . 0.0 109.575 170.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.36 -39.75 77.89 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.882 0.765 . . . . 0.0 110.503 -169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -56.89 -41.75 78.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -75.32 -34.63 61.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.091 0.556 . . . . 0.0 112.244 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mt -61.6 -53.78 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p -62.47 -46.22 89.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.795 0.438 . . . . 0.0 111.282 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.83 -39.98 82.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.909 0.322 . . . . 0.0 110.513 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 6' ' ' VAL . 23.6 t80 -66.46 -50.39 63.5 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.362 0.665 . . . . 0.0 111.747 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.76 -36.72 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.977 0.911 . . . . 0.0 109.759 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.33 -5.41 59.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.068 1.347 . . . . 0.0 113.332 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.48 86.51 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.766 -1.575 . . . . 0.0 113.112 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -29.28 67.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.291 1.437 . . . . 0.0 114.18 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.74 137.82 58.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.478 1.035 . . . . 0.0 110.684 -174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 p -78.74 130.51 35.86 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.941 0.897 . . . . 0.0 109.885 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -71.85 148.7 45.92 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.21 -0.931 . . . . 0.0 109.633 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.8 mt -87.23 141.36 14.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.9 p -132.11 -48.15 0.93 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.527 1.131 . . . . 0.0 110.38 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.15 76.7 23.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.992 2.117 . . . . 0.0 110.209 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 124.72 3.613 . . . . 0.0 111.699 167.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -142.35 136.34 29.54 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt -154.24 141.03 19.11 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.939 0.895 . . . . 0.0 109.681 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 mt -138.49 143.68 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.566 1.146 . . . . 0.0 110.134 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.262 58.6 t30 44.62 45.54 7.98 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.966 2.506 . . . . 0.0 112.733 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.2 tpp -72.47 145.69 47.38 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 163.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -136.32 137.97 41.21 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 163.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 93' ' ' PHE . 70.1 t -137.99 140.47 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.6 99.06 8.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.684 1.194 . . . . 0.0 108.72 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.72 114.16 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 p -68.32 128.62 37.24 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.317 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mtp -127.14 162.0 27.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.759 1.223 . . . . 0.0 110.805 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.7 -61.92 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.293 1.437 . . . . 0.0 109.53 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.14 -46.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 O-C-N 120.841 -1.162 . . . . 0.0 109.441 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -140.3 2.69 1.89 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.283 0.633 . . . . 0.0 112.211 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -157.57 175.21 14.24 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.449 1.5 . . . . 0.0 110.537 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.7 141.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.8 p -70.6 159.29 34.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.204 0.525 . . . . 0.0 110.643 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.02 -34.48 78.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.962 1.305 . . . . 0.0 111.266 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 167.12 25.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.506 0.722 . . . . 0.0 111.492 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' C ' ' H ' ' A' ' 21' ' ' ASP . 21.2 t80 -72.85 -53.31 11.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 18.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.211 1.405 . . . . 0.0 111.848 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 19' ' ' PHE . 16.6 t70 -145.18 5.52 1.11 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.563 1.945 . . . . 0.0 110.934 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 p -80.1 172.44 13.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.719 -1.238 . . . . 0.0 110.15 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -111.94 -24.58 9.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.672 1.589 . . . . 0.0 110.589 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -160.12 175.07 13.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.952 0.796 . . . . 0.0 110.071 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.68 126.62 51.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 170.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 111.69 18.97 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -79.83 104.22 7.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.64 150.21 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -124.63 115.89 21.52 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.81 123.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 167.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -126.66 -5.67 6.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.303 1.041 . . . . 0.0 111.536 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -158.51 55.46 0.44 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.93 2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.586 2.355 . . . . 0.0 116.386 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -118.77 154.01 33.5 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 129.712 3.205 . . . . 0.0 108.888 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.57 102.98 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-O 121.91 0.862 . . . . 0.0 108.806 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -71.68 -46.0 60.15 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -158.52 167.5 29.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.663 0.785 . . . . 0.0 110.406 -171.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -138.34 125.81 21.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.086 1.754 . . . . 0.0 108.981 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.84 164.39 14.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 109.604 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.13 134.31 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.3 mt -123.77 104.27 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.875 1.67 . . . . 0.0 106.551 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -58.09 136.53 57.2 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.473 0.579 . . . . 0.0 110.25 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -80.74 70.78 7.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.267 1.027 . . . . 0.0 110.773 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.65 84.74 1.62 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 71.14 -74.07 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.101 2.16 . . . . 0.0 113.375 151.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.7 t -52.34 -33.02 40.95 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.838 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.63 -59.85 9.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -58.58 -39.17 79.56 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.349 -1.089 . . . . 0.0 110.425 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -55.01 -46.36 75.21 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 118.662 0.665 . . . . 0.0 110.373 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.9 m -61.01 -36.32 79.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.631 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.33 -48.38 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.773 1.169 . . . . 0.0 109.452 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.08 -39.84 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.086 0.554 . . . . 0.0 110.396 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -73.17 -17.87 61.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.121 -0.987 . . . . 0.0 112.463 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.91 -174.53 5.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 120.273 1.397 . . . . 0.0 110.529 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -112.98 40.84 2.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.011 1.724 . . . . 0.0 109.235 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.75 141.49 17.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.24 -41.38 12.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.322 1.049 . . . . 0.0 109.943 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.15 151.09 36.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.29 1.036 . . . . 0.0 111.272 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.43 139.54 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 166.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.8 mt -116.51 127.53 74.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.7 p -154.19 176.42 12.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.527 1.531 . . . . 0.0 108.085 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -106.33 -24.77 12.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.607 1.163 . . . . 0.0 111.648 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -152.96 159.31 42.93 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.0 tt -161.02 137.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.552 ' H ' ' ND2' ' A' ' 68' ' ' ASN . 8.9 m -85.23 168.37 14.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.28 -35.42 75.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.286 1.434 . . . . 0.0 111.221 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.87 -47.03 32.37 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.365 1.078 . . . . 0.0 109.726 -170.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -58.48 -46.54 86.43 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.243 1.817 . . . . 0.0 110.057 172.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -54.6 -62.16 1.84 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.693 0.397 . . . . 0.0 111.109 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.98 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 112.553 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -62.81 1.52 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.893 0.877 . . . . 0.0 109.432 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -79.93 -30.49 39.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.971 -164.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -58.27 -12.45 3.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.454 1.102 . . . . 0.0 113.857 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -52.28 -31.57 33.3 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.124 -0.985 . . . . 0.0 111.871 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -151.82 -8.08 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mt -114.78 123.52 70.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.69 160.61 19.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.69 0.757 . . . . 0.0 109.434 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.7 mt -137.69 128.77 38.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.24 160.89 34.83 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.88 1.272 . . . . 0.0 111.534 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -106.71 121.82 45.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.892 1.677 . . . . 0.0 110.169 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.5 125.24 29.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.755 0.422 . . . . 0.0 110.163 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -9.38 29.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.341 1.857 . . . . 0.0 113.065 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.96 174.33 41.51 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -163.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -90.3 -6.3 55.29 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 99.68 5.45 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -173.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.6 t -49.82 -39.17 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 122.874 0.47 . . . . 0.0 110.277 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.19 -42.71 68.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -166.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -62.47 -45.36 93.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.853 -0.529 . . . . 0.0 110.383 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -71.75 -32.57 67.84 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.17 -0.331 . . . . 0.0 111.238 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.94 -50.91 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 p -67.0 -31.5 72.11 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 mt -69.18 -42.56 75.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 109.973 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CE2' HG22 ' A' ' 6' ' ' VAL . 40.5 t80 -59.25 -42.88 92.16 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.181 0.993 . . . . 0.0 113.124 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.3 mt -47.9 -54.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.429 1.492 . . . . 0.0 109.466 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -4.92 49.15 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.505 1.522 . . . . 0.0 113.306 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.09 14.76 80.2 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.079 0.854 . . . . 0.0 112.601 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.86 -19.4 61.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 112.116 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.13 140.48 50.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.07 0.938 . . . . 0.0 110.575 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -68.8 140.05 55.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.839 1.256 . . . . 0.0 108.749 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -72.59 153.82 41.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 165.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.6 mt -88.71 127.98 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 160.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -129.07 -18.61 3.69 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.263 0.625 . . . . 0.0 112.395 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.16 87.46 6.63 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 109.019 170.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.034 3.822 . . . . 0.0 112.647 -177.744 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.9 164.63 0.85 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.192 2.197 . . . . 0.0 107.852 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt -110.85 121.77 46.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.81 1.244 . . . . 0.0 107.858 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 mm -120.63 136.4 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 124.738 1.215 . . . . 0.0 108.309 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 47.78 53.41 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.008 1.723 . . . . 0.0 113.851 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -69.95 156.16 39.52 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 163.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -132.31 159.42 39.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 152.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 28' ' ' VAL . 12.0 p -156.64 163.8 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.7 124.8 47.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 164.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.39 113.58 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.7 p -57.38 128.39 36.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.2 mtp -131.16 157.71 42.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.489 1.04 . . . . 0.0 110.426 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.32 -63.29 1.14 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.555 1.542 . . . . 0.0 108.417 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -142.93 -74.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -119.43 10.88 12.0 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.031 1.332 . . . . 0.0 112.935 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.52 170.17 21.42 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.13 1.372 . . . . 0.0 108.35 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.8 mt -58.11 133.83 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 p -73.63 159.72 32.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.847 2.059 . . . . 0.0 111.311 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -73.55 -25.1 60.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.7 p -149.64 174.01 13.03 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.841 1.2 . . . . 0.0 111.605 169.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -72.56 -13.72 61.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.596 1.958 . . . . 0.0 111.653 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.94 7.99 15.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 111.467 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -133.01 2.9 3.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.073 1.749 . . . . 0.0 110.243 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.98 153.96 42.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.733 -1.23 . . . . 0.0 109.625 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -101.16 -24.67 14.23 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.87 1.268 . . . . 0.0 109.192 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.447 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 40.8 p90 -157.72 173.76 16.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.242 0.928 . . . . 0.0 111.003 171.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -115.83 105.1 12.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.308 2.243 . . . . 0.0 107.924 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.94 107.17 7.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -79.46 133.03 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.809 1.244 . . . . 0.0 109.027 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 6' ' ' VAL . 2.0 t -105.94 105.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttt-85 -98.68 103.99 15.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.56 138.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -125.25 -5.63 7.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.483 0.713 . . . . 0.0 112.689 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.491 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 5.5 p-10 -173.38 48.28 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.83 1.252 . . . . 0.0 108.855 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.36 18.67 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.184 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.74 152.96 47.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.37 90.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 122.549 1.166 . . . . 0.0 107.891 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.491 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 2.8 mmtp -73.02 -35.09 66.72 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 120.735 -1.228 . . . . 0.0 110.185 167.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 t -162.25 131.97 4.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.792 1.178 . . . . 0.0 110.075 167.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 174.71 9.82 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.272 1.029 . . . . 0.0 111.523 165.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.12 168.34 26.82 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 127.168 2.187 . . . . 0.0 110.303 171.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.553 0.9 OUTLIER -135.16 144.22 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 129.924 3.29 . . . . 0.0 117.476 171.104 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.7 mt -134.29 114.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 127.757 2.423 . . . . 0.0 106.655 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -61.44 136.11 57.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.213 0.915 . . . . 0.0 110.733 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -83.13 85.71 7.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.771 1.228 . . . . 0.0 108.545 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.54 -85.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 46' ' ' SER . 10.4 pt-20 -131.83 -64.09 0.8 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.394 -0.816 . . . . 0.0 111.67 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.422 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -57.99 -24.18 57.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.968 174.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.59 -74.08 0.36 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -57.71 -27.27 62.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.731 1.265 . . . . 0.0 111.537 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.32 -51.15 62.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.8 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -60.93 -37.4 82.2 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.669 1.588 . . . . 0.0 110.067 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.3 mt -52.46 -45.33 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.086 1.755 . . . . 0.0 110.93 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.71 -42.71 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 120.876 -1.14 . . . . 0.0 110.14 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.55 -30.63 59.77 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 118.445 0.566 . . . . 0.0 111.651 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -74.08 -19.84 60.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.533 0.606 . . . . 0.0 109.4 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.7 t30 50.89 55.38 9.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.703 2.801 . . . . 0.0 112.305 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.19 144.16 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.123 1.769 . . . . 0.0 111.543 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -39.99 18.53 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.111 1.364 . . . . 0.0 111.155 173.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.25 160.95 40.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 112.989 -166.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.3 mt -132.25 105.25 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 119.909 -1.745 . . . . 0.0 108.966 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.06 128.69 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -151.06 167.98 26.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.592 1.087 . . . . 0.0 111.189 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -82.2 -45.38 15.15 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.224 1.81 . . . . 0.0 109.262 165.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -147.43 164.26 33.89 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.379 0.991 . . . . 0.0 109.927 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.5 tt -154.32 138.1 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 m -73.31 155.99 38.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.327 0.512 . . . . 0.0 110.68 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.431 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 36.8 tt0 -66.67 -31.49 72.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.734 0.414 . . . . 0.0 111.4 -171.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.74 -50.91 31.07 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.087 0.858 . . . . 0.0 110.997 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -56.54 -43.8 80.24 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.734 0.414 . . . . 0.0 110.644 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -54.69 -60.79 2.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.512 1.125 . . . . 0.0 109.363 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HE3' ' HG2' ' A' ' 66' ' ' GLU . 50.5 mttt -64.31 -17.06 63.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.453 0.701 . . . . 0.0 112.61 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.34 -51.91 5.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.112 1.365 . . . . 0.0 110.338 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -76.55 -30.29 57.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.338 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -63.18 -7.77 6.6 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -20.06 39.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.937 -1.102 . . . . 0.0 111.709 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -145.14 2.59 1.01 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.944 1.247 . . . . 0.0 112.158 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.5 129.03 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -171.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.08 107.65 17.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.002 1.721 . . . . 0.0 109.645 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -87.16 131.89 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 120.455 -1.403 . . . . 0.0 108.52 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -118.16 144.22 45.87 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.702 1.601 . . . . 0.0 111.084 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -87.01 132.58 33.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.458 1.503 . . . . 0.0 107.583 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.81 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.241 -0.409 . . . . 0.0 110.541 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -12.53 60.43 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 169.64 34.15 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 126.99 2.234 . . . . 0.0 108.26 -164.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.7 -16.96 63.98 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.551 2.34 . . . . 0.0 111.37 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.64 97.34 3.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -168.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.1 t -50.38 -42.75 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.65 -44.52 81.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.404 0.682 . . . . 0.0 109.252 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -58.06 -42.54 85.69 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.89 0.852 . . . . 0.0 111.31 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -71.96 -27.2 62.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.113 -0.992 . . . . 0.0 111.974 -172.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.23 -53.7 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 p -61.23 -39.08 88.94 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.7 0.8 . . . . 0.0 111.332 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.4 mt -66.3 -44.59 83.04 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.148 0.579 . . . . 0.0 110.881 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.25 -39.06 85.43 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.987 0.812 . . . . 0.0 111.6 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.53 -42.82 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.436 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.35 -12.5 60.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.878 0.763 . . . . 0.0 112.632 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.11 6.94 84.12 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.927 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -34.17 77.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 112.536 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -55.61 140.43 41.1 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -61.56 130.12 44.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 108.947 172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -69.81 131.67 44.87 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.22 -0.925 . . . . 0.0 108.589 165.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.5 mt -60.4 111.96 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.2 m -79.56 -31.72 42.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.425 0.29 . . . . 0.0 111.585 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -151.02 153.64 33.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 126.884 2.074 . . . . 0.0 107.389 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 C--O 1.252 1.218 0 C-N-CA 122.624 2.216 . . . . 0.0 107.521 158.276 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.469 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.28 165.14 15.9 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 136.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt -148.42 140.95 24.39 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.039 -1.038 . . . . 0.0 108.625 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -137.34 138.61 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 69.38 17.47 8.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.587 1.955 . . . . 0.0 113.255 168.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.5 tpp -60.33 151.93 26.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.357 -0.839 . . . . 0.0 109.002 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -137.61 129.17 28.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 165.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.9 t -136.68 129.85 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-N 119.979 1.263 . . . . 0.0 108.717 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.05 83.79 2.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.584 1.553 . . . . 0.0 111.243 -169.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mt -83.74 129.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 120.873 -1.142 . . . . 0.0 110.088 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 p -71.07 94.47 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.482 1.113 . . . . 0.0 112.028 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 mtp -100.01 161.1 13.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.552 1.141 . . . . 0.0 111.341 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.5 -63.31 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 109.155 170.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.68 -60.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -130.41 -0.47 4.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.364 1.078 . . . . 0.0 112.528 -162.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -163.25 178.28 8.32 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.346 2.258 . . . . 0.0 108.736 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 99.1 mt -62.12 145.4 13.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -86.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.726 0.774 . . . . 0.0 109.772 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 175.8 -44.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.022 -1.049 . . . . 0.0 108.684 -156.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 p -158.78 169.36 24.55 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.373 0.988 . . . . 0.0 110.08 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -66.27 -34.04 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.131 0.973 . . . . 0.0 110.822 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -92.48 4.05 54.28 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -131.03 17.99 5.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.307 1.051 . . . . 0.0 111.303 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.93 167.6 16.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.294 1.045 . . . . 0.0 110.344 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.13 -31.24 7.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.215 1.406 . . . . 0.0 109.402 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -154.86 161.24 41.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.991 0.901 . . . . 0.0 109.89 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -100.09 111.7 23.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -76.46 108.97 9.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.6 mm -77.36 100.09 2.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.4 133.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.416 ' HE ' ' HB2' ' A' ' 37' ' ' SER . 26.7 mtm180 -115.68 114.45 24.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 mt -107.06 115.47 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.01 -10.98 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.441 1.088 . . . . 0.0 112.098 -162.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.64 57.19 0.62 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 122.352 1.072 . . . . 0.0 108.626 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.62 -9.92 0.08 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 129.137 2.975 . . . . 0.0 116.305 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -107.82 158.99 16.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.426 1.09 . . . . 0.0 110.4 170.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.76 90.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.278 1.431 . . . . 0.0 109.974 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.66 -20.88 30.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.779 1.632 . . . . 0.0 112.487 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.416 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 1.6 m -150.55 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 167.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 p -131.82 158.79 40.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 161.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 157.73 46.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 126.202 1.801 . . . . 0.0 106.723 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.24 140.87 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.1 mt -130.8 100.57 4.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -58.86 137.52 57.74 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -73.92 85.37 1.75 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.358 1.463 . . . . 0.0 108.042 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.5 33.83 2.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.462 1.505 . . . . 0.0 110.174 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 66.33 -69.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.144 1.777 . . . . 0.0 109.839 -172.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.3 t -52.99 -29.33 28.51 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.172 2.189 . . . . 0.0 111.413 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.1 16.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.983 0.81 . . . . 0.0 111.286 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -57.6 -32.2 66.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.086 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -56.5 -40.13 74.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.363 0.983 . . . . 0.0 108.397 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -30.79 66.97 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.136 0.974 . . . . 0.0 110.655 -172.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.85 -42.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.391 1.076 . . . . 0.0 108.308 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.1 -13.2 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.126 -0.984 . . . . 0.0 111.269 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -8.03 16.19 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.622 -1.298 . . . . 0.0 112.277 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -91.48 -15.09 29.33 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.557 1.526 . . . . 0.0 113.791 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 57.87 59.14 3.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.826 1.251 . . . . 0.0 109.946 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -47.8 140.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 161.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -50.96 19.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.62 39.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.898 0.479 . . . . 0.0 110.582 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mt -113.86 150.54 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.94 1.296 . . . . 0.0 107.707 173.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -120.22 121.9 66.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -144.24 168.89 18.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.212 1.005 . . . . 0.0 108.635 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -71.83 -57.3 4.45 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 155.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -140.7 160.72 39.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.401 0.546 . . . . 0.0 110.711 -167.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.2 tt -152.61 126.99 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 126.25 1.82 . . . . 0.0 106.613 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -54.44 143.54 23.61 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.621 1.568 . . . . 0.0 110.221 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -48.45 -49.04 37.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.169 1.787 . . . . 0.0 111.462 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.03 -42.04 99.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 0.0 110.666 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -68.5 -43.56 76.57 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.594 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.4 -57.83 9.25 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.02 -14.04 51.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.676 1.191 . . . . 0.0 113.628 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -90.99 -58.11 2.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.448 1.499 . . . . 0.0 109.793 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.33 -27.44 62.43 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 112.335 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -60.7 -11.85 8.67 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -58.18 -42.81 86.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 0.0 112.271 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 13.56 1.78 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.806 1.185 . . . . 0.0 111.743 -175.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mt -136.41 140.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.77 153.09 19.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.949 0.9 . . . . 0.0 108.779 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.52 113.59 23.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -160.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.86 151.07 37.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.544 1.137 . . . . 0.0 110.898 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -99.12 120.19 39.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.442 1.497 . . . . 0.0 109.95 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 138.94 55.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.414 0.686 . . . . 0.0 111.747 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -102.29 99.08 9.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 127.178 2.191 . . . . 0.0 109.284 172.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.42 -179.11 53.63 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -85.37 -10.84 55.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.703 0.801 . . . . 0.0 110.662 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.35 102.23 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.062 0.945 . . . . 0.0 110.563 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -48.35 -43.86 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 118.79 -0.624 . . . . 0.0 109.609 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.58 -42.84 77.7 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.968 0.804 . . . . 0.0 110.219 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -57.26 -40.02 76.83 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.902 -0.499 . . . . 0.0 110.289 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.51 -32.85 42.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.15 -50.47 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 p -62.4 -46.51 88.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.726 0.811 . . . . 0.0 111.436 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 122.56 0.344 . . . . 0.0 110.161 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -61.74 -52.5 64.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.321 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.3 mt -50.27 -40.93 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.969 1.308 . . . . 0.0 111.005 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.23 -2.84 50.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.941 0.896 . . . . 0.0 113.108 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.02 81.35 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.0 1.286 . . . . 0.0 111.193 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -27.26 61.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.41 1.884 . . . . 0.0 113.029 -174.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.38 139.47 58.56 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.577 0.704 . . . . 0.0 109.582 -174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.8 m -75.93 143.05 41.86 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -76.98 151.52 35.62 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.7 mt -78.69 151.03 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 166.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 m -140.77 -43.21 0.39 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.628 1.571 . . . . 0.0 109.999 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.67 86.2 2.78 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 126.25 1.82 . . . . 0.0 109.181 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.211 3.274 . . . . 0.0 111.684 175.752 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.589 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.78 165.54 27.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt -127.61 135.14 49.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 165.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.0 mt -139.54 152.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 47.18 73.02 0.21 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.874 1.67 . . . . 0.0 110.734 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ttt -131.92 152.33 51.14 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.157 -0.964 . . . . 0.0 108.59 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.6 141.52 33.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 165.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -134.05 132.62 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 171.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.99 144.57 25.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.71 119.98 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -75.88 84.16 2.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.147 0.979 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -86.3 155.26 20.73 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.895 2.478 . . . . 0.0 111.7 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -105.27 -55.96 2.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.128 0.966 . . . . 0.0 110.979 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -146.77 -55.02 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.8 -1.79 0.49 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.519 -158.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -157.06 173.17 17.41 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.706 2.002 . . . . 0.0 107.426 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.41 134.15 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -66.84 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.53 -38.66 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.395 1.478 . . . . 0.0 108.95 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 166.21 29.18 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.974 0.416 . . . . 0.0 111.042 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -55.88 -50.19 71.33 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.726 2.01 . . . . 0.0 108.891 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.12 -3.06 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.724 1.609 . . . . 0.0 112.812 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -120.91 -4.66 9.62 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.835 1.254 . . . . 0.0 111.068 -171.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.3 p -80.11 175.24 10.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.802 -1.186 . . . . 0.0 111.957 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -112.08 -34.67 5.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.741 1.616 . . . . 0.0 110.035 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -149.05 164.24 35.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.357 0.98 . . . . 0.0 111.904 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -109.85 103.35 12.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.382 2.673 . . . . 0.0 106.456 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tp -81.15 101.45 9.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.09 96.1 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 127.381 2.273 . . . . 0.0 107.31 168.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.52 139.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 160.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 118.55 18.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.868 0.758 . . . . 0.0 109.093 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.3 mt -119.82 138.28 50.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -164.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.0 -9.12 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -155.86 65.87 0.59 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.09 -8.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.21 3.004 . . . . 0.0 115.91 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.15 157.46 27.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 111.235 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.13 83.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.301 1.841 . . . . 0.0 106.864 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -64.85 -31.75 73.13 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.884 -1.135 . . . . 0.0 109.974 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -150.72 163.38 38.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.96 0.904 . . . . 0.0 109.469 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.67 161.28 36.91 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 108.231 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 137.8 19.11 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.92 0.888 . . . . 0.0 110.041 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.535 1.1 p -99.97 133.21 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 161.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.43 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 11.1 mt -129.74 114.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -63.31 160.42 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.156 1.343 . . . . 0.0 110.409 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -78.54 76.62 5.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.902 1.281 . . . . 0.0 109.777 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -125.74 170.17 11.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.34 1.456 . . . . 0.0 109.502 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -55.38 -40.67 71.65 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.445 -0.784 . . . . 0.0 110.672 164.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 m -76.34 -11.29 59.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.783 1.233 . . . . 0.0 111.693 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -72.47 -60.3 4.11 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 163.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 mppt? -62.58 -20.25 64.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -63.57 -46.25 86.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.932 1.242 . . . . 0.0 110.512 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 m -71.84 -40.79 68.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.223 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.7 mt -45.46 -51.44 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.929 1.292 . . . . 0.0 111.85 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.68 -34.69 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.87 -0.519 . . . . 0.0 111.468 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.89 -14.24 45.45 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.661 -0.649 . . . . 0.0 111.374 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.17 -16.21 61.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.525 1.53 . . . . 0.0 110.883 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 t30 47.47 65.06 1.36 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.975 2.11 . . . . 0.0 110.28 -167.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -67.45 140.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.94 -42.26 15.14 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.511 1.524 . . . . 0.0 109.979 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.69 160.95 39.82 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.422 1.089 . . . . 0.0 109.414 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -122.76 138.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.85 122.09 50.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.03 157.09 44.55 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.688 0.756 . . . . 0.0 111.255 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -68.99 -53.0 22.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 163.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -139.33 159.39 42.28 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.594 1.543 . . . . 0.0 111.204 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.9 tt -156.83 126.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.141 1.776 . . . . 0.0 110.257 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -61.13 141.89 57.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.222 1.009 . . . . 0.0 110.003 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.75 -37.62 76.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 111.845 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.61 -40.41 94.72 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.499 -0.75 . . . . 0.0 111.503 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -69.16 -47.58 64.59 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.792 0.837 . . . . 0.0 109.805 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -50.51 -58.68 5.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.858 1.263 . . . . 0.0 109.758 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -60.97 -18.12 55.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.436 0.694 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HE3' ' HA ' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -82.38 -47.45 12.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.06 -1.025 . . . . 0.0 111.04 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -84.87 -25.37 28.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.958 0.344 . . . . 0.0 111.027 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -62.12 -7.7 4.43 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.61 1.164 . . . . 0.0 113.231 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -40.42 11.56 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.208 1.403 . . . . 0.0 110.787 173.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -145.16 -30.55 0.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.552 1.141 . . . . 0.0 111.857 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.3 mt -90.04 135.1 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -163.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.56 139.2 33.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.679 . . . . 0.0 107.801 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.8 mt -119.74 114.21 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.24 -0.913 . . . . 0.0 108.671 -172.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 55.8 m-85 -104.63 139.85 38.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.096 1.758 . . . . 0.0 110.835 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.42 127.62 32.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 123.07 19.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -83.3 6.76 18.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.057 1.743 . . . . 0.0 112.389 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.4 -169.81 38.97 Favored Glycine 0 N--CA 1.449 -0.477 0 O-C-N 120.509 -1.369 . . . . 0.0 111.68 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.15 -18.05 15.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.921 1.688 . . . . 0.0 109.894 168.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -66.86 101.7 0.86 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.386 1.474 . . . . 0.0 107.387 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.4 t -57.73 -41.11 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.217 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.51 -36.31 73.69 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.578 0.751 . . . . 0.0 110.359 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -60.77 -42.07 96.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 171.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -71.87 -26.84 62.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.701 -0.625 . . . . 0.0 111.566 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -56.9 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.78 1.632 . . . . 0.0 107.561 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.7 p -65.57 -40.69 93.07 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.36 0.413 . . . . 0.0 110.605 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.12 -42.87 99.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.651 0.78 . . . . 0.0 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 6' ' ' VAL . 68.7 t80 -61.19 -52.59 64.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.528 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.2 mt -58.25 -40.74 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.496 1.119 . . . . 0.0 109.58 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -68.22 -18.71 64.64 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.26 8.24 78.51 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.717 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -69.92 -27.31 64.66 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.084 1.442 . . . . 0.0 112.329 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.31 138.83 55.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.432 1.111 . . . . 0.0 110.272 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.8 m -74.09 138.92 44.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.3 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 31.4 mtmm -78.98 147.75 32.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 162.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.9 mt -70.94 -39.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 123.7 0.625 . . . . 0.0 110.854 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.1 m 47.83 65.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.806 1.242 . . . . 0.0 110.429 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.59 150.48 0.1 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 131.182 3.793 . . . . 0.0 116.484 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--O 1.246 0.911 0 C-N-CA 122.279 1.986 . . . . 0.0 107.949 163.823 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.3 m170 58.96 -164.82 0.2 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.014 2.526 . . . . 0.0 112.638 166.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt -151.04 130.25 12.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.4 -0.812 . . . . 0.0 109.672 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.93 153.05 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.317 1.847 . . . . 0.0 107.86 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 67.01 8.93 6.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.1 1.76 . . . . 0.0 114.473 168.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 tpp -78.1 155.17 30.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.182 1.356 . . . . 0.0 108.938 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.42 143.42 25.71 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.18 141.93 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 108.962 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.72 101.89 13.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 166.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.47 117.91 28.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.5 p -66.38 143.78 56.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.8 mmm -138.66 149.07 44.77 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 119.449 -2.032 . . . . 0.0 109.078 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -89.44 -67.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.507 1.123 . . . . 0.0 109.01 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.9 t -140.53 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.38 -7.42 18.81 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -147.16 177.34 9.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.272 1.429 . . . . 0.0 110.155 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mt -62.77 141.22 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 t -71.02 -86.76 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 t30 174.75 -28.12 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.856 1.663 . . . . 0.0 112.068 -167.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.73 164.68 29.44 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.736 1.153 . . . . 0.0 110.726 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -66.32 -37.59 85.74 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.222 1.009 . . . . 0.0 108.435 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 1.0 56.64 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.416 1.486 . . . . 0.0 113.175 -171.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.54 -7.54 6.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.018 1.327 . . . . 0.0 111.74 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.9 p -65.66 169.37 6.37 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 123.471 1.605 . . . . 0.0 110.277 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -114.9 -19.59 10.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.722 -2.036 . . . . 0.0 111.119 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -161.33 172.16 17.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.67 0.668 . . . . 0.0 111.388 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -117.02 103.61 10.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.369 2.268 . . . . 0.0 106.441 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 tp -76.97 99.04 5.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.41 102.14 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 128.064 2.545 . . . . 0.0 105.923 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 t -95.87 112.2 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.0 140.57 34.04 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.679 1.127 . . . . 0.0 108.495 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -132.68 123.12 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -168.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.19 3.99 1.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -165.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -154.63 60.6 0.68 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 122.491 1.139 . . . . 0.0 109.702 155.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.18 7.32 1.58 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.637 1.575 . . . . 0.0 114.692 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -135.7 155.09 50.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 131.349 3.86 . . . . 0.0 106.807 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.65 124.72 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.616 1.166 . . . . 0.0 109.027 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -111.97 -34.34 6.01 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.641 0.776 . . . . 0.0 112.543 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 131.64 27.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -96.96 154.71 17.14 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 162.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 147.85 33.18 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.938 1.695 . . . . 0.0 107.093 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.453 1.2 p -106.83 134.87 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 125.791 1.636 . . . . 0.0 115.287 155.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.16 122.14 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -65.64 161.08 21.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.594 1.088 . . . . 0.0 111.213 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -81.14 99.83 8.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 167.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -154.47 38.22 0.43 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 108.486 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 60.49 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.103 2.961 . . . . 0.0 112.854 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 t -62.23 -10.78 11.72 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.586 -1.321 . . . . 0.0 111.464 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.7 -60.24 6.6 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 160.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -61.29 -26.88 68.08 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.183 0.993 . . . . 0.0 112.348 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -64.69 -53.0 54.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 120.078 1.308 . . . . 0.0 108.874 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 t -53.55 -45.95 70.03 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 110.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.8 mt -50.36 -43.04 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.882 0.873 . . . . 0.0 110.709 -176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.19 -23.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 O-C-N 121.052 -1.03 . . . . 0.0 111.906 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -98.64 12.42 35.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.078 0.951 . . . . 0.0 111.266 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.53 -6.42 11.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.807 0.843 . . . . 0.0 112.211 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.0 t30 49.89 61.95 2.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.406 1.483 . . . . 0.0 111.694 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.51 142.13 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 166.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -76.13 -52.72 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.27 162.5 39.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.56 141.16 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.88 2.072 . . . . 0.0 110.396 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.9 mt -127.14 125.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.201 1.8 . . . . 0.0 106.792 167.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 38.1 m -149.62 -13.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp 75.78 -34.42 0.24 Allowed 'General case' 0 C--O 1.221 -0.425 1 C-N-CA 132.526 4.331 . . . . 0.0 113.35 -162.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -149.97 168.07 24.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 122.088 2.222 . . . . 0.0 111.748 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -163.53 120.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.645 1.178 . . . . 0.0 108.65 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.35 147.79 43.61 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.18 -47.49 65.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.933 2.093 . . . . 0.0 111.345 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -59.76 -42.25 92.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.753 0.787 . . . . 0.0 111.154 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -72.56 -41.49 65.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.888 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.75 -61.17 2.42 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.201 0.91 . . . . 0.0 109.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -64.89 -24.08 67.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.89 -38.63 61.83 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 120.905 -1.122 . . . . 0.0 111.301 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.49 -30.46 21.97 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.056 -1.027 . . . . 0.0 111.485 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -63.8 -12.73 38.18 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -27.34 5.62 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.328 1.451 . . . . 0.0 113.903 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -155.75 -2.66 0.14 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.026 0.83 . . . . 0.0 113.207 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.29 121.07 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -75.06 117.36 16.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.484 1.513 . . . . 0.0 107.271 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.48 134.92 28.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -120.15 155.38 33.19 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 108.792 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -85.37 141.29 30.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 168.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.52 150.16 23.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.354 0.525 . . . . 0.0 110.486 173.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.77 71.36 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.876 2.47 . . . . 0.0 108.118 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.43 -178.85 17.52 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 124.466 1.031 . . . . 0.0 112.852 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -33.63 75.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.028 153.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.55 100.83 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 124.446 1.091 . . . . 0.0 109.9 -155.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -52.18 -43.85 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -44.22 92.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.575 0.625 . . . . 0.0 109.962 -175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.19 -39.26 78.47 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.69 -0.631 . . . . 0.0 110.982 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -76.87 -27.25 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 112.529 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.09 -50.43 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.6 p -61.87 -46.42 89.49 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.012 0.824 . . . . 0.0 110.898 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.4 mt -63.06 -30.24 71.44 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.084 0.554 . . . . 0.0 110.621 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.62 -48.38 48.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.46 -37.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.261 . . . . 0.0 109.928 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -76.84 -34.35 57.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.898 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.57 15.16 32.78 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.99 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -34.82 74.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.821 2.048 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.31 142.15 52.73 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.605 1.093 . . . . 0.0 109.495 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.4 t -91.55 144.75 25.22 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 123.275 1.512 . . . . 0.0 110.244 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -85.08 130.7 34.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.985 1.714 . . . . 0.0 108.896 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.2 mt -71.52 140.23 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.4 t -122.49 -55.63 1.83 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.927 0.891 . . . . 0.0 108.894 171.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -117.7 85.8 22.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 126.769 2.028 . . . . 0.0 107.964 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--O 1.248 0.995 0 C-N-CA 123.958 3.105 . . . . 0.0 110.615 168.763 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.45 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -141.35 163.83 31.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.032 1.733 . . . . 0.0 108.734 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.609 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 9.4 tpt -99.85 127.27 46.02 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.166 1.386 . . . . 0.0 111.301 171.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.53 150.86 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 172.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m120 66.23 8.94 5.95 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 171.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.405 ' HE2' ' CE2' ' A' ' 93' ' ' PHE . 3.7 ttp -68.5 155.8 39.21 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.351 1.432 . . . . 0.0 110.202 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -139.12 146.34 40.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.018 1.727 . . . . 0.0 107.517 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG21 ' CE2' ' A' ' 93' ' ' PHE . 31.3 t -137.75 135.08 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.675 1.19 . . . . 0.0 108.122 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 124.12 33.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 166.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mt -104.03 112.53 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -66.2 91.63 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.784 1.234 . . . . 0.0 110.007 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 91.3 mmm -92.08 159.51 15.66 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.492 1.117 . . . . 0.0 111.183 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.81 -81.4 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.178 2.191 . . . . 0.0 108.372 165.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.4 t -140.41 -59.71 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -121.87 2.69 9.99 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 170.44 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.645 1.178 . . . . 0.0 110.09 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.5 mt -53.96 139.54 12.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.793 1.637 . . . . 0.0 108.087 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -74.25 -179.49 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.707 1.603 . . . . 0.0 110.625 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -86.0 -34.39 20.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.705 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -153.27 168.3 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -67.03 -23.04 65.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.247 2.219 . . . . 0.0 111.406 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.8 19.72 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.052 1.341 . . . . 0.0 110.916 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.14 -7.3 1.58 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.2 p -74.46 154.49 38.7 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.265 1.031 . . . . 0.0 109.889 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.59 -34.25 14.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.365 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -158.54 175.55 13.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.656 0.741 . . . . 0.0 109.533 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -117.05 108.91 16.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.72 104.9 8.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 mm -69.0 99.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.18 147.37 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 161.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.03 140.22 51.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mt -110.55 142.52 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.28 124.55 10.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 175.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 44.46 57.7 4.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.614 1.565 . . . . 0.0 111.51 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.609 ' ND2' ' H ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 49.62 28.49 2.6 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 128.89 2.876 . . . . 0.0 114.138 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -132.07 157.16 44.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.09 1.314 . . . . 0.0 111.139 166.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.52 120.15 17.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -126.15 -7.62 6.52 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t -157.13 170.67 21.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 122.021 2.191 . . . . 0.0 107.813 164.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.24 156.26 45.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.609 1.564 . . . . 0.0 109.535 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 160.55 43.86 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 125.911 1.685 . . . . 0.0 109.142 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.7 OUTLIER -127.1 137.28 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 C-N-CA 130.062 3.345 . . . . 0.0 116.581 167.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.84 116.25 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -64.05 148.92 48.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.57 0.623 . . . . 0.0 110.25 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -69.95 88.73 0.58 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.2 166.23 24.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 128.309 2.644 . . . . 0.0 105.042 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.73 -45.98 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.49 -0.757 . . . . 0.0 109.778 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -26.3 68.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 110.178 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.18 -49.73 38.12 Favored Glycine 0 N--CA 1.444 -0.819 0 O-C-N 121.729 -0.607 . . . . 0.0 111.677 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -67.82 -21.52 65.21 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.067 0.934 . . . . 0.0 111.506 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.03 -58.16 6.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.736 -1.126 . . . . 0.0 110.551 161.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -53.51 -33.88 56.08 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.333 0.97 . . . . 0.0 112.824 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 mt -45.3 -46.64 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.557 1.143 . . . . 0.0 111.513 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.33 -33.37 63.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 123.225 0.61 . . . . 0.0 110.199 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -27.09 29.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.298 0.499 . . . . 0.0 111.223 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.02 -20.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.099 0.863 . . . . 0.0 112.155 -170.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.01 32.87 1.74 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.053 1.341 . . . . 0.0 110.58 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.02 146.1 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.34 -48.83 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.794 1.238 . . . . 0.0 109.669 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.47 163.3 40.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 110.057 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -117.19 150.07 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.7 mt -120.24 132.14 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 t -163.95 161.53 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.715 2.406 . . . . 0.0 108.476 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.3 -39.03 93.43 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.537 169.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.66 167.96 24.95 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.029 1.286 . . . . 0.0 109.34 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.9 tt -162.49 138.02 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.025 1.73 . . . . 0.0 107.751 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -76.29 152.11 36.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.964 -0.46 . . . . 0.0 110.581 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -48.91 -45.64 41.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.507 1.123 . . . . 0.0 111.456 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' CD ' ' HZ2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.768 0.827 . . . . 0.0 108.824 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -60.12 -41.5 92.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.99 0.916 . . . . 0.0 111.903 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -56.03 -65.01 0.67 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.915 0.78 . . . . 0.0 109.252 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -60.38 -28.1 67.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.634 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.493 ' HZ2' ' CD ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -67.88 -55.4 13.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.721 1.146 . . . . 0.0 110.341 176.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.88 -22.25 37.0 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.531 0.605 . . . . 0.0 112.589 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 t -72.44 69.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.029 1.395 . . . . 0.0 110.618 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 -32.49 0.28 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 129.006 2.922 . . . . 0.0 110.259 175.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.82 -6.32 0.6 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.81 136.67 58.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.62 155.46 19.23 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.977 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.3 mt -128.14 118.19 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.63 1.172 . . . . 0.0 108.658 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 60.1 m-85 -106.06 164.36 12.04 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.161 0.984 . . . . 0.0 110.321 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -98.41 145.97 26.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.885 0.766 . . . . 0.0 110.017 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.91 117.16 29.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.598 1.159 . . . . 0.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.24 -9.8 58.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.89 34.39 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.45 -18.26 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 158.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 98.53 0.91 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.985 2.514 . . . . 0.0 107.276 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -48.13 -41.42 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.02 -43.59 74.46 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.385 -0.822 . . . . 0.0 110.35 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -36.07 82.29 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 122.084 -0.385 . . . . 0.0 110.502 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.51 -38.32 74.28 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.736 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.05 -50.32 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -60.4 -36.45 78.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.623 0.647 . . . . 0.0 111.863 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.8 mt -67.89 -44.97 75.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.023 0.44 . . . . 0.0 110.77 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 6' ' ' VAL . 43.6 t80 -59.36 -37.19 77.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.358 1.063 . . . . 0.0 112.839 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.7 mt -64.34 -48.41 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.445 1.098 . . . . 0.0 109.807 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.72 -24.07 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.982 0.81 . . . . 0.0 110.868 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.16 8.37 58.92 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 123.914 0.769 . . . . 0.0 113.279 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -45.64 73.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.128 2.171 . . . . 0.0 109.901 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.62 137.78 42.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 124.204 1.002 . . . . 0.0 110.847 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 t -84.47 157.81 21.22 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 57.0 mtpt -76.35 145.63 39.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.5 mt -63.33 152.41 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.8 p -72.0 -153.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 127.113 2.165 . . . . 0.0 110.538 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.64 85.98 2.05 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 120.696 -1.252 . . . . 0.0 108.942 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--O 1.255 1.372 0 C-N-CA 123.317 2.678 . . . . 0.0 110.674 171.413 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 CA-C-O 118.394 -1.226 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -89.27 -66.76 0.89 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 118.646 1.223 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.0 tpt -129.72 124.41 33.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 123.806 0.843 . . . . 0.0 111.807 -164.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mm -134.01 143.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.533 2.333 . . . . 0.0 107.496 -167.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 45.65 58.74 4.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.464 1.506 . . . . 0.0 113.101 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -103.11 155.02 18.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.609 1.163 . . . . 0.0 108.328 166.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 143.12 31.9 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.495 1.918 . . . . 0.0 105.981 164.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 93' ' ' PHE . 95.4 t -132.78 137.17 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.49 74.26 0.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.689 0.796 . . . . 0.0 109.553 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.92 120.56 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.888 1.275 . . . . 0.0 109.103 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -67.96 117.92 10.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.046 0.938 . . . . 0.0 111.124 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.2 mmm -124.89 157.11 36.76 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.707 1.603 . . . . 0.0 110.159 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -106.78 -62.02 1.46 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.024 1.73 . . . . 0.0 110.635 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -142.27 -85.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 170.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.71 -8.45 24.3 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 165.93 19.99 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.799 1.24 . . . . 0.0 110.35 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.48 142.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 125.31 1.631 . . . . 0.0 108.036 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -73.18 -179.34 3.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.136 1.375 . . . . 0.0 112.881 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -88.14 -32.3 18.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.553 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.1 t -152.67 177.88 10.21 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.262 1.825 . . . . 0.0 108.289 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.32 -34.87 78.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 128.218 2.607 . . . . 0.0 110.723 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.8 -1.94 45.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.005 0.82 . . . . 0.0 111.979 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -121.1 52.77 1.18 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 p -133.25 173.04 11.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.184 2.994 . . . . 0.0 108.572 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -118.01 -28.65 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.906 1.682 . . . . 0.0 109.385 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -156.42 176.1 13.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.953 0.797 . . . . 0.0 111.78 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -123.08 115.92 22.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.823 2.849 . . . . 0.0 108.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 tp -89.07 103.35 15.97 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.327 2.251 . . . . 0.0 106.424 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 mm -68.79 76.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 129.732 3.213 . . . . 0.0 111.16 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -69.14 99.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -76.64 136.49 39.17 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 164.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.14 129.77 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 159.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -132.43 2.19 3.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 t0 174.59 72.13 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.253 3.021 . . . . 0.0 103.217 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 64.9 -25.56 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 131.146 3.778 . . . . 0.0 116.608 173.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -107.39 166.12 10.89 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.22 118.97 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.107 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 -5.35 8.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 113.203 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.7 m -170.02 168.14 8.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.7 2.4 . . . . 0.0 107.005 166.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 p -136.23 -46.01 0.63 Allowed 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.41 175.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.253 2.621 . . . . 0.0 117.682 -171.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.7 t -143.25 106.02 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mt -96.49 115.52 36.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 165.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -65.43 162.26 18.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.871 1.669 . . . . 0.0 110.461 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -73.58 80.98 1.49 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 0.0 108.1 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -134.04 168.16 19.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.628 1.171 . . . . 0.0 107.906 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -52.14 -46.46 65.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.199 1.799 . . . . 0.0 109.835 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -70.82 -39.92 72.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.784 1.234 . . . . 0.0 107.933 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -61.31 7.32 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -58.98 -39.54 82.08 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.23 1.012 . . . . 0.0 110.373 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -58.68 -42.44 88.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.137 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -44.42 92.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.578 1.551 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.7 mt -50.75 -43.81 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.15 -32.41 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.976 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -84.31 -25.93 28.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.47 1.032 . . . . 0.0 110.361 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.95 156.62 33.01 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.793 1.237 . . . . 0.0 108.503 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -83.17 28.31 0.53 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.178 1.391 . . . . 0.0 110.916 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.29 134.78 23.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 120.935 1.698 . . . . 0.0 108.559 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -82.26 -44.63 16.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.023 1.729 . . . . 0.0 109.655 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.25 162.2 40.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.121 0.568 . . . . 0.0 110.412 -168.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mt -113.51 141.69 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 171.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.14 122.64 55.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 162.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.04 151.72 38.19 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.914 1.285 . . . . 0.0 110.664 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -65.91 -46.65 77.49 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 163.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -148.21 166.89 26.56 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.83 119.85 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -52.05 138.58 24.88 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.506 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -51.87 -43.1 63.13 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.973 1.709 . . . . 0.0 112.071 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -22.72 66.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 0.0 112.625 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -84.61 -41.5 16.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.571 -0.705 . . . . 0.0 109.891 167.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.94 -59.95 4.29 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.941 1.246 . . . . 0.0 110.721 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -58.35 -22.8 54.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.904 0.482 . . . . 0.0 111.959 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.96 -50.05 8.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.834 1.254 . . . . 0.0 111.098 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -79.59 -24.27 42.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.095 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -60.85 -7.58 2.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.168 0.895 . . . . 0.0 113.302 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -39.33 21.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.332 1.453 . . . . 0.0 113.864 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -165.17 4.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.282 0.947 . . . . 0.0 112.173 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.7 mt -120.95 126.71 75.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.38 136.79 42.45 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.29 132.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.3 151.66 37.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.681 1.192 . . . . 0.0 109.908 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -99.54 134.56 42.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.968 1.707 . . . . 0.0 110.59 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.427 0.632 . . . . 0.0 109.94 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -128.85 26.67 5.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.791 2.436 . . . . 0.0 108.584 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.11 36.78 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.598 -1.314 . . . . 0.0 111.879 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -89.67 -23.93 21.74 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.966 1.306 . . . . 0.0 109.784 165.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.79 104.02 1.0 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.222 1.809 . . . . 0.0 107.705 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.73 -46.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.217 1.007 . . . . 0.0 108.844 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.33 -41.72 93.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.215 0.916 . . . . 0.0 109.609 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -56.54 -44.79 81.2 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.607 -0.683 . . . . 0.0 110.353 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -70.21 -44.93 67.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.096 -0.378 . . . . 0.0 110.894 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -41.52 92.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 97.4 p -68.52 -34.41 75.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.568 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.62 -41.36 84.09 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 120.991 0.424 . . . . 0.0 110.397 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 6' ' ' VAL . 56.0 t80 -61.66 -40.17 93.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.592 0.757 . . . . 0.0 112.051 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.1 mt -51.07 -52.47 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 109.163 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -74.11 -22.52 59.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.048 0.84 . . . . 0.0 112.445 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.65 -3.76 39.51 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.897 -0.946 . . . . 0.0 114.26 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -17.41 62.53 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.677 1.991 . . . . 0.0 113.577 -164.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.67 140.96 49.88 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.8 -1.188 . . . . 0.0 109.149 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -57.35 134.91 56.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -68.77 130.75 43.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 153.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.31 140.3 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 160.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -118.68 176.9 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -42.45 88.62 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 130.971 3.708 . . . . 0.0 113.69 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.248 1.006 0 C-N-CA 123.073 2.516 . . . . 0.0 110.684 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -147.3 -172.37 4.0 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt -144.07 145.73 32.36 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.1 mt -139.05 143.37 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.48 52.47 14.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.381 1.472 . . . . 0.0 111.433 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttp -113.55 137.77 51.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.871 1.268 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -133.85 153.05 52.01 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 126.098 1.759 . . . . 0.0 106.935 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.4 t -147.04 141.32 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.25 94.09 8.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.55 98.32 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 p -67.95 123.8 21.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.672 1.589 . . . . 0.0 113.032 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.1 mtp -124.46 162.02 24.82 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.453 -1.405 . . . . 0.0 112.403 -171.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.49 -60.76 1.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.681 1.192 . . . . 0.0 109.439 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -146.74 -73.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -122.59 0.46 9.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.944 1.298 . . . . 0.0 111.928 -167.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 178.18 7.34 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.25 -0.907 . . . . 0.0 110.547 165.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.8 mt -52.53 139.98 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.038 1.735 . . . . 0.0 109.156 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -68.39 166.39 16.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.041 1.336 . . . . 0.0 112.964 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.97 -46.29 71.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.39 1.476 . . . . 0.0 112.264 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 t -158.41 168.6 26.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 0.0 109.418 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.95 -33.52 75.53 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.534 1.934 . . . . 0.0 111.112 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.49 24.4 12.66 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.859 1.264 . . . . 0.0 110.198 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -139.99 32.17 1.98 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.829 0.852 . . . . 0.0 109.602 161.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.2 p -108.32 164.42 12.33 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.42 -29.22 9.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.091 0.956 . . . . 0.0 110.004 -171.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 31.8 p90 -159.96 163.53 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.339 0.59 . . . . 0.0 111.909 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' HD12 ' A' ' 51' ' ' ILE . 62.8 m-85 -104.87 107.57 18.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.69 1.996 . . . . 0.0 107.498 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 93.59 2.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -72.98 91.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 121.15 -0.969 . . . . 0.0 108.5 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 1.2 p -64.98 165.96 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.541 1.137 . . . . 0.0 109.939 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 127.52 24.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.973 1.715 . . . . 0.0 110.48 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.34 110.94 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 125.63 1.572 . . . . 0.0 107.233 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -118.04 -13.5 9.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.531 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -157.63 63.77 0.47 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 122.875 1.321 . . . . 0.0 108.615 170.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 53.58 18.59 1.48 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.123 2.169 . . . . 0.0 116.08 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.91 171.42 14.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.92 1.688 . . . . 0.0 108.355 170.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 113.24 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -105.35 -39.45 6.15 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.647 -0.658 . . . . 0.0 109.263 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.56 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.447 1.099 . . . . 0.0 108.078 176.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 28' ' ' VAL . 0.7 OUTLIER -159.98 176.93 11.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.513 1.925 . . . . 0.0 108.642 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.01 164.48 36.72 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 125.982 1.713 . . . . 0.0 110.903 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.477 0.6 OUTLIER -132.57 141.18 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 128.836 2.854 . . . . 0.0 117.076 164.728 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -129.47 117.82 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 129.695 3.198 . . . . 0.0 104.35 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -64.7 158.55 24.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.856 1.207 . . . . 0.0 111.758 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.84 89.37 4.06 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.578 0.751 . . . . 0.0 109.496 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -144.78 29.63 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.985 0.898 . . . . 0.0 112.546 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 75.24 -55.83 0.63 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.357 2.263 . . . . 0.0 111.771 170.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -60.48 -28.63 68.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.346 1.058 . . . . 0.0 109.864 166.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.04 -49.68 41.89 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -56.97 -39.04 73.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.884 0.842 . . . . 0.0 111.169 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -58.9 -47.16 85.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.463 1.029 . . . . 0.0 111.477 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 m -64.07 -33.54 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.051 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.424 HD12 ' CD2' ' A' ' 25' ' ' PHE . 84.2 mt -55.68 -40.35 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.148 0.885 . . . . 0.0 110.216 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -54.94 -47.12 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -81.21 -13.04 58.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -63.97 -19.34 65.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.221 1.373 . . . . 0.0 111.865 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 55.87 56.53 5.95 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.181 1.392 . . . . 0.0 109.068 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.31 146.45 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 171.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.93 -37.48 13.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.228 2.611 . . . . 0.0 110.578 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.6 168.12 24.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.159 0.983 . . . . 0.0 112.627 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -127.21 119.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.2 132.89 37.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 163.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.9 p -147.55 163.54 36.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.266 0.939 . . . . 0.0 108.672 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -75.07 -40.64 60.02 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 121.48 -0.763 . . . . 0.0 108.994 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -157.46 170.01 23.41 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.4 tt -163.49 124.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.64 0.776 . . . . 0.0 111.017 -170.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -51.15 141.31 14.63 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.56 0.744 . . . . 0.0 111.732 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.87 -45.82 60.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.852 1.661 . . . . 0.0 112.176 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -58.98 -52.43 65.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.97 0.804 . . . . 0.0 110.583 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -63.0 -41.41 99.58 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.227 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.15 -61.28 2.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.651 0.78 . . . . 0.0 109.642 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -63.49 -24.23 67.73 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 119.171 -0.442 . . . . 0.0 112.182 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -61.71 1.71 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.977 0.911 . . . . 0.0 109.517 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.69 -21.82 60.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.752 0.821 . . . . 0.0 112.499 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -63.15 -1.81 1.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -70.22 -32.96 71.09 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.999 -1.688 . . . . 0.0 113.492 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -153.86 13.56 0.46 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.301 1.409 . . . . 0.0 112.573 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -135.36 133.95 52.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -87.91 126.22 34.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.769 1.627 . . . . 0.0 108.601 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.2 mt -109.54 121.75 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.69 -1.256 . . . . 0.0 109.139 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 72.3 m-85 -121.18 146.9 46.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.364 2.266 . . . . 0.0 111.518 -166.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -90.1 146.58 24.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.73 0.412 . . . . 0.0 110.387 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 129.69 36.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.66 20.35 6.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.902 0.881 . . . . 0.0 112.135 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.74 -165.21 38.71 Favored Glycine 0 C--N 1.335 0.506 0 O-C-N 120.496 -1.378 . . . . 0.0 111.675 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.12 1.01 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.116 1.366 . . . . 0.0 109.499 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -86.92 104.75 16.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.6 -42.04 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -64.17 -47.48 79.68 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -168.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -61.53 -37.11 82.54 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.997 -1.065 . . . . 0.0 111.862 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.88 -33.8 76.39 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 120.891 -1.13 . . . . 0.0 111.386 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.97 -51.08 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -64.23 -37.68 88.33 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.447 0.567 . . . . 0.0 111.242 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.06 -43.91 94.04 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.065 0.393 . . . . 0.0 110.033 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -59.82 -44.81 93.84 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.72 0.408 . . . . 0.0 111.55 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.0 -48.49 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.228 1.011 . . . . 0.0 109.433 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.69 -36.53 84.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.911 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 9.11 21.34 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.062 -0.854 . . . . 0.0 113.237 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -29.66 59.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.289 1.036 . . . . 0.0 112.063 -167.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.73 138.38 58.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 135.68 42.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.6 mtmm -64.42 132.2 49.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 163.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.65 122.74 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -96.15 102.92 14.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 65.55 159.11 0.13 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 127.268 2.227 . . . . 0.0 113.735 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 123.142 2.562 . . . . 0.0 109.955 154.233 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 CA-C-O 119.217 -0.768 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 51.13 8.55 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 119.574 3.175 . . . . 0.0 119.574 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt -57.52 130.55 46.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.858 1.208 . . . . 0.0 113.165 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 mt -124.22 151.24 29.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 126.435 1.894 . . . . 0.0 108.789 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.3 t30 61.55 27.81 17.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.321 2.248 . . . . 0.0 113.198 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpp -78.08 149.12 33.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -140.81 140.39 34.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' A' ' 93' ' ' PHE . 54.7 t -140.69 130.86 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.284 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.26 106.89 18.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -92.32 123.75 44.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.453 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 79.3 p -62.43 128.32 35.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.588 1.086 . . . . 0.0 110.613 169.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 mtp -126.66 159.99 32.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.653 1.115 . . . . 0.0 110.689 172.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.22 -65.55 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.152 1.381 . . . . 0.0 107.948 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.54 -73.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 167.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -119.79 9.67 11.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.307 1.051 . . . . 0.0 112.482 -154.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 178.03 8.7 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 128.293 2.637 . . . . 0.0 107.603 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.82 146.03 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 p -83.54 -156.78 0.21 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.715 2.006 . . . . 0.0 111.985 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.55 -21.65 12.62 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' A' ' 63' ' ' ASN . 96.8 p -154.52 -167.89 2.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.892 1.224 . . . . 0.0 110.789 168.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -79.63 -29.01 40.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.84 1.256 . . . . 0.0 110.969 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -89.26 -43.17 11.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.764 0.711 . . . . 0.0 109.83 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.5 62.39 6.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.8 p -121.98 165.41 16.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.319 149.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -110.36 -29.31 8.18 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.702 1.201 . . . . 0.0 108.805 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.47 169.72 20.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 109.678 167.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.3 119.69 39.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.196 2.198 . . . . 0.0 105.662 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -79.98 105.72 11.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 mm -79.76 98.69 3.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 t -66.14 146.94 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 167.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.08 89.92 2.88 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.05 126.86 29.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 166.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -127.3 1.92 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 118.396 -0.812 . . . . 0.0 113.035 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -166.52 45.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.009 0.909 . . . . 0.0 110.488 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.66 8.56 1.79 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.895 -1.128 . . . . 0.0 114.01 -168.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.73 154.27 46.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.693 1.197 . . . . 0.0 109.883 162.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.64 108.12 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 107.757 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -88.95 -30.37 18.86 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.999 -1.063 . . . . 0.0 111.691 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -144.87 164.18 31.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 162.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.9 p -118.02 144.88 45.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.763 1.625 . . . . 0.0 106.912 165.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.86 155.59 27.65 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.535 1.134 . . . . 0.0 108.161 169.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.5 132.06 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.76 111.35 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -62.35 152.71 33.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.517 1.053 . . . . 0.0 109.768 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -74.73 88.3 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.67 165.28 27.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.174 1.789 . . . . 0.0 106.225 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -61.16 -39.31 89.64 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.523 -0.736 . . . . 0.0 111.737 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 t -63.97 -45.02 90.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.238 1.015 . . . . 0.0 108.481 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.95 -60.78 8.2 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 125.237 1.398 . . . . 0.0 112.062 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -62.75 -36.59 83.54 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 121.834 -0.804 . . . . 0.0 110.11 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -54.02 -44.87 71.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.637 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.1 m -70.69 -23.46 62.48 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.738 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.98 -46.18 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 121.478 1.944 . . . . 0.0 109.687 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -55.47 -18.11 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.64 . . . . 0.0 112.15 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.68 -14.85 14.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.735 -1.126 . . . . 0.0 112.592 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.06 -27.67 69.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.787 1.63 . . . . 0.0 111.026 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 63.42 53.89 2.06 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 125.238 1.415 . . . . 0.0 109.737 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.75 148.76 10.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -38.33 9.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.416 1.886 . . . . 0.0 110.257 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 161.17 43.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.07 0.548 . . . . 0.0 111.132 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -119.87 142.04 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.178 1.791 . . . . 0.0 107.221 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.34 106.35 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.749 1.22 . . . . 0.0 108.282 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 4.1 m -142.99 173.04 11.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' C ' HD21 ' A' ' 63' ' ' ASN . 64.1 mttt -71.86 -70.82 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.413 HD21 ' C ' ' A' ' 62' ' ' LYS . 2.6 m120 -119.58 170.26 9.33 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.532 -1.355 . . . . 0.0 108.021 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.89 137.87 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -68.5 141.32 55.61 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.194 0.997 . . . . 0.0 110.408 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -45.24 -52.35 9.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.355 2.262 . . . . 0.0 111.288 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -39.35 89.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.812 0.445 . . . . 0.0 110.966 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -69.86 -47.5 62.38 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -51.09 -62.97 1.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.38 -36.03 70.73 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.189 0.596 . . . . 0.0 110.993 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -63.95 -59.7 4.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.805 -0.56 . . . . 0.0 110.494 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -75.82 -28.75 58.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.544 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -65.78 -5.68 9.55 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.702 1.201 . . . . 0.0 113.548 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -47.03 -51.49 17.26 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.513 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -140.39 -15.97 0.94 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 87.9 mt -73.03 123.99 29.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.21 147.7 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.25 119.3 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -120.22 154.34 35.0 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.831 1.252 . . . . 0.0 110.555 -170.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -90.13 128.72 36.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 109.662 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.1 123.81 20.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.421 0.688 . . . . 0.0 111.037 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -108.39 100.42 9.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.925 2.09 . . . . 0.0 108.184 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.75 157.77 27.6 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -27.98 62.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.134 2.174 . . . . 0.0 111.823 164.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.8 103.66 6.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.058 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -44.75 -44.48 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 123.719 0.807 . . . . 0.0 109.097 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.17 -34.62 61.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.98 0.355 . . . . 0.0 110.603 -169.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -50.81 -53.16 34.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -67.22 -29.25 68.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.349 -170.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.09 -46.19 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -66.96 -39.3 87.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.887 0.767 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.4 -46.41 90.09 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CE2' HG21 ' A' ' 6' ' ' VAL . 78.5 t80 -62.05 -40.51 96.02 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 mt -55.68 -49.75 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.626 1.171 . . . . 0.0 109.464 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -73.22 -14.95 61.44 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.544 0.738 . . . . 0.0 112.805 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.81 18.53 63.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.077 0.853 . . . . 0.0 112.3 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.14 -27.92 62.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.548 1.539 . . . . 0.0 112.502 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.39 154.53 40.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.015 1.28 . . . . 0.0 109.464 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.35 149.5 35.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.043 0.937 . . . . 0.0 109.42 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -83.14 136.18 34.54 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 122.104 -0.373 . . . . 0.0 111.551 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.1 mt -65.25 115.98 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -85.25 0.05 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.136 1.374 . . . . 0.0 110.71 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -107.2 147.08 34.51 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.656 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.941 3.094 . . . . 0.0 113.138 -164.472 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 12.2 m170 73.31 -173.36 0.14 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.429 2.291 . . . . 0.0 108.431 -157.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt -133.32 145.61 50.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.536 HG23 ' H ' ' A' ' 3' ' ' ASN . 2.1 mm -95.17 -161.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.013 2.125 . . . . 0.0 108.164 -178.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.536 ' H ' HG23 ' A' ' 2' ' ' ILE . 17.3 t-20 -53.07 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.195 2.598 . . . . 0.0 110.424 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.462 ' HE2' ' CE2' ' A' ' 93' ' ' PHE . 1.4 ttp -110.17 148.49 31.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -131.22 129.65 41.93 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 125.674 1.589 . . . . 0.0 106.747 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.405 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.5 t -136.35 132.66 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.5 111.37 22.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.4 123.58 44.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -73.46 127.71 33.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 117.821 0.282 . . . . 0.0 110.279 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtp -130.65 156.63 44.57 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.189 1.396 . . . . 0.0 111.053 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -104.06 -69.93 0.79 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 109.675 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.8 t -146.75 -47.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.23 17.59 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.773 0.797 . . . . 0.0 111.14 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -160.79 172.64 16.67 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 120.481 -1.387 . . . . 0.0 109.087 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.6 138.6 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 107.88 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.3 p -73.38 167.99 20.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.739 0.781 . . . . 0.0 111.025 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.29 -46.11 57.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.266 0.3 OUTLIER -137.89 161.68 36.01 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.59 -1.319 . . . . 0.0 108.441 -175.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -68.33 -45.77 72.03 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.979 -1.076 . . . . 0.0 108.299 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.69 -33.32 75.62 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.374 0.67 . . . . 0.0 110.692 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.73 58.02 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.916 1.341 . . . . 0.0 107.807 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 p -121.35 175.91 5.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.481 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -104.69 -35.34 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.584 0.754 . . . . 0.0 109.53 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 29.5 p90 -156.1 170.76 21.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.422 0.629 . . . . 0.0 110.533 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.87 115.99 27.19 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.022 1.729 . . . . 0.0 107.257 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.14 107.28 11.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.01 100.17 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -63.31 137.38 24.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -125.01 118.46 26.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -119.02 139.89 44.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -140.36 7.06 2.15 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.603 0.761 . . . . 0.0 109.517 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -168.44 51.08 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.571 1.548 . . . . 0.0 112.127 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 64.15 -5.3 0.33 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.177 1.791 . . . . 0.0 115.323 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -121.64 154.2 37.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.22 2.208 . . . . 0.0 109.296 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.74 96.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 107.321 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -70.33 -33.31 71.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 171.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 m -161.77 167.09 25.55 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.087 0.858 . . . . 0.0 111.127 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -127.02 118.66 24.9 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.509 1.523 . . . . 0.0 108.77 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 168.53 9.01 Favored 'General case' 0 C--O 1.213 -0.861 0 C-N-CA 125.754 1.622 . . . . 0.0 108.792 171.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.79 1.1 p -155.17 124.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 131.085 3.754 . . . . 0.0 115.947 -175.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.52 109.41 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 129.586 3.155 . . . . 0.0 102.921 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -61.36 156.11 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.122 0.874 . . . . 0.0 109.654 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -72.43 55.85 0.35 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.84 2.056 . . . . 0.0 111.121 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -107.29 168.57 9.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.2 -43.89 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.854 0.862 . . . . 0.0 109.614 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -77.36 -34.19 55.11 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.21 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.76 17.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.107 0.861 . . . . 0.0 111.25 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -61.1 -37.68 83.6 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.078 -1.248 . . . . 0.0 109.622 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -59.39 -34.71 72.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.923 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -65.49 -48.69 71.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 119.36 0.982 . . . . 0.0 110.453 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -55.15 -44.16 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.153 0.888 . . . . 0.0 110.521 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.0 t -55.76 -35.59 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.632 0.773 . . . . 0.0 110.825 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -95.59 -3.09 47.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.915 0.779 . . . . 0.0 112.287 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.91 168.41 18.77 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.757 1.162 . . . . 0.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -95.39 37.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.102 1.761 . . . . 0.0 110.045 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.94 138.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -82.18 -45.62 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.438 1.495 . . . . 0.0 109.968 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.4 158.65 42.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.285 1.034 . . . . 0.0 109.949 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.25 122.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.89 123.02 47.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -148.07 161.15 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.421 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -81.78 -34.21 30.46 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 124.245 1.018 . . . . 0.0 111.335 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -149.85 159.78 44.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.674 1.579 . . . . 0.0 107.533 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.39 136.22 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.946 2.098 . . . . 0.0 108.69 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -77.94 148.88 34.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.22 -38.55 89.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.0 0.52 . . . . 0.0 112.104 -165.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.49 -42.97 99.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.195 0.598 . . . . 0.0 109.4 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -70.35 -31.74 69.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.941 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -58.41 -58.39 8.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.22 1.373 . . . . 0.0 109.655 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -54.95 -43.66 73.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.922 0.489 . . . . 0.0 110.586 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -54.0 -58.58 6.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.006 1.722 . . . . 0.0 111.276 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -78.38 -35.3 47.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.34 -0.838 . . . . 0.0 112.983 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.9 t -50.44 -27.19 6.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.547 1.939 . . . . 0.0 111.546 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -45.05 -46.07 11.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.226 1.01 . . . . 0.0 113.094 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -149.03 14.68 0.91 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.198 -172.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.6 mt -136.44 122.94 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.29 126.88 31.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.767 1.227 . . . . 0.0 108.647 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.87 129.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -116.49 148.79 40.45 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.885 2.074 . . . . 0.0 109.534 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -88.62 142.16 27.92 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.75 48.99 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 161.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -108.1 8.41 28.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.726 1.61 . . . . 0.0 111.107 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.09 -174.96 39.27 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.872 0.76 . . . . 0.0 111.235 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.78 -14.3 15.27 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.759 1.224 . . . . 0.0 110.635 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.1 106.72 5.08 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.419 1.088 . . . . 0.0 108.199 173.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -54.86 -43.71 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.917 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.47 -34.28 70.06 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.877 0.762 . . . . 0.0 109.039 -168.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -59.02 -49.3 78.43 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 120.853 -1.154 . . . . 0.0 109.448 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -74.04 -28.37 61.39 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.403 -0.811 . . . . 0.0 112.515 -170.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mt -66.0 -55.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 31.6 p -61.7 -38.73 88.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.331 0.514 . . . . 0.0 112.132 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.1 mt -61.53 -34.17 75.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.05 0.54 . . . . 0.0 111.434 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.462 ' CE2' ' HE2' ' A' ' 4' ' ' MET . 85.1 t80 -72.79 -41.16 65.29 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.953 -1.092 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 83.7 mt -51.01 -54.57 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.159 1.384 . . . . 0.0 109.698 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.68 -20.84 63.55 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.694 0.798 . . . . 0.0 111.668 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.45 56.59 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -41.78 88.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.925 1.29 . . . . 0.0 110.366 164.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.58 140.71 53.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.418 1.008 . . . . 0.0 111.968 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.9 m -75.61 142.72 42.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.827 1.251 . . . . 0.0 111.104 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -76.37 150.82 36.78 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 160.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.0 mt -81.85 -55.72 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.258 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.4 76.54 0.08 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.649 1.979 . . . . 0.0 112.781 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.81 85.33 0.16 Allowed Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 123.988 0.915 . . . . 0.0 111.699 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.456 3.437 . . . . 0.0 111.531 -175.651 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -153.82 152.11 30.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.662 1.185 . . . . 0.0 109.166 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt -147.24 122.35 10.14 Favored 'General case' 0 CA--C 1.522 -0.102 0 O-C-N 121.672 -0.642 . . . . 0.0 109.973 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.11 148.38 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t30 56.54 36.85 28.22 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.669 1.588 . . . . 0.0 112.948 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.9 tpp -80.76 148.74 29.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 174.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -137.27 141.59 41.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 165.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.77 138.65 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.378 171.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.7 104.35 16.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.31 111.37 24.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.2 p -63.21 151.06 41.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.195 1.816 . . . . 0.0 110.513 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 mtp -138.53 160.61 39.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.471 1.508 . . . . 0.0 109.06 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.57 -68.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.797 1.239 . . . . 0.0 108.417 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -142.89 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 120.369 -1.457 . . . . 0.0 108.295 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -118.14 -31.43 5.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.357 1.063 . . . . 0.0 112.199 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -139.44 179.66 6.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.367 1.067 . . . . 0.0 110.176 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.3 mt -51.47 127.36 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.495 1.918 . . . . 0.0 109.098 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 t -71.32 179.18 3.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.676 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -85.35 -31.09 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -161.44 148.17 14.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.393 1.451 . . . . 0.0 112.032 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.62 -27.08 66.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.496 1.518 . . . . 0.0 111.309 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.54 11.53 28.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.483 1.913 . . . . 0.0 113.001 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -139.89 -6.42 1.28 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.394 1.478 . . . . 0.0 112.734 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 p -74.23 161.55 29.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.151 0.581 . . . . 0.0 111.34 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -99.75 -32.58 10.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.147 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -155.61 171.14 20.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.451 -0.78 . . . . 0.0 111.588 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -115.61 115.27 26.13 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.742 2.017 . . . . 0.0 107.283 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.55 99.47 4.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.34 97.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.59 150.06 7.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.995 1.318 . . . . 0.0 108.398 168.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -127.28 132.18 50.37 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.68 143.9 39.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 170.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -147.96 -6.03 0.45 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -152.1 59.08 0.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 160.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.67 -24.19 0.12 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 128.788 2.835 . . . . 0.0 114.718 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -92.27 155.48 17.93 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.658 1.983 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.76 130.52 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.148 1.379 . . . . 0.0 109.108 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.18 -27.61 6.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 m -163.44 164.7 24.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 108.484 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.1 p -120.5 148.92 43.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 109.488 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 155.59 49.74 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.512 1.125 . . . . 0.0 108.805 172.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.6 OUTLIER -124.08 128.71 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 128.714 2.806 . . . . 0.0 117.538 166.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.56 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.98 134.85 53.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.982 0.81 . . . . 0.0 109.051 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -80.55 97.14 7.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -144.19 -68.95 0.31 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.317 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 46' ' ' SER . 1.6 pt-20 -155.78 -63.33 0.11 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.555 0.742 . . . . 0.0 109.058 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.436 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 39.0 m -53.9 -36.89 63.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.319 170.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.7 -63.07 3.68 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.163 0.887 . . . . 0.0 112.04 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -63.16 -37.13 86.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.856 0.862 . . . . 0.0 112.01 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -56.94 -44.01 82.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.751 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -64.55 -45.85 85.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.685 1.594 . . . . 0.0 111.273 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.8 mt -49.79 -44.45 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 120.156 1.344 . . . . 0.0 110.869 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.39 -31.92 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.245 -0.909 . . . . 0.0 110.964 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 8.64 43.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.867 0.867 . . . . 0.0 110.929 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -168.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -130.31 51.71 2.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.18 147.87 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -98.76 -31.31 11.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.5 1.12 . . . . 0.0 110.534 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.11 161.5 40.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.943 0.497 . . . . 0.0 111.936 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.97 125.37 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.69 114.83 40.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.1 m -141.04 165.5 27.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -69.13 -35.67 76.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.605 1.162 . . . . 0.0 111.207 172.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -155.3 161.8 41.02 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.79 142.65 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.044 1.738 . . . . 0.0 108.123 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -65.94 154.26 39.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.58 -51.74 68.63 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.075 0.55 . . . . 0.0 109.986 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.2 -46.38 88.59 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.08 -35.47 80.59 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.393 0.677 . . . . 0.0 111.791 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -59.92 -60.96 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.736 1.153 . . . . 0.0 109.693 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -65.37 -21.54 66.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 0.0 110.383 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -70.7 -66.91 0.55 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.443 1.497 . . . . 0.0 109.538 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.17 -18.77 60.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.547 -165.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 p -59.45 -9.35 2.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -74.36 104.79 5.24 Favored 'General case' 0 C--O 1.23 0.075 0 O-C-N 120.6 -1.313 . . . . 0.0 109.901 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 67.78 11.47 8.39 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.437 1.895 . . . . 0.0 114.031 174.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.4 142.84 42.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -109.8 144.03 38.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -122.12 117.35 51.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -164.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.4 148.87 42.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.399 1.88 . . . . 0.0 110.522 -167.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -96.12 118.97 33.77 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.573 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.62 124.83 22.9 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.806 0.843 . . . . 0.0 110.849 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.85 105.31 15.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.874 1.67 . . . . 0.0 107.923 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.7 176.93 49.42 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-O 122.623 1.124 . . . . 0.0 110.921 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.48 24.97 10.94 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.266 1.827 . . . . 0.0 107.046 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.55 105.84 15.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -52.42 -42.88 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.73 -47.06 86.98 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -57.14 -41.58 79.4 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.29 0.495 . . . . 0.0 110.898 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.45 -32.28 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.242 -0.911 . . . . 0.0 111.322 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.2 mt -67.95 -50.85 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 p -62.06 -42.96 99.73 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.937 0.789 . . . . 0.0 111.164 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.55 -43.31 99.09 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.956 0.502 . . . . 0.0 109.976 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -65.46 -48.46 72.61 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -52.61 -36.41 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.789 1.235 . . . . 0.0 110.237 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.05 -12.39 58.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.395 1.078 . . . . 0.0 113.538 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.94 4.38 88.62 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.838 1.209 . . . . 0.0 112.719 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -27.09 63.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.271 1.028 . . . . 0.0 112.572 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.56 145.64 55.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.688 0.677 . . . . 0.0 110.497 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -78.98 151.8 31.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.989 0.916 . . . . 0.0 108.615 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -81.0 134.84 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.46 131.52 22.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -65.92 152.25 44.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.18 143.16 92.76 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.254 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 C-N-CA 123.075 2.517 . . . . 0.0 109.684 -175.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.56 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -132.05 179.23 6.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.197 0.999 . . . . 0.0 108.675 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt -141.73 147.88 38.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.533 -0.73 . . . . 0.0 109.259 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.6 mm -127.63 154.98 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.346 1.458 . . . . 0.0 108.692 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 54.58 21.25 3.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.433 1.893 . . . . 0.0 113.457 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.52 134.18 35.2 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.747 -1.845 . . . . 0.0 108.763 -169.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -138.36 113.48 9.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.511 0.724 . . . . 0.0 109.298 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 t -120.44 144.61 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 102.45 13.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.798 1.239 . . . . 0.0 108.61 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mt -84.85 128.18 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 p -75.49 123.36 25.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 117.984 0.356 . . . . 0.0 111.001 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.7 mtp -123.19 154.71 38.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.254 1.022 . . . . 0.0 111.116 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -107.43 -61.57 1.54 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.716 2.006 . . . . 0.0 109.732 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.4 t -140.11 -76.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.38 14.32 8.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.031 0.933 . . . . 0.0 110.965 -169.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 21.3 ptmt -148.67 169.73 19.74 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.883 1.273 . . . . 0.0 108.649 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.17 131.39 28.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -67.35 159.09 30.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.577 0.751 . . . . 0.0 110.099 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -51.49 -36.02 42.74 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.698 0.799 . . . . 0.0 111.623 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -158.47 178.26 10.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.047 0.385 . . . . 0.0 111.377 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -73.15 -10.11 59.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.757 2.423 . . . . 0.0 111.817 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -107.87 -10.0 15.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.844 -1.16 . . . . 0.0 112.643 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -116.3 10.19 14.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.094 1.357 . . . . 0.0 110.415 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.9 p -70.13 164.47 24.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.716 -1.24 . . . . 0.0 110.038 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -119.95 -21.48 7.11 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.216 1.806 . . . . 0.0 109.898 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -158.88 176.42 12.35 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.956 0.884 . . . . 0.0 110.45 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -124.48 111.07 15.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.924 2.49 . . . . 0.0 106.212 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.9 tp -79.04 110.7 14.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -84.47 93.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.17 148.07 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.31 1.844 . . . . 0.0 107.892 171.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -133.9 86.75 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -80.81 130.6 35.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.15 1.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.01 64.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 159.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.28 10.6 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.133 1.373 . . . . 0.0 114.41 -172.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -138.29 150.37 46.58 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.48 1.912 . . . . 0.0 108.779 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.22 95.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 128.021 2.528 . . . . 0.0 108.374 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -88.77 -27.21 21.29 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.907 -1.121 . . . . 0.0 110.88 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.85 178.87 8.53 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.467 1.031 . . . . 0.0 109.704 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -140.27 178.48 7.26 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.508 1.523 . . . . 0.0 109.542 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.27 162.82 33.73 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.924 2.089 . . . . 0.0 107.036 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.22 142.4 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.2 mt -128.14 109.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 166.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -60.3 142.14 55.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.564 1.074 . . . . 0.0 110.609 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -77.94 65.57 3.39 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.873 1.669 . . . . 0.0 108.949 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.01 95.15 2.52 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 52.71 -69.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.348 3.059 . . . . 0.0 115.465 157.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -44.95 -33.35 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.574 1.95 . . . . 0.0 110.88 157.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.27 -67.22 2.28 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 124.019 0.819 . . . . 0.0 111.371 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.66 -27.12 66.59 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -52.85 -51.46 60.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.686 1.13 . . . . 0.0 110.634 163.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -70.67 -20.93 62.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.986 0.514 . . . . 0.0 112.079 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.18 -11.73 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.592 1.157 . . . . 0.0 111.035 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.77 -23.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 119.906 -1.746 . . . . 0.0 111.16 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -114.7 52.64 0.84 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.537 1.062 . . . . 0.0 110.155 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -168.07 2.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.69 32.76 4.08 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.13 1.772 . . . . 0.0 109.397 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.67 140.92 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.94 -37.39 12.26 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.827 1.251 . . . . 0.0 109.168 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.33 151.45 26.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.229 1.012 . . . . 0.0 111.476 -171.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.5 mt -98.48 151.96 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 165.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.7 mt -124.28 130.05 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 161.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.1 p -146.65 160.82 41.7 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.88 1.272 . . . . 0.0 109.689 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -66.66 -47.72 71.62 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 167.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -154.88 172.87 17.33 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.0 tt -167.26 121.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -169.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -56.49 146.71 23.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -48.98 -43.99 40.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.341 1.456 . . . . 0.0 111.348 -174.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.25 -49.72 66.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.646 -0.658 . . . . 0.0 112.118 177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -58.28 -41.28 84.01 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.704 1.202 . . . . 0.0 109.849 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -59.35 -63.27 1.36 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.408 1.083 . . . . 0.0 109.529 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HG3' ' A' ' 66' ' ' GLU . 36.9 mttt -62.38 -21.89 65.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.711 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -72.76 -60.45 2.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.133 0.973 . . . . 0.0 110.03 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -75.46 -10.46 59.47 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.0 p -63.58 -9.02 11.36 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -77.2 117.93 19.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 120.414 -1.429 . . . . 0.0 108.311 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? 75.4 -31.48 0.21 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.335 3.054 . . . . 0.0 112.47 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mt -103.67 120.13 53.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.4 153.98 31.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.98 116.74 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.316 -1.49 . . . . 0.0 107.111 -166.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 7.1 m-85 -113.17 160.64 18.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.534 1.933 . . . . 0.0 110.703 -168.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -99.46 130.89 45.76 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 0.0 110.617 -173.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 131.04 36.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.019 0.927 . . . . 0.0 109.526 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -110.26 15.64 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.421 1.488 . . . . 0.0 112.271 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.76 172.64 31.14 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.437 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 13.0 m-20 -83.61 -24.13 31.6 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.567 0.747 . . . . 0.0 109.673 151.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.1 106.86 4.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.1 0.56 . . . . 0.0 109.776 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.6 -46.93 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.147 0.979 . . . . 0.0 109.517 168.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.0 -58.3 9.03 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -45.09 -49.55 11.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.974 1.309 . . . . 0.0 110.853 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.69 -41.56 87.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.953 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.58 -48.15 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -15.03 63.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.4 mt -83.71 -38.84 20.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.371 1.442 . . . . 0.0 109.226 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.564 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 54.5 t80 -65.21 -41.42 94.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -169.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.14 -45.93 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.288 2.235 . . . . 0.0 110.728 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.31 -19.52 56.3 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.942 -1.099 . . . . 0.0 111.816 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.0 39.27 63.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -17.88 62.02 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.086 0.943 . . . . 0.0 109.054 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -89.54 124.92 34.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 m -72.67 153.72 41.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.617 169.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 9.3 mtpm? -61.19 144.06 54.4 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.9 mt -66.09 150.57 10.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.516 1.126 . . . . 0.0 108.275 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.7 m -136.67 -29.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.358 1.063 . . . . 0.0 111.596 167.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -128.94 85.6 59.69 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 126.798 2.039 . . . . 0.0 107.592 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 C--O 1.251 1.137 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 153.574 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -148.64 157.9 43.77 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.624 1.169 . . . . 0.0 107.886 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt -137.23 137.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 122.867 0.467 . . . . 0.0 109.916 172.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.5 142.66 41.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.986 0.914 . . . . 0.0 109.551 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 44.65 66.31 0.9 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.166 2.986 . . . . 0.0 113.267 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.3 ttt -107.15 147.82 29.6 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -133.66 129.22 36.53 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.9 t -132.54 144.84 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 118.314 -0.85 . . . . 0.0 108.707 168.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.35 77.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.384 1.073 . . . . 0.0 108.785 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.23 141.89 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 0.0 109.68 -165.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 p -74.46 115.73 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.71 0.631 . . . . 0.0 111.491 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.1 mtp -122.21 148.49 44.89 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.27 -0.894 . . . . 0.0 111.102 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.98 -75.34 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 109.54 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 t -144.12 -46.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.598 1.159 . . . . 0.0 107.925 -167.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.53 2.35 1.24 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.56 -179.9 8.51 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 126.858 2.063 . . . . 0.0 108.808 -176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.9 139.29 19.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.3 p -69.71 -84.52 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.704 1.602 . . . . 0.0 110.271 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 t30 177.0 -55.03 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 127.518 2.327 . . . . 0.0 107.304 -167.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.3 t -126.42 -175.15 3.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.931 1.242 . . . . 0.0 110.228 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -85.4 -43.3 13.76 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.3 1.44 . . . . 0.0 108.544 166.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.66 -19.43 60.84 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.028 -0.42 . . . . 0.0 110.414 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -119.96 74.32 1.02 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.0 p -134.27 165.16 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.212 1.805 . . . . 0.0 107.825 151.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -90.45 -37.43 13.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.352 0.661 . . . . 0.0 109.783 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.31 171.09 19.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.673 0.749 . . . . 0.0 110.456 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.04 108.8 16.19 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.091 2.556 . . . . 0.0 106.304 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.72 103.71 8.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.3 mm -79.19 88.36 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.558 0.695 . . . . 0.0 109.192 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -58.24 125.88 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 168.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -103.53 110.09 22.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.26 143.65 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 161.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -136.05 -0.36 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.92 45.52 0.28 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.665 0.745 . . . . 0.0 110.136 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.6 -9.7 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.252 2.221 . . . . 0.0 115.318 -167.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.99 163.46 22.27 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.105 1.32 . . . . 0.0 111.648 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -44.51 128.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 128.375 2.67 . . . . 0.0 111.159 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -91.17 -86.92 0.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.52 -0.66 9.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.316 1.416 . . . . 0.0 113.904 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 p 49.61 -166.4 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.894 -1.129 . . . . 0.0 110.723 -160.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.44 166.35 3.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.488 2.315 . . . . 0.0 107.442 165.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.89 132.3 65.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.9 mt -127.84 119.54 51.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 168.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.32 157.96 35.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.533 1.06 . . . . 0.0 110.722 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -84.11 65.21 8.63 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.884 -1.135 . . . . 0.0 108.578 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -130.55 28.42 4.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.236 1.017 . . . . 0.0 113.717 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 70.9 -54.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 128.759 2.824 . . . . 0.0 111.231 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.8 t -53.68 -36.27 61.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.085 1.354 . . . . 0.0 110.583 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.59 8.53 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 125.243 1.402 . . . . 0.0 111.891 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.83 -34.7 69.98 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.97 -0.724 . . . . 0.0 110.959 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -49.74 -44.03 48.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.018 0.927 . . . . 0.0 111.438 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -43.7 85.51 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.345 0.658 . . . . 0.0 111.315 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.6 -37.85 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 110.258 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -54.61 -45.43 71.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.138 0.427 . . . . 0.0 110.626 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -34.84 66.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.12 -14.75 62.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.859 -159.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.96 63.63 1.66 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.556 1.542 . . . . 0.0 109.355 -172.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.21 140.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.223 157.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -73.61 -47.82 37.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.1 40.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.22 108.0 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.23 125.37 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -142.51 177.02 8.57 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.573 1.149 . . . . 0.0 108.925 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -88.2 -38.45 15.29 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.273 -0.892 . . . . 0.0 110.972 166.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.65 162.79 35.04 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.495 1.043 . . . . 0.0 109.189 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 tt -165.56 132.72 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.257 1.423 . . . . 0.0 108.53 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.1 p -65.02 157.91 27.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.157 0.983 . . . . 0.0 112.162 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -50.8 -53.64 30.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.502 1.521 . . . . 0.0 110.635 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -38.5 79.31 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.42 0.628 . . . . 0.0 111.294 -166.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.96 -37.78 72.78 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.967 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -55.69 -57.01 13.78 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 120.045 1.293 . . . . 0.0 111.154 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -57.19 -43.51 82.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.774 0.716 . . . . 0.0 110.533 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -53.43 -69.36 0.12 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.648 1.579 . . . . 0.0 110.129 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -68.37 -36.69 79.57 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.346 0.521 . . . . 0.0 110.854 -169.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.2 t -54.14 -24.37 17.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.516 1.526 . . . . 0.0 112.908 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -65.2 -10.52 32.23 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.697 -1.252 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -156.16 3.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.932 1.696 . . . . 0.0 112.942 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -141.21 125.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.87 133.34 35.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.87 138.03 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 120.644 -1.285 . . . . 0.0 108.845 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -129.81 156.3 44.56 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.537 1.935 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -98.15 137.65 36.61 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.043 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.49 122.92 32.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.274 2.23 . . . . 0.0 112.498 -174.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.09 108.93 20.51 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.716 2.006 . . . . 0.0 109.939 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.48 -176.7 53.6 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -163.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -118.14 -2.21 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.918 0.887 . . . . 0.0 110.211 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.67 103.48 7.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.21 1.004 . . . . 0.0 108.475 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.45 -38.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.144 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.29 -40.97 86.15 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.878 0.763 . . . . 0.0 109.697 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -64.29 -43.04 96.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.875 -0.516 . . . . 0.0 110.727 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.18 -33.23 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.459 -1.401 . . . . 0.0 110.483 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.79 -51.68 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.548 1.539 . . . . 0.0 108.088 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 p -75.01 -18.75 60.31 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.83 -37.74 62.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.515 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 80.2 t80 -67.79 -42.58 81.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.776 -0.577 . . . . 0.0 111.963 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 mt -51.86 -50.99 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.72 1.608 . . . . 0.0 108.377 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.8 -18.39 62.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.529 1.132 . . . . 0.0 113.978 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.65 23.11 54.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 118.85 0.75 . . . . 0.0 111.919 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -28.6 66.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.118 1.459 . . . . 0.0 109.32 -170.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 1.2 mm? -82.11 135.73 35.27 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.78 1.232 . . . . 0.0 108.899 -163.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.5 p -71.06 157.45 38.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.469 1.107 . . . . 0.0 108.842 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -87.87 132.86 34.04 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.72 120.48 17.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -138.84 -4.86 1.54 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.781 1.632 . . . . 0.0 111.09 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -153.98 68.54 6.11 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.283 1.833 . . . . 0.0 108.897 -173.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.246 0.915 0 C-N-CA 124.421 3.414 . . . . 0.0 109.715 169.726 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.433 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 39.1 m170 59.27 178.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.703 1.201 . . . . 0.0 110.929 -167.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.07 127.39 32.09 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 111.029 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.62 146.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.547 1.539 . . . . 0.0 108.601 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 47.51 32.92 2.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.423 1.889 . . . . 0.0 115.061 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.9 151.06 31.17 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.663 -1.273 . . . . 0.0 107.625 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 155.04 50.29 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 156.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.424 ' CG1' ' HB ' ' A' ' 28' ' ' VAL . 7.3 p -146.68 165.74 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 128.097 2.559 . . . . 0.0 104.903 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.45 133.6 55.63 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 120.178 1.353 . . . . 0.0 111.646 153.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mt -105.43 119.29 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -62.45 114.32 3.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.864 1.211 . . . . 0.0 108.715 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.7 mtp -117.98 156.31 28.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 110.906 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.31 -69.63 0.76 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 127.752 2.421 . . . . 0.0 108.27 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 t -137.71 -67.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 168.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.3 -7.24 11.78 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 171.48 13.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.505 1.522 . . . . 0.0 110.058 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -59.54 139.32 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 p -84.04 166.42 17.74 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.528 0.731 . . . . 0.0 111.076 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -50.47 -43.99 55.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.833 1.653 . . . . 0.0 113.934 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.08 168.36 19.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.409 0.549 . . . . 0.0 110.133 -166.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -67.72 -23.45 65.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.01 1.724 . . . . 0.0 112.499 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.79 -30.19 13.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.791 1.178 . . . . 0.0 111.54 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.74 10.12 8.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.221 1.408 . . . . 0.0 111.809 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.5 p -80.1 167.62 20.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 122.174 0.988 . . . . 0.0 110.631 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -108.12 -28.71 9.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.516 1.526 . . . . 0.0 109.217 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -159.36 178.35 10.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.603 0.638 . . . . 0.0 111.451 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -125.49 105.64 9.2 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 129.24 3.016 . . . . 0.0 106.612 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.83 111.99 11.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -81.24 98.32 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 6' ' ' VAL . 2.9 t -63.96 132.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.08 98.51 6.11 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 163.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.37 152.75 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.41 -20.35 1.06 Allowed 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -161.31 68.59 0.31 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 169.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.6 m120 54.9 10.62 0.4 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.301 2.241 . . . . 0.0 115.269 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -129.23 158.54 38.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.379 1.072 . . . . 0.0 112.503 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.49 96.13 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.709 1.604 . . . . 0.0 107.753 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -100.48 -20.21 15.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.202 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -156.78 148.89 23.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.248 1.385 . . . . 0.0 111.167 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 p -126.18 156.94 39.39 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.534 1.934 . . . . 0.0 109.427 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 162.26 37.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.729 1.211 . . . . 0.0 108.881 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.82 112.11 23.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.26 115.57 34.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 161.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -66.77 158.09 31.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.081 1.31 . . . . 0.0 110.524 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.22 81.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -130.3 -170.97 2.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.685 1.231 . . . . 0.0 108.739 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.51 -49.92 75.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.33 1.852 . . . . 0.0 111.061 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.3 m -65.46 -37.68 87.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.894 0.316 . . . . 0.0 110.776 175.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.48 -62.98 5.73 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 123.552 0.596 . . . . 0.0 112.795 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -59.67 -28.93 67.69 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.589 0.756 . . . . 0.0 111.219 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -71.35 -32.51 68.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.943 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -65.22 -38.22 89.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 119.257 0.935 . . . . 0.0 110.357 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -62.49 -17.31 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 118.753 0.706 . . . . 0.0 111.715 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.7 t -82.2 -30.18 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 119.51 -1.994 . . . . 0.0 112.205 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.83 54.84 1.13 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.544 1.138 . . . . 0.0 109.08 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 -165.14 1.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.854 1.662 . . . . 0.0 111.017 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.46 19.33 7.44 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.199 2.2 . . . . 0.0 108.94 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.4 166.06 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.95 1.25 . . . . 0.0 109.944 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.72 -33.34 6.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 109.522 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.6 163.11 34.91 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -161.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.4 mt -134.14 118.34 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 163.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mt -81.08 133.35 29.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 120.488 1.494 . . . . 0.0 107.171 166.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 p -144.51 168.13 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.86 1.209 . . . . 0.0 112.251 168.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -93.4 -27.2 16.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 117.455 -1.259 . . . . 0.0 112.727 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -161.26 161.37 30.7 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.005 1.722 . . . . 0.0 107.061 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -151.46 127.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 126.403 1.881 . . . . 0.0 108.515 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -54.8 148.35 13.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.125 0.97 . . . . 0.0 110.442 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -61.6 -38.8 88.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.416 1.007 . . . . 0.0 111.524 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.21 -51.65 62.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -57.81 -43.13 85.47 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -56.41 -58.57 7.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.128 0.422 . . . . 0.0 110.145 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.46 -20.67 66.45 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 122.374 -0.204 . . . . 0.0 111.275 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -75.44 -35.74 60.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.18 -0.95 . . . . 0.0 111.941 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.09 -16.67 18.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.698 0.799 . . . . 0.0 111.812 -172.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.82 -17.45 56.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -71.99 106.99 4.48 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 120.566 -1.334 . . . . 0.0 109.611 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 tttm 73.95 21.28 2.66 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.143 1.777 . . . . 0.0 111.954 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.64 144.11 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.597 1.559 . . . . 0.0 107.742 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -102.59 108.8 20.21 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.42 114.83 30.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -105.92 149.15 26.85 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.685 1.194 . . . . 0.0 110.117 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -83.13 147.17 28.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.78 168.05 20.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 109.924 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.6 5.9 14.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.419 2.287 . . . . 0.0 112.366 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.96 -169.37 41.8 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.15 -14.17 34.14 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.539 1.135 . . . . 0.0 110.0 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.66 99.35 2.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.744 1.218 . . . . 0.0 109.659 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -52.97 -42.05 42.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.37 -38.49 71.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.116 0.871 . . . . 0.0 110.305 -171.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -57.14 -50.35 73.09 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.61 -31.74 65.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.1 -54.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.895 1.278 . . . . 0.0 108.053 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 p -66.82 -36.57 82.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.357 0.526 . . . . 0.0 111.184 -172.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.3 mt -63.93 -40.46 96.5 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.243 0.617 . . . . 0.0 111.171 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -63.85 -34.42 77.88 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.478 0.711 . . . . 0.0 112.223 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.4 mt -59.21 -45.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 -18.55 60.7 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.214 1.006 . . . . 0.0 112.135 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.73 14.17 81.4 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.468 -0.77 . . . . 0.0 112.217 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -19.9 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.631 1.973 . . . . 0.0 112.592 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -67.13 140.81 57.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.016 -1.052 . . . . 0.0 109.492 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.0 m -64.6 125.51 24.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.452 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -81.04 126.88 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.4 mt -74.17 143.07 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -168.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 -52.95 2.81 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.27 1.028 . . . . 0.0 112.403 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.25 149.83 62.02 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.211 3.274 . . . . 0.0 110.989 176.912 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.23 168.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.382 1.873 . . . . 0.0 113.374 -172.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt -120.51 127.3 52.06 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.8 mt -122.06 148.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.47 23.21 10.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.998 1.719 . . . . 0.0 113.42 171.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpp -68.57 147.06 52.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -134.34 141.09 46.78 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 166.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.24 140.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 110.02 21.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.493 0.717 . . . . 0.0 109.436 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.7 mt -95.07 123.96 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 p -80.91 112.19 18.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtp -108.87 158.12 17.97 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -108.08 -53.13 2.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 127.738 2.415 . . . . 0.0 109.143 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.26 -79.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.41 -3.37 16.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.134 0.974 . . . . 0.0 112.003 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 171.23 16.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.304 1.842 . . . . 0.0 110.955 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.5 mt -64.98 124.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.738 1.615 . . . . 0.0 107.3 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 t -66.55 173.1 3.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.155 0.889 . . . . 0.0 111.229 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.67 -27.75 67.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.53 0.732 . . . . 0.0 111.749 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 p -147.69 177.2 9.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.69 -0.631 . . . . 0.0 110.373 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -69.26 -37.28 77.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.511 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -88.48 -39.24 14.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.481 0.713 . . . . 0.0 109.629 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.27 31.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.648 2.379 . . . . 0.0 111.276 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 p -99.28 172.53 7.29 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 119.968 -1.707 . . . . 0.0 111.096 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -103.59 -30.05 10.73 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.592 1.557 . . . . 0.0 110.065 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -166.82 176.94 6.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 43' ' ' ASN . 41.9 m-85 -123.7 102.55 7.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 126.409 1.884 . . . . 0.0 107.29 -169.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 103.32 11.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.87 95.42 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.349 1.86 . . . . 0.0 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 t -76.2 92.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.83 115.99 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 156.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.59 131.89 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.06 3.03 3.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.55 44.33 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 111.545 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.55 8.16 2.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.007 0.923 . . . . 0.0 112.577 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -134.18 165.41 25.15 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 126.967 2.107 . . . . 0.0 111.212 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -61.82 128.73 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 127.068 2.147 . . . . 0.0 109.614 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.15 -85.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.757 -0.639 . . . . 0.0 109.7 167.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -15.19 14.45 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 44.84 -168.34 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.373 1.069 . . . . 0.0 112.11 -163.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 163.43 8.57 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 125.164 1.385 . . . . 0.0 109.784 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.669 0.7 OUTLIER -118.91 140.16 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 119.456 3.132 . . . . 0.0 119.456 159.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.7 mt -124.56 122.93 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 129.261 3.024 . . . . 0.0 105.175 164.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -68.01 155.57 39.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.365 1.893 . . . . 0.0 111.057 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 45.0 t30 -77.31 61.79 2.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.52 1.528 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -97.38 161.92 13.57 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 165.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -44.04 93.35 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.113 -0.992 . . . . 0.0 108.324 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -70.4 -16.23 62.93 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.962 -1.086 . . . . 0.0 111.293 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -64.03 2.89 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 166.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 43.3 pttt -65.87 -23.37 66.64 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.76 -0.847 . . . . 0.0 111.977 -172.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -38.57 83.92 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 171.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -72.86 -32.08 65.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.925 1.29 . . . . 0.0 110.172 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.407 HD13 ' CD2' ' A' ' 25' ' ' PHE . 58.8 mt -55.07 -42.97 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.78 1.232 . . . . 0.0 109.761 176.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.12 -26.36 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.406 -0.809 . . . . 0.0 111.667 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -97.7 -28.22 14.0 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.865 0.866 . . . . 0.0 110.97 -172.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -25.52 63.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.695 1.198 . . . . 0.0 111.884 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.2 t30 74.2 51.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.406 2.282 . . . . 0.0 109.958 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -50.82 152.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.868 1.667 . . . . 0.0 109.324 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -42.97 10.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.091 1.357 . . . . 0.0 109.175 171.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.24 160.12 42.72 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.3 mt -116.42 144.0 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.685 1.194 . . . . 0.0 107.962 171.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.8 mt -123.04 121.28 62.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.0 p -149.3 170.81 17.64 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.773 1.229 . . . . 0.0 109.345 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -82.66 -40.04 21.25 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.104 167.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -147.64 164.42 33.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.502 1.501 . . . . 0.0 109.61 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.5 tt -144.77 145.38 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.406 1.482 . . . . 0.0 109.095 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -62.49 155.47 25.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.197 0.908 . . . . 0.0 109.562 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.04 -43.37 87.75 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 118.824 0.738 . . . . 0.0 109.04 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.39 -45.24 94.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 110.666 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -61.79 -47.94 82.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.783 1.233 . . . . 0.0 109.263 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.56 -58.94 5.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.724 1.147 . . . . 0.0 110.541 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.51 -22.39 66.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.581 0.628 . . . . 0.0 111.892 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -76.66 -44.04 35.51 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 120.829 -1.169 . . . . 0.0 110.885 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -88.04 -8.28 55.8 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.148 0.979 . . . . 0.0 112.753 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 p -73.26 43.14 0.13 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.835 1.652 . . . . 0.0 112.551 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -139.91 111.84 7.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.412 1.885 . . . . 0.0 106.662 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? 60.81 -1.22 0.25 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 113.948 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.5 mt -131.27 134.25 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -169.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.56 130.49 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.499 1.52 . . . . 0.0 107.034 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.5 mt -104.17 118.5 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -110.29 155.38 22.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.237 1.815 . . . . 0.0 110.821 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -99.06 118.1 35.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.798 1.239 . . . . 0.0 110.348 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.95 135.15 57.7 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 168.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HG3' HD22 ' A' ' 89' ' ' ASN . 0.0 OUTLIER -79.74 -16.24 55.98 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.291 1.036 . . . . 0.0 112.722 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.89 -178.73 46.87 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 126.11 1.814 . . . . 0.0 109.078 -149.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -96.48 -15.35 21.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.097 0.959 . . . . 0.0 110.042 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.41 99.81 2.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.45 1.5 . . . . 0.0 110.014 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.57 -41.79 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.27 -39.28 89.31 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.8 0.727 . . . . 0.0 110.997 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -46.23 90.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.519 0.676 . . . . 0.0 109.517 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.413 HD22 ' HG3' ' A' ' 82' ' ' GLU . 32.6 m-80 -74.17 -26.22 60.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.702 -170.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.0 mt -67.19 -51.26 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.006 0.821 . . . . 0.0 108.797 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.8 p -71.38 -33.05 69.17 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.429 0.558 . . . . 0.0 111.503 -173.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -42.68 95.88 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.69 -0.631 . . . . 0.0 110.268 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -57.89 -47.56 82.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.781 0.433 . . . . 0.0 111.872 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 mt -51.03 -56.49 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.168 1.387 . . . . 0.0 111.119 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -73.43 -1.93 20.32 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.055 1.298 . . . . 0.0 113.573 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.61 86.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.263 0.935 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -27.56 67.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.077 1.751 . . . . 0.0 112.146 -173.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.22 144.42 57.15 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.46 139.39 49.61 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.33 -0.857 . . . . 0.0 110.188 172.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.92 123.0 30.76 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.8 mt -71.82 140.56 17.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.475 1.11 . . . . 0.0 109.752 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.48 120.81 27.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.606 1.162 . . . . 0.0 108.074 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 76.08 0.55 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.661 1.584 . . . . 0.0 112.205 166.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 123.579 2.853 . . . . 0.0 111.364 170.055 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.567 0 CA-C-O 118.762 -1.021 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 60.72 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 110.394 -146.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt -160.76 137.08 8.53 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.364 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.2 mt -146.8 46.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.352 0.596 . . . . 0.0 112.097 -173.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 t30 173.54 42.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.846 2.059 . . . . 0.0 107.509 163.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 146.79 32.94 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 120.598 -1.314 . . . . 0.0 108.127 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -145.85 120.41 9.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.892 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.9 152.98 25.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 109.613 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.75 120.62 40.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.653 1.181 . . . . 0.0 108.359 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.15 118.9 54.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -63.2 105.41 0.71 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.757 0.823 . . . . 0.0 109.636 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.15 155.85 22.26 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -93.71 -76.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.603 1.961 . . . . 0.0 107.393 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -139.61 -56.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 1.26 3.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -160.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -156.6 173.79 16.41 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.252 2.221 . . . . 0.0 108.519 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.31 139.31 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.788 0.68 . . . . 0.0 111.147 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 163.48 21.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 111.308 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.83 -16.82 60.02 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -166.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.46 172.63 17.92 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.672 1.989 . . . . 0.0 107.335 170.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.18 -50.54 73.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.34 1.056 . . . . 0.0 108.768 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -74.5 -44.49 51.13 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -165.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.9 4.15 0.91 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 128.55 2.74 . . . . 0.0 113.641 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 p -67.57 165.92 15.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 123.057 1.408 . . . . 0.0 110.742 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -106.58 -30.75 8.84 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.919 1.687 . . . . 0.0 108.688 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 28.2 p90 -155.35 164.94 38.07 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.158 0.98 . . . . 0.0 109.834 172.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.55 112.48 25.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.04 114.01 14.2 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mm -84.04 93.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.08 101.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -91.72 121.6 33.51 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -125.75 115.69 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.63 -0.64 6.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.387 -169.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.09 61.24 0.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.135 0.969 . . . . 0.0 110.433 156.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.63 6.89 0.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.238 1.815 . . . . 0.0 114.679 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.18 163.29 23.48 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.1 2.56 . . . . 0.0 109.378 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.91 74.96 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 122.408 1.099 . . . . 0.0 108.101 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -57.37 -29.58 64.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.909 1.684 . . . . 0.0 112.118 -170.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 m -154.82 115.26 3.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.401 1.0 . . . . 0.0 108.845 164.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -64.02 141.62 58.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 161.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.09 161.2 38.8 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 124.53 1.132 . . . . 0.0 109.274 -178.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.474 0.6 OUTLIER -142.53 132.44 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 178.602 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.423 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 66.0 mt -119.59 113.13 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -65.46 152.07 44.84 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.773 0.715 . . . . 0.0 109.439 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -75.57 87.38 2.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.57 174.99 10.0 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.57 2.748 . . . . 0.0 105.038 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -62.13 -38.64 89.71 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.487 -1.383 . . . . 0.0 111.567 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 t -61.43 -18.56 59.43 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.697 -0.627 . . . . 0.0 111.316 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -75.23 -61.09 3.1 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -66.91 -15.4 63.64 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.368 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -60.98 -64.57 0.91 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.837 1.199 . . . . 0.0 109.639 161.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.3 m -54.13 -37.73 64.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.991 0.916 . . . . 0.0 113.344 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.4 mt -50.74 -40.4 19.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.075 1.35 . . . . 0.0 111.608 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.48 -46.88 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.082 -1.012 . . . . 0.0 109.063 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -73.66 -21.77 60.17 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.833 0.853 . . . . 0.0 112.978 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.81 -26.65 63.41 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.346 -0.847 . . . . 0.0 111.094 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 74.25 38.33 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.849 1.66 . . . . 0.0 112.536 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.44 138.13 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.558 1.143 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -66.48 -56.68 9.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.019 1.728 . . . . 0.0 108.74 168.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.82 29.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -169.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.56 148.44 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.5 mt -119.41 123.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.35 2.26 . . . . 0.0 104.978 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.76 154.33 31.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.803 1.638 . . . . 0.0 111.141 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -71.94 -25.9 62.07 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.34 -0.85 . . . . 0.0 111.124 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -172.23 166.15 5.96 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.84 132.84 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.017 0.436 . . . . 0.0 110.285 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.42 147.25 32.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.528 0.731 . . . . 0.0 109.622 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -48.71 79.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.343 1.057 . . . . 0.0 110.506 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -56.67 -47.97 78.64 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -64.51 -44.94 89.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.724 1.21 . . . . 0.0 110.424 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -54.9 -64.88 0.7 Allowed 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 118.682 0.674 . . . . 0.0 109.552 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -57.02 -33.15 66.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.771 0.828 . . . . 0.0 111.518 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -71.33 -34.34 70.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.56 1.944 . . . . 0.0 113.457 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -99.26 -23.39 15.21 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.706 0.685 . . . . 0.0 112.541 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -68.68 15.24 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -166.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -19.04 13.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.754 1.161 . . . . 0.0 113.151 -174.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -34.78 0.48 Allowed 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.188 -0.945 . . . . 0.0 113.188 175.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.6 mt -89.53 127.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.95 145.44 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.132 0.973 . . . . 0.0 108.66 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -113.67 122.67 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 120.377 -1.452 . . . . 0.0 107.748 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 72.5 m-85 -105.81 156.07 18.68 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.43 1.892 . . . . 0.0 108.257 172.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -68.06 177.19 2.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.283 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.75 149.54 48.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.959 1.303 . . . . 0.0 110.45 165.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.254 19.6 mp0 -106.22 -162.35 0.85 Allowed 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 129.09 2.956 . . . . 0.0 106.097 -165.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.3 166.88 0.04 OUTLIER Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.043 -1.035 . . . . 0.0 114.272 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -23.3 19.53 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.185 1.794 . . . . 0.0 113.555 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -72.13 101.83 2.87 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 125.083 1.489 . . . . 0.0 107.645 -171.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -53.55 -39.89 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -39.7 82.38 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -174.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -59.3 -45.58 90.9 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.24 -0.912 . . . . 0.0 109.339 170.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.93 -38.8 89.6 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.453 1.024 . . . . 0.0 111.046 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.07 -49.45 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 108.522 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 p -65.98 -36.89 84.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.813 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.4 mt -61.67 -44.44 96.96 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.709 0.686 . . . . 0.0 109.22 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -57.78 -57.25 13.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.288 0.635 . . . . 0.0 110.91 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.6 mt -51.82 -34.42 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.496 1.919 . . . . 0.0 111.183 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -84.96 -14.86 46.22 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 24.61 54.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 119.509 1.05 . . . . 0.0 112.395 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -24.54 36.19 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.793 1.237 . . . . 0.0 112.54 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 29.3 mt -73.18 142.92 47.39 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.274 1.035 . . . . 0.0 110.402 -171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 133.27 34.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 110.819 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 9.9 mtpm? -72.07 142.76 49.24 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.48 107.94 6.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.9 p -79.66 90.66 5.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 108.913 166.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.39 162.06 0.12 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 127.984 2.514 . . . . 0.0 112.778 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.604 -1.344 . . . . 0.0 108.604 156.024 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.525 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 56.01 10.9 0.64 Allowed 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 126.061 1.744 . . . . 0.0 115.255 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HB2' ' A' ' 4' ' ' MET . 0.5 OUTLIER 45.0 128.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -171.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.01 147.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.793 172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.58 56.89 1.93 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.341 2.656 . . . . 0.0 112.162 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.412 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 25.1 tpp -83.78 149.33 26.5 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.907 0.776 . . . . 0.0 109.928 170.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 38.6 mtpt -142.56 132.95 24.93 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.232 0.958 . . . . 0.0 108.491 153.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 28' ' ' VAL . 4.9 p -128.93 166.14 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 128.523 2.729 . . . . 0.0 107.439 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.64 110.47 13.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.37 1.468 . . . . 0.0 109.74 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -94.72 122.65 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.242 0.928 . . . . 0.0 108.932 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 p -72.11 97.45 1.93 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.128 1.371 . . . . 0.0 109.95 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.0 mtp -102.98 154.73 18.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.27 1.028 . . . . 0.0 110.6 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.79 -61.08 1.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.2 t -141.7 -71.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.77 10.72 7.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.8 1.286 . . . . 0.0 112.944 -167.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 175.54 12.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.811 2.444 . . . . 0.0 108.948 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.42 140.72 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.763 1.225 . . . . 0.0 108.456 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 t -73.61 -87.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -178.48 -36.45 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.795 1.638 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.27 154.32 36.56 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.336 0.588 . . . . 0.0 110.332 -177.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.48 -48.32 82.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.766 0.826 . . . . 0.0 110.047 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -78.17 -6.41 54.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.395 0.678 . . . . 0.0 112.804 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.16 -16.71 14.03 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.08 0.854 . . . . 0.0 111.063 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.0 p -72.62 170.65 14.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 122.154 0.978 . . . . 0.0 111.755 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -106.09 -26.32 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.881 1.272 . . . . 0.0 110.331 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -161.22 166.49 27.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.518 0.675 . . . . 0.0 110.364 170.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -105.36 116.41 31.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.423 1.489 . . . . 0.0 108.044 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.61 118.44 20.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 170.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -92.0 95.11 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.394 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 6' ' ' VAL . 1.9 t -78.33 104.09 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.82 140.8 36.69 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 156.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 145.19 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 164.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.19 18.64 0.36 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.98 52.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 128.506 2.722 . . . . 0.0 107.263 169.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.75 2.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 129.288 3.035 . . . . 0.0 113.694 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.16 150.84 40.67 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 128.203 2.601 . . . . 0.0 107.876 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.3 91.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.042 2.137 . . . . 0.0 109.884 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -53.55 -70.16 0.1 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 110.979 174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -151.79 112.71 4.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -69.26 164.17 23.37 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.23 1.412 . . . . 0.0 110.452 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 164.79 30.18 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 125.944 1.698 . . . . 0.0 108.534 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.54 148.23 26.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mt -134.33 105.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 166.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -57.34 145.46 32.26 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.61 97.95 0.34 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.406 1.882 . . . . 0.0 106.096 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -51.26 67.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.068 0.947 . . . . 0.0 109.339 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 t -68.45 -26.54 65.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.968 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -63.58 4.97 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -65.39 -22.61 66.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.461 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -68.96 -47.42 65.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.222 1.374 . . . . 0.0 109.039 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -44.6 73.16 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 110.102 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.1 mt -52.59 -35.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.648 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.21 -40.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 120.586 -1.321 . . . . 0.0 110.649 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.2 -8.75 44.57 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.346 0.658 . . . . 0.0 111.854 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' CD ' ' HZ3' ' A' ' 5' ' ' LYS . 10.5 mm-40 -60.3 -16.37 33.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.538 1.535 . . . . 0.0 111.226 166.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 53.29 36.47 22.83 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.985 1.714 . . . . 0.0 111.031 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.13 134.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -73.05 -39.63 65.75 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.422 1.889 . . . . 0.0 110.519 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.58 165.47 26.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mt -131.45 132.5 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.068 1.347 . . . . 0.0 107.5 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -104.12 130.97 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -146.46 175.83 10.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.649 0.659 . . . . 0.0 111.32 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -96.9 -24.27 15.93 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.099 1.36 . . . . 0.0 111.47 164.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -155.74 161.33 40.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.075 1.75 . . . . 0.0 108.311 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.82 130.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.833 1.653 . . . . 0.0 108.643 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -63.41 147.1 52.14 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.417 1.087 . . . . 0.0 110.489 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -55.29 -45.17 76.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.247 2.219 . . . . 0.0 111.998 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.37 -50.95 63.62 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.721 -0.612 . . . . 0.0 109.743 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -62.51 -39.13 92.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.75 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -51.53 -56.61 12.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.396 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -61.6 -43.26 99.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.198 0.599 . . . . 0.0 110.45 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -59.35 -40.91 87.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.19 1.396 . . . . 0.0 112.783 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -92.39 -34.66 14.07 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.259 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 t -70.56 16.33 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.144 1.778 . . . . 0.0 114.185 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -100.64 -17.26 17.11 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.977 1.711 . . . . 0.0 113.031 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -145.22 -6.57 0.64 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.838 0.855 . . . . 0.0 112.776 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.7 mt -136.19 133.5 50.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -165.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.72 113.34 22.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.586 1.554 . . . . 0.0 108.307 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.05 130.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -126.45 146.62 50.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.759 1.224 . . . . 0.0 109.799 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -95.62 119.53 34.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.539 1.135 . . . . 0.0 109.332 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.43 119.72 10.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.69 -12.6 61.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.66 172.34 44.14 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -166.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.2 -5.14 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.883 0.873 . . . . 0.0 109.812 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.51 102.71 8.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.493 1.917 . . . . 0.0 107.386 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -52.44 -40.31 32.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.23 -45.7 72.55 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 118.36 0.527 . . . . 0.0 110.393 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -57.7 -37.18 73.04 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.943 0.497 . . . . 0.0 110.764 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -77.46 -22.6 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.232 -0.918 . . . . 0.0 112.191 -176.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.2 mt -70.87 -50.78 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 p -61.65 -48.21 81.89 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.685 0.675 . . . . 0.0 111.035 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.2 mt -56.51 -47.02 80.23 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.24 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.1 -44.9 87.89 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.759 0.823 . . . . 0.0 112.426 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.96 -41.09 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.55 -13.22 59.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.055 0.843 . . . . 0.0 112.638 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.51 -1.29 61.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.535 1.064 . . . . 0.0 113.758 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -12.48 61.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.386 2.274 . . . . 0.0 115.461 -171.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.77 143.15 57.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.823 1.647 . . . . 0.0 108.25 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -72.34 142.14 48.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -80.17 150.98 29.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -83.76 133.89 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 m -138.05 -42.48 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.927 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -131.06 80.15 69.69 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.412 1.485 . . . . 0.0 109.717 173.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 C--O 1.247 0.961 1 C-N-CA 125.496 4.131 . . . . 0.0 111.972 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -64.23 178.52 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.161 0.981 . . . . 0.0 109.911 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt -132.95 124.58 28.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.123 -0.986 . . . . 0.0 108.427 -169.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 mm -116.63 138.52 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 t30 45.42 63.99 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.302 1.041 . . . . 0.0 112.01 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpp -94.47 151.97 18.94 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -141.53 138.55 32.82 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 167.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.1 t -133.47 148.33 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.87 105.1 14.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.662 0.785 . . . . 0.0 108.981 168.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.73 117.73 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.2 p -73.55 111.16 8.42 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mmm -113.86 161.28 17.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 110.094 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.23 -73.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.951 1.3 . . . . 0.0 108.06 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.26 -45.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -135.58 -13.7 1.97 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.2 174.39 12.03 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.31 1.444 . . . . 0.0 107.901 -171.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mt -54.48 139.46 13.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.162 0.982 . . . . 0.0 108.524 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 p -68.33 163.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.485 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -71.58 -31.15 66.65 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.83 -0.544 . . . . 0.0 111.586 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.88 158.67 33.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.383 0.992 . . . . 0.0 109.859 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -66.05 -39.72 90.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HG2' HD21 ' A' ' 68' ' ' ASN . 1.4 mm-40 -78.74 1.27 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 175.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.16 1.17 8.5 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.846 0.859 . . . . 0.0 111.394 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 p -67.79 169.7 9.23 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.928 -1.107 . . . . 0.0 111.201 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -110.75 -25.7 9.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.124 1.37 . . . . 0.0 109.078 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -158.3 170.83 21.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.03 0.919 . . . . 0.0 111.488 174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -114.44 102.42 10.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.073 2.549 . . . . 0.0 106.259 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -77.79 97.65 5.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.4 mm -68.91 124.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.929 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.05 126.96 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 126.395 1.878 . . . . 0.0 105.934 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.68 97.51 6.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 165.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.81 149.55 5.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 163.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.23 133.77 10.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.648 1.179 . . . . 0.0 109.03 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t0 46.44 44.93 13.47 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.892 1.805 . . . . 0.0 110.945 -167.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 70.17 -13.8 0.42 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.686 3.195 . . . . 0.0 114.825 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.94 165.88 11.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.473 1.909 . . . . 0.0 110.091 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.2 129.47 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.786 -1.197 . . . . 0.0 111.616 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -100.02 -44.66 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 t -165.33 166.46 18.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.8 161.96 26.19 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.931 1.693 . . . . 0.0 108.039 -172.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.12 31.66 Favored 'General case' 0 C--O 1.19 -2.033 0 O-C-N 120.139 -1.601 . . . . 0.0 109.65 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.462 1.4 p -107.98 124.95 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 160.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -108.09 112.84 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.635 2.774 . . . . 0.0 103.747 165.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -59.4 154.59 16.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.824 1.193 . . . . 0.0 110.156 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -81.3 85.93 6.33 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -152.81 175.55 12.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.286 1.035 . . . . 0.0 109.129 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -52.61 -52.17 56.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.059 1.344 . . . . 0.0 110.509 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -5.78 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.762 0.425 . . . . 0.0 110.914 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.6 -69.76 1.38 Allowed Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -55.74 -29.05 58.9 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.513 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -34.92 63.85 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 120.16 1.345 . . . . 0.0 111.072 176.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -87.58 -24.16 24.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 116.582 -1.675 . . . . 0.0 113.034 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.583 ' HA ' ' CG ' ' A' ' 54' ' ' GLU . 62.2 mt -63.53 -30.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 121.357 1.89 . . . . 0.0 109.364 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.26 -3.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 119.82 -1.8 . . . . 0.0 111.314 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -110.53 21.99 15.97 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.114 -0.991 . . . . 0.0 109.517 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.583 ' CG ' ' HA ' ' A' ' 51' ' ' ILE . 8.1 pt-20 -138.63 144.67 39.83 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.969 -2.332 . . . . 0.0 111.215 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.85 62.51 7.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 109.409 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.01 134.88 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.63 -48.5 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.02 156.7 43.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.57 136.99 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 166.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.35 124.37 65.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.88 167.62 23.47 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -80.02 -32.51 39.58 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.381 -0.824 . . . . 0.0 112.01 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -155.98 173.76 16.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.458 1.026 . . . . 0.0 109.611 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.3 tt -165.14 154.67 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.802 1.241 . . . . 0.0 108.418 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -81.22 153.12 27.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.871 0.869 . . . . 0.0 112.128 169.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.56 -51.51 65.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.613 1.965 . . . . 0.0 110.929 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.61 -39.89 88.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.44 HD21 ' HG2' ' A' ' 20' ' ' GLU . 1.3 t-20 -66.68 -41.61 87.83 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.739 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -51.76 -63.79 1.02 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.83 -24.43 67.54 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.96 -0.462 . . . . 0.0 111.705 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -76.83 -36.11 57.09 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -98.52 -24.04 15.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.078 1.308 . . . . 0.0 112.062 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -71.86 9.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.622 1.969 . . . . 0.0 113.028 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -80.72 -0.13 37.06 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.965 -1.084 . . . . 0.0 113.517 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -165.63 -64.15 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.779 0.832 . . . . 0.0 109.858 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.91 144.67 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.953 . . . . 0.0 107.82 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -113.17 126.33 55.32 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 125.101 1.361 . . . . 0.0 109.477 -169.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.63 131.48 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 120.105 -1.622 . . . . 0.0 109.483 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 50.6 m-85 -116.04 150.63 36.96 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.76 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -80.14 135.82 36.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.99 128.1 34.35 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -24.82 43.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.725 0.774 . . . . 0.0 112.294 -174.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.52 161.53 28.9 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 127.308 2.385 . . . . 0.0 107.519 -159.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.54 -9.79 59.68 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.621 1.168 . . . . 0.0 110.343 -167.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.56 98.84 2.39 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.211 1.404 . . . . 0.0 108.686 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 t -51.36 -40.83 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 121.759 -0.588 . . . . 0.0 110.356 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -40.35 87.22 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.664 0.385 . . . . 0.0 110.4 -171.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -42.65 95.92 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.343 0.592 . . . . 0.0 110.783 171.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.809 -0.557 . . . . 0.0 110.661 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.22 -50.25 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.302 1.041 . . . . 0.0 108.781 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 p -64.21 -35.27 80.27 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.756 0.707 . . . . 0.0 111.475 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -66.14 -37.34 85.44 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.263 -0.898 . . . . 0.0 111.091 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -67.72 -44.04 78.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.183 0.593 . . . . 0.0 111.865 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.9 -41.26 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.266 1.027 . . . . 0.0 109.862 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -79.67 -30.83 41.31 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.48 4.38 52.79 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.021 -0.877 . . . . 0.0 113.985 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -39.22 81.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.228 1.411 . . . . 0.0 111.513 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.57 131.98 50.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.188 0.595 . . . . 0.0 110.722 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.32 156.97 30.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.57 1.176 . . . . 0.0 110.632 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 61.9 mtpt -82.58 156.32 24.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.651 171.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.26 155.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.99 -154.75 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.737 1.615 . . . . 0.0 111.846 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.27 86.11 0.28 Allowed Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 126.22 1.808 . . . . 0.0 109.488 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 N--CA 1.451 -1.019 0 CA-C-O 117.222 -1.241 . . . . 0.0 109.27 166.333 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -131.07 138.09 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 65.25 52.02 1.52 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.442 2.297 . . . . 0.0 113.254 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 ttt -82.87 154.53 24.58 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.245 168.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 15.6 mtpp -147.73 121.8 9.48 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.467 HG21 ' CE2' ' A' ' 93' ' ' PHE . 40.7 t -125.62 156.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.595 1.089 . . . . 0.0 108.902 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.47 118.1 35.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.543 1.137 . . . . 0.0 108.25 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.37 129.43 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.6 p -79.49 104.79 10.34 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.985 1.314 . . . . 0.0 109.576 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.92 151.74 22.11 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.174 -0.954 . . . . 0.0 111.011 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.36 -85.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.42 -39.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 O-C-N 119.883 -1.76 . . . . 0.0 108.238 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.74 3.35 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 -178.63 5.91 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.584 -1.323 . . . . 0.0 110.371 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.2 mt -53.58 127.52 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.746 1.619 . . . . 0.0 109.807 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.1 p -72.41 161.42 30.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.981 0.912 . . . . 0.0 110.248 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.93 -41.24 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -157.46 161.07 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -58.2 -42.58 86.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.353 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -15.33 57.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.052 1.741 . . . . 0.0 113.179 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.12 10.03 8.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.924 0.89 . . . . 0.0 112.734 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 p -64.9 160.71 19.94 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.652 -1.28 . . . . 0.0 109.616 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -107.55 -29.85 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.227 1.411 . . . . 0.0 107.886 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -153.55 167.0 30.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.755 0.788 . . . . 0.0 109.821 167.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -104.58 126.58 51.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.704 2.002 . . . . 0.0 108.063 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.13 113.89 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 166.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -83.32 105.03 12.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.96 141.91 14.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -117.12 123.45 46.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.046 1.739 . . . . 0.0 106.523 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 mt -124.02 136.4 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -136.03 -6.72 2.1 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.036 -173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.08 67.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.22 5.34 0.11 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.889 2.076 . . . . 0.0 115.201 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -134.2 152.62 51.91 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.366 1.466 . . . . 0.0 109.231 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.16 108.13 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.42 1.888 . . . . 0.0 109.393 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -96.62 -6.11 37.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.665 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 p -170.83 179.55 3.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.299 1.409 . . . . 0.0 111.069 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -147.93 168.48 22.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.402 1.081 . . . . 0.0 111.002 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.68 153.98 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 109.559 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.79 115.91 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.85 109.51 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -59.54 155.9 14.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.718 1.144 . . . . 0.0 109.92 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.07 65.93 0.89 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.222 0.609 . . . . 0.0 112.225 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -136.43 81.53 1.89 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.1 -72.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.403 1.881 . . . . 0.0 113.713 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -56.21 -25.93 49.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.234 1.813 . . . . 0.0 111.063 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -61.57 7.0 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 125.198 1.38 . . . . 0.0 111.813 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -58.0 -36.48 72.72 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.144 0.978 . . . . 0.0 110.87 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -52.3 -47.31 66.0 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 111.006 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.6 m -63.09 -37.93 89.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.252 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.9 mt -52.54 -38.16 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.485 1.114 . . . . 0.0 110.202 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -59.72 -48.94 85.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.54 -0.725 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -82.09 -14.14 56.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.39 1.076 . . . . 0.0 112.442 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 28.5 mm-40 -64.28 -23.14 67.19 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.775 1.17 . . . . 0.0 111.206 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 55.4 54.97 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.437 1.095 . . . . 0.0 109.681 -170.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.66 147.61 8.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.917 0.887 . . . . 0.0 109.286 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -78.53 -48.18 15.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.502 1.921 . . . . 0.0 110.099 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.43 158.48 41.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.199 0.6 . . . . 0.0 112.289 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.1 mt -110.77 147.02 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.98 135.59 60.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.2 p -155.47 161.21 41.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.655 1.182 . . . . 0.0 109.691 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -73.29 -36.42 66.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.241 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.71 165.97 33.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.257 1.39 . . . . 0.0 109.098 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 tt -140.28 153.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 107.845 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.2 p -77.1 150.86 35.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.584 0.353 . . . . 0.0 110.45 163.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -58.55 -45.11 89.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.771 0.828 . . . . 0.0 110.257 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.98 -50.43 72.13 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.924 -0.485 . . . . 0.0 111.171 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.24 -35.99 81.85 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.747 0.419 . . . . 0.0 109.984 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -54.65 -54.69 38.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.396 0.543 . . . . 0.0 110.215 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -58.39 -26.3 63.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 111.659 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -71.46 -62.15 1.51 Allowed 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.014 0.824 . . . . 0.0 110.205 171.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -77.27 -25.96 51.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.779 -164.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -73.53 30.77 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.735 2.014 . . . . 0.0 112.621 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.84 13.7 13.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.449 1.9 . . . . 0.0 111.575 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 mttt 179.11 -11.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.012 2.125 . . . . 0.0 113.172 164.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -116.39 128.98 73.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -77.42 121.84 24.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.537 1.135 . . . . 0.0 108.44 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.5 mt -100.08 127.39 53.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -118.32 154.61 32.05 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.254 1.422 . . . . 0.0 110.252 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.39 135.47 33.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.415 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.36 151.76 46.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 160.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -125.77 24.03 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.778 2.431 . . . . 0.0 109.428 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.09 -169.84 42.29 Favored Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.837 -1.164 . . . . 0.0 112.325 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.97 -21.55 9.45 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.961 2.105 . . . . 0.0 108.335 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.07 104.25 6.51 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.8 -40.64 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.81 -35.83 70.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.986 0.812 . . . . 0.0 110.265 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -61.17 -39.76 91.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.371 -0.831 . . . . 0.0 110.642 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -73.92 -27.28 60.95 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.179 -0.95 . . . . 0.0 111.276 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.65 -52.09 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p -58.64 -44.58 90.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 111.241 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.6 mt -61.92 -37.66 85.48 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.644 -0.66 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' HG21 ' A' ' 6' ' ' VAL . 77.1 t80 -70.1 -39.48 75.51 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.536 -0.728 . . . . 0.0 111.842 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.33 -44.2 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.648 1.179 . . . . 0.0 109.226 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.06 -16.03 45.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 19.92 63.73 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.009 0.822 . . . . 0.0 112.41 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.28 -22.56 60.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 111.916 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.52 137.7 54.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.86 0.754 . . . . 0.0 110.224 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.4 m -69.27 126.36 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.543 1.537 . . . . 0.0 111.809 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -74.7 119.21 18.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.672 1.189 . . . . 0.0 108.632 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.242 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG2' ' HE1' ' A' ' 4' ' ' MET . 12.9 tpt . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.3 mt -132.06 145.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m120 73.3 11.42 4.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.375 1.47 . . . . 0.0 114.27 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.426 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 2.7 tpp -74.51 145.7 43.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.585 1.084 . . . . 0.0 110.146 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -131.91 144.22 50.69 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.827 1.251 . . . . 0.0 107.734 161.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -136.45 143.81 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.593 1.157 . . . . 0.0 108.434 172.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.54 124.37 44.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.935 0.894 . . . . 0.0 109.243 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.5 125.89 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 108.167 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -83.07 96.34 8.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.218 1.009 . . . . 0.0 110.747 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.5 mtp -94.3 164.94 12.82 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.121 1.368 . . . . 0.0 111.174 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.97 -60.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.375 1.47 . . . . 0.0 108.946 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -142.95 -68.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -132.4 9.03 4.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.631 1.205 . . . . 0.0 112.479 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -155.35 173.09 17.14 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.041 2.536 . . . . 0.0 107.954 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.67 147.48 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -81.57 -85.26 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.831 0.852 . . . . 0.0 111.097 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -174.58 -39.09 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.373 1.469 . . . . 0.0 108.714 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -145.66 -171.29 3.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.013 0.37 . . . . 0.0 111.526 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -95.01 -8.09 37.83 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.398 1.879 . . . . 0.0 111.244 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 6.15 10.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 112.095 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -137.47 0.75 2.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.711 1.604 . . . . 0.0 109.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 p -76.46 166.62 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.126 0.97 . . . . 0.0 110.989 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -101.98 -35.77 8.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.418 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -154.31 173.59 15.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.837 0.827 . . . . 0.0 110.518 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -116.9 113.41 22.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 128.047 2.539 . . . . 0.0 106.676 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.38 108.36 13.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.7 94.66 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 145.3 12.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 166.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -134.12 123.49 24.52 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.0 mt -118.0 128.26 75.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -126.88 -19.07 4.53 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -155.76 74.04 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 162.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t30 58.43 10.78 1.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.6 2.36 . . . . 0.0 114.146 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -137.69 161.49 36.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.637 2.375 . . . . 0.0 110.085 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.99 115.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -117.28 -17.95 10.04 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.835 -1.166 . . . . 0.0 112.667 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -149.79 162.67 39.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.744 1.156 . . . . 0.0 108.752 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -144.38 160.54 40.87 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.942 1.297 . . . . 0.0 108.357 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.5 155.68 42.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.354 1.861 . . . . 0.0 107.703 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.9 t -111.78 145.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 168.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mt -135.08 109.5 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.24 146.94 14.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.043 0.838 . . . . 0.0 110.55 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.51 82.22 3.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.51 172.39 12.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 129.734 3.214 . . . . 0.0 104.586 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.39 -40.48 95.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.28 -0.887 . . . . 0.0 113.389 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.0 t -67.84 -21.35 65.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -67.78 1.99 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.461 1.13 . . . . 0.0 111.471 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -59.45 -54.66 44.06 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.9 1.227 . . . . 0.0 109.183 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -54.77 -39.69 68.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.379 0.672 . . . . 0.0 111.114 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mt -57.45 -46.71 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.014 0.825 . . . . 0.0 110.749 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -57.2 -39.57 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.571 0.623 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.3 7.86 30.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.198 0.999 . . . . 0.0 112.612 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.54 152.15 21.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.758 1.163 . . . . 0.0 108.915 172.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.73 43.65 0.34 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.783 1.233 . . . . 0.0 110.715 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.85 137.6 24.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 166.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.25 -36.76 14.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.44 159.95 41.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.251 0.62 . . . . 0.0 109.629 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.26 142.66 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.8 mt -107.56 131.29 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 167.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.1 p -150.69 158.04 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 167.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -72.96 -44.17 61.44 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.128 163.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -135.55 155.17 50.92 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 tt -153.21 119.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -59.94 146.79 41.1 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.199 0.6 . . . . 0.0 109.569 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.79 -47.64 67.42 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.395 2.278 . . . . 0.0 111.545 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -25.47 67.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.969 0.508 . . . . 0.0 111.275 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -84.13 -47.46 10.86 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.318 1.047 . . . . 0.0 110.27 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -54.98 -53.27 57.87 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.668 1.122 . . . . 0.0 110.239 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -57.76 -22.63 48.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.406 1.083 . . . . 0.0 112.56 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -79.59 -60.99 2.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.924 0.89 . . . . 0.0 109.096 173.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -65.92 -33.54 76.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.802 -166.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -65.81 -10.14 35.06 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -16.35 32.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.203 1.401 . . . . 0.0 114.385 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -154.55 -45.58 0.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.693 -1.255 . . . . 0.0 109.673 166.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.1 mt -63.46 138.04 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.79 1.236 . . . . 0.0 108.223 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -92.39 126.36 37.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.131 1.372 . . . . 0.0 107.538 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.62 130.02 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.66 148.0 44.51 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.256 1.423 . . . . 0.0 109.392 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -80.86 143.88 32.41 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.353 1.061 . . . . 0.0 108.705 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.86 116.79 23.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.509 0.671 . . . . 0.0 109.324 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.02 79.68 0.66 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.236 1.414 . . . . 0.0 108.243 163.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.01 25.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.137 0.854 . . . . 0.0 114.034 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.7 -14.25 40.35 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.414 1.485 . . . . 0.0 110.4 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -82.02 100.84 9.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.044 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.62 -49.02 6.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 123.941 0.896 . . . . 0.0 109.575 170.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.36 -39.75 77.89 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.882 0.765 . . . . 0.0 110.503 -169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -56.89 -41.75 78.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -75.32 -34.63 61.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.091 0.556 . . . . 0.0 112.244 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mt -61.6 -53.78 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p -62.47 -46.22 89.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.795 0.438 . . . . 0.0 111.282 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.83 -39.98 82.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.909 0.322 . . . . 0.0 110.513 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 6' ' ' VAL . 23.6 t80 -66.46 -50.39 63.5 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.362 0.665 . . . . 0.0 111.747 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.76 -36.72 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.977 0.911 . . . . 0.0 109.759 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.33 -5.41 59.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.068 1.347 . . . . 0.0 113.332 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.48 86.51 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.766 -1.575 . . . . 0.0 113.112 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -29.28 67.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.291 1.437 . . . . 0.0 114.18 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.74 137.82 58.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.478 1.035 . . . . 0.0 110.684 -174.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 p -78.74 130.51 35.86 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.941 0.897 . . . . 0.0 109.885 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -71.85 148.7 45.92 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.21 -0.931 . . . . 0.0 109.633 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--O 1.239 0.517 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.508 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 C--O 1.233 0.23 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 mt -138.49 143.68 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.566 1.146 . . . . 0.0 110.134 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.262 58.6 t30 44.62 45.54 7.98 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.966 2.506 . . . . 0.0 112.733 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.43 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.2 tpp -72.47 145.69 47.38 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 163.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -136.32 137.97 41.21 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 163.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.537 HG21 ' CE2' ' A' ' 93' ' ' PHE . 70.1 t -137.99 140.47 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.6 99.06 8.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.684 1.194 . . . . 0.0 108.72 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.72 114.16 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 p -68.32 128.62 37.24 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.317 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mtp -127.14 162.0 27.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.759 1.223 . . . . 0.0 110.805 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.7 -61.92 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.293 1.437 . . . . 0.0 109.53 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.14 -46.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 O-C-N 120.841 -1.162 . . . . 0.0 109.441 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -140.3 2.69 1.89 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.283 0.633 . . . . 0.0 112.211 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -157.57 175.21 14.24 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.449 1.5 . . . . 0.0 110.537 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.7 141.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.8 p -70.6 159.29 34.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.204 0.525 . . . . 0.0 110.643 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.02 -34.48 78.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.962 1.305 . . . . 0.0 111.266 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 167.12 25.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.506 0.722 . . . . 0.0 111.492 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -72.85 -53.31 11.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 18.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.211 1.405 . . . . 0.0 111.848 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.18 5.52 1.11 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.563 1.945 . . . . 0.0 110.934 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 p -80.1 172.44 13.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.719 -1.238 . . . . 0.0 110.15 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -111.94 -24.58 9.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.672 1.589 . . . . 0.0 110.589 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -160.12 175.07 13.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.952 0.796 . . . . 0.0 110.071 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CD1' HD11 ' A' ' 51' ' ' ILE . 88.6 m-85 -119.68 126.62 51.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 111.69 18.97 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -79.83 104.22 7.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.64 150.21 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -124.63 115.89 21.52 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 4' ' ' MET . 3.3 mp -114.81 123.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 167.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 6.7 m-20 -126.66 -5.67 6.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.303 1.041 . . . . 0.0 111.536 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -158.51 55.46 0.44 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.93 2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.586 2.355 . . . . 0.0 116.386 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -118.77 154.01 33.5 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 129.712 3.205 . . . . 0.0 108.888 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.57 102.98 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-O 121.91 0.862 . . . . 0.0 108.806 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 15.6 mmtt -71.68 -46.0 60.15 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -158.52 167.5 29.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.663 0.785 . . . . 0.0 110.406 -171.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -138.34 125.81 21.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.086 1.754 . . . . 0.0 108.981 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.84 164.39 14.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 109.604 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.13 134.31 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.3 mt -123.77 104.27 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.875 1.67 . . . . 0.0 106.551 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -58.09 136.53 57.2 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.473 0.579 . . . . 0.0 110.25 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -80.74 70.78 7.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.267 1.027 . . . . 0.0 110.773 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.65 84.74 1.62 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 71.14 -74.07 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.101 2.16 . . . . 0.0 113.375 151.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.7 t -52.34 -33.02 40.95 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.838 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.63 -59.85 9.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -58.58 -39.17 79.56 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.349 -1.089 . . . . 0.0 110.425 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -55.01 -46.36 75.21 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 118.662 0.665 . . . . 0.0 110.373 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.9 m -61.01 -36.32 79.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.631 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' CD1' ' A' ' 25' ' ' PHE . 55.9 mt -60.33 -48.38 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.773 1.169 . . . . 0.0 109.452 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.08 -39.84 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.086 0.554 . . . . 0.0 110.396 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -73.17 -17.87 61.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.121 -0.987 . . . . 0.0 112.463 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.91 -174.53 5.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 120.273 1.397 . . . . 0.0 110.529 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -112.98 40.84 2.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.011 1.724 . . . . 0.0 109.235 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.75 141.49 17.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.24 -41.38 12.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.322 1.049 . . . . 0.0 109.943 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.15 151.09 36.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.29 1.036 . . . . 0.0 111.272 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.43 139.54 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 166.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.8 mt -116.51 127.53 74.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.7 p -154.19 176.42 12.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.527 1.531 . . . . 0.0 108.085 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -106.33 -24.77 12.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.607 1.163 . . . . 0.0 111.648 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -152.96 159.31 42.93 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.0 tt -161.02 137.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.482 ' H ' ' ND2' ' A' ' 68' ' ' ASN . 8.9 m -85.23 168.37 14.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.28 -35.42 75.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.286 1.434 . . . . 0.0 111.221 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.87 -47.03 32.37 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.365 1.078 . . . . 0.0 109.726 -170.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -58.48 -46.54 86.43 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.243 1.817 . . . . 0.0 110.057 172.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -54.6 -62.16 1.84 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.693 0.397 . . . . 0.0 111.109 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.98 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 112.553 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -62.81 1.52 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.893 0.877 . . . . 0.0 109.432 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HD1' HD12 ' A' ' 76' ' ' ILE . 51.8 m-85 -79.93 -30.49 39.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.971 -164.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -58.27 -12.45 3.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.454 1.102 . . . . 0.0 113.857 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -52.28 -31.57 33.3 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.124 -0.985 . . . . 0.0 111.871 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -151.82 -8.08 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.425 HD12 ' HD1' ' A' ' 72' ' ' PHE . 8.0 mt -114.78 123.52 70.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -170.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.69 160.61 19.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.69 0.757 . . . . 0.0 109.434 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.7 mt -137.69 128.77 38.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.24 160.89 34.83 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.88 1.272 . . . . 0.0 111.534 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -106.71 121.82 45.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.892 1.677 . . . . 0.0 110.169 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.5 125.24 29.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.755 0.422 . . . . 0.0 110.163 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -9.38 29.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.341 1.857 . . . . 0.0 113.065 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.96 174.33 41.51 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -163.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -90.3 -6.3 55.29 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 99.68 5.45 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -173.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.6 t -49.82 -39.17 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 122.874 0.47 . . . . 0.0 110.277 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.19 -42.71 68.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -166.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -62.47 -45.36 93.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.853 -0.529 . . . . 0.0 110.383 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -71.75 -32.57 67.84 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.17 -0.331 . . . . 0.0 111.238 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.94 -50.91 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 94' ' ' ILE . 6.6 p -67.0 -31.5 72.11 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 mt -69.18 -42.56 75.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 109.973 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 6' ' ' VAL . 40.5 t80 -59.25 -42.88 92.16 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.181 0.993 . . . . 0.0 113.124 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 91' ' ' SER . 67.3 mt -47.9 -54.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.429 1.492 . . . . 0.0 109.466 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -4.92 49.15 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.505 1.522 . . . . 0.0 113.306 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.09 14.76 80.2 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.079 0.854 . . . . 0.0 112.601 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.86 -19.4 61.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 112.116 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.13 140.48 50.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.07 0.938 . . . . 0.0 110.575 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -68.8 140.05 55.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.839 1.256 . . . . 0.0 108.749 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -72.59 153.82 41.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 165.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.328 -0.349 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 160.894 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 mm -120.63 136.4 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 124.738 1.215 . . . . 0.0 108.309 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 47.78 53.41 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.008 1.723 . . . . 0.0 113.851 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -69.95 156.16 39.52 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 163.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -132.31 159.42 39.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 152.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 28' ' ' VAL . 12.0 p -156.64 163.8 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.7 124.8 47.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 164.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.39 113.58 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.7 p -57.38 128.39 36.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.2 mtp -131.16 157.71 42.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.489 1.04 . . . . 0.0 110.426 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.32 -63.29 1.14 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.555 1.542 . . . . 0.0 108.417 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -142.93 -74.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -119.43 10.88 12.0 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.031 1.332 . . . . 0.0 112.935 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.52 170.17 21.42 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.13 1.372 . . . . 0.0 108.35 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.8 mt -58.11 133.83 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 p -73.63 159.72 32.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.847 2.059 . . . . 0.0 111.311 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -73.55 -25.1 60.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.7 p -149.64 174.01 13.03 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.841 1.2 . . . . 0.0 111.605 169.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -72.56 -13.72 61.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.596 1.958 . . . . 0.0 111.653 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.94 7.99 15.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 111.467 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -133.01 2.9 3.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.073 1.749 . . . . 0.0 110.243 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.98 153.96 42.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.733 -1.23 . . . . 0.0 109.625 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -101.16 -24.67 14.23 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.87 1.268 . . . . 0.0 109.192 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.447 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 40.8 p90 -157.72 173.76 16.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.242 0.928 . . . . 0.0 111.003 171.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 51' ' ' ILE . 70.0 m-85 -115.83 105.1 12.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.308 2.243 . . . . 0.0 107.924 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.94 107.17 7.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -79.46 133.03 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.809 1.244 . . . . 0.0 109.027 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 6' ' ' VAL . 2.0 t -105.94 105.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttt-85 -98.68 103.99 15.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.56 138.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -125.25 -5.63 7.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.483 0.713 . . . . 0.0 112.689 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.499 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 5.5 p-10 -173.38 48.28 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.83 1.252 . . . . 0.0 108.855 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.36 18.67 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.184 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.74 152.96 47.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.37 90.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 122.549 1.166 . . . . 0.0 107.891 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 2.8 mmtp -73.02 -35.09 66.72 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 120.735 -1.228 . . . . 0.0 110.185 167.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 t -162.25 131.97 4.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.792 1.178 . . . . 0.0 110.075 167.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 174.71 9.82 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.272 1.029 . . . . 0.0 111.523 165.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.12 168.34 26.82 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 127.168 2.187 . . . . 0.0 110.303 171.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.553 0.9 OUTLIER -135.16 144.22 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 129.924 3.29 . . . . 0.0 117.476 171.104 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.7 mt -134.29 114.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 127.757 2.423 . . . . 0.0 106.655 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -61.44 136.11 57.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.213 0.915 . . . . 0.0 110.733 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -83.13 85.71 7.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.771 1.228 . . . . 0.0 108.545 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.54 -85.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 46' ' ' SER . 10.4 pt-20 -131.83 -64.09 0.8 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.394 -0.816 . . . . 0.0 111.67 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.472 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -57.99 -24.18 57.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.968 174.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.59 -74.08 0.36 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -57.71 -27.27 62.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.731 1.265 . . . . 0.0 111.537 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.32 -51.15 62.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.8 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -60.93 -37.4 82.2 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.669 1.588 . . . . 0.0 110.067 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 25' ' ' PHE . 43.3 mt -52.46 -45.33 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.086 1.755 . . . . 0.0 110.93 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.71 -42.71 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 120.876 -1.14 . . . . 0.0 110.14 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.55 -30.63 59.77 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 118.445 0.566 . . . . 0.0 111.651 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -74.08 -19.84 60.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.533 0.606 . . . . 0.0 109.4 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.7 t30 50.89 55.38 9.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.703 2.801 . . . . 0.0 112.305 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.19 144.16 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.123 1.769 . . . . 0.0 111.543 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -39.99 18.53 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.111 1.364 . . . . 0.0 111.155 173.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' VAL . . . -144.25 160.95 40.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 112.989 -166.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.3 mt -132.25 105.25 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 119.909 -1.745 . . . . 0.0 108.966 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.06 128.69 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -151.06 167.98 26.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.592 1.087 . . . . 0.0 111.189 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -82.2 -45.38 15.15 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.224 1.81 . . . . 0.0 109.262 165.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -147.43 164.26 33.89 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.379 0.991 . . . . 0.0 109.927 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.5 tt -154.32 138.1 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 m -73.31 155.99 38.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.327 0.512 . . . . 0.0 110.68 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 36.8 tt0 -66.67 -31.49 72.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.734 0.414 . . . . 0.0 111.4 -171.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.74 -50.91 31.07 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.087 0.858 . . . . 0.0 110.997 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -56.54 -43.8 80.24 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.734 0.414 . . . . 0.0 110.644 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -54.69 -60.79 2.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.512 1.125 . . . . 0.0 109.363 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HE3' ' HG2' ' A' ' 66' ' ' GLU . 50.5 mttt -64.31 -17.06 63.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.453 0.701 . . . . 0.0 112.61 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.34 -51.91 5.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.112 1.365 . . . . 0.0 110.338 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.532 ' HD1' HD12 ' A' ' 76' ' ' ILE . 49.9 m-85 -76.55 -30.29 57.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.338 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -63.18 -7.77 6.6 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -20.06 39.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.937 -1.102 . . . . 0.0 111.709 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -145.14 2.59 1.01 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.944 1.247 . . . . 0.0 112.158 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.532 HD12 ' HD1' ' A' ' 72' ' ' PHE . 3.2 mt -134.5 129.03 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -171.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.08 107.65 17.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.002 1.721 . . . . 0.0 109.645 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -87.16 131.89 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 120.455 -1.403 . . . . 0.0 108.52 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -118.16 144.22 45.87 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.702 1.601 . . . . 0.0 111.084 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -87.01 132.58 33.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.458 1.503 . . . . 0.0 107.583 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.81 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.241 -0.409 . . . . 0.0 110.541 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -12.53 60.43 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 169.64 34.15 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 126.99 2.234 . . . . 0.0 108.26 -164.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.7 -16.96 63.98 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.551 2.34 . . . . 0.0 111.37 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.64 97.34 3.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -168.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.1 t -50.38 -42.75 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.65 -44.52 81.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.404 0.682 . . . . 0.0 109.252 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -58.06 -42.54 85.69 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.89 0.852 . . . . 0.0 111.31 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -71.96 -27.2 62.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.113 -0.992 . . . . 0.0 111.974 -172.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.23 -53.7 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 p -61.23 -39.08 88.94 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.7 0.8 . . . . 0.0 111.332 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.4 mt -66.3 -44.59 83.04 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.148 0.579 . . . . 0.0 110.881 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.25 -39.06 85.43 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.987 0.812 . . . . 0.0 111.6 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.53 -42.82 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.436 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.35 -12.5 60.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.878 0.763 . . . . 0.0 112.632 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.11 6.94 84.12 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.927 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -34.17 77.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 112.536 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -55.61 140.43 41.1 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -61.56 130.12 44.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 108.947 172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -69.81 131.67 44.87 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.22 -0.925 . . . . 0.0 108.589 165.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.232 0.164 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.722 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -137.34 138.61 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 69.38 17.47 8.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.587 1.955 . . . . 0.0 113.255 168.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.5 tpp -60.33 151.93 26.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.357 -0.839 . . . . 0.0 109.002 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -137.61 129.17 28.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 165.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 93' ' ' PHE . 41.9 t -136.68 129.85 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-N 119.979 1.263 . . . . 0.0 108.717 172.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.05 83.79 2.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.584 1.553 . . . . 0.0 111.243 -169.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mt -83.74 129.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 120.873 -1.142 . . . . 0.0 110.088 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 p -71.07 94.47 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.482 1.113 . . . . 0.0 112.028 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 mtp -100.01 161.1 13.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.552 1.141 . . . . 0.0 111.341 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.5 -63.31 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 109.155 170.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.68 -60.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -130.41 -0.47 4.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.364 1.078 . . . . 0.0 112.528 -162.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -163.25 178.28 8.32 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.346 2.258 . . . . 0.0 108.736 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 99.1 mt -62.12 145.4 13.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -86.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.726 0.774 . . . . 0.0 109.772 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 175.8 -44.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.022 -1.049 . . . . 0.0 108.684 -156.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 p -158.78 169.36 24.55 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.373 0.988 . . . . 0.0 110.08 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -66.27 -34.04 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.131 0.973 . . . . 0.0 110.822 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -92.48 4.05 54.28 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -131.03 17.99 5.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.307 1.051 . . . . 0.0 111.303 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.93 167.6 16.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.294 1.045 . . . . 0.0 110.344 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.13 -31.24 7.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.215 1.406 . . . . 0.0 109.402 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -154.86 161.24 41.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.991 0.901 . . . . 0.0 109.89 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -100.09 111.7 23.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -76.46 108.97 9.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 41' ' ' ILE . 19.6 mm -77.36 100.09 2.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.4 133.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.521 ' HE ' ' HB2' ' A' ' 37' ' ' SER . 26.7 mtm180 -115.68 114.45 24.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 mt -107.06 115.47 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.01 -10.98 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.441 1.088 . . . . 0.0 112.098 -162.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.64 57.19 0.62 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 122.352 1.072 . . . . 0.0 108.626 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.62 -9.92 0.08 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 129.137 2.975 . . . . 0.0 116.305 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -107.82 158.99 16.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.426 1.09 . . . . 0.0 110.4 170.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.76 90.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.278 1.431 . . . . 0.0 109.974 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.66 -20.88 30.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.779 1.632 . . . . 0.0 112.487 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.521 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 1.6 m -150.55 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 167.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 p -131.82 158.79 40.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 161.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 157.73 46.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 126.202 1.801 . . . . 0.0 106.723 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.24 140.87 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.4 HD12 HD11 ' A' ' 27' ' ' ILE . 59.1 mt -130.8 100.57 4.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -58.86 137.52 57.74 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -73.92 85.37 1.75 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.358 1.463 . . . . 0.0 108.042 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.5 33.83 2.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.462 1.505 . . . . 0.0 110.174 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 66.33 -69.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.144 1.777 . . . . 0.0 109.839 -172.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.3 t -52.99 -29.33 28.51 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.172 2.189 . . . . 0.0 111.413 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.1 16.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.983 0.81 . . . . 0.0 111.286 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -57.6 -32.2 66.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.086 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -56.5 -40.13 74.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.363 0.983 . . . . 0.0 108.397 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -30.79 66.97 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.136 0.974 . . . . 0.0 110.655 -172.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.85 -42.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.391 1.076 . . . . 0.0 108.308 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.1 -13.2 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.126 -0.984 . . . . 0.0 111.269 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -8.03 16.19 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.622 -1.298 . . . . 0.0 112.277 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -91.48 -15.09 29.33 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.557 1.526 . . . . 0.0 113.791 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 57.87 59.14 3.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.826 1.251 . . . . 0.0 109.946 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -47.8 140.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 161.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -50.96 19.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.62 39.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.898 0.479 . . . . 0.0 110.582 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mt -113.86 150.54 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.94 1.296 . . . . 0.0 107.707 173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -120.22 121.9 66.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -144.24 168.89 18.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.212 1.005 . . . . 0.0 108.635 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -71.83 -57.3 4.45 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 155.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -140.7 160.72 39.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.401 0.546 . . . . 0.0 110.711 -167.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.2 tt -152.61 126.99 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 126.25 1.82 . . . . 0.0 106.613 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -54.44 143.54 23.61 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.621 1.568 . . . . 0.0 110.221 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -48.45 -49.04 37.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.169 1.787 . . . . 0.0 111.462 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.03 -42.04 99.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 0.0 110.666 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -68.5 -43.56 76.57 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.594 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.4 -57.83 9.25 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.02 -14.04 51.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.676 1.191 . . . . 0.0 113.628 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -90.99 -58.11 2.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.448 1.499 . . . . 0.0 109.793 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.33 -27.44 62.43 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 112.335 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -60.7 -11.85 8.67 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -58.18 -42.81 86.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 0.0 112.271 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 13.56 1.78 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.806 1.185 . . . . 0.0 111.743 -175.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mt -136.41 140.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.77 153.09 19.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.949 0.9 . . . . 0.0 108.779 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.52 113.59 23.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -160.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.86 151.07 37.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.544 1.137 . . . . 0.0 110.898 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -99.12 120.19 39.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.442 1.497 . . . . 0.0 109.95 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 138.94 55.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.414 0.686 . . . . 0.0 111.747 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -102.29 99.08 9.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 127.178 2.191 . . . . 0.0 109.284 172.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.42 -179.11 53.63 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -85.37 -10.84 55.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.703 0.801 . . . . 0.0 110.662 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.35 102.23 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.062 0.945 . . . . 0.0 110.563 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -48.35 -43.86 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 118.79 -0.624 . . . . 0.0 109.609 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.58 -42.84 77.7 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.968 0.804 . . . . 0.0 110.219 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -57.26 -40.02 76.83 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.902 -0.499 . . . . 0.0 110.289 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.51 -32.85 42.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.15 -50.47 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 p -62.4 -46.51 88.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.726 0.811 . . . . 0.0 111.436 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 122.56 0.344 . . . . 0.0 110.161 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 6' ' ' VAL . 48.6 t80 -61.74 -52.5 64.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.321 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.3 mt -50.27 -40.93 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.969 1.308 . . . . 0.0 111.005 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.23 -2.84 50.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.941 0.896 . . . . 0.0 113.108 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.02 81.35 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.0 1.286 . . . . 0.0 111.193 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -27.26 61.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.41 1.884 . . . . 0.0 113.029 -174.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.38 139.47 58.56 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.577 0.704 . . . . 0.0 109.582 -174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.8 m -75.93 143.05 41.86 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -76.98 151.52 35.62 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 166.278 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.0 mt -139.54 152.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 47.18 73.02 0.21 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.874 1.67 . . . . 0.0 110.734 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ttt -131.92 152.33 51.14 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.157 -0.964 . . . . 0.0 108.59 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.6 141.52 33.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 165.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -134.05 132.62 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 171.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.99 144.57 25.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.71 119.98 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -75.88 84.16 2.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.147 0.979 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -86.3 155.26 20.73 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.895 2.478 . . . . 0.0 111.7 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -105.27 -55.96 2.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.128 0.966 . . . . 0.0 110.979 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -146.77 -55.02 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.8 -1.79 0.49 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.519 -158.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -157.06 173.17 17.41 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.706 2.002 . . . . 0.0 107.426 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.41 134.15 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -66.84 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.53 -38.66 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.395 1.478 . . . . 0.0 108.95 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 166.21 29.18 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.974 0.416 . . . . 0.0 111.042 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -55.88 -50.19 71.33 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.726 2.01 . . . . 0.0 108.891 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.12 -3.06 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.724 1.609 . . . . 0.0 112.812 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -120.91 -4.66 9.62 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.835 1.254 . . . . 0.0 111.068 -171.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.3 p -80.11 175.24 10.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.802 -1.186 . . . . 0.0 111.957 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -112.08 -34.67 5.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.741 1.616 . . . . 0.0 110.035 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -149.05 164.24 35.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.357 0.98 . . . . 0.0 111.904 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -109.85 103.35 12.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.382 2.673 . . . . 0.0 106.456 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tp -81.15 101.45 9.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.09 96.1 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 127.381 2.273 . . . . 0.0 107.31 168.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.52 139.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 160.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 118.55 18.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.868 0.758 . . . . 0.0 109.093 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.3 mt -119.82 138.28 50.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -164.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.0 -9.12 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -155.86 65.87 0.59 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t30 61.09 -8.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.21 3.004 . . . . 0.0 115.91 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.15 157.46 27.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 111.235 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.13 83.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.301 1.841 . . . . 0.0 106.864 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -64.85 -31.75 73.13 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.884 -1.135 . . . . 0.0 109.974 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -150.72 163.38 38.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.96 0.904 . . . . 0.0 109.469 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.67 161.28 36.91 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 108.231 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 137.8 19.11 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.92 0.888 . . . . 0.0 110.041 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.535 1.1 p -99.97 133.21 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 161.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.499 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 11.1 mt -129.74 114.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -63.31 160.42 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.156 1.343 . . . . 0.0 110.409 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -78.54 76.62 5.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.902 1.281 . . . . 0.0 109.777 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -125.74 170.17 11.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.34 1.456 . . . . 0.0 109.502 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -55.38 -40.67 71.65 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.445 -0.784 . . . . 0.0 110.672 164.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 m -76.34 -11.29 59.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.783 1.233 . . . . 0.0 111.693 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -72.47 -60.3 4.11 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 163.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 mppt? -62.58 -20.25 64.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -63.57 -46.25 86.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.932 1.242 . . . . 0.0 110.512 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 m -71.84 -40.79 68.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.223 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.7 mt -45.46 -51.44 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.929 1.292 . . . . 0.0 111.85 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.68 -34.69 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.87 -0.519 . . . . 0.0 111.468 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.89 -14.24 45.45 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.661 -0.649 . . . . 0.0 111.374 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.17 -16.21 61.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.525 1.53 . . . . 0.0 110.883 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 t30 47.47 65.06 1.36 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.975 2.11 . . . . 0.0 110.28 -167.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -67.45 140.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.94 -42.26 15.14 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.511 1.524 . . . . 0.0 109.979 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.69 160.95 39.82 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.422 1.089 . . . . 0.0 109.414 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -122.76 138.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.85 122.09 50.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.03 157.09 44.55 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.688 0.756 . . . . 0.0 111.255 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -68.99 -53.0 22.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 163.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -139.33 159.39 42.28 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.594 1.543 . . . . 0.0 111.204 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.9 tt -156.83 126.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.141 1.776 . . . . 0.0 110.257 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -61.13 141.89 57.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.222 1.009 . . . . 0.0 110.003 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.75 -37.62 76.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 111.845 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.61 -40.41 94.72 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.499 -0.75 . . . . 0.0 111.503 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -69.16 -47.58 64.59 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.792 0.837 . . . . 0.0 109.805 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -50.51 -58.68 5.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.858 1.263 . . . . 0.0 109.758 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -60.97 -18.12 55.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.436 0.694 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -82.38 -47.45 12.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.06 -1.025 . . . . 0.0 111.04 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -84.87 -25.37 28.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.958 0.344 . . . . 0.0 111.027 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -62.12 -7.7 4.43 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.61 1.164 . . . . 0.0 113.231 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -40.42 11.56 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.208 1.403 . . . . 0.0 110.787 173.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -145.16 -30.55 0.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.552 1.141 . . . . 0.0 111.857 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.3 mt -90.04 135.1 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -163.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.56 139.2 33.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.679 . . . . 0.0 107.801 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.8 mt -119.74 114.21 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.24 -0.913 . . . . 0.0 108.671 -172.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 55.8 m-85 -104.63 139.85 38.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.096 1.758 . . . . 0.0 110.835 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.42 127.62 32.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 123.07 19.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -83.3 6.76 18.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.057 1.743 . . . . 0.0 112.389 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.4 -169.81 38.97 Favored Glycine 0 N--CA 1.449 -0.477 0 O-C-N 120.509 -1.369 . . . . 0.0 111.68 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.15 -18.05 15.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.921 1.688 . . . . 0.0 109.894 168.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -66.86 101.7 0.86 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.386 1.474 . . . . 0.0 107.387 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.4 t -57.73 -41.11 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.217 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.51 -36.31 73.69 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.578 0.751 . . . . 0.0 110.359 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -60.77 -42.07 96.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 171.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -71.87 -26.84 62.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.701 -0.625 . . . . 0.0 111.566 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -56.9 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.78 1.632 . . . . 0.0 107.561 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.7 p -65.57 -40.69 93.07 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.36 0.413 . . . . 0.0 110.605 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.12 -42.87 99.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.651 0.78 . . . . 0.0 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 6' ' ' VAL . 68.7 t80 -61.19 -52.59 64.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.528 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.2 mt -58.25 -40.74 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.496 1.119 . . . . 0.0 109.58 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -68.22 -18.71 64.64 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.26 8.24 78.51 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.717 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -69.92 -27.31 64.66 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.084 1.442 . . . . 0.0 112.329 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.31 138.83 55.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.432 1.111 . . . . 0.0 110.272 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.8 m -74.09 138.92 44.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.3 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 31.4 mtmm -78.98 147.75 32.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 162.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.9 mt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 123.7 0.625 . . . . 0.0 110.854 -174.84 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.93 153.05 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.317 1.847 . . . . 0.0 107.86 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 67.01 8.93 6.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.1 1.76 . . . . 0.0 114.473 168.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 tpp -78.1 155.17 30.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.182 1.356 . . . . 0.0 108.938 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.42 143.42 25.71 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.18 141.93 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 108.962 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.72 101.89 13.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 166.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.47 117.91 28.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB2' ' CB ' ' A' ' 22' ' ' CYS . 42.5 p -66.38 143.78 56.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.8 mmm -138.66 149.07 44.77 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 119.449 -2.032 . . . . 0.0 109.078 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -89.44 -67.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.507 1.123 . . . . 0.0 109.01 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.9 t -140.53 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.38 -7.42 18.81 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -147.16 177.34 9.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.272 1.429 . . . . 0.0 110.155 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mt -62.77 141.22 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 t -71.02 -86.76 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 t30 174.75 -28.12 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.856 1.663 . . . . 0.0 112.068 -167.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.73 164.68 29.44 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.736 1.153 . . . . 0.0 110.726 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -66.32 -37.59 85.74 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.222 1.009 . . . . 0.0 108.435 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 1.0 56.64 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.416 1.486 . . . . 0.0 113.175 -171.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.54 -7.54 6.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.018 1.327 . . . . 0.0 111.74 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 9' ' ' SER . 13.9 p -65.66 169.37 6.37 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 123.471 1.605 . . . . 0.0 110.277 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -114.9 -19.59 10.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.722 -2.036 . . . . 0.0 111.119 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.409 ' HB2' HG23 ' A' ' 40' ' ' VAL . 32.1 p90 -161.33 172.16 17.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.67 0.668 . . . . 0.0 111.388 172.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -117.02 103.61 10.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.369 2.268 . . . . 0.0 106.441 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 tp -76.97 99.04 5.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.41 102.14 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 128.064 2.545 . . . . 0.0 105.923 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 t -95.87 112.2 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.0 140.57 34.04 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.679 1.127 . . . . 0.0 108.495 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -132.68 123.12 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -168.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.19 3.99 1.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -165.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -154.63 60.6 0.68 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 122.491 1.139 . . . . 0.0 109.702 155.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.8 t30 61.18 7.32 1.58 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.637 1.575 . . . . 0.0 114.692 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -135.7 155.09 50.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 131.349 3.86 . . . . 0.0 106.807 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.65 124.72 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.616 1.166 . . . . 0.0 109.027 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -111.97 -34.34 6.01 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.641 0.776 . . . . 0.0 112.543 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 131.64 27.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -96.96 154.71 17.14 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 162.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 147.85 33.18 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.938 1.695 . . . . 0.0 107.093 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 24' ' ' TYR 0.453 1.2 p -106.83 134.87 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 125.791 1.636 . . . . 0.0 115.287 155.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.16 122.14 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -65.64 161.08 21.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.594 1.088 . . . . 0.0 111.213 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -81.14 99.83 8.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 167.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -154.47 38.22 0.43 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 108.486 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 60.49 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.103 2.961 . . . . 0.0 112.854 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 t -62.23 -10.78 11.72 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.586 -1.321 . . . . 0.0 111.464 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.7 -60.24 6.6 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 160.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -61.29 -26.88 68.08 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.183 0.993 . . . . 0.0 112.348 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -64.69 -53.0 54.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 120.078 1.308 . . . . 0.0 108.874 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 t -53.55 -45.95 70.03 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 110.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.8 mt -50.36 -43.04 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.882 0.873 . . . . 0.0 110.709 -176.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.19 -23.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 O-C-N 121.052 -1.03 . . . . 0.0 111.906 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -98.64 12.42 35.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.078 0.951 . . . . 0.0 111.266 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.53 -6.42 11.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.807 0.843 . . . . 0.0 112.211 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.0 t30 49.89 61.95 2.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.406 1.483 . . . . 0.0 111.694 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.51 142.13 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 166.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -76.13 -52.72 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.27 162.5 39.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.56 141.16 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.88 2.072 . . . . 0.0 110.396 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 81' ' ' ALA . 51.9 mt -127.14 125.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.201 1.8 . . . . 0.0 106.792 167.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 38.1 m -149.62 -13.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.789 ' HG3' ' HB3' ' A' ' 81' ' ' ALA . 9.5 mtpp 75.78 -34.42 0.24 Allowed 'General case' 0 C--O 1.221 -0.425 1 C-N-CA 132.526 4.331 . . . . 0.0 113.35 -162.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -149.97 168.07 24.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 122.088 2.222 . . . . 0.0 111.748 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -163.53 120.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.645 1.178 . . . . 0.0 108.65 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.35 147.79 43.61 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.18 -47.49 65.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.933 2.093 . . . . 0.0 111.345 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -59.76 -42.25 92.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.753 0.787 . . . . 0.0 111.154 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -72.56 -41.49 65.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.888 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.75 -61.17 2.42 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.201 0.91 . . . . 0.0 109.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -64.89 -24.08 67.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.89 -38.63 61.83 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 120.905 -1.122 . . . . 0.0 111.301 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.49 -30.46 21.97 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.056 -1.027 . . . . 0.0 111.485 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -63.8 -12.73 38.18 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -27.34 5.62 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.328 1.451 . . . . 0.0 113.903 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -155.75 -2.66 0.14 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.026 0.83 . . . . 0.0 113.207 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.29 121.07 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -75.06 117.36 16.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.484 1.513 . . . . 0.0 107.271 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.48 134.92 28.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -120.15 155.38 33.19 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 108.792 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -85.37 141.29 30.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 168.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.789 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . . . -88.52 150.16 23.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.354 0.525 . . . . 0.0 110.486 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.77 71.36 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.876 2.47 . . . . 0.0 108.118 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.43 -178.85 17.52 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 124.466 1.031 . . . . 0.0 112.852 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -33.63 75.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.028 153.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.55 100.83 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 124.446 1.091 . . . . 0.0 109.9 -155.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -52.18 -43.85 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -44.22 92.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.575 0.625 . . . . 0.0 109.962 -175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.19 -39.26 78.47 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.69 -0.631 . . . . 0.0 110.982 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -76.87 -27.25 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 112.529 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.09 -50.43 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.6 p -61.87 -46.42 89.49 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.012 0.824 . . . . 0.0 110.898 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.4 mt -63.06 -30.24 71.44 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.084 0.554 . . . . 0.0 110.621 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.62 -48.38 48.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.46 -37.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.261 . . . . 0.0 109.928 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -76.84 -34.35 57.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.898 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.57 15.16 32.78 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.99 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -34.82 74.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.821 2.048 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.31 142.15 52.73 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.605 1.093 . . . . 0.0 109.495 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.4 t -91.55 144.75 25.22 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 123.275 1.512 . . . . 0.0 110.244 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -85.08 130.7 34.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.985 1.714 . . . . 0.0 108.896 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.2 mt . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.694 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 tpt . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.485 0.183 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.53 150.86 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 172.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m120 66.23 8.94 5.95 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 171.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.7 ttp -68.5 155.8 39.21 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.351 1.432 . . . . 0.0 110.202 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -139.12 146.34 40.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.018 1.727 . . . . 0.0 107.517 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG21 ' CE2' ' A' ' 93' ' ' PHE . 31.3 t -137.75 135.08 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.675 1.19 . . . . 0.0 108.122 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 124.12 33.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 166.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mt -104.03 112.53 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -66.2 91.63 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.784 1.234 . . . . 0.0 110.007 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 91.3 mmm -92.08 159.51 15.66 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.492 1.117 . . . . 0.0 111.183 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.81 -81.4 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.178 2.191 . . . . 0.0 108.372 165.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.4 t -140.41 -59.71 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -121.87 2.69 9.99 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 170.44 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.645 1.178 . . . . 0.0 110.09 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.5 mt -53.96 139.54 12.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.793 1.637 . . . . 0.0 108.087 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -74.25 -179.49 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.707 1.603 . . . . 0.0 110.625 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -86.0 -34.39 20.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.705 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -153.27 168.3 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -67.03 -23.04 65.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.247 2.219 . . . . 0.0 111.406 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.8 19.72 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.052 1.341 . . . . 0.0 110.916 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.14 -7.3 1.58 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.2 p -74.46 154.49 38.7 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.265 1.031 . . . . 0.0 109.889 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.59 -34.25 14.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.365 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.454 ' HE2' HD23 ' A' ' 26' ' ' LEU . 27.4 p90 -158.54 175.55 13.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.656 0.741 . . . . 0.0 109.533 176.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -117.05 108.91 16.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD23 ' HE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -77.72 104.9 8.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 170.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 mm -69.0 99.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.18 147.37 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 161.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -129.03 140.22 51.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mt -110.55 142.52 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.28 124.55 10.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 175.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 44.46 57.7 4.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.614 1.565 . . . . 0.0 111.51 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.62 28.49 2.6 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 128.89 2.876 . . . . 0.0 114.138 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HB2' ' CE ' ' A' ' 36' ' ' LYS . 45.4 mt-10 -132.07 157.16 44.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.09 1.314 . . . . 0.0 111.139 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.52 120.15 17.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' CE ' ' HB2' ' A' ' 34' ' ' GLU . 21.3 mmtp -126.15 -7.62 6.52 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.437 ' HB3' ' HG2' ' A' ' 29' ' ' ARG . 47.7 t -157.13 170.67 21.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 122.021 2.191 . . . . 0.0 107.813 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.24 156.26 45.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.609 1.564 . . . . 0.0 109.535 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 160.55 43.86 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 125.911 1.685 . . . . 0.0 109.142 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.7 OUTLIER -127.1 137.28 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 C-N-CA 130.062 3.345 . . . . 0.0 116.581 167.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.84 116.25 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -64.05 148.92 48.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.57 0.623 . . . . 0.0 110.25 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -69.95 88.73 0.58 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.2 166.23 24.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 128.309 2.644 . . . . 0.0 105.042 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.73 -45.98 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.49 -0.757 . . . . 0.0 109.778 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -26.3 68.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 110.178 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.18 -49.73 38.12 Favored Glycine 0 N--CA 1.444 -0.819 0 O-C-N 121.729 -0.607 . . . . 0.0 111.677 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -67.82 -21.52 65.21 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.067 0.934 . . . . 0.0 111.506 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.03 -58.16 6.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.736 -1.126 . . . . 0.0 110.551 161.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -53.51 -33.88 56.08 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.333 0.97 . . . . 0.0 112.824 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 mt -45.3 -46.64 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.557 1.143 . . . . 0.0 111.513 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.33 -33.37 63.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 123.225 0.61 . . . . 0.0 110.199 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -27.09 29.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.298 0.499 . . . . 0.0 111.223 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.02 -20.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.099 0.863 . . . . 0.0 112.155 -170.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.01 32.87 1.74 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.053 1.341 . . . . 0.0 110.58 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.02 146.1 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.34 -48.83 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.794 1.238 . . . . 0.0 109.669 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.47 163.3 40.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 110.057 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -117.19 150.07 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.7 mt -120.24 132.14 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 t -163.95 161.53 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.715 2.406 . . . . 0.0 108.476 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.3 -39.03 93.43 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.537 169.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.66 167.96 24.95 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.029 1.286 . . . . 0.0 109.34 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.9 tt -162.49 138.02 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.025 1.73 . . . . 0.0 107.751 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -76.29 152.11 36.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.964 -0.46 . . . . 0.0 110.581 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -48.91 -45.64 41.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.507 1.123 . . . . 0.0 111.456 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.768 0.827 . . . . 0.0 108.824 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -60.12 -41.5 92.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.99 0.916 . . . . 0.0 111.903 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -56.03 -65.01 0.67 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.915 0.78 . . . . 0.0 109.252 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -60.38 -28.1 67.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.634 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -55.4 13.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.721 1.146 . . . . 0.0 110.341 176.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.88 -22.25 37.0 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.531 0.605 . . . . 0.0 112.589 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 t -72.44 69.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.029 1.395 . . . . 0.0 110.618 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 -32.49 0.28 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 129.006 2.922 . . . . 0.0 110.259 175.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.82 -6.32 0.6 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.81 136.67 58.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.62 155.46 19.23 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.977 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.3 mt -128.14 118.19 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.63 1.172 . . . . 0.0 108.658 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 60.1 m-85 -106.06 164.36 12.04 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.161 0.984 . . . . 0.0 110.321 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -98.41 145.97 26.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.885 0.766 . . . . 0.0 110.017 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.91 117.16 29.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.598 1.159 . . . . 0.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.24 -9.8 58.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.89 34.39 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.45 -18.26 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 158.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 98.53 0.91 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.985 2.514 . . . . 0.0 107.276 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -48.13 -41.42 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.02 -43.59 74.46 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.385 -0.822 . . . . 0.0 110.35 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -36.07 82.29 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 122.084 -0.385 . . . . 0.0 110.502 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.51 -38.32 74.28 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.736 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.05 -50.32 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -60.4 -36.45 78.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.623 0.647 . . . . 0.0 111.863 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.8 mt -67.89 -44.97 75.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.023 0.44 . . . . 0.0 110.77 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 6' ' ' VAL . 43.6 t80 -59.36 -37.19 77.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.358 1.063 . . . . 0.0 112.839 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.7 mt -64.34 -48.41 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.445 1.098 . . . . 0.0 109.807 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.72 -24.07 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.982 0.81 . . . . 0.0 110.868 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.16 8.37 58.92 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 123.914 0.769 . . . . 0.0 113.279 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -45.64 73.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.128 2.171 . . . . 0.0 109.901 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.62 137.78 42.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 124.204 1.002 . . . . 0.0 110.847 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 t -84.47 157.81 21.22 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 57.0 mtpt -76.35 145.63 39.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.173 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 CA--C 1.515 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mm -134.01 143.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.533 2.333 . . . . 0.0 107.496 -167.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 45.65 58.74 4.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.464 1.506 . . . . 0.0 113.101 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -103.11 155.02 18.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.609 1.163 . . . . 0.0 108.328 166.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 143.12 31.9 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.495 1.918 . . . . 0.0 105.981 164.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG21 ' CE2' ' A' ' 93' ' ' PHE . 95.4 t -132.78 137.17 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.49 74.26 0.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.689 0.796 . . . . 0.0 109.553 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.92 120.56 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.888 1.275 . . . . 0.0 109.103 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -67.96 117.92 10.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.046 0.938 . . . . 0.0 111.124 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.2 mmm -124.89 157.11 36.76 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.707 1.603 . . . . 0.0 110.159 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -106.78 -62.02 1.46 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.024 1.73 . . . . 0.0 110.635 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -142.27 -85.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 170.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.71 -8.45 24.3 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 165.93 19.99 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.799 1.24 . . . . 0.0 110.35 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.48 142.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 125.31 1.631 . . . . 0.0 108.036 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -73.18 -179.34 3.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.136 1.375 . . . . 0.0 112.881 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -88.14 -32.3 18.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.553 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.1 t -152.67 177.88 10.21 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.262 1.825 . . . . 0.0 108.289 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.32 -34.87 78.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 128.218 2.607 . . . . 0.0 110.723 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.8 -1.94 45.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.005 0.82 . . . . 0.0 111.979 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -121.1 52.77 1.18 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 p -133.25 173.04 11.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.184 2.994 . . . . 0.0 108.572 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -118.01 -28.65 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.906 1.682 . . . . 0.0 109.385 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -156.42 176.1 13.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.953 0.797 . . . . 0.0 111.78 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -123.08 115.92 22.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.823 2.849 . . . . 0.0 108.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 39' ' ' LYS . 14.2 tp -89.07 103.35 15.97 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.327 2.251 . . . . 0.0 106.424 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 41' ' ' ILE . 14.7 mm -68.79 76.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 129.732 3.213 . . . . 0.0 111.16 174.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -69.14 99.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -76.64 136.49 39.17 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 164.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.14 129.77 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 159.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -132.43 2.19 3.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 t0 174.59 72.13 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.253 3.021 . . . . 0.0 103.217 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.9 -25.56 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 131.146 3.778 . . . . 0.0 116.608 173.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -107.39 166.12 10.89 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.22 118.97 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.107 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 -5.35 8.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 113.203 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.7 m -170.02 168.14 8.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.7 2.4 . . . . 0.0 107.005 166.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 p -136.23 -46.01 0.63 Allowed 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER 44.41 175.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.253 2.621 . . . . 0.0 117.682 -171.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.7 t -143.25 106.02 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 27' ' ' ILE . 47.6 mt -96.49 115.52 36.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 165.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -65.43 162.26 18.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.871 1.669 . . . . 0.0 110.461 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -73.58 80.98 1.49 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 0.0 108.1 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -134.04 168.16 19.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.628 1.171 . . . . 0.0 107.906 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -52.14 -46.46 65.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.199 1.799 . . . . 0.0 109.835 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -70.82 -39.92 72.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.784 1.234 . . . . 0.0 107.933 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -61.31 7.32 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -58.98 -39.54 82.08 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.23 1.012 . . . . 0.0 110.373 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -58.68 -42.44 88.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.137 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -44.42 92.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.578 1.551 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.7 mt -50.75 -43.81 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.15 -32.41 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.976 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -84.31 -25.93 28.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.47 1.032 . . . . 0.0 110.361 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.95 156.62 33.01 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.793 1.237 . . . . 0.0 108.503 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -83.17 28.31 0.53 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.178 1.391 . . . . 0.0 110.916 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.29 134.78 23.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 120.935 1.698 . . . . 0.0 108.559 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -82.26 -44.63 16.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.023 1.729 . . . . 0.0 109.655 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.25 162.2 40.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.121 0.568 . . . . 0.0 110.412 -168.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mt -113.51 141.69 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 171.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.14 122.64 55.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 162.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.04 151.72 38.19 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.914 1.285 . . . . 0.0 110.664 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -65.91 -46.65 77.49 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 163.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -148.21 166.89 26.56 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.83 119.85 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -52.05 138.58 24.88 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.506 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -51.87 -43.1 63.13 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.973 1.709 . . . . 0.0 112.071 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -22.72 66.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 0.0 112.625 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -84.61 -41.5 16.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.571 -0.705 . . . . 0.0 109.891 167.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.94 -59.95 4.29 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.941 1.246 . . . . 0.0 110.721 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -58.35 -22.8 54.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.904 0.482 . . . . 0.0 111.959 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.96 -50.05 8.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.834 1.254 . . . . 0.0 111.098 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -79.59 -24.27 42.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.095 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -60.85 -7.58 2.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.168 0.895 . . . . 0.0 113.302 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -39.33 21.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.332 1.453 . . . . 0.0 113.864 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -165.17 4.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.282 0.947 . . . . 0.0 112.173 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.7 mt -120.95 126.71 75.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.38 136.79 42.45 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.29 132.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.3 151.66 37.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.681 1.192 . . . . 0.0 109.908 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -99.54 134.56 42.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.968 1.707 . . . . 0.0 110.59 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.427 0.632 . . . . 0.0 109.94 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -128.85 26.67 5.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.791 2.436 . . . . 0.0 108.584 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.11 36.78 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.598 -1.314 . . . . 0.0 111.879 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -89.67 -23.93 21.74 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.966 1.306 . . . . 0.0 109.784 165.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.79 104.02 1.0 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.222 1.809 . . . . 0.0 107.705 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.73 -46.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.217 1.007 . . . . 0.0 108.844 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.33 -41.72 93.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.215 0.916 . . . . 0.0 109.609 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -56.54 -44.79 81.2 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.607 -0.683 . . . . 0.0 110.353 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -70.21 -44.93 67.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.096 -0.378 . . . . 0.0 110.894 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -41.52 92.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 97.4 p -68.52 -34.41 75.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.568 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.62 -41.36 84.09 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 120.991 0.424 . . . . 0.0 110.397 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 6' ' ' VAL . 56.0 t80 -61.66 -40.17 93.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.592 0.757 . . . . 0.0 112.051 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.1 mt -51.07 -52.47 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 109.163 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -74.11 -22.52 59.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.048 0.84 . . . . 0.0 112.445 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.65 -3.76 39.51 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.897 -0.946 . . . . 0.0 114.26 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -17.41 62.53 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.677 1.991 . . . . 0.0 113.577 -164.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.67 140.96 49.88 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.8 -1.188 . . . . 0.0 109.149 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -57.35 134.91 56.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -68.77 130.75 43.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 153.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.4 mt . . . . . 0 C--O 1.235 0.329 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 160.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 CA--C 1.515 -0.401 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.1 mt -139.05 143.37 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.48 52.47 14.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.381 1.472 . . . . 0.0 111.433 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttp -113.55 137.77 51.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.871 1.268 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -133.85 153.05 52.01 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 126.098 1.759 . . . . 0.0 106.935 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 93' ' ' PHE . 53.4 t -147.04 141.32 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.25 94.09 8.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.55 98.32 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 p -67.95 123.8 21.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.672 1.589 . . . . 0.0 113.032 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.1 mtp -124.46 162.02 24.82 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.453 -1.405 . . . . 0.0 112.403 -171.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.49 -60.76 1.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.681 1.192 . . . . 0.0 109.439 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -146.74 -73.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -122.59 0.46 9.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.944 1.298 . . . . 0.0 111.928 -167.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 178.18 7.34 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.25 -0.907 . . . . 0.0 110.547 165.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.8 mt -52.53 139.98 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.038 1.735 . . . . 0.0 109.156 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -68.39 166.39 16.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.041 1.336 . . . . 0.0 112.964 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.97 -46.29 71.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.39 1.476 . . . . 0.0 112.264 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 t -158.41 168.6 26.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 0.0 109.418 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.95 -33.52 75.53 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.534 1.934 . . . . 0.0 111.112 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.49 24.4 12.66 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.859 1.264 . . . . 0.0 110.198 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -139.99 32.17 1.98 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.829 0.852 . . . . 0.0 109.602 161.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.2 p -108.32 164.42 12.33 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.42 -29.22 9.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.091 0.956 . . . . 0.0 110.004 -171.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 31.8 p90 -159.96 163.53 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.339 0.59 . . . . 0.0 111.909 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.675 ' CD2' HD11 ' A' ' 51' ' ' ILE . 62.8 m-85 -104.87 107.57 18.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.69 1.996 . . . . 0.0 107.498 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -75.12 93.59 2.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -72.98 91.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 121.15 -0.969 . . . . 0.0 108.5 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.88 ' HA ' HG22 ' A' ' 38' ' ' THR . 1.2 p -64.98 165.96 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.541 1.137 . . . . 0.0 109.939 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 127.52 24.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.973 1.715 . . . . 0.0 110.48 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.34 110.94 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 125.63 1.572 . . . . 0.0 107.233 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -118.04 -13.5 9.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.531 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -157.63 63.77 0.47 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 122.875 1.321 . . . . 0.0 108.615 170.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 t30 53.58 18.59 1.48 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.123 2.169 . . . . 0.0 116.08 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.91 171.42 14.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.92 1.688 . . . . 0.0 108.355 170.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 113.24 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -105.35 -39.45 6.15 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.647 -0.658 . . . . 0.0 109.263 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.56 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.447 1.099 . . . . 0.0 108.078 176.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.88 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.7 OUTLIER -159.98 176.93 11.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.513 1.925 . . . . 0.0 108.642 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -158.01 164.48 36.72 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 125.982 1.713 . . . . 0.0 110.903 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.477 0.6 OUTLIER -132.57 141.18 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 128.836 2.854 . . . . 0.0 117.076 164.728 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -129.47 117.82 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 129.695 3.198 . . . . 0.0 104.35 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -64.7 158.55 24.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.856 1.207 . . . . 0.0 111.758 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.84 89.37 4.06 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.578 0.751 . . . . 0.0 109.496 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -144.78 29.63 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.985 0.898 . . . . 0.0 112.546 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 75.24 -55.83 0.63 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.357 2.263 . . . . 0.0 111.771 170.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -60.48 -28.63 68.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.346 1.058 . . . . 0.0 109.864 166.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.04 -49.68 41.89 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -56.97 -39.04 73.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.884 0.842 . . . . 0.0 111.169 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -58.9 -47.16 85.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.463 1.029 . . . . 0.0 111.477 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 m -64.07 -33.54 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.051 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.675 HD11 ' CD2' ' A' ' 25' ' ' PHE . 84.2 mt -55.68 -40.35 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.148 0.885 . . . . 0.0 110.216 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -54.94 -47.12 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -81.21 -13.04 58.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -63.97 -19.34 65.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.221 1.373 . . . . 0.0 111.865 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 55.87 56.53 5.95 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.181 1.392 . . . . 0.0 109.068 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 51' ' ' ILE . 2.5 t -66.31 146.45 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.93 -37.48 13.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.228 2.611 . . . . 0.0 110.578 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.6 168.12 24.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.159 0.983 . . . . 0.0 112.627 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -127.21 119.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.2 132.89 37.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 163.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.9 p -147.55 163.54 36.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.266 0.939 . . . . 0.0 108.672 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -75.07 -40.64 60.02 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 121.48 -0.763 . . . . 0.0 108.994 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -157.46 170.01 23.41 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.4 tt -163.49 124.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.64 0.776 . . . . 0.0 111.017 -170.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -51.15 141.31 14.63 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.56 0.744 . . . . 0.0 111.732 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.87 -45.82 60.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.852 1.661 . . . . 0.0 112.176 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -58.98 -52.43 65.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.97 0.804 . . . . 0.0 110.583 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -63.0 -41.41 99.58 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.227 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.15 -61.28 2.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.651 0.78 . . . . 0.0 109.642 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -63.49 -24.23 67.73 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 119.171 -0.442 . . . . 0.0 112.182 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -61.71 1.71 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.977 0.911 . . . . 0.0 109.517 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.69 -21.82 60.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.752 0.821 . . . . 0.0 112.499 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -63.15 -1.81 1.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -70.22 -32.96 71.09 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.999 -1.688 . . . . 0.0 113.492 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -153.86 13.56 0.46 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.301 1.409 . . . . 0.0 112.573 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -135.36 133.95 52.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -87.91 126.22 34.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.769 1.627 . . . . 0.0 108.601 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.2 mt -109.54 121.75 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.69 -1.256 . . . . 0.0 109.139 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 72.3 m-85 -121.18 146.9 46.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.364 2.266 . . . . 0.0 111.518 -166.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -90.1 146.58 24.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.73 0.412 . . . . 0.0 110.387 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 129.69 36.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.66 20.35 6.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.902 0.881 . . . . 0.0 112.135 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.74 -165.21 38.71 Favored Glycine 0 C--N 1.335 0.506 0 O-C-N 120.496 -1.378 . . . . 0.0 111.675 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.12 1.01 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.116 1.366 . . . . 0.0 109.499 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . 3.0 t70 -86.92 104.75 16.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.6 -42.04 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -64.17 -47.48 79.68 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -168.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 2.7 tptm -61.53 -37.11 82.54 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.997 -1.065 . . . . 0.0 111.862 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.88 -33.8 76.39 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 120.891 -1.13 . . . . 0.0 111.386 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.97 -51.08 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -64.23 -37.68 88.33 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.447 0.567 . . . . 0.0 111.242 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.06 -43.91 94.04 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.065 0.393 . . . . 0.0 110.033 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CE2' HG21 ' A' ' 6' ' ' VAL . 67.2 t80 -59.82 -44.81 93.84 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.72 0.408 . . . . 0.0 111.55 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.0 -48.49 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.228 1.011 . . . . 0.0 109.433 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.69 -36.53 84.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.911 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 9.11 21.34 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.062 -0.854 . . . . 0.0 113.237 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -29.66 59.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.289 1.036 . . . . 0.0 112.063 -167.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.73 138.38 58.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 135.68 42.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.6 mtmm -64.42 132.2 49.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 163.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.1 mt . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.433 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 mt -124.22 151.24 29.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 126.435 1.894 . . . . 0.0 108.789 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.3 t30 61.55 27.81 17.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.321 2.248 . . . . 0.0 113.198 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpp -78.08 149.12 33.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -140.81 140.39 34.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 93' ' ' PHE . 54.7 t -140.69 130.86 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.284 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.26 106.89 18.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -92.32 123.75 44.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 79.3 p -62.43 128.32 35.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.588 1.086 . . . . 0.0 110.613 169.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 mtp -126.66 159.99 32.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.653 1.115 . . . . 0.0 110.689 172.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.22 -65.55 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.152 1.381 . . . . 0.0 107.948 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.54 -73.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 167.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -119.79 9.67 11.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.307 1.051 . . . . 0.0 112.482 -154.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 178.03 8.7 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 128.293 2.637 . . . . 0.0 107.603 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.82 146.03 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 p -83.54 -156.78 0.21 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.715 2.006 . . . . 0.0 111.985 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.55 -21.65 12.62 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 63' ' ' ASN . 96.8 p -154.52 -167.89 2.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.892 1.224 . . . . 0.0 110.789 168.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -79.63 -29.01 40.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.84 1.256 . . . . 0.0 110.969 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -89.26 -43.17 11.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.764 0.711 . . . . 0.0 109.83 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.5 62.39 6.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 9' ' ' SER . 17.8 p -121.98 165.41 16.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.319 149.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -110.36 -29.31 8.18 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.702 1.201 . . . . 0.0 108.805 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.47 169.72 20.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 109.678 167.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.3 119.69 39.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.196 2.198 . . . . 0.0 105.662 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD11 ' HB ' ' A' ' 38' ' ' THR . 1.2 tm? -79.98 105.72 11.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 mm -79.76 98.69 3.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 t -66.14 146.94 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 167.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.08 89.92 2.88 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.05 126.86 29.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 166.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -127.3 1.92 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 118.396 -0.812 . . . . 0.0 113.035 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -166.52 45.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.009 0.909 . . . . 0.0 110.488 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.66 8.56 1.79 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.895 -1.128 . . . . 0.0 114.01 -168.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.73 154.27 46.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.693 1.197 . . . . 0.0 109.883 162.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.64 108.12 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 107.757 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -88.95 -30.37 18.86 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.999 -1.063 . . . . 0.0 111.691 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -144.87 164.18 31.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 162.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.411 ' HB ' HD11 ' A' ' 26' ' ' LEU . 20.9 p -118.02 144.88 45.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.763 1.625 . . . . 0.0 106.912 165.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.86 155.59 27.65 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.535 1.134 . . . . 0.0 108.161 169.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.5 132.06 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.76 111.35 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -62.35 152.71 33.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.517 1.053 . . . . 0.0 109.768 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -74.73 88.3 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.67 165.28 27.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.174 1.789 . . . . 0.0 106.225 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -61.16 -39.31 89.64 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.523 -0.736 . . . . 0.0 111.737 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 t -63.97 -45.02 90.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.238 1.015 . . . . 0.0 108.481 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.95 -60.78 8.2 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 125.237 1.398 . . . . 0.0 112.062 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -62.75 -36.59 83.54 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 121.834 -0.804 . . . . 0.0 110.11 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -54.02 -44.87 71.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.637 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.1 m -70.69 -23.46 62.48 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.738 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.98 -46.18 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 121.478 1.944 . . . . 0.0 109.687 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -55.47 -18.11 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.64 . . . . 0.0 112.15 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.68 -14.85 14.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.735 -1.126 . . . . 0.0 112.592 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.06 -27.67 69.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.787 1.63 . . . . 0.0 111.026 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 63.42 53.89 2.06 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 125.238 1.415 . . . . 0.0 109.737 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.75 148.76 10.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -38.33 9.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.416 1.886 . . . . 0.0 110.257 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 161.17 43.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.07 0.548 . . . . 0.0 111.132 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -119.87 142.04 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.178 1.791 . . . . 0.0 107.221 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.34 106.35 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.749 1.22 . . . . 0.0 108.282 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 4.1 m -142.99 173.04 11.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -71.86 -70.82 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.43 ' H ' ' HA ' ' A' ' 18' ' ' SER . 24.5 m-20 -119.58 170.26 9.33 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.532 -1.355 . . . . 0.0 108.021 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.89 137.87 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -68.5 141.32 55.61 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.194 0.997 . . . . 0.0 110.408 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -45.24 -52.35 9.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.355 2.262 . . . . 0.0 111.288 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -39.35 89.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.812 0.445 . . . . 0.0 110.966 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -69.86 -47.5 62.38 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -51.09 -62.97 1.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.38 -36.03 70.73 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.189 0.596 . . . . 0.0 110.993 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -63.95 -59.7 4.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.805 -0.56 . . . . 0.0 110.494 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -75.82 -28.75 58.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.544 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -65.78 -5.68 9.55 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.702 1.201 . . . . 0.0 113.548 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -47.03 -51.49 17.26 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.513 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -140.39 -15.97 0.94 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 87.9 mt -73.03 123.99 29.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.21 147.7 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.25 119.3 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -120.22 154.34 35.0 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.831 1.252 . . . . 0.0 110.555 -170.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -90.13 128.72 36.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 109.662 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.1 123.81 20.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.421 0.688 . . . . 0.0 111.037 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -108.39 100.42 9.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.925 2.09 . . . . 0.0 108.184 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.75 157.77 27.6 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -27.98 62.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.134 2.174 . . . . 0.0 111.823 164.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.8 103.66 6.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.058 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -44.75 -44.48 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 123.719 0.807 . . . . 0.0 109.097 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.17 -34.62 61.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.98 0.355 . . . . 0.0 110.603 -169.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -50.81 -53.16 34.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -67.22 -29.25 68.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.349 -170.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.09 -46.19 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -66.96 -39.3 87.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.887 0.767 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.4 -46.41 90.09 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 6' ' ' VAL . 78.5 t80 -62.05 -40.51 96.02 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 mt -55.68 -49.75 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.626 1.171 . . . . 0.0 109.464 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -73.22 -14.95 61.44 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.544 0.738 . . . . 0.0 112.805 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.81 18.53 63.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.077 0.853 . . . . 0.0 112.3 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.14 -27.92 62.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.548 1.539 . . . . 0.0 112.502 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.39 154.53 40.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.015 1.28 . . . . 0.0 109.464 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.35 149.5 35.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.043 0.937 . . . . 0.0 109.42 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -83.14 136.18 34.54 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 122.104 -0.373 . . . . 0.0 111.551 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.579 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.447 ' HG2' ' HE1' ' A' ' 4' ' ' MET . 10.9 tpt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.683 HG22 ' H ' ' A' ' 3' ' ' ASN . 2.1 mm -95.17 -161.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.013 2.125 . . . . 0.0 108.164 -178.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.683 ' H ' HG22 ' A' ' 2' ' ' ILE . 17.3 t-20 -53.07 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.195 2.598 . . . . 0.0 110.424 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.447 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 1.4 ttp -110.17 148.49 31.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -131.22 129.65 41.93 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 125.674 1.589 . . . . 0.0 106.747 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.598 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.5 t -136.35 132.66 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.5 111.37 22.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.4 123.58 44.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -73.46 127.71 33.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 117.821 0.282 . . . . 0.0 110.279 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtp -130.65 156.63 44.57 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.189 1.396 . . . . 0.0 111.053 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -104.06 -69.93 0.79 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 109.675 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.8 t -146.75 -47.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.23 17.59 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.773 0.797 . . . . 0.0 111.14 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -160.79 172.64 16.67 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 120.481 -1.387 . . . . 0.0 109.087 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.6 138.6 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 107.88 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.3 p -73.38 167.99 20.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.739 0.781 . . . . 0.0 111.025 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.29 -46.11 57.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.266 0.3 OUTLIER -137.89 161.68 36.01 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.59 -1.319 . . . . 0.0 108.441 -175.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -68.33 -45.77 72.03 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.979 -1.076 . . . . 0.0 108.299 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.69 -33.32 75.62 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.374 0.67 . . . . 0.0 110.692 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.73 58.02 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.916 1.341 . . . . 0.0 107.807 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 p -121.35 175.91 5.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.481 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -104.69 -35.34 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.584 0.754 . . . . 0.0 109.53 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 29.5 p90 -156.1 170.76 21.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.422 0.629 . . . . 0.0 110.533 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.87 115.99 27.19 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.022 1.729 . . . . 0.0 107.257 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -79.14 107.28 11.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.01 100.17 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -63.31 137.38 24.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -125.01 118.46 26.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -119.02 139.89 44.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 16.8 m-20 -140.36 7.06 2.15 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.603 0.761 . . . . 0.0 109.517 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -168.44 51.08 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.571 1.548 . . . . 0.0 112.127 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 t30 64.15 -5.3 0.33 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.177 1.791 . . . . 0.0 115.323 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -121.64 154.2 37.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.22 2.208 . . . . 0.0 109.296 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.74 96.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 107.321 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 67.8 mmtt -70.33 -33.31 71.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 171.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 m -161.77 167.09 25.55 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.087 0.858 . . . . 0.0 111.127 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -127.02 118.66 24.9 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.509 1.523 . . . . 0.0 108.77 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.71 168.53 9.01 Favored 'General case' 0 C--O 1.213 -0.861 0 C-N-CA 125.754 1.622 . . . . 0.0 108.792 171.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.79 1.1 p -155.17 124.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 131.085 3.754 . . . . 0.0 115.947 -175.127 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.52 109.41 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 129.586 3.155 . . . . 0.0 102.921 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -61.36 156.11 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.122 0.874 . . . . 0.0 109.654 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -72.43 55.85 0.35 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.84 2.056 . . . . 0.0 111.121 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -107.29 168.57 9.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.2 -43.89 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.854 0.862 . . . . 0.0 109.614 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -77.36 -34.19 55.11 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.21 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.76 17.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.107 0.861 . . . . 0.0 111.25 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 52' ' ' VAL . 53.1 mttt -61.1 -37.68 83.6 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.078 -1.248 . . . . 0.0 109.622 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -59.39 -34.71 72.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.923 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -65.49 -48.69 71.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 119.36 0.982 . . . . 0.0 110.453 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -55.15 -44.16 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.153 0.888 . . . . 0.0 110.521 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 48' ' ' LYS . 62.0 t -55.76 -35.59 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.632 0.773 . . . . 0.0 110.825 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -95.59 -3.09 47.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.915 0.779 . . . . 0.0 112.287 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.91 168.41 18.77 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.757 1.162 . . . . 0.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -95.39 37.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.102 1.761 . . . . 0.0 110.045 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.94 138.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -82.18 -45.62 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.438 1.495 . . . . 0.0 109.968 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.4 158.65 42.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.285 1.034 . . . . 0.0 109.949 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.25 122.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.89 123.02 47.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -148.07 161.15 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.421 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -81.78 -34.21 30.46 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 124.245 1.018 . . . . 0.0 111.335 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -149.85 159.78 44.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.674 1.579 . . . . 0.0 107.533 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.39 136.22 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.946 2.098 . . . . 0.0 108.69 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -77.94 148.88 34.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.22 -38.55 89.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.0 0.52 . . . . 0.0 112.104 -165.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.49 -42.97 99.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.195 0.598 . . . . 0.0 109.4 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -70.35 -31.74 69.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.941 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -58.41 -58.39 8.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.22 1.373 . . . . 0.0 109.655 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -54.95 -43.66 73.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.922 0.489 . . . . 0.0 110.586 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -54.0 -58.58 6.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.006 1.722 . . . . 0.0 111.276 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' HD1' HD12 ' A' ' 76' ' ' ILE . 44.2 m-85 -78.38 -35.3 47.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.34 -0.838 . . . . 0.0 112.983 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.9 t -50.44 -27.19 6.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.547 1.939 . . . . 0.0 111.546 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -45.05 -46.07 11.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.226 1.01 . . . . 0.0 113.094 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -149.03 14.68 0.91 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.198 -172.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.482 HD12 ' HD1' ' A' ' 72' ' ' PHE . 37.6 mt -136.44 122.94 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.29 126.88 31.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.767 1.227 . . . . 0.0 108.647 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.87 129.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -116.49 148.79 40.45 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.885 2.074 . . . . 0.0 109.534 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -88.62 142.16 27.92 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.75 48.99 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 161.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -108.1 8.41 28.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.726 1.61 . . . . 0.0 111.107 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.09 -174.96 39.27 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.872 0.76 . . . . 0.0 111.235 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.78 -14.3 15.27 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.759 1.224 . . . . 0.0 110.635 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.1 106.72 5.08 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.419 1.088 . . . . 0.0 108.199 173.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -54.86 -43.71 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.917 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.47 -34.28 70.06 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.877 0.762 . . . . 0.0 109.039 -168.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -59.02 -49.3 78.43 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 120.853 -1.154 . . . . 0.0 109.448 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -74.04 -28.37 61.39 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.403 -0.811 . . . . 0.0 112.515 -170.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mt -66.0 -55.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.6 p -61.7 -38.73 88.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.331 0.514 . . . . 0.0 112.132 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.1 mt -61.53 -34.17 75.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.05 0.54 . . . . 0.0 111.434 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 6' ' ' VAL . 85.1 t80 -72.79 -41.16 65.29 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.953 -1.092 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 91' ' ' SER . 83.7 mt -51.01 -54.57 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.159 1.384 . . . . 0.0 109.698 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.68 -20.84 63.55 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.694 0.798 . . . . 0.0 111.668 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.45 56.59 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -41.78 88.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.925 1.29 . . . . 0.0 110.366 164.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.58 140.71 53.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.418 1.008 . . . . 0.0 111.968 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.9 m -75.61 142.72 42.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.827 1.251 . . . . 0.0 111.104 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -76.37 150.82 36.78 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 160.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.258 -177.858 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.11 148.38 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t30 56.54 36.85 28.22 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.669 1.588 . . . . 0.0 112.948 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.9 tpp -80.76 148.74 29.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 174.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -137.27 141.59 41.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 165.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 93' ' ' PHE . 42.0 t -139.77 138.65 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.378 171.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.7 104.35 16.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.31 111.37 24.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.2 p -63.21 151.06 41.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.195 1.816 . . . . 0.0 110.513 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 mtp -138.53 160.61 39.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.471 1.508 . . . . 0.0 109.06 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.57 -68.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.797 1.239 . . . . 0.0 108.417 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -142.89 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 120.369 -1.457 . . . . 0.0 108.295 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -118.14 -31.43 5.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.357 1.063 . . . . 0.0 112.199 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -139.44 179.66 6.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.367 1.067 . . . . 0.0 110.176 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.3 mt -51.47 127.36 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.495 1.918 . . . . 0.0 109.098 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 t -71.32 179.18 3.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.676 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -85.35 -31.09 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -161.44 148.17 14.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.393 1.451 . . . . 0.0 112.032 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.62 -27.08 66.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.496 1.518 . . . . 0.0 111.309 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.54 11.53 28.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.483 1.913 . . . . 0.0 113.001 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -139.89 -6.42 1.28 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.394 1.478 . . . . 0.0 112.734 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 p -74.23 161.55 29.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.151 0.581 . . . . 0.0 111.34 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -99.75 -32.58 10.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.147 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.432 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 34.0 p90 -155.61 171.14 20.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.451 -0.78 . . . . 0.0 111.588 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -115.61 115.27 26.13 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.742 2.017 . . . . 0.0 107.283 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -76.55 99.47 4.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.234 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.34 97.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.59 150.06 7.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.995 1.318 . . . . 0.0 108.398 168.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -127.28 132.18 50.37 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.68 143.9 39.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 170.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -147.96 -6.03 0.45 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -152.1 59.08 0.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 160.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.67 -24.19 0.12 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 128.788 2.835 . . . . 0.0 114.718 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -92.27 155.48 17.93 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.658 1.983 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.76 130.52 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.148 1.379 . . . . 0.0 109.108 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.18 -27.61 6.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 m -163.44 164.7 24.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 108.484 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.482 ' HB ' HD11 ' A' ' 26' ' ' LEU . 12.1 p -120.5 148.92 43.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 109.488 171.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.05 155.59 49.74 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.512 1.125 . . . . 0.0 108.805 172.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.6 OUTLIER -124.08 128.71 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 128.714 2.806 . . . . 0.0 117.538 166.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.56 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.98 134.85 53.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.982 0.81 . . . . 0.0 109.051 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' H ' ' HA ' ' A' ' 24' ' ' TYR . 39.6 t30 -80.55 97.14 7.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -144.19 -68.95 0.31 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.317 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 46' ' ' SER . 1.6 pt-20 -155.78 -63.33 0.11 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.555 0.742 . . . . 0.0 109.058 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 39.0 m -53.9 -36.89 63.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.319 170.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.7 -63.07 3.68 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.163 0.887 . . . . 0.0 112.04 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -63.16 -37.13 86.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.856 0.862 . . . . 0.0 112.01 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -56.94 -44.01 82.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.751 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -64.55 -45.85 85.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.685 1.594 . . . . 0.0 111.273 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.8 mt -49.79 -44.45 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 120.156 1.344 . . . . 0.0 110.869 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.39 -31.92 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.245 -0.909 . . . . 0.0 110.964 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 8.64 43.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.867 0.867 . . . . 0.0 110.929 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -168.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -130.31 51.71 2.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.18 147.87 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -98.76 -31.31 11.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.5 1.12 . . . . 0.0 110.534 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.11 161.5 40.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.943 0.497 . . . . 0.0 111.936 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.97 125.37 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.69 114.83 40.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.1 m -141.04 165.5 27.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -69.13 -35.67 76.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.605 1.162 . . . . 0.0 111.207 172.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -155.3 161.8 41.02 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.79 142.65 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.044 1.738 . . . . 0.0 108.123 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -65.94 154.26 39.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.58 -51.74 68.63 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.075 0.55 . . . . 0.0 109.986 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.2 -46.38 88.59 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.08 -35.47 80.59 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.393 0.677 . . . . 0.0 111.791 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -59.92 -60.96 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.736 1.153 . . . . 0.0 109.693 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -65.37 -21.54 66.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 0.0 110.383 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -70.7 -66.91 0.55 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.443 1.497 . . . . 0.0 109.538 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.17 -18.77 60.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.547 -165.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 p -59.45 -9.35 2.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -74.36 104.79 5.24 Favored 'General case' 0 C--O 1.23 0.075 0 O-C-N 120.6 -1.313 . . . . 0.0 109.901 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 67.78 11.47 8.39 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.437 1.895 . . . . 0.0 114.031 174.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.4 142.84 42.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -109.8 144.03 38.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -122.12 117.35 51.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -164.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.4 148.87 42.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.399 1.88 . . . . 0.0 110.522 -167.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -96.12 118.97 33.77 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.573 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.62 124.83 22.9 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.806 0.843 . . . . 0.0 110.849 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.85 105.31 15.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.874 1.67 . . . . 0.0 107.923 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.7 176.93 49.42 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-O 122.623 1.124 . . . . 0.0 110.921 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.48 24.97 10.94 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.266 1.827 . . . . 0.0 107.046 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.55 105.84 15.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -52.42 -42.88 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.73 -47.06 86.98 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -57.14 -41.58 79.4 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.29 0.495 . . . . 0.0 110.898 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.45 -32.28 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.242 -0.911 . . . . 0.0 111.322 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.2 mt -67.95 -50.85 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 p -62.06 -42.96 99.73 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.937 0.789 . . . . 0.0 111.164 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.55 -43.31 99.09 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.956 0.502 . . . . 0.0 109.976 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 6' ' ' VAL . 55.8 t80 -65.46 -48.46 72.61 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -52.61 -36.41 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.789 1.235 . . . . 0.0 110.237 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.05 -12.39 58.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.395 1.078 . . . . 0.0 113.538 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.94 4.38 88.62 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.838 1.209 . . . . 0.0 112.719 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -27.09 63.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.271 1.028 . . . . 0.0 112.572 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.56 145.64 55.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.688 0.677 . . . . 0.0 110.497 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -78.98 151.8 31.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.989 0.916 . . . . 0.0 108.615 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -81.0 134.84 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.1 mt . . . . . 0 C--O 1.241 0.616 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.409 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.6 mm -127.63 154.98 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.346 1.458 . . . . 0.0 108.692 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 54.58 21.25 3.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.433 1.893 . . . . 0.0 113.457 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.52 134.18 35.2 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.747 -1.845 . . . . 0.0 108.763 -169.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -138.36 113.48 9.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.511 0.724 . . . . 0.0 109.298 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG21 ' CE2' ' A' ' 93' ' ' PHE . 27.5 t -120.44 144.61 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 102.45 13.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.798 1.239 . . . . 0.0 108.61 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mt -84.85 128.18 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 p -75.49 123.36 25.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 117.984 0.356 . . . . 0.0 111.001 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.7 mtp -123.19 154.71 38.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.254 1.022 . . . . 0.0 111.116 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -107.43 -61.57 1.54 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.716 2.006 . . . . 0.0 109.732 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.4 t -140.11 -76.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.38 14.32 8.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.031 0.933 . . . . 0.0 110.965 -169.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 21.3 ptmt -148.67 169.73 19.74 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.883 1.273 . . . . 0.0 108.649 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.17 131.39 28.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -67.35 159.09 30.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.577 0.751 . . . . 0.0 110.099 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -51.49 -36.02 42.74 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.698 0.799 . . . . 0.0 111.623 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -158.47 178.26 10.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.047 0.385 . . . . 0.0 111.377 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -73.15 -10.11 59.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.757 2.423 . . . . 0.0 111.817 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -107.87 -10.0 15.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.844 -1.16 . . . . 0.0 112.643 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -116.3 10.19 14.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.094 1.357 . . . . 0.0 110.415 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.9 p -70.13 164.47 24.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.716 -1.24 . . . . 0.0 110.038 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -119.95 -21.48 7.11 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.216 1.806 . . . . 0.0 109.898 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -158.88 176.42 12.35 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.956 0.884 . . . . 0.0 110.45 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -124.48 111.07 15.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.924 2.49 . . . . 0.0 106.212 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 39' ' ' LYS . 17.9 tp -79.04 110.7 14.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -84.47 93.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.17 148.07 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.31 1.844 . . . . 0.0 107.892 171.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -133.9 86.75 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -80.81 130.6 35.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.15 1.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.01 64.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 159.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t30 55.28 10.6 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.133 1.373 . . . . 0.0 114.41 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -138.29 150.37 46.58 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.48 1.912 . . . . 0.0 108.779 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.22 95.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 128.021 2.528 . . . . 0.0 108.374 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -88.77 -27.21 21.29 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.907 -1.121 . . . . 0.0 110.88 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.85 178.87 8.53 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.467 1.031 . . . . 0.0 109.704 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -140.27 178.48 7.26 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.508 1.523 . . . . 0.0 109.542 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.558 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -160.27 162.82 33.73 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.924 2.089 . . . . 0.0 107.036 177.096 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.22 142.4 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.2 mt -128.14 109.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 166.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -60.3 142.14 55.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.564 1.074 . . . . 0.0 110.609 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -77.94 65.57 3.39 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.873 1.669 . . . . 0.0 108.949 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.01 95.15 2.52 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 52.71 -69.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.348 3.059 . . . . 0.0 115.465 157.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -44.95 -33.35 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.574 1.95 . . . . 0.0 110.88 157.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.27 -67.22 2.28 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 124.019 0.819 . . . . 0.0 111.371 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.66 -27.12 66.59 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -52.85 -51.46 60.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.686 1.13 . . . . 0.0 110.634 163.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -70.67 -20.93 62.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.986 0.514 . . . . 0.0 112.079 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.18 -11.73 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.592 1.157 . . . . 0.0 111.035 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.77 -23.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 119.906 -1.746 . . . . 0.0 111.16 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -114.7 52.64 0.84 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.537 1.062 . . . . 0.0 110.155 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -168.07 2.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.69 32.76 4.08 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.13 1.772 . . . . 0.0 109.397 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.67 140.92 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.94 -37.39 12.26 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.827 1.251 . . . . 0.0 109.168 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.33 151.45 26.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.229 1.012 . . . . 0.0 111.476 -171.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.5 mt -98.48 151.96 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 165.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.7 mt -124.28 130.05 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 161.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.1 p -146.65 160.82 41.7 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.88 1.272 . . . . 0.0 109.689 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -66.66 -47.72 71.62 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 167.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -154.88 172.87 17.33 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.0 tt -167.26 121.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -169.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -56.49 146.71 23.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -48.98 -43.99 40.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.341 1.456 . . . . 0.0 111.348 -174.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.25 -49.72 66.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.646 -0.658 . . . . 0.0 112.118 177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -58.28 -41.28 84.01 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.704 1.202 . . . . 0.0 109.849 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -59.35 -63.27 1.36 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.408 1.083 . . . . 0.0 109.529 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HE3' ' HG3' ' A' ' 66' ' ' GLU . 36.9 mttt -62.38 -21.89 65.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.711 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -72.76 -60.45 2.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.133 0.973 . . . . 0.0 110.03 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -75.46 -10.46 59.47 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.0 p -63.58 -9.02 11.36 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -77.2 117.93 19.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 120.414 -1.429 . . . . 0.0 108.311 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? 75.4 -31.48 0.21 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.335 3.054 . . . . 0.0 112.47 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mt -103.67 120.13 53.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.4 153.98 31.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.98 116.74 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.316 -1.49 . . . . 0.0 107.111 -166.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 7.1 m-85 -113.17 160.64 18.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.534 1.933 . . . . 0.0 110.703 -168.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -99.46 130.89 45.76 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 0.0 110.617 -173.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 131.04 36.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.019 0.927 . . . . 0.0 109.526 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -110.26 15.64 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.421 1.488 . . . . 0.0 112.271 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.76 172.64 31.14 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 13.0 m-20 -83.61 -24.13 31.6 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.567 0.747 . . . . 0.0 109.673 151.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.1 106.86 4.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.1 0.56 . . . . 0.0 109.776 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.6 -46.93 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.147 0.979 . . . . 0.0 109.517 168.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.0 -58.3 9.03 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -45.09 -49.55 11.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.974 1.309 . . . . 0.0 110.853 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.69 -41.56 87.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.953 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.58 -48.15 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -15.03 63.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.47 ' CB ' HD11 ' A' ' 98' ' ' LEU . 44.4 mt -83.71 -38.84 20.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.371 1.442 . . . . 0.0 109.226 172.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.513 ' CE2' HG21 ' A' ' 6' ' ' VAL . 54.5 t80 -65.21 -41.42 94.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -169.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.14 -45.93 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.288 2.235 . . . . 0.0 110.728 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.31 -19.52 56.3 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.942 -1.099 . . . . 0.0 111.816 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.0 39.27 63.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -17.88 62.02 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.086 0.943 . . . . 0.0 109.054 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -89.54 124.92 34.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 m -72.67 153.72 41.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.617 169.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 9.3 mtpm? -61.19 144.06 54.4 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 C--O 1.236 0.385 0 C-N-CA 124.516 1.126 . . . . 0.0 108.275 168.156 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.5 142.66 41.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.986 0.914 . . . . 0.0 109.551 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 44.65 66.31 0.9 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.166 2.986 . . . . 0.0 113.267 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.3 ttt -107.15 147.82 29.6 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -133.66 129.22 36.53 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.9 t -132.54 144.84 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 118.314 -0.85 . . . . 0.0 108.707 168.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.35 77.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.384 1.073 . . . . 0.0 108.785 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.23 141.89 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 0.0 109.68 -165.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 p -74.46 115.73 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.71 0.631 . . . . 0.0 111.491 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.1 mtp -122.21 148.49 44.89 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.27 -0.894 . . . . 0.0 111.102 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.98 -75.34 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 109.54 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 t -144.12 -46.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.598 1.159 . . . . 0.0 107.925 -167.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.53 2.35 1.24 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.56 -179.9 8.51 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 126.858 2.063 . . . . 0.0 108.808 -176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.9 139.29 19.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.3 p -69.71 -84.52 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.704 1.602 . . . . 0.0 110.271 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 t30 177.0 -55.03 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 127.518 2.327 . . . . 0.0 107.304 -167.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.3 t -126.42 -175.15 3.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.931 1.242 . . . . 0.0 110.228 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -85.4 -43.3 13.76 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.3 1.44 . . . . 0.0 108.544 166.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.66 -19.43 60.84 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.028 -0.42 . . . . 0.0 110.414 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -119.96 74.32 1.02 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.0 p -134.27 165.16 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.212 1.805 . . . . 0.0 107.825 151.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -90.45 -37.43 13.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.352 0.661 . . . . 0.0 109.783 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.31 171.09 19.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.673 0.749 . . . . 0.0 110.456 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.04 108.8 16.19 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.091 2.556 . . . . 0.0 106.304 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 39' ' ' LYS . 1.3 tm? -78.72 103.71 8.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.456 HD11 HD12 ' A' ' 41' ' ' ILE . 5.3 mm -79.19 88.36 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.558 0.695 . . . . 0.0 109.192 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -58.24 125.88 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 168.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -103.53 110.09 22.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.26 143.65 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 161.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -136.05 -0.36 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.92 45.52 0.28 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.665 0.745 . . . . 0.0 110.136 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.6 -9.7 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.252 2.221 . . . . 0.0 115.318 -167.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.99 163.46 22.27 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.105 1.32 . . . . 0.0 111.648 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -44.51 128.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 128.375 2.67 . . . . 0.0 111.159 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -91.17 -86.92 0.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.52 -0.66 9.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.316 1.416 . . . . 0.0 113.904 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 p 49.61 -166.4 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.894 -1.129 . . . . 0.0 110.723 -160.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -174.44 166.35 3.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.488 2.315 . . . . 0.0 107.442 165.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.89 132.3 65.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.456 HD12 HD11 ' A' ' 27' ' ' ILE . 55.9 mt -127.84 119.54 51.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 168.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.32 157.96 35.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.533 1.06 . . . . 0.0 110.722 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -84.11 65.21 8.63 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.884 -1.135 . . . . 0.0 108.578 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -130.55 28.42 4.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.236 1.017 . . . . 0.0 113.717 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 70.9 -54.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 128.759 2.824 . . . . 0.0 111.231 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.8 t -53.68 -36.27 61.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.085 1.354 . . . . 0.0 110.583 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.59 8.53 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 125.243 1.402 . . . . 0.0 111.891 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.83 -34.7 69.98 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.97 -0.724 . . . . 0.0 110.959 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -49.74 -44.03 48.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.018 0.927 . . . . 0.0 111.438 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -43.7 85.51 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.345 0.658 . . . . 0.0 111.315 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.6 -37.85 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 110.258 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -54.61 -45.43 71.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.138 0.427 . . . . 0.0 110.626 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -34.84 66.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.12 -14.75 62.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.859 -159.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 44.96 63.63 1.66 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.556 1.542 . . . . 0.0 109.355 -172.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.21 140.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.223 157.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -73.61 -47.82 37.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.1 40.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.22 108.0 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.23 125.37 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -142.51 177.02 8.57 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.573 1.149 . . . . 0.0 108.925 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 81' ' ' ALA . 59.4 mttm -88.2 -38.45 15.29 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.273 -0.892 . . . . 0.0 110.972 166.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.65 162.79 35.04 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.495 1.043 . . . . 0.0 109.189 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 tt -165.56 132.72 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.257 1.423 . . . . 0.0 108.53 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.1 p -65.02 157.91 27.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.157 0.983 . . . . 0.0 112.162 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -50.8 -53.64 30.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.502 1.521 . . . . 0.0 110.635 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -38.5 79.31 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.42 0.628 . . . . 0.0 111.294 -166.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.96 -37.78 72.78 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.967 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -55.69 -57.01 13.78 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 120.045 1.293 . . . . 0.0 111.154 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -57.19 -43.51 82.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.774 0.716 . . . . 0.0 110.533 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -53.43 -69.36 0.12 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.648 1.579 . . . . 0.0 110.129 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -68.37 -36.69 79.57 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.346 0.521 . . . . 0.0 110.854 -169.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.2 t -54.14 -24.37 17.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.516 1.526 . . . . 0.0 112.908 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -65.2 -10.52 32.23 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.697 -1.252 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -156.16 3.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.932 1.696 . . . . 0.0 112.942 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -141.21 125.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.87 133.34 35.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.87 138.03 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 120.644 -1.285 . . . . 0.0 108.845 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -129.81 156.3 44.56 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.537 1.935 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -98.15 137.65 36.61 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.043 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . . . -88.49 122.92 32.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.274 2.23 . . . . 0.0 112.498 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.09 108.93 20.51 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.716 2.006 . . . . 0.0 109.939 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.48 -176.7 53.6 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -163.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -118.14 -2.21 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.918 0.887 . . . . 0.0 110.211 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.67 103.48 7.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.21 1.004 . . . . 0.0 108.475 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.45 -38.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.144 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.29 -40.97 86.15 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.878 0.763 . . . . 0.0 109.697 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -64.29 -43.04 96.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.875 -0.516 . . . . 0.0 110.727 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.18 -33.23 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.459 -1.401 . . . . 0.0 110.483 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.79 -51.68 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.548 1.539 . . . . 0.0 108.088 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 p -75.01 -18.75 60.31 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HB3' HD11 ' A' ' 98' ' ' LEU . 90.7 mt -74.83 -37.74 62.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 6' ' ' VAL . 80.2 t80 -67.79 -42.58 81.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.776 -0.577 . . . . 0.0 111.963 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 mt -51.86 -50.99 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.72 1.608 . . . . 0.0 108.377 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.8 -18.39 62.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.529 1.132 . . . . 0.0 113.978 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.65 23.11 54.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 118.85 0.75 . . . . 0.0 111.919 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -28.6 66.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.118 1.459 . . . . 0.0 109.32 -170.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 1.2 mm? -82.11 135.73 35.27 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.78 1.232 . . . . 0.0 108.899 -163.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.5 p -71.06 157.45 38.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.469 1.107 . . . . 0.0 108.842 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -87.87 132.86 34.04 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt . . . . . 0 C--O 1.236 0.36 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.674 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 CA--C 1.511 -0.556 0 CA-C-O 121.352 0.596 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.62 146.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.547 1.539 . . . . 0.0 108.601 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' A' ' 31' ' ' ASP . 1.8 m-80 47.51 32.92 2.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.423 1.889 . . . . 0.0 115.061 172.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.9 151.06 31.17 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.663 -1.273 . . . . 0.0 107.625 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 155.04 50.29 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 156.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 28' ' ' VAL . 7.3 p -146.68 165.74 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 128.097 2.559 . . . . 0.0 104.903 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 25' ' ' PHE . . . -114.45 133.6 55.63 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 120.178 1.353 . . . . 0.0 111.646 153.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mt -105.43 119.29 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -62.45 114.32 3.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.864 1.211 . . . . 0.0 108.715 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.7 mtp -117.98 156.31 28.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 110.906 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.31 -69.63 0.76 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 127.752 2.421 . . . . 0.0 108.27 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 t -137.71 -67.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 168.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.3 -7.24 11.78 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 171.48 13.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.505 1.522 . . . . 0.0 110.058 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -59.54 139.32 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 p -84.04 166.42 17.74 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.528 0.731 . . . . 0.0 111.076 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -50.47 -43.99 55.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.833 1.653 . . . . 0.0 113.934 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.08 168.36 19.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.409 0.549 . . . . 0.0 110.133 -166.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -67.72 -23.45 65.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.01 1.724 . . . . 0.0 112.499 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.79 -30.19 13.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.791 1.178 . . . . 0.0 111.54 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.74 10.12 8.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.221 1.408 . . . . 0.0 111.809 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.5 p -80.1 167.62 20.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 122.174 0.988 . . . . 0.0 110.631 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -108.12 -28.71 9.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.516 1.526 . . . . 0.0 109.217 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -159.36 178.35 10.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.603 0.638 . . . . 0.0 111.451 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.463 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 78.8 m-85 -125.49 105.64 9.2 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 129.24 3.016 . . . . 0.0 106.612 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.83 111.99 11.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 27.1 mm -81.24 98.32 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 6' ' ' VAL . 2.9 t -63.96 132.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.08 98.51 6.11 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 163.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.37 152.75 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HA ' ' H ' ' A' ' 3' ' ' ASN . 2.8 m-20 -138.41 -20.35 1.06 Allowed 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -161.31 68.59 0.31 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 169.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 54.9 10.62 0.4 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.301 2.241 . . . . 0.0 115.269 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -129.23 158.54 38.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.379 1.072 . . . . 0.0 112.503 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.49 96.13 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.709 1.604 . . . . 0.0 107.753 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -100.48 -20.21 15.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.202 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -156.78 148.89 23.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.248 1.385 . . . . 0.0 111.167 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 p -126.18 156.94 39.39 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.534 1.934 . . . . 0.0 109.427 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 162.26 37.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.729 1.211 . . . . 0.0 108.881 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.82 112.11 23.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.26 115.57 34.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 161.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -66.77 158.09 31.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.081 1.31 . . . . 0.0 110.524 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.22 81.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -130.3 -170.97 2.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.685 1.231 . . . . 0.0 108.739 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.51 -49.92 75.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.33 1.852 . . . . 0.0 111.061 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.3 m -65.46 -37.68 87.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.894 0.316 . . . . 0.0 110.776 175.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.48 -62.98 5.73 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 123.552 0.596 . . . . 0.0 112.795 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -59.67 -28.93 67.69 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.589 0.756 . . . . 0.0 111.219 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -71.35 -32.51 68.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.943 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -65.22 -38.22 89.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 119.257 0.935 . . . . 0.0 110.357 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -62.49 -17.31 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 118.753 0.706 . . . . 0.0 111.715 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.7 t -82.2 -30.18 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 119.51 -1.994 . . . . 0.0 112.205 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.83 54.84 1.13 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.544 1.138 . . . . 0.0 109.08 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 -165.14 1.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.854 1.662 . . . . 0.0 111.017 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.46 19.33 7.44 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.199 2.2 . . . . 0.0 108.94 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 58' ' ' ALA . 44.7 t -67.4 166.06 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.95 1.25 . . . . 0.0 109.944 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.72 -33.34 6.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 109.522 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.662 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -144.6 163.11 34.91 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -161.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.4 mt -134.14 118.34 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 163.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mt -81.08 133.35 29.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 120.488 1.494 . . . . 0.0 107.171 166.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 p -144.51 168.13 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.86 1.209 . . . . 0.0 112.251 168.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -93.4 -27.2 16.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 117.455 -1.259 . . . . 0.0 112.727 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -161.26 161.37 30.7 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.005 1.722 . . . . 0.0 107.061 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -151.46 127.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 126.403 1.881 . . . . 0.0 108.515 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -54.8 148.35 13.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.125 0.97 . . . . 0.0 110.442 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -61.6 -38.8 88.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.416 1.007 . . . . 0.0 111.524 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.21 -51.65 62.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -57.81 -43.13 85.47 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -56.41 -58.57 7.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.128 0.422 . . . . 0.0 110.145 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.46 -20.67 66.45 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 122.374 -0.204 . . . . 0.0 111.275 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -75.44 -35.74 60.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.18 -0.95 . . . . 0.0 111.941 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.09 -16.67 18.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.698 0.799 . . . . 0.0 111.812 -172.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.82 -17.45 56.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -71.99 106.99 4.48 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 120.566 -1.334 . . . . 0.0 109.611 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 tttm 73.95 21.28 2.66 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.143 1.777 . . . . 0.0 111.954 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.64 144.11 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.597 1.559 . . . . 0.0 107.742 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -102.59 108.8 20.21 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.42 114.83 30.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -105.92 149.15 26.85 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.685 1.194 . . . . 0.0 110.117 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -83.13 147.17 28.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.78 168.05 20.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 109.924 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.6 5.9 14.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.419 2.287 . . . . 0.0 112.366 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.96 -169.37 41.8 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.15 -14.17 34.14 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.539 1.135 . . . . 0.0 110.0 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.66 99.35 2.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.744 1.218 . . . . 0.0 109.659 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -52.97 -42.05 42.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.37 -38.49 71.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.116 0.871 . . . . 0.0 110.305 -171.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -57.14 -50.35 73.09 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.61 -31.74 65.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.1 -54.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.895 1.278 . . . . 0.0 108.053 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.579 ' HA ' HD12 ' A' ' 94' ' ' ILE . 35.6 p -66.82 -36.57 82.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.357 0.526 . . . . 0.0 111.184 -172.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.3 mt -63.93 -40.46 96.5 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.243 0.617 . . . . 0.0 111.171 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -63.85 -34.42 77.88 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.478 0.711 . . . . 0.0 112.223 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 91' ' ' SER . 58.4 mt -59.21 -45.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 -18.55 60.7 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.214 1.006 . . . . 0.0 112.135 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.73 14.17 81.4 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.468 -0.77 . . . . 0.0 112.217 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -19.9 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.631 1.973 . . . . 0.0 112.592 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -67.13 140.81 57.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.016 -1.052 . . . . 0.0 109.492 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.0 m -64.6 125.51 24.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.452 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -81.04 126.88 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--O 1.24 0.58 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.8 mt -122.06 148.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.47 23.21 10.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.998 1.719 . . . . 0.0 113.42 171.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpp -68.57 147.06 52.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -134.34 141.09 46.78 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 166.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 93' ' ' PHE . 44.9 t -140.24 140.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 110.02 21.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.493 0.717 . . . . 0.0 109.436 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.7 mt -95.07 123.96 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 p -80.91 112.19 18.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtp -108.87 158.12 17.97 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -108.08 -53.13 2.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 127.738 2.415 . . . . 0.0 109.143 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.26 -79.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.41 -3.37 16.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.134 0.974 . . . . 0.0 112.003 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 171.23 16.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.304 1.842 . . . . 0.0 110.955 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.5 mt -64.98 124.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.738 1.615 . . . . 0.0 107.3 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 t -66.55 173.1 3.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.155 0.889 . . . . 0.0 111.229 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.67 -27.75 67.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.53 0.732 . . . . 0.0 111.749 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 p -147.69 177.2 9.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.69 -0.631 . . . . 0.0 110.373 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -69.26 -37.28 77.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.511 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -88.48 -39.24 14.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.481 0.713 . . . . 0.0 109.629 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.27 31.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.648 2.379 . . . . 0.0 111.276 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 p -99.28 172.53 7.29 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 119.968 -1.707 . . . . 0.0 111.096 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -103.59 -30.05 10.73 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.592 1.557 . . . . 0.0 110.065 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.427 ' HE2' HD23 ' A' ' 26' ' ' LEU . 41.2 p90 -166.82 176.94 6.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CG ' HD11 ' A' ' 51' ' ' ILE . 41.9 m-85 -123.7 102.55 7.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 126.409 1.884 . . . . 0.0 107.29 -169.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.427 HD23 ' HE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -81.84 103.32 11.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.87 95.42 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.349 1.86 . . . . 0.0 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 t -76.2 92.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.83 115.99 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 156.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.59 131.89 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.06 3.03 3.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.55 44.33 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 111.545 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 t30 61.55 8.16 2.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.007 0.923 . . . . 0.0 112.577 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -134.18 165.41 25.15 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 126.967 2.107 . . . . 0.0 111.212 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -61.82 128.73 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 127.068 2.147 . . . . 0.0 109.614 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.15 -85.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.757 -0.639 . . . . 0.0 109.7 167.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -15.19 14.45 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 44.84 -168.34 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.373 1.069 . . . . 0.0 112.11 -163.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 163.43 8.57 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 125.164 1.385 . . . . 0.0 109.784 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.669 0.7 OUTLIER -118.91 140.16 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 119.456 3.132 . . . . 0.0 119.456 159.284 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.7 mt -124.56 122.93 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 129.261 3.024 . . . . 0.0 105.175 164.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -68.01 155.57 39.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.365 1.893 . . . . 0.0 111.057 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 45.0 t30 -77.31 61.79 2.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.52 1.528 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -97.38 161.92 13.57 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 165.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -44.04 93.35 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.113 -0.992 . . . . 0.0 108.324 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -70.4 -16.23 62.93 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.962 -1.086 . . . . 0.0 111.293 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -64.03 2.89 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 166.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 25' ' ' PHE 0.253 43.3 pttt -65.87 -23.37 66.64 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.76 -0.847 . . . . 0.0 111.977 -172.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -38.57 83.92 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 171.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -72.86 -32.08 65.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.925 1.29 . . . . 0.0 110.172 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.434 HD11 ' CG ' ' A' ' 25' ' ' PHE . 58.8 mt -55.07 -42.97 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.78 1.232 . . . . 0.0 109.761 176.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.12 -26.36 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.406 -0.809 . . . . 0.0 111.667 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -97.7 -28.22 14.0 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.865 0.866 . . . . 0.0 110.97 -172.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -25.52 63.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.695 1.198 . . . . 0.0 111.884 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.2 t30 74.2 51.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.406 2.282 . . . . 0.0 109.958 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -50.82 152.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.868 1.667 . . . . 0.0 109.324 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -42.97 10.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.091 1.357 . . . . 0.0 109.175 171.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.24 160.12 42.72 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.3 mt -116.42 144.0 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.685 1.194 . . . . 0.0 107.962 171.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.8 mt -123.04 121.28 62.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.0 p -149.3 170.81 17.64 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.773 1.229 . . . . 0.0 109.345 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -82.66 -40.04 21.25 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.104 167.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -147.64 164.42 33.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.502 1.501 . . . . 0.0 109.61 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.5 tt -144.77 145.38 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.406 1.482 . . . . 0.0 109.095 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -62.49 155.47 25.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.197 0.908 . . . . 0.0 109.562 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.04 -43.37 87.75 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 118.824 0.738 . . . . 0.0 109.04 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.39 -45.24 94.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 110.666 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -61.79 -47.94 82.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.783 1.233 . . . . 0.0 109.263 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.56 -58.94 5.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.724 1.147 . . . . 0.0 110.541 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.51 -22.39 66.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.581 0.628 . . . . 0.0 111.892 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -76.66 -44.04 35.51 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 120.829 -1.169 . . . . 0.0 110.885 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -88.04 -8.28 55.8 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.148 0.979 . . . . 0.0 112.753 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 p -73.26 43.14 0.13 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.835 1.652 . . . . 0.0 112.551 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -139.91 111.84 7.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.412 1.885 . . . . 0.0 106.662 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? 60.81 -1.22 0.25 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 113.948 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.5 mt -131.27 134.25 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -169.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.56 130.49 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.499 1.52 . . . . 0.0 107.034 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.5 mt -104.17 118.5 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -110.29 155.38 22.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.237 1.815 . . . . 0.0 110.821 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -99.06 118.1 35.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.798 1.239 . . . . 0.0 110.348 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.95 135.15 57.7 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 168.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -16.24 55.98 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.291 1.036 . . . . 0.0 112.722 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.89 -178.73 46.87 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 126.11 1.814 . . . . 0.0 109.078 -149.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -96.48 -15.35 21.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.097 0.959 . . . . 0.0 110.042 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.41 99.81 2.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.45 1.5 . . . . 0.0 110.014 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.57 -41.79 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.27 -39.28 89.31 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.8 0.727 . . . . 0.0 110.997 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -46.23 90.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.519 0.676 . . . . 0.0 109.517 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -74.17 -26.22 60.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.0 mt -67.19 -51.26 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.006 0.821 . . . . 0.0 108.797 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.8 p -71.38 -33.05 69.17 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.429 0.558 . . . . 0.0 111.503 -173.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -42.68 95.88 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.69 -0.631 . . . . 0.0 110.268 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 6' ' ' VAL . 31.7 t80 -57.89 -47.56 82.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.781 0.433 . . . . 0.0 111.872 -177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 mt -51.03 -56.49 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.168 1.387 . . . . 0.0 111.119 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -73.43 -1.93 20.32 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.055 1.298 . . . . 0.0 113.573 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.61 86.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.263 0.935 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -27.56 67.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.077 1.751 . . . . 0.0 112.146 -173.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.22 144.42 57.15 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.46 139.39 49.61 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.33 -0.857 . . . . 0.0 110.188 172.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.92 123.0 30.76 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 C--O 1.239 0.536 0 C-N-CA 124.475 1.11 . . . . 0.0 109.752 -175.167 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 31' ' ' ASP . 13.2 mt -146.8 46.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.352 0.596 . . . . 0.0 112.097 -173.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 t30 173.54 42.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.846 2.059 . . . . 0.0 107.509 163.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 146.79 32.94 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 120.598 -1.314 . . . . 0.0 108.127 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -145.85 120.41 9.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.892 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.9 152.98 25.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 109.613 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.75 120.62 40.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.653 1.181 . . . . 0.0 108.359 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.15 118.9 54.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -63.2 105.41 0.71 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.757 0.823 . . . . 0.0 109.636 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.15 155.85 22.26 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -93.71 -76.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.603 1.961 . . . . 0.0 107.393 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -139.61 -56.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 1.26 3.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -160.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -156.6 173.79 16.41 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.252 2.221 . . . . 0.0 108.519 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.31 139.31 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.788 0.68 . . . . 0.0 111.147 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 163.48 21.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 111.308 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.83 -16.82 60.02 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -166.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.46 172.63 17.92 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.672 1.989 . . . . 0.0 107.335 170.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.18 -50.54 73.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.34 1.056 . . . . 0.0 108.768 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -74.5 -44.49 51.13 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -165.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.9 4.15 0.91 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 128.55 2.74 . . . . 0.0 113.641 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 p -67.57 165.92 15.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 123.057 1.408 . . . . 0.0 110.742 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -106.58 -30.75 8.84 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.919 1.687 . . . . 0.0 108.688 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 28.2 p90 -155.35 164.94 38.07 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.158 0.98 . . . . 0.0 109.834 172.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.55 112.48 25.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.04 114.01 14.2 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HB ' ' CB ' ' A' ' 39' ' ' LYS . 5.0 mm -84.04 93.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.08 101.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -91.72 121.6 33.51 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -125.75 115.69 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 2' ' ' ILE . 5.1 m-20 -126.63 -0.64 6.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.387 -169.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.09 61.24 0.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.135 0.969 . . . . 0.0 110.433 156.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 t30 58.63 6.89 0.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.238 1.815 . . . . 0.0 114.679 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.18 163.29 23.48 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.1 2.56 . . . . 0.0 109.378 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.91 74.96 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 122.408 1.099 . . . . 0.0 108.101 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -57.37 -29.58 64.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.909 1.684 . . . . 0.0 112.118 -170.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 m -154.82 115.26 3.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.401 1.0 . . . . 0.0 108.845 164.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -64.02 141.62 58.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 161.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -143.09 161.2 38.8 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 124.53 1.132 . . . . 0.0 109.274 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.474 0.6 OUTLIER -142.53 132.44 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 178.602 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.488 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 66.0 mt -119.59 113.13 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -65.46 152.07 44.84 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.773 0.715 . . . . 0.0 109.439 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -75.57 87.38 2.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.57 174.99 10.0 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.57 2.748 . . . . 0.0 105.038 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -62.13 -38.64 89.71 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.487 -1.383 . . . . 0.0 111.567 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 t -61.43 -18.56 59.43 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.697 -0.627 . . . . 0.0 111.316 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.488 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -75.23 -61.09 3.1 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -66.91 -15.4 63.64 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.368 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -60.98 -64.57 0.91 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.837 1.199 . . . . 0.0 109.639 161.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.3 m -54.13 -37.73 64.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.991 0.916 . . . . 0.0 113.344 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.4 mt -50.74 -40.4 19.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.075 1.35 . . . . 0.0 111.608 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.48 -46.88 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.082 -1.012 . . . . 0.0 109.063 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -73.66 -21.77 60.17 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.833 0.853 . . . . 0.0 112.978 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.81 -26.65 63.41 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.346 -0.847 . . . . 0.0 111.094 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 74.25 38.33 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.849 1.66 . . . . 0.0 112.536 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.44 138.13 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.558 1.143 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -66.48 -56.68 9.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.019 1.728 . . . . 0.0 108.74 168.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.82 29.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -169.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.56 148.44 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.5 mt -119.41 123.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.35 2.26 . . . . 0.0 104.978 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.76 154.33 31.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.803 1.638 . . . . 0.0 111.141 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -71.94 -25.9 62.07 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.34 -0.85 . . . . 0.0 111.124 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -172.23 166.15 5.96 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.84 132.84 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.017 0.436 . . . . 0.0 110.285 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.42 147.25 32.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.528 0.731 . . . . 0.0 109.622 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -48.71 79.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.343 1.057 . . . . 0.0 110.506 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -56.67 -47.97 78.64 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -64.51 -44.94 89.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.724 1.21 . . . . 0.0 110.424 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -54.9 -64.88 0.7 Allowed 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 118.682 0.674 . . . . 0.0 109.552 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -57.02 -33.15 66.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.771 0.828 . . . . 0.0 111.518 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -71.33 -34.34 70.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.56 1.944 . . . . 0.0 113.457 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -99.26 -23.39 15.21 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.706 0.685 . . . . 0.0 112.541 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -68.68 15.24 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -166.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -19.04 13.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.754 1.161 . . . . 0.0 113.151 -174.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -34.78 0.48 Allowed 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.188 -0.945 . . . . 0.0 113.188 175.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.6 mt -89.53 127.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.95 145.44 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.132 0.973 . . . . 0.0 108.66 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -113.67 122.67 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 120.377 -1.452 . . . . 0.0 107.748 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -105.81 156.07 18.68 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.43 1.892 . . . . 0.0 108.257 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -68.06 177.19 2.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.283 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.75 149.54 48.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.959 1.303 . . . . 0.0 110.45 165.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.421 ' OE1' HD22 ' A' ' 98' ' ' LEU 0.254 19.6 mp0 -106.22 -162.35 0.85 Allowed 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 129.09 2.956 . . . . 0.0 106.097 -165.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.3 166.88 0.04 OUTLIER Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.043 -1.035 . . . . 0.0 114.272 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -23.3 19.53 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.185 1.794 . . . . 0.0 113.555 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . 2.4 t0 -72.13 101.83 2.87 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 125.083 1.489 . . . . 0.0 107.645 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -53.55 -39.89 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -39.7 82.38 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -174.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 1.4 tppp? -59.3 -45.58 90.9 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.24 -0.912 . . . . 0.0 109.339 170.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.93 -38.8 89.6 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.453 1.024 . . . . 0.0 111.046 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.07 -49.45 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 108.522 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 p -65.98 -36.89 84.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.813 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.4 mt -61.67 -44.44 96.96 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.709 0.686 . . . . 0.0 109.22 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -57.78 -57.25 13.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.288 0.635 . . . . 0.0 110.91 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.6 mt -51.82 -34.42 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.496 1.919 . . . . 0.0 111.183 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -84.96 -14.86 46.22 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 24.61 54.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 119.509 1.05 . . . . 0.0 112.395 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -24.54 36.19 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.793 1.237 . . . . 0.0 112.54 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD22 ' OE1' ' A' ' 82' ' ' GLU . 29.3 mt -73.18 142.92 47.39 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.274 1.035 . . . . 0.0 110.402 -171.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 133.27 34.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 110.819 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -72.07 142.76 49.24 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 C--O 1.239 0.51 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.544 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 4' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.01 147.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.793 172.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.58 56.89 1.93 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.341 2.656 . . . . 0.0 112.162 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.426 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 25.1 tpp -83.78 149.33 26.5 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.907 0.776 . . . . 0.0 109.928 170.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -142.56 132.95 24.93 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.232 0.958 . . . . 0.0 108.491 153.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 28' ' ' VAL . 4.9 p -128.93 166.14 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 128.523 2.729 . . . . 0.0 107.439 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.64 110.47 13.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.37 1.468 . . . . 0.0 109.74 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -94.72 122.65 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.242 0.928 . . . . 0.0 108.932 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 p -72.11 97.45 1.93 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.128 1.371 . . . . 0.0 109.95 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.0 mtp -102.98 154.73 18.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.27 1.028 . . . . 0.0 110.6 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.79 -61.08 1.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.2 t -141.7 -71.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.77 10.72 7.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.8 1.286 . . . . 0.0 112.944 -167.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 175.54 12.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.811 2.444 . . . . 0.0 108.948 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.42 140.72 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.763 1.225 . . . . 0.0 108.456 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 t -73.61 -87.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -178.48 -36.45 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.795 1.638 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.27 154.32 36.56 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.336 0.588 . . . . 0.0 110.332 -177.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.48 -48.32 82.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.766 0.826 . . . . 0.0 110.047 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -78.17 -6.41 54.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.395 0.678 . . . . 0.0 112.804 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.16 -16.71 14.03 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.08 0.854 . . . . 0.0 111.063 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.0 p -72.62 170.65 14.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 122.154 0.978 . . . . 0.0 111.755 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -106.09 -26.32 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.881 1.272 . . . . 0.0 110.331 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -161.22 166.49 27.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.518 0.675 . . . . 0.0 110.364 170.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CD2' HD11 ' A' ' 51' ' ' ILE . 91.1 m-85 -105.36 116.41 31.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.423 1.489 . . . . 0.0 108.044 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.61 118.44 20.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 170.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -92.0 95.11 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.394 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.562 ' HB ' HG12 ' A' ' 6' ' ' VAL . 1.9 t -78.33 104.09 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.82 140.8 36.69 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 156.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 145.19 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 164.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.19 18.64 0.36 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.98 52.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 128.506 2.722 . . . . 0.0 107.263 169.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.75 2.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 129.288 3.035 . . . . 0.0 113.694 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.16 150.84 40.67 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 128.203 2.601 . . . . 0.0 107.876 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.3 91.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.042 2.137 . . . . 0.0 109.884 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -53.55 -70.16 0.1 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 110.979 174.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -151.79 112.71 4.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -69.26 164.17 23.37 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.23 1.412 . . . . 0.0 110.452 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 164.79 30.18 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 125.944 1.698 . . . . 0.0 108.534 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.54 148.23 26.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mt -134.33 105.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 166.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -57.34 145.46 32.26 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.61 97.95 0.34 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.406 1.882 . . . . 0.0 106.096 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -51.26 67.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.068 0.947 . . . . 0.0 109.339 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 t -68.45 -26.54 65.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.968 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -63.58 4.97 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -65.39 -22.61 66.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.461 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -68.96 -47.42 65.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.222 1.374 . . . . 0.0 109.039 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -44.6 73.16 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 110.102 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 25' ' ' PHE . 58.1 mt -52.59 -35.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.648 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.21 -40.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 120.586 -1.321 . . . . 0.0 110.649 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.2 -8.75 44.57 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.346 0.658 . . . . 0.0 111.854 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.3 -16.37 33.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.538 1.535 . . . . 0.0 111.226 166.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 53.29 36.47 22.83 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.985 1.714 . . . . 0.0 111.031 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.13 134.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -73.05 -39.63 65.75 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.422 1.889 . . . . 0.0 110.519 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.58 165.47 26.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mt -131.45 132.5 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.068 1.347 . . . . 0.0 107.5 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -104.12 130.97 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -146.46 175.83 10.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.649 0.659 . . . . 0.0 111.32 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -96.9 -24.27 15.93 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.099 1.36 . . . . 0.0 111.47 164.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -155.74 161.33 40.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.075 1.75 . . . . 0.0 108.311 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.82 130.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.833 1.653 . . . . 0.0 108.643 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -63.41 147.1 52.14 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.417 1.087 . . . . 0.0 110.489 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -55.29 -45.17 76.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.247 2.219 . . . . 0.0 111.998 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.37 -50.95 63.62 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.721 -0.612 . . . . 0.0 109.743 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -62.51 -39.13 92.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.75 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -51.53 -56.61 12.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.396 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -61.6 -43.26 99.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.198 0.599 . . . . 0.0 110.45 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -59.35 -40.91 87.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.19 1.396 . . . . 0.0 112.783 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -92.39 -34.66 14.07 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.259 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 t -70.56 16.33 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.144 1.778 . . . . 0.0 114.185 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -100.64 -17.26 17.11 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.977 1.711 . . . . 0.0 113.031 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -145.22 -6.57 0.64 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.838 0.855 . . . . 0.0 112.776 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.7 mt -136.19 133.5 50.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -165.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.72 113.34 22.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.586 1.554 . . . . 0.0 108.307 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.05 130.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 100' ' ' LYS . 88.1 m-85 -126.45 146.62 50.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.759 1.224 . . . . 0.0 109.799 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -95.62 119.53 34.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.539 1.135 . . . . 0.0 109.332 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.43 119.72 10.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.69 -12.6 61.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.66 172.34 44.14 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -166.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.2 -5.14 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.883 0.873 . . . . 0.0 109.812 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.51 102.71 8.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.493 1.917 . . . . 0.0 107.386 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -52.44 -40.31 32.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.23 -45.7 72.55 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 118.36 0.527 . . . . 0.0 110.393 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -57.7 -37.18 73.04 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.943 0.497 . . . . 0.0 110.764 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -77.46 -22.6 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.232 -0.918 . . . . 0.0 112.191 -176.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.2 mt -70.87 -50.78 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 p -61.65 -48.21 81.89 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.685 0.675 . . . . 0.0 111.035 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.2 mt -56.51 -47.02 80.23 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.24 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.1 -44.9 87.89 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.759 0.823 . . . . 0.0 112.426 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.96 -41.09 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.55 -13.22 59.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.055 0.843 . . . . 0.0 112.638 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.51 -1.29 61.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.535 1.064 . . . . 0.0 113.758 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -12.48 61.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.386 2.274 . . . . 0.0 115.461 -171.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.77 143.15 57.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.823 1.647 . . . . 0.0 108.25 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -72.34 142.14 48.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 7.3 mtpt -80.17 150.98 29.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.322 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 mm -116.63 138.52 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 t30 45.42 63.99 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.302 1.041 . . . . 0.0 112.01 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpp -94.47 151.97 18.94 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -141.53 138.55 32.82 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 167.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG21 ' CE2' ' A' ' 93' ' ' PHE . 36.1 t -133.47 148.33 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB3' HG12 ' A' ' 59' ' ' ILE . . . -105.87 105.1 14.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.662 0.785 . . . . 0.0 108.981 168.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.73 117.73 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.2 p -73.55 111.16 8.42 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mmm -113.86 161.28 17.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 110.094 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.23 -73.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.951 1.3 . . . . 0.0 108.06 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.26 -45.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -135.58 -13.7 1.97 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.2 174.39 12.03 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.31 1.444 . . . . 0.0 107.901 -171.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mt -54.48 139.46 13.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.162 0.982 . . . . 0.0 108.524 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 p -68.33 163.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.485 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -71.58 -31.15 66.65 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.83 -0.544 . . . . 0.0 111.586 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.88 158.67 33.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.383 0.992 . . . . 0.0 109.859 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 59' ' ' ILE . 65.1 t80 -66.05 -39.72 90.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -78.74 1.27 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.16 1.17 8.5 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.846 0.859 . . . . 0.0 111.394 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 p -67.79 169.7 9.23 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.928 -1.107 . . . . 0.0 111.201 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -110.75 -25.7 9.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.124 1.37 . . . . 0.0 109.078 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 40' ' ' VAL . 22.8 p90 -158.3 170.83 21.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.03 0.919 . . . . 0.0 111.488 174.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -114.44 102.42 10.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.073 2.549 . . . . 0.0 106.259 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -77.79 97.65 5.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.4 mm -68.91 124.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.929 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.05 126.96 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 126.395 1.878 . . . . 0.0 105.934 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.68 97.51 6.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 165.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.81 149.55 5.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 163.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.23 133.77 10.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.648 1.179 . . . . 0.0 109.03 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t0 46.44 44.93 13.47 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.892 1.805 . . . . 0.0 110.945 -167.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 t30 70.17 -13.8 0.42 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.686 3.195 . . . . 0.0 114.825 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.94 165.88 11.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.473 1.909 . . . . 0.0 110.091 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.2 129.47 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.786 -1.197 . . . . 0.0 111.616 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -100.02 -44.66 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 t -165.33 166.46 18.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.8 161.96 26.19 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.931 1.693 . . . . 0.0 108.039 -172.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.12 31.66 Favored 'General case' 0 C--O 1.19 -2.033 0 O-C-N 120.139 -1.601 . . . . 0.0 109.65 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 24' ' ' TYR 0.462 1.4 p -107.98 124.95 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 160.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -108.09 112.84 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.635 2.774 . . . . 0.0 103.747 165.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -59.4 154.59 16.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.824 1.193 . . . . 0.0 110.156 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -81.3 85.93 6.33 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -152.81 175.55 12.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.286 1.035 . . . . 0.0 109.129 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -52.61 -52.17 56.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.059 1.344 . . . . 0.0 110.509 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -5.78 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.762 0.425 . . . . 0.0 110.914 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.6 -69.76 1.38 Allowed Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -55.74 -29.05 58.9 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.513 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -34.92 63.85 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 120.16 1.345 . . . . 0.0 111.072 176.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -87.58 -24.16 24.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 116.582 -1.675 . . . . 0.0 113.034 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 54' ' ' GLU . 62.2 mt -63.53 -30.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 121.357 1.89 . . . . 0.0 109.364 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.26 -3.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 119.82 -1.8 . . . . 0.0 111.314 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -110.53 21.99 15.97 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.114 -0.991 . . . . 0.0 109.517 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.55 ' CG ' ' HA ' ' A' ' 51' ' ' ILE . 8.1 pt-20 -138.63 144.67 39.83 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.969 -2.332 . . . . 0.0 111.215 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.85 62.51 7.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 109.409 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.01 134.88 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.63 -48.5 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.02 156.7 43.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 7' ' ' ALA . 94.4 mt -110.57 136.99 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 166.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.35 124.37 65.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.88 167.62 23.47 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -80.02 -32.51 39.58 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.381 -0.824 . . . . 0.0 112.01 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -155.98 173.76 16.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.458 1.026 . . . . 0.0 109.611 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.3 tt -165.14 154.67 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.802 1.241 . . . . 0.0 108.418 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -81.22 153.12 27.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.871 0.869 . . . . 0.0 112.128 169.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.56 -51.51 65.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.613 1.965 . . . . 0.0 110.929 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.61 -39.89 88.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -41.61 87.83 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.739 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -51.76 -63.79 1.02 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.83 -24.43 67.54 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.96 -0.462 . . . . 0.0 111.705 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -76.83 -36.11 57.09 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -98.52 -24.04 15.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.078 1.308 . . . . 0.0 112.062 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -71.86 9.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.622 1.969 . . . . 0.0 113.028 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -80.72 -0.13 37.06 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.965 -1.084 . . . . 0.0 113.517 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -165.63 -64.15 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.779 0.832 . . . . 0.0 109.858 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.91 144.67 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.953 . . . . 0.0 107.82 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -113.17 126.33 55.32 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 125.101 1.361 . . . . 0.0 109.477 -169.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.63 131.48 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 120.105 -1.622 . . . . 0.0 109.483 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 50.6 m-85 -116.04 150.63 36.96 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.76 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -80.14 135.82 36.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.99 128.1 34.35 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -24.82 43.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.725 0.774 . . . . 0.0 112.294 -174.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.52 161.53 28.9 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 127.308 2.385 . . . . 0.0 107.519 -159.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.54 -9.79 59.68 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.621 1.168 . . . . 0.0 110.343 -167.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.56 98.84 2.39 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.211 1.404 . . . . 0.0 108.686 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 t -51.36 -40.83 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 121.759 -0.588 . . . . 0.0 110.356 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -40.35 87.22 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.664 0.385 . . . . 0.0 110.4 -171.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -42.65 95.92 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.343 0.592 . . . . 0.0 110.783 171.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.809 -0.557 . . . . 0.0 110.661 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.22 -50.25 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.302 1.041 . . . . 0.0 108.781 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 p -64.21 -35.27 80.27 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.756 0.707 . . . . 0.0 111.475 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -66.14 -37.34 85.44 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.263 -0.898 . . . . 0.0 111.091 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 6' ' ' VAL . 71.6 t80 -67.72 -44.04 78.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.183 0.593 . . . . 0.0 111.865 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.9 -41.26 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.266 1.027 . . . . 0.0 109.862 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -79.67 -30.83 41.31 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.48 4.38 52.79 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.021 -0.877 . . . . 0.0 113.985 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -39.22 81.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.228 1.411 . . . . 0.0 111.513 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.57 131.98 50.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.188 0.595 . . . . 0.0 110.722 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.32 156.97 30.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.57 1.176 . . . . 0.0 110.632 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 61.9 mtpt -82.58 156.32 24.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.651 171.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.595 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' HIS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 74.8 m80 57.54 176.26 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.56 1.544 . . . . 0.0 114.011 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -160.56 147.43 15.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.688 1.195 . . . . 0.0 107.877 171.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -131.07 138.09 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 65.25 52.02 1.52 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.442 2.297 . . . . 0.0 113.254 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 ttt -82.87 154.53 24.58 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.245 168.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 15.6 mtpp -147.73 121.8 9.48 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.467 HG21 ' CE2' ' A' ' 93' ' ' PHE . 40.7 t -125.62 156.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.595 1.089 . . . . 0.0 108.902 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.47 118.1 35.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.543 1.137 . . . . 0.0 108.25 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.37 129.43 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.6 p -79.49 104.79 10.34 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.985 1.314 . . . . 0.0 109.576 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.92 151.74 22.11 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.174 -0.954 . . . . 0.0 111.011 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.36 -85.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.42 -39.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 O-C-N 119.883 -1.76 . . . . 0.0 108.238 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.74 3.35 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 -178.63 5.91 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.584 -1.323 . . . . 0.0 110.371 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.2 mt -53.58 127.52 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.746 1.619 . . . . 0.0 109.807 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.1 p -72.41 161.42 30.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.981 0.912 . . . . 0.0 110.248 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.93 -41.24 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -157.46 161.07 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -58.2 -42.58 86.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.353 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -15.33 57.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.052 1.741 . . . . 0.0 113.179 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.12 10.03 8.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.924 0.89 . . . . 0.0 112.734 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 p -64.9 160.71 19.94 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.652 -1.28 . . . . 0.0 109.616 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -107.55 -29.85 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.227 1.411 . . . . 0.0 107.886 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -153.55 167.0 30.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.755 0.788 . . . . 0.0 109.821 167.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -104.58 126.58 51.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.704 2.002 . . . . 0.0 108.063 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.13 113.89 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 166.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -83.32 105.03 12.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.96 141.91 14.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -117.12 123.45 46.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.046 1.739 . . . . 0.0 106.523 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 mt -124.02 136.4 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -136.03 -6.72 2.1 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.036 -173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.08 67.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' -1' ' ' HIS . 0.9 OUTLIER 55.22 5.34 0.11 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.889 2.076 . . . . 0.0 115.201 -175.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -134.2 152.62 51.91 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.366 1.466 . . . . 0.0 109.231 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.16 108.13 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.42 1.888 . . . . 0.0 109.393 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -96.62 -6.11 37.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.665 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 p -170.83 179.55 3.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.299 1.409 . . . . 0.0 111.069 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -147.93 168.48 22.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.402 1.081 . . . . 0.0 111.002 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.68 153.98 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 109.559 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.79 115.91 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.85 109.51 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -59.54 155.9 14.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.718 1.144 . . . . 0.0 109.92 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.07 65.93 0.89 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.222 0.609 . . . . 0.0 112.225 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -136.43 81.53 1.89 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.1 -72.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.403 1.881 . . . . 0.0 113.713 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -56.21 -25.93 49.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.234 1.813 . . . . 0.0 111.063 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -61.57 7.0 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 125.198 1.38 . . . . 0.0 111.813 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -58.0 -36.48 72.72 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.144 0.978 . . . . 0.0 110.87 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -52.3 -47.31 66.0 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 111.006 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.6 m -63.09 -37.93 89.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.252 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.9 mt -52.54 -38.16 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.485 1.114 . . . . 0.0 110.202 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -59.72 -48.94 85.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.54 -0.725 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -82.09 -14.14 56.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.39 1.076 . . . . 0.0 112.442 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 28.5 mm-40 -64.28 -23.14 67.19 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.775 1.17 . . . . 0.0 111.206 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 55.4 54.97 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.437 1.095 . . . . 0.0 109.681 -170.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.66 147.61 8.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.917 0.887 . . . . 0.0 109.286 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -78.53 -48.18 15.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.502 1.921 . . . . 0.0 110.099 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.43 158.48 41.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.199 0.6 . . . . 0.0 112.289 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.1 mt -110.77 147.02 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.98 135.59 60.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.2 p -155.47 161.21 41.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.655 1.182 . . . . 0.0 109.691 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -73.29 -36.42 66.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.241 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.71 165.97 33.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.257 1.39 . . . . 0.0 109.098 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 tt -140.28 153.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 107.845 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.2 p -77.1 150.86 35.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.584 0.353 . . . . 0.0 110.45 163.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -58.55 -45.11 89.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.771 0.828 . . . . 0.0 110.257 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.98 -50.43 72.13 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.924 -0.485 . . . . 0.0 111.171 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.24 -35.99 81.85 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.747 0.419 . . . . 0.0 109.984 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -54.65 -54.69 38.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.396 0.543 . . . . 0.0 110.215 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -58.39 -26.3 63.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 111.659 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -71.46 -62.15 1.51 Allowed 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.014 0.824 . . . . 0.0 110.205 171.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -77.27 -25.96 51.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.779 -164.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -73.53 30.77 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.735 2.014 . . . . 0.0 112.621 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.84 13.7 13.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.449 1.9 . . . . 0.0 111.575 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 mttt 179.11 -11.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.012 2.125 . . . . 0.0 113.172 164.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -116.39 128.98 73.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -77.42 121.84 24.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.537 1.135 . . . . 0.0 108.44 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.5 mt -100.08 127.39 53.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -118.32 154.61 32.05 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.254 1.422 . . . . 0.0 110.252 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.39 135.47 33.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.415 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.36 151.76 46.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 160.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -125.77 24.03 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.778 2.431 . . . . 0.0 109.428 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.09 -169.84 42.29 Favored Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.837 -1.164 . . . . 0.0 112.325 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.97 -21.55 9.45 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.961 2.105 . . . . 0.0 108.335 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.07 104.25 6.51 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.8 -40.64 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.81 -35.83 70.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.986 0.812 . . . . 0.0 110.265 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -61.17 -39.76 91.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.371 -0.831 . . . . 0.0 110.642 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -73.92 -27.28 60.95 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.179 -0.95 . . . . 0.0 111.276 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.65 -52.09 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p -58.64 -44.58 90.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 111.241 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.6 mt -61.92 -37.66 85.48 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.644 -0.66 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' HG21 ' A' ' 6' ' ' VAL . 77.1 t80 -70.1 -39.48 75.51 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.536 -0.728 . . . . 0.0 111.842 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.33 -44.2 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.648 1.179 . . . . 0.0 109.226 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.06 -16.03 45.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 19.92 63.73 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.009 0.822 . . . . 0.0 112.41 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.28 -22.56 60.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 111.916 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.52 137.7 54.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.86 0.754 . . . . 0.0 110.224 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.4 m -69.27 126.36 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.543 1.537 . . . . 0.0 111.809 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -74.7 119.21 18.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.672 1.189 . . . . 0.0 108.632 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.61 111.42 5.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -119.0 -0.07 11.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.287 1.035 . . . . 0.0 111.386 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -131.3 67.0 79.94 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 127.319 2.248 . . . . 0.0 109.928 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.316 2.011 . . . . 0.0 109.618 168.888 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.413 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.8 m80 57.24 178.12 0.05 OUTLIER 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.867 2.067 . . . . 0.0 112.231 -167.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG2' ' HE1' ' A' ' 4' ' ' MET . 12.9 tpt -142.31 132.8 25.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.83 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.3 mt -132.06 145.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m120 73.3 11.42 4.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.375 1.47 . . . . 0.0 114.27 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.426 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 2.7 tpp -74.51 145.7 43.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.585 1.084 . . . . 0.0 110.146 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -131.91 144.22 50.69 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.827 1.251 . . . . 0.0 107.734 161.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -136.45 143.81 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.593 1.157 . . . . 0.0 108.434 172.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.54 124.37 44.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.935 0.894 . . . . 0.0 109.243 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.5 125.89 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 108.167 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -83.07 96.34 8.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.218 1.009 . . . . 0.0 110.747 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.5 mtp -94.3 164.94 12.82 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.121 1.368 . . . . 0.0 111.174 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.97 -60.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.375 1.47 . . . . 0.0 108.946 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -142.95 -68.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -132.4 9.03 4.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.631 1.205 . . . . 0.0 112.479 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -155.35 173.09 17.14 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.041 2.536 . . . . 0.0 107.954 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.67 147.48 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -81.57 -85.26 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.831 0.852 . . . . 0.0 111.097 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -174.58 -39.09 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.373 1.469 . . . . 0.0 108.714 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -145.66 -171.29 3.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.013 0.37 . . . . 0.0 111.526 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -95.01 -8.09 37.83 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.398 1.879 . . . . 0.0 111.244 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 6.15 10.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 112.095 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -137.47 0.75 2.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.711 1.604 . . . . 0.0 109.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 p -76.46 166.62 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.126 0.97 . . . . 0.0 110.989 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -101.98 -35.77 8.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.418 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -154.31 173.59 15.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.837 0.827 . . . . 0.0 110.518 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -116.9 113.41 22.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 128.047 2.539 . . . . 0.0 106.676 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.38 108.36 13.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.7 94.66 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 145.3 12.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 166.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -134.12 123.49 24.52 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.0 mt -118.0 128.26 75.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -126.88 -19.07 4.53 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -155.76 74.04 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 162.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t30 58.43 10.78 1.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.6 2.36 . . . . 0.0 114.146 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -137.69 161.49 36.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.637 2.375 . . . . 0.0 110.085 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.99 115.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -117.28 -17.95 10.04 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.835 -1.166 . . . . 0.0 112.667 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -149.79 162.67 39.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.744 1.156 . . . . 0.0 108.752 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -144.38 160.54 40.87 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.942 1.297 . . . . 0.0 108.357 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.5 155.68 42.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.354 1.861 . . . . 0.0 107.703 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.9 t -111.78 145.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 168.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mt -135.08 109.5 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.24 146.94 14.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.043 0.838 . . . . 0.0 110.55 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.51 82.22 3.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.51 172.39 12.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 129.734 3.214 . . . . 0.0 104.586 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.39 -40.48 95.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.28 -0.887 . . . . 0.0 113.389 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.0 t -67.84 -21.35 65.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -67.78 1.99 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.461 1.13 . . . . 0.0 111.471 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -59.45 -54.66 44.06 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.9 1.227 . . . . 0.0 109.183 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -54.77 -39.69 68.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.379 0.672 . . . . 0.0 111.114 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mt -57.45 -46.71 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.014 0.825 . . . . 0.0 110.749 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -57.2 -39.57 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.571 0.623 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.3 7.86 30.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.198 0.999 . . . . 0.0 112.612 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.54 152.15 21.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.758 1.163 . . . . 0.0 108.915 172.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.73 43.65 0.34 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.783 1.233 . . . . 0.0 110.715 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.85 137.6 24.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 166.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.25 -36.76 14.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.44 159.95 41.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.251 0.62 . . . . 0.0 109.629 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.26 142.66 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.8 mt -107.56 131.29 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 167.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.1 p -150.69 158.04 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 167.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -72.96 -44.17 61.44 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.128 163.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -135.55 155.17 50.92 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 tt -153.21 119.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -59.94 146.79 41.1 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.199 0.6 . . . . 0.0 109.569 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.79 -47.64 67.42 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.395 2.278 . . . . 0.0 111.545 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -25.47 67.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.969 0.508 . . . . 0.0 111.275 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -84.13 -47.46 10.86 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.318 1.047 . . . . 0.0 110.27 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -54.98 -53.27 57.87 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.668 1.122 . . . . 0.0 110.239 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -57.76 -22.63 48.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.406 1.083 . . . . 0.0 112.56 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -79.59 -60.99 2.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.924 0.89 . . . . 0.0 109.096 173.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -65.92 -33.54 76.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.802 -166.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -65.81 -10.14 35.06 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -16.35 32.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.203 1.401 . . . . 0.0 114.385 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -154.55 -45.58 0.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.693 -1.255 . . . . 0.0 109.673 166.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.1 mt -63.46 138.04 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.79 1.236 . . . . 0.0 108.223 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -92.39 126.36 37.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.131 1.372 . . . . 0.0 107.538 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.62 130.02 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.66 148.0 44.51 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.256 1.423 . . . . 0.0 109.392 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -80.86 143.88 32.41 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.353 1.061 . . . . 0.0 108.705 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.86 116.79 23.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.509 0.671 . . . . 0.0 109.324 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.02 79.68 0.66 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.236 1.414 . . . . 0.0 108.243 163.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.01 25.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.137 0.854 . . . . 0.0 114.034 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.7 -14.25 40.35 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.414 1.485 . . . . 0.0 110.4 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -82.02 100.84 9.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.044 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.62 -49.02 6.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 123.941 0.896 . . . . 0.0 109.575 170.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.36 -39.75 77.89 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.882 0.765 . . . . 0.0 110.503 -169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -56.89 -41.75 78.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -75.32 -34.63 61.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.091 0.556 . . . . 0.0 112.244 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mt -61.6 -53.78 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p -62.47 -46.22 89.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.795 0.438 . . . . 0.0 111.282 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.83 -39.98 82.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.909 0.322 . . . . 0.0 110.513 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 6' ' ' VAL . 23.6 t80 -66.46 -50.39 63.5 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.362 0.665 . . . . 0.0 111.747 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.76 -36.72 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.977 0.911 . . . . 0.0 109.759 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.33 -5.41 59.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.068 1.347 . . . . 0.0 113.332 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.48 86.51 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.766 -1.575 . . . . 0.0 113.112 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -29.28 67.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.291 1.437 . . . . 0.0 114.18 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.74 137.82 58.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.478 1.035 . . . . 0.0 110.684 -174.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 p -78.74 130.51 35.86 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.941 0.897 . . . . 0.0 109.885 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -71.85 148.7 45.92 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.21 -0.931 . . . . 0.0 109.633 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.8 mt -87.23 141.36 14.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.9 p -132.11 -48.15 0.93 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.527 1.131 . . . . 0.0 110.38 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.15 76.7 23.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.992 2.117 . . . . 0.0 110.209 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 124.72 3.613 . . . . 0.0 111.699 167.936 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -142.35 136.34 29.54 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt -154.24 141.03 19.11 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.939 0.895 . . . . 0.0 109.681 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 mt -138.49 143.68 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.566 1.146 . . . . 0.0 110.134 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.262 58.6 t30 44.62 45.54 7.98 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.966 2.506 . . . . 0.0 112.733 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.43 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.2 tpp -72.47 145.69 47.38 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 163.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -136.32 137.97 41.21 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 163.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.537 HG21 ' CE2' ' A' ' 93' ' ' PHE . 70.1 t -137.99 140.47 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.6 99.06 8.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.684 1.194 . . . . 0.0 108.72 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.72 114.16 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 p -68.32 128.62 37.24 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.317 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mtp -127.14 162.0 27.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.759 1.223 . . . . 0.0 110.805 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.7 -61.92 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.293 1.437 . . . . 0.0 109.53 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.14 -46.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 O-C-N 120.841 -1.162 . . . . 0.0 109.441 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -140.3 2.69 1.89 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.283 0.633 . . . . 0.0 112.211 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -157.57 175.21 14.24 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.449 1.5 . . . . 0.0 110.537 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.7 141.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.8 p -70.6 159.29 34.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.204 0.525 . . . . 0.0 110.643 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.02 -34.48 78.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.962 1.305 . . . . 0.0 111.266 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 167.12 25.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.506 0.722 . . . . 0.0 111.492 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -72.85 -53.31 11.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 18.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.211 1.405 . . . . 0.0 111.848 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.18 5.52 1.11 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.563 1.945 . . . . 0.0 110.934 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 p -80.1 172.44 13.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.719 -1.238 . . . . 0.0 110.15 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -111.94 -24.58 9.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.672 1.589 . . . . 0.0 110.589 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -160.12 175.07 13.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.952 0.796 . . . . 0.0 110.071 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CD1' HD11 ' A' ' 51' ' ' ILE . 88.6 m-85 -119.68 126.62 51.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 111.69 18.97 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -79.83 104.22 7.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.64 150.21 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -124.63 115.89 21.52 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 4' ' ' MET . 3.3 mp -114.81 123.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 167.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 6.7 m-20 -126.66 -5.67 6.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.303 1.041 . . . . 0.0 111.536 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -158.51 55.46 0.44 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.93 2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.586 2.355 . . . . 0.0 116.386 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -118.77 154.01 33.5 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 129.712 3.205 . . . . 0.0 108.888 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.57 102.98 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-O 121.91 0.862 . . . . 0.0 108.806 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 15.6 mmtt -71.68 -46.0 60.15 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -158.52 167.5 29.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.663 0.785 . . . . 0.0 110.406 -171.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -138.34 125.81 21.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.086 1.754 . . . . 0.0 108.981 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.84 164.39 14.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 109.604 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.13 134.31 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.3 mt -123.77 104.27 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.875 1.67 . . . . 0.0 106.551 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -58.09 136.53 57.2 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.473 0.579 . . . . 0.0 110.25 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -80.74 70.78 7.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.267 1.027 . . . . 0.0 110.773 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.65 84.74 1.62 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 71.14 -74.07 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.101 2.16 . . . . 0.0 113.375 151.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.7 t -52.34 -33.02 40.95 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.838 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.63 -59.85 9.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -58.58 -39.17 79.56 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.349 -1.089 . . . . 0.0 110.425 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -55.01 -46.36 75.21 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 118.662 0.665 . . . . 0.0 110.373 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.9 m -61.01 -36.32 79.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.631 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' CD1' ' A' ' 25' ' ' PHE . 55.9 mt -60.33 -48.38 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.773 1.169 . . . . 0.0 109.452 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.08 -39.84 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.086 0.554 . . . . 0.0 110.396 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -73.17 -17.87 61.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.121 -0.987 . . . . 0.0 112.463 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.91 -174.53 5.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 120.273 1.397 . . . . 0.0 110.529 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -112.98 40.84 2.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.011 1.724 . . . . 0.0 109.235 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.75 141.49 17.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.24 -41.38 12.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.322 1.049 . . . . 0.0 109.943 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.15 151.09 36.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.29 1.036 . . . . 0.0 111.272 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.43 139.54 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 166.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.8 mt -116.51 127.53 74.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.7 p -154.19 176.42 12.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.527 1.531 . . . . 0.0 108.085 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -106.33 -24.77 12.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.607 1.163 . . . . 0.0 111.648 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -152.96 159.31 42.93 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.0 tt -161.02 137.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.482 ' H ' ' ND2' ' A' ' 68' ' ' ASN . 8.9 m -85.23 168.37 14.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.28 -35.42 75.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.286 1.434 . . . . 0.0 111.221 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.87 -47.03 32.37 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.365 1.078 . . . . 0.0 109.726 -170.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -58.48 -46.54 86.43 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.243 1.817 . . . . 0.0 110.057 172.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -54.6 -62.16 1.84 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.693 0.397 . . . . 0.0 111.109 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.98 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 112.553 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -62.81 1.52 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.893 0.877 . . . . 0.0 109.432 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HD1' HD12 ' A' ' 76' ' ' ILE . 51.8 m-85 -79.93 -30.49 39.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.971 -164.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -58.27 -12.45 3.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.454 1.102 . . . . 0.0 113.857 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -52.28 -31.57 33.3 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.124 -0.985 . . . . 0.0 111.871 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -151.82 -8.08 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.425 HD12 ' HD1' ' A' ' 72' ' ' PHE . 8.0 mt -114.78 123.52 70.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -170.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.69 160.61 19.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.69 0.757 . . . . 0.0 109.434 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.7 mt -137.69 128.77 38.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.24 160.89 34.83 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.88 1.272 . . . . 0.0 111.534 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -106.71 121.82 45.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.892 1.677 . . . . 0.0 110.169 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.5 125.24 29.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.755 0.422 . . . . 0.0 110.163 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -9.38 29.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.341 1.857 . . . . 0.0 113.065 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.96 174.33 41.51 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -163.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -90.3 -6.3 55.29 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 99.68 5.45 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -173.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.6 t -49.82 -39.17 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 122.874 0.47 . . . . 0.0 110.277 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.19 -42.71 68.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -166.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -62.47 -45.36 93.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.853 -0.529 . . . . 0.0 110.383 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -71.75 -32.57 67.84 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.17 -0.331 . . . . 0.0 111.238 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.94 -50.91 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 94' ' ' ILE . 6.6 p -67.0 -31.5 72.11 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 mt -69.18 -42.56 75.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 109.973 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 6' ' ' VAL . 40.5 t80 -59.25 -42.88 92.16 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.181 0.993 . . . . 0.0 113.124 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 91' ' ' SER . 67.3 mt -47.9 -54.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.429 1.492 . . . . 0.0 109.466 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -4.92 49.15 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.505 1.522 . . . . 0.0 113.306 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.09 14.76 80.2 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.079 0.854 . . . . 0.0 112.601 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.86 -19.4 61.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 112.116 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.13 140.48 50.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.07 0.938 . . . . 0.0 110.575 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -68.8 140.05 55.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.839 1.256 . . . . 0.0 108.749 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -72.59 153.82 41.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 165.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.6 mt -88.71 127.98 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 160.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -129.07 -18.61 3.69 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.263 0.625 . . . . 0.0 112.395 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.16 87.46 6.63 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 109.019 170.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.034 3.822 . . . . 0.0 112.647 -177.744 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.9 164.63 0.85 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.192 2.197 . . . . 0.0 107.852 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt -110.85 121.77 46.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.81 1.244 . . . . 0.0 107.858 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 mm -120.63 136.4 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 124.738 1.215 . . . . 0.0 108.309 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 47.78 53.41 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.008 1.723 . . . . 0.0 113.851 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -69.95 156.16 39.52 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 163.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -132.31 159.42 39.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 152.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 28' ' ' VAL . 12.0 p -156.64 163.8 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.7 124.8 47.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 164.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.39 113.58 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.7 p -57.38 128.39 36.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.2 mtp -131.16 157.71 42.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.489 1.04 . . . . 0.0 110.426 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.32 -63.29 1.14 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.555 1.542 . . . . 0.0 108.417 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -142.93 -74.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -119.43 10.88 12.0 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.031 1.332 . . . . 0.0 112.935 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.52 170.17 21.42 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.13 1.372 . . . . 0.0 108.35 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.8 mt -58.11 133.83 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 p -73.63 159.72 32.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.847 2.059 . . . . 0.0 111.311 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -73.55 -25.1 60.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.7 p -149.64 174.01 13.03 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.841 1.2 . . . . 0.0 111.605 169.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -72.56 -13.72 61.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.596 1.958 . . . . 0.0 111.653 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.94 7.99 15.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 111.467 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -133.01 2.9 3.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.073 1.749 . . . . 0.0 110.243 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.98 153.96 42.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.733 -1.23 . . . . 0.0 109.625 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -101.16 -24.67 14.23 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.87 1.268 . . . . 0.0 109.192 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.447 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 40.8 p90 -157.72 173.76 16.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.242 0.928 . . . . 0.0 111.003 171.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 51' ' ' ILE . 70.0 m-85 -115.83 105.1 12.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.308 2.243 . . . . 0.0 107.924 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.94 107.17 7.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -79.46 133.03 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.809 1.244 . . . . 0.0 109.027 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 6' ' ' VAL . 2.0 t -105.94 105.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttt-85 -98.68 103.99 15.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.56 138.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -125.25 -5.63 7.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.483 0.713 . . . . 0.0 112.689 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.499 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 5.5 p-10 -173.38 48.28 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.83 1.252 . . . . 0.0 108.855 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.36 18.67 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.184 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.74 152.96 47.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.37 90.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 122.549 1.166 . . . . 0.0 107.891 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 2.8 mmtp -73.02 -35.09 66.72 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 120.735 -1.228 . . . . 0.0 110.185 167.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 t -162.25 131.97 4.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.792 1.178 . . . . 0.0 110.075 167.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 174.71 9.82 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.272 1.029 . . . . 0.0 111.523 165.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.12 168.34 26.82 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 127.168 2.187 . . . . 0.0 110.303 171.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.553 0.9 OUTLIER -135.16 144.22 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 129.924 3.29 . . . . 0.0 117.476 171.104 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.7 mt -134.29 114.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 127.757 2.423 . . . . 0.0 106.655 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -61.44 136.11 57.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.213 0.915 . . . . 0.0 110.733 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -83.13 85.71 7.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.771 1.228 . . . . 0.0 108.545 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.54 -85.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 46' ' ' SER . 10.4 pt-20 -131.83 -64.09 0.8 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.394 -0.816 . . . . 0.0 111.67 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.472 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -57.99 -24.18 57.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.968 174.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.59 -74.08 0.36 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -57.71 -27.27 62.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.731 1.265 . . . . 0.0 111.537 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.32 -51.15 62.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.8 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -60.93 -37.4 82.2 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.669 1.588 . . . . 0.0 110.067 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 25' ' ' PHE . 43.3 mt -52.46 -45.33 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.086 1.755 . . . . 0.0 110.93 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.71 -42.71 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 120.876 -1.14 . . . . 0.0 110.14 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.55 -30.63 59.77 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 118.445 0.566 . . . . 0.0 111.651 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -74.08 -19.84 60.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.533 0.606 . . . . 0.0 109.4 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.7 t30 50.89 55.38 9.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.703 2.801 . . . . 0.0 112.305 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.19 144.16 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.123 1.769 . . . . 0.0 111.543 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -39.99 18.53 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.111 1.364 . . . . 0.0 111.155 173.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' VAL . . . -144.25 160.95 40.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 112.989 -166.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.3 mt -132.25 105.25 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 119.909 -1.745 . . . . 0.0 108.966 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.06 128.69 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -151.06 167.98 26.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.592 1.087 . . . . 0.0 111.189 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -82.2 -45.38 15.15 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.224 1.81 . . . . 0.0 109.262 165.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -147.43 164.26 33.89 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.379 0.991 . . . . 0.0 109.927 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.5 tt -154.32 138.1 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 m -73.31 155.99 38.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.327 0.512 . . . . 0.0 110.68 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 36.8 tt0 -66.67 -31.49 72.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.734 0.414 . . . . 0.0 111.4 -171.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.74 -50.91 31.07 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.087 0.858 . . . . 0.0 110.997 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -56.54 -43.8 80.24 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.734 0.414 . . . . 0.0 110.644 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -54.69 -60.79 2.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.512 1.125 . . . . 0.0 109.363 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HE3' ' HG2' ' A' ' 66' ' ' GLU . 50.5 mttt -64.31 -17.06 63.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.453 0.701 . . . . 0.0 112.61 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.34 -51.91 5.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.112 1.365 . . . . 0.0 110.338 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.532 ' HD1' HD12 ' A' ' 76' ' ' ILE . 49.9 m-85 -76.55 -30.29 57.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.338 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -63.18 -7.77 6.6 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -20.06 39.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.937 -1.102 . . . . 0.0 111.709 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -145.14 2.59 1.01 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.944 1.247 . . . . 0.0 112.158 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.532 HD12 ' HD1' ' A' ' 72' ' ' PHE . 3.2 mt -134.5 129.03 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -171.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.08 107.65 17.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.002 1.721 . . . . 0.0 109.645 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -87.16 131.89 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 120.455 -1.403 . . . . 0.0 108.52 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -118.16 144.22 45.87 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.702 1.601 . . . . 0.0 111.084 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -87.01 132.58 33.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.458 1.503 . . . . 0.0 107.583 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.81 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.241 -0.409 . . . . 0.0 110.541 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -12.53 60.43 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 169.64 34.15 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 126.99 2.234 . . . . 0.0 108.26 -164.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.7 -16.96 63.98 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.551 2.34 . . . . 0.0 111.37 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.64 97.34 3.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -168.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.1 t -50.38 -42.75 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.65 -44.52 81.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.404 0.682 . . . . 0.0 109.252 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -58.06 -42.54 85.69 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.89 0.852 . . . . 0.0 111.31 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -71.96 -27.2 62.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.113 -0.992 . . . . 0.0 111.974 -172.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.23 -53.7 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 p -61.23 -39.08 88.94 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.7 0.8 . . . . 0.0 111.332 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.4 mt -66.3 -44.59 83.04 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.148 0.579 . . . . 0.0 110.881 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.25 -39.06 85.43 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.987 0.812 . . . . 0.0 111.6 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.53 -42.82 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.436 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.35 -12.5 60.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.878 0.763 . . . . 0.0 112.632 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.11 6.94 84.12 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.927 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -34.17 77.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 112.536 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -55.61 140.43 41.1 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -61.56 130.12 44.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 108.947 172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -69.81 131.67 44.87 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.22 -0.925 . . . . 0.0 108.589 165.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.5 mt -60.4 111.96 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.2 m -79.56 -31.72 42.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.425 0.29 . . . . 0.0 111.585 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -151.02 153.64 33.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 126.884 2.074 . . . . 0.0 107.389 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 C--O 1.252 1.218 0 C-N-CA 122.624 2.216 . . . . 0.0 107.521 158.276 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.469 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.28 165.14 15.9 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 136.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt -148.42 140.95 24.39 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.039 -1.038 . . . . 0.0 108.625 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -137.34 138.61 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 69.38 17.47 8.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.587 1.955 . . . . 0.0 113.255 168.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.5 tpp -60.33 151.93 26.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.357 -0.839 . . . . 0.0 109.002 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -137.61 129.17 28.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 165.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 93' ' ' PHE . 41.9 t -136.68 129.85 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-N 119.979 1.263 . . . . 0.0 108.717 172.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.05 83.79 2.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.584 1.553 . . . . 0.0 111.243 -169.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mt -83.74 129.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 120.873 -1.142 . . . . 0.0 110.088 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 p -71.07 94.47 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.482 1.113 . . . . 0.0 112.028 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 mtp -100.01 161.1 13.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.552 1.141 . . . . 0.0 111.341 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.5 -63.31 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 109.155 170.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.68 -60.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -130.41 -0.47 4.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.364 1.078 . . . . 0.0 112.528 -162.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -163.25 178.28 8.32 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.346 2.258 . . . . 0.0 108.736 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 99.1 mt -62.12 145.4 13.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -86.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.726 0.774 . . . . 0.0 109.772 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 175.8 -44.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.022 -1.049 . . . . 0.0 108.684 -156.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 p -158.78 169.36 24.55 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.373 0.988 . . . . 0.0 110.08 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -66.27 -34.04 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.131 0.973 . . . . 0.0 110.822 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -92.48 4.05 54.28 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -131.03 17.99 5.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.307 1.051 . . . . 0.0 111.303 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.93 167.6 16.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.294 1.045 . . . . 0.0 110.344 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.13 -31.24 7.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.215 1.406 . . . . 0.0 109.402 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -154.86 161.24 41.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.991 0.901 . . . . 0.0 109.89 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -100.09 111.7 23.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -76.46 108.97 9.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 41' ' ' ILE . 19.6 mm -77.36 100.09 2.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.4 133.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.521 ' HE ' ' HB2' ' A' ' 37' ' ' SER . 26.7 mtm180 -115.68 114.45 24.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 mt -107.06 115.47 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.01 -10.98 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.441 1.088 . . . . 0.0 112.098 -162.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.64 57.19 0.62 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 122.352 1.072 . . . . 0.0 108.626 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.62 -9.92 0.08 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 129.137 2.975 . . . . 0.0 116.305 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -107.82 158.99 16.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.426 1.09 . . . . 0.0 110.4 170.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.76 90.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.278 1.431 . . . . 0.0 109.974 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.66 -20.88 30.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.779 1.632 . . . . 0.0 112.487 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.521 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 1.6 m -150.55 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 167.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 p -131.82 158.79 40.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 161.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 157.73 46.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 126.202 1.801 . . . . 0.0 106.723 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.24 140.87 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.4 HD12 HD11 ' A' ' 27' ' ' ILE . 59.1 mt -130.8 100.57 4.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -58.86 137.52 57.74 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -73.92 85.37 1.75 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.358 1.463 . . . . 0.0 108.042 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.5 33.83 2.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.462 1.505 . . . . 0.0 110.174 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 66.33 -69.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.144 1.777 . . . . 0.0 109.839 -172.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.3 t -52.99 -29.33 28.51 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.172 2.189 . . . . 0.0 111.413 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.1 16.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.983 0.81 . . . . 0.0 111.286 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -57.6 -32.2 66.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.086 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -56.5 -40.13 74.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.363 0.983 . . . . 0.0 108.397 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -30.79 66.97 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.136 0.974 . . . . 0.0 110.655 -172.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.85 -42.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.391 1.076 . . . . 0.0 108.308 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.1 -13.2 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.126 -0.984 . . . . 0.0 111.269 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -8.03 16.19 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.622 -1.298 . . . . 0.0 112.277 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -91.48 -15.09 29.33 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.557 1.526 . . . . 0.0 113.791 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 57.87 59.14 3.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.826 1.251 . . . . 0.0 109.946 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -47.8 140.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 161.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -50.96 19.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.62 39.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.898 0.479 . . . . 0.0 110.582 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mt -113.86 150.54 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.94 1.296 . . . . 0.0 107.707 173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -120.22 121.9 66.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -144.24 168.89 18.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.212 1.005 . . . . 0.0 108.635 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -71.83 -57.3 4.45 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 155.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -140.7 160.72 39.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.401 0.546 . . . . 0.0 110.711 -167.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.2 tt -152.61 126.99 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 126.25 1.82 . . . . 0.0 106.613 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -54.44 143.54 23.61 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.621 1.568 . . . . 0.0 110.221 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -48.45 -49.04 37.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.169 1.787 . . . . 0.0 111.462 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.03 -42.04 99.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 0.0 110.666 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -68.5 -43.56 76.57 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.594 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.4 -57.83 9.25 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.02 -14.04 51.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.676 1.191 . . . . 0.0 113.628 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -90.99 -58.11 2.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.448 1.499 . . . . 0.0 109.793 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.33 -27.44 62.43 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 112.335 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -60.7 -11.85 8.67 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -58.18 -42.81 86.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 0.0 112.271 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 13.56 1.78 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.806 1.185 . . . . 0.0 111.743 -175.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mt -136.41 140.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.77 153.09 19.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.949 0.9 . . . . 0.0 108.779 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.52 113.59 23.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -160.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.86 151.07 37.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.544 1.137 . . . . 0.0 110.898 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -99.12 120.19 39.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.442 1.497 . . . . 0.0 109.95 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 138.94 55.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.414 0.686 . . . . 0.0 111.747 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -102.29 99.08 9.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 127.178 2.191 . . . . 0.0 109.284 172.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.42 -179.11 53.63 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -85.37 -10.84 55.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.703 0.801 . . . . 0.0 110.662 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.35 102.23 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.062 0.945 . . . . 0.0 110.563 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -48.35 -43.86 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 118.79 -0.624 . . . . 0.0 109.609 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.58 -42.84 77.7 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.968 0.804 . . . . 0.0 110.219 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -57.26 -40.02 76.83 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.902 -0.499 . . . . 0.0 110.289 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.51 -32.85 42.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.15 -50.47 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 p -62.4 -46.51 88.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.726 0.811 . . . . 0.0 111.436 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 122.56 0.344 . . . . 0.0 110.161 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 6' ' ' VAL . 48.6 t80 -61.74 -52.5 64.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.321 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.3 mt -50.27 -40.93 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.969 1.308 . . . . 0.0 111.005 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.23 -2.84 50.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.941 0.896 . . . . 0.0 113.108 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.02 81.35 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.0 1.286 . . . . 0.0 111.193 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -27.26 61.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.41 1.884 . . . . 0.0 113.029 -174.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.38 139.47 58.56 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.577 0.704 . . . . 0.0 109.582 -174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.8 m -75.93 143.05 41.86 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -76.98 151.52 35.62 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.7 mt -78.69 151.03 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 166.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 m -140.77 -43.21 0.39 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.628 1.571 . . . . 0.0 109.999 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.67 86.2 2.78 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 126.25 1.82 . . . . 0.0 109.181 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.211 3.274 . . . . 0.0 111.684 175.752 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.589 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.78 165.54 27.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt -127.61 135.14 49.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 165.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.0 mt -139.54 152.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 47.18 73.02 0.21 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.874 1.67 . . . . 0.0 110.734 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ttt -131.92 152.33 51.14 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.157 -0.964 . . . . 0.0 108.59 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.6 141.52 33.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 165.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -134.05 132.62 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 171.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.99 144.57 25.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.71 119.98 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -75.88 84.16 2.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.147 0.979 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -86.3 155.26 20.73 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.895 2.478 . . . . 0.0 111.7 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -105.27 -55.96 2.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.128 0.966 . . . . 0.0 110.979 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -146.77 -55.02 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.8 -1.79 0.49 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.519 -158.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -157.06 173.17 17.41 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.706 2.002 . . . . 0.0 107.426 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.41 134.15 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -66.84 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.53 -38.66 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.395 1.478 . . . . 0.0 108.95 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 166.21 29.18 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.974 0.416 . . . . 0.0 111.042 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -55.88 -50.19 71.33 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.726 2.01 . . . . 0.0 108.891 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.12 -3.06 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.724 1.609 . . . . 0.0 112.812 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -120.91 -4.66 9.62 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.835 1.254 . . . . 0.0 111.068 -171.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.3 p -80.11 175.24 10.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.802 -1.186 . . . . 0.0 111.957 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -112.08 -34.67 5.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.741 1.616 . . . . 0.0 110.035 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -149.05 164.24 35.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.357 0.98 . . . . 0.0 111.904 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -109.85 103.35 12.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.382 2.673 . . . . 0.0 106.456 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tp -81.15 101.45 9.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.09 96.1 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 127.381 2.273 . . . . 0.0 107.31 168.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.52 139.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 160.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 118.55 18.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.868 0.758 . . . . 0.0 109.093 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.3 mt -119.82 138.28 50.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -164.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.0 -9.12 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -155.86 65.87 0.59 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.09 -8.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.21 3.004 . . . . 0.0 115.91 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.15 157.46 27.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 111.235 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.13 83.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.301 1.841 . . . . 0.0 106.864 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -64.85 -31.75 73.13 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.884 -1.135 . . . . 0.0 109.974 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -150.72 163.38 38.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.96 0.904 . . . . 0.0 109.469 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.67 161.28 36.91 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 108.231 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 137.8 19.11 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.92 0.888 . . . . 0.0 110.041 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.535 1.1 p -99.97 133.21 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 161.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.499 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 11.1 mt -129.74 114.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -63.31 160.42 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.156 1.343 . . . . 0.0 110.409 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -78.54 76.62 5.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.902 1.281 . . . . 0.0 109.777 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -125.74 170.17 11.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.34 1.456 . . . . 0.0 109.502 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -55.38 -40.67 71.65 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.445 -0.784 . . . . 0.0 110.672 164.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 m -76.34 -11.29 59.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.783 1.233 . . . . 0.0 111.693 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -72.47 -60.3 4.11 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 163.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 mppt? -62.58 -20.25 64.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -63.57 -46.25 86.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.932 1.242 . . . . 0.0 110.512 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 m -71.84 -40.79 68.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.223 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.7 mt -45.46 -51.44 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.929 1.292 . . . . 0.0 111.85 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.68 -34.69 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.87 -0.519 . . . . 0.0 111.468 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.89 -14.24 45.45 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.661 -0.649 . . . . 0.0 111.374 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.17 -16.21 61.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.525 1.53 . . . . 0.0 110.883 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 t30 47.47 65.06 1.36 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.975 2.11 . . . . 0.0 110.28 -167.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -67.45 140.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.94 -42.26 15.14 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.511 1.524 . . . . 0.0 109.979 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.69 160.95 39.82 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.422 1.089 . . . . 0.0 109.414 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -122.76 138.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.85 122.09 50.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.03 157.09 44.55 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.688 0.756 . . . . 0.0 111.255 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -68.99 -53.0 22.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 163.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -139.33 159.39 42.28 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.594 1.543 . . . . 0.0 111.204 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.9 tt -156.83 126.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.141 1.776 . . . . 0.0 110.257 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -61.13 141.89 57.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.222 1.009 . . . . 0.0 110.003 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.75 -37.62 76.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 111.845 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.61 -40.41 94.72 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.499 -0.75 . . . . 0.0 111.503 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -69.16 -47.58 64.59 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.792 0.837 . . . . 0.0 109.805 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -50.51 -58.68 5.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.858 1.263 . . . . 0.0 109.758 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -60.97 -18.12 55.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.436 0.694 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -82.38 -47.45 12.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.06 -1.025 . . . . 0.0 111.04 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -84.87 -25.37 28.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.958 0.344 . . . . 0.0 111.027 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -62.12 -7.7 4.43 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.61 1.164 . . . . 0.0 113.231 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -40.42 11.56 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.208 1.403 . . . . 0.0 110.787 173.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -145.16 -30.55 0.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.552 1.141 . . . . 0.0 111.857 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.3 mt -90.04 135.1 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -163.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.56 139.2 33.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.679 . . . . 0.0 107.801 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.8 mt -119.74 114.21 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.24 -0.913 . . . . 0.0 108.671 -172.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 55.8 m-85 -104.63 139.85 38.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.096 1.758 . . . . 0.0 110.835 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.42 127.62 32.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 123.07 19.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -83.3 6.76 18.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.057 1.743 . . . . 0.0 112.389 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.4 -169.81 38.97 Favored Glycine 0 N--CA 1.449 -0.477 0 O-C-N 120.509 -1.369 . . . . 0.0 111.68 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.15 -18.05 15.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.921 1.688 . . . . 0.0 109.894 168.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -66.86 101.7 0.86 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.386 1.474 . . . . 0.0 107.387 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.4 t -57.73 -41.11 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.217 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.51 -36.31 73.69 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.578 0.751 . . . . 0.0 110.359 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -60.77 -42.07 96.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 171.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -71.87 -26.84 62.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.701 -0.625 . . . . 0.0 111.566 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -56.9 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.78 1.632 . . . . 0.0 107.561 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.7 p -65.57 -40.69 93.07 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.36 0.413 . . . . 0.0 110.605 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.12 -42.87 99.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.651 0.78 . . . . 0.0 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 6' ' ' VAL . 68.7 t80 -61.19 -52.59 64.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.528 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.2 mt -58.25 -40.74 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.496 1.119 . . . . 0.0 109.58 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -68.22 -18.71 64.64 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.26 8.24 78.51 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.717 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -69.92 -27.31 64.66 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.084 1.442 . . . . 0.0 112.329 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.31 138.83 55.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.432 1.111 . . . . 0.0 110.272 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.8 m -74.09 138.92 44.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.3 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 31.4 mtmm -78.98 147.75 32.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 162.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.9 mt -70.94 -39.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 123.7 0.625 . . . . 0.0 110.854 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.1 m 47.83 65.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.806 1.242 . . . . 0.0 110.429 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 62.59 150.48 0.1 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 131.182 3.793 . . . . 0.0 116.484 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--O 1.246 0.911 0 C-N-CA 122.279 1.986 . . . . 0.0 107.949 163.823 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.3 m170 58.96 -164.82 0.2 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.014 2.526 . . . . 0.0 112.638 166.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt -151.04 130.25 12.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.4 -0.812 . . . . 0.0 109.672 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.93 153.05 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.317 1.847 . . . . 0.0 107.86 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 67.01 8.93 6.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.1 1.76 . . . . 0.0 114.473 168.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 tpp -78.1 155.17 30.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.182 1.356 . . . . 0.0 108.938 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.42 143.42 25.71 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.18 141.93 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 108.962 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.72 101.89 13.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 166.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.47 117.91 28.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB2' ' CB ' ' A' ' 22' ' ' CYS . 42.5 p -66.38 143.78 56.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.8 mmm -138.66 149.07 44.77 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 119.449 -2.032 . . . . 0.0 109.078 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -89.44 -67.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.507 1.123 . . . . 0.0 109.01 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.9 t -140.53 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.38 -7.42 18.81 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -147.16 177.34 9.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.272 1.429 . . . . 0.0 110.155 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mt -62.77 141.22 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 t -71.02 -86.76 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 t30 174.75 -28.12 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.856 1.663 . . . . 0.0 112.068 -167.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.73 164.68 29.44 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.736 1.153 . . . . 0.0 110.726 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -66.32 -37.59 85.74 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.222 1.009 . . . . 0.0 108.435 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 1.0 56.64 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.416 1.486 . . . . 0.0 113.175 -171.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.54 -7.54 6.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.018 1.327 . . . . 0.0 111.74 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 9' ' ' SER . 13.9 p -65.66 169.37 6.37 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 123.471 1.605 . . . . 0.0 110.277 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -114.9 -19.59 10.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.722 -2.036 . . . . 0.0 111.119 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.409 ' HB2' HG23 ' A' ' 40' ' ' VAL . 32.1 p90 -161.33 172.16 17.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.67 0.668 . . . . 0.0 111.388 172.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -117.02 103.61 10.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.369 2.268 . . . . 0.0 106.441 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 tp -76.97 99.04 5.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.41 102.14 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 128.064 2.545 . . . . 0.0 105.923 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 t -95.87 112.2 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.0 140.57 34.04 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.679 1.127 . . . . 0.0 108.495 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -132.68 123.12 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -168.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.19 3.99 1.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -165.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -154.63 60.6 0.68 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 122.491 1.139 . . . . 0.0 109.702 155.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.8 t30 61.18 7.32 1.58 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.637 1.575 . . . . 0.0 114.692 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -135.7 155.09 50.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 131.349 3.86 . . . . 0.0 106.807 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.65 124.72 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.616 1.166 . . . . 0.0 109.027 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -111.97 -34.34 6.01 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.641 0.776 . . . . 0.0 112.543 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 131.64 27.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -96.96 154.71 17.14 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 162.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 147.85 33.18 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.938 1.695 . . . . 0.0 107.093 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 24' ' ' TYR 0.453 1.2 p -106.83 134.87 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 125.791 1.636 . . . . 0.0 115.287 155.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.16 122.14 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -65.64 161.08 21.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.594 1.088 . . . . 0.0 111.213 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -81.14 99.83 8.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 167.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -154.47 38.22 0.43 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 108.486 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 60.49 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.103 2.961 . . . . 0.0 112.854 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 t -62.23 -10.78 11.72 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.586 -1.321 . . . . 0.0 111.464 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.7 -60.24 6.6 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 160.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -61.29 -26.88 68.08 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.183 0.993 . . . . 0.0 112.348 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -64.69 -53.0 54.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 120.078 1.308 . . . . 0.0 108.874 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 t -53.55 -45.95 70.03 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 110.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.8 mt -50.36 -43.04 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.882 0.873 . . . . 0.0 110.709 -176.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.19 -23.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 O-C-N 121.052 -1.03 . . . . 0.0 111.906 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -98.64 12.42 35.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.078 0.951 . . . . 0.0 111.266 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.53 -6.42 11.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.807 0.843 . . . . 0.0 112.211 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.0 t30 49.89 61.95 2.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.406 1.483 . . . . 0.0 111.694 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.51 142.13 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 166.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -76.13 -52.72 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.27 162.5 39.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.56 141.16 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.88 2.072 . . . . 0.0 110.396 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 81' ' ' ALA . 51.9 mt -127.14 125.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.201 1.8 . . . . 0.0 106.792 167.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 38.1 m -149.62 -13.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.789 ' HG3' ' HB3' ' A' ' 81' ' ' ALA . 9.5 mtpp 75.78 -34.42 0.24 Allowed 'General case' 0 C--O 1.221 -0.425 1 C-N-CA 132.526 4.331 . . . . 0.0 113.35 -162.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -149.97 168.07 24.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 122.088 2.222 . . . . 0.0 111.748 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -163.53 120.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.645 1.178 . . . . 0.0 108.65 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.35 147.79 43.61 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.18 -47.49 65.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.933 2.093 . . . . 0.0 111.345 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -59.76 -42.25 92.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.753 0.787 . . . . 0.0 111.154 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -72.56 -41.49 65.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.888 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.75 -61.17 2.42 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.201 0.91 . . . . 0.0 109.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -64.89 -24.08 67.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.89 -38.63 61.83 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 120.905 -1.122 . . . . 0.0 111.301 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.49 -30.46 21.97 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.056 -1.027 . . . . 0.0 111.485 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -63.8 -12.73 38.18 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -27.34 5.62 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.328 1.451 . . . . 0.0 113.903 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -155.75 -2.66 0.14 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.026 0.83 . . . . 0.0 113.207 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.29 121.07 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -75.06 117.36 16.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.484 1.513 . . . . 0.0 107.271 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.48 134.92 28.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -120.15 155.38 33.19 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 108.792 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -85.37 141.29 30.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 168.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.789 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . . . -88.52 150.16 23.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.354 0.525 . . . . 0.0 110.486 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.77 71.36 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.876 2.47 . . . . 0.0 108.118 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.43 -178.85 17.52 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 124.466 1.031 . . . . 0.0 112.852 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -33.63 75.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.028 153.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.55 100.83 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 124.446 1.091 . . . . 0.0 109.9 -155.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -52.18 -43.85 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -44.22 92.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.575 0.625 . . . . 0.0 109.962 -175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.19 -39.26 78.47 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.69 -0.631 . . . . 0.0 110.982 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -76.87 -27.25 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 112.529 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.09 -50.43 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.6 p -61.87 -46.42 89.49 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.012 0.824 . . . . 0.0 110.898 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.4 mt -63.06 -30.24 71.44 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.084 0.554 . . . . 0.0 110.621 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.62 -48.38 48.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.46 -37.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.261 . . . . 0.0 109.928 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -76.84 -34.35 57.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.898 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.57 15.16 32.78 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.99 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -34.82 74.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.821 2.048 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.31 142.15 52.73 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.605 1.093 . . . . 0.0 109.495 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.4 t -91.55 144.75 25.22 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 123.275 1.512 . . . . 0.0 110.244 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -85.08 130.7 34.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.985 1.714 . . . . 0.0 108.896 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.2 mt -71.52 140.23 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.4 t -122.49 -55.63 1.83 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.927 0.891 . . . . 0.0 108.894 171.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -117.7 85.8 22.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 126.769 2.028 . . . . 0.0 107.964 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--O 1.248 0.995 0 C-N-CA 123.958 3.105 . . . . 0.0 110.615 168.763 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.45 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -141.35 163.83 31.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.032 1.733 . . . . 0.0 108.734 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 tpt -99.85 127.27 46.02 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.166 1.386 . . . . 0.0 111.301 171.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.53 150.86 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 172.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m120 66.23 8.94 5.95 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 171.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.7 ttp -68.5 155.8 39.21 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.351 1.432 . . . . 0.0 110.202 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -139.12 146.34 40.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.018 1.727 . . . . 0.0 107.517 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG21 ' CE2' ' A' ' 93' ' ' PHE . 31.3 t -137.75 135.08 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.675 1.19 . . . . 0.0 108.122 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 124.12 33.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 166.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mt -104.03 112.53 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -66.2 91.63 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.784 1.234 . . . . 0.0 110.007 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 91.3 mmm -92.08 159.51 15.66 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.492 1.117 . . . . 0.0 111.183 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.81 -81.4 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.178 2.191 . . . . 0.0 108.372 165.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.4 t -140.41 -59.71 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -121.87 2.69 9.99 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 170.44 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.645 1.178 . . . . 0.0 110.09 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.5 mt -53.96 139.54 12.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.793 1.637 . . . . 0.0 108.087 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -74.25 -179.49 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.707 1.603 . . . . 0.0 110.625 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -86.0 -34.39 20.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.705 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -153.27 168.3 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -67.03 -23.04 65.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.247 2.219 . . . . 0.0 111.406 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.8 19.72 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.052 1.341 . . . . 0.0 110.916 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.14 -7.3 1.58 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.2 p -74.46 154.49 38.7 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.265 1.031 . . . . 0.0 109.889 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.59 -34.25 14.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.365 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.454 ' HE2' HD23 ' A' ' 26' ' ' LEU . 27.4 p90 -158.54 175.55 13.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.656 0.741 . . . . 0.0 109.533 176.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -117.05 108.91 16.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD23 ' HE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -77.72 104.9 8.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 170.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 mm -69.0 99.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.18 147.37 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 161.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -129.03 140.22 51.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mt -110.55 142.52 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.28 124.55 10.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 175.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 44.46 57.7 4.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.614 1.565 . . . . 0.0 111.51 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.62 28.49 2.6 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 128.89 2.876 . . . . 0.0 114.138 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HB2' ' CE ' ' A' ' 36' ' ' LYS . 45.4 mt-10 -132.07 157.16 44.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.09 1.314 . . . . 0.0 111.139 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.52 120.15 17.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' CE ' ' HB2' ' A' ' 34' ' ' GLU . 21.3 mmtp -126.15 -7.62 6.52 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.437 ' HB3' ' HG2' ' A' ' 29' ' ' ARG . 47.7 t -157.13 170.67 21.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 122.021 2.191 . . . . 0.0 107.813 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.24 156.26 45.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.609 1.564 . . . . 0.0 109.535 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 160.55 43.86 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 125.911 1.685 . . . . 0.0 109.142 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.7 OUTLIER -127.1 137.28 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 C-N-CA 130.062 3.345 . . . . 0.0 116.581 167.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.84 116.25 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -64.05 148.92 48.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.57 0.623 . . . . 0.0 110.25 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -69.95 88.73 0.58 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.2 166.23 24.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 128.309 2.644 . . . . 0.0 105.042 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.73 -45.98 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.49 -0.757 . . . . 0.0 109.778 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -26.3 68.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 110.178 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.18 -49.73 38.12 Favored Glycine 0 N--CA 1.444 -0.819 0 O-C-N 121.729 -0.607 . . . . 0.0 111.677 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -67.82 -21.52 65.21 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.067 0.934 . . . . 0.0 111.506 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.03 -58.16 6.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.736 -1.126 . . . . 0.0 110.551 161.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -53.51 -33.88 56.08 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.333 0.97 . . . . 0.0 112.824 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 mt -45.3 -46.64 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.557 1.143 . . . . 0.0 111.513 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.33 -33.37 63.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 123.225 0.61 . . . . 0.0 110.199 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -27.09 29.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.298 0.499 . . . . 0.0 111.223 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.02 -20.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.099 0.863 . . . . 0.0 112.155 -170.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.01 32.87 1.74 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.053 1.341 . . . . 0.0 110.58 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.02 146.1 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.34 -48.83 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.794 1.238 . . . . 0.0 109.669 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.47 163.3 40.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 110.057 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -117.19 150.07 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.7 mt -120.24 132.14 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 t -163.95 161.53 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.715 2.406 . . . . 0.0 108.476 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.3 -39.03 93.43 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.537 169.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.66 167.96 24.95 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.029 1.286 . . . . 0.0 109.34 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.9 tt -162.49 138.02 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.025 1.73 . . . . 0.0 107.751 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -76.29 152.11 36.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.964 -0.46 . . . . 0.0 110.581 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -48.91 -45.64 41.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.507 1.123 . . . . 0.0 111.456 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.768 0.827 . . . . 0.0 108.824 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -60.12 -41.5 92.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.99 0.916 . . . . 0.0 111.903 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -56.03 -65.01 0.67 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.915 0.78 . . . . 0.0 109.252 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -60.38 -28.1 67.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.634 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -55.4 13.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.721 1.146 . . . . 0.0 110.341 176.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.88 -22.25 37.0 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.531 0.605 . . . . 0.0 112.589 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 t -72.44 69.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.029 1.395 . . . . 0.0 110.618 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 -32.49 0.28 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 129.006 2.922 . . . . 0.0 110.259 175.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.82 -6.32 0.6 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.81 136.67 58.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.62 155.46 19.23 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.977 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.3 mt -128.14 118.19 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.63 1.172 . . . . 0.0 108.658 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 60.1 m-85 -106.06 164.36 12.04 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.161 0.984 . . . . 0.0 110.321 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -98.41 145.97 26.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.885 0.766 . . . . 0.0 110.017 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.91 117.16 29.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.598 1.159 . . . . 0.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.24 -9.8 58.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.89 34.39 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.45 -18.26 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 158.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 98.53 0.91 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.985 2.514 . . . . 0.0 107.276 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -48.13 -41.42 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.02 -43.59 74.46 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.385 -0.822 . . . . 0.0 110.35 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -36.07 82.29 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 122.084 -0.385 . . . . 0.0 110.502 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.51 -38.32 74.28 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.736 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.05 -50.32 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -60.4 -36.45 78.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.623 0.647 . . . . 0.0 111.863 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.8 mt -67.89 -44.97 75.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.023 0.44 . . . . 0.0 110.77 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 6' ' ' VAL . 43.6 t80 -59.36 -37.19 77.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.358 1.063 . . . . 0.0 112.839 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.7 mt -64.34 -48.41 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.445 1.098 . . . . 0.0 109.807 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.72 -24.07 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.982 0.81 . . . . 0.0 110.868 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.16 8.37 58.92 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 123.914 0.769 . . . . 0.0 113.279 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -45.64 73.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.128 2.171 . . . . 0.0 109.901 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.62 137.78 42.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 124.204 1.002 . . . . 0.0 110.847 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 t -84.47 157.81 21.22 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 57.0 mtpt -76.35 145.63 39.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.5 mt -63.33 152.41 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.8 p -72.0 -153.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 127.113 2.165 . . . . 0.0 110.538 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.64 85.98 2.05 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 120.696 -1.252 . . . . 0.0 108.942 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--O 1.255 1.372 0 C-N-CA 123.317 2.678 . . . . 0.0 110.674 171.413 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 CA-C-O 118.394 -1.226 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -89.27 -66.76 0.89 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 118.646 1.223 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt -129.72 124.41 33.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 123.806 0.843 . . . . 0.0 111.807 -164.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mm -134.01 143.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.533 2.333 . . . . 0.0 107.496 -167.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 45.65 58.74 4.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.464 1.506 . . . . 0.0 113.101 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -103.11 155.02 18.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.609 1.163 . . . . 0.0 108.328 166.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 143.12 31.9 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.495 1.918 . . . . 0.0 105.981 164.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG21 ' CE2' ' A' ' 93' ' ' PHE . 95.4 t -132.78 137.17 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.49 74.26 0.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.689 0.796 . . . . 0.0 109.553 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.92 120.56 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.888 1.275 . . . . 0.0 109.103 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -67.96 117.92 10.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.046 0.938 . . . . 0.0 111.124 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.2 mmm -124.89 157.11 36.76 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.707 1.603 . . . . 0.0 110.159 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -106.78 -62.02 1.46 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.024 1.73 . . . . 0.0 110.635 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -142.27 -85.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 170.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.71 -8.45 24.3 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 165.93 19.99 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.799 1.24 . . . . 0.0 110.35 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.48 142.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 125.31 1.631 . . . . 0.0 108.036 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -73.18 -179.34 3.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.136 1.375 . . . . 0.0 112.881 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -88.14 -32.3 18.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.553 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.1 t -152.67 177.88 10.21 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.262 1.825 . . . . 0.0 108.289 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.32 -34.87 78.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 128.218 2.607 . . . . 0.0 110.723 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.8 -1.94 45.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.005 0.82 . . . . 0.0 111.979 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -121.1 52.77 1.18 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 p -133.25 173.04 11.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.184 2.994 . . . . 0.0 108.572 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -118.01 -28.65 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.906 1.682 . . . . 0.0 109.385 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -156.42 176.1 13.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.953 0.797 . . . . 0.0 111.78 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -123.08 115.92 22.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.823 2.849 . . . . 0.0 108.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 39' ' ' LYS . 14.2 tp -89.07 103.35 15.97 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.327 2.251 . . . . 0.0 106.424 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 41' ' ' ILE . 14.7 mm -68.79 76.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 129.732 3.213 . . . . 0.0 111.16 174.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -69.14 99.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -76.64 136.49 39.17 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 164.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.14 129.77 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 159.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -132.43 2.19 3.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 t0 174.59 72.13 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.253 3.021 . . . . 0.0 103.217 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.9 -25.56 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 131.146 3.778 . . . . 0.0 116.608 173.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -107.39 166.12 10.89 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.22 118.97 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.107 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 -5.35 8.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 113.203 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.7 m -170.02 168.14 8.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.7 2.4 . . . . 0.0 107.005 166.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 p -136.23 -46.01 0.63 Allowed 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER 44.41 175.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.253 2.621 . . . . 0.0 117.682 -171.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.7 t -143.25 106.02 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 27' ' ' ILE . 47.6 mt -96.49 115.52 36.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 165.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -65.43 162.26 18.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.871 1.669 . . . . 0.0 110.461 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -73.58 80.98 1.49 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 0.0 108.1 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -134.04 168.16 19.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.628 1.171 . . . . 0.0 107.906 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -52.14 -46.46 65.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.199 1.799 . . . . 0.0 109.835 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -70.82 -39.92 72.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.784 1.234 . . . . 0.0 107.933 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -61.31 7.32 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -58.98 -39.54 82.08 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.23 1.012 . . . . 0.0 110.373 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -58.68 -42.44 88.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.137 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -44.42 92.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.578 1.551 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.7 mt -50.75 -43.81 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.15 -32.41 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.976 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -84.31 -25.93 28.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.47 1.032 . . . . 0.0 110.361 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.95 156.62 33.01 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.793 1.237 . . . . 0.0 108.503 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -83.17 28.31 0.53 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.178 1.391 . . . . 0.0 110.916 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.29 134.78 23.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 120.935 1.698 . . . . 0.0 108.559 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -82.26 -44.63 16.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.023 1.729 . . . . 0.0 109.655 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.25 162.2 40.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.121 0.568 . . . . 0.0 110.412 -168.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mt -113.51 141.69 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 171.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.14 122.64 55.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 162.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.04 151.72 38.19 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.914 1.285 . . . . 0.0 110.664 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -65.91 -46.65 77.49 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 163.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -148.21 166.89 26.56 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.83 119.85 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -52.05 138.58 24.88 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.506 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -51.87 -43.1 63.13 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.973 1.709 . . . . 0.0 112.071 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -22.72 66.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 0.0 112.625 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -84.61 -41.5 16.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.571 -0.705 . . . . 0.0 109.891 167.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.94 -59.95 4.29 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.941 1.246 . . . . 0.0 110.721 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -58.35 -22.8 54.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.904 0.482 . . . . 0.0 111.959 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.96 -50.05 8.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.834 1.254 . . . . 0.0 111.098 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -79.59 -24.27 42.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.095 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -60.85 -7.58 2.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.168 0.895 . . . . 0.0 113.302 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -39.33 21.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.332 1.453 . . . . 0.0 113.864 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -165.17 4.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.282 0.947 . . . . 0.0 112.173 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.7 mt -120.95 126.71 75.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.38 136.79 42.45 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.29 132.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.3 151.66 37.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.681 1.192 . . . . 0.0 109.908 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -99.54 134.56 42.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.968 1.707 . . . . 0.0 110.59 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.427 0.632 . . . . 0.0 109.94 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -128.85 26.67 5.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.791 2.436 . . . . 0.0 108.584 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.11 36.78 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.598 -1.314 . . . . 0.0 111.879 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -89.67 -23.93 21.74 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.966 1.306 . . . . 0.0 109.784 165.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.79 104.02 1.0 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.222 1.809 . . . . 0.0 107.705 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.73 -46.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.217 1.007 . . . . 0.0 108.844 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.33 -41.72 93.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.215 0.916 . . . . 0.0 109.609 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -56.54 -44.79 81.2 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.607 -0.683 . . . . 0.0 110.353 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -70.21 -44.93 67.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.096 -0.378 . . . . 0.0 110.894 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -41.52 92.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 97.4 p -68.52 -34.41 75.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.568 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.62 -41.36 84.09 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 120.991 0.424 . . . . 0.0 110.397 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 6' ' ' VAL . 56.0 t80 -61.66 -40.17 93.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.592 0.757 . . . . 0.0 112.051 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.1 mt -51.07 -52.47 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 109.163 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -74.11 -22.52 59.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.048 0.84 . . . . 0.0 112.445 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.65 -3.76 39.51 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.897 -0.946 . . . . 0.0 114.26 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -17.41 62.53 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.677 1.991 . . . . 0.0 113.577 -164.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.67 140.96 49.88 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.8 -1.188 . . . . 0.0 109.149 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -57.35 134.91 56.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -68.77 130.75 43.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 153.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.31 140.3 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 160.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -118.68 176.9 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -42.45 88.62 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 130.971 3.708 . . . . 0.0 113.69 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.248 1.006 0 C-N-CA 123.073 2.516 . . . . 0.0 110.684 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -147.3 -172.37 4.0 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt -144.07 145.73 32.36 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.1 mt -139.05 143.37 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.48 52.47 14.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.381 1.472 . . . . 0.0 111.433 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttp -113.55 137.77 51.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.871 1.268 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -133.85 153.05 52.01 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 126.098 1.759 . . . . 0.0 106.935 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 93' ' ' PHE . 53.4 t -147.04 141.32 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.25 94.09 8.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.55 98.32 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 p -67.95 123.8 21.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.672 1.589 . . . . 0.0 113.032 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.1 mtp -124.46 162.02 24.82 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.453 -1.405 . . . . 0.0 112.403 -171.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.49 -60.76 1.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.681 1.192 . . . . 0.0 109.439 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -146.74 -73.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -122.59 0.46 9.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.944 1.298 . . . . 0.0 111.928 -167.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 178.18 7.34 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.25 -0.907 . . . . 0.0 110.547 165.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.8 mt -52.53 139.98 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.038 1.735 . . . . 0.0 109.156 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -68.39 166.39 16.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.041 1.336 . . . . 0.0 112.964 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.97 -46.29 71.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.39 1.476 . . . . 0.0 112.264 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 t -158.41 168.6 26.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 0.0 109.418 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.95 -33.52 75.53 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.534 1.934 . . . . 0.0 111.112 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.49 24.4 12.66 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.859 1.264 . . . . 0.0 110.198 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -139.99 32.17 1.98 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.829 0.852 . . . . 0.0 109.602 161.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.2 p -108.32 164.42 12.33 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.42 -29.22 9.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.091 0.956 . . . . 0.0 110.004 -171.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 31.8 p90 -159.96 163.53 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.339 0.59 . . . . 0.0 111.909 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.675 ' CD2' HD11 ' A' ' 51' ' ' ILE . 62.8 m-85 -104.87 107.57 18.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.69 1.996 . . . . 0.0 107.498 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -75.12 93.59 2.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -72.98 91.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 121.15 -0.969 . . . . 0.0 108.5 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.88 ' HA ' HG22 ' A' ' 38' ' ' THR . 1.2 p -64.98 165.96 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.541 1.137 . . . . 0.0 109.939 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 127.52 24.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.973 1.715 . . . . 0.0 110.48 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.34 110.94 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 125.63 1.572 . . . . 0.0 107.233 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -118.04 -13.5 9.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.531 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -157.63 63.77 0.47 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 122.875 1.321 . . . . 0.0 108.615 170.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 t30 53.58 18.59 1.48 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.123 2.169 . . . . 0.0 116.08 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.91 171.42 14.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.92 1.688 . . . . 0.0 108.355 170.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 113.24 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -105.35 -39.45 6.15 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.647 -0.658 . . . . 0.0 109.263 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.56 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.447 1.099 . . . . 0.0 108.078 176.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.88 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.7 OUTLIER -159.98 176.93 11.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.513 1.925 . . . . 0.0 108.642 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -158.01 164.48 36.72 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 125.982 1.713 . . . . 0.0 110.903 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.477 0.6 OUTLIER -132.57 141.18 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 128.836 2.854 . . . . 0.0 117.076 164.728 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -129.47 117.82 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 129.695 3.198 . . . . 0.0 104.35 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -64.7 158.55 24.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.856 1.207 . . . . 0.0 111.758 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.84 89.37 4.06 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.578 0.751 . . . . 0.0 109.496 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -144.78 29.63 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.985 0.898 . . . . 0.0 112.546 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 75.24 -55.83 0.63 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.357 2.263 . . . . 0.0 111.771 170.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -60.48 -28.63 68.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.346 1.058 . . . . 0.0 109.864 166.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.04 -49.68 41.89 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -56.97 -39.04 73.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.884 0.842 . . . . 0.0 111.169 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -58.9 -47.16 85.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.463 1.029 . . . . 0.0 111.477 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 m -64.07 -33.54 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.051 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.675 HD11 ' CD2' ' A' ' 25' ' ' PHE . 84.2 mt -55.68 -40.35 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.148 0.885 . . . . 0.0 110.216 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -54.94 -47.12 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -81.21 -13.04 58.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -63.97 -19.34 65.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.221 1.373 . . . . 0.0 111.865 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 55.87 56.53 5.95 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.181 1.392 . . . . 0.0 109.068 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 51' ' ' ILE . 2.5 t -66.31 146.45 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.93 -37.48 13.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.228 2.611 . . . . 0.0 110.578 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.6 168.12 24.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.159 0.983 . . . . 0.0 112.627 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -127.21 119.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.2 132.89 37.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 163.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.9 p -147.55 163.54 36.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.266 0.939 . . . . 0.0 108.672 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -75.07 -40.64 60.02 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 121.48 -0.763 . . . . 0.0 108.994 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -157.46 170.01 23.41 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.4 tt -163.49 124.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.64 0.776 . . . . 0.0 111.017 -170.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -51.15 141.31 14.63 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.56 0.744 . . . . 0.0 111.732 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.87 -45.82 60.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.852 1.661 . . . . 0.0 112.176 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -58.98 -52.43 65.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.97 0.804 . . . . 0.0 110.583 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -63.0 -41.41 99.58 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.227 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.15 -61.28 2.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.651 0.78 . . . . 0.0 109.642 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -63.49 -24.23 67.73 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 119.171 -0.442 . . . . 0.0 112.182 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -61.71 1.71 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.977 0.911 . . . . 0.0 109.517 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.69 -21.82 60.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.752 0.821 . . . . 0.0 112.499 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -63.15 -1.81 1.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -70.22 -32.96 71.09 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.999 -1.688 . . . . 0.0 113.492 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -153.86 13.56 0.46 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.301 1.409 . . . . 0.0 112.573 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -135.36 133.95 52.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -87.91 126.22 34.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.769 1.627 . . . . 0.0 108.601 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.2 mt -109.54 121.75 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.69 -1.256 . . . . 0.0 109.139 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 72.3 m-85 -121.18 146.9 46.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.364 2.266 . . . . 0.0 111.518 -166.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -90.1 146.58 24.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.73 0.412 . . . . 0.0 110.387 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 129.69 36.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.66 20.35 6.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.902 0.881 . . . . 0.0 112.135 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.74 -165.21 38.71 Favored Glycine 0 C--N 1.335 0.506 0 O-C-N 120.496 -1.378 . . . . 0.0 111.675 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.12 1.01 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.116 1.366 . . . . 0.0 109.499 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . 3.0 t70 -86.92 104.75 16.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.6 -42.04 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -64.17 -47.48 79.68 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -168.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 2.7 tptm -61.53 -37.11 82.54 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.997 -1.065 . . . . 0.0 111.862 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.88 -33.8 76.39 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 120.891 -1.13 . . . . 0.0 111.386 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.97 -51.08 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -64.23 -37.68 88.33 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.447 0.567 . . . . 0.0 111.242 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.06 -43.91 94.04 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.065 0.393 . . . . 0.0 110.033 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CE2' HG21 ' A' ' 6' ' ' VAL . 67.2 t80 -59.82 -44.81 93.84 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.72 0.408 . . . . 0.0 111.55 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.0 -48.49 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.228 1.011 . . . . 0.0 109.433 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.69 -36.53 84.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.911 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 9.11 21.34 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.062 -0.854 . . . . 0.0 113.237 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -29.66 59.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.289 1.036 . . . . 0.0 112.063 -167.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.73 138.38 58.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 135.68 42.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.6 mtmm -64.42 132.2 49.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 163.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.65 122.74 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -96.15 102.92 14.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 65.55 159.11 0.13 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 127.268 2.227 . . . . 0.0 113.735 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 123.142 2.562 . . . . 0.0 109.955 154.233 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . 0.491 ' HA3' ' ND2' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.464 0.55 0 CA-C-O 119.217 -0.768 . . . . 0.0 111.726 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 51.13 8.55 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 119.574 3.175 . . . . 0.0 119.574 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt -57.52 130.55 46.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.858 1.208 . . . . 0.0 113.165 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 mt -124.22 151.24 29.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 126.435 1.894 . . . . 0.0 108.789 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.3 t30 61.55 27.81 17.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.321 2.248 . . . . 0.0 113.198 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpp -78.08 149.12 33.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -140.81 140.39 34.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 93' ' ' PHE . 54.7 t -140.69 130.86 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.284 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.26 106.89 18.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -92.32 123.75 44.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 79.3 p -62.43 128.32 35.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.588 1.086 . . . . 0.0 110.613 169.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 mtp -126.66 159.99 32.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.653 1.115 . . . . 0.0 110.689 172.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.22 -65.55 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.152 1.381 . . . . 0.0 107.948 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.54 -73.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 167.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -119.79 9.67 11.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.307 1.051 . . . . 0.0 112.482 -154.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 178.03 8.7 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 128.293 2.637 . . . . 0.0 107.603 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.82 146.03 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 p -83.54 -156.78 0.21 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.715 2.006 . . . . 0.0 111.985 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.55 -21.65 12.62 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 63' ' ' ASN . 96.8 p -154.52 -167.89 2.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.892 1.224 . . . . 0.0 110.789 168.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -79.63 -29.01 40.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.84 1.256 . . . . 0.0 110.969 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -89.26 -43.17 11.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.764 0.711 . . . . 0.0 109.83 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.5 62.39 6.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 9' ' ' SER . 17.8 p -121.98 165.41 16.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.319 149.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -110.36 -29.31 8.18 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.702 1.201 . . . . 0.0 108.805 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.47 169.72 20.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 109.678 167.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.3 119.69 39.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.196 2.198 . . . . 0.0 105.662 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD11 ' HB ' ' A' ' 38' ' ' THR . 1.2 tm? -79.98 105.72 11.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 mm -79.76 98.69 3.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 t -66.14 146.94 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 167.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.08 89.92 2.88 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.05 126.86 29.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 166.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -127.3 1.92 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 118.396 -0.812 . . . . 0.0 113.035 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -166.52 45.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.009 0.909 . . . . 0.0 110.488 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.491 ' ND2' ' HA3' ' A' ' -2' ' ' GLY . 0.8 OUTLIER 60.66 8.56 1.79 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.895 -1.128 . . . . 0.0 114.01 -168.25 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.73 154.27 46.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.693 1.197 . . . . 0.0 109.883 162.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.64 108.12 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 107.757 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -88.95 -30.37 18.86 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.999 -1.063 . . . . 0.0 111.691 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -144.87 164.18 31.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 162.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.411 ' HB ' HD11 ' A' ' 26' ' ' LEU . 20.9 p -118.02 144.88 45.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.763 1.625 . . . . 0.0 106.912 165.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.86 155.59 27.65 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.535 1.134 . . . . 0.0 108.161 169.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.5 132.06 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.76 111.35 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -62.35 152.71 33.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.517 1.053 . . . . 0.0 109.768 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -74.73 88.3 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.67 165.28 27.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.174 1.789 . . . . 0.0 106.225 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -61.16 -39.31 89.64 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.523 -0.736 . . . . 0.0 111.737 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 t -63.97 -45.02 90.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.238 1.015 . . . . 0.0 108.481 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.95 -60.78 8.2 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 125.237 1.398 . . . . 0.0 112.062 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -62.75 -36.59 83.54 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 121.834 -0.804 . . . . 0.0 110.11 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -54.02 -44.87 71.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.637 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.1 m -70.69 -23.46 62.48 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.738 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.98 -46.18 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 121.478 1.944 . . . . 0.0 109.687 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -55.47 -18.11 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.64 . . . . 0.0 112.15 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.68 -14.85 14.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.735 -1.126 . . . . 0.0 112.592 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.06 -27.67 69.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.787 1.63 . . . . 0.0 111.026 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 63.42 53.89 2.06 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 125.238 1.415 . . . . 0.0 109.737 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.75 148.76 10.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -38.33 9.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.416 1.886 . . . . 0.0 110.257 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 161.17 43.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.07 0.548 . . . . 0.0 111.132 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -119.87 142.04 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.178 1.791 . . . . 0.0 107.221 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.34 106.35 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.749 1.22 . . . . 0.0 108.282 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 4.1 m -142.99 173.04 11.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -71.86 -70.82 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.43 ' H ' ' HA ' ' A' ' 18' ' ' SER . 24.5 m-20 -119.58 170.26 9.33 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.532 -1.355 . . . . 0.0 108.021 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.89 137.87 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -68.5 141.32 55.61 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.194 0.997 . . . . 0.0 110.408 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -45.24 -52.35 9.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.355 2.262 . . . . 0.0 111.288 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -39.35 89.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.812 0.445 . . . . 0.0 110.966 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -69.86 -47.5 62.38 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -51.09 -62.97 1.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.38 -36.03 70.73 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.189 0.596 . . . . 0.0 110.993 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -63.95 -59.7 4.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.805 -0.56 . . . . 0.0 110.494 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -75.82 -28.75 58.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.544 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -65.78 -5.68 9.55 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.702 1.201 . . . . 0.0 113.548 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -47.03 -51.49 17.26 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.513 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -140.39 -15.97 0.94 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 87.9 mt -73.03 123.99 29.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.21 147.7 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.25 119.3 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -120.22 154.34 35.0 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.831 1.252 . . . . 0.0 110.555 -170.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -90.13 128.72 36.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 109.662 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.1 123.81 20.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.421 0.688 . . . . 0.0 111.037 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -108.39 100.42 9.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.925 2.09 . . . . 0.0 108.184 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.75 157.77 27.6 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -27.98 62.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.134 2.174 . . . . 0.0 111.823 164.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.8 103.66 6.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.058 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -44.75 -44.48 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 123.719 0.807 . . . . 0.0 109.097 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.17 -34.62 61.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.98 0.355 . . . . 0.0 110.603 -169.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -50.81 -53.16 34.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -67.22 -29.25 68.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.349 -170.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.09 -46.19 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -66.96 -39.3 87.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.887 0.767 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.4 -46.41 90.09 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 6' ' ' VAL . 78.5 t80 -62.05 -40.51 96.02 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 mt -55.68 -49.75 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.626 1.171 . . . . 0.0 109.464 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -73.22 -14.95 61.44 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.544 0.738 . . . . 0.0 112.805 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.81 18.53 63.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.077 0.853 . . . . 0.0 112.3 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.14 -27.92 62.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.548 1.539 . . . . 0.0 112.502 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.39 154.53 40.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.015 1.28 . . . . 0.0 109.464 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.35 149.5 35.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.043 0.937 . . . . 0.0 109.42 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -83.14 136.18 34.54 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 122.104 -0.373 . . . . 0.0 111.551 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.1 mt -65.25 115.98 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -85.25 0.05 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.136 1.374 . . . . 0.0 110.71 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -107.2 147.08 34.51 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.656 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.941 3.094 . . . . 0.0 113.138 -164.472 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 12.2 m170 73.31 -173.36 0.14 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.429 2.291 . . . . 0.0 108.431 -157.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HG2' ' HE1' ' A' ' 4' ' ' MET . 10.9 tpt -133.32 145.61 50.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 173.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.683 HG22 ' H ' ' A' ' 3' ' ' ASN . 2.1 mm -95.17 -161.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.013 2.125 . . . . 0.0 108.164 -178.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.683 ' H ' HG22 ' A' ' 2' ' ' ILE . 17.3 t-20 -53.07 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.195 2.598 . . . . 0.0 110.424 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.447 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 1.4 ttp -110.17 148.49 31.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -131.22 129.65 41.93 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 125.674 1.589 . . . . 0.0 106.747 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.5 t -136.35 132.66 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.5 111.37 22.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.4 123.58 44.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -73.46 127.71 33.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 117.821 0.282 . . . . 0.0 110.279 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtp -130.65 156.63 44.57 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.189 1.396 . . . . 0.0 111.053 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -104.06 -69.93 0.79 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 109.675 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.8 t -146.75 -47.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.23 17.59 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.773 0.797 . . . . 0.0 111.14 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -160.79 172.64 16.67 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 120.481 -1.387 . . . . 0.0 109.087 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.6 138.6 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 107.88 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.3 p -73.38 167.99 20.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.739 0.781 . . . . 0.0 111.025 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.29 -46.11 57.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.266 0.3 OUTLIER -137.89 161.68 36.01 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.59 -1.319 . . . . 0.0 108.441 -175.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -68.33 -45.77 72.03 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.979 -1.076 . . . . 0.0 108.299 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.69 -33.32 75.62 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.374 0.67 . . . . 0.0 110.692 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.73 58.02 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.916 1.341 . . . . 0.0 107.807 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 p -121.35 175.91 5.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.481 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -104.69 -35.34 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.584 0.754 . . . . 0.0 109.53 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 29.5 p90 -156.1 170.76 21.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.422 0.629 . . . . 0.0 110.533 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.87 115.99 27.19 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.022 1.729 . . . . 0.0 107.257 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -79.14 107.28 11.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.01 100.17 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -63.31 137.38 24.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -125.01 118.46 26.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -119.02 139.89 44.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 16.8 m-20 -140.36 7.06 2.15 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.603 0.761 . . . . 0.0 109.517 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -168.44 51.08 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.571 1.548 . . . . 0.0 112.127 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 t30 64.15 -5.3 0.33 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.177 1.791 . . . . 0.0 115.323 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -121.64 154.2 37.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.22 2.208 . . . . 0.0 109.296 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.74 96.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 107.321 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 67.8 mmtt -70.33 -33.31 71.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 171.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 m -161.77 167.09 25.55 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.087 0.858 . . . . 0.0 111.127 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -127.02 118.66 24.9 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.509 1.523 . . . . 0.0 108.77 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.71 168.53 9.01 Favored 'General case' 0 C--O 1.213 -0.861 0 C-N-CA 125.754 1.622 . . . . 0.0 108.792 171.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.79 1.1 p -155.17 124.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 131.085 3.754 . . . . 0.0 115.947 -175.127 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.52 109.41 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 129.586 3.155 . . . . 0.0 102.921 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -61.36 156.11 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.122 0.874 . . . . 0.0 109.654 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -72.43 55.85 0.35 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.84 2.056 . . . . 0.0 111.121 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -107.29 168.57 9.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.2 -43.89 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.854 0.862 . . . . 0.0 109.614 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -77.36 -34.19 55.11 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.21 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.76 17.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.107 0.861 . . . . 0.0 111.25 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 52' ' ' VAL . 53.1 mttt -61.1 -37.68 83.6 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.078 -1.248 . . . . 0.0 109.622 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -59.39 -34.71 72.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.923 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -65.49 -48.69 71.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 119.36 0.982 . . . . 0.0 110.453 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -55.15 -44.16 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.153 0.888 . . . . 0.0 110.521 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 48' ' ' LYS . 62.0 t -55.76 -35.59 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.632 0.773 . . . . 0.0 110.825 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -95.59 -3.09 47.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.915 0.779 . . . . 0.0 112.287 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.91 168.41 18.77 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.757 1.162 . . . . 0.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -95.39 37.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.102 1.761 . . . . 0.0 110.045 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.94 138.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -82.18 -45.62 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.438 1.495 . . . . 0.0 109.968 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.4 158.65 42.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.285 1.034 . . . . 0.0 109.949 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.25 122.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.89 123.02 47.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -148.07 161.15 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.421 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -81.78 -34.21 30.46 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 124.245 1.018 . . . . 0.0 111.335 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -149.85 159.78 44.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.674 1.579 . . . . 0.0 107.533 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.39 136.22 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.946 2.098 . . . . 0.0 108.69 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -77.94 148.88 34.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.22 -38.55 89.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.0 0.52 . . . . 0.0 112.104 -165.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.49 -42.97 99.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.195 0.598 . . . . 0.0 109.4 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -70.35 -31.74 69.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.941 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -58.41 -58.39 8.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.22 1.373 . . . . 0.0 109.655 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -54.95 -43.66 73.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.922 0.489 . . . . 0.0 110.586 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -54.0 -58.58 6.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.006 1.722 . . . . 0.0 111.276 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' HD1' HD12 ' A' ' 76' ' ' ILE . 44.2 m-85 -78.38 -35.3 47.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.34 -0.838 . . . . 0.0 112.983 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.9 t -50.44 -27.19 6.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.547 1.939 . . . . 0.0 111.546 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -45.05 -46.07 11.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.226 1.01 . . . . 0.0 113.094 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -149.03 14.68 0.91 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.198 -172.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.482 HD12 ' HD1' ' A' ' 72' ' ' PHE . 37.6 mt -136.44 122.94 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.29 126.88 31.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.767 1.227 . . . . 0.0 108.647 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.87 129.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -116.49 148.79 40.45 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.885 2.074 . . . . 0.0 109.534 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -88.62 142.16 27.92 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.75 48.99 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 161.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -108.1 8.41 28.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.726 1.61 . . . . 0.0 111.107 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.09 -174.96 39.27 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.872 0.76 . . . . 0.0 111.235 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.78 -14.3 15.27 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.759 1.224 . . . . 0.0 110.635 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.1 106.72 5.08 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.419 1.088 . . . . 0.0 108.199 173.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -54.86 -43.71 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.917 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.47 -34.28 70.06 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.877 0.762 . . . . 0.0 109.039 -168.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -59.02 -49.3 78.43 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 120.853 -1.154 . . . . 0.0 109.448 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -74.04 -28.37 61.39 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.403 -0.811 . . . . 0.0 112.515 -170.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mt -66.0 -55.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.6 p -61.7 -38.73 88.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.331 0.514 . . . . 0.0 112.132 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.1 mt -61.53 -34.17 75.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.05 0.54 . . . . 0.0 111.434 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 6' ' ' VAL . 85.1 t80 -72.79 -41.16 65.29 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.953 -1.092 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 91' ' ' SER . 83.7 mt -51.01 -54.57 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.159 1.384 . . . . 0.0 109.698 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.68 -20.84 63.55 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.694 0.798 . . . . 0.0 111.668 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.45 56.59 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -41.78 88.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.925 1.29 . . . . 0.0 110.366 164.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.58 140.71 53.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.418 1.008 . . . . 0.0 111.968 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.9 m -75.61 142.72 42.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.827 1.251 . . . . 0.0 111.104 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -76.37 150.82 36.78 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 160.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.0 mt -81.85 -55.72 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.258 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.4 76.54 0.08 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.649 1.979 . . . . 0.0 112.781 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.81 85.33 0.16 Allowed Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 123.988 0.915 . . . . 0.0 111.699 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.456 3.437 . . . . 0.0 111.531 -175.651 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -153.82 152.11 30.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.662 1.185 . . . . 0.0 109.166 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt -147.24 122.35 10.14 Favored 'General case' 0 CA--C 1.522 -0.102 0 O-C-N 121.672 -0.642 . . . . 0.0 109.973 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.11 148.38 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t30 56.54 36.85 28.22 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.669 1.588 . . . . 0.0 112.948 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.9 tpp -80.76 148.74 29.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 174.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -137.27 141.59 41.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 165.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 93' ' ' PHE . 42.0 t -139.77 138.65 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.378 171.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.7 104.35 16.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.31 111.37 24.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.2 p -63.21 151.06 41.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.195 1.816 . . . . 0.0 110.513 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 mtp -138.53 160.61 39.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.471 1.508 . . . . 0.0 109.06 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.57 -68.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.797 1.239 . . . . 0.0 108.417 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -142.89 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 120.369 -1.457 . . . . 0.0 108.295 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -118.14 -31.43 5.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.357 1.063 . . . . 0.0 112.199 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -139.44 179.66 6.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.367 1.067 . . . . 0.0 110.176 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.3 mt -51.47 127.36 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.495 1.918 . . . . 0.0 109.098 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 t -71.32 179.18 3.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.676 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -85.35 -31.09 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -161.44 148.17 14.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.393 1.451 . . . . 0.0 112.032 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.62 -27.08 66.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.496 1.518 . . . . 0.0 111.309 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.54 11.53 28.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.483 1.913 . . . . 0.0 113.001 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -139.89 -6.42 1.28 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.394 1.478 . . . . 0.0 112.734 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 p -74.23 161.55 29.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.151 0.581 . . . . 0.0 111.34 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -99.75 -32.58 10.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.147 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.432 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 34.0 p90 -155.61 171.14 20.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.451 -0.78 . . . . 0.0 111.588 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -115.61 115.27 26.13 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.742 2.017 . . . . 0.0 107.283 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -76.55 99.47 4.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.234 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.34 97.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.59 150.06 7.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.995 1.318 . . . . 0.0 108.398 168.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -127.28 132.18 50.37 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.68 143.9 39.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 170.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -147.96 -6.03 0.45 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -152.1 59.08 0.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 160.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.67 -24.19 0.12 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 128.788 2.835 . . . . 0.0 114.718 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -92.27 155.48 17.93 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.658 1.983 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.76 130.52 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.148 1.379 . . . . 0.0 109.108 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.18 -27.61 6.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 m -163.44 164.7 24.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 108.484 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.482 ' HB ' HD11 ' A' ' 26' ' ' LEU . 12.1 p -120.5 148.92 43.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 109.488 171.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.05 155.59 49.74 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.512 1.125 . . . . 0.0 108.805 172.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.6 OUTLIER -124.08 128.71 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 128.714 2.806 . . . . 0.0 117.538 166.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.56 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.98 134.85 53.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.982 0.81 . . . . 0.0 109.051 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' H ' ' HA ' ' A' ' 24' ' ' TYR . 39.6 t30 -80.55 97.14 7.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -144.19 -68.95 0.31 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.317 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 46' ' ' SER . 1.6 pt-20 -155.78 -63.33 0.11 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.555 0.742 . . . . 0.0 109.058 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 39.0 m -53.9 -36.89 63.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.319 170.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.7 -63.07 3.68 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.163 0.887 . . . . 0.0 112.04 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -63.16 -37.13 86.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.856 0.862 . . . . 0.0 112.01 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -56.94 -44.01 82.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.751 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -64.55 -45.85 85.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.685 1.594 . . . . 0.0 111.273 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.8 mt -49.79 -44.45 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 120.156 1.344 . . . . 0.0 110.869 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.39 -31.92 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.245 -0.909 . . . . 0.0 110.964 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 8.64 43.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.867 0.867 . . . . 0.0 110.929 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -168.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -130.31 51.71 2.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.18 147.87 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -98.76 -31.31 11.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.5 1.12 . . . . 0.0 110.534 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.11 161.5 40.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.943 0.497 . . . . 0.0 111.936 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.97 125.37 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.69 114.83 40.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.1 m -141.04 165.5 27.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -69.13 -35.67 76.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.605 1.162 . . . . 0.0 111.207 172.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -155.3 161.8 41.02 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.79 142.65 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.044 1.738 . . . . 0.0 108.123 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -65.94 154.26 39.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.58 -51.74 68.63 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.075 0.55 . . . . 0.0 109.986 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.2 -46.38 88.59 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.08 -35.47 80.59 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.393 0.677 . . . . 0.0 111.791 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -59.92 -60.96 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.736 1.153 . . . . 0.0 109.693 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 104' ' ' PRO . 44.5 mttm -65.37 -21.54 66.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 0.0 110.383 -174.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -70.7 -66.91 0.55 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.443 1.497 . . . . 0.0 109.538 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.17 -18.77 60.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.547 -165.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 p -59.45 -9.35 2.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -74.36 104.79 5.24 Favored 'General case' 0 C--O 1.23 0.075 0 O-C-N 120.6 -1.313 . . . . 0.0 109.901 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 67.78 11.47 8.39 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.437 1.895 . . . . 0.0 114.031 174.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.4 142.84 42.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -109.8 144.03 38.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -122.12 117.35 51.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -164.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.4 148.87 42.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.399 1.88 . . . . 0.0 110.522 -167.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -96.12 118.97 33.77 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.573 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.62 124.83 22.9 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.806 0.843 . . . . 0.0 110.849 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.85 105.31 15.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.874 1.67 . . . . 0.0 107.923 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.7 176.93 49.42 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-O 122.623 1.124 . . . . 0.0 110.921 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.48 24.97 10.94 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.266 1.827 . . . . 0.0 107.046 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.55 105.84 15.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -52.42 -42.88 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.73 -47.06 86.98 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -57.14 -41.58 79.4 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.29 0.495 . . . . 0.0 110.898 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.45 -32.28 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.242 -0.911 . . . . 0.0 111.322 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.2 mt -67.95 -50.85 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 p -62.06 -42.96 99.73 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.937 0.789 . . . . 0.0 111.164 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.55 -43.31 99.09 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.956 0.502 . . . . 0.0 109.976 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 6' ' ' VAL . 55.8 t80 -65.46 -48.46 72.61 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -52.61 -36.41 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.789 1.235 . . . . 0.0 110.237 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.05 -12.39 58.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.395 1.078 . . . . 0.0 113.538 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.94 4.38 88.62 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.838 1.209 . . . . 0.0 112.719 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -27.09 63.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.271 1.028 . . . . 0.0 112.572 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.56 145.64 55.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.688 0.677 . . . . 0.0 110.497 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -78.98 151.8 31.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.989 0.916 . . . . 0.0 108.615 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -81.0 134.84 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.46 131.52 22.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -65.92 152.25 44.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.18 143.16 92.76 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.254 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HE2' ' A' ' 70' ' ' LYS . 85.6 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 C-N-CA 123.075 2.517 . . . . 0.0 109.684 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.56 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -132.05 179.23 6.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.197 0.999 . . . . 0.0 108.675 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt -141.73 147.88 38.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.533 -0.73 . . . . 0.0 109.259 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.6 mm -127.63 154.98 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.346 1.458 . . . . 0.0 108.692 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 54.58 21.25 3.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.433 1.893 . . . . 0.0 113.457 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.52 134.18 35.2 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.747 -1.845 . . . . 0.0 108.763 -169.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -138.36 113.48 9.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.511 0.724 . . . . 0.0 109.298 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG21 ' CE2' ' A' ' 93' ' ' PHE . 27.5 t -120.44 144.61 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 102.45 13.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.798 1.239 . . . . 0.0 108.61 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mt -84.85 128.18 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 p -75.49 123.36 25.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 117.984 0.356 . . . . 0.0 111.001 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.7 mtp -123.19 154.71 38.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.254 1.022 . . . . 0.0 111.116 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -107.43 -61.57 1.54 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.716 2.006 . . . . 0.0 109.732 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.4 t -140.11 -76.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.38 14.32 8.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.031 0.933 . . . . 0.0 110.965 -169.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 21.3 ptmt -148.67 169.73 19.74 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.883 1.273 . . . . 0.0 108.649 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.17 131.39 28.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -67.35 159.09 30.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.577 0.751 . . . . 0.0 110.099 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -51.49 -36.02 42.74 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.698 0.799 . . . . 0.0 111.623 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -158.47 178.26 10.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.047 0.385 . . . . 0.0 111.377 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -73.15 -10.11 59.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.757 2.423 . . . . 0.0 111.817 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -107.87 -10.0 15.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.844 -1.16 . . . . 0.0 112.643 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -116.3 10.19 14.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.094 1.357 . . . . 0.0 110.415 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.9 p -70.13 164.47 24.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.716 -1.24 . . . . 0.0 110.038 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -119.95 -21.48 7.11 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.216 1.806 . . . . 0.0 109.898 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -158.88 176.42 12.35 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.956 0.884 . . . . 0.0 110.45 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -124.48 111.07 15.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.924 2.49 . . . . 0.0 106.212 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 39' ' ' LYS . 17.9 tp -79.04 110.7 14.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -84.47 93.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.17 148.07 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.31 1.844 . . . . 0.0 107.892 171.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -133.9 86.75 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -80.81 130.6 35.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.15 1.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.01 64.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 159.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.28 10.6 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.133 1.373 . . . . 0.0 114.41 -172.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -138.29 150.37 46.58 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.48 1.912 . . . . 0.0 108.779 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.22 95.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 128.021 2.528 . . . . 0.0 108.374 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -88.77 -27.21 21.29 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.907 -1.121 . . . . 0.0 110.88 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.85 178.87 8.53 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.467 1.031 . . . . 0.0 109.704 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -140.27 178.48 7.26 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.508 1.523 . . . . 0.0 109.542 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.558 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -160.27 162.82 33.73 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.924 2.089 . . . . 0.0 107.036 177.096 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.22 142.4 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.2 mt -128.14 109.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 166.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -60.3 142.14 55.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.564 1.074 . . . . 0.0 110.609 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -77.94 65.57 3.39 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.873 1.669 . . . . 0.0 108.949 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.01 95.15 2.52 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 52.71 -69.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.348 3.059 . . . . 0.0 115.465 157.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -44.95 -33.35 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.574 1.95 . . . . 0.0 110.88 157.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.27 -67.22 2.28 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 124.019 0.819 . . . . 0.0 111.371 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.66 -27.12 66.59 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -52.85 -51.46 60.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.686 1.13 . . . . 0.0 110.634 163.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -70.67 -20.93 62.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.986 0.514 . . . . 0.0 112.079 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.18 -11.73 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.592 1.157 . . . . 0.0 111.035 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.77 -23.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 119.906 -1.746 . . . . 0.0 111.16 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -114.7 52.64 0.84 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.537 1.062 . . . . 0.0 110.155 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -168.07 2.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.69 32.76 4.08 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.13 1.772 . . . . 0.0 109.397 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.67 140.92 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.94 -37.39 12.26 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.827 1.251 . . . . 0.0 109.168 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.33 151.45 26.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.229 1.012 . . . . 0.0 111.476 -171.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.5 mt -98.48 151.96 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 165.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.7 mt -124.28 130.05 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 161.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.1 p -146.65 160.82 41.7 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.88 1.272 . . . . 0.0 109.689 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -66.66 -47.72 71.62 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 167.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -154.88 172.87 17.33 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.0 tt -167.26 121.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -169.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -56.49 146.71 23.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -48.98 -43.99 40.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.341 1.456 . . . . 0.0 111.348 -174.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.25 -49.72 66.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.646 -0.658 . . . . 0.0 112.118 177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -58.28 -41.28 84.01 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.704 1.202 . . . . 0.0 109.849 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -59.35 -63.27 1.36 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.408 1.083 . . . . 0.0 109.529 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HE3' ' HG3' ' A' ' 66' ' ' GLU . 36.9 mttt -62.38 -21.89 65.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.711 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -72.76 -60.45 2.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.133 0.973 . . . . 0.0 110.03 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -75.46 -10.46 59.47 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.0 p -63.58 -9.02 11.36 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -77.2 117.93 19.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 120.414 -1.429 . . . . 0.0 108.311 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? 75.4 -31.48 0.21 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.335 3.054 . . . . 0.0 112.47 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mt -103.67 120.13 53.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.4 153.98 31.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.98 116.74 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.316 -1.49 . . . . 0.0 107.111 -166.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 7.1 m-85 -113.17 160.64 18.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.534 1.933 . . . . 0.0 110.703 -168.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -99.46 130.89 45.76 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 0.0 110.617 -173.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 131.04 36.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.019 0.927 . . . . 0.0 109.526 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -110.26 15.64 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.421 1.488 . . . . 0.0 112.271 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.76 172.64 31.14 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 13.0 m-20 -83.61 -24.13 31.6 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.567 0.747 . . . . 0.0 109.673 151.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.1 106.86 4.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.1 0.56 . . . . 0.0 109.776 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.6 -46.93 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.147 0.979 . . . . 0.0 109.517 168.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.0 -58.3 9.03 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -45.09 -49.55 11.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.974 1.309 . . . . 0.0 110.853 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.69 -41.56 87.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.953 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.58 -48.15 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -15.03 63.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.47 ' CB ' HD11 ' A' ' 98' ' ' LEU . 44.4 mt -83.71 -38.84 20.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.371 1.442 . . . . 0.0 109.226 172.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.513 ' CE2' HG21 ' A' ' 6' ' ' VAL . 54.5 t80 -65.21 -41.42 94.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -169.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.14 -45.93 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.288 2.235 . . . . 0.0 110.728 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.31 -19.52 56.3 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.942 -1.099 . . . . 0.0 111.816 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.0 39.27 63.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -17.88 62.02 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.086 0.943 . . . . 0.0 109.054 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -89.54 124.92 34.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 m -72.67 153.72 41.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.617 169.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 9.3 mtpm? -61.19 144.06 54.4 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.9 mt -66.09 150.57 10.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.516 1.126 . . . . 0.0 108.275 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.7 m -136.67 -29.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.358 1.063 . . . . 0.0 111.596 167.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -128.94 85.6 59.69 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 126.798 2.039 . . . . 0.0 107.592 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 C--O 1.251 1.137 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 153.574 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -148.64 157.9 43.77 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.624 1.169 . . . . 0.0 107.886 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt -137.23 137.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 122.867 0.467 . . . . 0.0 109.916 172.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.5 142.66 41.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.986 0.914 . . . . 0.0 109.551 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 44.65 66.31 0.9 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.166 2.986 . . . . 0.0 113.267 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.3 ttt -107.15 147.82 29.6 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -133.66 129.22 36.53 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.9 t -132.54 144.84 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 118.314 -0.85 . . . . 0.0 108.707 168.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.35 77.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.384 1.073 . . . . 0.0 108.785 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.23 141.89 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 0.0 109.68 -165.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 p -74.46 115.73 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.71 0.631 . . . . 0.0 111.491 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.1 mtp -122.21 148.49 44.89 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.27 -0.894 . . . . 0.0 111.102 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.98 -75.34 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 109.54 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 t -144.12 -46.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.598 1.159 . . . . 0.0 107.925 -167.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.53 2.35 1.24 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.56 -179.9 8.51 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 126.858 2.063 . . . . 0.0 108.808 -176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.9 139.29 19.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.3 p -69.71 -84.52 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.704 1.602 . . . . 0.0 110.271 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 t30 177.0 -55.03 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 127.518 2.327 . . . . 0.0 107.304 -167.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.3 t -126.42 -175.15 3.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.931 1.242 . . . . 0.0 110.228 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -85.4 -43.3 13.76 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.3 1.44 . . . . 0.0 108.544 166.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.66 -19.43 60.84 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.028 -0.42 . . . . 0.0 110.414 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -119.96 74.32 1.02 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.0 p -134.27 165.16 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.212 1.805 . . . . 0.0 107.825 151.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -90.45 -37.43 13.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.352 0.661 . . . . 0.0 109.783 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.31 171.09 19.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.673 0.749 . . . . 0.0 110.456 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.04 108.8 16.19 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.091 2.556 . . . . 0.0 106.304 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 39' ' ' LYS . 1.3 tm? -78.72 103.71 8.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.456 HD11 HD12 ' A' ' 41' ' ' ILE . 5.3 mm -79.19 88.36 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.558 0.695 . . . . 0.0 109.192 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -58.24 125.88 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 168.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -103.53 110.09 22.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.26 143.65 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 161.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -136.05 -0.36 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.92 45.52 0.28 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.665 0.745 . . . . 0.0 110.136 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.6 -9.7 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.252 2.221 . . . . 0.0 115.318 -167.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.99 163.46 22.27 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.105 1.32 . . . . 0.0 111.648 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -44.51 128.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 128.375 2.67 . . . . 0.0 111.159 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -91.17 -86.92 0.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.52 -0.66 9.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.316 1.416 . . . . 0.0 113.904 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 p 49.61 -166.4 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.894 -1.129 . . . . 0.0 110.723 -160.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -174.44 166.35 3.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.488 2.315 . . . . 0.0 107.442 165.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.89 132.3 65.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.456 HD12 HD11 ' A' ' 27' ' ' ILE . 55.9 mt -127.84 119.54 51.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 168.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.32 157.96 35.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.533 1.06 . . . . 0.0 110.722 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -84.11 65.21 8.63 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.884 -1.135 . . . . 0.0 108.578 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -130.55 28.42 4.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.236 1.017 . . . . 0.0 113.717 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 70.9 -54.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 128.759 2.824 . . . . 0.0 111.231 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.8 t -53.68 -36.27 61.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.085 1.354 . . . . 0.0 110.583 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.59 8.53 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 125.243 1.402 . . . . 0.0 111.891 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.83 -34.7 69.98 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.97 -0.724 . . . . 0.0 110.959 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -49.74 -44.03 48.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.018 0.927 . . . . 0.0 111.438 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -43.7 85.51 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.345 0.658 . . . . 0.0 111.315 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.6 -37.85 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 110.258 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -54.61 -45.43 71.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.138 0.427 . . . . 0.0 110.626 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -34.84 66.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.12 -14.75 62.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.859 -159.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 44.96 63.63 1.66 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.556 1.542 . . . . 0.0 109.355 -172.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.21 140.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.223 157.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -73.61 -47.82 37.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.1 40.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.22 108.0 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.23 125.37 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -142.51 177.02 8.57 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.573 1.149 . . . . 0.0 108.925 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 81' ' ' ALA . 59.4 mttm -88.2 -38.45 15.29 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.273 -0.892 . . . . 0.0 110.972 166.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.65 162.79 35.04 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.495 1.043 . . . . 0.0 109.189 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 tt -165.56 132.72 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.257 1.423 . . . . 0.0 108.53 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.1 p -65.02 157.91 27.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.157 0.983 . . . . 0.0 112.162 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -50.8 -53.64 30.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.502 1.521 . . . . 0.0 110.635 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -38.5 79.31 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.42 0.628 . . . . 0.0 111.294 -166.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.96 -37.78 72.78 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.967 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -55.69 -57.01 13.78 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 120.045 1.293 . . . . 0.0 111.154 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -57.19 -43.51 82.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.774 0.716 . . . . 0.0 110.533 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -53.43 -69.36 0.12 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.648 1.579 . . . . 0.0 110.129 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -68.37 -36.69 79.57 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.346 0.521 . . . . 0.0 110.854 -169.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.2 t -54.14 -24.37 17.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.516 1.526 . . . . 0.0 112.908 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -65.2 -10.52 32.23 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.697 -1.252 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -156.16 3.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.932 1.696 . . . . 0.0 112.942 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -141.21 125.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.87 133.34 35.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.87 138.03 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 120.644 -1.285 . . . . 0.0 108.845 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -129.81 156.3 44.56 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.537 1.935 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -98.15 137.65 36.61 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.043 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . . . -88.49 122.92 32.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.274 2.23 . . . . 0.0 112.498 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.09 108.93 20.51 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.716 2.006 . . . . 0.0 109.939 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.48 -176.7 53.6 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -163.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -118.14 -2.21 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.918 0.887 . . . . 0.0 110.211 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.67 103.48 7.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.21 1.004 . . . . 0.0 108.475 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.45 -38.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.144 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.29 -40.97 86.15 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.878 0.763 . . . . 0.0 109.697 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -64.29 -43.04 96.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.875 -0.516 . . . . 0.0 110.727 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.18 -33.23 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.459 -1.401 . . . . 0.0 110.483 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.79 -51.68 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.548 1.539 . . . . 0.0 108.088 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 p -75.01 -18.75 60.31 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HB3' HD11 ' A' ' 98' ' ' LEU . 90.7 mt -74.83 -37.74 62.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 6' ' ' VAL . 80.2 t80 -67.79 -42.58 81.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.776 -0.577 . . . . 0.0 111.963 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 mt -51.86 -50.99 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.72 1.608 . . . . 0.0 108.377 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.8 -18.39 62.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.529 1.132 . . . . 0.0 113.978 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.65 23.11 54.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 118.85 0.75 . . . . 0.0 111.919 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -28.6 66.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.118 1.459 . . . . 0.0 109.32 -170.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 1.2 mm? -82.11 135.73 35.27 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.78 1.232 . . . . 0.0 108.899 -163.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.5 p -71.06 157.45 38.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.469 1.107 . . . . 0.0 108.842 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -87.87 132.86 34.04 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.72 120.48 17.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -138.84 -4.86 1.54 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.781 1.632 . . . . 0.0 111.09 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -153.98 68.54 6.11 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.283 1.833 . . . . 0.0 108.897 -173.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.246 0.915 0 C-N-CA 124.421 3.414 . . . . 0.0 109.715 169.726 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.433 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 39.1 m170 59.27 178.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.703 1.201 . . . . 0.0 110.929 -167.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.07 127.39 32.09 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 111.029 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.62 146.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.547 1.539 . . . . 0.0 108.601 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' A' ' 31' ' ' ASP . 1.8 m-80 47.51 32.92 2.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.423 1.889 . . . . 0.0 115.061 172.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.9 151.06 31.17 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.663 -1.273 . . . . 0.0 107.625 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 155.04 50.29 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 156.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 28' ' ' VAL . 7.3 p -146.68 165.74 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 128.097 2.559 . . . . 0.0 104.903 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 25' ' ' PHE . . . -114.45 133.6 55.63 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 120.178 1.353 . . . . 0.0 111.646 153.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mt -105.43 119.29 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -62.45 114.32 3.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.864 1.211 . . . . 0.0 108.715 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.7 mtp -117.98 156.31 28.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 110.906 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.31 -69.63 0.76 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 127.752 2.421 . . . . 0.0 108.27 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 t -137.71 -67.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 168.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.3 -7.24 11.78 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 171.48 13.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.505 1.522 . . . . 0.0 110.058 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -59.54 139.32 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 p -84.04 166.42 17.74 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.528 0.731 . . . . 0.0 111.076 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -50.47 -43.99 55.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.833 1.653 . . . . 0.0 113.934 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.08 168.36 19.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.409 0.549 . . . . 0.0 110.133 -166.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -67.72 -23.45 65.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.01 1.724 . . . . 0.0 112.499 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.79 -30.19 13.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.791 1.178 . . . . 0.0 111.54 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.74 10.12 8.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.221 1.408 . . . . 0.0 111.809 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.5 p -80.1 167.62 20.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 122.174 0.988 . . . . 0.0 110.631 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -108.12 -28.71 9.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.516 1.526 . . . . 0.0 109.217 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -159.36 178.35 10.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.603 0.638 . . . . 0.0 111.451 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.463 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 78.8 m-85 -125.49 105.64 9.2 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 129.24 3.016 . . . . 0.0 106.612 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.83 111.99 11.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 27.1 mm -81.24 98.32 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 6' ' ' VAL . 2.9 t -63.96 132.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.08 98.51 6.11 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 163.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.37 152.75 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HA ' ' H ' ' A' ' 3' ' ' ASN . 2.8 m-20 -138.41 -20.35 1.06 Allowed 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -161.31 68.59 0.31 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 169.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.6 m120 54.9 10.62 0.4 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.301 2.241 . . . . 0.0 115.269 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -129.23 158.54 38.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.379 1.072 . . . . 0.0 112.503 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.49 96.13 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.709 1.604 . . . . 0.0 107.753 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -100.48 -20.21 15.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.202 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -156.78 148.89 23.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.248 1.385 . . . . 0.0 111.167 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 p -126.18 156.94 39.39 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.534 1.934 . . . . 0.0 109.427 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 162.26 37.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.729 1.211 . . . . 0.0 108.881 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.82 112.11 23.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.26 115.57 34.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 161.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -66.77 158.09 31.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.081 1.31 . . . . 0.0 110.524 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.22 81.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -130.3 -170.97 2.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.685 1.231 . . . . 0.0 108.739 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.51 -49.92 75.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.33 1.852 . . . . 0.0 111.061 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.3 m -65.46 -37.68 87.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.894 0.316 . . . . 0.0 110.776 175.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.48 -62.98 5.73 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 123.552 0.596 . . . . 0.0 112.795 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -59.67 -28.93 67.69 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.589 0.756 . . . . 0.0 111.219 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -71.35 -32.51 68.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.943 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -65.22 -38.22 89.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 119.257 0.935 . . . . 0.0 110.357 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -62.49 -17.31 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 118.753 0.706 . . . . 0.0 111.715 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.7 t -82.2 -30.18 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 119.51 -1.994 . . . . 0.0 112.205 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.83 54.84 1.13 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.544 1.138 . . . . 0.0 109.08 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 -165.14 1.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.854 1.662 . . . . 0.0 111.017 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.46 19.33 7.44 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.199 2.2 . . . . 0.0 108.94 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 58' ' ' ALA . 44.7 t -67.4 166.06 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.95 1.25 . . . . 0.0 109.944 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.72 -33.34 6.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 109.522 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.662 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -144.6 163.11 34.91 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -161.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.4 mt -134.14 118.34 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 163.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mt -81.08 133.35 29.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 120.488 1.494 . . . . 0.0 107.171 166.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 p -144.51 168.13 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.86 1.209 . . . . 0.0 112.251 168.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -93.4 -27.2 16.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 117.455 -1.259 . . . . 0.0 112.727 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -161.26 161.37 30.7 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.005 1.722 . . . . 0.0 107.061 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -151.46 127.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 126.403 1.881 . . . . 0.0 108.515 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -54.8 148.35 13.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.125 0.97 . . . . 0.0 110.442 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -61.6 -38.8 88.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.416 1.007 . . . . 0.0 111.524 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.21 -51.65 62.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -57.81 -43.13 85.47 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -56.41 -58.57 7.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.128 0.422 . . . . 0.0 110.145 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.46 -20.67 66.45 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 122.374 -0.204 . . . . 0.0 111.275 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -75.44 -35.74 60.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.18 -0.95 . . . . 0.0 111.941 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.09 -16.67 18.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.698 0.799 . . . . 0.0 111.812 -172.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.82 -17.45 56.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -71.99 106.99 4.48 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 120.566 -1.334 . . . . 0.0 109.611 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 tttm 73.95 21.28 2.66 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.143 1.777 . . . . 0.0 111.954 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.64 144.11 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.597 1.559 . . . . 0.0 107.742 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -102.59 108.8 20.21 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.42 114.83 30.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -105.92 149.15 26.85 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.685 1.194 . . . . 0.0 110.117 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -83.13 147.17 28.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.78 168.05 20.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 109.924 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.6 5.9 14.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.419 2.287 . . . . 0.0 112.366 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.96 -169.37 41.8 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.15 -14.17 34.14 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.539 1.135 . . . . 0.0 110.0 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.66 99.35 2.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.744 1.218 . . . . 0.0 109.659 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -52.97 -42.05 42.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.37 -38.49 71.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.116 0.871 . . . . 0.0 110.305 -171.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -57.14 -50.35 73.09 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.61 -31.74 65.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.1 -54.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.895 1.278 . . . . 0.0 108.053 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.579 ' HA ' HD12 ' A' ' 94' ' ' ILE . 35.6 p -66.82 -36.57 82.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.357 0.526 . . . . 0.0 111.184 -172.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.3 mt -63.93 -40.46 96.5 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.243 0.617 . . . . 0.0 111.171 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -63.85 -34.42 77.88 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.478 0.711 . . . . 0.0 112.223 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 91' ' ' SER . 58.4 mt -59.21 -45.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 -18.55 60.7 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.214 1.006 . . . . 0.0 112.135 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.73 14.17 81.4 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.468 -0.77 . . . . 0.0 112.217 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -19.9 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.631 1.973 . . . . 0.0 112.592 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -67.13 140.81 57.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.016 -1.052 . . . . 0.0 109.492 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.0 m -64.6 125.51 24.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.452 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -81.04 126.88 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.4 mt -74.17 143.07 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -168.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 -52.95 2.81 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.27 1.028 . . . . 0.0 112.403 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.25 149.83 62.02 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.211 3.274 . . . . 0.0 110.989 176.912 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.23 168.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.382 1.873 . . . . 0.0 113.374 -172.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt -120.51 127.3 52.06 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.8 mt -122.06 148.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.47 23.21 10.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.998 1.719 . . . . 0.0 113.42 171.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpp -68.57 147.06 52.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -134.34 141.09 46.78 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 166.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 93' ' ' PHE . 44.9 t -140.24 140.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 110.02 21.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.493 0.717 . . . . 0.0 109.436 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.7 mt -95.07 123.96 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 p -80.91 112.19 18.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtp -108.87 158.12 17.97 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -108.08 -53.13 2.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 127.738 2.415 . . . . 0.0 109.143 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.26 -79.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.41 -3.37 16.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.134 0.974 . . . . 0.0 112.003 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 171.23 16.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.304 1.842 . . . . 0.0 110.955 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.5 mt -64.98 124.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.738 1.615 . . . . 0.0 107.3 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 t -66.55 173.1 3.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.155 0.889 . . . . 0.0 111.229 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.67 -27.75 67.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.53 0.732 . . . . 0.0 111.749 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 p -147.69 177.2 9.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.69 -0.631 . . . . 0.0 110.373 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -69.26 -37.28 77.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.511 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -88.48 -39.24 14.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.481 0.713 . . . . 0.0 109.629 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.27 31.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.648 2.379 . . . . 0.0 111.276 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 p -99.28 172.53 7.29 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 119.968 -1.707 . . . . 0.0 111.096 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -103.59 -30.05 10.73 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.592 1.557 . . . . 0.0 110.065 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.427 ' HE2' HD23 ' A' ' 26' ' ' LEU . 41.2 p90 -166.82 176.94 6.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CG ' HD11 ' A' ' 51' ' ' ILE . 41.9 m-85 -123.7 102.55 7.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 126.409 1.884 . . . . 0.0 107.29 -169.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.427 HD23 ' HE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -81.84 103.32 11.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.87 95.42 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.349 1.86 . . . . 0.0 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 t -76.2 92.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.83 115.99 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 156.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.59 131.89 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.06 3.03 3.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.55 44.33 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 111.545 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 t30 61.55 8.16 2.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.007 0.923 . . . . 0.0 112.577 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -134.18 165.41 25.15 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 126.967 2.107 . . . . 0.0 111.212 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -61.82 128.73 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 127.068 2.147 . . . . 0.0 109.614 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.15 -85.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.757 -0.639 . . . . 0.0 109.7 167.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -15.19 14.45 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 44.84 -168.34 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.373 1.069 . . . . 0.0 112.11 -163.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 163.43 8.57 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 125.164 1.385 . . . . 0.0 109.784 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.669 0.7 OUTLIER -118.91 140.16 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 119.456 3.132 . . . . 0.0 119.456 159.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.7 mt -124.56 122.93 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 129.261 3.024 . . . . 0.0 105.175 164.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -68.01 155.57 39.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.365 1.893 . . . . 0.0 111.057 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 45.0 t30 -77.31 61.79 2.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.52 1.528 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -97.38 161.92 13.57 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 165.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -44.04 93.35 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.113 -0.992 . . . . 0.0 108.324 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -70.4 -16.23 62.93 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.962 -1.086 . . . . 0.0 111.293 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -64.03 2.89 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 166.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 25' ' ' PHE 0.253 43.3 pttt -65.87 -23.37 66.64 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.76 -0.847 . . . . 0.0 111.977 -172.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -38.57 83.92 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 171.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -72.86 -32.08 65.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.925 1.29 . . . . 0.0 110.172 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.434 HD11 ' CG ' ' A' ' 25' ' ' PHE . 58.8 mt -55.07 -42.97 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.78 1.232 . . . . 0.0 109.761 176.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.12 -26.36 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.406 -0.809 . . . . 0.0 111.667 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -97.7 -28.22 14.0 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.865 0.866 . . . . 0.0 110.97 -172.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -25.52 63.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.695 1.198 . . . . 0.0 111.884 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.2 t30 74.2 51.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.406 2.282 . . . . 0.0 109.958 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -50.82 152.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.868 1.667 . . . . 0.0 109.324 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -42.97 10.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.091 1.357 . . . . 0.0 109.175 171.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.24 160.12 42.72 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.3 mt -116.42 144.0 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.685 1.194 . . . . 0.0 107.962 171.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.8 mt -123.04 121.28 62.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.0 p -149.3 170.81 17.64 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.773 1.229 . . . . 0.0 109.345 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -82.66 -40.04 21.25 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.104 167.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -147.64 164.42 33.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.502 1.501 . . . . 0.0 109.61 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.5 tt -144.77 145.38 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.406 1.482 . . . . 0.0 109.095 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -62.49 155.47 25.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.197 0.908 . . . . 0.0 109.562 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.04 -43.37 87.75 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 118.824 0.738 . . . . 0.0 109.04 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.39 -45.24 94.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 110.666 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -61.79 -47.94 82.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.783 1.233 . . . . 0.0 109.263 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.56 -58.94 5.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.724 1.147 . . . . 0.0 110.541 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.51 -22.39 66.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.581 0.628 . . . . 0.0 111.892 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -76.66 -44.04 35.51 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 120.829 -1.169 . . . . 0.0 110.885 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -88.04 -8.28 55.8 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.148 0.979 . . . . 0.0 112.753 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 p -73.26 43.14 0.13 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.835 1.652 . . . . 0.0 112.551 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -139.91 111.84 7.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.412 1.885 . . . . 0.0 106.662 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? 60.81 -1.22 0.25 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 113.948 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.5 mt -131.27 134.25 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -169.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.56 130.49 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.499 1.52 . . . . 0.0 107.034 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.5 mt -104.17 118.5 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -110.29 155.38 22.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.237 1.815 . . . . 0.0 110.821 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -99.06 118.1 35.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.798 1.239 . . . . 0.0 110.348 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.95 135.15 57.7 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 168.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -16.24 55.98 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.291 1.036 . . . . 0.0 112.722 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.89 -178.73 46.87 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 126.11 1.814 . . . . 0.0 109.078 -149.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -96.48 -15.35 21.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.097 0.959 . . . . 0.0 110.042 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.41 99.81 2.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.45 1.5 . . . . 0.0 110.014 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.57 -41.79 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.27 -39.28 89.31 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.8 0.727 . . . . 0.0 110.997 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -46.23 90.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.519 0.676 . . . . 0.0 109.517 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -74.17 -26.22 60.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.0 mt -67.19 -51.26 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.006 0.821 . . . . 0.0 108.797 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.8 p -71.38 -33.05 69.17 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.429 0.558 . . . . 0.0 111.503 -173.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -42.68 95.88 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.69 -0.631 . . . . 0.0 110.268 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 6' ' ' VAL . 31.7 t80 -57.89 -47.56 82.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.781 0.433 . . . . 0.0 111.872 -177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 mt -51.03 -56.49 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.168 1.387 . . . . 0.0 111.119 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -73.43 -1.93 20.32 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.055 1.298 . . . . 0.0 113.573 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.61 86.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.263 0.935 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -27.56 67.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.077 1.751 . . . . 0.0 112.146 -173.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.22 144.42 57.15 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.46 139.39 49.61 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.33 -0.857 . . . . 0.0 110.188 172.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.92 123.0 30.76 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.8 mt -71.82 140.56 17.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.475 1.11 . . . . 0.0 109.752 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.48 120.81 27.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.606 1.162 . . . . 0.0 108.074 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 76.08 0.55 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.661 1.584 . . . . 0.0 112.205 166.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 123.579 2.853 . . . . 0.0 111.364 170.055 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.567 0 CA-C-O 118.762 -1.021 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 60.72 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 110.394 -146.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt -160.76 137.08 8.53 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.364 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 31' ' ' ASP . 13.2 mt -146.8 46.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.352 0.596 . . . . 0.0 112.097 -173.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 t30 173.54 42.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.846 2.059 . . . . 0.0 107.509 163.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 146.79 32.94 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 120.598 -1.314 . . . . 0.0 108.127 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -145.85 120.41 9.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.892 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.9 152.98 25.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 109.613 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.75 120.62 40.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.653 1.181 . . . . 0.0 108.359 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.15 118.9 54.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -63.2 105.41 0.71 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.757 0.823 . . . . 0.0 109.636 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.15 155.85 22.26 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -93.71 -76.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.603 1.961 . . . . 0.0 107.393 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -139.61 -56.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 1.26 3.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -160.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -156.6 173.79 16.41 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.252 2.221 . . . . 0.0 108.519 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.31 139.31 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.788 0.68 . . . . 0.0 111.147 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 163.48 21.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 111.308 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.83 -16.82 60.02 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -166.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.46 172.63 17.92 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.672 1.989 . . . . 0.0 107.335 170.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.18 -50.54 73.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.34 1.056 . . . . 0.0 108.768 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -74.5 -44.49 51.13 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -165.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.9 4.15 0.91 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 128.55 2.74 . . . . 0.0 113.641 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 p -67.57 165.92 15.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 123.057 1.408 . . . . 0.0 110.742 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -106.58 -30.75 8.84 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.919 1.687 . . . . 0.0 108.688 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 28.2 p90 -155.35 164.94 38.07 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.158 0.98 . . . . 0.0 109.834 172.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.55 112.48 25.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.04 114.01 14.2 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HB ' ' CB ' ' A' ' 39' ' ' LYS . 5.0 mm -84.04 93.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.08 101.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -91.72 121.6 33.51 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -125.75 115.69 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 2' ' ' ILE . 5.1 m-20 -126.63 -0.64 6.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.387 -169.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.09 61.24 0.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.135 0.969 . . . . 0.0 110.433 156.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.63 6.89 0.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.238 1.815 . . . . 0.0 114.679 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.18 163.29 23.48 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.1 2.56 . . . . 0.0 109.378 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.91 74.96 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 122.408 1.099 . . . . 0.0 108.101 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -57.37 -29.58 64.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.909 1.684 . . . . 0.0 112.118 -170.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 m -154.82 115.26 3.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.401 1.0 . . . . 0.0 108.845 164.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -64.02 141.62 58.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 161.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -143.09 161.2 38.8 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 124.53 1.132 . . . . 0.0 109.274 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.474 0.6 OUTLIER -142.53 132.44 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 178.602 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.488 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 66.0 mt -119.59 113.13 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -65.46 152.07 44.84 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.773 0.715 . . . . 0.0 109.439 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -75.57 87.38 2.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.57 174.99 10.0 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.57 2.748 . . . . 0.0 105.038 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -62.13 -38.64 89.71 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.487 -1.383 . . . . 0.0 111.567 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 t -61.43 -18.56 59.43 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.697 -0.627 . . . . 0.0 111.316 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.488 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -75.23 -61.09 3.1 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -66.91 -15.4 63.64 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.368 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -60.98 -64.57 0.91 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.837 1.199 . . . . 0.0 109.639 161.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.3 m -54.13 -37.73 64.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.991 0.916 . . . . 0.0 113.344 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.4 mt -50.74 -40.4 19.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.075 1.35 . . . . 0.0 111.608 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.48 -46.88 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.082 -1.012 . . . . 0.0 109.063 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -73.66 -21.77 60.17 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.833 0.853 . . . . 0.0 112.978 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.81 -26.65 63.41 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.346 -0.847 . . . . 0.0 111.094 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 74.25 38.33 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.849 1.66 . . . . 0.0 112.536 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.44 138.13 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.558 1.143 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -66.48 -56.68 9.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.019 1.728 . . . . 0.0 108.74 168.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.82 29.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -169.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.56 148.44 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.5 mt -119.41 123.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.35 2.26 . . . . 0.0 104.978 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.76 154.33 31.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.803 1.638 . . . . 0.0 111.141 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -71.94 -25.9 62.07 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.34 -0.85 . . . . 0.0 111.124 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -172.23 166.15 5.96 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.84 132.84 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.017 0.436 . . . . 0.0 110.285 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.42 147.25 32.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.528 0.731 . . . . 0.0 109.622 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -48.71 79.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.343 1.057 . . . . 0.0 110.506 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -56.67 -47.97 78.64 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -64.51 -44.94 89.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.724 1.21 . . . . 0.0 110.424 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -54.9 -64.88 0.7 Allowed 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 118.682 0.674 . . . . 0.0 109.552 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -57.02 -33.15 66.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.771 0.828 . . . . 0.0 111.518 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -71.33 -34.34 70.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.56 1.944 . . . . 0.0 113.457 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -99.26 -23.39 15.21 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.706 0.685 . . . . 0.0 112.541 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -68.68 15.24 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -166.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -19.04 13.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.754 1.161 . . . . 0.0 113.151 -174.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -34.78 0.48 Allowed 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.188 -0.945 . . . . 0.0 113.188 175.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.6 mt -89.53 127.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.95 145.44 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.132 0.973 . . . . 0.0 108.66 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -113.67 122.67 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 120.377 -1.452 . . . . 0.0 107.748 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -105.81 156.07 18.68 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.43 1.892 . . . . 0.0 108.257 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -68.06 177.19 2.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.283 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.75 149.54 48.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.959 1.303 . . . . 0.0 110.45 165.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.421 ' OE1' HD22 ' A' ' 98' ' ' LEU 0.254 19.6 mp0 -106.22 -162.35 0.85 Allowed 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 129.09 2.956 . . . . 0.0 106.097 -165.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.3 166.88 0.04 OUTLIER Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.043 -1.035 . . . . 0.0 114.272 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -23.3 19.53 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.185 1.794 . . . . 0.0 113.555 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . 2.4 t0 -72.13 101.83 2.87 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 125.083 1.489 . . . . 0.0 107.645 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -53.55 -39.89 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -39.7 82.38 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -174.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 1.4 tppp? -59.3 -45.58 90.9 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.24 -0.912 . . . . 0.0 109.339 170.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.93 -38.8 89.6 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.453 1.024 . . . . 0.0 111.046 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.07 -49.45 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 108.522 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 p -65.98 -36.89 84.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.813 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.4 mt -61.67 -44.44 96.96 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.709 0.686 . . . . 0.0 109.22 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -57.78 -57.25 13.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.288 0.635 . . . . 0.0 110.91 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.6 mt -51.82 -34.42 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.496 1.919 . . . . 0.0 111.183 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -84.96 -14.86 46.22 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 24.61 54.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 119.509 1.05 . . . . 0.0 112.395 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -24.54 36.19 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.793 1.237 . . . . 0.0 112.54 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD22 ' OE1' ' A' ' 82' ' ' GLU . 29.3 mt -73.18 142.92 47.39 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.274 1.035 . . . . 0.0 110.402 -171.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 133.27 34.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 110.819 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -72.07 142.76 49.24 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.48 107.94 6.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.9 p -79.66 90.66 5.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 108.913 166.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 65.39 162.06 0.12 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 127.984 2.514 . . . . 0.0 112.778 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.604 -1.344 . . . . 0.0 108.604 156.024 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.525 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 56.01 10.9 0.64 Allowed 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 126.061 1.744 . . . . 0.0 115.255 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 4' ' ' MET . 0.5 OUTLIER 45.0 128.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -171.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.01 147.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.793 172.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.58 56.89 1.93 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.341 2.656 . . . . 0.0 112.162 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.426 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 25.1 tpp -83.78 149.33 26.5 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.907 0.776 . . . . 0.0 109.928 170.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -142.56 132.95 24.93 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.232 0.958 . . . . 0.0 108.491 153.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 28' ' ' VAL . 4.9 p -128.93 166.14 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 128.523 2.729 . . . . 0.0 107.439 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.64 110.47 13.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.37 1.468 . . . . 0.0 109.74 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -94.72 122.65 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.242 0.928 . . . . 0.0 108.932 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 p -72.11 97.45 1.93 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.128 1.371 . . . . 0.0 109.95 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.0 mtp -102.98 154.73 18.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.27 1.028 . . . . 0.0 110.6 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.79 -61.08 1.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.2 t -141.7 -71.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.77 10.72 7.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.8 1.286 . . . . 0.0 112.944 -167.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 175.54 12.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.811 2.444 . . . . 0.0 108.948 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.42 140.72 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.763 1.225 . . . . 0.0 108.456 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 t -73.61 -87.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -178.48 -36.45 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.795 1.638 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.27 154.32 36.56 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.336 0.588 . . . . 0.0 110.332 -177.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.48 -48.32 82.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.766 0.826 . . . . 0.0 110.047 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -78.17 -6.41 54.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.395 0.678 . . . . 0.0 112.804 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.16 -16.71 14.03 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.08 0.854 . . . . 0.0 111.063 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.0 p -72.62 170.65 14.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 122.154 0.978 . . . . 0.0 111.755 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -106.09 -26.32 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.881 1.272 . . . . 0.0 110.331 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -161.22 166.49 27.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.518 0.675 . . . . 0.0 110.364 170.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CD2' HD11 ' A' ' 51' ' ' ILE . 91.1 m-85 -105.36 116.41 31.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.423 1.489 . . . . 0.0 108.044 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.61 118.44 20.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 170.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -92.0 95.11 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.394 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.562 ' HB ' HG12 ' A' ' 6' ' ' VAL . 1.9 t -78.33 104.09 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.82 140.8 36.69 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 156.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 145.19 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 164.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.19 18.64 0.36 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.98 52.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 128.506 2.722 . . . . 0.0 107.263 169.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.75 2.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 129.288 3.035 . . . . 0.0 113.694 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.16 150.84 40.67 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 128.203 2.601 . . . . 0.0 107.876 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.3 91.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.042 2.137 . . . . 0.0 109.884 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -53.55 -70.16 0.1 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 110.979 174.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -151.79 112.71 4.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -69.26 164.17 23.37 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.23 1.412 . . . . 0.0 110.452 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 164.79 30.18 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 125.944 1.698 . . . . 0.0 108.534 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.54 148.23 26.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mt -134.33 105.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 166.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -57.34 145.46 32.26 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.61 97.95 0.34 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.406 1.882 . . . . 0.0 106.096 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -51.26 67.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.068 0.947 . . . . 0.0 109.339 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 t -68.45 -26.54 65.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.968 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -63.58 4.97 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -65.39 -22.61 66.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.461 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -68.96 -47.42 65.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.222 1.374 . . . . 0.0 109.039 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -44.6 73.16 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 110.102 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 25' ' ' PHE . 58.1 mt -52.59 -35.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.648 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.21 -40.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 120.586 -1.321 . . . . 0.0 110.649 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.2 -8.75 44.57 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.346 0.658 . . . . 0.0 111.854 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.3 -16.37 33.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.538 1.535 . . . . 0.0 111.226 166.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 53.29 36.47 22.83 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.985 1.714 . . . . 0.0 111.031 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.13 134.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -73.05 -39.63 65.75 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.422 1.889 . . . . 0.0 110.519 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.58 165.47 26.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mt -131.45 132.5 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.068 1.347 . . . . 0.0 107.5 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -104.12 130.97 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -146.46 175.83 10.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.649 0.659 . . . . 0.0 111.32 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -96.9 -24.27 15.93 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.099 1.36 . . . . 0.0 111.47 164.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -155.74 161.33 40.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.075 1.75 . . . . 0.0 108.311 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.82 130.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.833 1.653 . . . . 0.0 108.643 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -63.41 147.1 52.14 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.417 1.087 . . . . 0.0 110.489 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -55.29 -45.17 76.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.247 2.219 . . . . 0.0 111.998 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.37 -50.95 63.62 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.721 -0.612 . . . . 0.0 109.743 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -62.51 -39.13 92.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.75 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -51.53 -56.61 12.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.396 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -61.6 -43.26 99.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.198 0.599 . . . . 0.0 110.45 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -59.35 -40.91 87.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.19 1.396 . . . . 0.0 112.783 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -92.39 -34.66 14.07 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.259 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 t -70.56 16.33 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.144 1.778 . . . . 0.0 114.185 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -100.64 -17.26 17.11 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.977 1.711 . . . . 0.0 113.031 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -145.22 -6.57 0.64 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.838 0.855 . . . . 0.0 112.776 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.7 mt -136.19 133.5 50.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -165.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.72 113.34 22.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.586 1.554 . . . . 0.0 108.307 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.05 130.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 100' ' ' LYS . 88.1 m-85 -126.45 146.62 50.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.759 1.224 . . . . 0.0 109.799 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -95.62 119.53 34.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.539 1.135 . . . . 0.0 109.332 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.43 119.72 10.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.69 -12.6 61.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.66 172.34 44.14 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -166.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.2 -5.14 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.883 0.873 . . . . 0.0 109.812 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.51 102.71 8.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.493 1.917 . . . . 0.0 107.386 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -52.44 -40.31 32.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.23 -45.7 72.55 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 118.36 0.527 . . . . 0.0 110.393 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -57.7 -37.18 73.04 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.943 0.497 . . . . 0.0 110.764 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -77.46 -22.6 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.232 -0.918 . . . . 0.0 112.191 -176.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.2 mt -70.87 -50.78 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 p -61.65 -48.21 81.89 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.685 0.675 . . . . 0.0 111.035 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.2 mt -56.51 -47.02 80.23 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.24 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.1 -44.9 87.89 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.759 0.823 . . . . 0.0 112.426 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.96 -41.09 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.55 -13.22 59.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.055 0.843 . . . . 0.0 112.638 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.51 -1.29 61.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.535 1.064 . . . . 0.0 113.758 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -12.48 61.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.386 2.274 . . . . 0.0 115.461 -171.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.77 143.15 57.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.823 1.647 . . . . 0.0 108.25 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -72.34 142.14 48.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 7.3 mtpt -80.17 150.98 29.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -83.76 133.89 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 m -138.05 -42.48 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.927 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -131.06 80.15 69.69 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.412 1.485 . . . . 0.0 109.717 173.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 C--O 1.247 0.961 1 C-N-CA 125.496 4.131 . . . . 0.0 111.972 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -64.23 178.52 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.161 0.981 . . . . 0.0 109.911 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt -132.95 124.58 28.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.123 -0.986 . . . . 0.0 108.427 -169.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 mm -116.63 138.52 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 t30 45.42 63.99 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.302 1.041 . . . . 0.0 112.01 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpp -94.47 151.97 18.94 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -141.53 138.55 32.82 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 167.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG21 ' CE2' ' A' ' 93' ' ' PHE . 36.1 t -133.47 148.33 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB3' HG12 ' A' ' 59' ' ' ILE . . . -105.87 105.1 14.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.662 0.785 . . . . 0.0 108.981 168.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.73 117.73 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.2 p -73.55 111.16 8.42 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mmm -113.86 161.28 17.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 110.094 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.23 -73.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.951 1.3 . . . . 0.0 108.06 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.26 -45.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -135.58 -13.7 1.97 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.2 174.39 12.03 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.31 1.444 . . . . 0.0 107.901 -171.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mt -54.48 139.46 13.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.162 0.982 . . . . 0.0 108.524 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 p -68.33 163.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.485 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -71.58 -31.15 66.65 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.83 -0.544 . . . . 0.0 111.586 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.88 158.67 33.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.383 0.992 . . . . 0.0 109.859 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 59' ' ' ILE . 65.1 t80 -66.05 -39.72 90.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -78.74 1.27 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.16 1.17 8.5 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.846 0.859 . . . . 0.0 111.394 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 p -67.79 169.7 9.23 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.928 -1.107 . . . . 0.0 111.201 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -110.75 -25.7 9.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.124 1.37 . . . . 0.0 109.078 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 40' ' ' VAL . 22.8 p90 -158.3 170.83 21.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.03 0.919 . . . . 0.0 111.488 174.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -114.44 102.42 10.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.073 2.549 . . . . 0.0 106.259 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -77.79 97.65 5.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.4 mm -68.91 124.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.929 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.05 126.96 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 126.395 1.878 . . . . 0.0 105.934 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.68 97.51 6.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 165.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.81 149.55 5.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 163.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.23 133.77 10.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.648 1.179 . . . . 0.0 109.03 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t0 46.44 44.93 13.47 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.892 1.805 . . . . 0.0 110.945 -167.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 70.17 -13.8 0.42 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.686 3.195 . . . . 0.0 114.825 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.94 165.88 11.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.473 1.909 . . . . 0.0 110.091 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.2 129.47 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.786 -1.197 . . . . 0.0 111.616 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -100.02 -44.66 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 t -165.33 166.46 18.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.8 161.96 26.19 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.931 1.693 . . . . 0.0 108.039 -172.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.12 31.66 Favored 'General case' 0 C--O 1.19 -2.033 0 O-C-N 120.139 -1.601 . . . . 0.0 109.65 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 24' ' ' TYR 0.462 1.4 p -107.98 124.95 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 160.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -108.09 112.84 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.635 2.774 . . . . 0.0 103.747 165.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -59.4 154.59 16.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.824 1.193 . . . . 0.0 110.156 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -81.3 85.93 6.33 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -152.81 175.55 12.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.286 1.035 . . . . 0.0 109.129 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -52.61 -52.17 56.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.059 1.344 . . . . 0.0 110.509 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -5.78 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.762 0.425 . . . . 0.0 110.914 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.6 -69.76 1.38 Allowed Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -55.74 -29.05 58.9 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.513 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -34.92 63.85 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 120.16 1.345 . . . . 0.0 111.072 176.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -87.58 -24.16 24.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 116.582 -1.675 . . . . 0.0 113.034 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 54' ' ' GLU . 62.2 mt -63.53 -30.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 121.357 1.89 . . . . 0.0 109.364 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.26 -3.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 119.82 -1.8 . . . . 0.0 111.314 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -110.53 21.99 15.97 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.114 -0.991 . . . . 0.0 109.517 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.55 ' CG ' ' HA ' ' A' ' 51' ' ' ILE . 8.1 pt-20 -138.63 144.67 39.83 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.969 -2.332 . . . . 0.0 111.215 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.85 62.51 7.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 109.409 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.01 134.88 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.63 -48.5 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.02 156.7 43.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 7' ' ' ALA . 94.4 mt -110.57 136.99 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 166.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.35 124.37 65.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.88 167.62 23.47 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -80.02 -32.51 39.58 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.381 -0.824 . . . . 0.0 112.01 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -155.98 173.76 16.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.458 1.026 . . . . 0.0 109.611 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.3 tt -165.14 154.67 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.802 1.241 . . . . 0.0 108.418 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -81.22 153.12 27.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.871 0.869 . . . . 0.0 112.128 169.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.56 -51.51 65.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.613 1.965 . . . . 0.0 110.929 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.61 -39.89 88.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -41.61 87.83 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.739 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -51.76 -63.79 1.02 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.83 -24.43 67.54 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.96 -0.462 . . . . 0.0 111.705 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -76.83 -36.11 57.09 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -98.52 -24.04 15.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.078 1.308 . . . . 0.0 112.062 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -71.86 9.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.622 1.969 . . . . 0.0 113.028 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -80.72 -0.13 37.06 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.965 -1.084 . . . . 0.0 113.517 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -165.63 -64.15 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.779 0.832 . . . . 0.0 109.858 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.91 144.67 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.953 . . . . 0.0 107.82 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -113.17 126.33 55.32 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 125.101 1.361 . . . . 0.0 109.477 -169.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.63 131.48 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 120.105 -1.622 . . . . 0.0 109.483 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 50.6 m-85 -116.04 150.63 36.96 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.76 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -80.14 135.82 36.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.99 128.1 34.35 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -24.82 43.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.725 0.774 . . . . 0.0 112.294 -174.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.52 161.53 28.9 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 127.308 2.385 . . . . 0.0 107.519 -159.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.54 -9.79 59.68 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.621 1.168 . . . . 0.0 110.343 -167.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.56 98.84 2.39 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.211 1.404 . . . . 0.0 108.686 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 t -51.36 -40.83 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 121.759 -0.588 . . . . 0.0 110.356 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -40.35 87.22 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.664 0.385 . . . . 0.0 110.4 -171.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -42.65 95.92 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.343 0.592 . . . . 0.0 110.783 171.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.809 -0.557 . . . . 0.0 110.661 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.22 -50.25 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.302 1.041 . . . . 0.0 108.781 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 p -64.21 -35.27 80.27 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.756 0.707 . . . . 0.0 111.475 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -66.14 -37.34 85.44 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.263 -0.898 . . . . 0.0 111.091 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 6' ' ' VAL . 71.6 t80 -67.72 -44.04 78.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.183 0.593 . . . . 0.0 111.865 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.9 -41.26 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.266 1.027 . . . . 0.0 109.862 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -79.67 -30.83 41.31 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.48 4.38 52.79 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.021 -0.877 . . . . 0.0 113.985 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -39.22 81.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.228 1.411 . . . . 0.0 111.513 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.57 131.98 50.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.188 0.595 . . . . 0.0 110.722 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.32 156.97 30.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.57 1.176 . . . . 0.0 110.632 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 61.9 mtpt -82.58 156.32 24.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.651 171.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.26 155.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.99 -154.75 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.737 1.615 . . . . 0.0 111.846 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.27 86.11 0.28 Allowed Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 126.22 1.808 . . . . 0.0 109.488 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 N--CA 1.451 -1.019 0 CA-C-O 117.222 -1.241 . . . . 0.0 109.27 166.333 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -131.07 138.09 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 65.25 52.02 1.52 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.442 2.297 . . . . 0.0 113.254 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 ttt -82.87 154.53 24.58 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.245 168.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 15.6 mtpp -147.73 121.8 9.48 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.467 HG21 ' CE2' ' A' ' 93' ' ' PHE . 40.7 t -125.62 156.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.595 1.089 . . . . 0.0 108.902 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.47 118.1 35.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.543 1.137 . . . . 0.0 108.25 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.37 129.43 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.6 p -79.49 104.79 10.34 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.985 1.314 . . . . 0.0 109.576 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.92 151.74 22.11 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.174 -0.954 . . . . 0.0 111.011 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.36 -85.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.42 -39.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 O-C-N 119.883 -1.76 . . . . 0.0 108.238 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.74 3.35 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 -178.63 5.91 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.584 -1.323 . . . . 0.0 110.371 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.2 mt -53.58 127.52 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.746 1.619 . . . . 0.0 109.807 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.1 p -72.41 161.42 30.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.981 0.912 . . . . 0.0 110.248 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.93 -41.24 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -157.46 161.07 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -58.2 -42.58 86.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.353 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -15.33 57.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.052 1.741 . . . . 0.0 113.179 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.12 10.03 8.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.924 0.89 . . . . 0.0 112.734 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 p -64.9 160.71 19.94 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.652 -1.28 . . . . 0.0 109.616 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -107.55 -29.85 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.227 1.411 . . . . 0.0 107.886 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -153.55 167.0 30.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.755 0.788 . . . . 0.0 109.821 167.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -104.58 126.58 51.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.704 2.002 . . . . 0.0 108.063 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.13 113.89 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 166.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -83.32 105.03 12.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.96 141.91 14.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -117.12 123.45 46.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.046 1.739 . . . . 0.0 106.523 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 mt -124.02 136.4 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -136.03 -6.72 2.1 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.036 -173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.08 67.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.22 5.34 0.11 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.889 2.076 . . . . 0.0 115.201 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -134.2 152.62 51.91 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.366 1.466 . . . . 0.0 109.231 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.16 108.13 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.42 1.888 . . . . 0.0 109.393 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -96.62 -6.11 37.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.665 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 p -170.83 179.55 3.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.299 1.409 . . . . 0.0 111.069 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -147.93 168.48 22.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.402 1.081 . . . . 0.0 111.002 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.68 153.98 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 109.559 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.79 115.91 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.85 109.51 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -59.54 155.9 14.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.718 1.144 . . . . 0.0 109.92 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.07 65.93 0.89 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.222 0.609 . . . . 0.0 112.225 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -136.43 81.53 1.89 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.1 -72.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.403 1.881 . . . . 0.0 113.713 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -56.21 -25.93 49.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.234 1.813 . . . . 0.0 111.063 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -61.57 7.0 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 125.198 1.38 . . . . 0.0 111.813 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -58.0 -36.48 72.72 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.144 0.978 . . . . 0.0 110.87 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -52.3 -47.31 66.0 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 111.006 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.6 m -63.09 -37.93 89.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.252 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.9 mt -52.54 -38.16 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.485 1.114 . . . . 0.0 110.202 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -59.72 -48.94 85.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.54 -0.725 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -82.09 -14.14 56.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.39 1.076 . . . . 0.0 112.442 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 28.5 mm-40 -64.28 -23.14 67.19 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.775 1.17 . . . . 0.0 111.206 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 55.4 54.97 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.437 1.095 . . . . 0.0 109.681 -170.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.66 147.61 8.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.917 0.887 . . . . 0.0 109.286 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -78.53 -48.18 15.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.502 1.921 . . . . 0.0 110.099 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.43 158.48 41.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.199 0.6 . . . . 0.0 112.289 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.1 mt -110.77 147.02 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.98 135.59 60.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.2 p -155.47 161.21 41.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.655 1.182 . . . . 0.0 109.691 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -73.29 -36.42 66.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.241 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.71 165.97 33.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.257 1.39 . . . . 0.0 109.098 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 tt -140.28 153.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 107.845 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.2 p -77.1 150.86 35.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.584 0.353 . . . . 0.0 110.45 163.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -58.55 -45.11 89.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.771 0.828 . . . . 0.0 110.257 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.98 -50.43 72.13 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.924 -0.485 . . . . 0.0 111.171 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.24 -35.99 81.85 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.747 0.419 . . . . 0.0 109.984 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -54.65 -54.69 38.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.396 0.543 . . . . 0.0 110.215 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -58.39 -26.3 63.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 111.659 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -71.46 -62.15 1.51 Allowed 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.014 0.824 . . . . 0.0 110.205 171.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -77.27 -25.96 51.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.779 -164.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -73.53 30.77 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.735 2.014 . . . . 0.0 112.621 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.84 13.7 13.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.449 1.9 . . . . 0.0 111.575 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 mttt 179.11 -11.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.012 2.125 . . . . 0.0 113.172 164.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -116.39 128.98 73.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -77.42 121.84 24.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.537 1.135 . . . . 0.0 108.44 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.5 mt -100.08 127.39 53.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -118.32 154.61 32.05 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.254 1.422 . . . . 0.0 110.252 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.39 135.47 33.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.415 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.36 151.76 46.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 160.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -125.77 24.03 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.778 2.431 . . . . 0.0 109.428 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.09 -169.84 42.29 Favored Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.837 -1.164 . . . . 0.0 112.325 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.97 -21.55 9.45 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.961 2.105 . . . . 0.0 108.335 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.07 104.25 6.51 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.8 -40.64 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.81 -35.83 70.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.986 0.812 . . . . 0.0 110.265 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -61.17 -39.76 91.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.371 -0.831 . . . . 0.0 110.642 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -73.92 -27.28 60.95 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.179 -0.95 . . . . 0.0 111.276 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.65 -52.09 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p -58.64 -44.58 90.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 111.241 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.6 mt -61.92 -37.66 85.48 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.644 -0.66 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' HG21 ' A' ' 6' ' ' VAL . 77.1 t80 -70.1 -39.48 75.51 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.536 -0.728 . . . . 0.0 111.842 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.33 -44.2 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.648 1.179 . . . . 0.0 109.226 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.06 -16.03 45.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 19.92 63.73 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.009 0.822 . . . . 0.0 112.41 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.28 -22.56 60.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 111.916 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.52 137.7 54.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.86 0.754 . . . . 0.0 110.224 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.4 m -69.27 126.36 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.543 1.537 . . . . 0.0 111.809 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -74.7 119.21 18.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.672 1.189 . . . . 0.0 108.632 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.242 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG2' ' HE1' ' A' ' 4' ' ' MET . 12.9 tpt . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.3 mt -132.06 145.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 73.3 11.42 4.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.375 1.47 . . . . 0.0 114.27 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.426 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 2.7 tpp -74.51 145.7 43.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.585 1.084 . . . . 0.0 110.146 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -131.91 144.22 50.69 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.827 1.251 . . . . 0.0 107.734 161.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -136.45 143.81 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.593 1.157 . . . . 0.0 108.434 172.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.54 124.37 44.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.935 0.894 . . . . 0.0 109.243 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.5 125.89 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 108.167 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -83.07 96.34 8.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.218 1.009 . . . . 0.0 110.747 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.5 mtp -94.3 164.94 12.82 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.121 1.368 . . . . 0.0 111.174 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.97 -60.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.375 1.47 . . . . 0.0 108.946 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -142.95 -68.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -132.4 9.03 4.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.631 1.205 . . . . 0.0 112.479 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -155.35 173.09 17.14 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.041 2.536 . . . . 0.0 107.954 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.67 147.48 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -81.57 -85.26 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.831 0.852 . . . . 0.0 111.097 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -174.58 -39.09 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.373 1.469 . . . . 0.0 108.714 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -145.66 -171.29 3.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.013 0.37 . . . . 0.0 111.526 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -95.01 -8.09 37.83 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.398 1.879 . . . . 0.0 111.244 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 6.15 10.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 112.095 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -137.47 0.75 2.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.711 1.604 . . . . 0.0 109.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 p -76.46 166.62 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.126 0.97 . . . . 0.0 110.989 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -101.98 -35.77 8.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.418 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -154.31 173.59 15.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.837 0.827 . . . . 0.0 110.518 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -116.9 113.41 22.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 128.047 2.539 . . . . 0.0 106.676 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.38 108.36 13.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.7 94.66 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 145.3 12.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 166.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -134.12 123.49 24.52 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.0 mt -118.0 128.26 75.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -126.88 -19.07 4.53 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -155.76 74.04 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 162.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.43 10.78 1.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.6 2.36 . . . . 0.0 114.146 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -137.69 161.49 36.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.637 2.375 . . . . 0.0 110.085 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.99 115.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -117.28 -17.95 10.04 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.835 -1.166 . . . . 0.0 112.667 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -149.79 162.67 39.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.744 1.156 . . . . 0.0 108.752 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -144.38 160.54 40.87 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.942 1.297 . . . . 0.0 108.357 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.5 155.68 42.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.354 1.861 . . . . 0.0 107.703 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.9 t -111.78 145.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 168.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mt -135.08 109.5 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.24 146.94 14.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.043 0.838 . . . . 0.0 110.55 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.51 82.22 3.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.51 172.39 12.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 129.734 3.214 . . . . 0.0 104.586 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.39 -40.48 95.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.28 -0.887 . . . . 0.0 113.389 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.0 t -67.84 -21.35 65.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -67.78 1.99 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.461 1.13 . . . . 0.0 111.471 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -59.45 -54.66 44.06 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.9 1.227 . . . . 0.0 109.183 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -54.77 -39.69 68.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.379 0.672 . . . . 0.0 111.114 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mt -57.45 -46.71 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.014 0.825 . . . . 0.0 110.749 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -57.2 -39.57 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.571 0.623 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.3 7.86 30.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.198 0.999 . . . . 0.0 112.612 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.54 152.15 21.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.758 1.163 . . . . 0.0 108.915 172.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.73 43.65 0.34 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.783 1.233 . . . . 0.0 110.715 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.85 137.6 24.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 166.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.25 -36.76 14.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.44 159.95 41.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.251 0.62 . . . . 0.0 109.629 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.26 142.66 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.8 mt -107.56 131.29 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 167.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.1 p -150.69 158.04 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 167.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -72.96 -44.17 61.44 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.128 163.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -135.55 155.17 50.92 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 tt -153.21 119.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -59.94 146.79 41.1 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.199 0.6 . . . . 0.0 109.569 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.79 -47.64 67.42 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.395 2.278 . . . . 0.0 111.545 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -25.47 67.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.969 0.508 . . . . 0.0 111.275 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -84.13 -47.46 10.86 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.318 1.047 . . . . 0.0 110.27 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -54.98 -53.27 57.87 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.668 1.122 . . . . 0.0 110.239 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -57.76 -22.63 48.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.406 1.083 . . . . 0.0 112.56 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -79.59 -60.99 2.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.924 0.89 . . . . 0.0 109.096 173.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -65.92 -33.54 76.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.802 -166.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -65.81 -10.14 35.06 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -16.35 32.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.203 1.401 . . . . 0.0 114.385 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -154.55 -45.58 0.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.693 -1.255 . . . . 0.0 109.673 166.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.1 mt -63.46 138.04 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.79 1.236 . . . . 0.0 108.223 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -92.39 126.36 37.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.131 1.372 . . . . 0.0 107.538 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.62 130.02 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.66 148.0 44.51 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.256 1.423 . . . . 0.0 109.392 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -80.86 143.88 32.41 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.353 1.061 . . . . 0.0 108.705 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.86 116.79 23.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.509 0.671 . . . . 0.0 109.324 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.02 79.68 0.66 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.236 1.414 . . . . 0.0 108.243 163.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.01 25.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.137 0.854 . . . . 0.0 114.034 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.7 -14.25 40.35 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.414 1.485 . . . . 0.0 110.4 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -82.02 100.84 9.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.044 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.62 -49.02 6.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 123.941 0.896 . . . . 0.0 109.575 170.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.36 -39.75 77.89 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.882 0.765 . . . . 0.0 110.503 -169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -56.89 -41.75 78.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -75.32 -34.63 61.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.091 0.556 . . . . 0.0 112.244 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mt -61.6 -53.78 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p -62.47 -46.22 89.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.795 0.438 . . . . 0.0 111.282 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.83 -39.98 82.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.909 0.322 . . . . 0.0 110.513 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 6' ' ' VAL . 23.6 t80 -66.46 -50.39 63.5 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.362 0.665 . . . . 0.0 111.747 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.76 -36.72 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.977 0.911 . . . . 0.0 109.759 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.33 -5.41 59.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.068 1.347 . . . . 0.0 113.332 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.48 86.51 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.766 -1.575 . . . . 0.0 113.112 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -29.28 67.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.291 1.437 . . . . 0.0 114.18 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.74 137.82 58.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.478 1.035 . . . . 0.0 110.684 -174.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 p -78.74 130.51 35.86 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.941 0.897 . . . . 0.0 109.885 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -71.85 148.7 45.92 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.21 -0.931 . . . . 0.0 109.633 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--O 1.239 0.517 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.508 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 C--O 1.233 0.23 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 mt -138.49 143.68 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.566 1.146 . . . . 0.0 110.134 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.262 58.6 t30 44.62 45.54 7.98 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.966 2.506 . . . . 0.0 112.733 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.43 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.2 tpp -72.47 145.69 47.38 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 163.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -136.32 137.97 41.21 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 163.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.537 HG21 ' CE2' ' A' ' 93' ' ' PHE . 70.1 t -137.99 140.47 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.6 99.06 8.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.684 1.194 . . . . 0.0 108.72 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.72 114.16 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 p -68.32 128.62 37.24 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.317 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mtp -127.14 162.0 27.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.759 1.223 . . . . 0.0 110.805 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.7 -61.92 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.293 1.437 . . . . 0.0 109.53 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.14 -46.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 O-C-N 120.841 -1.162 . . . . 0.0 109.441 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -140.3 2.69 1.89 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.283 0.633 . . . . 0.0 112.211 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -157.57 175.21 14.24 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.449 1.5 . . . . 0.0 110.537 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.7 141.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.8 p -70.6 159.29 34.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.204 0.525 . . . . 0.0 110.643 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.02 -34.48 78.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.962 1.305 . . . . 0.0 111.266 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 167.12 25.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.506 0.722 . . . . 0.0 111.492 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -72.85 -53.31 11.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 18.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.211 1.405 . . . . 0.0 111.848 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.18 5.52 1.11 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.563 1.945 . . . . 0.0 110.934 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 p -80.1 172.44 13.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.719 -1.238 . . . . 0.0 110.15 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -111.94 -24.58 9.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.672 1.589 . . . . 0.0 110.589 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -160.12 175.07 13.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.952 0.796 . . . . 0.0 110.071 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CD1' HD11 ' A' ' 51' ' ' ILE . 88.6 m-85 -119.68 126.62 51.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 111.69 18.97 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -79.83 104.22 7.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.64 150.21 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -124.63 115.89 21.52 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 4' ' ' MET . 3.3 mp -114.81 123.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 167.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 6.7 m-20 -126.66 -5.67 6.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.303 1.041 . . . . 0.0 111.536 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -158.51 55.46 0.44 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.93 2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.586 2.355 . . . . 0.0 116.386 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -118.77 154.01 33.5 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 129.712 3.205 . . . . 0.0 108.888 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.57 102.98 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-O 121.91 0.862 . . . . 0.0 108.806 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 15.6 mmtt -71.68 -46.0 60.15 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -158.52 167.5 29.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.663 0.785 . . . . 0.0 110.406 -171.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -138.34 125.81 21.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.086 1.754 . . . . 0.0 108.981 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.84 164.39 14.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 109.604 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.13 134.31 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.3 mt -123.77 104.27 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.875 1.67 . . . . 0.0 106.551 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -58.09 136.53 57.2 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.473 0.579 . . . . 0.0 110.25 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -80.74 70.78 7.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.267 1.027 . . . . 0.0 110.773 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.65 84.74 1.62 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 71.14 -74.07 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.101 2.16 . . . . 0.0 113.375 151.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.7 t -52.34 -33.02 40.95 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.838 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.63 -59.85 9.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -58.58 -39.17 79.56 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.349 -1.089 . . . . 0.0 110.425 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -55.01 -46.36 75.21 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 118.662 0.665 . . . . 0.0 110.373 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.9 m -61.01 -36.32 79.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.631 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' CD1' ' A' ' 25' ' ' PHE . 55.9 mt -60.33 -48.38 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.773 1.169 . . . . 0.0 109.452 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.08 -39.84 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.086 0.554 . . . . 0.0 110.396 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -73.17 -17.87 61.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.121 -0.987 . . . . 0.0 112.463 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.91 -174.53 5.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 120.273 1.397 . . . . 0.0 110.529 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -112.98 40.84 2.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.011 1.724 . . . . 0.0 109.235 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.75 141.49 17.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.24 -41.38 12.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.322 1.049 . . . . 0.0 109.943 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.15 151.09 36.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.29 1.036 . . . . 0.0 111.272 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.43 139.54 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 166.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.8 mt -116.51 127.53 74.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.7 p -154.19 176.42 12.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.527 1.531 . . . . 0.0 108.085 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -106.33 -24.77 12.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.607 1.163 . . . . 0.0 111.648 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -152.96 159.31 42.93 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.0 tt -161.02 137.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.482 ' H ' ' ND2' ' A' ' 68' ' ' ASN . 8.9 m -85.23 168.37 14.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.28 -35.42 75.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.286 1.434 . . . . 0.0 111.221 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.87 -47.03 32.37 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.365 1.078 . . . . 0.0 109.726 -170.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -58.48 -46.54 86.43 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.243 1.817 . . . . 0.0 110.057 172.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -54.6 -62.16 1.84 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.693 0.397 . . . . 0.0 111.109 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.98 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 112.553 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -62.81 1.52 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.893 0.877 . . . . 0.0 109.432 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HD1' HD12 ' A' ' 76' ' ' ILE . 51.8 m-85 -79.93 -30.49 39.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.971 -164.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -58.27 -12.45 3.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.454 1.102 . . . . 0.0 113.857 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -52.28 -31.57 33.3 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.124 -0.985 . . . . 0.0 111.871 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -151.82 -8.08 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.425 HD12 ' HD1' ' A' ' 72' ' ' PHE . 8.0 mt -114.78 123.52 70.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -170.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.69 160.61 19.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.69 0.757 . . . . 0.0 109.434 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.7 mt -137.69 128.77 38.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.24 160.89 34.83 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.88 1.272 . . . . 0.0 111.534 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -106.71 121.82 45.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.892 1.677 . . . . 0.0 110.169 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.5 125.24 29.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.755 0.422 . . . . 0.0 110.163 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -9.38 29.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.341 1.857 . . . . 0.0 113.065 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.96 174.33 41.51 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -163.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -90.3 -6.3 55.29 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 99.68 5.45 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -173.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.6 t -49.82 -39.17 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 122.874 0.47 . . . . 0.0 110.277 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.19 -42.71 68.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -166.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -62.47 -45.36 93.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.853 -0.529 . . . . 0.0 110.383 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -71.75 -32.57 67.84 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.17 -0.331 . . . . 0.0 111.238 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.94 -50.91 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 94' ' ' ILE . 6.6 p -67.0 -31.5 72.11 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 mt -69.18 -42.56 75.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 109.973 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 6' ' ' VAL . 40.5 t80 -59.25 -42.88 92.16 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.181 0.993 . . . . 0.0 113.124 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 91' ' ' SER . 67.3 mt -47.9 -54.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.429 1.492 . . . . 0.0 109.466 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -4.92 49.15 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.505 1.522 . . . . 0.0 113.306 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.09 14.76 80.2 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.079 0.854 . . . . 0.0 112.601 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.86 -19.4 61.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 112.116 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.13 140.48 50.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.07 0.938 . . . . 0.0 110.575 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -68.8 140.05 55.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.839 1.256 . . . . 0.0 108.749 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -72.59 153.82 41.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 165.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.328 -0.349 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 160.894 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 mm -120.63 136.4 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 124.738 1.215 . . . . 0.0 108.309 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 47.78 53.41 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.008 1.723 . . . . 0.0 113.851 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -69.95 156.16 39.52 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 163.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -132.31 159.42 39.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 152.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 28' ' ' VAL . 12.0 p -156.64 163.8 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.7 124.8 47.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 164.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.39 113.58 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.7 p -57.38 128.39 36.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.2 mtp -131.16 157.71 42.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.489 1.04 . . . . 0.0 110.426 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.32 -63.29 1.14 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.555 1.542 . . . . 0.0 108.417 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -142.93 -74.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -119.43 10.88 12.0 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.031 1.332 . . . . 0.0 112.935 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.52 170.17 21.42 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.13 1.372 . . . . 0.0 108.35 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.8 mt -58.11 133.83 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 p -73.63 159.72 32.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.847 2.059 . . . . 0.0 111.311 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -73.55 -25.1 60.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.7 p -149.64 174.01 13.03 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.841 1.2 . . . . 0.0 111.605 169.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -72.56 -13.72 61.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.596 1.958 . . . . 0.0 111.653 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.94 7.99 15.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 111.467 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -133.01 2.9 3.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.073 1.749 . . . . 0.0 110.243 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.98 153.96 42.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.733 -1.23 . . . . 0.0 109.625 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -101.16 -24.67 14.23 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.87 1.268 . . . . 0.0 109.192 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.447 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 40.8 p90 -157.72 173.76 16.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.242 0.928 . . . . 0.0 111.003 171.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 51' ' ' ILE . 70.0 m-85 -115.83 105.1 12.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.308 2.243 . . . . 0.0 107.924 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.94 107.17 7.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -79.46 133.03 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.809 1.244 . . . . 0.0 109.027 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 6' ' ' VAL . 2.0 t -105.94 105.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttt-85 -98.68 103.99 15.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.56 138.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -125.25 -5.63 7.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.483 0.713 . . . . 0.0 112.689 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.499 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 5.5 p-10 -173.38 48.28 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.83 1.252 . . . . 0.0 108.855 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.36 18.67 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.184 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.74 152.96 47.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.37 90.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 122.549 1.166 . . . . 0.0 107.891 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 2.8 mmtp -73.02 -35.09 66.72 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 120.735 -1.228 . . . . 0.0 110.185 167.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 t -162.25 131.97 4.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.792 1.178 . . . . 0.0 110.075 167.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 174.71 9.82 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.272 1.029 . . . . 0.0 111.523 165.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.12 168.34 26.82 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 127.168 2.187 . . . . 0.0 110.303 171.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.553 0.9 OUTLIER -135.16 144.22 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 129.924 3.29 . . . . 0.0 117.476 171.104 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.7 mt -134.29 114.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 127.757 2.423 . . . . 0.0 106.655 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -61.44 136.11 57.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.213 0.915 . . . . 0.0 110.733 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -83.13 85.71 7.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.771 1.228 . . . . 0.0 108.545 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.54 -85.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 46' ' ' SER . 10.4 pt-20 -131.83 -64.09 0.8 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.394 -0.816 . . . . 0.0 111.67 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.472 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -57.99 -24.18 57.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.968 174.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.59 -74.08 0.36 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -57.71 -27.27 62.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.731 1.265 . . . . 0.0 111.537 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.32 -51.15 62.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.8 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -60.93 -37.4 82.2 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.669 1.588 . . . . 0.0 110.067 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 25' ' ' PHE . 43.3 mt -52.46 -45.33 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.086 1.755 . . . . 0.0 110.93 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.71 -42.71 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 120.876 -1.14 . . . . 0.0 110.14 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.55 -30.63 59.77 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 118.445 0.566 . . . . 0.0 111.651 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -74.08 -19.84 60.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.533 0.606 . . . . 0.0 109.4 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.7 t30 50.89 55.38 9.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.703 2.801 . . . . 0.0 112.305 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.19 144.16 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.123 1.769 . . . . 0.0 111.543 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -39.99 18.53 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.111 1.364 . . . . 0.0 111.155 173.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' VAL . . . -144.25 160.95 40.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 112.989 -166.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.3 mt -132.25 105.25 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 119.909 -1.745 . . . . 0.0 108.966 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.06 128.69 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -151.06 167.98 26.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.592 1.087 . . . . 0.0 111.189 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -82.2 -45.38 15.15 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.224 1.81 . . . . 0.0 109.262 165.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -147.43 164.26 33.89 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.379 0.991 . . . . 0.0 109.927 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.5 tt -154.32 138.1 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 m -73.31 155.99 38.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.327 0.512 . . . . 0.0 110.68 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 36.8 tt0 -66.67 -31.49 72.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.734 0.414 . . . . 0.0 111.4 -171.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.74 -50.91 31.07 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.087 0.858 . . . . 0.0 110.997 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -56.54 -43.8 80.24 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.734 0.414 . . . . 0.0 110.644 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -54.69 -60.79 2.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.512 1.125 . . . . 0.0 109.363 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HE3' ' HG2' ' A' ' 66' ' ' GLU . 50.5 mttt -64.31 -17.06 63.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.453 0.701 . . . . 0.0 112.61 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.34 -51.91 5.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.112 1.365 . . . . 0.0 110.338 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.532 ' HD1' HD12 ' A' ' 76' ' ' ILE . 49.9 m-85 -76.55 -30.29 57.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.338 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -63.18 -7.77 6.6 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -20.06 39.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.937 -1.102 . . . . 0.0 111.709 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -145.14 2.59 1.01 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.944 1.247 . . . . 0.0 112.158 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.532 HD12 ' HD1' ' A' ' 72' ' ' PHE . 3.2 mt -134.5 129.03 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -171.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.08 107.65 17.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.002 1.721 . . . . 0.0 109.645 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -87.16 131.89 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 120.455 -1.403 . . . . 0.0 108.52 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -118.16 144.22 45.87 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.702 1.601 . . . . 0.0 111.084 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -87.01 132.58 33.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.458 1.503 . . . . 0.0 107.583 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.81 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.241 -0.409 . . . . 0.0 110.541 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -12.53 60.43 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 169.64 34.15 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 126.99 2.234 . . . . 0.0 108.26 -164.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.7 -16.96 63.98 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.551 2.34 . . . . 0.0 111.37 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.64 97.34 3.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -168.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.1 t -50.38 -42.75 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.65 -44.52 81.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.404 0.682 . . . . 0.0 109.252 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -58.06 -42.54 85.69 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.89 0.852 . . . . 0.0 111.31 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -71.96 -27.2 62.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.113 -0.992 . . . . 0.0 111.974 -172.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.23 -53.7 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 p -61.23 -39.08 88.94 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.7 0.8 . . . . 0.0 111.332 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.4 mt -66.3 -44.59 83.04 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.148 0.579 . . . . 0.0 110.881 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.25 -39.06 85.43 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.987 0.812 . . . . 0.0 111.6 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.53 -42.82 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.436 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.35 -12.5 60.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.878 0.763 . . . . 0.0 112.632 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.11 6.94 84.12 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.927 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -34.17 77.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 112.536 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -55.61 140.43 41.1 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -61.56 130.12 44.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 108.947 172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -69.81 131.67 44.87 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.22 -0.925 . . . . 0.0 108.589 165.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.232 0.164 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.722 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -137.34 138.61 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 69.38 17.47 8.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.587 1.955 . . . . 0.0 113.255 168.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.5 tpp -60.33 151.93 26.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.357 -0.839 . . . . 0.0 109.002 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -137.61 129.17 28.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 165.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 93' ' ' PHE . 41.9 t -136.68 129.85 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-N 119.979 1.263 . . . . 0.0 108.717 172.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.05 83.79 2.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.584 1.553 . . . . 0.0 111.243 -169.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mt -83.74 129.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 120.873 -1.142 . . . . 0.0 110.088 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 p -71.07 94.47 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.482 1.113 . . . . 0.0 112.028 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 mtp -100.01 161.1 13.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.552 1.141 . . . . 0.0 111.341 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.5 -63.31 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 109.155 170.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.68 -60.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -130.41 -0.47 4.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.364 1.078 . . . . 0.0 112.528 -162.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -163.25 178.28 8.32 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.346 2.258 . . . . 0.0 108.736 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 99.1 mt -62.12 145.4 13.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -86.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.726 0.774 . . . . 0.0 109.772 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 175.8 -44.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.022 -1.049 . . . . 0.0 108.684 -156.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 p -158.78 169.36 24.55 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.373 0.988 . . . . 0.0 110.08 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -66.27 -34.04 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.131 0.973 . . . . 0.0 110.822 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -92.48 4.05 54.28 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -131.03 17.99 5.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.307 1.051 . . . . 0.0 111.303 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.93 167.6 16.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.294 1.045 . . . . 0.0 110.344 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.13 -31.24 7.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.215 1.406 . . . . 0.0 109.402 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -154.86 161.24 41.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.991 0.901 . . . . 0.0 109.89 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -100.09 111.7 23.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -76.46 108.97 9.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 41' ' ' ILE . 19.6 mm -77.36 100.09 2.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.4 133.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.521 ' HE ' ' HB2' ' A' ' 37' ' ' SER . 26.7 mtm180 -115.68 114.45 24.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 mt -107.06 115.47 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.01 -10.98 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.441 1.088 . . . . 0.0 112.098 -162.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.64 57.19 0.62 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 122.352 1.072 . . . . 0.0 108.626 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.62 -9.92 0.08 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 129.137 2.975 . . . . 0.0 116.305 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -107.82 158.99 16.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.426 1.09 . . . . 0.0 110.4 170.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.76 90.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.278 1.431 . . . . 0.0 109.974 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.66 -20.88 30.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.779 1.632 . . . . 0.0 112.487 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.521 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 1.6 m -150.55 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 167.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 p -131.82 158.79 40.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 161.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 157.73 46.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 126.202 1.801 . . . . 0.0 106.723 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.24 140.87 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.4 HD12 HD11 ' A' ' 27' ' ' ILE . 59.1 mt -130.8 100.57 4.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -58.86 137.52 57.74 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -73.92 85.37 1.75 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.358 1.463 . . . . 0.0 108.042 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.5 33.83 2.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.462 1.505 . . . . 0.0 110.174 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 66.33 -69.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.144 1.777 . . . . 0.0 109.839 -172.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.3 t -52.99 -29.33 28.51 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.172 2.189 . . . . 0.0 111.413 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.1 16.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.983 0.81 . . . . 0.0 111.286 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -57.6 -32.2 66.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.086 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -56.5 -40.13 74.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.363 0.983 . . . . 0.0 108.397 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -30.79 66.97 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.136 0.974 . . . . 0.0 110.655 -172.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.85 -42.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.391 1.076 . . . . 0.0 108.308 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.1 -13.2 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.126 -0.984 . . . . 0.0 111.269 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -8.03 16.19 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.622 -1.298 . . . . 0.0 112.277 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -91.48 -15.09 29.33 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.557 1.526 . . . . 0.0 113.791 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 57.87 59.14 3.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.826 1.251 . . . . 0.0 109.946 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -47.8 140.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 161.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -50.96 19.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.62 39.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.898 0.479 . . . . 0.0 110.582 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mt -113.86 150.54 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.94 1.296 . . . . 0.0 107.707 173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -120.22 121.9 66.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -144.24 168.89 18.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.212 1.005 . . . . 0.0 108.635 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -71.83 -57.3 4.45 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 155.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -140.7 160.72 39.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.401 0.546 . . . . 0.0 110.711 -167.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.2 tt -152.61 126.99 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 126.25 1.82 . . . . 0.0 106.613 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -54.44 143.54 23.61 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.621 1.568 . . . . 0.0 110.221 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -48.45 -49.04 37.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.169 1.787 . . . . 0.0 111.462 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.03 -42.04 99.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 0.0 110.666 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -68.5 -43.56 76.57 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.594 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.4 -57.83 9.25 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.02 -14.04 51.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.676 1.191 . . . . 0.0 113.628 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -90.99 -58.11 2.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.448 1.499 . . . . 0.0 109.793 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.33 -27.44 62.43 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 112.335 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -60.7 -11.85 8.67 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -58.18 -42.81 86.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 0.0 112.271 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 13.56 1.78 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.806 1.185 . . . . 0.0 111.743 -175.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mt -136.41 140.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.77 153.09 19.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.949 0.9 . . . . 0.0 108.779 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.52 113.59 23.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -160.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.86 151.07 37.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.544 1.137 . . . . 0.0 110.898 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -99.12 120.19 39.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.442 1.497 . . . . 0.0 109.95 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 138.94 55.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.414 0.686 . . . . 0.0 111.747 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -102.29 99.08 9.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 127.178 2.191 . . . . 0.0 109.284 172.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.42 -179.11 53.63 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -85.37 -10.84 55.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.703 0.801 . . . . 0.0 110.662 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.35 102.23 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.062 0.945 . . . . 0.0 110.563 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -48.35 -43.86 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 118.79 -0.624 . . . . 0.0 109.609 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.58 -42.84 77.7 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.968 0.804 . . . . 0.0 110.219 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -57.26 -40.02 76.83 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.902 -0.499 . . . . 0.0 110.289 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.51 -32.85 42.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.15 -50.47 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 p -62.4 -46.51 88.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.726 0.811 . . . . 0.0 111.436 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 122.56 0.344 . . . . 0.0 110.161 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 6' ' ' VAL . 48.6 t80 -61.74 -52.5 64.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.321 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.3 mt -50.27 -40.93 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.969 1.308 . . . . 0.0 111.005 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.23 -2.84 50.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.941 0.896 . . . . 0.0 113.108 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.02 81.35 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.0 1.286 . . . . 0.0 111.193 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -27.26 61.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.41 1.884 . . . . 0.0 113.029 -174.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.38 139.47 58.56 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.577 0.704 . . . . 0.0 109.582 -174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.8 m -75.93 143.05 41.86 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -76.98 151.52 35.62 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 166.278 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.0 mt -139.54 152.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 47.18 73.02 0.21 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.874 1.67 . . . . 0.0 110.734 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ttt -131.92 152.33 51.14 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.157 -0.964 . . . . 0.0 108.59 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.6 141.52 33.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 165.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -134.05 132.62 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 171.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.99 144.57 25.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.71 119.98 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -75.88 84.16 2.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.147 0.979 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -86.3 155.26 20.73 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.895 2.478 . . . . 0.0 111.7 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -105.27 -55.96 2.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.128 0.966 . . . . 0.0 110.979 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -146.77 -55.02 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.8 -1.79 0.49 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.519 -158.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -157.06 173.17 17.41 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.706 2.002 . . . . 0.0 107.426 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.41 134.15 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -66.84 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.53 -38.66 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.395 1.478 . . . . 0.0 108.95 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 166.21 29.18 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.974 0.416 . . . . 0.0 111.042 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -55.88 -50.19 71.33 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.726 2.01 . . . . 0.0 108.891 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.12 -3.06 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.724 1.609 . . . . 0.0 112.812 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -120.91 -4.66 9.62 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.835 1.254 . . . . 0.0 111.068 -171.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.3 p -80.11 175.24 10.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.802 -1.186 . . . . 0.0 111.957 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -112.08 -34.67 5.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.741 1.616 . . . . 0.0 110.035 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -149.05 164.24 35.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.357 0.98 . . . . 0.0 111.904 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -109.85 103.35 12.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.382 2.673 . . . . 0.0 106.456 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tp -81.15 101.45 9.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.09 96.1 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 127.381 2.273 . . . . 0.0 107.31 168.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.52 139.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 160.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 118.55 18.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.868 0.758 . . . . 0.0 109.093 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.3 mt -119.82 138.28 50.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -164.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.0 -9.12 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -155.86 65.87 0.59 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.09 -8.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.21 3.004 . . . . 0.0 115.91 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.15 157.46 27.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 111.235 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.13 83.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.301 1.841 . . . . 0.0 106.864 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -64.85 -31.75 73.13 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.884 -1.135 . . . . 0.0 109.974 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -150.72 163.38 38.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.96 0.904 . . . . 0.0 109.469 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.67 161.28 36.91 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 108.231 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 137.8 19.11 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.92 0.888 . . . . 0.0 110.041 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.535 1.1 p -99.97 133.21 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 161.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.499 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 11.1 mt -129.74 114.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -63.31 160.42 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.156 1.343 . . . . 0.0 110.409 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -78.54 76.62 5.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.902 1.281 . . . . 0.0 109.777 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -125.74 170.17 11.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.34 1.456 . . . . 0.0 109.502 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -55.38 -40.67 71.65 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.445 -0.784 . . . . 0.0 110.672 164.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 m -76.34 -11.29 59.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.783 1.233 . . . . 0.0 111.693 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -72.47 -60.3 4.11 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 163.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 mppt? -62.58 -20.25 64.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -63.57 -46.25 86.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.932 1.242 . . . . 0.0 110.512 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 m -71.84 -40.79 68.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.223 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.7 mt -45.46 -51.44 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.929 1.292 . . . . 0.0 111.85 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.68 -34.69 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.87 -0.519 . . . . 0.0 111.468 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.89 -14.24 45.45 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.661 -0.649 . . . . 0.0 111.374 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.17 -16.21 61.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.525 1.53 . . . . 0.0 110.883 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 t30 47.47 65.06 1.36 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.975 2.11 . . . . 0.0 110.28 -167.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -67.45 140.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.94 -42.26 15.14 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.511 1.524 . . . . 0.0 109.979 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.69 160.95 39.82 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.422 1.089 . . . . 0.0 109.414 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -122.76 138.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.85 122.09 50.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.03 157.09 44.55 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.688 0.756 . . . . 0.0 111.255 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -68.99 -53.0 22.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 163.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -139.33 159.39 42.28 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.594 1.543 . . . . 0.0 111.204 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.9 tt -156.83 126.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.141 1.776 . . . . 0.0 110.257 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -61.13 141.89 57.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.222 1.009 . . . . 0.0 110.003 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.75 -37.62 76.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 111.845 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.61 -40.41 94.72 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.499 -0.75 . . . . 0.0 111.503 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -69.16 -47.58 64.59 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.792 0.837 . . . . 0.0 109.805 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -50.51 -58.68 5.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.858 1.263 . . . . 0.0 109.758 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -60.97 -18.12 55.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.436 0.694 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -82.38 -47.45 12.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.06 -1.025 . . . . 0.0 111.04 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -84.87 -25.37 28.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.958 0.344 . . . . 0.0 111.027 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -62.12 -7.7 4.43 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.61 1.164 . . . . 0.0 113.231 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -40.42 11.56 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.208 1.403 . . . . 0.0 110.787 173.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -145.16 -30.55 0.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.552 1.141 . . . . 0.0 111.857 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.3 mt -90.04 135.1 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -163.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.56 139.2 33.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.679 . . . . 0.0 107.801 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.8 mt -119.74 114.21 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.24 -0.913 . . . . 0.0 108.671 -172.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 55.8 m-85 -104.63 139.85 38.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.096 1.758 . . . . 0.0 110.835 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.42 127.62 32.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 123.07 19.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -83.3 6.76 18.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.057 1.743 . . . . 0.0 112.389 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.4 -169.81 38.97 Favored Glycine 0 N--CA 1.449 -0.477 0 O-C-N 120.509 -1.369 . . . . 0.0 111.68 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.15 -18.05 15.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.921 1.688 . . . . 0.0 109.894 168.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -66.86 101.7 0.86 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.386 1.474 . . . . 0.0 107.387 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.4 t -57.73 -41.11 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.217 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.51 -36.31 73.69 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.578 0.751 . . . . 0.0 110.359 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -60.77 -42.07 96.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 171.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -71.87 -26.84 62.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.701 -0.625 . . . . 0.0 111.566 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -56.9 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.78 1.632 . . . . 0.0 107.561 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.7 p -65.57 -40.69 93.07 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.36 0.413 . . . . 0.0 110.605 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.12 -42.87 99.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.651 0.78 . . . . 0.0 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 6' ' ' VAL . 68.7 t80 -61.19 -52.59 64.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.528 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.2 mt -58.25 -40.74 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.496 1.119 . . . . 0.0 109.58 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -68.22 -18.71 64.64 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.26 8.24 78.51 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.717 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -69.92 -27.31 64.66 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.084 1.442 . . . . 0.0 112.329 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.31 138.83 55.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.432 1.111 . . . . 0.0 110.272 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.8 m -74.09 138.92 44.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.3 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 31.4 mtmm -78.98 147.75 32.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 162.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.9 mt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 123.7 0.625 . . . . 0.0 110.854 -174.84 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.93 153.05 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.317 1.847 . . . . 0.0 107.86 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 67.01 8.93 6.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.1 1.76 . . . . 0.0 114.473 168.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 tpp -78.1 155.17 30.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.182 1.356 . . . . 0.0 108.938 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.42 143.42 25.71 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.18 141.93 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 108.962 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.72 101.89 13.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 166.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.47 117.91 28.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB2' ' CB ' ' A' ' 22' ' ' CYS . 42.5 p -66.38 143.78 56.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.8 mmm -138.66 149.07 44.77 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 119.449 -2.032 . . . . 0.0 109.078 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -89.44 -67.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.507 1.123 . . . . 0.0 109.01 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.9 t -140.53 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.38 -7.42 18.81 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -147.16 177.34 9.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.272 1.429 . . . . 0.0 110.155 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mt -62.77 141.22 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 t -71.02 -86.76 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 t30 174.75 -28.12 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.856 1.663 . . . . 0.0 112.068 -167.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.73 164.68 29.44 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.736 1.153 . . . . 0.0 110.726 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -66.32 -37.59 85.74 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.222 1.009 . . . . 0.0 108.435 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 1.0 56.64 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.416 1.486 . . . . 0.0 113.175 -171.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.54 -7.54 6.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.018 1.327 . . . . 0.0 111.74 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 9' ' ' SER . 13.9 p -65.66 169.37 6.37 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 123.471 1.605 . . . . 0.0 110.277 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -114.9 -19.59 10.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.722 -2.036 . . . . 0.0 111.119 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.409 ' HB2' HG23 ' A' ' 40' ' ' VAL . 32.1 p90 -161.33 172.16 17.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.67 0.668 . . . . 0.0 111.388 172.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -117.02 103.61 10.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.369 2.268 . . . . 0.0 106.441 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 tp -76.97 99.04 5.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.41 102.14 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 128.064 2.545 . . . . 0.0 105.923 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 t -95.87 112.2 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.0 140.57 34.04 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.679 1.127 . . . . 0.0 108.495 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -132.68 123.12 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -168.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.19 3.99 1.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -165.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -154.63 60.6 0.68 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 122.491 1.139 . . . . 0.0 109.702 155.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.18 7.32 1.58 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.637 1.575 . . . . 0.0 114.692 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -135.7 155.09 50.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 131.349 3.86 . . . . 0.0 106.807 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.65 124.72 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.616 1.166 . . . . 0.0 109.027 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -111.97 -34.34 6.01 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.641 0.776 . . . . 0.0 112.543 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 131.64 27.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -96.96 154.71 17.14 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 162.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 147.85 33.18 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.938 1.695 . . . . 0.0 107.093 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 24' ' ' TYR 0.453 1.2 p -106.83 134.87 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 125.791 1.636 . . . . 0.0 115.287 155.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.16 122.14 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -65.64 161.08 21.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.594 1.088 . . . . 0.0 111.213 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -81.14 99.83 8.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 167.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -154.47 38.22 0.43 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 108.486 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 60.49 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.103 2.961 . . . . 0.0 112.854 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 t -62.23 -10.78 11.72 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.586 -1.321 . . . . 0.0 111.464 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.7 -60.24 6.6 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 160.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -61.29 -26.88 68.08 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.183 0.993 . . . . 0.0 112.348 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -64.69 -53.0 54.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 120.078 1.308 . . . . 0.0 108.874 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 t -53.55 -45.95 70.03 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 110.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.8 mt -50.36 -43.04 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.882 0.873 . . . . 0.0 110.709 -176.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.19 -23.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 O-C-N 121.052 -1.03 . . . . 0.0 111.906 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -98.64 12.42 35.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.078 0.951 . . . . 0.0 111.266 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.53 -6.42 11.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.807 0.843 . . . . 0.0 112.211 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.0 t30 49.89 61.95 2.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.406 1.483 . . . . 0.0 111.694 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.51 142.13 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 166.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -76.13 -52.72 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.27 162.5 39.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.56 141.16 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.88 2.072 . . . . 0.0 110.396 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 81' ' ' ALA . 51.9 mt -127.14 125.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.201 1.8 . . . . 0.0 106.792 167.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 38.1 m -149.62 -13.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.789 ' HG3' ' HB3' ' A' ' 81' ' ' ALA . 9.5 mtpp 75.78 -34.42 0.24 Allowed 'General case' 0 C--O 1.221 -0.425 1 C-N-CA 132.526 4.331 . . . . 0.0 113.35 -162.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -149.97 168.07 24.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 122.088 2.222 . . . . 0.0 111.748 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -163.53 120.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.645 1.178 . . . . 0.0 108.65 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.35 147.79 43.61 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.18 -47.49 65.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.933 2.093 . . . . 0.0 111.345 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -59.76 -42.25 92.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.753 0.787 . . . . 0.0 111.154 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -72.56 -41.49 65.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.888 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.75 -61.17 2.42 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.201 0.91 . . . . 0.0 109.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -64.89 -24.08 67.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.89 -38.63 61.83 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 120.905 -1.122 . . . . 0.0 111.301 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.49 -30.46 21.97 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.056 -1.027 . . . . 0.0 111.485 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -63.8 -12.73 38.18 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -27.34 5.62 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.328 1.451 . . . . 0.0 113.903 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -155.75 -2.66 0.14 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.026 0.83 . . . . 0.0 113.207 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.29 121.07 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -75.06 117.36 16.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.484 1.513 . . . . 0.0 107.271 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.48 134.92 28.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -120.15 155.38 33.19 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 108.792 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -85.37 141.29 30.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 168.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.789 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . . . -88.52 150.16 23.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.354 0.525 . . . . 0.0 110.486 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.77 71.36 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.876 2.47 . . . . 0.0 108.118 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.43 -178.85 17.52 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 124.466 1.031 . . . . 0.0 112.852 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -33.63 75.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.028 153.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.55 100.83 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 124.446 1.091 . . . . 0.0 109.9 -155.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -52.18 -43.85 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -44.22 92.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.575 0.625 . . . . 0.0 109.962 -175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.19 -39.26 78.47 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.69 -0.631 . . . . 0.0 110.982 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -76.87 -27.25 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 112.529 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.09 -50.43 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.6 p -61.87 -46.42 89.49 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.012 0.824 . . . . 0.0 110.898 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.4 mt -63.06 -30.24 71.44 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.084 0.554 . . . . 0.0 110.621 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.62 -48.38 48.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.46 -37.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.261 . . . . 0.0 109.928 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -76.84 -34.35 57.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.898 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.57 15.16 32.78 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.99 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -34.82 74.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.821 2.048 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.31 142.15 52.73 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.605 1.093 . . . . 0.0 109.495 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.4 t -91.55 144.75 25.22 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 123.275 1.512 . . . . 0.0 110.244 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -85.08 130.7 34.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.985 1.714 . . . . 0.0 108.896 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.2 mt . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.694 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 tpt . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.485 0.183 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.53 150.86 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 172.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m120 66.23 8.94 5.95 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 171.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.7 ttp -68.5 155.8 39.21 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.351 1.432 . . . . 0.0 110.202 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -139.12 146.34 40.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.018 1.727 . . . . 0.0 107.517 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG21 ' CE2' ' A' ' 93' ' ' PHE . 31.3 t -137.75 135.08 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.675 1.19 . . . . 0.0 108.122 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 124.12 33.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 166.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mt -104.03 112.53 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -66.2 91.63 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.784 1.234 . . . . 0.0 110.007 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 91.3 mmm -92.08 159.51 15.66 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.492 1.117 . . . . 0.0 111.183 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.81 -81.4 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.178 2.191 . . . . 0.0 108.372 165.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.4 t -140.41 -59.71 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -121.87 2.69 9.99 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 170.44 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.645 1.178 . . . . 0.0 110.09 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.5 mt -53.96 139.54 12.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.793 1.637 . . . . 0.0 108.087 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -74.25 -179.49 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.707 1.603 . . . . 0.0 110.625 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -86.0 -34.39 20.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.705 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -153.27 168.3 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -67.03 -23.04 65.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.247 2.219 . . . . 0.0 111.406 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.8 19.72 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.052 1.341 . . . . 0.0 110.916 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.14 -7.3 1.58 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.2 p -74.46 154.49 38.7 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.265 1.031 . . . . 0.0 109.889 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.59 -34.25 14.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.365 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.454 ' HE2' HD23 ' A' ' 26' ' ' LEU . 27.4 p90 -158.54 175.55 13.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.656 0.741 . . . . 0.0 109.533 176.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -117.05 108.91 16.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD23 ' HE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -77.72 104.9 8.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 170.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 mm -69.0 99.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.18 147.37 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 161.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -129.03 140.22 51.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mt -110.55 142.52 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.28 124.55 10.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 175.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 44.46 57.7 4.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.614 1.565 . . . . 0.0 111.51 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.62 28.49 2.6 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 128.89 2.876 . . . . 0.0 114.138 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HB2' ' CE ' ' A' ' 36' ' ' LYS . 45.4 mt-10 -132.07 157.16 44.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.09 1.314 . . . . 0.0 111.139 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.52 120.15 17.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' CE ' ' HB2' ' A' ' 34' ' ' GLU . 21.3 mmtp -126.15 -7.62 6.52 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.437 ' HB3' ' HG2' ' A' ' 29' ' ' ARG . 47.7 t -157.13 170.67 21.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 122.021 2.191 . . . . 0.0 107.813 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.24 156.26 45.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.609 1.564 . . . . 0.0 109.535 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 160.55 43.86 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 125.911 1.685 . . . . 0.0 109.142 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.7 OUTLIER -127.1 137.28 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 C-N-CA 130.062 3.345 . . . . 0.0 116.581 167.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.84 116.25 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -64.05 148.92 48.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.57 0.623 . . . . 0.0 110.25 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -69.95 88.73 0.58 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.2 166.23 24.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 128.309 2.644 . . . . 0.0 105.042 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.73 -45.98 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.49 -0.757 . . . . 0.0 109.778 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -26.3 68.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 110.178 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.18 -49.73 38.12 Favored Glycine 0 N--CA 1.444 -0.819 0 O-C-N 121.729 -0.607 . . . . 0.0 111.677 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -67.82 -21.52 65.21 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.067 0.934 . . . . 0.0 111.506 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.03 -58.16 6.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.736 -1.126 . . . . 0.0 110.551 161.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -53.51 -33.88 56.08 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.333 0.97 . . . . 0.0 112.824 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 mt -45.3 -46.64 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.557 1.143 . . . . 0.0 111.513 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.33 -33.37 63.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 123.225 0.61 . . . . 0.0 110.199 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -27.09 29.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.298 0.499 . . . . 0.0 111.223 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.02 -20.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.099 0.863 . . . . 0.0 112.155 -170.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.01 32.87 1.74 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.053 1.341 . . . . 0.0 110.58 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.02 146.1 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.34 -48.83 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.794 1.238 . . . . 0.0 109.669 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.47 163.3 40.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 110.057 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -117.19 150.07 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.7 mt -120.24 132.14 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 t -163.95 161.53 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.715 2.406 . . . . 0.0 108.476 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.3 -39.03 93.43 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.537 169.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.66 167.96 24.95 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.029 1.286 . . . . 0.0 109.34 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.9 tt -162.49 138.02 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.025 1.73 . . . . 0.0 107.751 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -76.29 152.11 36.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.964 -0.46 . . . . 0.0 110.581 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -48.91 -45.64 41.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.507 1.123 . . . . 0.0 111.456 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.768 0.827 . . . . 0.0 108.824 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -60.12 -41.5 92.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.99 0.916 . . . . 0.0 111.903 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -56.03 -65.01 0.67 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.915 0.78 . . . . 0.0 109.252 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -60.38 -28.1 67.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.634 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -55.4 13.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.721 1.146 . . . . 0.0 110.341 176.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.88 -22.25 37.0 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.531 0.605 . . . . 0.0 112.589 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 t -72.44 69.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.029 1.395 . . . . 0.0 110.618 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 -32.49 0.28 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 129.006 2.922 . . . . 0.0 110.259 175.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.82 -6.32 0.6 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.81 136.67 58.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.62 155.46 19.23 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.977 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.3 mt -128.14 118.19 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.63 1.172 . . . . 0.0 108.658 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 60.1 m-85 -106.06 164.36 12.04 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.161 0.984 . . . . 0.0 110.321 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -98.41 145.97 26.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.885 0.766 . . . . 0.0 110.017 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.91 117.16 29.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.598 1.159 . . . . 0.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.24 -9.8 58.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.89 34.39 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.45 -18.26 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 158.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 98.53 0.91 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.985 2.514 . . . . 0.0 107.276 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -48.13 -41.42 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.02 -43.59 74.46 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.385 -0.822 . . . . 0.0 110.35 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -36.07 82.29 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 122.084 -0.385 . . . . 0.0 110.502 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.51 -38.32 74.28 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.736 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.05 -50.32 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -60.4 -36.45 78.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.623 0.647 . . . . 0.0 111.863 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.8 mt -67.89 -44.97 75.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.023 0.44 . . . . 0.0 110.77 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 6' ' ' VAL . 43.6 t80 -59.36 -37.19 77.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.358 1.063 . . . . 0.0 112.839 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.7 mt -64.34 -48.41 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.445 1.098 . . . . 0.0 109.807 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.72 -24.07 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.982 0.81 . . . . 0.0 110.868 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.16 8.37 58.92 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 123.914 0.769 . . . . 0.0 113.279 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -45.64 73.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.128 2.171 . . . . 0.0 109.901 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.62 137.78 42.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 124.204 1.002 . . . . 0.0 110.847 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 t -84.47 157.81 21.22 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 57.0 mtpt -76.35 145.63 39.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.173 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 CA--C 1.515 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mm -134.01 143.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.533 2.333 . . . . 0.0 107.496 -167.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 45.65 58.74 4.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.464 1.506 . . . . 0.0 113.101 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -103.11 155.02 18.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.609 1.163 . . . . 0.0 108.328 166.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 143.12 31.9 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.495 1.918 . . . . 0.0 105.981 164.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG21 ' CE2' ' A' ' 93' ' ' PHE . 95.4 t -132.78 137.17 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.49 74.26 0.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.689 0.796 . . . . 0.0 109.553 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.92 120.56 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.888 1.275 . . . . 0.0 109.103 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -67.96 117.92 10.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.046 0.938 . . . . 0.0 111.124 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.2 mmm -124.89 157.11 36.76 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.707 1.603 . . . . 0.0 110.159 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -106.78 -62.02 1.46 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.024 1.73 . . . . 0.0 110.635 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -142.27 -85.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 170.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.71 -8.45 24.3 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 165.93 19.99 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.799 1.24 . . . . 0.0 110.35 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.48 142.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 125.31 1.631 . . . . 0.0 108.036 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -73.18 -179.34 3.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.136 1.375 . . . . 0.0 112.881 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -88.14 -32.3 18.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.553 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.1 t -152.67 177.88 10.21 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.262 1.825 . . . . 0.0 108.289 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.32 -34.87 78.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 128.218 2.607 . . . . 0.0 110.723 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.8 -1.94 45.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.005 0.82 . . . . 0.0 111.979 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -121.1 52.77 1.18 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 p -133.25 173.04 11.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.184 2.994 . . . . 0.0 108.572 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -118.01 -28.65 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.906 1.682 . . . . 0.0 109.385 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -156.42 176.1 13.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.953 0.797 . . . . 0.0 111.78 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -123.08 115.92 22.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.823 2.849 . . . . 0.0 108.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 39' ' ' LYS . 14.2 tp -89.07 103.35 15.97 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.327 2.251 . . . . 0.0 106.424 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 41' ' ' ILE . 14.7 mm -68.79 76.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 129.732 3.213 . . . . 0.0 111.16 174.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -69.14 99.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -76.64 136.49 39.17 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 164.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.14 129.77 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 159.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -132.43 2.19 3.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 t0 174.59 72.13 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.253 3.021 . . . . 0.0 103.217 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.9 -25.56 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 131.146 3.778 . . . . 0.0 116.608 173.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -107.39 166.12 10.89 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.22 118.97 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.107 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 -5.35 8.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 113.203 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.7 m -170.02 168.14 8.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.7 2.4 . . . . 0.0 107.005 166.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 p -136.23 -46.01 0.63 Allowed 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER 44.41 175.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.253 2.621 . . . . 0.0 117.682 -171.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.7 t -143.25 106.02 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 27' ' ' ILE . 47.6 mt -96.49 115.52 36.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 165.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -65.43 162.26 18.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.871 1.669 . . . . 0.0 110.461 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -73.58 80.98 1.49 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 0.0 108.1 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -134.04 168.16 19.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.628 1.171 . . . . 0.0 107.906 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -52.14 -46.46 65.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.199 1.799 . . . . 0.0 109.835 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -70.82 -39.92 72.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.784 1.234 . . . . 0.0 107.933 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -61.31 7.32 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -58.98 -39.54 82.08 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.23 1.012 . . . . 0.0 110.373 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -58.68 -42.44 88.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.137 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -44.42 92.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.578 1.551 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.7 mt -50.75 -43.81 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.15 -32.41 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.976 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -84.31 -25.93 28.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.47 1.032 . . . . 0.0 110.361 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.95 156.62 33.01 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.793 1.237 . . . . 0.0 108.503 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -83.17 28.31 0.53 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.178 1.391 . . . . 0.0 110.916 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.29 134.78 23.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 120.935 1.698 . . . . 0.0 108.559 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -82.26 -44.63 16.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.023 1.729 . . . . 0.0 109.655 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.25 162.2 40.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.121 0.568 . . . . 0.0 110.412 -168.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mt -113.51 141.69 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 171.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.14 122.64 55.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 162.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.04 151.72 38.19 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.914 1.285 . . . . 0.0 110.664 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -65.91 -46.65 77.49 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 163.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -148.21 166.89 26.56 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.83 119.85 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -52.05 138.58 24.88 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.506 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -51.87 -43.1 63.13 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.973 1.709 . . . . 0.0 112.071 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -22.72 66.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 0.0 112.625 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -84.61 -41.5 16.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.571 -0.705 . . . . 0.0 109.891 167.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.94 -59.95 4.29 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.941 1.246 . . . . 0.0 110.721 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -58.35 -22.8 54.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.904 0.482 . . . . 0.0 111.959 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.96 -50.05 8.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.834 1.254 . . . . 0.0 111.098 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -79.59 -24.27 42.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.095 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -60.85 -7.58 2.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.168 0.895 . . . . 0.0 113.302 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -39.33 21.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.332 1.453 . . . . 0.0 113.864 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -165.17 4.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.282 0.947 . . . . 0.0 112.173 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.7 mt -120.95 126.71 75.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.38 136.79 42.45 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.29 132.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.3 151.66 37.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.681 1.192 . . . . 0.0 109.908 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -99.54 134.56 42.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.968 1.707 . . . . 0.0 110.59 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.427 0.632 . . . . 0.0 109.94 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -128.85 26.67 5.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.791 2.436 . . . . 0.0 108.584 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.11 36.78 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.598 -1.314 . . . . 0.0 111.879 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -89.67 -23.93 21.74 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.966 1.306 . . . . 0.0 109.784 165.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.79 104.02 1.0 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.222 1.809 . . . . 0.0 107.705 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.73 -46.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.217 1.007 . . . . 0.0 108.844 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.33 -41.72 93.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.215 0.916 . . . . 0.0 109.609 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -56.54 -44.79 81.2 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.607 -0.683 . . . . 0.0 110.353 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -70.21 -44.93 67.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.096 -0.378 . . . . 0.0 110.894 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -41.52 92.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 97.4 p -68.52 -34.41 75.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.568 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.62 -41.36 84.09 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 120.991 0.424 . . . . 0.0 110.397 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 6' ' ' VAL . 56.0 t80 -61.66 -40.17 93.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.592 0.757 . . . . 0.0 112.051 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.1 mt -51.07 -52.47 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 109.163 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -74.11 -22.52 59.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.048 0.84 . . . . 0.0 112.445 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.65 -3.76 39.51 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.897 -0.946 . . . . 0.0 114.26 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -17.41 62.53 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.677 1.991 . . . . 0.0 113.577 -164.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.67 140.96 49.88 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.8 -1.188 . . . . 0.0 109.149 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -57.35 134.91 56.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -68.77 130.75 43.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 153.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.4 mt . . . . . 0 C--O 1.235 0.329 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 160.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 CA--C 1.515 -0.401 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.1 mt -139.05 143.37 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.48 52.47 14.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.381 1.472 . . . . 0.0 111.433 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttp -113.55 137.77 51.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.871 1.268 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -133.85 153.05 52.01 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 126.098 1.759 . . . . 0.0 106.935 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 28' ' ' VAL . 53.4 t -147.04 141.32 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.25 94.09 8.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.55 98.32 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 p -67.95 123.8 21.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.672 1.589 . . . . 0.0 113.032 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.1 mtp -124.46 162.02 24.82 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.453 -1.405 . . . . 0.0 112.403 -171.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.49 -60.76 1.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.681 1.192 . . . . 0.0 109.439 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -146.74 -73.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -122.59 0.46 9.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.944 1.298 . . . . 0.0 111.928 -167.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 178.18 7.34 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.25 -0.907 . . . . 0.0 110.547 165.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.8 mt -52.53 139.98 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.038 1.735 . . . . 0.0 109.156 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -68.39 166.39 16.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.041 1.336 . . . . 0.0 112.964 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.97 -46.29 71.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.39 1.476 . . . . 0.0 112.264 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 t -158.41 168.6 26.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 0.0 109.418 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.95 -33.52 75.53 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.534 1.934 . . . . 0.0 111.112 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.49 24.4 12.66 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.859 1.264 . . . . 0.0 110.198 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -139.99 32.17 1.98 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.829 0.852 . . . . 0.0 109.602 161.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.2 p -108.32 164.42 12.33 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.42 -29.22 9.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.091 0.956 . . . . 0.0 110.004 -171.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 31.8 p90 -159.96 163.53 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.339 0.59 . . . . 0.0 111.909 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.675 ' CD2' HD11 ' A' ' 51' ' ' ILE . 62.8 m-85 -104.87 107.57 18.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.69 1.996 . . . . 0.0 107.498 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -75.12 93.59 2.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -72.98 91.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 121.15 -0.969 . . . . 0.0 108.5 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.88 ' HA ' HG22 ' A' ' 38' ' ' THR . 1.2 p -64.98 165.96 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.541 1.137 . . . . 0.0 109.939 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 127.52 24.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.973 1.715 . . . . 0.0 110.48 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.34 110.94 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 125.63 1.572 . . . . 0.0 107.233 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -118.04 -13.5 9.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.531 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -157.63 63.77 0.47 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 122.875 1.321 . . . . 0.0 108.615 170.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 53.58 18.59 1.48 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.123 2.169 . . . . 0.0 116.08 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.91 171.42 14.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.92 1.688 . . . . 0.0 108.355 170.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 113.24 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -105.35 -39.45 6.15 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.647 -0.658 . . . . 0.0 109.263 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.56 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.447 1.099 . . . . 0.0 108.078 176.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.88 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.7 OUTLIER -159.98 176.93 11.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.513 1.925 . . . . 0.0 108.642 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -158.01 164.48 36.72 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 125.982 1.713 . . . . 0.0 110.903 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.477 0.6 OUTLIER -132.57 141.18 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 128.836 2.854 . . . . 0.0 117.076 164.728 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -129.47 117.82 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 129.695 3.198 . . . . 0.0 104.35 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -64.7 158.55 24.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.856 1.207 . . . . 0.0 111.758 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.84 89.37 4.06 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.578 0.751 . . . . 0.0 109.496 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -144.78 29.63 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.985 0.898 . . . . 0.0 112.546 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 75.24 -55.83 0.63 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.357 2.263 . . . . 0.0 111.771 170.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -60.48 -28.63 68.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.346 1.058 . . . . 0.0 109.864 166.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.04 -49.68 41.89 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -56.97 -39.04 73.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.884 0.842 . . . . 0.0 111.169 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -58.9 -47.16 85.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.463 1.029 . . . . 0.0 111.477 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 m -64.07 -33.54 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.051 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.675 HD11 ' CD2' ' A' ' 25' ' ' PHE . 84.2 mt -55.68 -40.35 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.148 0.885 . . . . 0.0 110.216 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -54.94 -47.12 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -81.21 -13.04 58.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -63.97 -19.34 65.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.221 1.373 . . . . 0.0 111.865 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 55.87 56.53 5.95 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.181 1.392 . . . . 0.0 109.068 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 51' ' ' ILE . 2.5 t -66.31 146.45 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.93 -37.48 13.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.228 2.611 . . . . 0.0 110.578 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.6 168.12 24.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.159 0.983 . . . . 0.0 112.627 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -127.21 119.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.2 132.89 37.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 163.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.9 p -147.55 163.54 36.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.266 0.939 . . . . 0.0 108.672 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -75.07 -40.64 60.02 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 121.48 -0.763 . . . . 0.0 108.994 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -157.46 170.01 23.41 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.4 tt -163.49 124.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.64 0.776 . . . . 0.0 111.017 -170.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -51.15 141.31 14.63 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.56 0.744 . . . . 0.0 111.732 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.87 -45.82 60.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.852 1.661 . . . . 0.0 112.176 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -58.98 -52.43 65.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.97 0.804 . . . . 0.0 110.583 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -63.0 -41.41 99.58 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.227 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.15 -61.28 2.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.651 0.78 . . . . 0.0 109.642 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -63.49 -24.23 67.73 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 119.171 -0.442 . . . . 0.0 112.182 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -61.71 1.71 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.977 0.911 . . . . 0.0 109.517 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.69 -21.82 60.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.752 0.821 . . . . 0.0 112.499 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -63.15 -1.81 1.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -70.22 -32.96 71.09 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.999 -1.688 . . . . 0.0 113.492 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -153.86 13.56 0.46 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.301 1.409 . . . . 0.0 112.573 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -135.36 133.95 52.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -87.91 126.22 34.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.769 1.627 . . . . 0.0 108.601 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.2 mt -109.54 121.75 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.69 -1.256 . . . . 0.0 109.139 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 72.3 m-85 -121.18 146.9 46.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.364 2.266 . . . . 0.0 111.518 -166.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -90.1 146.58 24.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.73 0.412 . . . . 0.0 110.387 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 129.69 36.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.66 20.35 6.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.902 0.881 . . . . 0.0 112.135 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.74 -165.21 38.71 Favored Glycine 0 C--N 1.335 0.506 0 O-C-N 120.496 -1.378 . . . . 0.0 111.675 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.12 1.01 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.116 1.366 . . . . 0.0 109.499 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . 3.0 t70 -86.92 104.75 16.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.6 -42.04 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -64.17 -47.48 79.68 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -168.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 2.7 tptm -61.53 -37.11 82.54 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.997 -1.065 . . . . 0.0 111.862 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.88 -33.8 76.39 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 120.891 -1.13 . . . . 0.0 111.386 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.97 -51.08 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -64.23 -37.68 88.33 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.447 0.567 . . . . 0.0 111.242 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.06 -43.91 94.04 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.065 0.393 . . . . 0.0 110.033 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CE2' HG21 ' A' ' 6' ' ' VAL . 67.2 t80 -59.82 -44.81 93.84 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.72 0.408 . . . . 0.0 111.55 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.0 -48.49 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.228 1.011 . . . . 0.0 109.433 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.69 -36.53 84.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.911 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 9.11 21.34 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.062 -0.854 . . . . 0.0 113.237 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -29.66 59.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.289 1.036 . . . . 0.0 112.063 -167.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.73 138.38 58.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 135.68 42.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.6 mtmm -64.42 132.2 49.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 163.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.1 mt . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.433 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 mt -124.22 151.24 29.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 126.435 1.894 . . . . 0.0 108.789 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.3 t30 61.55 27.81 17.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.321 2.248 . . . . 0.0 113.198 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpp -78.08 149.12 33.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -140.81 140.39 34.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 93' ' ' PHE . 54.7 t -140.69 130.86 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.284 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.26 106.89 18.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -92.32 123.75 44.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 79.3 p -62.43 128.32 35.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.588 1.086 . . . . 0.0 110.613 169.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 mtp -126.66 159.99 32.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.653 1.115 . . . . 0.0 110.689 172.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.22 -65.55 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.152 1.381 . . . . 0.0 107.948 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.54 -73.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 167.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -119.79 9.67 11.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.307 1.051 . . . . 0.0 112.482 -154.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 178.03 8.7 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 128.293 2.637 . . . . 0.0 107.603 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.82 146.03 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 p -83.54 -156.78 0.21 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.715 2.006 . . . . 0.0 111.985 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.55 -21.65 12.62 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 63' ' ' ASN . 96.8 p -154.52 -167.89 2.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.892 1.224 . . . . 0.0 110.789 168.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -79.63 -29.01 40.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.84 1.256 . . . . 0.0 110.969 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -89.26 -43.17 11.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.764 0.711 . . . . 0.0 109.83 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.5 62.39 6.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 9' ' ' SER . 17.8 p -121.98 165.41 16.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.319 149.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -110.36 -29.31 8.18 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.702 1.201 . . . . 0.0 108.805 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.47 169.72 20.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 109.678 167.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.3 119.69 39.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.196 2.198 . . . . 0.0 105.662 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD11 ' HB ' ' A' ' 38' ' ' THR . 1.2 tm? -79.98 105.72 11.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 mm -79.76 98.69 3.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 t -66.14 146.94 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 167.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.08 89.92 2.88 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.05 126.86 29.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 166.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -127.3 1.92 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 118.396 -0.812 . . . . 0.0 113.035 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -166.52 45.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.009 0.909 . . . . 0.0 110.488 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.66 8.56 1.79 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.895 -1.128 . . . . 0.0 114.01 -168.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.73 154.27 46.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.693 1.197 . . . . 0.0 109.883 162.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.64 108.12 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 107.757 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -88.95 -30.37 18.86 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.999 -1.063 . . . . 0.0 111.691 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -144.87 164.18 31.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 162.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.411 ' HB ' HD11 ' A' ' 26' ' ' LEU . 20.9 p -118.02 144.88 45.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.763 1.625 . . . . 0.0 106.912 165.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.86 155.59 27.65 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.535 1.134 . . . . 0.0 108.161 169.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.5 132.06 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.76 111.35 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -62.35 152.71 33.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.517 1.053 . . . . 0.0 109.768 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -74.73 88.3 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.67 165.28 27.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.174 1.789 . . . . 0.0 106.225 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -61.16 -39.31 89.64 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.523 -0.736 . . . . 0.0 111.737 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 t -63.97 -45.02 90.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.238 1.015 . . . . 0.0 108.481 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.95 -60.78 8.2 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 125.237 1.398 . . . . 0.0 112.062 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -62.75 -36.59 83.54 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 121.834 -0.804 . . . . 0.0 110.11 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -54.02 -44.87 71.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.637 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.1 m -70.69 -23.46 62.48 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.738 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.98 -46.18 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 121.478 1.944 . . . . 0.0 109.687 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -55.47 -18.11 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.64 . . . . 0.0 112.15 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.68 -14.85 14.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.735 -1.126 . . . . 0.0 112.592 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.06 -27.67 69.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.787 1.63 . . . . 0.0 111.026 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 63.42 53.89 2.06 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 125.238 1.415 . . . . 0.0 109.737 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.75 148.76 10.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -38.33 9.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.416 1.886 . . . . 0.0 110.257 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 161.17 43.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.07 0.548 . . . . 0.0 111.132 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -119.87 142.04 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.178 1.791 . . . . 0.0 107.221 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.34 106.35 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.749 1.22 . . . . 0.0 108.282 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 4.1 m -142.99 173.04 11.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' C ' HD22 ' A' ' 63' ' ' ASN . 64.1 mttt -71.86 -70.82 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.43 ' H ' ' HA ' ' A' ' 18' ' ' SER . 2.6 m120 -119.58 170.26 9.33 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.532 -1.355 . . . . 0.0 108.021 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.89 137.87 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -68.5 141.32 55.61 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.194 0.997 . . . . 0.0 110.408 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -45.24 -52.35 9.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.355 2.262 . . . . 0.0 111.288 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -39.35 89.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.812 0.445 . . . . 0.0 110.966 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -69.86 -47.5 62.38 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -51.09 -62.97 1.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.38 -36.03 70.73 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.189 0.596 . . . . 0.0 110.993 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -63.95 -59.7 4.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.805 -0.56 . . . . 0.0 110.494 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -75.82 -28.75 58.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.544 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -65.78 -5.68 9.55 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.702 1.201 . . . . 0.0 113.548 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -47.03 -51.49 17.26 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.513 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -140.39 -15.97 0.94 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 87.9 mt -73.03 123.99 29.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.21 147.7 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.25 119.3 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -120.22 154.34 35.0 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.831 1.252 . . . . 0.0 110.555 -170.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -90.13 128.72 36.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 109.662 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.1 123.81 20.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.421 0.688 . . . . 0.0 111.037 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -108.39 100.42 9.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.925 2.09 . . . . 0.0 108.184 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.75 157.77 27.6 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -27.98 62.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.134 2.174 . . . . 0.0 111.823 164.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.8 103.66 6.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.058 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -44.75 -44.48 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 123.719 0.807 . . . . 0.0 109.097 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.17 -34.62 61.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.98 0.355 . . . . 0.0 110.603 -169.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -50.81 -53.16 34.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -67.22 -29.25 68.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.349 -170.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.09 -46.19 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -66.96 -39.3 87.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.887 0.767 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.4 -46.41 90.09 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 6' ' ' VAL . 78.5 t80 -62.05 -40.51 96.02 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 mt -55.68 -49.75 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.626 1.171 . . . . 0.0 109.464 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -73.22 -14.95 61.44 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.544 0.738 . . . . 0.0 112.805 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.81 18.53 63.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.077 0.853 . . . . 0.0 112.3 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.14 -27.92 62.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.548 1.539 . . . . 0.0 112.502 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.39 154.53 40.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.015 1.28 . . . . 0.0 109.464 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.35 149.5 35.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.043 0.937 . . . . 0.0 109.42 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -83.14 136.18 34.54 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 122.104 -0.373 . . . . 0.0 111.551 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.579 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.447 ' HG2' ' HE1' ' A' ' 4' ' ' MET . 10.9 tpt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.683 HG22 ' H ' ' A' ' 3' ' ' ASN . 2.1 mm -95.17 -161.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.013 2.125 . . . . 0.0 108.164 -178.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.683 ' H ' HG22 ' A' ' 2' ' ' ILE . 17.3 t-20 -53.07 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.195 2.598 . . . . 0.0 110.424 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.447 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 1.4 ttp -110.17 148.49 31.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -131.22 129.65 41.93 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 125.674 1.589 . . . . 0.0 106.747 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.598 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.5 t -136.35 132.66 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.5 111.37 22.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.4 123.58 44.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -73.46 127.71 33.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 117.821 0.282 . . . . 0.0 110.279 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtp -130.65 156.63 44.57 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.189 1.396 . . . . 0.0 111.053 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -104.06 -69.93 0.79 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 109.675 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.8 t -146.75 -47.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.23 17.59 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.773 0.797 . . . . 0.0 111.14 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -160.79 172.64 16.67 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 120.481 -1.387 . . . . 0.0 109.087 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.6 138.6 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 107.88 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.3 p -73.38 167.99 20.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.739 0.781 . . . . 0.0 111.025 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.29 -46.11 57.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.266 0.3 OUTLIER -137.89 161.68 36.01 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.59 -1.319 . . . . 0.0 108.441 -175.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -68.33 -45.77 72.03 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.979 -1.076 . . . . 0.0 108.299 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.69 -33.32 75.62 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.374 0.67 . . . . 0.0 110.692 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.73 58.02 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.916 1.341 . . . . 0.0 107.807 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 p -121.35 175.91 5.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.481 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -104.69 -35.34 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.584 0.754 . . . . 0.0 109.53 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 29.5 p90 -156.1 170.76 21.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.422 0.629 . . . . 0.0 110.533 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.87 115.99 27.19 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.022 1.729 . . . . 0.0 107.257 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -79.14 107.28 11.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.01 100.17 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -63.31 137.38 24.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -125.01 118.46 26.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -119.02 139.89 44.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 16.8 m-20 -140.36 7.06 2.15 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.603 0.761 . . . . 0.0 109.517 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -168.44 51.08 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.571 1.548 . . . . 0.0 112.127 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 64.15 -5.3 0.33 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.177 1.791 . . . . 0.0 115.323 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -121.64 154.2 37.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.22 2.208 . . . . 0.0 109.296 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.74 96.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 107.321 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 67.8 mmtt -70.33 -33.31 71.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 171.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 m -161.77 167.09 25.55 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.087 0.858 . . . . 0.0 111.127 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -127.02 118.66 24.9 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.509 1.523 . . . . 0.0 108.77 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.71 168.53 9.01 Favored 'General case' 0 C--O 1.213 -0.861 0 C-N-CA 125.754 1.622 . . . . 0.0 108.792 171.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.79 1.1 p -155.17 124.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 131.085 3.754 . . . . 0.0 115.947 -175.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.52 109.41 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 129.586 3.155 . . . . 0.0 102.921 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -61.36 156.11 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.122 0.874 . . . . 0.0 109.654 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -72.43 55.85 0.35 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.84 2.056 . . . . 0.0 111.121 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -107.29 168.57 9.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.2 -43.89 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.854 0.862 . . . . 0.0 109.614 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -77.36 -34.19 55.11 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.21 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.76 17.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.107 0.861 . . . . 0.0 111.25 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 52' ' ' VAL . 53.1 mttt -61.1 -37.68 83.6 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.078 -1.248 . . . . 0.0 109.622 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -59.39 -34.71 72.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.923 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -65.49 -48.69 71.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 119.36 0.982 . . . . 0.0 110.453 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -55.15 -44.16 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.153 0.888 . . . . 0.0 110.521 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 48' ' ' LYS . 62.0 t -55.76 -35.59 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.632 0.773 . . . . 0.0 110.825 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -95.59 -3.09 47.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.915 0.779 . . . . 0.0 112.287 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.91 168.41 18.77 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.757 1.162 . . . . 0.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -95.39 37.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.102 1.761 . . . . 0.0 110.045 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.94 138.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -82.18 -45.62 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.438 1.495 . . . . 0.0 109.968 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.4 158.65 42.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.285 1.034 . . . . 0.0 109.949 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.25 122.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.89 123.02 47.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -148.07 161.15 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.421 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -81.78 -34.21 30.46 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 124.245 1.018 . . . . 0.0 111.335 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -149.85 159.78 44.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.674 1.579 . . . . 0.0 107.533 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.39 136.22 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.946 2.098 . . . . 0.0 108.69 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -77.94 148.88 34.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.22 -38.55 89.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.0 0.52 . . . . 0.0 112.104 -165.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.49 -42.97 99.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.195 0.598 . . . . 0.0 109.4 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -70.35 -31.74 69.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.941 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -58.41 -58.39 8.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.22 1.373 . . . . 0.0 109.655 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -54.95 -43.66 73.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.922 0.489 . . . . 0.0 110.586 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -54.0 -58.58 6.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.006 1.722 . . . . 0.0 111.276 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' HD1' HD12 ' A' ' 76' ' ' ILE . 44.2 m-85 -78.38 -35.3 47.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.34 -0.838 . . . . 0.0 112.983 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.9 t -50.44 -27.19 6.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.547 1.939 . . . . 0.0 111.546 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -45.05 -46.07 11.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.226 1.01 . . . . 0.0 113.094 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -149.03 14.68 0.91 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.198 -172.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.482 HD12 ' HD1' ' A' ' 72' ' ' PHE . 37.6 mt -136.44 122.94 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.29 126.88 31.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.767 1.227 . . . . 0.0 108.647 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.87 129.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -116.49 148.79 40.45 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.885 2.074 . . . . 0.0 109.534 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -88.62 142.16 27.92 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.75 48.99 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 161.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -108.1 8.41 28.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.726 1.61 . . . . 0.0 111.107 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.09 -174.96 39.27 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.872 0.76 . . . . 0.0 111.235 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.78 -14.3 15.27 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.759 1.224 . . . . 0.0 110.635 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.1 106.72 5.08 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.419 1.088 . . . . 0.0 108.199 173.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -54.86 -43.71 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.917 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.47 -34.28 70.06 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.877 0.762 . . . . 0.0 109.039 -168.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -59.02 -49.3 78.43 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 120.853 -1.154 . . . . 0.0 109.448 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -74.04 -28.37 61.39 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.403 -0.811 . . . . 0.0 112.515 -170.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mt -66.0 -55.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.6 p -61.7 -38.73 88.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.331 0.514 . . . . 0.0 112.132 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.1 mt -61.53 -34.17 75.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.05 0.54 . . . . 0.0 111.434 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 6' ' ' VAL . 85.1 t80 -72.79 -41.16 65.29 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.953 -1.092 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 91' ' ' SER . 83.7 mt -51.01 -54.57 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.159 1.384 . . . . 0.0 109.698 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.68 -20.84 63.55 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.694 0.798 . . . . 0.0 111.668 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.45 56.59 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -41.78 88.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.925 1.29 . . . . 0.0 110.366 164.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.58 140.71 53.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.418 1.008 . . . . 0.0 111.968 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.9 m -75.61 142.72 42.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.827 1.251 . . . . 0.0 111.104 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -76.37 150.82 36.78 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 160.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.258 -177.858 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.11 148.38 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t30 56.54 36.85 28.22 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.669 1.588 . . . . 0.0 112.948 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.9 tpp -80.76 148.74 29.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 174.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -137.27 141.59 41.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 165.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 93' ' ' PHE . 42.0 t -139.77 138.65 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.378 171.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.7 104.35 16.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.31 111.37 24.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.2 p -63.21 151.06 41.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.195 1.816 . . . . 0.0 110.513 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 mtp -138.53 160.61 39.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.471 1.508 . . . . 0.0 109.06 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.57 -68.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.797 1.239 . . . . 0.0 108.417 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -142.89 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 120.369 -1.457 . . . . 0.0 108.295 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -118.14 -31.43 5.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.357 1.063 . . . . 0.0 112.199 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -139.44 179.66 6.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.367 1.067 . . . . 0.0 110.176 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.3 mt -51.47 127.36 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.495 1.918 . . . . 0.0 109.098 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 t -71.32 179.18 3.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.676 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -85.35 -31.09 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -161.44 148.17 14.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.393 1.451 . . . . 0.0 112.032 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.62 -27.08 66.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.496 1.518 . . . . 0.0 111.309 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.54 11.53 28.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.483 1.913 . . . . 0.0 113.001 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -139.89 -6.42 1.28 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.394 1.478 . . . . 0.0 112.734 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 p -74.23 161.55 29.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.151 0.581 . . . . 0.0 111.34 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -99.75 -32.58 10.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.147 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.432 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 34.0 p90 -155.61 171.14 20.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.451 -0.78 . . . . 0.0 111.588 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -115.61 115.27 26.13 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.742 2.017 . . . . 0.0 107.283 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -76.55 99.47 4.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.34 97.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.59 150.06 7.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.995 1.318 . . . . 0.0 108.398 168.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -127.28 132.18 50.37 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.68 143.9 39.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 170.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -147.96 -6.03 0.45 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -152.1 59.08 0.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 160.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.67 -24.19 0.12 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 128.788 2.835 . . . . 0.0 114.718 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -92.27 155.48 17.93 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.658 1.983 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.76 130.52 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.148 1.379 . . . . 0.0 109.108 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.18 -27.61 6.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 m -163.44 164.7 24.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 108.484 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.482 ' HB ' HD11 ' A' ' 26' ' ' LEU . 12.1 p -120.5 148.92 43.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 109.488 171.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.05 155.59 49.74 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.512 1.125 . . . . 0.0 108.805 172.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.6 OUTLIER -124.08 128.71 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 128.714 2.806 . . . . 0.0 117.538 166.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.56 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.98 134.85 53.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.982 0.81 . . . . 0.0 109.051 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' H ' ' HA ' ' A' ' 24' ' ' TYR . 39.6 t30 -80.55 97.14 7.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -144.19 -68.95 0.31 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.317 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 46' ' ' SER . 1.6 pt-20 -155.78 -63.33 0.11 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.555 0.742 . . . . 0.0 109.058 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 39.0 m -53.9 -36.89 63.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.319 170.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.7 -63.07 3.68 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.163 0.887 . . . . 0.0 112.04 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -63.16 -37.13 86.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.856 0.862 . . . . 0.0 112.01 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -56.94 -44.01 82.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.751 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -64.55 -45.85 85.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.685 1.594 . . . . 0.0 111.273 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.8 mt -49.79 -44.45 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 120.156 1.344 . . . . 0.0 110.869 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.39 -31.92 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.245 -0.909 . . . . 0.0 110.964 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 8.64 43.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.867 0.867 . . . . 0.0 110.929 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -168.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -130.31 51.71 2.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.18 147.87 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -98.76 -31.31 11.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.5 1.12 . . . . 0.0 110.534 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.11 161.5 40.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.943 0.497 . . . . 0.0 111.936 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.97 125.37 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.69 114.83 40.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.1 m -141.04 165.5 27.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -69.13 -35.67 76.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.605 1.162 . . . . 0.0 111.207 172.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -155.3 161.8 41.02 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.79 142.65 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.044 1.738 . . . . 0.0 108.123 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -65.94 154.26 39.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.58 -51.74 68.63 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.075 0.55 . . . . 0.0 109.986 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.2 -46.38 88.59 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.08 -35.47 80.59 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.393 0.677 . . . . 0.0 111.791 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -59.92 -60.96 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.736 1.153 . . . . 0.0 109.693 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -65.37 -21.54 66.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 0.0 110.383 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -70.7 -66.91 0.55 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.443 1.497 . . . . 0.0 109.538 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.17 -18.77 60.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.547 -165.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 p -59.45 -9.35 2.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -74.36 104.79 5.24 Favored 'General case' 0 C--O 1.23 0.075 0 O-C-N 120.6 -1.313 . . . . 0.0 109.901 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 67.78 11.47 8.39 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.437 1.895 . . . . 0.0 114.031 174.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.4 142.84 42.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -109.8 144.03 38.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -122.12 117.35 51.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -164.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.4 148.87 42.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.399 1.88 . . . . 0.0 110.522 -167.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -96.12 118.97 33.77 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.573 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.62 124.83 22.9 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.806 0.843 . . . . 0.0 110.849 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.85 105.31 15.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.874 1.67 . . . . 0.0 107.923 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.7 176.93 49.42 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-O 122.623 1.124 . . . . 0.0 110.921 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.48 24.97 10.94 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.266 1.827 . . . . 0.0 107.046 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.55 105.84 15.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -52.42 -42.88 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.73 -47.06 86.98 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -57.14 -41.58 79.4 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.29 0.495 . . . . 0.0 110.898 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.45 -32.28 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.242 -0.911 . . . . 0.0 111.322 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.2 mt -67.95 -50.85 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 p -62.06 -42.96 99.73 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.937 0.789 . . . . 0.0 111.164 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.55 -43.31 99.09 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.956 0.502 . . . . 0.0 109.976 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 6' ' ' VAL . 55.8 t80 -65.46 -48.46 72.61 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -52.61 -36.41 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.789 1.235 . . . . 0.0 110.237 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.05 -12.39 58.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.395 1.078 . . . . 0.0 113.538 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.94 4.38 88.62 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.838 1.209 . . . . 0.0 112.719 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -27.09 63.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.271 1.028 . . . . 0.0 112.572 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.56 145.64 55.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.688 0.677 . . . . 0.0 110.497 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -78.98 151.8 31.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.989 0.916 . . . . 0.0 108.615 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -81.0 134.84 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.1 mt . . . . . 0 C--O 1.241 0.616 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.409 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.6 mm -127.63 154.98 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.346 1.458 . . . . 0.0 108.692 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 54.58 21.25 3.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.433 1.893 . . . . 0.0 113.457 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.52 134.18 35.2 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.747 -1.845 . . . . 0.0 108.763 -169.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -138.36 113.48 9.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.511 0.724 . . . . 0.0 109.298 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG21 ' CE2' ' A' ' 93' ' ' PHE . 27.5 t -120.44 144.61 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 102.45 13.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.798 1.239 . . . . 0.0 108.61 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mt -84.85 128.18 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 p -75.49 123.36 25.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 117.984 0.356 . . . . 0.0 111.001 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.7 mtp -123.19 154.71 38.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.254 1.022 . . . . 0.0 111.116 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -107.43 -61.57 1.54 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.716 2.006 . . . . 0.0 109.732 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.4 t -140.11 -76.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.38 14.32 8.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.031 0.933 . . . . 0.0 110.965 -169.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 21.3 ptmt -148.67 169.73 19.74 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.883 1.273 . . . . 0.0 108.649 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.17 131.39 28.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -67.35 159.09 30.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.577 0.751 . . . . 0.0 110.099 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -51.49 -36.02 42.74 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.698 0.799 . . . . 0.0 111.623 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -158.47 178.26 10.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.047 0.385 . . . . 0.0 111.377 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -73.15 -10.11 59.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.757 2.423 . . . . 0.0 111.817 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -107.87 -10.0 15.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.844 -1.16 . . . . 0.0 112.643 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -116.3 10.19 14.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.094 1.357 . . . . 0.0 110.415 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.9 p -70.13 164.47 24.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.716 -1.24 . . . . 0.0 110.038 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -119.95 -21.48 7.11 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.216 1.806 . . . . 0.0 109.898 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -158.88 176.42 12.35 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.956 0.884 . . . . 0.0 110.45 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -124.48 111.07 15.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.924 2.49 . . . . 0.0 106.212 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 39' ' ' LYS . 17.9 tp -79.04 110.7 14.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -84.47 93.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.17 148.07 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.31 1.844 . . . . 0.0 107.892 171.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -133.9 86.75 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -80.81 130.6 35.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.15 1.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.01 64.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 159.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.28 10.6 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.133 1.373 . . . . 0.0 114.41 -172.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -138.29 150.37 46.58 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.48 1.912 . . . . 0.0 108.779 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.22 95.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 128.021 2.528 . . . . 0.0 108.374 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -88.77 -27.21 21.29 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.907 -1.121 . . . . 0.0 110.88 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.85 178.87 8.53 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.467 1.031 . . . . 0.0 109.704 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -140.27 178.48 7.26 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.508 1.523 . . . . 0.0 109.542 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.558 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -160.27 162.82 33.73 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.924 2.089 . . . . 0.0 107.036 177.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.22 142.4 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.2 mt -128.14 109.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 166.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -60.3 142.14 55.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.564 1.074 . . . . 0.0 110.609 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -77.94 65.57 3.39 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.873 1.669 . . . . 0.0 108.949 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.01 95.15 2.52 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 52.71 -69.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.348 3.059 . . . . 0.0 115.465 157.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -44.95 -33.35 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.574 1.95 . . . . 0.0 110.88 157.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.27 -67.22 2.28 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 124.019 0.819 . . . . 0.0 111.371 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.66 -27.12 66.59 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -52.85 -51.46 60.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.686 1.13 . . . . 0.0 110.634 163.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -70.67 -20.93 62.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.986 0.514 . . . . 0.0 112.079 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.18 -11.73 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.592 1.157 . . . . 0.0 111.035 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.77 -23.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 119.906 -1.746 . . . . 0.0 111.16 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -114.7 52.64 0.84 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.537 1.062 . . . . 0.0 110.155 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -168.07 2.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.69 32.76 4.08 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.13 1.772 . . . . 0.0 109.397 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.67 140.92 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.94 -37.39 12.26 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.827 1.251 . . . . 0.0 109.168 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.33 151.45 26.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.229 1.012 . . . . 0.0 111.476 -171.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.5 mt -98.48 151.96 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 165.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.7 mt -124.28 130.05 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 161.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.1 p -146.65 160.82 41.7 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.88 1.272 . . . . 0.0 109.689 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -66.66 -47.72 71.62 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 167.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -154.88 172.87 17.33 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.0 tt -167.26 121.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -169.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -56.49 146.71 23.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -48.98 -43.99 40.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.341 1.456 . . . . 0.0 111.348 -174.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.25 -49.72 66.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.646 -0.658 . . . . 0.0 112.118 177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -58.28 -41.28 84.01 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.704 1.202 . . . . 0.0 109.849 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -59.35 -63.27 1.36 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.408 1.083 . . . . 0.0 109.529 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HE3' ' HG3' ' A' ' 66' ' ' GLU . 36.9 mttt -62.38 -21.89 65.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.711 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -72.76 -60.45 2.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.133 0.973 . . . . 0.0 110.03 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -75.46 -10.46 59.47 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.0 p -63.58 -9.02 11.36 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -77.2 117.93 19.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 120.414 -1.429 . . . . 0.0 108.311 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? 75.4 -31.48 0.21 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.335 3.054 . . . . 0.0 112.47 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mt -103.67 120.13 53.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.4 153.98 31.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.98 116.74 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.316 -1.49 . . . . 0.0 107.111 -166.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 7.1 m-85 -113.17 160.64 18.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.534 1.933 . . . . 0.0 110.703 -168.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -99.46 130.89 45.76 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 0.0 110.617 -173.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 131.04 36.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.019 0.927 . . . . 0.0 109.526 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -110.26 15.64 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.421 1.488 . . . . 0.0 112.271 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.76 172.64 31.14 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 13.0 m-20 -83.61 -24.13 31.6 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.567 0.747 . . . . 0.0 109.673 151.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.1 106.86 4.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.1 0.56 . . . . 0.0 109.776 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.6 -46.93 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.147 0.979 . . . . 0.0 109.517 168.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.0 -58.3 9.03 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -45.09 -49.55 11.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.974 1.309 . . . . 0.0 110.853 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.69 -41.56 87.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.953 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.58 -48.15 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -15.03 63.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.47 ' CB ' HD11 ' A' ' 98' ' ' LEU . 44.4 mt -83.71 -38.84 20.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.371 1.442 . . . . 0.0 109.226 172.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.513 ' CE2' HG21 ' A' ' 6' ' ' VAL . 54.5 t80 -65.21 -41.42 94.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -169.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.14 -45.93 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.288 2.235 . . . . 0.0 110.728 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.31 -19.52 56.3 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.942 -1.099 . . . . 0.0 111.816 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.0 39.27 63.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -17.88 62.02 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.086 0.943 . . . . 0.0 109.054 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -89.54 124.92 34.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 m -72.67 153.72 41.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.617 169.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 9.3 mtpm? -61.19 144.06 54.4 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 C--O 1.236 0.385 0 C-N-CA 124.516 1.126 . . . . 0.0 108.275 168.156 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.5 142.66 41.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.986 0.914 . . . . 0.0 109.551 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 44.65 66.31 0.9 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.166 2.986 . . . . 0.0 113.267 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.3 ttt -107.15 147.82 29.6 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -133.66 129.22 36.53 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.9 t -132.54 144.84 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 118.314 -0.85 . . . . 0.0 108.707 168.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.35 77.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.384 1.073 . . . . 0.0 108.785 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.23 141.89 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 0.0 109.68 -165.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 p -74.46 115.73 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.71 0.631 . . . . 0.0 111.491 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.1 mtp -122.21 148.49 44.89 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.27 -0.894 . . . . 0.0 111.102 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.98 -75.34 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 109.54 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 t -144.12 -46.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.598 1.159 . . . . 0.0 107.925 -167.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.53 2.35 1.24 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.56 -179.9 8.51 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 126.858 2.063 . . . . 0.0 108.808 -176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.9 139.29 19.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.3 p -69.71 -84.52 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.704 1.602 . . . . 0.0 110.271 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 t30 177.0 -55.03 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 127.518 2.327 . . . . 0.0 107.304 -167.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.3 t -126.42 -175.15 3.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.931 1.242 . . . . 0.0 110.228 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -85.4 -43.3 13.76 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.3 1.44 . . . . 0.0 108.544 166.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.66 -19.43 60.84 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.028 -0.42 . . . . 0.0 110.414 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -119.96 74.32 1.02 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.0 p -134.27 165.16 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.212 1.805 . . . . 0.0 107.825 151.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -90.45 -37.43 13.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.352 0.661 . . . . 0.0 109.783 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.31 171.09 19.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.673 0.749 . . . . 0.0 110.456 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.04 108.8 16.19 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.091 2.556 . . . . 0.0 106.304 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 39' ' ' LYS . 1.3 tm? -78.72 103.71 8.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 HD11 HD12 ' A' ' 41' ' ' ILE . 5.3 mm -79.19 88.36 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.558 0.695 . . . . 0.0 109.192 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -58.24 125.88 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 168.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -103.53 110.09 22.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.26 143.65 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 161.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -136.05 -0.36 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.92 45.52 0.28 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.665 0.745 . . . . 0.0 110.136 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.6 -9.7 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.252 2.221 . . . . 0.0 115.318 -167.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.99 163.46 22.27 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.105 1.32 . . . . 0.0 111.648 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -44.51 128.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 128.375 2.67 . . . . 0.0 111.159 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -91.17 -86.92 0.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.52 -0.66 9.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.316 1.416 . . . . 0.0 113.904 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 p 49.61 -166.4 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.894 -1.129 . . . . 0.0 110.723 -160.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -174.44 166.35 3.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.488 2.315 . . . . 0.0 107.442 165.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.89 132.3 65.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.456 HD12 HD11 ' A' ' 27' ' ' ILE . 55.9 mt -127.84 119.54 51.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 168.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.32 157.96 35.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.533 1.06 . . . . 0.0 110.722 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -84.11 65.21 8.63 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.884 -1.135 . . . . 0.0 108.578 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -130.55 28.42 4.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.236 1.017 . . . . 0.0 113.717 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 70.9 -54.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 128.759 2.824 . . . . 0.0 111.231 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.8 t -53.68 -36.27 61.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.085 1.354 . . . . 0.0 110.583 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.59 8.53 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 125.243 1.402 . . . . 0.0 111.891 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.83 -34.7 69.98 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.97 -0.724 . . . . 0.0 110.959 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -49.74 -44.03 48.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.018 0.927 . . . . 0.0 111.438 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -43.7 85.51 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.345 0.658 . . . . 0.0 111.315 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.6 -37.85 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 110.258 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -54.61 -45.43 71.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.138 0.427 . . . . 0.0 110.626 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -34.84 66.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.12 -14.75 62.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.859 -159.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.96 63.63 1.66 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.556 1.542 . . . . 0.0 109.355 -172.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.21 140.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.223 157.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -73.61 -47.82 37.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.1 40.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.22 108.0 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.23 125.37 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -142.51 177.02 8.57 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.573 1.149 . . . . 0.0 108.925 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 81' ' ' ALA . 59.4 mttm -88.2 -38.45 15.29 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.273 -0.892 . . . . 0.0 110.972 166.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.65 162.79 35.04 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.495 1.043 . . . . 0.0 109.189 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 tt -165.56 132.72 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.257 1.423 . . . . 0.0 108.53 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.1 p -65.02 157.91 27.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.157 0.983 . . . . 0.0 112.162 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -50.8 -53.64 30.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.502 1.521 . . . . 0.0 110.635 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -38.5 79.31 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.42 0.628 . . . . 0.0 111.294 -166.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.96 -37.78 72.78 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.967 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -55.69 -57.01 13.78 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 120.045 1.293 . . . . 0.0 111.154 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -57.19 -43.51 82.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.774 0.716 . . . . 0.0 110.533 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -53.43 -69.36 0.12 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.648 1.579 . . . . 0.0 110.129 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -68.37 -36.69 79.57 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.346 0.521 . . . . 0.0 110.854 -169.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.2 t -54.14 -24.37 17.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.516 1.526 . . . . 0.0 112.908 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -65.2 -10.52 32.23 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.697 -1.252 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -156.16 3.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.932 1.696 . . . . 0.0 112.942 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -141.21 125.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.87 133.34 35.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.87 138.03 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 120.644 -1.285 . . . . 0.0 108.845 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -129.81 156.3 44.56 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.537 1.935 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -98.15 137.65 36.61 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.043 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . . . -88.49 122.92 32.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.274 2.23 . . . . 0.0 112.498 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.09 108.93 20.51 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.716 2.006 . . . . 0.0 109.939 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.48 -176.7 53.6 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -163.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -118.14 -2.21 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.918 0.887 . . . . 0.0 110.211 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.67 103.48 7.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.21 1.004 . . . . 0.0 108.475 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.45 -38.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.144 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.29 -40.97 86.15 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.878 0.763 . . . . 0.0 109.697 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -64.29 -43.04 96.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.875 -0.516 . . . . 0.0 110.727 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.18 -33.23 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.459 -1.401 . . . . 0.0 110.483 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.79 -51.68 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.548 1.539 . . . . 0.0 108.088 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 p -75.01 -18.75 60.31 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HB3' HD11 ' A' ' 98' ' ' LEU . 90.7 mt -74.83 -37.74 62.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 6' ' ' VAL . 80.2 t80 -67.79 -42.58 81.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.776 -0.577 . . . . 0.0 111.963 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 mt -51.86 -50.99 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.72 1.608 . . . . 0.0 108.377 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.8 -18.39 62.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.529 1.132 . . . . 0.0 113.978 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.65 23.11 54.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 118.85 0.75 . . . . 0.0 111.919 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -28.6 66.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.118 1.459 . . . . 0.0 109.32 -170.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 1.2 mm? -82.11 135.73 35.27 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.78 1.232 . . . . 0.0 108.899 -163.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.5 p -71.06 157.45 38.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.469 1.107 . . . . 0.0 108.842 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -87.87 132.86 34.04 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt . . . . . 0 C--O 1.236 0.36 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.674 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 CA--C 1.511 -0.556 0 CA-C-O 121.352 0.596 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.62 146.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.547 1.539 . . . . 0.0 108.601 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' A' ' 31' ' ' ASP . 1.8 m-80 47.51 32.92 2.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.423 1.889 . . . . 0.0 115.061 172.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.9 151.06 31.17 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.663 -1.273 . . . . 0.0 107.625 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 155.04 50.29 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 156.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 28' ' ' VAL . 7.3 p -146.68 165.74 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 128.097 2.559 . . . . 0.0 104.903 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 25' ' ' PHE . . . -114.45 133.6 55.63 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 120.178 1.353 . . . . 0.0 111.646 153.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mt -105.43 119.29 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -62.45 114.32 3.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.864 1.211 . . . . 0.0 108.715 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.7 mtp -117.98 156.31 28.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 110.906 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.31 -69.63 0.76 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 127.752 2.421 . . . . 0.0 108.27 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 t -137.71 -67.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 168.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.3 -7.24 11.78 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 171.48 13.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.505 1.522 . . . . 0.0 110.058 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -59.54 139.32 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 p -84.04 166.42 17.74 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.528 0.731 . . . . 0.0 111.076 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -50.47 -43.99 55.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.833 1.653 . . . . 0.0 113.934 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.08 168.36 19.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.409 0.549 . . . . 0.0 110.133 -166.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -67.72 -23.45 65.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.01 1.724 . . . . 0.0 112.499 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.79 -30.19 13.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.791 1.178 . . . . 0.0 111.54 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.74 10.12 8.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.221 1.408 . . . . 0.0 111.809 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.5 p -80.1 167.62 20.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 122.174 0.988 . . . . 0.0 110.631 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -108.12 -28.71 9.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.516 1.526 . . . . 0.0 109.217 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -159.36 178.35 10.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.603 0.638 . . . . 0.0 111.451 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.463 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 78.8 m-85 -125.49 105.64 9.2 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 129.24 3.016 . . . . 0.0 106.612 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.83 111.99 11.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 27.1 mm -81.24 98.32 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 6' ' ' VAL . 2.9 t -63.96 132.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.08 98.51 6.11 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 163.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.37 152.75 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HA ' ' H ' ' A' ' 3' ' ' ASN . 2.8 m-20 -138.41 -20.35 1.06 Allowed 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -161.31 68.59 0.31 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 169.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.6 m120 54.9 10.62 0.4 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.301 2.241 . . . . 0.0 115.269 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -129.23 158.54 38.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.379 1.072 . . . . 0.0 112.503 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.49 96.13 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.709 1.604 . . . . 0.0 107.753 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -100.48 -20.21 15.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.202 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -156.78 148.89 23.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.248 1.385 . . . . 0.0 111.167 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 p -126.18 156.94 39.39 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.534 1.934 . . . . 0.0 109.427 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 162.26 37.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.729 1.211 . . . . 0.0 108.881 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.82 112.11 23.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.26 115.57 34.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 161.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -66.77 158.09 31.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.081 1.31 . . . . 0.0 110.524 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.22 81.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -130.3 -170.97 2.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.685 1.231 . . . . 0.0 108.739 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.51 -49.92 75.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.33 1.852 . . . . 0.0 111.061 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.3 m -65.46 -37.68 87.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.894 0.316 . . . . 0.0 110.776 175.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.48 -62.98 5.73 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 123.552 0.596 . . . . 0.0 112.795 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -59.67 -28.93 67.69 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.589 0.756 . . . . 0.0 111.219 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -71.35 -32.51 68.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.943 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -65.22 -38.22 89.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 119.257 0.935 . . . . 0.0 110.357 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -62.49 -17.31 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 118.753 0.706 . . . . 0.0 111.715 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.7 t -82.2 -30.18 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 119.51 -1.994 . . . . 0.0 112.205 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.83 54.84 1.13 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.544 1.138 . . . . 0.0 109.08 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 -165.14 1.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.854 1.662 . . . . 0.0 111.017 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.46 19.33 7.44 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.199 2.2 . . . . 0.0 108.94 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 58' ' ' ALA . 44.7 t -67.4 166.06 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.95 1.25 . . . . 0.0 109.944 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.72 -33.34 6.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 109.522 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.662 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -144.6 163.11 34.91 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -161.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.4 mt -134.14 118.34 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 163.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mt -81.08 133.35 29.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 120.488 1.494 . . . . 0.0 107.171 166.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 p -144.51 168.13 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.86 1.209 . . . . 0.0 112.251 168.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -93.4 -27.2 16.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 117.455 -1.259 . . . . 0.0 112.727 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -161.26 161.37 30.7 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.005 1.722 . . . . 0.0 107.061 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -151.46 127.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 126.403 1.881 . . . . 0.0 108.515 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -54.8 148.35 13.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.125 0.97 . . . . 0.0 110.442 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -61.6 -38.8 88.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.416 1.007 . . . . 0.0 111.524 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.21 -51.65 62.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -57.81 -43.13 85.47 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -56.41 -58.57 7.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.128 0.422 . . . . 0.0 110.145 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.46 -20.67 66.45 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 122.374 -0.204 . . . . 0.0 111.275 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -75.44 -35.74 60.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.18 -0.95 . . . . 0.0 111.941 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.09 -16.67 18.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.698 0.799 . . . . 0.0 111.812 -172.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.82 -17.45 56.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -71.99 106.99 4.48 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 120.566 -1.334 . . . . 0.0 109.611 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 tttm 73.95 21.28 2.66 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.143 1.777 . . . . 0.0 111.954 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.64 144.11 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.597 1.559 . . . . 0.0 107.742 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -102.59 108.8 20.21 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.42 114.83 30.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -105.92 149.15 26.85 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.685 1.194 . . . . 0.0 110.117 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -83.13 147.17 28.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.78 168.05 20.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 109.924 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.6 5.9 14.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.419 2.287 . . . . 0.0 112.366 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.96 -169.37 41.8 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.15 -14.17 34.14 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.539 1.135 . . . . 0.0 110.0 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.66 99.35 2.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.744 1.218 . . . . 0.0 109.659 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -52.97 -42.05 42.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.37 -38.49 71.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.116 0.871 . . . . 0.0 110.305 -171.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -57.14 -50.35 73.09 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.61 -31.74 65.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.1 -54.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.895 1.278 . . . . 0.0 108.053 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.579 ' HA ' HD12 ' A' ' 94' ' ' ILE . 35.6 p -66.82 -36.57 82.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.357 0.526 . . . . 0.0 111.184 -172.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.3 mt -63.93 -40.46 96.5 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.243 0.617 . . . . 0.0 111.171 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -63.85 -34.42 77.88 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.478 0.711 . . . . 0.0 112.223 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 91' ' ' SER . 58.4 mt -59.21 -45.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 -18.55 60.7 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.214 1.006 . . . . 0.0 112.135 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.73 14.17 81.4 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.468 -0.77 . . . . 0.0 112.217 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -19.9 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.631 1.973 . . . . 0.0 112.592 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -67.13 140.81 57.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.016 -1.052 . . . . 0.0 109.492 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.0 m -64.6 125.51 24.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.452 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -81.04 126.88 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--O 1.24 0.58 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -168.841 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.8 mt -122.06 148.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.47 23.21 10.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.998 1.719 . . . . 0.0 113.42 171.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpp -68.57 147.06 52.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -134.34 141.09 46.78 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 166.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 93' ' ' PHE . 44.9 t -140.24 140.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 110.02 21.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.493 0.717 . . . . 0.0 109.436 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.7 mt -95.07 123.96 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 p -80.91 112.19 18.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtp -108.87 158.12 17.97 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -108.08 -53.13 2.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 127.738 2.415 . . . . 0.0 109.143 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.26 -79.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.41 -3.37 16.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.134 0.974 . . . . 0.0 112.003 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 171.23 16.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.304 1.842 . . . . 0.0 110.955 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.5 mt -64.98 124.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.738 1.615 . . . . 0.0 107.3 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 t -66.55 173.1 3.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.155 0.889 . . . . 0.0 111.229 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.67 -27.75 67.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.53 0.732 . . . . 0.0 111.749 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 p -147.69 177.2 9.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.69 -0.631 . . . . 0.0 110.373 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -69.26 -37.28 77.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.511 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -88.48 -39.24 14.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.481 0.713 . . . . 0.0 109.629 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.27 31.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.648 2.379 . . . . 0.0 111.276 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 p -99.28 172.53 7.29 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 119.968 -1.707 . . . . 0.0 111.096 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -103.59 -30.05 10.73 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.592 1.557 . . . . 0.0 110.065 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.427 ' HE2' HD23 ' A' ' 26' ' ' LEU . 41.2 p90 -166.82 176.94 6.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CG ' HD11 ' A' ' 51' ' ' ILE . 41.9 m-85 -123.7 102.55 7.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 126.409 1.884 . . . . 0.0 107.29 -169.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.427 HD23 ' HE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -81.84 103.32 11.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.87 95.42 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.349 1.86 . . . . 0.0 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 t -76.2 92.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.83 115.99 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 156.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.59 131.89 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.06 3.03 3.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.55 44.33 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 111.545 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.55 8.16 2.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.007 0.923 . . . . 0.0 112.577 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -134.18 165.41 25.15 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 126.967 2.107 . . . . 0.0 111.212 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -61.82 128.73 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 127.068 2.147 . . . . 0.0 109.614 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.15 -85.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.757 -0.639 . . . . 0.0 109.7 167.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -15.19 14.45 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 44.84 -168.34 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.373 1.069 . . . . 0.0 112.11 -163.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 163.43 8.57 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 125.164 1.385 . . . . 0.0 109.784 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.669 0.7 OUTLIER -118.91 140.16 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 119.456 3.132 . . . . 0.0 119.456 159.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.7 mt -124.56 122.93 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 129.261 3.024 . . . . 0.0 105.175 164.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -68.01 155.57 39.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.365 1.893 . . . . 0.0 111.057 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 45.0 t30 -77.31 61.79 2.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.52 1.528 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -97.38 161.92 13.57 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 165.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -44.04 93.35 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.113 -0.992 . . . . 0.0 108.324 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -70.4 -16.23 62.93 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.962 -1.086 . . . . 0.0 111.293 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -64.03 2.89 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 166.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 25' ' ' PHE 0.253 43.3 pttt -65.87 -23.37 66.64 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.76 -0.847 . . . . 0.0 111.977 -172.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -38.57 83.92 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 171.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -72.86 -32.08 65.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.925 1.29 . . . . 0.0 110.172 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.434 HD11 ' CG ' ' A' ' 25' ' ' PHE . 58.8 mt -55.07 -42.97 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.78 1.232 . . . . 0.0 109.761 176.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.12 -26.36 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.406 -0.809 . . . . 0.0 111.667 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -97.7 -28.22 14.0 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.865 0.866 . . . . 0.0 110.97 -172.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -25.52 63.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.695 1.198 . . . . 0.0 111.884 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.2 t30 74.2 51.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.406 2.282 . . . . 0.0 109.958 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -50.82 152.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.868 1.667 . . . . 0.0 109.324 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -42.97 10.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.091 1.357 . . . . 0.0 109.175 171.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.24 160.12 42.72 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.3 mt -116.42 144.0 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.685 1.194 . . . . 0.0 107.962 171.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.8 mt -123.04 121.28 62.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.0 p -149.3 170.81 17.64 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.773 1.229 . . . . 0.0 109.345 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -82.66 -40.04 21.25 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.104 167.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -147.64 164.42 33.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.502 1.501 . . . . 0.0 109.61 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.5 tt -144.77 145.38 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.406 1.482 . . . . 0.0 109.095 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -62.49 155.47 25.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.197 0.908 . . . . 0.0 109.562 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.04 -43.37 87.75 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 118.824 0.738 . . . . 0.0 109.04 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.39 -45.24 94.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 110.666 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -61.79 -47.94 82.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.783 1.233 . . . . 0.0 109.263 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.56 -58.94 5.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.724 1.147 . . . . 0.0 110.541 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.51 -22.39 66.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.581 0.628 . . . . 0.0 111.892 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -76.66 -44.04 35.51 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 120.829 -1.169 . . . . 0.0 110.885 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -88.04 -8.28 55.8 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.148 0.979 . . . . 0.0 112.753 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 p -73.26 43.14 0.13 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.835 1.652 . . . . 0.0 112.551 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -139.91 111.84 7.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.412 1.885 . . . . 0.0 106.662 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? 60.81 -1.22 0.25 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 113.948 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.5 mt -131.27 134.25 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -169.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.56 130.49 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.499 1.52 . . . . 0.0 107.034 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.5 mt -104.17 118.5 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -110.29 155.38 22.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.237 1.815 . . . . 0.0 110.821 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -99.06 118.1 35.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.798 1.239 . . . . 0.0 110.348 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.95 135.15 57.7 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 168.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -16.24 55.98 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.291 1.036 . . . . 0.0 112.722 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.89 -178.73 46.87 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 126.11 1.814 . . . . 0.0 109.078 -149.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -96.48 -15.35 21.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.097 0.959 . . . . 0.0 110.042 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.41 99.81 2.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.45 1.5 . . . . 0.0 110.014 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.57 -41.79 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.27 -39.28 89.31 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.8 0.727 . . . . 0.0 110.997 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -46.23 90.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.519 0.676 . . . . 0.0 109.517 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -74.17 -26.22 60.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.0 mt -67.19 -51.26 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.006 0.821 . . . . 0.0 108.797 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.8 p -71.38 -33.05 69.17 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.429 0.558 . . . . 0.0 111.503 -173.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -42.68 95.88 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.69 -0.631 . . . . 0.0 110.268 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 6' ' ' VAL . 31.7 t80 -57.89 -47.56 82.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.781 0.433 . . . . 0.0 111.872 -177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 mt -51.03 -56.49 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.168 1.387 . . . . 0.0 111.119 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -73.43 -1.93 20.32 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.055 1.298 . . . . 0.0 113.573 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.61 86.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.263 0.935 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -27.56 67.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.077 1.751 . . . . 0.0 112.146 -173.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.22 144.42 57.15 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.46 139.39 49.61 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.33 -0.857 . . . . 0.0 110.188 172.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.92 123.0 30.76 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 C--O 1.239 0.536 0 C-N-CA 124.475 1.11 . . . . 0.0 109.752 -175.167 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 31' ' ' ASP . 13.2 mt -146.8 46.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.352 0.596 . . . . 0.0 112.097 -173.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 t30 173.54 42.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.846 2.059 . . . . 0.0 107.509 163.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 146.79 32.94 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 120.598 -1.314 . . . . 0.0 108.127 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -145.85 120.41 9.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.892 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.9 152.98 25.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 109.613 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.75 120.62 40.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.653 1.181 . . . . 0.0 108.359 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.15 118.9 54.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -63.2 105.41 0.71 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.757 0.823 . . . . 0.0 109.636 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.15 155.85 22.26 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -93.71 -76.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.603 1.961 . . . . 0.0 107.393 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -139.61 -56.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 1.26 3.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -160.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -156.6 173.79 16.41 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.252 2.221 . . . . 0.0 108.519 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.31 139.31 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.788 0.68 . . . . 0.0 111.147 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 163.48 21.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 111.308 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.83 -16.82 60.02 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -166.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.46 172.63 17.92 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.672 1.989 . . . . 0.0 107.335 170.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.18 -50.54 73.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.34 1.056 . . . . 0.0 108.768 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -74.5 -44.49 51.13 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -165.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.9 4.15 0.91 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 128.55 2.74 . . . . 0.0 113.641 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 p -67.57 165.92 15.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 123.057 1.408 . . . . 0.0 110.742 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -106.58 -30.75 8.84 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.919 1.687 . . . . 0.0 108.688 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 28.2 p90 -155.35 164.94 38.07 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.158 0.98 . . . . 0.0 109.834 172.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.55 112.48 25.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.04 114.01 14.2 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HB ' ' CB ' ' A' ' 39' ' ' LYS . 5.0 mm -84.04 93.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.08 101.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -91.72 121.6 33.51 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -125.75 115.69 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 2' ' ' ILE . 5.1 m-20 -126.63 -0.64 6.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.387 -169.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.09 61.24 0.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.135 0.969 . . . . 0.0 110.433 156.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.63 6.89 0.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.238 1.815 . . . . 0.0 114.679 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.18 163.29 23.48 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.1 2.56 . . . . 0.0 109.378 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.91 74.96 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 122.408 1.099 . . . . 0.0 108.101 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -57.37 -29.58 64.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.909 1.684 . . . . 0.0 112.118 -170.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 m -154.82 115.26 3.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.401 1.0 . . . . 0.0 108.845 164.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -64.02 141.62 58.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 161.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -143.09 161.2 38.8 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 124.53 1.132 . . . . 0.0 109.274 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.474 0.6 OUTLIER -142.53 132.44 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 178.602 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.488 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 66.0 mt -119.59 113.13 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -65.46 152.07 44.84 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.773 0.715 . . . . 0.0 109.439 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -75.57 87.38 2.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.57 174.99 10.0 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.57 2.748 . . . . 0.0 105.038 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -62.13 -38.64 89.71 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.487 -1.383 . . . . 0.0 111.567 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 t -61.43 -18.56 59.43 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.697 -0.627 . . . . 0.0 111.316 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.488 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -75.23 -61.09 3.1 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -66.91 -15.4 63.64 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.368 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -60.98 -64.57 0.91 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.837 1.199 . . . . 0.0 109.639 161.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.3 m -54.13 -37.73 64.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.991 0.916 . . . . 0.0 113.344 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.4 mt -50.74 -40.4 19.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.075 1.35 . . . . 0.0 111.608 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.48 -46.88 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.082 -1.012 . . . . 0.0 109.063 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -73.66 -21.77 60.17 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.833 0.853 . . . . 0.0 112.978 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.81 -26.65 63.41 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.346 -0.847 . . . . 0.0 111.094 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 74.25 38.33 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.849 1.66 . . . . 0.0 112.536 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.44 138.13 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.558 1.143 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -66.48 -56.68 9.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.019 1.728 . . . . 0.0 108.74 168.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.82 29.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -169.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.56 148.44 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.5 mt -119.41 123.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.35 2.26 . . . . 0.0 104.978 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.76 154.33 31.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.803 1.638 . . . . 0.0 111.141 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -71.94 -25.9 62.07 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.34 -0.85 . . . . 0.0 111.124 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -172.23 166.15 5.96 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.84 132.84 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.017 0.436 . . . . 0.0 110.285 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.42 147.25 32.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.528 0.731 . . . . 0.0 109.622 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -48.71 79.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.343 1.057 . . . . 0.0 110.506 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -56.67 -47.97 78.64 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -64.51 -44.94 89.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.724 1.21 . . . . 0.0 110.424 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -54.9 -64.88 0.7 Allowed 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 118.682 0.674 . . . . 0.0 109.552 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -57.02 -33.15 66.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.771 0.828 . . . . 0.0 111.518 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -71.33 -34.34 70.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.56 1.944 . . . . 0.0 113.457 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -99.26 -23.39 15.21 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.706 0.685 . . . . 0.0 112.541 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -68.68 15.24 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -166.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -19.04 13.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.754 1.161 . . . . 0.0 113.151 -174.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -34.78 0.48 Allowed 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.188 -0.945 . . . . 0.0 113.188 175.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.6 mt -89.53 127.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.95 145.44 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.132 0.973 . . . . 0.0 108.66 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -113.67 122.67 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 120.377 -1.452 . . . . 0.0 107.748 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -105.81 156.07 18.68 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.43 1.892 . . . . 0.0 108.257 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -68.06 177.19 2.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.283 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.75 149.54 48.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.959 1.303 . . . . 0.0 110.45 165.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.421 ' OE1' HD22 ' A' ' 98' ' ' LEU 0.254 19.6 mp0 -106.22 -162.35 0.85 Allowed 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 129.09 2.956 . . . . 0.0 106.097 -165.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.3 166.88 0.04 OUTLIER Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.043 -1.035 . . . . 0.0 114.272 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -23.3 19.53 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.185 1.794 . . . . 0.0 113.555 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . 2.4 t0 -72.13 101.83 2.87 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 125.083 1.489 . . . . 0.0 107.645 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -53.55 -39.89 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -39.7 82.38 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -174.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 1.4 tppp? -59.3 -45.58 90.9 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.24 -0.912 . . . . 0.0 109.339 170.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.93 -38.8 89.6 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.453 1.024 . . . . 0.0 111.046 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.07 -49.45 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 108.522 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 p -65.98 -36.89 84.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.813 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.4 mt -61.67 -44.44 96.96 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.709 0.686 . . . . 0.0 109.22 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -57.78 -57.25 13.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.288 0.635 . . . . 0.0 110.91 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.6 mt -51.82 -34.42 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.496 1.919 . . . . 0.0 111.183 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -84.96 -14.86 46.22 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 24.61 54.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 119.509 1.05 . . . . 0.0 112.395 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -24.54 36.19 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.793 1.237 . . . . 0.0 112.54 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD22 ' OE1' ' A' ' 82' ' ' GLU . 29.3 mt -73.18 142.92 47.39 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.274 1.035 . . . . 0.0 110.402 -171.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 133.27 34.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 110.819 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -72.07 142.76 49.24 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 C--O 1.239 0.51 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.544 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 4' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.01 147.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.793 172.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.58 56.89 1.93 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.341 2.656 . . . . 0.0 112.162 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.426 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 25.1 tpp -83.78 149.33 26.5 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.907 0.776 . . . . 0.0 109.928 170.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -142.56 132.95 24.93 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.232 0.958 . . . . 0.0 108.491 153.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 28' ' ' VAL . 4.9 p -128.93 166.14 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 128.523 2.729 . . . . 0.0 107.439 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.64 110.47 13.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.37 1.468 . . . . 0.0 109.74 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -94.72 122.65 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.242 0.928 . . . . 0.0 108.932 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 p -72.11 97.45 1.93 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.128 1.371 . . . . 0.0 109.95 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.0 mtp -102.98 154.73 18.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.27 1.028 . . . . 0.0 110.6 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.79 -61.08 1.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.2 t -141.7 -71.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.77 10.72 7.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.8 1.286 . . . . 0.0 112.944 -167.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 175.54 12.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.811 2.444 . . . . 0.0 108.948 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.42 140.72 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.763 1.225 . . . . 0.0 108.456 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 t -73.61 -87.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -178.48 -36.45 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.795 1.638 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.27 154.32 36.56 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.336 0.588 . . . . 0.0 110.332 -177.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.48 -48.32 82.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.766 0.826 . . . . 0.0 110.047 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -78.17 -6.41 54.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.395 0.678 . . . . 0.0 112.804 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.16 -16.71 14.03 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.08 0.854 . . . . 0.0 111.063 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.0 p -72.62 170.65 14.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 122.154 0.978 . . . . 0.0 111.755 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -106.09 -26.32 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.881 1.272 . . . . 0.0 110.331 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -161.22 166.49 27.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.518 0.675 . . . . 0.0 110.364 170.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CD2' HD11 ' A' ' 51' ' ' ILE . 91.1 m-85 -105.36 116.41 31.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.423 1.489 . . . . 0.0 108.044 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.61 118.44 20.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 170.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -92.0 95.11 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.394 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.562 ' HB ' HG12 ' A' ' 6' ' ' VAL . 1.9 t -78.33 104.09 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.82 140.8 36.69 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 156.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 145.19 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 164.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.19 18.64 0.36 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.98 52.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 128.506 2.722 . . . . 0.0 107.263 169.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.75 2.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 129.288 3.035 . . . . 0.0 113.694 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.16 150.84 40.67 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 128.203 2.601 . . . . 0.0 107.876 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.3 91.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.042 2.137 . . . . 0.0 109.884 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -53.55 -70.16 0.1 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 110.979 174.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -151.79 112.71 4.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -69.26 164.17 23.37 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.23 1.412 . . . . 0.0 110.452 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 164.79 30.18 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 125.944 1.698 . . . . 0.0 108.534 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.54 148.23 26.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mt -134.33 105.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 166.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -57.34 145.46 32.26 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.61 97.95 0.34 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.406 1.882 . . . . 0.0 106.096 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -51.26 67.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.068 0.947 . . . . 0.0 109.339 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 t -68.45 -26.54 65.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.968 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -63.58 4.97 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -65.39 -22.61 66.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.461 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -68.96 -47.42 65.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.222 1.374 . . . . 0.0 109.039 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -44.6 73.16 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 110.102 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 25' ' ' PHE . 58.1 mt -52.59 -35.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.648 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.21 -40.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 120.586 -1.321 . . . . 0.0 110.649 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.2 -8.75 44.57 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.346 0.658 . . . . 0.0 111.854 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.3 -16.37 33.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.538 1.535 . . . . 0.0 111.226 166.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 53.29 36.47 22.83 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.985 1.714 . . . . 0.0 111.031 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.13 134.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -73.05 -39.63 65.75 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.422 1.889 . . . . 0.0 110.519 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.58 165.47 26.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mt -131.45 132.5 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.068 1.347 . . . . 0.0 107.5 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -104.12 130.97 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -146.46 175.83 10.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.649 0.659 . . . . 0.0 111.32 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -96.9 -24.27 15.93 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.099 1.36 . . . . 0.0 111.47 164.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -155.74 161.33 40.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.075 1.75 . . . . 0.0 108.311 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.82 130.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.833 1.653 . . . . 0.0 108.643 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -63.41 147.1 52.14 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.417 1.087 . . . . 0.0 110.489 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -55.29 -45.17 76.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.247 2.219 . . . . 0.0 111.998 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.37 -50.95 63.62 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.721 -0.612 . . . . 0.0 109.743 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -62.51 -39.13 92.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.75 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -51.53 -56.61 12.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.396 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -61.6 -43.26 99.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.198 0.599 . . . . 0.0 110.45 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -59.35 -40.91 87.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.19 1.396 . . . . 0.0 112.783 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -92.39 -34.66 14.07 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.259 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 t -70.56 16.33 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.144 1.778 . . . . 0.0 114.185 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -100.64 -17.26 17.11 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.977 1.711 . . . . 0.0 113.031 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -145.22 -6.57 0.64 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.838 0.855 . . . . 0.0 112.776 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.7 mt -136.19 133.5 50.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -165.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.72 113.34 22.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.586 1.554 . . . . 0.0 108.307 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.05 130.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 100' ' ' LYS . 88.1 m-85 -126.45 146.62 50.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.759 1.224 . . . . 0.0 109.799 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -95.62 119.53 34.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.539 1.135 . . . . 0.0 109.332 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.43 119.72 10.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.69 -12.6 61.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.66 172.34 44.14 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -166.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.2 -5.14 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.883 0.873 . . . . 0.0 109.812 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.51 102.71 8.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.493 1.917 . . . . 0.0 107.386 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -52.44 -40.31 32.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.23 -45.7 72.55 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 118.36 0.527 . . . . 0.0 110.393 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -57.7 -37.18 73.04 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.943 0.497 . . . . 0.0 110.764 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -77.46 -22.6 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.232 -0.918 . . . . 0.0 112.191 -176.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.2 mt -70.87 -50.78 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 p -61.65 -48.21 81.89 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.685 0.675 . . . . 0.0 111.035 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.2 mt -56.51 -47.02 80.23 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.24 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.1 -44.9 87.89 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.759 0.823 . . . . 0.0 112.426 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.96 -41.09 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.55 -13.22 59.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.055 0.843 . . . . 0.0 112.638 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.51 -1.29 61.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.535 1.064 . . . . 0.0 113.758 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -12.48 61.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.386 2.274 . . . . 0.0 115.461 -171.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.77 143.15 57.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.823 1.647 . . . . 0.0 108.25 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -72.34 142.14 48.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 7.3 mtpt -80.17 150.98 29.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.322 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 mm -116.63 138.52 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 t30 45.42 63.99 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.302 1.041 . . . . 0.0 112.01 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpp -94.47 151.97 18.94 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -141.53 138.55 32.82 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 167.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG21 ' CE2' ' A' ' 93' ' ' PHE . 36.1 t -133.47 148.33 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB3' HG12 ' A' ' 59' ' ' ILE . . . -105.87 105.1 14.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.662 0.785 . . . . 0.0 108.981 168.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.73 117.73 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.2 p -73.55 111.16 8.42 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mmm -113.86 161.28 17.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 110.094 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.23 -73.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.951 1.3 . . . . 0.0 108.06 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.26 -45.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -135.58 -13.7 1.97 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.2 174.39 12.03 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.31 1.444 . . . . 0.0 107.901 -171.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mt -54.48 139.46 13.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.162 0.982 . . . . 0.0 108.524 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 p -68.33 163.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.485 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -71.58 -31.15 66.65 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.83 -0.544 . . . . 0.0 111.586 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.88 158.67 33.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.383 0.992 . . . . 0.0 109.859 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 59' ' ' ILE . 65.1 t80 -66.05 -39.72 90.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' HG2' HD22 ' A' ' 68' ' ' ASN . 1.4 mm-40 -78.74 1.27 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 175.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.16 1.17 8.5 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.846 0.859 . . . . 0.0 111.394 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 p -67.79 169.7 9.23 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.928 -1.107 . . . . 0.0 111.201 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -110.75 -25.7 9.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.124 1.37 . . . . 0.0 109.078 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 40' ' ' VAL . 22.8 p90 -158.3 170.83 21.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.03 0.919 . . . . 0.0 111.488 174.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -114.44 102.42 10.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.073 2.549 . . . . 0.0 106.259 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -77.79 97.65 5.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.4 mm -68.91 124.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.929 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.05 126.96 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 126.395 1.878 . . . . 0.0 105.934 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.68 97.51 6.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 165.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.81 149.55 5.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 163.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.23 133.77 10.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.648 1.179 . . . . 0.0 109.03 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t0 46.44 44.93 13.47 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.892 1.805 . . . . 0.0 110.945 -167.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 70.17 -13.8 0.42 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.686 3.195 . . . . 0.0 114.825 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.94 165.88 11.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.473 1.909 . . . . 0.0 110.091 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.2 129.47 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.786 -1.197 . . . . 0.0 111.616 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -100.02 -44.66 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 t -165.33 166.46 18.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.8 161.96 26.19 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.931 1.693 . . . . 0.0 108.039 -172.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.12 31.66 Favored 'General case' 0 C--O 1.19 -2.033 0 O-C-N 120.139 -1.601 . . . . 0.0 109.65 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 24' ' ' TYR 0.462 1.4 p -107.98 124.95 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 160.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -108.09 112.84 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.635 2.774 . . . . 0.0 103.747 165.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -59.4 154.59 16.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.824 1.193 . . . . 0.0 110.156 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -81.3 85.93 6.33 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -152.81 175.55 12.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.286 1.035 . . . . 0.0 109.129 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -52.61 -52.17 56.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.059 1.344 . . . . 0.0 110.509 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -5.78 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.762 0.425 . . . . 0.0 110.914 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.6 -69.76 1.38 Allowed Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -55.74 -29.05 58.9 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.513 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -34.92 63.85 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 120.16 1.345 . . . . 0.0 111.072 176.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -87.58 -24.16 24.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 116.582 -1.675 . . . . 0.0 113.034 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 54' ' ' GLU . 62.2 mt -63.53 -30.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 121.357 1.89 . . . . 0.0 109.364 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.26 -3.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 119.82 -1.8 . . . . 0.0 111.314 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -110.53 21.99 15.97 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.114 -0.991 . . . . 0.0 109.517 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.55 ' CG ' ' HA ' ' A' ' 51' ' ' ILE . 8.1 pt-20 -138.63 144.67 39.83 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.969 -2.332 . . . . 0.0 111.215 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.85 62.51 7.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 109.409 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.01 134.88 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.63 -48.5 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.02 156.7 43.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 7' ' ' ALA . 94.4 mt -110.57 136.99 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 166.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.35 124.37 65.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.88 167.62 23.47 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -80.02 -32.51 39.58 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.381 -0.824 . . . . 0.0 112.01 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -155.98 173.76 16.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.458 1.026 . . . . 0.0 109.611 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.3 tt -165.14 154.67 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.802 1.241 . . . . 0.0 108.418 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -81.22 153.12 27.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.871 0.869 . . . . 0.0 112.128 169.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.56 -51.51 65.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.613 1.965 . . . . 0.0 110.929 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.61 -39.89 88.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.46 HD22 ' HG2' ' A' ' 20' ' ' GLU . 1.3 t-20 -66.68 -41.61 87.83 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.739 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -51.76 -63.79 1.02 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.83 -24.43 67.54 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.96 -0.462 . . . . 0.0 111.705 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -76.83 -36.11 57.09 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -98.52 -24.04 15.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.078 1.308 . . . . 0.0 112.062 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -71.86 9.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.622 1.969 . . . . 0.0 113.028 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -80.72 -0.13 37.06 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.965 -1.084 . . . . 0.0 113.517 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -165.63 -64.15 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.779 0.832 . . . . 0.0 109.858 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.91 144.67 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.953 . . . . 0.0 107.82 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -113.17 126.33 55.32 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 125.101 1.361 . . . . 0.0 109.477 -169.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.63 131.48 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 120.105 -1.622 . . . . 0.0 109.483 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 50.6 m-85 -116.04 150.63 36.96 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.76 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -80.14 135.82 36.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.99 128.1 34.35 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -24.82 43.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.725 0.774 . . . . 0.0 112.294 -174.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.52 161.53 28.9 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 127.308 2.385 . . . . 0.0 107.519 -159.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.54 -9.79 59.68 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.621 1.168 . . . . 0.0 110.343 -167.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.56 98.84 2.39 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.211 1.404 . . . . 0.0 108.686 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 t -51.36 -40.83 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 121.759 -0.588 . . . . 0.0 110.356 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -40.35 87.22 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.664 0.385 . . . . 0.0 110.4 -171.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -42.65 95.92 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.343 0.592 . . . . 0.0 110.783 171.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.809 -0.557 . . . . 0.0 110.661 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.22 -50.25 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.302 1.041 . . . . 0.0 108.781 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 p -64.21 -35.27 80.27 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.756 0.707 . . . . 0.0 111.475 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -66.14 -37.34 85.44 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.263 -0.898 . . . . 0.0 111.091 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 6' ' ' VAL . 71.6 t80 -67.72 -44.04 78.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.183 0.593 . . . . 0.0 111.865 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.9 -41.26 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.266 1.027 . . . . 0.0 109.862 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -79.67 -30.83 41.31 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.48 4.38 52.79 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.021 -0.877 . . . . 0.0 113.985 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -39.22 81.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.228 1.411 . . . . 0.0 111.513 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.57 131.98 50.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.188 0.595 . . . . 0.0 110.722 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.32 156.97 30.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.57 1.176 . . . . 0.0 110.632 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 61.9 mtpt -82.58 156.32 24.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.651 171.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.595 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 74.8 m80 57.54 176.26 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.56 1.544 . . . . 0.0 114.011 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -160.56 147.43 15.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.688 1.195 . . . . 0.0 107.877 171.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -131.07 138.09 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 65.25 52.02 1.52 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.442 2.297 . . . . 0.0 113.254 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 ttt -82.87 154.53 24.58 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.485 1.114 . . . . 0.0 108.245 168.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 15.6 mtpp -147.73 121.8 9.48 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.467 HG21 ' CE2' ' A' ' 93' ' ' PHE . 40.7 t -125.62 156.12 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.595 1.089 . . . . 0.0 108.902 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.47 118.1 35.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.543 1.137 . . . . 0.0 108.25 161.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.37 129.43 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.6 p -79.49 104.79 10.34 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.985 1.314 . . . . 0.0 109.576 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.92 151.74 22.11 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.174 -0.954 . . . . 0.0 111.011 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.36 -85.34 0.22 Allowed 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.42 -39.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 O-C-N 119.883 -1.76 . . . . 0.0 108.238 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.74 3.35 2.05 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 -178.63 5.91 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.584 -1.323 . . . . 0.0 110.371 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.2 mt -53.58 127.52 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.746 1.619 . . . . 0.0 109.807 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.1 p -72.41 161.42 30.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.981 0.912 . . . . 0.0 110.248 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.93 -41.24 95.81 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -157.46 161.07 38.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -58.2 -42.58 86.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.353 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -15.33 57.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.052 1.741 . . . . 0.0 113.179 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.12 10.03 8.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.924 0.89 . . . . 0.0 112.734 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 p -64.9 160.71 19.94 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.652 -1.28 . . . . 0.0 109.616 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -107.55 -29.85 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.227 1.411 . . . . 0.0 107.886 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -153.55 167.0 30.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.755 0.788 . . . . 0.0 109.821 167.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -104.58 126.58 51.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.704 2.002 . . . . 0.0 108.063 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.13 113.89 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 166.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -83.32 105.03 12.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.96 141.91 14.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -117.12 123.45 46.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.046 1.739 . . . . 0.0 106.523 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.5 mt -124.02 136.4 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -136.03 -6.72 2.1 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.036 -173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.08 67.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' -1' ' ' HIS . 0.1 OUTLIER 55.22 5.34 0.11 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.889 2.076 . . . . 0.0 115.201 -175.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -134.2 152.62 51.91 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.366 1.466 . . . . 0.0 109.231 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.16 108.13 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.42 1.888 . . . . 0.0 109.393 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -96.62 -6.11 37.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 112.665 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 p -170.83 179.55 3.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.299 1.409 . . . . 0.0 111.069 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -147.93 168.48 22.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.402 1.081 . . . . 0.0 111.002 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.68 153.98 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.35 1.46 . . . . 0.0 109.559 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.79 115.91 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.85 109.51 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -59.54 155.9 14.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.718 1.144 . . . . 0.0 109.92 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.07 65.93 0.89 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.222 0.609 . . . . 0.0 112.225 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -136.43 81.53 1.89 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.1 -72.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.403 1.881 . . . . 0.0 113.713 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -56.21 -25.93 49.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.234 1.813 . . . . 0.0 111.063 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.11 -61.57 7.0 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 125.198 1.38 . . . . 0.0 111.813 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -58.0 -36.48 72.72 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.144 0.978 . . . . 0.0 110.87 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -52.3 -47.31 66.0 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.384 0.538 . . . . 0.0 111.006 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.6 m -63.09 -37.93 89.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.252 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.9 mt -52.54 -38.16 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.485 1.114 . . . . 0.0 110.202 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -59.72 -48.94 85.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.54 -0.725 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -82.09 -14.14 56.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.39 1.076 . . . . 0.0 112.442 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 28.5 mm-40 -64.28 -23.14 67.19 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.775 1.17 . . . . 0.0 111.206 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 55.4 54.97 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.437 1.095 . . . . 0.0 109.681 -170.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.66 147.61 8.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.917 0.887 . . . . 0.0 109.286 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -78.53 -48.18 15.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.502 1.921 . . . . 0.0 110.099 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.43 158.48 41.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.199 0.6 . . . . 0.0 112.289 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.1 mt -110.77 147.02 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.98 135.59 60.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.2 p -155.47 161.21 41.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.655 1.182 . . . . 0.0 109.691 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -73.29 -36.42 66.28 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.241 166.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.71 165.97 33.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.257 1.39 . . . . 0.0 109.098 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 tt -140.28 153.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 107.845 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.2 p -77.1 150.86 35.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.584 0.353 . . . . 0.0 110.45 163.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -58.55 -45.11 89.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.771 0.828 . . . . 0.0 110.257 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.98 -50.43 72.13 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.924 -0.485 . . . . 0.0 111.171 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.24 -35.99 81.85 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.747 0.419 . . . . 0.0 109.984 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -54.65 -54.69 38.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.396 0.543 . . . . 0.0 110.215 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -58.39 -26.3 63.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.385 0.674 . . . . 0.0 111.659 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -71.46 -62.15 1.51 Allowed 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.014 0.824 . . . . 0.0 110.205 171.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -77.27 -25.96 51.93 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.934 -1.031 . . . . 0.0 112.779 -164.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -73.53 30.77 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.735 2.014 . . . . 0.0 112.621 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.84 13.7 13.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.449 1.9 . . . . 0.0 111.575 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 mttt 179.11 -11.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.012 2.125 . . . . 0.0 113.172 164.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -116.39 128.98 73.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -77.42 121.84 24.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.537 1.135 . . . . 0.0 108.44 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.5 mt -100.08 127.39 53.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -118.32 154.61 32.05 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.254 1.422 . . . . 0.0 110.252 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.39 135.47 33.49 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.415 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.36 151.76 46.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 160.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -125.77 24.03 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.778 2.431 . . . . 0.0 109.428 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.09 -169.84 42.29 Favored Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.837 -1.164 . . . . 0.0 112.325 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -115.97 -21.55 9.45 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.961 2.105 . . . . 0.0 108.335 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.07 104.25 6.51 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.8 -40.64 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.81 -35.83 70.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.986 0.812 . . . . 0.0 110.265 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -61.17 -39.76 91.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.371 -0.831 . . . . 0.0 110.642 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -73.92 -27.28 60.95 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.179 -0.95 . . . . 0.0 111.276 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.65 -52.09 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p -58.64 -44.58 90.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 111.241 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.6 mt -61.92 -37.66 85.48 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.644 -0.66 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' HG21 ' A' ' 6' ' ' VAL . 77.1 t80 -70.1 -39.48 75.51 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.536 -0.728 . . . . 0.0 111.842 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.33 -44.2 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.648 1.179 . . . . 0.0 109.226 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.06 -16.03 45.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 19.92 63.73 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.009 0.822 . . . . 0.0 112.41 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.28 -22.56 60.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 111.916 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.52 137.7 54.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.86 0.754 . . . . 0.0 110.224 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.4 m -69.27 126.36 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.543 1.537 . . . . 0.0 111.809 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -74.7 119.21 18.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.672 1.189 . . . . 0.0 108.632 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.61 111.42 5.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -119.0 -0.07 11.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.287 1.035 . . . . 0.0 111.386 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -131.3 67.0 79.94 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 127.319 2.248 . . . . 0.0 109.928 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 C--O 1.254 1.307 0 C-N-CA 122.316 2.011 . . . . 0.0 109.618 168.888 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.413 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.8 m80 57.24 178.12 0.05 OUTLIER 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.867 2.067 . . . . 0.0 112.231 -167.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG2' ' HE1' ' A' ' 4' ' ' MET . 12.9 tpt -142.31 132.8 25.15 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.83 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.3 mt -132.06 145.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 73.3 11.42 4.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.375 1.47 . . . . 0.0 114.27 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.426 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 2.7 tpp -74.51 145.7 43.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.585 1.084 . . . . 0.0 110.146 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -131.91 144.22 50.69 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.827 1.251 . . . . 0.0 107.734 161.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -136.45 143.81 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 124.593 1.157 . . . . 0.0 108.434 172.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.54 124.37 44.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.935 0.894 . . . . 0.0 109.243 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.5 125.89 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 108.167 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -83.07 96.34 8.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.218 1.009 . . . . 0.0 110.747 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.5 mtp -94.3 164.94 12.82 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.121 1.368 . . . . 0.0 111.174 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.97 -60.13 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.375 1.47 . . . . 0.0 108.946 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -142.95 -68.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -132.4 9.03 4.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.631 1.205 . . . . 0.0 112.479 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -155.35 173.09 17.14 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.041 2.536 . . . . 0.0 107.954 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.67 147.48 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -81.57 -85.26 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.831 0.852 . . . . 0.0 111.097 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -174.58 -39.09 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.373 1.469 . . . . 0.0 108.714 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.7 p -145.66 -171.29 3.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.013 0.37 . . . . 0.0 111.526 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -95.01 -8.09 37.83 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.398 1.879 . . . . 0.0 111.244 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 6.15 10.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 112.095 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -137.47 0.75 2.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.711 1.604 . . . . 0.0 109.921 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 p -76.46 166.62 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.126 0.97 . . . . 0.0 110.989 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -101.98 -35.77 8.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.418 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -154.31 173.59 15.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.837 0.827 . . . . 0.0 110.518 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -116.9 113.41 22.41 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 128.047 2.539 . . . . 0.0 106.676 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.38 108.36 13.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.7 94.66 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 145.3 12.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 166.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -134.12 123.49 24.52 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.0 mt -118.0 128.26 75.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -126.88 -19.07 4.53 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -155.76 74.04 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 162.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.43 10.78 1.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.6 2.36 . . . . 0.0 114.146 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -137.69 161.49 36.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.637 2.375 . . . . 0.0 110.085 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.99 115.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -117.28 -17.95 10.04 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.835 -1.166 . . . . 0.0 112.667 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -149.79 162.67 39.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 119.744 1.156 . . . . 0.0 108.752 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -144.38 160.54 40.87 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.942 1.297 . . . . 0.0 108.357 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.5 155.68 42.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.354 1.861 . . . . 0.0 107.703 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.9 t -111.78 145.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 168.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mt -135.08 109.5 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.24 146.94 14.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.043 0.838 . . . . 0.0 110.55 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.51 82.22 3.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -134.51 172.39 12.98 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 129.734 3.214 . . . . 0.0 104.586 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.39 -40.48 95.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.28 -0.887 . . . . 0.0 113.389 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.0 t -67.84 -21.35 65.2 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -67.78 1.99 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -62.6 -29.48 70.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.461 1.13 . . . . 0.0 111.471 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -59.45 -54.66 44.06 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.9 1.227 . . . . 0.0 109.183 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -54.77 -39.69 68.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.379 0.672 . . . . 0.0 111.114 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mt -57.45 -46.71 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.014 0.825 . . . . 0.0 110.749 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -57.2 -39.57 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.571 0.623 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.3 7.86 30.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.198 0.999 . . . . 0.0 112.612 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.54 152.15 21.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.758 1.163 . . . . 0.0 108.915 172.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -76.73 43.65 0.34 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.783 1.233 . . . . 0.0 110.715 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.85 137.6 24.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 166.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.25 -36.76 14.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.44 159.95 41.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.251 0.62 . . . . 0.0 109.629 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.26 142.66 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.8 mt -107.56 131.29 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 167.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.1 p -150.69 158.04 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 167.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -72.96 -44.17 61.44 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.128 163.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -135.55 155.17 50.92 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 tt -153.21 119.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -59.94 146.79 41.1 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.199 0.6 . . . . 0.0 109.569 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.79 -47.64 67.42 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.395 2.278 . . . . 0.0 111.545 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -25.47 67.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.969 0.508 . . . . 0.0 111.275 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -84.13 -47.46 10.86 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.318 1.047 . . . . 0.0 110.27 172.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -54.98 -53.27 57.87 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.668 1.122 . . . . 0.0 110.239 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -57.76 -22.63 48.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.406 1.083 . . . . 0.0 112.56 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -79.59 -60.99 2.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.924 0.89 . . . . 0.0 109.096 173.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -65.92 -33.54 76.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.802 -166.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.7 p -65.81 -10.14 35.06 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -16.35 32.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.203 1.401 . . . . 0.0 114.385 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -154.55 -45.58 0.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.693 -1.255 . . . . 0.0 109.673 166.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.1 mt -63.46 138.04 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.79 1.236 . . . . 0.0 108.223 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -92.39 126.36 37.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.131 1.372 . . . . 0.0 107.538 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.62 130.02 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.66 148.0 44.51 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.256 1.423 . . . . 0.0 109.392 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -80.86 143.88 32.41 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.353 1.061 . . . . 0.0 108.705 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.86 116.79 23.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.509 0.671 . . . . 0.0 109.324 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.02 79.68 0.66 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.236 1.414 . . . . 0.0 108.243 163.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.01 25.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.137 0.854 . . . . 0.0 114.034 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.7 -14.25 40.35 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.414 1.485 . . . . 0.0 110.4 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -82.02 100.84 9.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.044 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.62 -49.02 6.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 123.941 0.896 . . . . 0.0 109.575 170.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.36 -39.75 77.89 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.882 0.765 . . . . 0.0 110.503 -169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -56.89 -41.75 78.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -75.32 -34.63 61.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.091 0.556 . . . . 0.0 112.244 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mt -61.6 -53.78 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p -62.47 -46.22 89.5 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.795 0.438 . . . . 0.0 111.282 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.83 -39.98 82.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.909 0.322 . . . . 0.0 110.513 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 6' ' ' VAL . 23.6 t80 -66.46 -50.39 63.5 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.362 0.665 . . . . 0.0 111.747 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.76 -36.72 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.977 0.911 . . . . 0.0 109.759 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -84.33 -5.41 59.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.068 1.347 . . . . 0.0 113.332 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.48 86.51 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.766 -1.575 . . . . 0.0 113.112 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -29.28 67.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.291 1.437 . . . . 0.0 114.18 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.74 137.82 58.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.478 1.035 . . . . 0.0 110.684 -174.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 p -78.74 130.51 35.86 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.941 0.897 . . . . 0.0 109.885 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -71.85 148.7 45.92 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.21 -0.931 . . . . 0.0 109.633 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.8 mt -87.23 141.36 14.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.9 p -132.11 -48.15 0.93 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.527 1.131 . . . . 0.0 110.38 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.15 76.7 23.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.992 2.117 . . . . 0.0 110.209 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo . . . . . 0 C--O 1.247 0.93 0 C-N-CA 124.72 3.613 . . . . 0.0 111.699 167.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -142.35 136.34 29.54 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt -154.24 141.03 19.11 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.939 0.895 . . . . 0.0 109.681 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 mt -138.49 143.68 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.566 1.146 . . . . 0.0 110.134 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.262 58.6 t30 44.62 45.54 7.98 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.966 2.506 . . . . 0.0 112.733 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.43 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.2 tpp -72.47 145.69 47.38 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 163.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -136.32 137.97 41.21 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 163.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.537 HG21 ' CE2' ' A' ' 93' ' ' PHE . 70.1 t -137.99 140.47 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.6 99.06 8.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.684 1.194 . . . . 0.0 108.72 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -90.72 114.16 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 p -68.32 128.62 37.24 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.317 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mtp -127.14 162.0 27.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.759 1.223 . . . . 0.0 110.805 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.7 -61.92 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.293 1.437 . . . . 0.0 109.53 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.3 t -148.14 -46.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 O-C-N 120.841 -1.162 . . . . 0.0 109.441 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -140.3 2.69 1.89 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.283 0.633 . . . . 0.0 112.211 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -157.57 175.21 14.24 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.449 1.5 . . . . 0.0 110.537 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.7 141.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.8 p -70.6 159.29 34.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.204 0.525 . . . . 0.0 110.643 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.02 -34.48 78.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.962 1.305 . . . . 0.0 111.266 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 167.12 25.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.506 0.722 . . . . 0.0 111.492 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -72.85 -53.31 11.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 18.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.211 1.405 . . . . 0.0 111.848 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.18 5.52 1.11 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.563 1.945 . . . . 0.0 110.934 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 p -80.1 172.44 13.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.719 -1.238 . . . . 0.0 110.15 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -111.94 -24.58 9.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.672 1.589 . . . . 0.0 110.589 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -160.12 175.07 13.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.952 0.796 . . . . 0.0 110.071 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CD1' HD11 ' A' ' 51' ' ' ILE . 88.6 m-85 -119.68 126.62 51.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 111.69 18.97 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -79.83 104.22 7.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.64 150.21 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -124.63 115.89 21.52 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 4' ' ' MET . 3.3 mp -114.81 123.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 105.383 -2.081 . . . . 0.0 105.383 167.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 6.7 m-20 -126.66 -5.67 6.38 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.303 1.041 . . . . 0.0 111.536 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -158.51 55.46 0.44 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.93 2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.586 2.355 . . . . 0.0 116.386 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -118.77 154.01 33.5 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 129.712 3.205 . . . . 0.0 108.888 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.57 102.98 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-O 121.91 0.862 . . . . 0.0 108.806 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 15.6 mmtt -71.68 -46.0 60.15 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.079 -1.013 . . . . 0.0 109.877 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -158.52 167.5 29.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.663 0.785 . . . . 0.0 110.406 -171.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -138.34 125.81 21.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.086 1.754 . . . . 0.0 108.981 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.84 164.39 14.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 109.604 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.13 134.31 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.3 mt -123.77 104.27 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.875 1.67 . . . . 0.0 106.551 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -58.09 136.53 57.2 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.473 0.579 . . . . 0.0 110.25 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -80.74 70.78 7.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.267 1.027 . . . . 0.0 110.773 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.65 84.74 1.62 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 71.14 -74.07 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.101 2.16 . . . . 0.0 113.375 151.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.7 t -52.34 -33.02 40.95 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.313 1.045 . . . . 0.0 109.838 166.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.63 -59.85 9.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -58.58 -39.17 79.56 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.349 -1.089 . . . . 0.0 110.425 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -55.01 -46.36 75.21 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 118.662 0.665 . . . . 0.0 110.373 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.9 m -61.01 -36.32 79.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.631 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' CD1' ' A' ' 25' ' ' PHE . 55.9 mt -60.33 -48.38 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.773 1.169 . . . . 0.0 109.452 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.08 -39.84 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.086 0.554 . . . . 0.0 110.396 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -73.17 -17.87 61.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.121 -0.987 . . . . 0.0 112.463 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.91 -174.53 5.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 120.273 1.397 . . . . 0.0 110.529 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -112.98 40.84 2.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.011 1.724 . . . . 0.0 109.235 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.75 141.49 17.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.24 -41.38 12.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.322 1.049 . . . . 0.0 109.943 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.15 151.09 36.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.29 1.036 . . . . 0.0 111.272 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.43 139.54 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 166.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.8 mt -116.51 127.53 74.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.7 p -154.19 176.42 12.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.527 1.531 . . . . 0.0 108.085 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -106.33 -24.77 12.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.607 1.163 . . . . 0.0 111.648 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -152.96 159.31 42.93 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.0 tt -161.02 137.99 2.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.482 ' H ' ' ND2' ' A' ' 68' ' ' ASN . 8.9 m -85.23 168.37 14.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.28 -35.42 75.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.286 1.434 . . . . 0.0 111.221 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.87 -47.03 32.37 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.365 1.078 . . . . 0.0 109.726 -170.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -58.48 -46.54 86.43 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.243 1.817 . . . . 0.0 110.057 172.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -54.6 -62.16 1.84 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.693 0.397 . . . . 0.0 111.109 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.98 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 112.553 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -62.81 1.52 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.893 0.877 . . . . 0.0 109.432 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HD1' HD12 ' A' ' 76' ' ' ILE . 51.8 m-85 -79.93 -30.49 39.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.971 -164.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 p -58.27 -12.45 3.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.454 1.102 . . . . 0.0 113.857 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -52.28 -31.57 33.3 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.124 -0.985 . . . . 0.0 111.871 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -151.82 -8.08 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.425 HD12 ' HD1' ' A' ' 72' ' ' PHE . 8.0 mt -114.78 123.52 70.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -170.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.69 160.61 19.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.69 0.757 . . . . 0.0 109.434 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.7 mt -137.69 128.77 38.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.24 160.89 34.83 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.88 1.272 . . . . 0.0 111.534 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -106.71 121.82 45.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.892 1.677 . . . . 0.0 110.169 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.5 125.24 29.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.755 0.422 . . . . 0.0 110.163 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -9.38 29.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.341 1.857 . . . . 0.0 113.065 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.96 174.33 41.51 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -163.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -90.3 -6.3 55.29 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.1 99.68 5.45 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 -173.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.6 t -49.82 -39.17 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 122.874 0.47 . . . . 0.0 110.277 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.19 -42.71 68.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -166.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -62.47 -45.36 93.41 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.853 -0.529 . . . . 0.0 110.383 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -71.75 -32.57 67.84 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.17 -0.331 . . . . 0.0 111.238 -171.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.94 -50.91 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 94' ' ' ILE . 6.6 p -67.0 -31.5 72.11 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 mt -69.18 -42.56 75.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 109.973 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 6' ' ' VAL . 40.5 t80 -59.25 -42.88 92.16 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.181 0.993 . . . . 0.0 113.124 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 91' ' ' SER . 67.3 mt -47.9 -54.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.429 1.492 . . . . 0.0 109.466 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.89 -4.92 49.15 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.505 1.522 . . . . 0.0 113.306 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.09 14.76 80.2 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 119.079 0.854 . . . . 0.0 112.601 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.86 -19.4 61.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 112.116 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.13 140.48 50.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.07 0.938 . . . . 0.0 110.575 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -68.8 140.05 55.27 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.839 1.256 . . . . 0.0 108.749 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -72.59 153.82 41.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 165.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.6 mt -88.71 127.98 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 160.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -129.07 -18.61 3.69 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.263 0.625 . . . . 0.0 112.395 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.16 87.46 6.63 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 109.019 170.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.034 3.822 . . . . 0.0 112.647 -177.744 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.9 164.63 0.85 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.192 2.197 . . . . 0.0 107.852 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt -110.85 121.77 46.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.81 1.244 . . . . 0.0 107.858 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 mm -120.63 136.4 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 124.738 1.215 . . . . 0.0 108.309 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 47.78 53.41 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.008 1.723 . . . . 0.0 113.851 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -69.95 156.16 39.52 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 163.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -132.31 159.42 39.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 152.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 28' ' ' VAL . 12.0 p -156.64 163.8 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.7 124.8 47.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 164.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.8 mt -101.39 113.58 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.7 p -57.38 128.39 36.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.2 mtp -131.16 157.71 42.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.489 1.04 . . . . 0.0 110.426 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.32 -63.29 1.14 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.555 1.542 . . . . 0.0 108.417 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -142.93 -74.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -119.43 10.88 12.0 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.031 1.332 . . . . 0.0 112.935 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.52 170.17 21.42 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.13 1.372 . . . . 0.0 108.35 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.8 mt -58.11 133.83 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 p -73.63 159.72 32.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.847 2.059 . . . . 0.0 111.311 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -73.55 -25.1 60.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.7 p -149.64 174.01 13.03 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.841 1.2 . . . . 0.0 111.605 169.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -72.56 -13.72 61.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.596 1.958 . . . . 0.0 111.653 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.94 7.99 15.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 111.467 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -133.01 2.9 3.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.073 1.749 . . . . 0.0 110.243 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.98 153.96 42.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 120.733 -1.23 . . . . 0.0 109.625 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -101.16 -24.67 14.23 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.87 1.268 . . . . 0.0 109.192 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.447 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 40.8 p90 -157.72 173.76 16.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.242 0.928 . . . . 0.0 111.003 171.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 51' ' ' ILE . 70.0 m-85 -115.83 105.1 12.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.308 2.243 . . . . 0.0 107.924 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.94 107.17 7.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -79.46 133.03 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.809 1.244 . . . . 0.0 109.027 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 6' ' ' VAL . 2.0 t -105.94 105.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 ttt-85 -98.68 103.99 15.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.56 138.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -125.25 -5.63 7.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.483 0.713 . . . . 0.0 112.689 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.499 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 5.5 p-10 -173.38 48.28 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.83 1.252 . . . . 0.0 108.855 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.36 18.67 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.184 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -127.74 152.96 47.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.37 90.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 122.549 1.166 . . . . 0.0 107.891 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 2.8 mmtp -73.02 -35.09 66.72 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 120.735 -1.228 . . . . 0.0 110.185 167.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 t -162.25 131.97 4.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.792 1.178 . . . . 0.0 110.075 167.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 174.71 9.82 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.272 1.029 . . . . 0.0 111.523 165.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.12 168.34 26.82 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 127.168 2.187 . . . . 0.0 110.303 171.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.553 0.9 OUTLIER -135.16 144.22 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 129.924 3.29 . . . . 0.0 117.476 171.104 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.7 mt -134.29 114.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 127.757 2.423 . . . . 0.0 106.655 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -61.44 136.11 57.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.213 0.915 . . . . 0.0 110.733 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -83.13 85.71 7.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.771 1.228 . . . . 0.0 108.545 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.54 -85.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 46' ' ' SER . 10.4 pt-20 -131.83 -64.09 0.8 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.394 -0.816 . . . . 0.0 111.67 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.472 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -57.99 -24.18 57.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.968 174.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.59 -74.08 0.36 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -57.71 -27.27 62.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.731 1.265 . . . . 0.0 111.537 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.32 -51.15 62.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.8 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -60.93 -37.4 82.2 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.669 1.588 . . . . 0.0 110.067 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 25' ' ' PHE . 43.3 mt -52.46 -45.33 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.086 1.755 . . . . 0.0 110.93 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.71 -42.71 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 120.876 -1.14 . . . . 0.0 110.14 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.55 -30.63 59.77 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 118.445 0.566 . . . . 0.0 111.651 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -74.08 -19.84 60.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.533 0.606 . . . . 0.0 109.4 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.7 t30 50.89 55.38 9.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.703 2.801 . . . . 0.0 112.305 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.19 144.16 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.123 1.769 . . . . 0.0 111.543 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.29 -39.99 18.53 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.111 1.364 . . . . 0.0 111.155 173.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' VAL . . . -144.25 160.95 40.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 112.989 -166.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.3 mt -132.25 105.25 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 119.909 -1.745 . . . . 0.0 108.966 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.06 128.69 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.5 p -151.06 167.98 26.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.592 1.087 . . . . 0.0 111.189 168.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -82.2 -45.38 15.15 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.224 1.81 . . . . 0.0 109.262 165.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -147.43 164.26 33.89 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.379 0.991 . . . . 0.0 109.927 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.5 tt -154.32 138.1 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 m -73.31 155.99 38.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.327 0.512 . . . . 0.0 110.68 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 36.8 tt0 -66.67 -31.49 72.2 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.734 0.414 . . . . 0.0 111.4 -171.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.74 -50.91 31.07 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.087 0.858 . . . . 0.0 110.997 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -56.54 -43.8 80.24 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.734 0.414 . . . . 0.0 110.644 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -54.69 -60.79 2.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.512 1.125 . . . . 0.0 109.363 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HE3' ' HG2' ' A' ' 66' ' ' GLU . 50.5 mttt -64.31 -17.06 63.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.453 0.701 . . . . 0.0 112.61 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.34 -51.91 5.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.112 1.365 . . . . 0.0 110.338 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.532 ' HD1' HD12 ' A' ' 76' ' ' ILE . 49.9 m-85 -76.55 -30.29 57.04 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.338 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -63.18 -7.77 6.6 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -20.06 39.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.937 -1.102 . . . . 0.0 111.709 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -145.14 2.59 1.01 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.944 1.247 . . . . 0.0 112.158 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.532 HD12 ' HD1' ' A' ' 72' ' ' PHE . 3.2 mt -134.5 129.03 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -171.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.08 107.65 17.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.002 1.721 . . . . 0.0 109.645 -173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -87.16 131.89 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 120.455 -1.403 . . . . 0.0 108.52 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -118.16 144.22 45.87 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.702 1.601 . . . . 0.0 111.084 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -87.01 132.58 33.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.458 1.503 . . . . 0.0 107.583 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.81 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.241 -0.409 . . . . 0.0 110.541 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -12.53 60.43 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 169.64 34.15 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 126.99 2.234 . . . . 0.0 108.26 -164.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.7 -16.96 63.98 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.551 2.34 . . . . 0.0 111.37 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.64 97.34 3.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -168.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.1 t -50.38 -42.75 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.65 -44.52 81.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.404 0.682 . . . . 0.0 109.252 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -58.06 -42.54 85.69 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.89 0.852 . . . . 0.0 111.31 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -71.96 -27.2 62.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.113 -0.992 . . . . 0.0 111.974 -172.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.23 -53.7 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 p -61.23 -39.08 88.94 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.7 0.8 . . . . 0.0 111.332 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.4 mt -66.3 -44.59 83.04 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.148 0.579 . . . . 0.0 110.881 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.25 -39.06 85.43 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.987 0.812 . . . . 0.0 111.6 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.53 -42.82 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.436 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.35 -12.5 60.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.878 0.763 . . . . 0.0 112.632 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.11 6.94 84.12 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.927 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -34.17 77.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.011 1.724 . . . . 0.0 112.536 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 mt -55.61 140.43 41.1 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -61.56 130.12 44.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 108.947 172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -69.81 131.67 44.87 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.22 -0.925 . . . . 0.0 108.589 165.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.5 mt -60.4 111.96 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.2 m -79.56 -31.72 42.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.425 0.29 . . . . 0.0 111.585 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -151.02 153.64 33.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 126.884 2.074 . . . . 0.0 107.389 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 C--O 1.252 1.218 0 C-N-CA 122.624 2.216 . . . . 0.0 107.521 158.276 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.469 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.28 165.14 15.9 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 136.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt -148.42 140.95 24.39 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.039 -1.038 . . . . 0.0 108.625 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -137.34 138.61 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 69.38 17.47 8.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.587 1.955 . . . . 0.0 113.255 168.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.5 tpp -60.33 151.93 26.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.357 -0.839 . . . . 0.0 109.002 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -137.61 129.17 28.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 165.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' CE2' ' A' ' 93' ' ' PHE . 41.9 t -136.68 129.85 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-N 119.979 1.263 . . . . 0.0 108.717 172.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.05 83.79 2.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.584 1.553 . . . . 0.0 111.243 -169.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mt -83.74 129.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 120.873 -1.142 . . . . 0.0 110.088 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 p -71.07 94.47 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.482 1.113 . . . . 0.0 112.028 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 mtp -100.01 161.1 13.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.552 1.141 . . . . 0.0 111.341 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.5 -63.31 1.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 109.155 170.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.68 -60.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -130.41 -0.47 4.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.364 1.078 . . . . 0.0 112.528 -162.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -163.25 178.28 8.32 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.346 2.258 . . . . 0.0 108.736 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 99.1 mt -62.12 145.4 13.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -86.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.726 0.774 . . . . 0.0 109.772 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 175.8 -44.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.022 -1.049 . . . . 0.0 108.684 -156.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 p -158.78 169.36 24.55 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.373 0.988 . . . . 0.0 110.08 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -66.27 -34.04 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.131 0.973 . . . . 0.0 110.822 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -92.48 4.05 54.28 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -131.03 17.99 5.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.307 1.051 . . . . 0.0 111.303 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.93 167.6 16.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.294 1.045 . . . . 0.0 110.344 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -109.13 -31.24 7.68 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.215 1.406 . . . . 0.0 109.402 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -154.86 161.24 41.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.991 0.901 . . . . 0.0 109.89 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -100.09 111.7 23.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -76.46 108.97 9.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 41' ' ' ILE . 19.6 mm -77.36 100.09 2.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.4 133.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.521 ' HE ' ' HB2' ' A' ' 37' ' ' SER . 26.7 mtm180 -115.68 114.45 24.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 mt -107.06 115.47 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.01 -10.98 5.97 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 124.441 1.088 . . . . 0.0 112.098 -162.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.64 57.19 0.62 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 122.352 1.072 . . . . 0.0 108.626 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.62 -9.92 0.08 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 129.137 2.975 . . . . 0.0 116.305 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -107.82 158.99 16.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.426 1.09 . . . . 0.0 110.4 170.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.76 90.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.278 1.431 . . . . 0.0 109.974 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.66 -20.88 30.58 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.779 1.632 . . . . 0.0 112.487 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.521 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 1.6 m -150.55 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 167.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.4 p -131.82 158.79 40.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 161.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 157.73 46.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 126.202 1.801 . . . . 0.0 106.723 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.24 140.87 38.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.4 HD12 HD11 ' A' ' 27' ' ' ILE . 59.1 mt -130.8 100.57 4.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -58.86 137.52 57.74 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -73.92 85.37 1.75 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.358 1.463 . . . . 0.0 108.042 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.5 33.83 2.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.462 1.505 . . . . 0.0 110.174 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 66.33 -69.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.144 1.777 . . . . 0.0 109.839 -172.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.3 t -52.99 -29.33 28.51 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.172 2.189 . . . . 0.0 111.413 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.1 16.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.983 0.81 . . . . 0.0 111.286 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -57.6 -32.2 66.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.086 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -56.5 -40.13 74.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.363 0.983 . . . . 0.0 108.397 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -30.79 66.97 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.136 0.974 . . . . 0.0 110.655 -172.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.85 -42.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.391 1.076 . . . . 0.0 108.308 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.1 -13.2 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.126 -0.984 . . . . 0.0 111.269 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -8.03 16.19 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.622 -1.298 . . . . 0.0 112.277 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -91.48 -15.09 29.33 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.557 1.526 . . . . 0.0 113.791 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 57.87 59.14 3.29 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.826 1.251 . . . . 0.0 109.946 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -47.8 140.04 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 161.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -50.96 19.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.62 39.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.898 0.479 . . . . 0.0 110.582 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mt -113.86 150.54 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.94 1.296 . . . . 0.0 107.707 173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -120.22 121.9 66.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 167.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -144.24 168.89 18.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.212 1.005 . . . . 0.0 108.635 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -71.83 -57.3 4.45 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 155.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -140.7 160.72 39.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.401 0.546 . . . . 0.0 110.711 -167.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.2 tt -152.61 126.99 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 126.25 1.82 . . . . 0.0 106.613 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -54.44 143.54 23.61 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.621 1.568 . . . . 0.0 110.221 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -48.45 -49.04 37.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.169 1.787 . . . . 0.0 111.462 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.03 -42.04 99.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 0.0 110.666 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -68.5 -43.56 76.57 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.594 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.4 -57.83 9.25 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -64.02 -14.04 51.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.676 1.191 . . . . 0.0 113.628 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -90.99 -58.11 2.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.448 1.499 . . . . 0.0 109.793 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -72.33 -27.44 62.43 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 112.335 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 p -60.7 -11.85 8.67 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -58.18 -42.81 86.87 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 0.0 112.271 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 13.56 1.78 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.806 1.185 . . . . 0.0 111.743 -175.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mt -136.41 140.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.77 153.09 19.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.949 0.9 . . . . 0.0 108.779 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.52 113.59 23.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -160.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.86 151.07 37.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.544 1.137 . . . . 0.0 110.898 -169.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -99.12 120.19 39.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.442 1.497 . . . . 0.0 109.95 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 138.94 55.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.414 0.686 . . . . 0.0 111.747 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -102.29 99.08 9.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 127.178 2.191 . . . . 0.0 109.284 172.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.42 -179.11 53.63 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -85.37 -10.84 55.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.703 0.801 . . . . 0.0 110.662 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.35 102.23 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.062 0.945 . . . . 0.0 110.563 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -48.35 -43.86 12.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 118.79 -0.624 . . . . 0.0 109.609 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.58 -42.84 77.7 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.968 0.804 . . . . 0.0 110.219 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -57.26 -40.02 76.83 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.902 -0.499 . . . . 0.0 110.289 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.51 -32.85 42.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.15 -50.47 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 p -62.4 -46.51 88.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.726 0.811 . . . . 0.0 111.436 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 122.56 0.344 . . . . 0.0 110.161 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 6' ' ' VAL . 48.6 t80 -61.74 -52.5 64.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.321 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.3 mt -50.27 -40.93 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.969 1.308 . . . . 0.0 111.005 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -81.23 -2.84 50.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.941 0.896 . . . . 0.0 113.108 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.02 81.35 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.0 1.286 . . . . 0.0 111.193 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -27.26 61.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.41 1.884 . . . . 0.0 113.029 -174.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.38 139.47 58.56 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.577 0.704 . . . . 0.0 109.582 -174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.8 m -75.93 143.05 41.86 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -76.98 151.52 35.62 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.7 mt -78.69 151.03 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 166.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 m -140.77 -43.21 0.39 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.628 1.571 . . . . 0.0 109.999 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.67 86.2 2.78 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 126.25 1.82 . . . . 0.0 109.181 169.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.211 3.274 . . . . 0.0 111.684 175.752 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.589 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.78 165.54 27.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 169.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt -127.61 135.14 49.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 165.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.0 mt -139.54 152.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 47.18 73.02 0.21 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.874 1.67 . . . . 0.0 110.734 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ttt -131.92 152.33 51.14 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.157 -0.964 . . . . 0.0 108.59 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.6 141.52 33.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 165.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 93' ' ' PHE . 25.6 t -134.05 132.62 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 171.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.99 144.57 25.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.71 119.98 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -75.88 84.16 2.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.147 0.979 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -86.3 155.26 20.73 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.895 2.478 . . . . 0.0 111.7 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -105.27 -55.96 2.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.128 0.966 . . . . 0.0 110.979 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -146.77 -55.02 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.8 -1.79 0.49 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.519 -158.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -157.06 173.17 17.41 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 126.706 2.002 . . . . 0.0 107.426 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.41 134.15 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -66.84 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.53 -38.66 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.395 1.478 . . . . 0.0 108.95 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.83 166.21 29.18 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.974 0.416 . . . . 0.0 111.042 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -55.88 -50.19 71.33 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.726 2.01 . . . . 0.0 108.891 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.12 -3.06 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.724 1.609 . . . . 0.0 112.812 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -120.91 -4.66 9.62 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.835 1.254 . . . . 0.0 111.068 -171.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.3 p -80.11 175.24 10.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 120.802 -1.186 . . . . 0.0 111.957 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -112.08 -34.67 5.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.741 1.616 . . . . 0.0 110.035 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -149.05 164.24 35.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.357 0.98 . . . . 0.0 111.904 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -109.85 103.35 12.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.382 2.673 . . . . 0.0 106.456 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tp -81.15 101.45 9.66 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.9 mm -69.09 96.1 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 127.381 2.273 . . . . 0.0 107.31 168.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.52 139.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 160.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 118.55 18.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.868 0.758 . . . . 0.0 109.093 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.3 mt -119.82 138.28 50.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -164.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.0 -9.12 0.53 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -155.86 65.87 0.59 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.09 -8.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.21 3.004 . . . . 0.0 115.91 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.15 157.46 27.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 111.235 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.13 83.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.301 1.841 . . . . 0.0 106.864 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -64.85 -31.75 73.13 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.884 -1.135 . . . . 0.0 109.974 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -150.72 163.38 38.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.96 0.904 . . . . 0.0 109.469 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.67 161.28 36.91 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 108.231 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 137.8 19.11 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 123.92 0.888 . . . . 0.0 110.041 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.535 1.1 p -99.97 133.21 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 161.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.499 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 11.1 mt -129.74 114.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -63.31 160.42 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.156 1.343 . . . . 0.0 110.409 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -78.54 76.62 5.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.902 1.281 . . . . 0.0 109.777 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -125.74 170.17 11.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.34 1.456 . . . . 0.0 109.502 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -55.38 -40.67 71.65 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.445 -0.784 . . . . 0.0 110.672 164.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 m -76.34 -11.29 59.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.783 1.233 . . . . 0.0 111.693 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -72.47 -60.3 4.11 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 163.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 mppt? -62.58 -20.25 64.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -63.57 -46.25 86.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.932 1.242 . . . . 0.0 110.512 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 m -71.84 -40.79 68.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.223 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.7 mt -45.46 -51.44 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.929 1.292 . . . . 0.0 111.85 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.68 -34.69 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.87 -0.519 . . . . 0.0 111.468 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.89 -14.24 45.45 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.661 -0.649 . . . . 0.0 111.374 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.17 -16.21 61.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.525 1.53 . . . . 0.0 110.883 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 t30 47.47 65.06 1.36 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.975 2.11 . . . . 0.0 110.28 -167.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -67.45 140.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.94 -42.26 15.14 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.511 1.524 . . . . 0.0 109.979 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.69 160.95 39.82 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.422 1.089 . . . . 0.0 109.414 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -122.76 138.9 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.3 mt -98.85 122.09 50.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.7 p -144.03 157.09 44.55 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.688 0.756 . . . . 0.0 111.255 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -68.99 -53.0 22.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 163.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -139.33 159.39 42.28 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.594 1.543 . . . . 0.0 111.204 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.9 tt -156.83 126.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.141 1.776 . . . . 0.0 110.257 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -61.13 141.89 57.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.222 1.009 . . . . 0.0 110.003 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.75 -37.62 76.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 111.845 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.61 -40.41 94.72 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.499 -0.75 . . . . 0.0 111.503 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -69.16 -47.58 64.59 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.792 0.837 . . . . 0.0 109.805 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -50.51 -58.68 5.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.858 1.263 . . . . 0.0 109.758 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -60.97 -18.12 55.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.436 0.694 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -82.38 -47.45 12.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.06 -1.025 . . . . 0.0 111.04 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -84.87 -25.37 28.06 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.958 0.344 . . . . 0.0 111.027 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -62.12 -7.7 4.43 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.61 1.164 . . . . 0.0 113.231 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -40.42 11.56 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.208 1.403 . . . . 0.0 110.787 173.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -145.16 -30.55 0.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.552 1.141 . . . . 0.0 111.857 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.3 mt -90.04 135.1 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -163.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.56 139.2 33.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.679 . . . . 0.0 107.801 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.8 mt -119.74 114.21 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.24 -0.913 . . . . 0.0 108.671 -172.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 55.8 m-85 -104.63 139.85 38.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.096 1.758 . . . . 0.0 110.835 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.42 127.62 32.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.67 123.07 19.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -83.3 6.76 18.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.057 1.743 . . . . 0.0 112.389 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.4 -169.81 38.97 Favored Glycine 0 N--CA 1.449 -0.477 0 O-C-N 120.509 -1.369 . . . . 0.0 111.68 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.15 -18.05 15.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.921 1.688 . . . . 0.0 109.894 168.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -66.86 101.7 0.86 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.386 1.474 . . . . 0.0 107.387 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.4 t -57.73 -41.11 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.217 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.51 -36.31 73.69 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.578 0.751 . . . . 0.0 110.359 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -60.77 -42.07 96.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 171.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -71.87 -26.84 62.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.701 -0.625 . . . . 0.0 111.566 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -56.9 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.78 1.632 . . . . 0.0 107.561 170.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.7 p -65.57 -40.69 93.07 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.36 0.413 . . . . 0.0 110.605 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.6 mt -62.12 -42.87 99.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.651 0.78 . . . . 0.0 109.881 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 6' ' ' VAL . 68.7 t80 -61.19 -52.59 64.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.528 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.2 mt -58.25 -40.74 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.496 1.119 . . . . 0.0 109.58 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -68.22 -18.71 64.64 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.26 8.24 78.51 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.717 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -69.92 -27.31 64.66 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.084 1.442 . . . . 0.0 112.329 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.31 138.83 55.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.432 1.111 . . . . 0.0 110.272 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.8 m -74.09 138.92 44.27 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.3 170.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 31.4 mtmm -78.98 147.75 32.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 162.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.9 mt -70.94 -39.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 123.7 0.625 . . . . 0.0 110.854 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.1 m 47.83 65.7 1.23 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.806 1.242 . . . . 0.0 110.429 -174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.59 150.48 0.1 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 131.182 3.793 . . . . 0.0 116.484 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--O 1.246 0.911 0 C-N-CA 122.279 1.986 . . . . 0.0 107.949 163.823 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.3 m170 58.96 -164.82 0.2 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.014 2.526 . . . . 0.0 112.638 166.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt -151.04 130.25 12.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.4 -0.812 . . . . 0.0 109.672 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.93 153.05 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.317 1.847 . . . . 0.0 107.86 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 67.01 8.93 6.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.1 1.76 . . . . 0.0 114.473 168.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 tpp -78.1 155.17 30.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.182 1.356 . . . . 0.0 108.938 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.42 143.42 25.71 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.18 141.93 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 108.962 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.72 101.89 13.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 166.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.9 mt -81.47 117.91 28.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB2' ' CB ' ' A' ' 22' ' ' CYS . 42.5 p -66.38 143.78 56.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.8 mmm -138.66 149.07 44.77 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 119.449 -2.032 . . . . 0.0 109.078 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -89.44 -67.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.507 1.123 . . . . 0.0 109.01 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.9 t -140.53 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.344 -3.206 . . . . 0.0 102.344 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.38 -7.42 18.81 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -147.16 177.34 9.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.272 1.429 . . . . 0.0 110.155 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mt -62.77 141.22 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 t -71.02 -86.76 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.6 t30 174.75 -28.12 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.856 1.663 . . . . 0.0 112.068 -167.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.73 164.68 29.44 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.736 1.153 . . . . 0.0 110.726 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -66.32 -37.59 85.74 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.222 1.009 . . . . 0.0 108.435 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 1.0 56.64 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.416 1.486 . . . . 0.0 113.175 -171.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.54 -7.54 6.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.018 1.327 . . . . 0.0 111.74 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 9' ' ' SER . 13.9 p -65.66 169.37 6.37 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 123.471 1.605 . . . . 0.0 110.277 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -114.9 -19.59 10.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.722 -2.036 . . . . 0.0 111.119 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.409 ' HB2' HG23 ' A' ' 40' ' ' VAL . 32.1 p90 -161.33 172.16 17.06 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.67 0.668 . . . . 0.0 111.388 172.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -117.02 103.61 10.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.369 2.268 . . . . 0.0 106.441 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 tp -76.97 99.04 5.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mm -72.41 102.14 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 128.064 2.545 . . . . 0.0 105.923 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 t -95.87 112.2 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.0 140.57 34.04 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.679 1.127 . . . . 0.0 108.495 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -132.68 123.12 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -168.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.19 3.99 1.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -165.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -154.63 60.6 0.68 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 122.491 1.139 . . . . 0.0 109.702 155.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.18 7.32 1.58 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.637 1.575 . . . . 0.0 114.692 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -135.7 155.09 50.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 131.349 3.86 . . . . 0.0 106.807 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.65 124.72 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.616 1.166 . . . . 0.0 109.027 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -111.97 -34.34 6.01 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.641 0.776 . . . . 0.0 112.543 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 131.64 27.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -96.96 154.71 17.14 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 162.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 147.85 33.18 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.938 1.695 . . . . 0.0 107.093 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 24' ' ' TYR 0.453 1.2 p -106.83 134.87 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 125.791 1.636 . . . . 0.0 115.287 155.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.16 122.14 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -65.64 161.08 21.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.594 1.088 . . . . 0.0 111.213 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -81.14 99.83 8.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 167.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -154.47 38.22 0.43 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 108.486 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 60.49 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.103 2.961 . . . . 0.0 112.854 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 t -62.23 -10.78 11.72 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.586 -1.321 . . . . 0.0 111.464 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -49.7 -60.24 6.6 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 160.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -61.29 -26.88 68.08 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.183 0.993 . . . . 0.0 112.348 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -64.69 -53.0 54.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 120.078 1.308 . . . . 0.0 108.874 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 t -53.55 -45.95 70.03 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 110.194 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.8 mt -50.36 -43.04 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.882 0.873 . . . . 0.0 110.709 -176.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.19 -23.28 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 O-C-N 121.052 -1.03 . . . . 0.0 111.906 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -98.64 12.42 35.43 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.078 0.951 . . . . 0.0 111.266 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.53 -6.42 11.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.807 0.843 . . . . 0.0 112.211 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.0 t30 49.89 61.95 2.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.406 1.483 . . . . 0.0 111.694 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.51 142.13 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 166.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -76.13 -52.72 9.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.27 162.5 39.37 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -167.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.56 141.16 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.88 2.072 . . . . 0.0 110.396 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 81' ' ' ALA . 51.9 mt -127.14 125.75 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.201 1.8 . . . . 0.0 106.792 167.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 38.1 m -149.62 -13.59 0.28 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.789 ' HG3' ' HB3' ' A' ' 81' ' ' ALA . 9.5 mtpp 75.78 -34.42 0.24 Allowed 'General case' 0 C--O 1.221 -0.425 1 C-N-CA 132.526 4.331 . . . . 0.0 113.35 -162.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -149.97 168.07 24.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 122.088 2.222 . . . . 0.0 111.748 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -163.53 120.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.645 1.178 . . . . 0.0 108.65 -171.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.35 147.79 43.61 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.18 -47.49 65.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.933 2.093 . . . . 0.0 111.345 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -59.76 -42.25 92.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.753 0.787 . . . . 0.0 111.154 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -72.56 -41.49 65.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.888 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -51.75 -61.17 2.42 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.201 0.91 . . . . 0.0 109.896 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -64.89 -24.08 67.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.89 -38.63 61.83 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 120.905 -1.122 . . . . 0.0 111.301 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.49 -30.46 21.97 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.056 -1.027 . . . . 0.0 111.485 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -63.8 -12.73 38.18 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -27.34 5.62 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.328 1.451 . . . . 0.0 113.903 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -155.75 -2.66 0.14 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.026 0.83 . . . . 0.0 113.207 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.29 121.07 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -75.06 117.36 16.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.484 1.513 . . . . 0.0 107.271 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.48 134.92 28.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -120.15 155.38 33.19 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 108.792 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -85.37 141.29 30.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 168.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.789 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . . . -88.52 150.16 23.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.354 0.525 . . . . 0.0 110.486 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.77 71.36 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 127.876 2.47 . . . . 0.0 108.118 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.43 -178.85 17.52 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 124.466 1.031 . . . . 0.0 112.852 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -33.63 75.57 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.028 153.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -74.55 100.83 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 124.446 1.091 . . . . 0.0 109.9 -155.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -52.18 -43.85 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -44.22 92.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.575 0.625 . . . . 0.0 109.962 -175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.19 -39.26 78.47 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.69 -0.631 . . . . 0.0 110.982 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -76.87 -27.25 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.745 -0.597 . . . . 0.0 112.529 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.09 -50.43 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.6 p -61.87 -46.42 89.49 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.012 0.824 . . . . 0.0 110.898 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 69.4 mt -63.06 -30.24 71.44 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.084 0.554 . . . . 0.0 110.621 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.62 -48.38 48.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.46 -37.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.854 1.261 . . . . 0.0 109.928 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -76.84 -34.35 57.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.898 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.57 15.16 32.78 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.99 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -34.82 74.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.821 2.048 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.31 142.15 52.73 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.605 1.093 . . . . 0.0 109.495 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.4 t -91.55 144.75 25.22 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 123.275 1.512 . . . . 0.0 110.244 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -85.08 130.7 34.57 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.985 1.714 . . . . 0.0 108.896 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.2 mt -71.52 140.23 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.4 t -122.49 -55.63 1.83 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.927 0.891 . . . . 0.0 108.894 171.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -117.7 85.8 22.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 126.769 2.028 . . . . 0.0 107.964 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--O 1.248 0.995 0 C-N-CA 123.958 3.105 . . . . 0.0 110.615 168.763 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.45 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -141.35 163.83 31.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.032 1.733 . . . . 0.0 108.734 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.605 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 9.4 tpt -99.85 127.27 46.02 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.166 1.386 . . . . 0.0 111.301 171.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.53 150.86 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 172.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m120 66.23 8.94 5.95 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 171.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.7 ttp -68.5 155.8 39.21 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.351 1.432 . . . . 0.0 110.202 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -139.12 146.34 40.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.018 1.727 . . . . 0.0 107.517 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG21 ' CE2' ' A' ' 93' ' ' PHE . 31.3 t -137.75 135.08 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.675 1.19 . . . . 0.0 108.122 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 124.12 33.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 166.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mt -104.03 112.53 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -66.2 91.63 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.784 1.234 . . . . 0.0 110.007 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 91.3 mmm -92.08 159.51 15.66 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.492 1.117 . . . . 0.0 111.183 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.81 -81.4 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.178 2.191 . . . . 0.0 108.372 165.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.4 t -140.41 -59.71 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -121.87 2.69 9.99 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 170.44 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.645 1.178 . . . . 0.0 110.09 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.5 mt -53.96 139.54 12.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.793 1.637 . . . . 0.0 108.087 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.8 t -74.25 -179.49 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.707 1.603 . . . . 0.0 110.625 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -86.0 -34.39 20.82 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.705 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -153.27 168.3 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.987 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -67.03 -23.04 65.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.247 2.219 . . . . 0.0 111.406 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.8 19.72 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.052 1.341 . . . . 0.0 110.916 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.14 -7.3 1.58 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.2 p -74.46 154.49 38.7 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.265 1.031 . . . . 0.0 109.889 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.59 -34.25 14.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.365 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.454 ' HE2' HD23 ' A' ' 26' ' ' LEU . 27.4 p90 -158.54 175.55 13.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.656 0.741 . . . . 0.0 109.533 176.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -117.05 108.91 16.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD23 ' HE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -77.72 104.9 8.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 170.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 mm -69.0 99.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.18 147.37 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 161.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -129.03 140.22 51.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.2 mt -110.55 142.52 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.28 124.55 10.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 175.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 44.46 57.7 4.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.614 1.565 . . . . 0.0 111.51 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 49.62 28.49 2.6 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 128.89 2.876 . . . . 0.0 114.138 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HB2' ' CE ' ' A' ' 36' ' ' LYS . 45.4 mt-10 -132.07 157.16 44.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.09 1.314 . . . . 0.0 111.139 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.52 120.15 17.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' CE ' ' HB2' ' A' ' 34' ' ' GLU . 21.3 mmtp -126.15 -7.62 6.52 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.437 ' HB3' ' HG2' ' A' ' 29' ' ' ARG . 47.7 t -157.13 170.67 21.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 122.021 2.191 . . . . 0.0 107.813 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.24 156.26 45.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.609 1.564 . . . . 0.0 109.535 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 160.55 43.86 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 125.911 1.685 . . . . 0.0 109.142 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.7 OUTLIER -127.1 137.28 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 C-N-CA 130.062 3.345 . . . . 0.0 116.581 167.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.5 mt -127.84 116.25 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -64.05 148.92 48.61 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.57 0.623 . . . . 0.0 110.25 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -69.95 88.73 0.58 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.2 166.23 24.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 128.309 2.644 . . . . 0.0 105.042 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.73 -45.98 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.49 -0.757 . . . . 0.0 109.778 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -26.3 68.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 110.178 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.18 -49.73 38.12 Favored Glycine 0 N--CA 1.444 -0.819 0 O-C-N 121.729 -0.607 . . . . 0.0 111.677 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -67.82 -21.52 65.21 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.067 0.934 . . . . 0.0 111.506 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.03 -58.16 6.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.736 -1.126 . . . . 0.0 110.551 161.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -53.51 -33.88 56.08 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.333 0.97 . . . . 0.0 112.824 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 mt -45.3 -46.64 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.557 1.143 . . . . 0.0 111.513 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.4 t -66.33 -33.37 63.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 123.225 0.61 . . . . 0.0 110.199 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -27.09 29.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.298 0.499 . . . . 0.0 111.223 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.02 -20.17 66.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.099 0.863 . . . . 0.0 112.155 -170.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.01 32.87 1.74 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.053 1.341 . . . . 0.0 110.58 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.02 146.1 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.34 -48.83 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.794 1.238 . . . . 0.0 109.669 170.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.47 163.3 40.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 110.057 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -117.19 150.07 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.7 mt -120.24 132.14 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 t -163.95 161.53 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.715 2.406 . . . . 0.0 108.476 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.3 -39.03 93.43 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.537 169.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.66 167.96 24.95 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.029 1.286 . . . . 0.0 109.34 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.9 tt -162.49 138.02 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.025 1.73 . . . . 0.0 107.751 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -76.29 152.11 36.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.964 -0.46 . . . . 0.0 110.581 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -48.91 -45.64 41.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.507 1.123 . . . . 0.0 111.456 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.768 0.827 . . . . 0.0 108.824 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -60.12 -41.5 92.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.99 0.916 . . . . 0.0 111.903 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -56.03 -65.01 0.67 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.915 0.78 . . . . 0.0 109.252 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -60.38 -28.1 67.94 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.634 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -55.4 13.01 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.721 1.146 . . . . 0.0 110.341 176.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.88 -22.25 37.0 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.531 0.605 . . . . 0.0 112.589 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 t -72.44 69.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.029 1.395 . . . . 0.0 110.618 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 -32.49 0.28 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 129.006 2.922 . . . . 0.0 110.259 175.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.82 -6.32 0.6 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.81 136.67 58.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.62 155.46 19.23 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.977 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.3 mt -128.14 118.19 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 124.63 1.172 . . . . 0.0 108.658 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 60.1 m-85 -106.06 164.36 12.04 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.161 0.984 . . . . 0.0 110.321 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -98.41 145.97 26.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.885 0.766 . . . . 0.0 110.017 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.91 117.16 29.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.598 1.159 . . . . 0.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.24 -9.8 58.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.89 34.39 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.45 -18.26 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 158.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 98.53 0.91 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.985 2.514 . . . . 0.0 107.276 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -48.13 -41.42 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.02 -43.59 74.46 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.385 -0.822 . . . . 0.0 110.35 -169.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -36.07 82.29 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 122.084 -0.385 . . . . 0.0 110.502 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.51 -38.32 74.28 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.736 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.05 -50.32 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -60.4 -36.45 78.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.623 0.647 . . . . 0.0 111.863 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.8 mt -67.89 -44.97 75.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.023 0.44 . . . . 0.0 110.77 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 6' ' ' VAL . 43.6 t80 -59.36 -37.19 77.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.358 1.063 . . . . 0.0 112.839 -176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.7 mt -64.34 -48.41 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.445 1.098 . . . . 0.0 109.807 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.72 -24.07 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.982 0.81 . . . . 0.0 110.868 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.16 8.37 58.92 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 123.914 0.769 . . . . 0.0 113.279 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -45.64 73.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.128 2.171 . . . . 0.0 109.901 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 35.3 mt -54.62 137.78 42.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 124.204 1.002 . . . . 0.0 110.847 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 t -84.47 157.81 21.22 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 57.0 mtpt -76.35 145.63 39.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.5 mt -63.33 152.41 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.8 p -72.0 -153.39 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 127.113 2.165 . . . . 0.0 110.538 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.64 85.98 2.05 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 120.696 -1.252 . . . . 0.0 108.942 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--O 1.255 1.372 0 C-N-CA 123.317 2.678 . . . . 0.0 110.674 171.413 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 CA-C-O 118.394 -1.226 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -89.27 -66.76 0.89 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 118.646 1.223 . . . . 0.0 112.689 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.575 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.0 tpt -129.72 124.41 33.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 123.806 0.843 . . . . 0.0 111.807 -164.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mm -134.01 143.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.533 2.333 . . . . 0.0 107.496 -167.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 45.65 58.74 4.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.464 1.506 . . . . 0.0 113.101 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.3 tpp -103.11 155.02 18.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.609 1.163 . . . . 0.0 108.328 166.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 143.12 31.9 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.495 1.918 . . . . 0.0 105.981 164.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG21 ' CE2' ' A' ' 93' ' ' PHE . 95.4 t -132.78 137.17 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.49 74.26 0.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.689 0.796 . . . . 0.0 109.553 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.92 120.56 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.888 1.275 . . . . 0.0 109.103 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -67.96 117.92 10.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.046 0.938 . . . . 0.0 111.124 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.2 mmm -124.89 157.11 36.76 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.707 1.603 . . . . 0.0 110.159 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -106.78 -62.02 1.46 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.024 1.73 . . . . 0.0 110.635 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -142.27 -85.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 170.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.71 -8.45 24.3 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 165.93 19.99 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.799 1.24 . . . . 0.0 110.35 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.48 142.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 125.31 1.631 . . . . 0.0 108.036 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -73.18 -179.34 3.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.136 1.375 . . . . 0.0 112.881 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -88.14 -32.3 18.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.553 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.1 t -152.67 177.88 10.21 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.262 1.825 . . . . 0.0 108.289 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.32 -34.87 78.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 128.218 2.607 . . . . 0.0 110.723 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.8 -1.94 45.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.005 0.82 . . . . 0.0 111.979 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -121.1 52.77 1.18 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 p -133.25 173.04 11.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.184 2.994 . . . . 0.0 108.572 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -118.01 -28.65 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.906 1.682 . . . . 0.0 109.385 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -156.42 176.1 13.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.953 0.797 . . . . 0.0 111.78 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -123.08 115.92 22.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.823 2.849 . . . . 0.0 108.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 39' ' ' LYS . 14.2 tp -89.07 103.35 15.97 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.327 2.251 . . . . 0.0 106.424 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 41' ' ' ILE . 14.7 mm -68.79 76.12 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 129.732 3.213 . . . . 0.0 111.16 174.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -69.14 99.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -76.64 136.49 39.17 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 164.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.14 129.77 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 159.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -132.43 2.19 3.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 t0 174.59 72.13 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.253 3.021 . . . . 0.0 103.217 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' ND2' ' H ' ' A' ' 1' ' ' MET . 0.6 OUTLIER 64.9 -25.56 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 131.146 3.778 . . . . 0.0 116.608 173.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -107.39 166.12 10.89 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.22 118.97 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.107 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 -5.35 8.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 113.203 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.7 m -170.02 168.14 8.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.7 2.4 . . . . 0.0 107.005 166.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 p -136.23 -46.01 0.63 Allowed 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER 44.41 175.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.253 2.621 . . . . 0.0 117.682 -171.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.7 t -143.25 106.02 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 167.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 27' ' ' ILE . 47.6 mt -96.49 115.52 36.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 165.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -65.43 162.26 18.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.871 1.669 . . . . 0.0 110.461 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -73.58 80.98 1.49 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 0.0 108.1 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -134.04 168.16 19.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.628 1.171 . . . . 0.0 107.906 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -52.14 -46.46 65.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.199 1.799 . . . . 0.0 109.835 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -70.82 -39.92 72.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.784 1.234 . . . . 0.0 107.933 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -61.31 7.32 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -58.98 -39.54 82.08 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.23 1.012 . . . . 0.0 110.373 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -58.68 -42.44 88.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.137 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.08 -44.42 92.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.578 1.551 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.7 mt -50.75 -43.81 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.15 -32.41 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.976 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -84.31 -25.93 28.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.47 1.032 . . . . 0.0 110.361 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.95 156.62 33.01 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.793 1.237 . . . . 0.0 108.503 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -83.17 28.31 0.53 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.178 1.391 . . . . 0.0 110.916 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.29 134.78 23.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 120.935 1.698 . . . . 0.0 108.559 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -82.26 -44.63 16.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.023 1.729 . . . . 0.0 109.655 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.25 162.2 40.17 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.121 0.568 . . . . 0.0 110.412 -168.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mt -113.51 141.69 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 171.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.14 122.64 55.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 162.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.04 151.72 38.19 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.914 1.285 . . . . 0.0 110.664 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -65.91 -46.65 77.49 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 121.632 -0.668 . . . . 0.0 109.343 163.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -148.21 166.89 26.56 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.83 119.85 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -52.05 138.58 24.88 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.506 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -51.87 -43.1 63.13 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.973 1.709 . . . . 0.0 112.071 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -22.72 66.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.82 0.848 . . . . 0.0 112.625 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -84.61 -41.5 16.33 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.571 -0.705 . . . . 0.0 109.891 167.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -56.94 -59.95 4.29 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.941 1.246 . . . . 0.0 110.721 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -58.35 -22.8 54.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.904 0.482 . . . . 0.0 111.959 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.96 -50.05 8.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.834 1.254 . . . . 0.0 111.098 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -79.59 -24.27 42.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.095 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -60.85 -7.58 2.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.168 0.895 . . . . 0.0 113.302 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 -39.33 21.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.332 1.453 . . . . 0.0 113.864 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -165.17 4.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.282 0.947 . . . . 0.0 112.173 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.7 mt -120.95 126.71 75.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.38 136.79 42.45 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.29 132.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.3 151.66 37.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.681 1.192 . . . . 0.0 109.908 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -99.54 134.56 42.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.968 1.707 . . . . 0.0 110.59 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.74 158.52 33.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.427 0.632 . . . . 0.0 109.94 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -128.85 26.67 5.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.791 2.436 . . . . 0.0 108.584 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.11 36.78 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.598 -1.314 . . . . 0.0 111.879 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -89.67 -23.93 21.74 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.966 1.306 . . . . 0.0 109.784 165.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.79 104.02 1.0 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.222 1.809 . . . . 0.0 107.705 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.2 t -51.73 -46.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.217 1.007 . . . . 0.0 108.844 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.33 -41.72 93.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 119.215 0.916 . . . . 0.0 109.609 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -56.54 -44.79 81.2 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.607 -0.683 . . . . 0.0 110.353 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -70.21 -44.93 67.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.096 -0.378 . . . . 0.0 110.894 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -41.52 92.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 97.4 p -68.52 -34.41 75.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.568 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.62 -41.36 84.09 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 120.991 0.424 . . . . 0.0 110.397 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 6' ' ' VAL . 56.0 t80 -61.66 -40.17 93.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.592 0.757 . . . . 0.0 112.051 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.1 mt -51.07 -52.47 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 109.163 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -74.11 -22.52 59.45 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.048 0.84 . . . . 0.0 112.445 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.65 -3.76 39.51 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.897 -0.946 . . . . 0.0 114.26 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -17.41 62.53 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.677 1.991 . . . . 0.0 113.577 -164.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.67 140.96 49.88 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 120.8 -1.188 . . . . 0.0 109.149 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -57.35 134.91 56.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -68.77 130.75 43.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 153.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.31 140.3 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 160.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -118.68 176.9 5.05 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -42.45 88.62 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 130.971 3.708 . . . . 0.0 113.69 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.248 1.006 0 C-N-CA 123.073 2.516 . . . . 0.0 110.684 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -147.3 -172.37 4.0 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt -144.07 145.73 32.36 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.1 mt -139.05 143.37 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.48 52.47 14.07 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.381 1.472 . . . . 0.0 111.433 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttp -113.55 137.77 51.09 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.871 1.268 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -133.85 153.05 52.01 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 126.098 1.759 . . . . 0.0 106.935 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 28' ' ' VAL . 53.4 t -147.04 141.32 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.25 94.09 8.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.55 98.32 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 p -67.95 123.8 21.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.672 1.589 . . . . 0.0 113.032 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.1 mtp -124.46 162.02 24.82 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.453 -1.405 . . . . 0.0 112.403 -171.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.49 -60.76 1.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.681 1.192 . . . . 0.0 109.439 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -146.74 -73.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -122.59 0.46 9.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.944 1.298 . . . . 0.0 111.928 -167.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 178.18 7.34 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.25 -0.907 . . . . 0.0 110.547 165.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.8 mt -52.53 139.98 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.038 1.735 . . . . 0.0 109.156 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -68.39 166.39 16.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.041 1.336 . . . . 0.0 112.964 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.97 -46.29 71.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.39 1.476 . . . . 0.0 112.264 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 t -158.41 168.6 26.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 0.0 109.418 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.95 -33.52 75.53 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.534 1.934 . . . . 0.0 111.112 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.49 24.4 12.66 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.859 1.264 . . . . 0.0 110.198 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -139.99 32.17 1.98 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.829 0.852 . . . . 0.0 109.602 161.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.2 p -108.32 164.42 12.33 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.42 -29.22 9.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.091 0.956 . . . . 0.0 110.004 -171.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 31.8 p90 -159.96 163.53 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.339 0.59 . . . . 0.0 111.909 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.675 ' CD2' HD11 ' A' ' 51' ' ' ILE . 62.8 m-85 -104.87 107.57 18.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.69 1.996 . . . . 0.0 107.498 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -75.12 93.59 2.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -72.98 91.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 121.15 -0.969 . . . . 0.0 108.5 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.88 ' HA ' HG22 ' A' ' 38' ' ' THR . 1.2 p -64.98 165.96 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.541 1.137 . . . . 0.0 109.939 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 127.52 24.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.973 1.715 . . . . 0.0 110.48 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.34 110.94 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 125.63 1.572 . . . . 0.0 107.233 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -118.04 -13.5 9.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.531 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -157.63 63.77 0.47 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 122.875 1.321 . . . . 0.0 108.615 170.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 53.58 18.59 1.48 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.123 2.169 . . . . 0.0 116.08 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.91 171.42 14.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.92 1.688 . . . . 0.0 108.355 170.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 113.24 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -105.35 -39.45 6.15 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.647 -0.658 . . . . 0.0 109.263 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.56 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.447 1.099 . . . . 0.0 108.078 176.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.88 HG22 ' HA ' ' A' ' 28' ' ' VAL . 0.7 OUTLIER -159.98 176.93 11.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.513 1.925 . . . . 0.0 108.642 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -158.01 164.48 36.72 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 125.982 1.713 . . . . 0.0 110.903 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.477 0.6 OUTLIER -132.57 141.18 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 128.836 2.854 . . . . 0.0 117.076 164.728 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -129.47 117.82 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 129.695 3.198 . . . . 0.0 104.35 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -64.7 158.55 24.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.856 1.207 . . . . 0.0 111.758 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.84 89.37 4.06 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.578 0.751 . . . . 0.0 109.496 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -144.78 29.63 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.985 0.898 . . . . 0.0 112.546 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 75.24 -55.83 0.63 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.357 2.263 . . . . 0.0 111.771 170.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -60.48 -28.63 68.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.346 1.058 . . . . 0.0 109.864 166.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.04 -49.68 41.89 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -56.97 -39.04 73.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.884 0.842 . . . . 0.0 111.169 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -58.9 -47.16 85.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.463 1.029 . . . . 0.0 111.477 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 m -64.07 -33.54 75.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.051 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.675 HD11 ' CD2' ' A' ' 25' ' ' PHE . 84.2 mt -55.68 -40.35 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.148 0.885 . . . . 0.0 110.216 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -54.94 -47.12 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -81.21 -13.04 58.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -63.97 -19.34 65.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.221 1.373 . . . . 0.0 111.865 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 55.87 56.53 5.95 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.181 1.392 . . . . 0.0 109.068 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 51' ' ' ILE . 2.5 t -66.31 146.45 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.93 -37.48 13.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.228 2.611 . . . . 0.0 110.578 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.6 168.12 24.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.159 0.983 . . . . 0.0 112.627 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -127.21 119.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.2 132.89 37.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 163.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 9.9 p -147.55 163.54 36.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.266 0.939 . . . . 0.0 108.672 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -75.07 -40.64 60.02 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 121.48 -0.763 . . . . 0.0 108.994 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -157.46 170.01 23.41 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.4 tt -163.49 124.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.64 0.776 . . . . 0.0 111.017 -170.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -51.15 141.31 14.63 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.56 0.744 . . . . 0.0 111.732 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -50.87 -45.82 60.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.852 1.661 . . . . 0.0 112.176 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -58.98 -52.43 65.8 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.97 0.804 . . . . 0.0 110.583 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -63.0 -41.41 99.58 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.227 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.15 -61.28 2.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.651 0.78 . . . . 0.0 109.642 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -63.49 -24.23 67.73 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 119.171 -0.442 . . . . 0.0 112.182 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -61.71 1.71 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.977 0.911 . . . . 0.0 109.517 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.69 -21.82 60.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.752 0.821 . . . . 0.0 112.499 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -63.15 -1.81 1.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -70.22 -32.96 71.09 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 119.999 -1.688 . . . . 0.0 113.492 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -153.86 13.56 0.46 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.301 1.409 . . . . 0.0 112.573 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -135.36 133.95 52.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -87.91 126.22 34.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.769 1.627 . . . . 0.0 108.601 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.2 mt -109.54 121.75 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.69 -1.256 . . . . 0.0 109.139 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 72.3 m-85 -121.18 146.9 46.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.364 2.266 . . . . 0.0 111.518 -166.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -90.1 146.58 24.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.73 0.412 . . . . 0.0 110.387 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 129.69 36.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.66 20.35 6.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.902 0.881 . . . . 0.0 112.135 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.74 -165.21 38.71 Favored Glycine 0 C--N 1.335 0.506 0 O-C-N 120.496 -1.378 . . . . 0.0 111.675 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.12 1.01 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.116 1.366 . . . . 0.0 109.499 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . 3.0 t70 -86.92 104.75 16.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.6 -42.04 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -64.17 -47.48 79.68 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -168.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 2.7 tptm -61.53 -37.11 82.54 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.997 -1.065 . . . . 0.0 111.862 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.88 -33.8 76.39 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 120.891 -1.13 . . . . 0.0 111.386 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.97 -51.08 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -64.23 -37.68 88.33 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.447 0.567 . . . . 0.0 111.242 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.06 -43.91 94.04 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.065 0.393 . . . . 0.0 110.033 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CE2' HG21 ' A' ' 6' ' ' VAL . 67.2 t80 -59.82 -44.81 93.84 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.72 0.408 . . . . 0.0 111.55 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.0 -48.49 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.228 1.011 . . . . 0.0 109.433 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -64.69 -36.53 84.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.911 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 9.11 21.34 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.062 -0.854 . . . . 0.0 113.237 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -29.66 59.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.289 1.036 . . . . 0.0 112.063 -167.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.73 138.38 58.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.6 135.68 42.03 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.6 mtmm -64.42 132.2 49.37 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 163.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.65 122.74 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -96.15 102.92 14.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 65.55 159.11 0.13 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 127.268 2.227 . . . . 0.0 113.735 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.25 1.093 0 C-N-CA 123.142 2.562 . . . . 0.0 109.955 154.233 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 CA-C-O 119.217 -0.768 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 51.13 8.55 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 119.574 3.175 . . . . 0.0 119.574 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 13.4 tpt -57.52 130.55 46.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.858 1.208 . . . . 0.0 113.165 -176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 mt -124.22 151.24 29.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 126.435 1.894 . . . . 0.0 108.789 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.3 t30 61.55 27.81 17.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.321 2.248 . . . . 0.0 113.198 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpp -78.08 149.12 33.97 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -140.81 140.39 34.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 93' ' ' PHE . 54.7 t -140.69 130.86 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.284 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.26 106.89 18.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -92.32 123.75 44.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 79.3 p -62.43 128.32 35.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.588 1.086 . . . . 0.0 110.613 169.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.2 mtp -126.66 159.99 32.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.653 1.115 . . . . 0.0 110.689 172.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.22 -65.55 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.152 1.381 . . . . 0.0 107.948 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.54 -73.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 167.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -119.79 9.67 11.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.307 1.051 . . . . 0.0 112.482 -154.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 178.03 8.7 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 128.293 2.637 . . . . 0.0 107.603 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.82 146.03 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 p -83.54 -156.78 0.21 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.715 2.006 . . . . 0.0 111.985 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.55 -21.65 12.62 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 63' ' ' ASN . 96.8 p -154.52 -167.89 2.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.892 1.224 . . . . 0.0 110.789 168.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -79.63 -29.01 40.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.84 1.256 . . . . 0.0 110.969 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -89.26 -43.17 11.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.764 0.711 . . . . 0.0 109.83 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.5 62.39 6.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 9' ' ' SER . 17.8 p -121.98 165.41 16.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.319 149.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -110.36 -29.31 8.18 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.702 1.201 . . . . 0.0 108.805 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.47 169.72 20.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 109.678 167.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.3 119.69 39.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.196 2.198 . . . . 0.0 105.662 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD11 ' HB ' ' A' ' 38' ' ' THR . 1.2 tm? -79.98 105.72 11.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 mm -79.76 98.69 3.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.6 t -66.14 146.94 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 167.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.08 89.92 2.88 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 167.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.05 126.86 29.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 166.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -127.3 1.92 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 118.396 -0.812 . . . . 0.0 113.035 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -166.52 45.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.009 0.909 . . . . 0.0 110.488 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 1' ' ' MET . 0.4 OUTLIER 60.66 8.56 1.79 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.895 -1.128 . . . . 0.0 114.01 -168.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.73 154.27 46.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.693 1.197 . . . . 0.0 109.883 162.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.64 108.12 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 107.757 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -88.95 -30.37 18.86 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.999 -1.063 . . . . 0.0 111.691 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -144.87 164.18 31.84 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 162.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.411 ' HB ' HD11 ' A' ' 26' ' ' LEU . 20.9 p -118.02 144.88 45.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.763 1.625 . . . . 0.0 106.912 165.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.86 155.59 27.65 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.535 1.134 . . . . 0.0 108.161 169.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.5 132.06 68.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.76 111.35 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -62.35 152.71 33.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.517 1.053 . . . . 0.0 109.768 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -74.73 88.3 2.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.67 165.28 27.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.174 1.789 . . . . 0.0 106.225 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -61.16 -39.31 89.64 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.523 -0.736 . . . . 0.0 111.737 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 t -63.97 -45.02 90.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.238 1.015 . . . . 0.0 108.481 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.95 -60.78 8.2 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 125.237 1.398 . . . . 0.0 112.062 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -62.75 -36.59 83.54 Favored 'General case' 0 CA--C 1.516 -0.344 0 O-C-N 121.834 -0.804 . . . . 0.0 110.11 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -54.02 -44.87 71.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.637 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.1 m -70.69 -23.46 62.48 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.738 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.98 -46.18 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 121.478 1.944 . . . . 0.0 109.687 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -55.47 -18.11 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.801 1.64 . . . . 0.0 112.15 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.68 -14.85 14.72 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.735 -1.126 . . . . 0.0 112.592 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.06 -27.67 69.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.787 1.63 . . . . 0.0 111.026 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 63.42 53.89 2.06 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 125.238 1.415 . . . . 0.0 109.737 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.75 148.76 10.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -38.33 9.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.416 1.886 . . . . 0.0 110.257 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 161.17 43.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.07 0.548 . . . . 0.0 111.132 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -119.87 142.04 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.178 1.791 . . . . 0.0 107.221 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.34 106.35 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.749 1.22 . . . . 0.0 108.282 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 9' ' ' SER . 4.1 m -142.99 173.04 11.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' C ' HD22 ' A' ' 63' ' ' ASN . 64.1 mttt -71.86 -70.82 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.43 ' H ' ' HA ' ' A' ' 18' ' ' SER . 2.6 m120 -119.58 170.26 9.33 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.532 -1.355 . . . . 0.0 108.021 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.89 137.87 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -68.5 141.32 55.61 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.194 0.997 . . . . 0.0 110.408 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -45.24 -52.35 9.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.355 2.262 . . . . 0.0 111.288 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -39.35 89.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.812 0.445 . . . . 0.0 110.966 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -69.86 -47.5 62.38 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -51.09 -62.97 1.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.38 -36.03 70.73 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.189 0.596 . . . . 0.0 110.993 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -63.95 -59.7 4.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.805 -0.56 . . . . 0.0 110.494 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -75.82 -28.75 58.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.544 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.0 p -65.78 -5.68 9.55 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.702 1.201 . . . . 0.0 113.548 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -47.03 -51.49 17.26 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.513 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -140.39 -15.97 0.94 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 87.9 mt -73.03 123.99 29.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.21 147.7 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.25 119.3 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -120.22 154.34 35.0 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.831 1.252 . . . . 0.0 110.555 -170.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -90.13 128.72 36.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 109.662 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.1 123.81 20.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.421 0.688 . . . . 0.0 111.037 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -108.39 100.42 9.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.925 2.09 . . . . 0.0 108.184 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.75 157.77 27.6 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -27.98 62.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.134 2.174 . . . . 0.0 111.823 164.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.8 103.66 6.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.192 -1.822 . . . . 0.0 107.058 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -44.75 -44.48 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 123.719 0.807 . . . . 0.0 109.097 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.17 -34.62 61.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.98 0.355 . . . . 0.0 110.603 -169.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -50.81 -53.16 34.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -67.22 -29.25 68.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.349 -170.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.09 -46.19 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -66.96 -39.3 87.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.887 0.767 . . . . 0.0 111.3 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.4 -46.41 90.09 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 6' ' ' VAL . 78.5 t80 -62.05 -40.51 96.02 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 mt -55.68 -49.75 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.626 1.171 . . . . 0.0 109.464 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -73.22 -14.95 61.44 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.544 0.738 . . . . 0.0 112.805 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.81 18.53 63.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.077 0.853 . . . . 0.0 112.3 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.14 -27.92 62.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.548 1.539 . . . . 0.0 112.502 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.39 154.53 40.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.015 1.28 . . . . 0.0 109.464 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.35 149.5 35.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.043 0.937 . . . . 0.0 109.42 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -83.14 136.18 34.54 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 122.104 -0.373 . . . . 0.0 111.551 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.1 mt -65.25 115.98 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -85.25 0.05 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.136 1.374 . . . . 0.0 110.71 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -107.2 147.08 34.51 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.656 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.941 3.094 . . . . 0.0 113.138 -164.472 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 12.2 m170 73.31 -173.36 0.14 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.429 2.291 . . . . 0.0 108.431 -157.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HG2' ' HE1' ' A' ' 4' ' ' MET . 10.9 tpt -133.32 145.61 50.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 173.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.683 HG22 ' H ' ' A' ' 3' ' ' ASN . 2.1 mm -95.17 -161.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.013 2.125 . . . . 0.0 108.164 -178.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.683 ' H ' HG22 ' A' ' 2' ' ' ILE . 17.3 t-20 -53.07 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.195 2.598 . . . . 0.0 110.424 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.447 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 1.4 ttp -110.17 148.49 31.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -131.22 129.65 41.93 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 125.674 1.589 . . . . 0.0 106.747 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.5 t -136.35 132.66 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.5 111.37 22.84 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.4 123.58 44.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -73.46 127.71 33.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 117.821 0.282 . . . . 0.0 110.279 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mtp -130.65 156.63 44.57 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.189 1.396 . . . . 0.0 111.053 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -104.06 -69.93 0.79 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.348 1.059 . . . . 0.0 109.675 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.8 t -146.75 -47.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.23 17.59 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.773 0.797 . . . . 0.0 111.14 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -160.79 172.64 16.67 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 120.481 -1.387 . . . . 0.0 109.087 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.6 138.6 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.621 1.568 . . . . 0.0 107.88 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.3 p -73.38 167.99 20.13 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.739 0.781 . . . . 0.0 111.025 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.29 -46.11 57.19 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.266 0.3 OUTLIER -137.89 161.68 36.01 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.59 -1.319 . . . . 0.0 108.441 -175.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -68.33 -45.77 72.03 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.979 -1.076 . . . . 0.0 108.299 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.69 -33.32 75.62 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.374 0.67 . . . . 0.0 110.692 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.73 58.02 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.916 1.341 . . . . 0.0 107.807 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 p -121.35 175.91 5.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.481 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -104.69 -35.34 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.584 0.754 . . . . 0.0 109.53 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 29.5 p90 -156.1 170.76 21.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.422 0.629 . . . . 0.0 110.533 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -115.87 115.99 27.19 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.022 1.729 . . . . 0.0 107.257 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -79.14 107.28 11.79 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.01 100.17 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -63.31 137.38 24.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -125.01 118.46 26.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -119.02 139.89 44.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . 16.8 m-20 -140.36 7.06 2.15 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.603 0.761 . . . . 0.0 109.517 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -168.44 51.08 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.571 1.548 . . . . 0.0 112.127 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 64.15 -5.3 0.33 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.177 1.791 . . . . 0.0 115.323 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -121.64 154.2 37.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.22 2.208 . . . . 0.0 109.296 -175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.74 96.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 107.321 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' HB2' ' A' ' 31' ' ' ASP . 67.8 mmtt -70.33 -33.31 71.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 171.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.2 m -161.77 167.09 25.55 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.087 0.858 . . . . 0.0 111.127 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -127.02 118.66 24.9 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.509 1.523 . . . . 0.0 108.77 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.71 168.53 9.01 Favored 'General case' 0 C--O 1.213 -0.861 0 C-N-CA 125.754 1.622 . . . . 0.0 108.792 171.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.79 1.1 p -155.17 124.28 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 131.085 3.754 . . . . 0.0 115.947 -175.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.52 109.41 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 129.586 3.155 . . . . 0.0 102.921 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -61.36 156.11 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.122 0.874 . . . . 0.0 109.654 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -72.43 55.85 0.35 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.84 2.056 . . . . 0.0 111.121 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -107.29 168.57 9.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.2 -43.89 98.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.854 0.862 . . . . 0.0 109.614 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -77.36 -34.19 55.11 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.21 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.76 17.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.107 0.861 . . . . 0.0 111.25 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 52' ' ' VAL . 53.1 mttt -61.1 -37.68 83.6 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.078 -1.248 . . . . 0.0 109.622 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -59.39 -34.71 72.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.923 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -65.49 -48.69 71.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 119.36 0.982 . . . . 0.0 110.453 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -55.15 -44.16 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.153 0.888 . . . . 0.0 110.521 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 48' ' ' LYS . 62.0 t -55.76 -35.59 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.632 0.773 . . . . 0.0 110.825 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -95.59 -3.09 47.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.915 0.779 . . . . 0.0 112.287 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.91 168.41 18.77 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.757 1.162 . . . . 0.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -95.39 37.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.102 1.761 . . . . 0.0 110.045 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -61.94 138.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -82.18 -45.62 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.438 1.495 . . . . 0.0 109.968 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.4 158.65 42.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.285 1.034 . . . . 0.0 109.949 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.7 mt -121.25 122.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.89 123.02 47.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -148.07 161.15 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.421 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -81.78 -34.21 30.46 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 124.245 1.018 . . . . 0.0 111.335 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -149.85 159.78 44.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.674 1.579 . . . . 0.0 107.533 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.39 136.22 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.946 2.098 . . . . 0.0 108.69 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -77.94 148.88 34.29 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.22 -38.55 89.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.0 0.52 . . . . 0.0 112.104 -165.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.49 -42.97 99.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.195 0.598 . . . . 0.0 109.4 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -70.35 -31.74 69.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.941 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -58.41 -58.39 8.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.22 1.373 . . . . 0.0 109.655 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -54.95 -43.66 73.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.922 0.489 . . . . 0.0 110.586 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -54.0 -58.58 6.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.006 1.722 . . . . 0.0 111.276 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' HD1' HD12 ' A' ' 76' ' ' ILE . 44.2 m-85 -78.38 -35.3 47.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.34 -0.838 . . . . 0.0 112.983 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.9 t -50.44 -27.19 6.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.547 1.939 . . . . 0.0 111.546 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -45.05 -46.07 11.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.226 1.01 . . . . 0.0 113.094 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -149.03 14.68 0.91 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.198 -172.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.482 HD12 ' HD1' ' A' ' 72' ' ' PHE . 37.6 mt -136.44 122.94 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.29 126.88 31.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.767 1.227 . . . . 0.0 108.647 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.87 129.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -116.49 148.79 40.45 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.885 2.074 . . . . 0.0 109.534 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -88.62 142.16 27.92 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.75 48.99 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 161.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -108.1 8.41 28.12 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.726 1.61 . . . . 0.0 111.107 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.09 -174.96 39.27 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.872 0.76 . . . . 0.0 111.235 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.78 -14.3 15.27 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.759 1.224 . . . . 0.0 110.635 170.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.1 106.72 5.08 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.419 1.088 . . . . 0.0 108.199 173.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -54.86 -43.71 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.917 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.47 -34.28 70.06 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.877 0.762 . . . . 0.0 109.039 -168.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptp -59.02 -49.3 78.43 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 120.853 -1.154 . . . . 0.0 109.448 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -74.04 -28.37 61.39 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.403 -0.811 . . . . 0.0 112.515 -170.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mt -66.0 -55.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.6 p -61.7 -38.73 88.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.331 0.514 . . . . 0.0 112.132 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.1 mt -61.53 -34.17 75.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.05 0.54 . . . . 0.0 111.434 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 6' ' ' VAL . 85.1 t80 -72.79 -41.16 65.29 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.953 -1.092 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 91' ' ' SER . 83.7 mt -51.01 -54.57 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.159 1.384 . . . . 0.0 109.698 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.68 -20.84 63.55 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.694 0.798 . . . . 0.0 111.668 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.45 56.59 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.41 -41.78 88.75 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.925 1.29 . . . . 0.0 110.366 164.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.58 140.71 53.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.418 1.008 . . . . 0.0 111.968 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.9 m -75.61 142.72 42.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.827 1.251 . . . . 0.0 111.104 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -76.37 150.82 36.78 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 160.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.0 mt -81.85 -55.72 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.258 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.4 76.54 0.08 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.649 1.979 . . . . 0.0 112.781 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.81 85.33 0.16 Allowed Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 123.988 0.915 . . . . 0.0 111.699 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.456 3.437 . . . . 0.0 111.531 -175.651 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -153.82 152.11 30.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.662 1.185 . . . . 0.0 109.166 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt -147.24 122.35 10.14 Favored 'General case' 0 CA--C 1.522 -0.102 0 O-C-N 121.672 -0.642 . . . . 0.0 109.973 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -104.11 148.38 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t30 56.54 36.85 28.22 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.669 1.588 . . . . 0.0 112.948 164.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.9 tpp -80.76 148.74 29.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 174.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -137.27 141.59 41.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 165.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 93' ' ' PHE . 42.0 t -139.77 138.65 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.378 171.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.7 104.35 16.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.31 111.37 24.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.2 p -63.21 151.06 41.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 121.195 1.816 . . . . 0.0 110.513 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 mtp -138.53 160.61 39.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.471 1.508 . . . . 0.0 109.06 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.57 -68.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.797 1.239 . . . . 0.0 108.417 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -142.89 -47.17 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 120.369 -1.457 . . . . 0.0 108.295 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -118.14 -31.43 5.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.357 1.063 . . . . 0.0 112.199 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -139.44 179.66 6.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.367 1.067 . . . . 0.0 110.176 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.3 mt -51.47 127.36 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.495 1.918 . . . . 0.0 109.098 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 t -71.32 179.18 3.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.676 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -85.35 -31.09 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -161.44 148.17 14.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.393 1.451 . . . . 0.0 112.032 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -59.62 -27.08 66.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.496 1.518 . . . . 0.0 111.309 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.54 11.53 28.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.483 1.913 . . . . 0.0 113.001 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -139.89 -6.42 1.28 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.394 1.478 . . . . 0.0 112.734 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 p -74.23 161.55 29.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.151 0.581 . . . . 0.0 111.34 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -99.75 -32.58 10.97 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.147 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.432 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 34.0 p90 -155.61 171.14 20.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.451 -0.78 . . . . 0.0 111.588 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -115.61 115.27 26.13 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.742 2.017 . . . . 0.0 107.283 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -76.55 99.47 4.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.34 97.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.59 150.06 7.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.995 1.318 . . . . 0.0 108.398 168.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -127.28 132.18 50.37 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.68 143.9 39.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 170.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -147.96 -6.03 0.45 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -152.1 59.08 0.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 160.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 67.67 -24.19 0.12 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 128.788 2.835 . . . . 0.0 114.718 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -92.27 155.48 17.93 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.658 1.983 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.76 130.52 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.148 1.379 . . . . 0.0 109.108 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.18 -27.61 6.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 m -163.44 164.7 24.44 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.748 1.158 . . . . 0.0 108.484 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.482 ' HB ' HD11 ' A' ' 26' ' ' LEU . 12.1 p -120.5 148.92 43.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 109.488 171.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.05 155.59 49.74 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.512 1.125 . . . . 0.0 108.805 172.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.585 0.6 OUTLIER -124.08 128.71 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 C-N-CA 128.714 2.806 . . . . 0.0 117.538 166.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.56 116.09 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.98 134.85 53.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.982 0.81 . . . . 0.0 109.051 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' H ' ' HA ' ' A' ' 24' ' ' TYR . 39.6 t30 -80.55 97.14 7.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -144.19 -68.95 0.31 Allowed 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.317 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 46' ' ' SER . 1.6 pt-20 -155.78 -63.33 0.11 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.555 0.742 . . . . 0.0 109.058 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 39.0 m -53.9 -36.89 63.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.319 170.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.7 -63.07 3.68 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.163 0.887 . . . . 0.0 112.04 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -63.16 -37.13 86.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.856 0.862 . . . . 0.0 112.01 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -56.94 -44.01 82.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.179 -0.915 . . . . 0.0 109.751 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -64.55 -45.85 85.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.685 1.594 . . . . 0.0 111.273 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.8 mt -49.79 -44.45 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 120.156 1.344 . . . . 0.0 110.869 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.39 -31.92 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.245 -0.909 . . . . 0.0 110.964 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 8.64 43.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.867 0.867 . . . . 0.0 110.929 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -168.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -130.31 51.71 2.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.18 147.87 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -98.76 -31.31 11.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.5 1.12 . . . . 0.0 110.534 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.11 161.5 40.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.943 0.497 . . . . 0.0 111.936 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.97 125.37 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 170.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.69 114.83 40.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 163.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.1 m -141.04 165.5 27.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -69.13 -35.67 76.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.605 1.162 . . . . 0.0 111.207 172.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -155.3 161.8 41.02 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.79 142.65 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.044 1.738 . . . . 0.0 108.123 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -65.94 154.26 39.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.58 -51.74 68.63 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.075 0.55 . . . . 0.0 109.986 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.2 -46.38 88.59 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.08 -35.47 80.59 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 123.393 0.677 . . . . 0.0 111.791 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -59.92 -60.96 3.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.736 1.153 . . . . 0.0 109.693 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 104' ' ' PRO . 44.5 mttm -65.37 -21.54 66.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 0.0 110.383 -174.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -70.7 -66.91 0.55 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.443 1.497 . . . . 0.0 109.538 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -74.17 -18.77 60.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.547 -165.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 p -59.45 -9.35 2.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -74.36 104.79 5.24 Favored 'General case' 0 C--O 1.23 0.075 0 O-C-N 120.6 -1.313 . . . . 0.0 109.901 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 67.78 11.47 8.39 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.437 1.895 . . . . 0.0 114.031 174.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.4 142.84 42.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -109.8 144.03 38.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -122.12 117.35 51.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -164.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.4 148.87 42.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.399 1.88 . . . . 0.0 110.522 -167.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -96.12 118.97 33.77 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.573 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.62 124.83 22.9 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.806 0.843 . . . . 0.0 110.849 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.85 105.31 15.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.874 1.67 . . . . 0.0 107.923 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.7 176.93 49.42 Favored Glycine 0 C--O 1.235 0.216 0 CA-C-O 122.623 1.124 . . . . 0.0 110.921 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.48 24.97 10.94 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.266 1.827 . . . . 0.0 107.046 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.55 105.84 15.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -52.42 -42.88 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.73 -47.06 86.98 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -57.14 -41.58 79.4 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.29 0.495 . . . . 0.0 110.898 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -71.45 -32.28 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.242 -0.911 . . . . 0.0 111.322 -173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.2 mt -67.95 -50.85 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 p -62.06 -42.96 99.73 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.937 0.789 . . . . 0.0 111.164 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.55 -43.31 99.09 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.956 0.502 . . . . 0.0 109.976 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 6' ' ' VAL . 55.8 t80 -65.46 -48.46 72.61 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -52.61 -36.41 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.789 1.235 . . . . 0.0 110.237 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.05 -12.39 58.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.395 1.078 . . . . 0.0 113.538 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.94 4.38 88.62 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.838 1.209 . . . . 0.0 112.719 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -27.09 63.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.271 1.028 . . . . 0.0 112.572 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.56 145.64 55.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.688 0.677 . . . . 0.0 110.497 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 t -78.98 151.8 31.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.989 0.916 . . . . 0.0 108.615 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -81.0 134.84 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.46 131.52 22.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.1 m -65.92 152.25 44.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.18 143.16 92.76 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.254 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HG2' ' HE2' ' A' ' 70' ' ' LYS . 85.6 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 C-N-CA 123.075 2.517 . . . . 0.0 109.684 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.56 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -132.05 179.23 6.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.197 0.999 . . . . 0.0 108.675 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt -141.73 147.88 38.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.533 -0.73 . . . . 0.0 109.259 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.6 mm -127.63 154.98 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.346 1.458 . . . . 0.0 108.692 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 54.58 21.25 3.28 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.433 1.893 . . . . 0.0 113.457 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.52 134.18 35.2 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 119.747 -1.845 . . . . 0.0 108.763 -169.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -138.36 113.48 9.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.511 0.724 . . . . 0.0 109.298 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG21 ' CE2' ' A' ' 93' ' ' PHE . 27.5 t -120.44 144.61 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.62 102.45 13.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.798 1.239 . . . . 0.0 108.61 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mt -84.85 128.18 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 p -75.49 123.36 25.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 117.984 0.356 . . . . 0.0 111.001 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.7 mtp -123.19 154.71 38.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.254 1.022 . . . . 0.0 111.116 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -107.43 -61.57 1.54 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.716 2.006 . . . . 0.0 109.732 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.4 t -140.11 -76.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.38 14.32 8.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.031 0.933 . . . . 0.0 110.965 -169.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 21.3 ptmt -148.67 169.73 19.74 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.883 1.273 . . . . 0.0 108.649 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.17 131.39 28.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -67.35 159.09 30.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.577 0.751 . . . . 0.0 110.099 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -51.49 -36.02 42.74 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.698 0.799 . . . . 0.0 111.623 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -158.47 178.26 10.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.047 0.385 . . . . 0.0 111.377 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -73.15 -10.11 59.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.757 2.423 . . . . 0.0 111.817 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -107.87 -10.0 15.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.844 -1.16 . . . . 0.0 112.643 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -116.3 10.19 14.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.094 1.357 . . . . 0.0 110.415 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.9 p -70.13 164.47 24.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.716 -1.24 . . . . 0.0 110.038 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -119.95 -21.48 7.11 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.216 1.806 . . . . 0.0 109.898 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -158.88 176.42 12.35 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.956 0.884 . . . . 0.0 110.45 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -124.48 111.07 15.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.924 2.49 . . . . 0.0 106.212 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 39' ' ' LYS . 17.9 tp -79.04 110.7 14.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -84.47 93.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.17 148.07 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.31 1.844 . . . . 0.0 107.892 171.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -133.9 86.75 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -80.81 130.6 35.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.15 1.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -157.01 64.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 159.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.28 10.6 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.133 1.373 . . . . 0.0 114.41 -172.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -138.29 150.37 46.58 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.48 1.912 . . . . 0.0 108.779 -170.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.22 95.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 128.021 2.528 . . . . 0.0 108.374 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -88.77 -27.21 21.29 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.907 -1.121 . . . . 0.0 110.88 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.85 178.87 8.53 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.467 1.031 . . . . 0.0 109.704 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -140.27 178.48 7.26 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.508 1.523 . . . . 0.0 109.542 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.558 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -160.27 162.82 33.73 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.924 2.089 . . . . 0.0 107.036 177.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.22 142.4 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.2 mt -128.14 109.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 166.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -60.3 142.14 55.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.564 1.074 . . . . 0.0 110.609 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -77.94 65.57 3.39 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.873 1.669 . . . . 0.0 108.949 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.01 95.15 2.52 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 52.71 -69.93 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.348 3.059 . . . . 0.0 115.465 157.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -44.95 -33.35 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.574 1.95 . . . . 0.0 110.88 157.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.27 -67.22 2.28 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 124.019 0.819 . . . . 0.0 111.371 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.66 -27.12 66.59 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -52.85 -51.46 60.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.686 1.13 . . . . 0.0 110.634 163.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -70.67 -20.93 62.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.986 0.514 . . . . 0.0 112.079 -173.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.18 -11.73 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.592 1.157 . . . . 0.0 111.035 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.77 -23.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 119.906 -1.746 . . . . 0.0 111.16 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -114.7 52.64 0.84 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.537 1.062 . . . . 0.0 110.155 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 -168.07 2.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.893 1.677 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.69 32.76 4.08 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.13 1.772 . . . . 0.0 109.397 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.67 140.92 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.94 -37.39 12.26 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.827 1.251 . . . . 0.0 109.168 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.33 151.45 26.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.229 1.012 . . . . 0.0 111.476 -171.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.5 mt -98.48 151.96 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 165.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.7 mt -124.28 130.05 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 161.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.1 p -146.65 160.82 41.7 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.88 1.272 . . . . 0.0 109.689 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -66.66 -47.72 71.62 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 167.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -154.88 172.87 17.33 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.0 tt -167.26 121.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -169.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -56.49 146.71 23.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -48.98 -43.99 40.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.341 1.456 . . . . 0.0 111.348 -174.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -66.25 -49.72 66.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.646 -0.658 . . . . 0.0 112.118 177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -58.28 -41.28 84.01 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.704 1.202 . . . . 0.0 109.849 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -59.35 -63.27 1.36 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.408 1.083 . . . . 0.0 109.529 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HE3' ' HG3' ' A' ' 66' ' ' GLU . 36.9 mttt -62.38 -21.89 65.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.711 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -72.76 -60.45 2.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.133 0.973 . . . . 0.0 110.03 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -75.46 -10.46 59.47 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.0 p -63.58 -9.02 11.36 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -77.2 117.93 19.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 120.414 -1.429 . . . . 0.0 108.311 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? 75.4 -31.48 0.21 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.335 3.054 . . . . 0.0 112.47 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mt -103.67 120.13 53.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.4 153.98 31.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.98 116.74 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.316 -1.49 . . . . 0.0 107.111 -166.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 7.1 m-85 -113.17 160.64 18.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.534 1.933 . . . . 0.0 110.703 -168.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -99.46 130.89 45.76 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 0.0 110.617 -173.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 131.04 36.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.019 0.927 . . . . 0.0 109.526 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -110.26 15.64 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.421 1.488 . . . . 0.0 112.271 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.76 172.64 31.14 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 108.484 -1.847 . . . . 0.0 108.484 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 13.0 m-20 -83.61 -24.13 31.6 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.567 0.747 . . . . 0.0 109.673 151.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.1 106.86 4.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.1 0.56 . . . . 0.0 109.776 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.7 t -48.6 -46.93 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.147 0.979 . . . . 0.0 109.517 168.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.0 -58.3 9.03 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -45.09 -49.55 11.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.974 1.309 . . . . 0.0 110.853 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -66.69 -41.56 87.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.953 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.58 -48.15 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.6 -15.03 63.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.47 ' CB ' HD11 ' A' ' 98' ' ' LEU . 44.4 mt -83.71 -38.84 20.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 120.371 1.442 . . . . 0.0 109.226 172.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.513 ' CE2' HG21 ' A' ' 6' ' ' VAL . 54.5 t80 -65.21 -41.42 94.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -169.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.14 -45.93 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.288 2.235 . . . . 0.0 110.728 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.31 -19.52 56.3 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.942 -1.099 . . . . 0.0 111.816 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.0 39.27 63.62 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -17.88 62.02 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.086 0.943 . . . . 0.0 109.054 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -89.54 124.92 34.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 m -72.67 153.72 41.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.617 169.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 9.3 mtpm? -61.19 144.06 54.4 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.9 mt -66.09 150.57 10.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.516 1.126 . . . . 0.0 108.275 168.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.7 m -136.67 -29.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.358 1.063 . . . . 0.0 111.596 167.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -128.94 85.6 59.69 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 126.798 2.039 . . . . 0.0 107.592 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 C--O 1.251 1.137 0 N-CA-C 108.011 -1.573 . . . . 0.0 108.011 153.574 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -148.64 157.9 43.77 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.624 1.169 . . . . 0.0 107.886 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt -137.23 137.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 122.867 0.467 . . . . 0.0 109.916 172.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.5 142.66 41.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.986 0.914 . . . . 0.0 109.551 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 44.65 66.31 0.9 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.166 2.986 . . . . 0.0 113.267 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.3 ttt -107.15 147.82 29.6 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -133.66 129.22 36.53 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 93' ' ' PHE . 28.9 t -132.54 144.84 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 118.314 -0.85 . . . . 0.0 108.707 168.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.35 77.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.384 1.073 . . . . 0.0 108.785 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.23 141.89 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 0.0 109.68 -165.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 p -74.46 115.73 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.71 0.631 . . . . 0.0 111.491 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.1 mtp -122.21 148.49 44.89 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.27 -0.894 . . . . 0.0 111.102 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.98 -75.34 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 109.54 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 t -144.12 -46.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.598 1.159 . . . . 0.0 107.925 -167.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.53 2.35 1.24 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.56 -179.9 8.51 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 126.858 2.063 . . . . 0.0 108.808 -176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.9 139.29 19.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.3 p -69.71 -84.52 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.704 1.602 . . . . 0.0 110.271 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.9 t30 177.0 -55.03 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 127.518 2.327 . . . . 0.0 107.304 -167.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.3 t -126.42 -175.15 3.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.931 1.242 . . . . 0.0 110.228 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -85.4 -43.3 13.76 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.3 1.44 . . . . 0.0 108.544 166.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.66 -19.43 60.84 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.028 -0.42 . . . . 0.0 110.414 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -119.96 74.32 1.02 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 167.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.0 p -134.27 165.16 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.212 1.805 . . . . 0.0 107.825 151.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -90.45 -37.43 13.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.352 0.661 . . . . 0.0 109.783 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.31 171.09 19.11 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.673 0.749 . . . . 0.0 110.456 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.04 108.8 16.19 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.091 2.556 . . . . 0.0 106.304 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 39' ' ' LYS . 1.3 tm? -78.72 103.71 8.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 HD11 HD12 ' A' ' 41' ' ' ILE . 5.3 mm -79.19 88.36 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.558 0.695 . . . . 0.0 109.192 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -58.24 125.88 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 168.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -103.53 110.09 22.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.26 143.65 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 161.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -136.05 -0.36 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.92 45.52 0.28 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 121.665 0.745 . . . . 0.0 110.136 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.6 -9.7 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.252 2.221 . . . . 0.0 115.318 -167.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.99 163.46 22.27 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.105 1.32 . . . . 0.0 111.648 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -44.51 128.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 128.375 2.67 . . . . 0.0 111.159 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -91.17 -86.92 0.21 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.52 -0.66 9.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.316 1.416 . . . . 0.0 113.904 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 p 49.61 -166.4 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.894 -1.129 . . . . 0.0 110.723 -160.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -174.44 166.35 3.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.488 2.315 . . . . 0.0 107.442 165.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.89 132.3 65.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.456 HD12 HD11 ' A' ' 27' ' ' ILE . 55.9 mt -127.84 119.54 51.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 168.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.32 157.96 35.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.533 1.06 . . . . 0.0 110.722 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -84.11 65.21 8.63 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.884 -1.135 . . . . 0.0 108.578 174.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -130.55 28.42 4.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.236 1.017 . . . . 0.0 113.717 -168.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 70.9 -54.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 128.759 2.824 . . . . 0.0 111.231 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.8 t -53.68 -36.27 61.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.085 1.354 . . . . 0.0 110.583 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.59 8.53 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 125.243 1.402 . . . . 0.0 111.891 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.83 -34.7 69.98 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.97 -0.724 . . . . 0.0 110.959 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -49.74 -44.03 48.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.018 0.927 . . . . 0.0 111.438 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -43.7 85.51 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.345 0.658 . . . . 0.0 111.315 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.6 -37.85 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 110.258 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -54.61 -45.43 71.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.138 0.427 . . . . 0.0 110.626 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -34.84 66.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.12 -14.75 62.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.859 -159.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.96 63.63 1.66 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.556 1.542 . . . . 0.0 109.355 -172.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.21 140.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.223 157.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -73.61 -47.82 37.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.1 40.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.22 108.0 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.23 125.37 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -142.51 177.02 8.57 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.573 1.149 . . . . 0.0 108.925 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 81' ' ' ALA . 59.4 mttm -88.2 -38.45 15.29 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.273 -0.892 . . . . 0.0 110.972 166.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -143.65 162.79 35.04 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.495 1.043 . . . . 0.0 109.189 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 tt -165.56 132.72 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.257 1.423 . . . . 0.0 108.53 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.1 p -65.02 157.91 27.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.157 0.983 . . . . 0.0 112.162 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -50.8 -53.64 30.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.502 1.521 . . . . 0.0 110.635 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -38.5 79.31 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.42 0.628 . . . . 0.0 111.294 -166.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.96 -37.78 72.78 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.967 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -55.69 -57.01 13.78 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 120.045 1.293 . . . . 0.0 111.154 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -57.19 -43.51 82.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.774 0.716 . . . . 0.0 110.533 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -53.43 -69.36 0.12 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.648 1.579 . . . . 0.0 110.129 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -68.37 -36.69 79.57 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.346 0.521 . . . . 0.0 110.854 -169.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.2 t -54.14 -24.37 17.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.516 1.526 . . . . 0.0 112.908 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -65.2 -10.52 32.23 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.697 -1.252 . . . . 0.0 113.72 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -156.16 3.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.932 1.696 . . . . 0.0 112.942 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -141.21 125.04 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.87 133.34 35.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.87 138.03 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 120.644 -1.285 . . . . 0.0 108.845 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -129.81 156.3 44.56 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.537 1.935 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -98.15 137.65 36.61 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.043 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 62' ' ' LYS . . . -88.49 122.92 32.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.274 2.23 . . . . 0.0 112.498 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.09 108.93 20.51 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.716 2.006 . . . . 0.0 109.939 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.48 -176.7 53.6 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -163.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -118.14 -2.21 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.918 0.887 . . . . 0.0 110.211 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.67 103.48 7.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.21 1.004 . . . . 0.0 108.475 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.45 -38.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.144 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.29 -40.97 86.15 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.878 0.763 . . . . 0.0 109.697 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -64.29 -43.04 96.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.875 -0.516 . . . . 0.0 110.727 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.18 -33.23 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.459 -1.401 . . . . 0.0 110.483 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.79 -51.68 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.548 1.539 . . . . 0.0 108.088 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 p -75.01 -18.75 60.31 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HB3' HD11 ' A' ' 98' ' ' LEU . 90.7 mt -74.83 -37.74 62.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 169.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 6' ' ' VAL . 80.2 t80 -67.79 -42.58 81.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.776 -0.577 . . . . 0.0 111.963 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.5 mt -51.86 -50.99 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.72 1.608 . . . . 0.0 108.377 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.8 -18.39 62.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.529 1.132 . . . . 0.0 113.978 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.65 23.11 54.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 118.85 0.75 . . . . 0.0 111.919 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -28.6 66.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.118 1.459 . . . . 0.0 109.32 -170.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 93' ' ' PHE . 1.2 mm? -82.11 135.73 35.27 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.78 1.232 . . . . 0.0 108.899 -163.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.5 p -71.06 157.45 38.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.469 1.107 . . . . 0.0 108.842 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -87.87 132.86 34.04 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.72 120.48 17.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -138.84 -4.86 1.54 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.781 1.632 . . . . 0.0 111.09 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -153.98 68.54 6.11 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.283 1.833 . . . . 0.0 108.897 -173.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.246 0.915 0 C-N-CA 124.421 3.414 . . . . 0.0 109.715 169.726 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.433 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 39.1 m170 59.27 178.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.703 1.201 . . . . 0.0 110.929 -167.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.07 127.39 32.09 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 111.029 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.62 146.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.547 1.539 . . . . 0.0 108.601 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' A' ' 31' ' ' ASP . 1.8 m-80 47.51 32.92 2.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.423 1.889 . . . . 0.0 115.061 172.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.9 151.06 31.17 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.663 -1.273 . . . . 0.0 107.625 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 155.04 50.29 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 156.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 28' ' ' VAL . 7.3 p -146.68 165.74 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 128.097 2.559 . . . . 0.0 104.903 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 25' ' ' PHE . . . -114.45 133.6 55.63 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 120.178 1.353 . . . . 0.0 111.646 153.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mt -105.43 119.29 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -62.45 114.32 3.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.864 1.211 . . . . 0.0 108.715 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.7 mtp -117.98 156.31 28.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 110.906 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.31 -69.63 0.76 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 127.752 2.421 . . . . 0.0 108.27 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 t -137.71 -67.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 168.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.3 -7.24 11.78 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.4 171.48 13.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.505 1.522 . . . . 0.0 110.058 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.3 mt -59.54 139.32 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 p -84.04 166.42 17.74 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.528 0.731 . . . . 0.0 111.076 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -50.47 -43.99 55.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.833 1.653 . . . . 0.0 113.934 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.08 168.36 19.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.409 0.549 . . . . 0.0 110.133 -166.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -67.72 -23.45 65.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.01 1.724 . . . . 0.0 112.499 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.79 -30.19 13.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.791 1.178 . . . . 0.0 111.54 171.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.74 10.12 8.27 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.221 1.408 . . . . 0.0 111.809 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.5 p -80.1 167.62 20.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 122.174 0.988 . . . . 0.0 110.631 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -108.12 -28.71 9.35 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.516 1.526 . . . . 0.0 109.217 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -159.36 178.35 10.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.603 0.638 . . . . 0.0 111.451 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.463 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 78.8 m-85 -125.49 105.64 9.2 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 129.24 3.016 . . . . 0.0 106.612 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.83 111.99 11.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 27.1 mm -81.24 98.32 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 6' ' ' VAL . 2.9 t -63.96 132.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -120.08 98.51 6.11 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 163.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.37 152.75 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HA ' ' H ' ' A' ' 3' ' ' ASN . 2.8 m-20 -138.41 -20.35 1.06 Allowed 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -161.31 68.59 0.31 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 169.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.6 m120 54.9 10.62 0.4 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.301 2.241 . . . . 0.0 115.269 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -129.23 158.54 38.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.379 1.072 . . . . 0.0 112.503 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.49 96.13 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.709 1.604 . . . . 0.0 107.753 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -100.48 -20.21 15.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.202 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -156.78 148.89 23.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.248 1.385 . . . . 0.0 111.167 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 p -126.18 156.94 39.39 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.534 1.934 . . . . 0.0 109.427 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 162.26 37.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.729 1.211 . . . . 0.0 108.881 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.82 112.11 23.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.26 115.57 34.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 161.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -66.77 158.09 31.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.081 1.31 . . . . 0.0 110.524 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.22 81.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -130.3 -170.97 2.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.685 1.231 . . . . 0.0 108.739 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.51 -49.92 75.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.33 1.852 . . . . 0.0 111.061 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.3 m -65.46 -37.68 87.59 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.894 0.316 . . . . 0.0 110.776 175.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.48 -62.98 5.73 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 123.552 0.596 . . . . 0.0 112.795 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -59.67 -28.93 67.69 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.589 0.756 . . . . 0.0 111.219 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -71.35 -32.51 68.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 117.644 -1.17 . . . . 0.0 111.943 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -65.22 -38.22 89.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 119.257 0.935 . . . . 0.0 110.357 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -62.49 -17.31 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 118.753 0.706 . . . . 0.0 111.715 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.7 t -82.2 -30.18 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 119.51 -1.994 . . . . 0.0 112.205 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.83 54.84 1.13 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.544 1.138 . . . . 0.0 109.08 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 -165.14 1.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.854 1.662 . . . . 0.0 111.017 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.46 19.33 7.44 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.199 2.2 . . . . 0.0 108.94 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 58' ' ' ALA . 44.7 t -67.4 166.06 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.95 1.25 . . . . 0.0 109.944 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.72 -33.34 6.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 109.522 171.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.662 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -144.6 163.11 34.91 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -161.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.4 mt -134.14 118.34 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 163.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mt -81.08 133.35 29.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 120.488 1.494 . . . . 0.0 107.171 166.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 p -144.51 168.13 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.86 1.209 . . . . 0.0 112.251 168.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -93.4 -27.2 16.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 117.455 -1.259 . . . . 0.0 112.727 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -161.26 161.37 30.7 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.005 1.722 . . . . 0.0 107.061 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.6 tt -151.46 127.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 126.403 1.881 . . . . 0.0 108.515 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -54.8 148.35 13.2 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.125 0.97 . . . . 0.0 110.442 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -61.6 -38.8 88.9 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.416 1.007 . . . . 0.0 111.524 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.21 -51.65 62.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -57.81 -43.13 85.47 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -56.41 -58.57 7.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.128 0.422 . . . . 0.0 110.145 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.46 -20.67 66.45 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 122.374 -0.204 . . . . 0.0 111.275 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -75.44 -35.74 60.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.18 -0.95 . . . . 0.0 111.941 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.09 -16.67 18.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.698 0.799 . . . . 0.0 111.812 -172.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.82 -17.45 56.29 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -71.99 106.99 4.48 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 120.566 -1.334 . . . . 0.0 109.611 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 tttm 73.95 21.28 2.66 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.143 1.777 . . . . 0.0 111.954 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.64 144.11 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.597 1.559 . . . . 0.0 107.742 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -102.59 108.8 20.21 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.42 114.83 30.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -105.92 149.15 26.85 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.685 1.194 . . . . 0.0 110.117 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -83.13 147.17 28.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.78 168.05 20.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.496 0.665 . . . . 0.0 109.924 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.6 5.9 14.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.419 2.287 . . . . 0.0 112.366 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.96 -169.37 41.8 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.15 -14.17 34.14 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.539 1.135 . . . . 0.0 110.0 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.66 99.35 2.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.744 1.218 . . . . 0.0 109.659 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -52.97 -42.05 42.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.37 -38.49 71.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.116 0.871 . . . . 0.0 110.305 -171.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -57.14 -50.35 73.09 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 169.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.61 -31.74 65.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.1 -54.69 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.895 1.278 . . . . 0.0 108.053 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.579 ' HA ' HD12 ' A' ' 94' ' ' ILE . 35.6 p -66.82 -36.57 82.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.357 0.526 . . . . 0.0 111.184 -172.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.3 mt -63.93 -40.46 96.5 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.243 0.617 . . . . 0.0 111.171 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -63.85 -34.42 77.88 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.478 0.711 . . . . 0.0 112.223 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 91' ' ' SER . 58.4 mt -59.21 -45.7 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 -18.55 60.7 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.214 1.006 . . . . 0.0 112.135 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.73 14.17 81.4 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.468 -0.77 . . . . 0.0 112.217 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -19.9 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.631 1.973 . . . . 0.0 112.592 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.7 mt -67.13 140.81 57.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.016 -1.052 . . . . 0.0 109.492 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.0 m -64.6 125.51 24.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.452 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -81.04 126.88 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.4 mt -74.17 143.07 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -168.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 -52.95 2.81 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.27 1.028 . . . . 0.0 112.403 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.25 149.83 62.02 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.211 3.274 . . . . 0.0 110.989 176.912 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.23 168.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.382 1.873 . . . . 0.0 113.374 -172.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt -120.51 127.3 52.06 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.8 mt -122.06 148.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 58.47 23.21 10.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.998 1.719 . . . . 0.0 113.42 171.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpp -68.57 147.06 52.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -134.34 141.09 46.78 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 166.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 93' ' ' PHE . 44.9 t -140.24 140.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 110.02 21.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.493 0.717 . . . . 0.0 109.436 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.7 mt -95.07 123.96 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 p -80.91 112.19 18.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtp -108.87 158.12 17.97 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.156 0.982 . . . . 0.0 111.39 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -108.08 -53.13 2.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 127.738 2.415 . . . . 0.0 109.143 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.26 -79.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.41 -3.37 16.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.134 0.974 . . . . 0.0 112.003 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 171.23 16.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.304 1.842 . . . . 0.0 110.955 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.5 mt -64.98 124.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.738 1.615 . . . . 0.0 107.3 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 t -66.55 173.1 3.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.155 0.889 . . . . 0.0 111.229 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.67 -27.75 67.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.53 0.732 . . . . 0.0 111.749 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 p -147.69 177.2 9.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.69 -0.631 . . . . 0.0 110.373 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -69.26 -37.28 77.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.511 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -88.48 -39.24 14.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.481 0.713 . . . . 0.0 109.629 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.27 31.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.648 2.379 . . . . 0.0 111.276 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 p -99.28 172.53 7.29 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 119.968 -1.707 . . . . 0.0 111.096 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -103.59 -30.05 10.73 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.592 1.557 . . . . 0.0 110.065 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.427 ' HE2' HD23 ' A' ' 26' ' ' LEU . 41.2 p90 -166.82 176.94 6.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CG ' HD11 ' A' ' 51' ' ' ILE . 41.9 m-85 -123.7 102.55 7.89 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 126.409 1.884 . . . . 0.0 107.29 -169.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.427 HD23 ' HE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -81.84 103.32 11.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mm -77.87 95.42 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.349 1.86 . . . . 0.0 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 t -76.2 92.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.83 115.99 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 156.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.59 131.89 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -133.06 3.03 3.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -156.55 44.33 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 111.545 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.55 8.16 2.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.007 0.923 . . . . 0.0 112.577 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -134.18 165.41 25.15 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 126.967 2.107 . . . . 0.0 111.212 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -61.82 128.73 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 127.068 2.147 . . . . 0.0 109.614 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.15 -85.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.757 -0.639 . . . . 0.0 109.7 167.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -15.19 14.45 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 44.84 -168.34 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.373 1.069 . . . . 0.0 112.11 -163.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 163.43 8.57 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 125.164 1.385 . . . . 0.0 109.784 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.669 0.7 OUTLIER -118.91 140.16 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 119.456 3.132 . . . . 0.0 119.456 159.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.7 mt -124.56 122.93 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 129.261 3.024 . . . . 0.0 105.175 164.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -68.01 155.57 39.2 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.365 1.893 . . . . 0.0 111.057 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 45.0 t30 -77.31 61.79 2.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.52 1.528 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -97.38 161.92 13.57 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 165.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -44.04 93.35 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.113 -0.992 . . . . 0.0 108.324 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -70.4 -16.23 62.93 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.962 -1.086 . . . . 0.0 111.293 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -64.03 2.89 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 166.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 25' ' ' PHE 0.253 43.3 pttt -65.87 -23.37 66.64 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.76 -0.847 . . . . 0.0 111.977 -172.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -38.57 83.92 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 171.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -72.86 -32.08 65.17 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.925 1.29 . . . . 0.0 110.172 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.434 HD11 ' CG ' ' A' ' 25' ' ' PHE . 58.8 mt -55.07 -42.97 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.78 1.232 . . . . 0.0 109.761 176.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.12 -26.36 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.406 -0.809 . . . . 0.0 111.667 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -97.7 -28.22 14.0 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.865 0.866 . . . . 0.0 110.97 -172.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -25.52 63.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.695 1.198 . . . . 0.0 111.884 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.2 t30 74.2 51.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.406 2.282 . . . . 0.0 109.958 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -50.82 152.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.868 1.667 . . . . 0.0 109.324 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -42.97 10.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.091 1.357 . . . . 0.0 109.175 171.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.24 160.12 42.72 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.3 mt -116.42 144.0 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.685 1.194 . . . . 0.0 107.962 171.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.8 mt -123.04 121.28 62.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.0 p -149.3 170.81 17.64 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.773 1.229 . . . . 0.0 109.345 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -82.66 -40.04 21.25 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.104 167.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -147.64 164.42 33.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.502 1.501 . . . . 0.0 109.61 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.5 tt -144.77 145.38 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.406 1.482 . . . . 0.0 109.095 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -62.49 155.47 25.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.197 0.908 . . . . 0.0 109.562 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.04 -43.37 87.75 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 118.824 0.738 . . . . 0.0 109.04 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.39 -45.24 94.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 110.666 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -61.79 -47.94 82.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.783 1.233 . . . . 0.0 109.263 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.56 -58.94 5.37 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.724 1.147 . . . . 0.0 110.541 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.51 -22.39 66.86 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.581 0.628 . . . . 0.0 111.892 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -76.66 -44.04 35.51 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 120.829 -1.169 . . . . 0.0 110.885 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -88.04 -8.28 55.8 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.148 0.979 . . . . 0.0 112.753 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 p -73.26 43.14 0.13 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.835 1.652 . . . . 0.0 112.551 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -139.91 111.84 7.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 126.412 1.885 . . . . 0.0 106.662 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? 60.81 -1.22 0.25 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 113.948 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.5 mt -131.27 134.25 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -169.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.56 130.49 43.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.499 1.52 . . . . 0.0 107.034 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.5 mt -104.17 118.5 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -110.29 155.38 22.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.237 1.815 . . . . 0.0 110.821 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -99.06 118.1 35.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.798 1.239 . . . . 0.0 110.348 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.95 135.15 57.7 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 168.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -16.24 55.98 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.291 1.036 . . . . 0.0 112.722 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -176.89 -178.73 46.87 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 126.11 1.814 . . . . 0.0 109.078 -149.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -96.48 -15.35 21.75 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.097 0.959 . . . . 0.0 110.042 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.41 99.81 2.54 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.45 1.5 . . . . 0.0 110.014 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.57 -41.79 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.27 -39.28 89.31 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.8 0.727 . . . . 0.0 110.997 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -46.23 90.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.519 0.676 . . . . 0.0 109.517 173.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -74.17 -26.22 60.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.0 mt -67.19 -51.26 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 119.006 0.821 . . . . 0.0 108.797 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.8 p -71.38 -33.05 69.17 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.429 0.558 . . . . 0.0 111.503 -173.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -42.68 95.88 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.69 -0.631 . . . . 0.0 110.268 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 6' ' ' VAL . 31.7 t80 -57.89 -47.56 82.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.781 0.433 . . . . 0.0 111.872 -177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 mt -51.03 -56.49 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.168 1.387 . . . . 0.0 111.119 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -73.43 -1.93 20.32 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.055 1.298 . . . . 0.0 113.573 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.61 86.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.263 0.935 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -27.56 67.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.077 1.751 . . . . 0.0 112.146 -173.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.4 mt -64.22 144.42 57.15 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.46 139.39 49.61 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.33 -0.857 . . . . 0.0 110.188 172.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -85.92 123.0 30.76 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 61.8 mt -71.82 140.56 17.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.475 1.11 . . . . 0.0 109.752 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.48 120.81 27.53 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.606 1.162 . . . . 0.0 108.074 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 76.08 0.55 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.661 1.584 . . . . 0.0 112.205 166.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 123.579 2.853 . . . . 0.0 111.364 170.055 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.567 0 CA-C-O 118.762 -1.021 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 60.72 152.82 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 110.394 -146.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt -160.76 137.08 8.53 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.364 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 31' ' ' ASP . 13.2 mt -146.8 46.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.352 0.596 . . . . 0.0 112.097 -173.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 t30 173.54 42.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.846 2.059 . . . . 0.0 107.509 163.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 146.79 32.94 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 120.598 -1.314 . . . . 0.0 108.127 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -145.85 120.41 9.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.892 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.9 152.98 25.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.534 1.534 . . . . 0.0 109.613 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.75 120.62 40.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.653 1.181 . . . . 0.0 108.359 162.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.15 118.9 54.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -63.2 105.41 0.71 Allowed 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.757 0.823 . . . . 0.0 109.636 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.5 mmm -111.15 155.85 22.26 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.77 0.828 . . . . 0.0 109.964 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -93.71 -76.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.603 1.961 . . . . 0.0 107.393 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -139.61 -56.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 1.26 3.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -160.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -156.6 173.79 16.41 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.252 2.221 . . . . 0.0 108.519 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.31 139.31 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.788 0.68 . . . . 0.0 111.147 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.41 163.48 21.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 111.308 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -75.83 -16.82 60.02 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -166.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.46 172.63 17.92 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.672 1.989 . . . . 0.0 107.335 170.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.18 -50.54 73.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.34 1.056 . . . . 0.0 108.768 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -74.5 -44.49 51.13 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -165.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.9 4.15 0.91 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 128.55 2.74 . . . . 0.0 113.641 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 p -67.57 165.92 15.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 123.057 1.408 . . . . 0.0 110.742 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -106.58 -30.75 8.84 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.919 1.687 . . . . 0.0 108.688 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 28.2 p90 -155.35 164.94 38.07 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.158 0.98 . . . . 0.0 109.834 172.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.55 112.48 25.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.04 114.01 14.2 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HB ' ' CB ' ' A' ' 39' ' ' LYS . 5.0 mm -84.04 93.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.08 101.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -91.72 121.6 33.51 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -125.75 115.69 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 2' ' ' ILE . 5.1 m-20 -126.63 -0.64 6.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.387 -169.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -157.09 61.24 0.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.135 0.969 . . . . 0.0 110.433 156.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.63 6.89 0.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.238 1.815 . . . . 0.0 114.679 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.18 163.29 23.48 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.1 2.56 . . . . 0.0 109.378 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.91 74.96 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 122.408 1.099 . . . . 0.0 108.101 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -57.37 -29.58 64.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.909 1.684 . . . . 0.0 112.118 -170.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 m -154.82 115.26 3.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.401 1.0 . . . . 0.0 108.845 164.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -64.02 141.62 58.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 161.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -143.09 161.2 38.8 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 124.53 1.132 . . . . 0.0 109.274 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 24' ' ' TYR 0.474 0.6 OUTLIER -142.53 132.44 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 178.602 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.488 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 66.0 mt -119.59 113.13 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -65.46 152.07 44.84 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.773 0.715 . . . . 0.0 109.439 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -75.57 87.38 2.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.57 174.99 10.0 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.57 2.748 . . . . 0.0 105.038 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -62.13 -38.64 89.71 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.487 -1.383 . . . . 0.0 111.567 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 t -61.43 -18.56 59.43 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.697 -0.627 . . . . 0.0 111.316 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.488 ' HA2' ' CG2' ' A' ' 41' ' ' ILE . . . -75.23 -61.09 3.1 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -66.91 -15.4 63.64 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.368 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -60.98 -64.57 0.91 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.837 1.199 . . . . 0.0 109.639 161.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.3 m -54.13 -37.73 64.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.991 0.916 . . . . 0.0 113.344 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.4 mt -50.74 -40.4 19.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.075 1.35 . . . . 0.0 111.608 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.48 -46.88 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.082 -1.012 . . . . 0.0 109.063 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -73.66 -21.77 60.17 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 123.833 0.853 . . . . 0.0 112.978 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.81 -26.65 63.41 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.346 -0.847 . . . . 0.0 111.094 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 74.25 38.33 0.54 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.849 1.66 . . . . 0.0 112.536 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.44 138.13 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.558 1.143 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -66.48 -56.68 9.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.019 1.728 . . . . 0.0 108.74 168.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.82 29.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -169.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.56 148.44 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.5 mt -119.41 123.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 127.35 2.26 . . . . 0.0 104.978 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.76 154.33 31.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.803 1.638 . . . . 0.0 111.141 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -71.94 -25.9 62.07 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.34 -0.85 . . . . 0.0 111.124 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -172.23 166.15 5.96 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.84 132.84 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.017 0.436 . . . . 0.0 110.285 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.42 147.25 32.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.528 0.731 . . . . 0.0 109.622 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -48.71 79.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.343 1.057 . . . . 0.0 110.506 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -56.67 -47.97 78.64 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -64.51 -44.94 89.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.724 1.21 . . . . 0.0 110.424 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -54.9 -64.88 0.7 Allowed 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 118.682 0.674 . . . . 0.0 109.552 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -57.02 -33.15 66.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.771 0.828 . . . . 0.0 111.518 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -71.33 -34.34 70.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.56 1.944 . . . . 0.0 113.457 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -99.26 -23.39 15.21 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.706 0.685 . . . . 0.0 112.541 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 p -68.68 15.24 0.06 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -166.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.96 -19.04 13.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.754 1.161 . . . . 0.0 113.151 -174.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -34.78 0.48 Allowed 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 121.188 -0.945 . . . . 0.0 113.188 175.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.6 mt -89.53 127.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.95 145.44 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.132 0.973 . . . . 0.0 108.66 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -113.67 122.67 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 O-C-N 120.377 -1.452 . . . . 0.0 107.748 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -105.81 156.07 18.68 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.43 1.892 . . . . 0.0 108.257 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -68.06 177.19 2.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.283 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.75 149.54 48.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.959 1.303 . . . . 0.0 110.45 165.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.421 ' OE1' HD22 ' A' ' 98' ' ' LEU 0.254 19.6 mp0 -106.22 -162.35 0.85 Allowed 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 129.09 2.956 . . . . 0.0 106.097 -165.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.3 166.88 0.04 OUTLIER Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.043 -1.035 . . . . 0.0 114.272 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -23.3 19.53 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.185 1.794 . . . . 0.0 113.555 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . 2.4 t0 -72.13 101.83 2.87 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 125.083 1.489 . . . . 0.0 107.645 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -53.55 -39.89 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -39.7 82.38 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 -174.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 1.4 tppp? -59.3 -45.58 90.9 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.24 -0.912 . . . . 0.0 109.339 170.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.93 -38.8 89.6 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.453 1.024 . . . . 0.0 111.046 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.07 -49.45 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 108.522 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 p -65.98 -36.89 84.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.813 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.4 mt -61.67 -44.44 96.96 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.709 0.686 . . . . 0.0 109.22 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -57.78 -57.25 13.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.288 0.635 . . . . 0.0 110.91 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.6 mt -51.82 -34.42 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.496 1.919 . . . . 0.0 111.183 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -84.96 -14.86 46.22 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.21 24.61 54.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 119.509 1.05 . . . . 0.0 112.395 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -24.54 36.19 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.793 1.237 . . . . 0.0 112.54 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD22 ' OE1' ' A' ' 82' ' ' GLU . 29.3 mt -73.18 142.92 47.39 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.274 1.035 . . . . 0.0 110.402 -171.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 133.27 34.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 110.819 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -72.07 142.76 49.24 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.48 107.94 6.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.9 p -79.66 90.66 5.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.173 0.989 . . . . 0.0 108.913 166.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.39 162.06 0.12 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 127.984 2.514 . . . . 0.0 112.778 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.604 -1.344 . . . . 0.0 108.604 156.024 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.525 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 56.01 10.9 0.64 Allowed 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 126.061 1.744 . . . . 0.0 115.255 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 4' ' ' MET . 0.5 OUTLIER 45.0 128.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -171.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.01 147.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.793 172.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.58 56.89 1.93 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.341 2.656 . . . . 0.0 112.162 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.426 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 25.1 tpp -83.78 149.33 26.5 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.907 0.776 . . . . 0.0 109.928 170.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -142.56 132.95 24.93 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.232 0.958 . . . . 0.0 108.491 153.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 28' ' ' VAL . 4.9 p -128.93 166.14 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 128.523 2.729 . . . . 0.0 107.439 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.64 110.47 13.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.37 1.468 . . . . 0.0 109.74 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -94.72 122.65 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.242 0.928 . . . . 0.0 108.932 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 p -72.11 97.45 1.93 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.128 1.371 . . . . 0.0 109.95 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.0 mtp -102.98 154.73 18.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.27 1.028 . . . . 0.0 110.6 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.79 -61.08 1.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.2 t -141.7 -71.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.77 10.72 7.75 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.8 1.286 . . . . 0.0 112.944 -167.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 175.54 12.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 127.811 2.444 . . . . 0.0 108.948 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.42 140.72 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.763 1.225 . . . . 0.0 108.456 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 t -73.61 -87.03 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -178.48 -36.45 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.795 1.638 . . . . 0.0 110.138 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.27 154.32 36.56 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.336 0.588 . . . . 0.0 110.332 -177.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.48 -48.32 82.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.766 0.826 . . . . 0.0 110.047 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -78.17 -6.41 54.72 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.395 0.678 . . . . 0.0 112.804 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.16 -16.71 14.03 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.08 0.854 . . . . 0.0 111.063 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.0 p -72.62 170.65 14.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 122.154 0.978 . . . . 0.0 111.755 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -106.09 -26.32 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.881 1.272 . . . . 0.0 110.331 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -161.22 166.49 27.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.518 0.675 . . . . 0.0 110.364 170.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CD2' HD11 ' A' ' 51' ' ' ILE . 91.1 m-85 -105.36 116.41 31.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.423 1.489 . . . . 0.0 108.044 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.61 118.44 20.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 170.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -92.0 95.11 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 125.14 1.376 . . . . 0.0 107.394 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.562 ' HB ' HG12 ' A' ' 6' ' ' VAL . 1.9 t -78.33 104.09 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.82 140.8 36.69 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 156.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 145.19 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 164.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.19 18.64 0.36 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.98 52.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 128.506 2.722 . . . . 0.0 107.263 169.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.75 2.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 129.288 3.035 . . . . 0.0 113.694 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.16 150.84 40.67 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 128.203 2.601 . . . . 0.0 107.876 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.3 91.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.042 2.137 . . . . 0.0 109.884 172.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -53.55 -70.16 0.1 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 110.979 174.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -151.79 112.71 4.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 p -69.26 164.17 23.37 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.23 1.412 . . . . 0.0 110.452 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 164.79 30.18 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 125.944 1.698 . . . . 0.0 108.534 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.54 148.23 26.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mt -134.33 105.79 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 166.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -57.34 145.46 32.26 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.61 97.95 0.34 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.406 1.882 . . . . 0.0 106.096 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -51.26 67.07 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.068 0.947 . . . . 0.0 109.339 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 t -68.45 -26.54 65.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.968 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -63.58 4.97 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -65.39 -22.61 66.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.461 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -68.96 -47.42 65.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.222 1.374 . . . . 0.0 109.039 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -44.6 73.16 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 110.102 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 25' ' ' PHE . 58.1 mt -52.59 -35.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.648 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.21 -40.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 120.586 -1.321 . . . . 0.0 110.649 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.2 -8.75 44.57 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.346 0.658 . . . . 0.0 111.854 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.3 -16.37 33.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.538 1.535 . . . . 0.0 111.226 166.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 53.29 36.47 22.83 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.985 1.714 . . . . 0.0 111.031 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.13 134.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -73.05 -39.63 65.75 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.422 1.889 . . . . 0.0 110.519 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.58 165.47 26.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mt -131.45 132.5 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.068 1.347 . . . . 0.0 107.5 164.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -104.12 130.97 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 166.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -146.46 175.83 10.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.649 0.659 . . . . 0.0 111.32 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -96.9 -24.27 15.93 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.099 1.36 . . . . 0.0 111.47 164.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -155.74 161.33 40.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.075 1.75 . . . . 0.0 108.311 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.82 130.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.833 1.653 . . . . 0.0 108.643 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -63.41 147.1 52.14 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.417 1.087 . . . . 0.0 110.489 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -55.29 -45.17 76.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.247 2.219 . . . . 0.0 111.998 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -65.37 -50.95 63.62 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.721 -0.612 . . . . 0.0 109.743 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -62.51 -39.13 92.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.75 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -51.53 -56.61 12.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.396 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -61.6 -43.26 99.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.198 0.599 . . . . 0.0 110.45 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -59.35 -40.91 87.9 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.19 1.396 . . . . 0.0 112.783 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -92.39 -34.66 14.07 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.259 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 t -70.56 16.33 0.08 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.144 1.778 . . . . 0.0 114.185 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -100.64 -17.26 17.11 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.977 1.711 . . . . 0.0 113.031 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -145.22 -6.57 0.64 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.838 0.855 . . . . 0.0 112.776 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.7 mt -136.19 133.5 50.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -165.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.72 113.34 22.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.586 1.554 . . . . 0.0 108.307 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.05 130.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 100' ' ' LYS . 88.1 m-85 -126.45 146.62 50.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.759 1.224 . . . . 0.0 109.799 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -95.62 119.53 34.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.539 1.135 . . . . 0.0 109.332 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.43 119.72 10.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.946 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.69 -12.6 61.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.66 172.34 44.14 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -166.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.2 -5.14 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.883 0.873 . . . . 0.0 109.812 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.51 102.71 8.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.493 1.917 . . . . 0.0 107.386 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -52.44 -40.31 32.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.23 -45.7 72.55 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 118.36 0.527 . . . . 0.0 110.393 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -57.7 -37.18 73.04 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.943 0.497 . . . . 0.0 110.764 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -77.46 -22.6 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.232 -0.918 . . . . 0.0 112.191 -176.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.2 mt -70.87 -50.78 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 p -61.65 -48.21 81.89 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.685 0.675 . . . . 0.0 111.035 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.2 mt -56.51 -47.02 80.23 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.116 0.566 . . . . 0.0 110.24 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.1 -44.9 87.89 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.759 0.823 . . . . 0.0 112.426 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.96 -41.09 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.55 -13.22 59.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.055 0.843 . . . . 0.0 112.638 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.51 -1.29 61.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.535 1.064 . . . . 0.0 113.758 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -12.48 61.64 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.386 2.274 . . . . 0.0 115.461 -171.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.77 143.15 57.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 120.823 1.647 . . . . 0.0 108.25 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -72.34 142.14 48.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 7.3 mtpt -80.17 150.98 29.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -83.76 133.89 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.2 m -138.05 -42.48 0.52 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.927 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -131.06 80.15 69.69 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.412 1.485 . . . . 0.0 109.717 173.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 C--O 1.247 0.961 1 C-N-CA 125.496 4.131 . . . . 0.0 111.972 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -64.23 178.52 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.161 0.981 . . . . 0.0 109.911 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt -132.95 124.58 28.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.123 -0.986 . . . . 0.0 108.427 -169.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 mm -116.63 138.52 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.7 t30 45.42 63.99 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.302 1.041 . . . . 0.0 112.01 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpp -94.47 151.97 18.94 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -141.53 138.55 32.82 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 167.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG21 ' CE2' ' A' ' 93' ' ' PHE . 36.1 t -133.47 148.33 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB3' HG12 ' A' ' 59' ' ' ILE . . . -105.87 105.1 14.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.662 0.785 . . . . 0.0 108.981 168.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.73 117.73 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.2 p -73.55 111.16 8.42 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.5 mmm -113.86 161.28 17.79 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 110.094 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.23 -73.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.951 1.3 . . . . 0.0 108.06 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.26 -45.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -135.58 -13.7 1.97 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.2 174.39 12.03 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.31 1.444 . . . . 0.0 107.901 -171.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mt -54.48 139.46 13.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.162 0.982 . . . . 0.0 108.524 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 p -68.33 163.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.485 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -71.58 -31.15 66.65 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.83 -0.544 . . . . 0.0 111.586 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.88 158.67 33.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.383 0.992 . . . . 0.0 109.859 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 59' ' ' ILE . 65.1 t80 -66.05 -39.72 90.36 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' HG2' HD22 ' A' ' 68' ' ' ASN . 1.4 mm-40 -78.74 1.27 23.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 175.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.16 1.17 8.5 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.846 0.859 . . . . 0.0 111.394 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 p -67.79 169.7 9.23 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.928 -1.107 . . . . 0.0 111.201 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -110.75 -25.7 9.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.124 1.37 . . . . 0.0 109.078 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 40' ' ' VAL . 22.8 p90 -158.3 170.83 21.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.03 0.919 . . . . 0.0 111.488 174.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -114.44 102.42 10.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.073 2.549 . . . . 0.0 106.259 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -77.79 97.65 5.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.4 mm -68.91 124.98 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.929 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.05 126.96 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 126.395 1.878 . . . . 0.0 105.934 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.68 97.51 6.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 165.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.81 149.55 5.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 163.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.23 133.77 10.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.648 1.179 . . . . 0.0 109.03 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t0 46.44 44.93 13.47 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.892 1.805 . . . . 0.0 110.945 -167.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 70.17 -13.8 0.42 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.686 3.195 . . . . 0.0 114.825 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.94 165.88 11.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.473 1.909 . . . . 0.0 110.091 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.2 129.47 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.786 -1.197 . . . . 0.0 111.616 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -100.02 -44.66 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 t -165.33 166.46 18.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.8 161.96 26.19 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.931 1.693 . . . . 0.0 108.039 -172.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.76 141.12 31.66 Favored 'General case' 0 C--O 1.19 -2.033 0 O-C-N 120.139 -1.601 . . . . 0.0 109.65 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 24' ' ' TYR 0.462 1.4 p -107.98 124.95 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 160.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -108.09 112.84 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.635 2.774 . . . . 0.0 103.747 165.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -59.4 154.59 16.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.824 1.193 . . . . 0.0 110.156 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -81.3 85.93 6.33 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -152.81 175.55 12.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.286 1.035 . . . . 0.0 109.129 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -52.61 -52.17 56.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.059 1.344 . . . . 0.0 110.509 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -5.78 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.762 0.425 . . . . 0.0 110.914 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.6 -69.76 1.38 Allowed Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -55.74 -29.05 58.9 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.513 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -34.92 63.85 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 120.16 1.345 . . . . 0.0 111.072 176.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -87.58 -24.16 24.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 116.582 -1.675 . . . . 0.0 113.034 -175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 54' ' ' GLU . 62.2 mt -63.53 -30.52 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 121.357 1.89 . . . . 0.0 109.364 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.26 -3.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 O-C-N 119.82 -1.8 . . . . 0.0 111.314 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -110.53 21.99 15.97 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.114 -0.991 . . . . 0.0 109.517 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.55 ' CG ' ' HA ' ' A' ' 51' ' ' ILE . 8.1 pt-20 -138.63 144.67 39.83 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.969 -2.332 . . . . 0.0 111.215 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.85 62.51 7.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.075 0.95 . . . . 0.0 109.409 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.01 134.88 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.63 -48.5 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.02 156.7 43.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 7' ' ' ALA . 94.4 mt -110.57 136.99 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 166.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -109.35 124.37 65.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.88 167.62 23.47 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -80.02 -32.51 39.58 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.381 -0.824 . . . . 0.0 112.01 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -155.98 173.76 16.33 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.458 1.026 . . . . 0.0 109.611 -171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.3 tt -165.14 154.67 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.802 1.241 . . . . 0.0 108.418 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -81.22 153.12 27.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.871 0.869 . . . . 0.0 112.128 169.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.56 -51.51 65.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.613 1.965 . . . . 0.0 110.929 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.61 -39.89 88.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.46 HD22 ' HG2' ' A' ' 20' ' ' GLU . 1.3 t-20 -66.68 -41.61 87.83 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 118.871 -0.585 . . . . 0.0 109.739 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -51.76 -63.79 1.02 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -64.83 -24.43 67.54 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.96 -0.462 . . . . 0.0 111.705 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -76.83 -36.11 57.09 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -98.52 -24.04 15.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.078 1.308 . . . . 0.0 112.062 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -71.86 9.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.622 1.969 . . . . 0.0 113.028 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -80.72 -0.13 37.06 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.965 -1.084 . . . . 0.0 113.517 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -165.63 -64.15 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.779 0.832 . . . . 0.0 109.858 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.91 144.67 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.584 1.953 . . . . 0.0 107.82 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -113.17 126.33 55.32 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 125.101 1.361 . . . . 0.0 109.477 -169.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.63 131.48 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 120.105 -1.622 . . . . 0.0 109.483 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' LYS . 50.6 m-85 -116.04 150.63 36.96 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.76 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -80.14 135.82 36.39 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.99 128.1 34.35 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 162.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -24.82 43.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.725 0.774 . . . . 0.0 112.294 -174.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.52 161.53 28.9 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 127.308 2.385 . . . . 0.0 107.519 -159.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.54 -9.79 59.68 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.621 1.168 . . . . 0.0 110.343 -167.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.56 98.84 2.39 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.211 1.404 . . . . 0.0 108.686 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 t -51.36 -40.83 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 121.759 -0.588 . . . . 0.0 110.356 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -40.35 87.22 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.664 0.385 . . . . 0.0 110.4 -171.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -42.65 95.92 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.343 0.592 . . . . 0.0 110.783 171.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.809 -0.557 . . . . 0.0 110.661 -169.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.22 -50.25 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.302 1.041 . . . . 0.0 108.781 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 p -64.21 -35.27 80.27 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.756 0.707 . . . . 0.0 111.475 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -66.14 -37.34 85.44 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.263 -0.898 . . . . 0.0 111.091 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 6' ' ' VAL . 71.6 t80 -67.72 -44.04 78.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.183 0.593 . . . . 0.0 111.865 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.9 -41.26 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.266 1.027 . . . . 0.0 109.862 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -79.67 -30.83 41.31 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.48 4.38 52.79 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.021 -0.877 . . . . 0.0 113.985 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -39.22 81.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.228 1.411 . . . . 0.0 111.513 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.57 131.98 50.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.188 0.595 . . . . 0.0 110.722 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.32 156.97 30.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.57 1.176 . . . . 0.0 110.632 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 61.9 mtpt -82.58 156.32 24.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.651 171.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.26 155.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.99 -154.75 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.737 1.615 . . . . 0.0 111.846 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.27 86.11 0.28 Allowed Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 126.22 1.808 . . . . 0.0 109.488 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 N--CA 1.451 -1.019 0 CA-C-O 117.222 -1.241 . . . . 0.0 109.27 166.333 . . . . . . . . 0 0 . 1 stop_ save_